{
  "file_name": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
  "total_pages": 139,
  "pdf_type": "normal",
  "font_analysis": {
    "font_sizes_frequency": {
      "26.03999900817871": 3,
      "23.03999900817871": 1,
      "18.0": 1,
      "17.03999900817871": 2,
      "11.039999961853027": 494,
      "15.0": 1554,
      "14.039999961853027": 8,
      "12.0": 1372,
      "9.960000038146973": 370,
      "32.040000915527344": 2,
      "15.960000038146973": 36,
      "20.03999900817871": 9,
      "12.960000038146973": 168,
      "11.939848899841309": 2,
      "14.880475997924805": 2,
      "11.279999732971191": 1,
      "8.759956359863281": 3,
      "10.199999809265137": 6,
      "7.679999828338623": 3,
      "59.3115234375": 1,
      "58.88851547241211": 1,
      "7.079999923706055": 10,
      "18.959999084472656": 2,
      "21.0": 2,
      "9.0": 30
    },
    "heading_sizes": [
      32.040000915527344,
      26.03999900817871,
      21.0,
      20.03999900817871,
      18.959999084472656,
      17.03999900817871,
      15.960000038146973
    ]
  },
  "table_analysis": {
    "total_tables": 23,
    "tables_info": [
      {
        "bbox": [
          68.04000091552734,
          185.26429748535156,
          527.7637329101562,
          611.308349609375
        ],
        "num_rows": 8,
        "num_cols": 2
      },
      {
        "bbox": [
          62.63999938964844,
          140.51998901367188,
          530.592041015625,
          311.03997802734375
        ],
        "num_rows": 9,
        "num_cols": 3
      },
      {
        "bbox": [
          77.63999938964844,
          604.3200073242188,
          524.9520263671875,
          657.1199951171875
        ],
        "num_rows": 3,
        "num_cols": 2
      },
      {
        "bbox": [
          65.63999938964844,
          128.75999450683594,
          525.0,
          299.2799987792969
        ],
        "num_rows": 3,
        "num_cols": 2
      },
      {
        "bbox": [
          65.15999603271484,
          103.79999542236328,
          529.6799926757812,
          648.8400268554688
        ],
        "num_rows": 5,
        "num_cols": 2
      },
      {
        "bbox": [
          74.87999725341797,
          359.3999938964844,
          523.4400024414062,
          729.8400268554688
        ],
        "num_rows": 12,
        "num_cols": 4
      },
      {
        "bbox": [
          74.87999725341797,
          132.72000122070312,
          525.239990234375,
          729.9600219726562
        ],
        "num_rows": 10,
        "num_cols": 4
      },
      {
        "bbox": [
          73.19999694824219,
          136.9199981689453,
          525.239990234375,
          711.0
        ],
        "num_rows": 13,
        "num_cols": 3
      },
      {
        "bbox": [
          76.31999969482422,
          178.55999755859375,
          530.760009765625,
          635.0400390625
        ],
        "num_rows": 5,
        "num_cols": 2
      },
      {
        "bbox": [
          77.15999603271484,
          235.55999755859375,
          507.239990234375,
          750.0
        ],
        "num_rows": 3,
        "num_cols": 3
      },
      {
        "bbox": [
          76.79999542236328,
          299.03997802734375,
          521.760009765625,
          743.6400146484375
        ],
        "num_rows": 8,
        "num_cols": 3
      },
      {
        "bbox": [
          93.36000061035156,
          402.7200012207031,
          527.8800048828125,
          515.280029296875
        ],
        "num_rows": 4,
        "num_cols": 2
      },
      {
        "bbox": [
          61.79999923706055,
          278.7599792480469,
          530.2804565429688,
          699.5280151367188
        ],
        "num_rows": 10,
        "num_cols": 2
      },
      {
        "bbox": [
          61.79999923706055,
          118.31999206542969,
          530.2804565429688,
          725.5679931640625
        ],
        "num_rows": 8,
        "num_cols": 3
      },
      {
        "bbox": [
          61.79999923706055,
          119.6399917602539,
          530.2804565429688,
          667.6079711914062
        ],
        "num_rows": 7,
        "num_cols": 2
      },
      {
        "bbox": [
          316.32000732421875,
          111.23999786376953,
          530.2804565429688,
          476.447998046875
        ],
        "num_rows": 4,
        "num_cols": 2
      },
      {
        "bbox": [
          73.55999755859375,
          289.1999816894531,
          529.2000122070312,
          658.9199829101562
        ],
        "num_rows": 15,
        "num_cols": 3
      },
      {
        "bbox": [
          82.31999969482422,
          503.8800048828125,
          453.8399963378906,
          578.6400146484375
        ],
        "num_rows": 4,
        "num_cols": 3
      },
      {
        "bbox": [
          64.79999542236328,
          309.3599853515625,
          527.760009765625,
          754.6799926757812
        ],
        "num_rows": 5,
        "num_cols": 2
      },
      {
        "bbox": [
          64.79999542236328,
          125.87998962402344,
          527.8800048828125,
          636.8400268554688
        ],
        "num_rows": 5,
        "num_cols": 2
      },
      {
        "bbox": [
          97.43999481201172,
          391.0799865722656,
          530.7601928710938,
          499.8479919433594
        ],
        "num_rows": 4,
        "num_cols": 2
      },
      {
        "bbox": [
          97.43999481201172,
          180.9600067138672,
          530.7601928710938,
          318.0480041503906
        ],
        "num_rows": 4,
        "num_cols": 2
      },
      {
        "bbox": [
          64.55999755859375,
          218.75999450683594,
          528.0001831054688,
          427.24798583984375
        ],
        "num_rows": 13,
        "num_cols": 5
      }
    ]
  },
  "text_blocks": [
    {
      "text": "불면증 개선 디지털치료기기",
      "font_size": 26.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        128.63999938964844,
        236.6072998046875,
        466.680419921875,
        262.6473083496094
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성·성능 평가 및 임상시험계획서",
      "font_size": 26.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        70.08000183105469,
        278.1272888183594,
        525.1204223632812,
        304.16729736328125
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성 가이드라인(민원인 안내서)",
      "font_size": 26.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        108.0,
        319.7673034667969,
        487.218017578125,
        345.80731201171875
      ],
      "page_num": 1,
      "block_type": "heading",
      "level": 2,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2021. 12.",
      "font_size": 23.03999900817871,
      "font_name": "T2",
      "bbox": [
        259.32000732421875,
        503.0400085449219,
        350.8342590332031,
        530.6649780273438
      ],
      "page_num": 1,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 료 기 기 심 사 부",
      "font_size": 18.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        193.0800018310547,
        679.0491943359375,
        417.1199951171875,
        702.9906005859375
      ],
      "page_num": 1,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침서·안내서 제·개정 점검표",
      "font_size": 17.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        168.0,
        93.37289428710938,
        423.0,
        110.41288757324219
      ],
      "page_num": 3,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명칭",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        82.55999755859375,
        137.50430297851562,
        103.08004760742188,
        152.18836975097656
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        132.72000122070312,
        128.62429809570312,
        527.7599487304688,
        143.30836486816406
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "드라인(민원인 안내서)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        132.72000122070312,
        146.26429748535156,
        244.5513153076172,
        160.9483642578125
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아래에 해당하는 사항에 체크하여 주시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        165.0,
        165.7042999267578,
        426.3693542480469,
        180.38836669921875
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등록대상",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        70.79999542236328,
        321.58428955078125,
        114.83966064453125,
        336.26837158203125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여부",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        81.83999633789062,
        339.2242736816406,
        103.91999816894531,
        353.9083557128906
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        185.26429748535156,
        450.76171875,
        199.9483642578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서가 있습니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        151.67999267578125,
        200.62429809570312,
        294.8779602050781,
        215.30836486816406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        185.26429748535156,
        506.6396484375,
        215.30836486816406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        185.26429748535156,
        506.6396484375,
        215.30836486816406
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        220.06430053710938,
        527.760009765625,
        234.7483673095703
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.63999938964844,
        235.54429626464844,
        531.6412353515625,
        265.5883483886719
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.63999938964844,
        235.54429626464844,
        531.6412353515625,
        265.5883483886719
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(사유 :                                                                )",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        266.2642822265625,
        525.4837646484375,
        280.9483642578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        285.82427978515625,
        446.9993591308594,
        300.50836181640625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규)의 내용을 단순 편집 또는 나열한 것입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.75999450683594,
        301.18426513671875,
        389.0779724121094,
        315.86834716796875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        285.82427978515625,
        506.6396484375,
        315.86834716796875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        285.82427978515625,
        506.6396484375,
        315.86834716796875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        320.624267578125,
        506.6396484375,
        350.7883605957031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        320.624267578125,
        506.6396484375,
        350.7883605957031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        320.624267578125,
        506.6396484375,
        350.7883605957031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        355.5442810058594,
        446.9996643066406,
        370.2283630371094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.27999877929688,
        370.9042663574219,
        209.31796264648438,
        385.5883483886719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        355.5442810058594,
        506.6396484375,
        385.5883483886719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        355.5442810058594,
        506.6396484375,
        385.5883483886719
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 외국 규정을 번역하거나 설명하는 내용입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        390.4642639160156,
        506.6396484375,
        420.50836181640625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        390.4642639160156,
        506.6396484375,
        420.50836181640625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        390.4642639160156,
        506.6396484375,
        420.50836181640625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        425.2642822265625,
        450.76092529296875,
        439.9483642578125
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정리한 자료입니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        150.47999572753906,
        440.7442626953125,
        249.0379638671875,
        455.4283447265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        425.2642822265625,
        506.6396484375,
        455.4283447265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        425.2642822265625,
        506.6396484375,
        455.4283447265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        460.18426513671875,
        525.7349853515625,
        490.2283630371094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        460.18426513671875,
        525.7349853515625,
        490.2283630371094
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지침서ㆍ안내서",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        63.23999786376953,
        519.1043090820312,
        122.52259063720703,
        533.788330078125
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        81.83999633789062,
        536.7443237304688,
        103.91999816894531,
        551.4283447265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        495.1042785644531,
        450.7612609863281,
        509.7883605957031
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.27999877929688,
        510.4642639160156,
        443.64373779296875,
        525.1483154296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예(☞지침서)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        495.1042785644531,
        527.7637329101562,
        525.1483154296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        495.1042785644531,
        527.7637329101562,
        525.1483154296875
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        529.904296875,
        450.76092529296875,
        544.5883178710938
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.27999877929688,
        545.38427734375,
        450.7612609863281,
        575.4283447265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입장을 기술하는 것입니까? (민원인용)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.27999877929688,
        545.38427734375,
        450.7612609863281,
        575.4283447265625
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 예(☞안내서)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        537.7042846679688,
        527.0437622070312,
        567.7483520507812
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        537.7042846679688,
        527.0437622070312,
        567.7483520507812
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기타 확인",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        68.04000091552734,
        596.6243286132812,
        117.5999984741211,
        611.308349609375
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        81.83999633789062,
        614.144287109375,
        103.91999816894531,
        628.8283081054688
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        580.184326171875,
        450.7625427246094,
        594.8683471679688
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "민원인을 구속하는 내용이 있습니까?",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        151.67999267578125,
        595.664306640625,
        338.1979675292969,
        610.3483276367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        580.184326171875,
        506.6396484375,
        610.3483276367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 아니오",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        457.1999816894531,
        580.184326171875,
        506.6396484375,
        610.3483276367188
      ],
      "page_num": 3,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        132.72000122070312,
        612.3442993164062,
        527.7615356445312,
        627.0283203125
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서 제ㆍ개정 절차를 진행하시기 바랍니다.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        149.52000427246094,
        627.7042846679688,
        382.81500244140625,
        642.3883056640625
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상기 사항에 대하여 확인하였음.",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        213.239990234375,
        652.7843017578125,
        379.08935546875,
        667.4683227539062
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2021년  12월  8일",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        241.79998779296875,
        692.9843139648438,
        339.1199951171875,
        707.6683349609375
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담당자",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        276.239990234375,
        719.144287109375,
        519.9599609375,
        733.8283081054688
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한 영 민",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        276.239990234375,
        719.144287109375,
        519.9599609375,
        733.8283081054688
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확  인(부서장)",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        276.239990234375,
        747.1043090820312,
        519.9599609375,
        761.788330078125
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "강 영 규",
      "font_size": 11.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        276.239990234375,
        747.1043090820312,
        519.9599609375,
        761.788330078125
      ],
      "page_num": 3,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정 이력",
      "font_size": 17.03999900817871,
      "font_name": "MalgunGothicBold",
      "bbox": [
        249.0,
        93.05402374267578,
        346.20001220703125,
        115.71855163574219
      ],
      "page_num": 4,
      "block_type": "heading",
      "level": 6,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        71.04000091552734,
        143.03431701660156,
        529.4334106445312,
        162.98548889160156
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성 가이드라인(민원인 안내서)",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        188.0399932861328,
        165.5943145751953,
        407.9686584472656,
        185.5454864501953
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제·개정번호",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        82.91999816894531,
        216.07916259765625,
        440.3994140625,
        234.7534637451172
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "승인일자",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        82.91999816894531,
        216.07916259765625,
        440.3994140625,
        234.7534637451172
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 내용",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothicBold",
      "bbox": [
        82.91999816894531,
        216.07916259765625,
        440.3994140625,
        234.7534637451172
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안내서-1176-01",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        69.0,
        262.6391296386719,
        268.7518005371094,
        281.3134460449219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2021. 12. 8.",
      "font_size": 14.039999961853027,
      "font_name": "MalgunGothic",
      "bbox": [
        69.0,
        262.6391296386719,
        268.7518005371094,
        281.3134460449219
      ],
      "page_num": 4,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불면증 개선 디지털치료기기 안전성·성능",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        287.1600036621094,
        246.25946044921875,
        533.4187622070312,
        298.22039794921875
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 및 임상시험계획서 작성 가이드라인",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        287.1600036621094,
        246.25946044921875,
        533.4187622070312,
        298.22039794921875
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(민원인 안내서) 제정",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        287.1600036621094,
        246.25946044921875,
        533.4187622070312,
        298.22039794921875
      ],
      "page_num": 4,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        92.0594482421875,
        534.3787231445312,
        108.0203857421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        116.0594482421875,
        528.5849609375,
        132.0203857421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        140.0594482421875,
        530.1599731445312,
        156.0203857421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        164.0594482421875,
        534.3787231445312,
        180.0203857421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아님을 알려드립니다. 또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        188.0594482421875,
        534.3787231445312,
        204.0203857421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        212.0594482421875,
        534.3787231445312,
        228.0203857421875
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.",
      "font_size": 12.0,
      "font_name": "MalgunGothic",
      "bbox": [
        69.95999908447266,
        236.0594482421875,
        390.5849914550781,
        252.0203857421875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        75.0,
        265.6397399902344,
        528.62158203125,
        278.8872985839844
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        88.19999694824219,
        281.5997619628906,
        528.6220703125,
        294.8473205566406
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리에 관한 규정 제2조)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        88.19999694824219,
        299.3597412109375,
        200.43467712402344,
        312.6072998046875
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 관련 규정",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        357.72747802734375,
        140.87998962402344,
        370.38372802734375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 「의료기기법」 제2조 (정의)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        381.72747802734375,
        254.6699981689453,
        394.38372802734375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 「의료기기법」 제3조 (등급분류와 지정)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        405.72747802734375,
        320.66998291015625,
        418.38372802734375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 「의료기기법」 제10조 (임상시험계획의 승인 등)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        429.72747802734375,
        368.66998291015625,
        442.38372802734375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        453.72747802734375,
        392.66998291015625,
        466.38372802734375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        477.72747802734375,
        422.66998291015625,
        490.38372802734375
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        501.72747802734375,
        410.66998291015625,
        514.3837280273438
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(7) 「의료기기 허가·신고·심사 등에 관한 규정」",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        525.7274780273438,
        361.1999816894531,
        538.3837280273438
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(8) 「의료기기 임상시험계획 승인에 관한 규정」",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        549.7274780273438,
        349.1999816894531,
        562.3837280273438
      ],
      "page_num": 5,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 문의처",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        621.7274780273438,
        122.87999725341797,
        634.3837280273438
      ],
      "page_num": 5,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        645.7274780273438,
        499.1099853515625,
        658.3837280273438
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전화 : (043) 719-3948",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        669.7274780273438,
        202.44000244140625,
        682.3837280273438
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "FAX : (043) 719-3940",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.63999938964844,
        693.7274780273438,
        201.83999633789062,
        706.3837280273438
      ],
      "page_num": 5,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목",
      "font_size": 32.040000915527344,
      "font_name": "T6",
      "bbox": [
        240.1199951171875,
        83.03999328613281,
        352.20001220703125,
        121.48799133300781
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차",
      "font_size": 32.040000915527344,
      "font_name": "T6",
      "bbox": [
        240.1199951171875,
        83.03999328613281,
        352.20001220703125,
        121.48799133300781
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 1,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ. 개 요 ····························································································· 1",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        168.41812133789062,
        538.4999389648438,
        189.55406188964844
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 배경 및 목적 ················································································· 1",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        208.5243682861328,
        538.4999389648438,
        225.357177734375
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 적용 범위 ······················································································· 1",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        240.5643768310547,
        538.4999389648438,
        257.3971862792969
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 용어 설명 ······················································································· 3",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        272.6043701171875,
        538.4999389648438,
        289.43719482421875
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 현 황 ······························································································· 5",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        304.52435302734375,
        538.4999389648438,
        321.357177734375
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ. 안전성·성능 평가 ····························································· 28",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        368.4581298828125,
        538.5006103515625,
        389.59405517578125
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 국내외 관련 규격 및 가이드라인 ··········································· 28",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        408.5643615722656,
        538.5006103515625,
        425.3971862792969
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 안전성 평가 항목 ······································································· 31",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        440.6043395996094,
        538.5006103515625,
        457.4371643066406
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 성능 평가 항목 ··········································································· 43",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        472.52435302734375,
        538.5006103515625,
        489.357177734375
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ. 임상시험계획서 작성 시 고려사항 및 예시 ······ 45",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        536.4581298828125,
        538.5006103515625,
        557.5940551757812
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ. 참고문헌 ················································································· 118",
      "font_size": 15.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        608.4581298828125,
        538.4999389648438,
        629.5940551757812
      ],
      "page_num": 7,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 1 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 8,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅰ",
      "font_size": 20.03999900817871,
      "font_name": "T9",
      "bbox": [
        68.4000015258789,
        91.31999969482422,
        168.3599853515625,
        115.36800384521484
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개 요",
      "font_size": 20.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        68.4000015258789,
        91.31999969482422,
        168.3599853515625,
        115.36800384521484
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 배경 및 목적",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        66.0,
        152.13995361328125,
        182.52000427246094,
        168.09996032714844
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        200.349365234375,
        546.0599975585938,
        216.169677734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        230.349365234375,
        538.5599975585938,
        246.169677734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        260.349365234375,
        485.72296142578125,
        276.169677734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        290.349365234375,
        546.0599975585938,
        306.169677734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        320.349365234375,
        545.9400024414062,
        336.169677734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        350.349365234375,
        510.5629577636719,
        366.169677734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 적용 범위",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        66.0,
        418.8999328613281,
        158.52000427246094,
        434.85992431640625
      ],
      "page_num": 8,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        460.14935302734375,
        546.0599975585938,
        475.96966552734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        490.14935302734375,
        545.9400024414062,
        505.96966552734375
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        520.1493530273438,
        538.5599975585938,
        535.9696655273438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        550.1493530273438,
        90.68296813964844,
        565.9696655273438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        580.1493530273438,
        545.9400024414062,
        595.9696655273438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        610.1493530273438,
        546.0599975585938,
        625.9696655273438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        640.1493530273438,
        546.0599975585938,
        655.9696655273438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조합의료기기로 분류할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        670.1493530273438,
        278.1229553222656,
        685.9696655273438
      ],
      "page_num": 8,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 2 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 9,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        120.0,
        456.239990234375,
        134.39999389648438
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영문명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        120.0,
        456.239990234375,
        134.39999389648438
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등급",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        120.0,
        456.239990234375,
        134.39999389648438
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류번호",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        120.0,
        456.239990234375,
        134.39999389648438
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목 정의",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        120.0,
        456.239990234375,
        134.39999389648438
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지치료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.63999938964844,
        150.1199951171875,
        122.63999938964844,
        164.51998901367188
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        68.63999938964844,
        169.3199920654297,
        128.63999938964844,
        183.71998596191406
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cognitive",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        157.3199920654297,
        140.51998901367188,
        204.86399841308594,
        154.91998291015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "therapy",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        162.1199951171875,
        159.72000122070312,
        200.1119842529297,
        174.1199951171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "software",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        159.47999572753906,
        178.9199981689453,
        202.70399475097656,
        193.3199920654297
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        236.51998901367188,
        159.72000122070312,
        315.8399963378906,
        174.1199951171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "E06060.02",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        236.51998901367188,
        159.72000122070312,
        315.8399963378906,
        174.1199951171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인지기능을 개선하는데 사용하는 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        140.51998901367188,
        530.5199584960938,
        154.91998291015625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어. 가상ㆍ증강(VRㆍAR) 기반 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        159.72000122070312,
        530.5199584960938,
        174.1199951171875
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어를 포함",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        178.9199981689453,
        387.239990234375,
        193.3199920654297
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심리평가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.63999938964844,
        209.0399932861328,
        122.63999938964844,
        223.4399871826172
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        68.63999938964844,
        228.239990234375,
        128.63999938964844,
        242.63998413085938
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Psychological",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        146.27999877929688,
        199.44000244140625,
        215.9399871826172,
        213.83999633789062
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "assessment",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        150.36000061035156,
        218.63999938964844,
        211.739990234375,
        233.0399932861328
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "software",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        159.47999572753906,
        237.83999633789062,
        202.70399475097656,
        252.239990234375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        236.51998901367188,
        218.63999938964844,
        315.8399963378906,
        233.0399932861328
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "E06050.01",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        236.51998901367188,
        218.63999938964844,
        315.8399963378906,
        233.0399932861328
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료인이 환자의 심리학적 상태를 평가,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        209.0399932861328,
        530.592041015625,
        223.4399871826172
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결정하는데 사용하기 위한 소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        228.239990234375,
        518.760009765625,
        242.63998413085938
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정서장애치료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        62.63999938964844,
        277.44000244140625,
        134.63999938964844,
        291.8399963378906
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        68.63999938964844,
        296.6399841308594,
        128.63999938964844,
        311.03997802734375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Affective",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        159.36000061035156,
        258.239990234375,
        202.82400512695312,
        272.6399841308594
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "disorder",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        160.55999755859375,
        277.44000244140625,
        201.72000122070312,
        291.8399963378906
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "therapy",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        162.1199951171875,
        296.6399841308594,
        200.1119842529297,
        311.03997802734375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "software",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        159.47999572753906,
        315.8399963378906,
        202.70399475097656,
        330.239990234375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        236.51998901367188,
        287.0400085449219,
        315.8399963378906,
        301.44000244140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "E06070.01",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        236.51998901367188,
        287.0400085449219,
        315.8399963378906,
        301.44000244140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정서장애(우울증 등)를 개선하는데 사용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        267.8399963378906,
        530.5199584960938,
        282.239990234375
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 소프트웨어. 가상ㆍ증강(VRㆍAR) 기반",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        287.0400085449219,
        530.5199584960938,
        301.44000244140625
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어를 포함",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        326.6399841308594,
        306.239990234375,
        421.44000244140625,
        320.6399841308594
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 1. 불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        60.47999954223633,
        95.27999877929688,
        531.2520141601562,
        109.68000030517578
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        56.63999938964844,
        359.0400085449219,
        538.5081787109375,
        374.5920104980469
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        384.9599914550781,
        538.4390258789062,
        400.5119934082031
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        411.0,
        538.4402465820312,
        426.552001953125
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 인증을 통과한 제품을 사용해야 한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        437.0400085449219,
        319.4952087402344,
        452.5920104980469
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        56.63999938964844,
        462.9599914550781,
        538.4404907226562,
        478.5119934082031
      ],
      "page_num": 9,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        489.0,
        527.6951293945312,
        504.552001953125
      ],
      "page_num": 9,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 3 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 용어 설명",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        157.19970703125,
        115.0599594116211
      ],
      "page_num": 10,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 소프트웨어 의료기기(Software as a Medical Device, SaMD)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        143.46937561035156,
        487.6875,
        159.28968811035156
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        173.46937561035156,
        546.0599975585938,
        189.28968811035156
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        203.46937561035156,
        534.802978515625,
        219.28968811035156
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 디지털치료기기(Digital Therapeutics)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        233.46937561035156,
        332.2875061035156,
        249.28968811035156
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        263.4693603515625,
        546.0599975585938,
        279.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        293.4693603515625,
        538.4400024414062,
        309.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        323.4693603515625,
        538.4400024414062,
        339.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "웨어 의료기기(SaMD)이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        353.4693603515625,
        260.96295166015625,
        369.2896728515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        383.4693603515625,
        534.9674682617188,
        399.2896728515625
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        413.4693603515625,
        546.0599975585938,
        429.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        443.4693603515625,
        545.9400024414062,
        459.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        473.4693603515625,
        537.0829467773438,
        489.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 수면 위생(Sleep hygiene)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        503.4693603515625,
        253.927490234375,
        519.2896728515625
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        533.4693603515625,
        519.2029418945312,
        549.2896728515625
      ],
      "page_num": 10,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 수면 일기(Sleep diary)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        563.4693603515625,
        235.08749389648438,
        579.2896728515625
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        593.4693603515625,
        546.0599975585938,
        609.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        623.4693603515625,
        545.9400024414062,
        639.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        653.4693603515625,
        499.52294921875,
        669.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 자극 조절법(Stimulus control therapy)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        683.4693603515625,
        340.8074951171875,
        699.2896728515625
      ],
      "page_num": 10,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        713.4693603515625,
        545.9400024414062,
        729.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각성 자극을 분리시키는 치료이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        743.4693603515625,
        319.6429748535156,
        759.2896728515625
      ],
      "page_num": 10,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 4 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사. 수면 제한법(Sleep restriction therapy)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        342.60748291015625,
        100.72968292236328
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증가시키는 치료이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        144.9093780517578,
        229.64295959472656,
        160.7296905517578
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아. 불면증 심각도 척도(Insomnia Severity Index, ISI)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        415.4474792480469,
        190.7296905517578
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설문이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        264.90936279296875,
        149.60296630859375,
        280.72967529296875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자. 수면 효율(Sleep Efficiency, SE)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        297.7275085449219,
        310.72967529296875
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        324.90936279296875,
        507.08294677734375,
        340.72967529296875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "차. 정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Mental Disorders, Fifth Edition, DSM-5)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.27999877929688,
        384.90936279296875,
        353.4075012207031,
        400.72967529296875
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국정신의학협회(American Psychiatric Association, APA)에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.27999877929688,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.27999877929688,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준들을 통칭하는 정신질환 분류법이다. DSM-5는 2013년도의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.27999877929688,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "새로운 업데이트 버전이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.27999877929688,
        504.90936279296875,
        267.8029479980469,
        520.7296752929688
      ],
      "page_num": 11,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "카. 국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        534.4874877929688,
        550.7296752929688
      ],
      "page_num": 11,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국수면의학회(American Academy of Sleep Medicine, AASM)에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발행한 제3판 국제수면장애분류(International Classification of Sleep",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Disorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        83.15999603271484,
        624.9093627929688,
        493.6429443359375,
        640.7296752929688
      ],
      "page_num": 11,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 5 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 현 황",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        125.15999603271484,
        109.41996002197266
      ],
      "page_num": 12,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 불면증의 인구학적 특성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        136.74937438964844,
        246.36000061035156,
        152.56968688964844
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        166.74937438964844,
        545.9400024414062,
        182.56968688964844
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        196.74937438964844,
        546.0599975585938,
        212.56968688964844
      ],
      "page_num": 12,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3개월 이상 지속될 때로 정의하고 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        226.74937438964844,
        330.5629577636719,
        242.56968688964844
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        256.7493591308594,
        545.9400024414062,
        272.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        286.7493591308594,
        538.5599975585938,
        302.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이다. 성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        316.7493591308594,
        546.0599975585938,
        332.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다. 일반",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        346.7493591308594,
        538.5599975585938,
        362.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        376.7493591308594,
        538.4400024414062,
        392.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        406.7493591308594,
        458.0029602050781,
        422.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        436.7493591308594,
        545.9400024414062,
        452.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지속되는 경우도 흔하다. 불면증의 자연 경과에 관한 연구를 보면, 약",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        466.7493591308594,
        545.9400024414062,
        482.5696716308594
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        496.7493591308594,
        545.9400024414062,
        512.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지속적인 증상을 보인 것으로 나타났다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        526.7493896484375,
        330.5629577636719,
        542.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        556.7493896484375,
        546.0599975585938,
        572.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간접적으로 가늠해 볼 수도 있다. 2011년 국내 의료보험 자료를 이용한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        586.7493896484375,
        545.9400024414062,
        602.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        616.7493896484375,
        546.0599975585938,
        632.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "노인의 5.4%가 처방을 받은 것으로 보고되었다. 따라서, 실제 국내",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        646.7493896484375,
        538.4400024414062,
        662.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        676.7493896484375,
        545.9400024414062,
        692.5697021484375
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접근성을 높이는 방안의 모색이 요구된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        706.7493286132812,
        343.8829650878906,
        722.5696411132812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        736.7493286132812,
        546.0599975585938,
        752.5696411132812
      ],
      "page_num": 12,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 6 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "49분으로 최하위를 기록하였다. 이러한 수면 부족은 집중력 장애, 성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        525.5399780273438,
        190.7296905517578
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        538.5599975585938,
        220.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        538.5599975585938,
        280.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 추산되었다. 이는 생산성 손실과도 관련 있어, 근로자 평균 주당",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "추정된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        120.68296813964844,
        370.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 불면증의 진단 절차·과정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        261.239990234375,
        430.72967529296875
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단적 평가 항목은 <표 2>와 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        300.6829528808594,
        490.72967529296875
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 항목",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        76.43999481201172,
        563.2799682617188,
        351.9599914550781,
        577.6799926757812
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내용",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        76.43999481201172,
        563.2799682617188,
        351.9599914550781,
        577.6799926757812
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병력 청취",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        77.63999938964844,
        604.3200073242188,
        131.63999938964844,
        618.7200317382812
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 검사",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.63999938964844,
        623.5199584960938,
        125.63999938964844,
        637.9199829101562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(필수)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.27999877929688,
        642.719970703125,
        120.13199615478516,
        657.1199951171875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        585.1199951171875,
        431.6520080566406,
        599.52001953125
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 신체검사",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        604.3200073242188,
        215.0399932861328,
        618.7200317382812
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        623.5199584960938,
        524.9520263671875,
        637.9199829101562
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파,",
      "font_size": 11.939848899841309,
      "font_name": "T11",
      "bbox": [
        167.0399932861328,
        642.719970703125,
        524.9224853515625,
        657.1199951171875
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "CT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        167.0399932861328,
        661.9199829101562,
        429.25201416015625,
        676.3200073242188
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정신과적",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.63999938964844,
        692.0399780273438,
        128.63999938964844,
        706.4400024414062
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "/심리학적 병력",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        711.239990234375,
        144.72000122070312,
        725.6400146484375
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(필수)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.27999877929688,
        730.4400024414062,
        120.13199615478516,
        744.8400268554688
      ],
      "page_num": 13,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 이전과 현재의 정신장애",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        682.4400024414062,
        299.0400085449219,
        696.8400268554688
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 성격적 요인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        701.6399536132812,
        233.0399932861328,
        716.0399780273438
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 직업 및 가족 상황",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        720.8399658203125,
        269.0400085449219,
        735.239990234375
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 대인관계 갈등",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        740.0399780273438,
        245.0399932861328,
        754.4400024414062
      ],
      "page_num": 13,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 2. 불면증 진단적 평가 항목 권고표",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        174.36000061035156,
        536.0399780273438,
        414.4806213378906,
        551.5919799804688
      ],
      "page_num": 13,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 7 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        394.5093688964844,
        546.0599975585938,
        410.3296813964844
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        424.5093688964844,
        546.0599975585938,
        440.3296813964844
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        454.5093688964844,
        538.4400024414062,
        470.3296813964844
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        484.5093688964844,
        535.260009765625,
        500.3296813964844
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        514.5093383789062,
        545.9400024414062,
        530.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        544.5093383789062,
        546.0599975585938,
        560.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        574.5093383789062,
        120.08296966552734,
        590.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        604.5093383789062,
        538.5599975585938,
        620.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다. 예를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        634.5093383789062,
        546.0599975585938,
        650.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        664.5093383789062,
        545.9400024414062,
        680.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        694.5093383789062,
        545.9400024414062,
        710.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        724.5093383789062,
        546.0599975585938,
        740.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        754.5093383789062,
        546.0599975585938,
        770.3296508789062
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면 병력",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        77.63999938964844,
        128.75999450683594,
        131.63999938964844,
        143.1599884033203
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(필수)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.27999877929688,
        147.95999145507812,
        120.13199615478516,
        162.3599853515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면장애의 병력(유발 요인 포함)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        90.36000061035156,
        347.7720031738281,
        104.76000213623047
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        109.55999755859375,
        524.9520263671875,
        123.95999908447266
      ],
      "page_num": 14,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자는 동안 숨이 멎는지 등)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        167.0399932861328,
        128.75999450683594,
        314.4119873046875,
        143.1599884033203
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        147.95999145507812,
        525.0,
        162.3599853515625
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "뒤로 늦춰져 있지 않은지)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        167.0399932861328,
        167.1599884033203,
        308.4119873046875,
        181.5599822998047
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        186.36000061035156,
        525.0120239257812,
        200.75999450683594
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활동기록계",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.63999938964844,
        216.47999572753906,
        134.63999938964844,
        230.87998962402344
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        206.87998962402344,
        525.0,
        221.2799835205078
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 정량적으로 수면지표 등을 파악하고자 할 때",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        226.0800018310547,
        413.03997802734375,
        240.47999572753906
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면다원 검사",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.63999938964844,
        284.8800048828125,
        143.63999938964844,
        299.2799987792969
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        246.47998046875,
        524.8800048828125,
        260.8799743652344
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료에 잘 반응하지 않는 불면증",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        265.67999267578125,
        347.03997802734375,
        280.0799865722656
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        284.8800048828125,
        524.8919677734375,
        299.2799987792969
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        304.0799865722656,
        524.8800048828125,
        318.47998046875
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의심되는 경우",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        167.0399932861328,
        323.2799987792969,
        245.0399932861328,
        337.67999267578125
      ],
      "page_num": 14,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        343.79998779296875,
        408.1319885253906,
        358.1999816894531
      ],
      "page_num": 14,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 8 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 15,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        535.4029541015625,
        100.72968292236328
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        538.5599975585938,
        130.72967529296875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        538.4400024414062,
        160.7296905517578
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        538.4400024414062,
        190.7296905517578
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해야 하는 질환이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        195.68296813964844,
        220.72967529296875
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그림 1. 불면증 진단 및 치료 흐름도",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        191.51998901367188,
        702.5999755859375,
        417.96063232421875,
        718.1519775390625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        133.3199920654297,
        720.9599609375,
        476.8919982910156,
        735.3599853515625
      ],
      "page_num": 15,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 9 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        283.44000244140625,
        803.6103515625,
        311.7449951171875,
        813.5703125
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        456.24749755859375,
        100.72968292236328
      ],
      "page_num": 16,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        435.5629577636719,
        190.7296905517578
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        538.5599975585938,
        250.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료로 권장하였다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        188.1229705810547,
        340.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        545.9400024414062,
        370.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의존 및 남용의 문제가 있을 수 있다. 따라서 수면제를 사용하기 이전에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        491.84295654296875,
        490.72967529296875
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        546.0599975585938,
        550.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동 치료적 기법을 사용한다. 이러한 불면증 인지행동치료(CBT-I)의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        538.4400024414062,
        640.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "많다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        91.28296661376953,
        700.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        546.0599975585938,
        730.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 16,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 10 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "therapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "therapy) 등으로 구성된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        236.00296020507812,
        160.7296905517578
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상황에 맞게 조정이 가능하다. 선행연구에 의하면 단기 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        538.4400024414062,
        250.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적으로 권장된다. 불면증 인지행동치료(CBT-I)의 일반적 구성은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<표 3>과 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        158.2429656982422,
        370.72967529296875
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.04000091552734,
        441.239990234375,
        378.0,
        455.6399841308594
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제목",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.04000091552734,
        441.239990234375,
        378.0,
        455.6399841308594
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.04000091552734,
        441.239990234375,
        378.0,
        455.6399841308594
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1회기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        62.63999938964844,
        579.3599853515625,
        92.63999938964844,
        593.760009765625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정상 수면,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        118.43999481201172,
        531.3599853515625,
        175.39199829101562,
        545.760009765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 위생,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        118.43999481201172,
        550.5599975585938,
        175.39199829101562,
        564.9600219726562
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 일기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.87999725341797,
        569.760009765625,
        173.87998962402344,
        584.1600341796875
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Sleep education,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        104.04000091552734,
        588.9599609375,
        189.7919921875,
        603.3599853515625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "sleep hygiene",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        112.31999969482422,
        608.1599731445312,
        181.343994140625,
        622.5599975585938
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "and sleep diary)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        106.31999969482422,
        627.3599853515625,
        187.45199584960938,
        641.760009765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        477.3599853515625,
        531.8399658203125,
        491.7599792480469
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        497.7599792480469,
        531.7919921875,
        512.1599731445312
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이외 감별이 필요한 질환을 소개한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        518.1599731445312,
        419.1000061035156,
        532.5599975585938
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 위생에 대한 교육을 수행한다. 수면 위생이란 질 좋은",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        538.5599975585938,
        531.8399658203125,
        552.9600219726562
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        558.9599609375,
        531.8399658203125,
        573.3599853515625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 이후 수면 위생에 대한 점검을 권유한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        579.3599853515625,
        470.1000061035156,
        593.760009765625
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 일기 작성법을 교육한다. 수면 일기란 자리에 누운 시각,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        599.760009765625,
        531.7919921875,
        614.1600341796875
      ],
      "page_num": 17,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        620.1599731445312,
        531.9119873046875,
        634.5599975585938
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        640.5599975585938,
        531.8399658203125,
        654.9600219726562
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정에 필요한 지수들의 자가 기록지이다. 이후 불면증 인지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        660.9599609375,
        531.8399658203125,
        675.3599853515625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        681.3599853515625,
        531.7799682617188,
        695.760009765625
      ],
      "page_num": 17,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 3. 불면증 인지행동치료(CBT-I)의 구성",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        166.1999969482422,
        413.1600036621094,
        426.6005554199219,
        428.7120056152344
      ],
      "page_num": 17,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 11 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2회기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        62.63999938964844,
        193.9199981689453,
        92.63999938964844,
        208.3199920654297
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자극 조절법",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.87999725341797,
        165.1199951171875,
        179.87998962402344,
        179.51998901367188
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Stimulus",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        123.36000061035156,
        184.3199920654297,
        170.39999389648438,
        198.71998596191406
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "control",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        129.72000122070312,
        203.51998901367188,
        163.97999572753906,
        217.91998291015625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "therapy)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        126.23999786376953,
        222.72000122070312,
        167.53199768066406,
        237.1199951171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        112.31999969482422,
        531.8399658203125,
        126.72000122070312
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        132.72000122070312,
        512.0999755859375,
        147.1199951171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        153.1199951171875,
        531.8399658203125,
        167.51998901367188
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        173.51998901367188,
        531.9599609375,
        187.91998291015625
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        193.9199981689453,
        531.8399658203125,
        208.3199920654297
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하기 때문에 더욱 수면을 취하기 어려워진다. 잠자리에서는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        214.3199920654297,
        531.8399658203125,
        228.71998596191406
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "잠만 자야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        234.72000122070312,
        299.1000061035156,
        249.1199951171875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        200.1599884033203,
        255.1199951171875,
        531.9599609375,
        269.5199890136719
      ],
      "page_num": 18,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "매회기 점검한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        275.5199890136719,
        305.1000061035156,
        289.91998291015625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3회기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        62.63999938964844,
        457.79998779296875,
        92.63999938964844,
        472.1999816894531
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면 제한법",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.87999725341797,
        429.0,
        179.87998962402344,
        443.3999938964844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Sleep",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        130.55999755859375,
        448.1999816894531,
        163.13999938964844,
        462.5999755859375
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "restriction",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        122.27999877929688,
        467.3999938964844,
        171.46800231933594,
        481.79998779296875
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "therapy)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        126.23999786376953,
        486.5999755859375,
        167.53199768066406,
        500.9999694824219
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        345.6000061035156,
        531.8399658203125,
        360.0
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료로서, 수면 효율을 증가시키는 치료이다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        366.0,
        458.1000061035156,
        380.3999938964844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        386.3999938964844,
        531.8399658203125,
        400.79998779296875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간의 비율이다. 잠을 제대로 자지 못하는데도 오래 누워",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        406.79998779296875,
        531.8399658203125,
        421.1999816894531
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        427.1999816894531,
        531.8399658203125,
        441.5999755859375
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        447.5999755859375,
        531.8399658203125,
        461.9999694824219
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "만든다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        468.0,
        251.09999084472656,
        482.3999938964844
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        200.1599884033203,
        488.3999938964844,
        531.8399658203125,
        502.79998779296875
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        508.79998779296875,
        531.8399658203125,
        523.2000122070312
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        529.2000122070312,
        531.8999633789062,
        543.6000366210938
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        549.5999755859375,
        531.8399658203125,
        564.0
      ],
      "page_num": 18,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 누워있는 시간을 지속적으로 증진시킨다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        570.0,
        467.1000061035156,
        584.4000244140625
      ],
      "page_num": 18,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 12 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 불면증의 약물 치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        550.7493896484375,
        216.72000122070312,
        566.5697021484375
      ],
      "page_num": 19,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        580.7493896484375,
        546.0599975585938,
        596.5697021484375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        610.7493896484375,
        545.9400024414062,
        626.5697021484375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        640.7493896484375,
        520.1400146484375,
        656.5697021484375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        670.7493896484375,
        545.9400024414062,
        686.5697021484375
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        700.7493286132812,
        545.9400024414062,
        716.5696411132812
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불필요한 사용을 줄인다는 측면에서 큰 도움이 된다. 물론 각 약물의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        730.7493286132812,
        545.9400024414062,
        746.5696411132812
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4회기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        62.63999938964844,
        229.3199920654297,
        92.63999938964844,
        243.71998596191406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인지치료,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        121.43999481201172,
        171.72000122070312,
        172.39199829101562,
        186.1199951171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "필요시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        128.87998962402344,
        190.9199981689453,
        164.87998962402344,
        205.3199920654297
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이완 요법",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.87999725341797,
        210.1199951171875,
        173.87998962402344,
        224.51998901367188
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Cognitive",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        229.3199920654297,
        172.343994140625,
        243.71998596191406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "therapy plus",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        114.36000061035156,
        248.51998901367188,
        179.2799835205078,
        262.91998291015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "relaxation",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        122.27999877929688,
        267.7200012207031,
        171.46800231933594,
        282.1199951171875
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "technique)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        120.47999572753906,
        286.91998291015625,
        173.2919921875,
        301.3199768066406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        96.72000122070312,
        531.8399658203125,
        111.12000274658203
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        117.1199951171875,
        531.8399658203125,
        131.51998901367188
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 치료이다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        137.52000427246094,
        293.1000061035156,
        151.9199981689453
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        157.9199981689453,
        531.719970703125,
        172.3199920654297
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "높으며, 왜곡된 인지를 가지고 있다. 왜곡된 인지에는 잠에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        178.3199920654297,
        531.8399658203125,
        192.71998596191406
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        198.72000122070312,
        531.8399658203125,
        213.1199951171875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        219.1199951171875,
        531.8399658203125,
        233.51998901367188
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있다. 잠과 관련된 불안이 높을 경우 특히 잠자리에 누운",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        239.51998901367188,
        531.8399658203125,
        253.91998291015625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상태에서의 걱정이 많고 과각성이 일어난다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        259.91998291015625,
        455.1000061035156,
        274.3199768066406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        280.32000732421875,
        531.7799682617188,
        294.7200012207031
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        300.7200012207031,
        531.8399658203125,
        315.1199951171875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과각성된 자율 신경계를 이완시키는 것을 목표로 한다. 다만",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        321.1199951171875,
        531.8399658203125,
        335.5199890136719
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        341.5199890136719,
        531.8399658203125,
        355.91998291015625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        361.91998291015625,
        527.0999755859375,
        376.3199768066406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5회기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        62.63999938964844,
        436.3199768066406,
        92.63999938964844,
        450.719970703125
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문제 해결법",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.87999725341797,
        417.1199951171875,
        179.87998962402344,
        431.5199890136719
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Trouble",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        125.87999725341797,
        436.3199768066406,
        167.90399169921875,
        450.719970703125
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "shooting)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        123.5999984741211,
        455.5199890136719,
        170.1719970703125,
        469.91998291015625
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        405.7200012207031,
        531.8399658203125,
        420.1199951171875
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        426.1199951171875,
        531.8999633789062,
        440.5199890136719
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.1599884033203,
        446.5199890136719,
        531.8399658203125,
        460.91998291015625
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피드백을 제공한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        466.91998291015625,
        323.2200012207031,
        481.3199768066406
      ],
      "page_num": 19,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,.(2003))",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.68000030517578,
        502.20001220703125,
        510.2519836425781,
        516.6000366210938
      ],
      "page_num": 19,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 13 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적절한 판단하에 사용하여야 한다. 단, 이는 본 가이드라인에서 다루는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        538.4400024414062,
        220.72967529296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자 상태를 파악하기를 권고한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        293.1229553222656,
        280.72967529296875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종류",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        163.0800018310547,
        349.0799865722656,
        469.67999267578125,
        363.47998046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주로 사용되는 용량",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        163.0800018310547,
        349.0799865722656,
        469.67999267578125,
        363.47998046875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A. Benzodiazepine",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        61.79999923706055,
        368.03997802734375,
        346.18798828125,
        400.0799865722656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Flurazepam*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        368.03997802734375,
        346.18798828125,
        400.0799865722656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15-30mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        368.03997802734375,
        346.18798828125,
        400.0799865722656
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Triazolam*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        67.79999542236328,
        403.44000244140625,
        370.0679931640625,
        417.8399963378906
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.125-0.25mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        403.44000244140625,
        370.0679931640625,
        417.8399963378906
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Flunitrazepam*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        67.79999542236328,
        421.0799865722656,
        321.947998046875,
        435.47998046875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        421.0799865722656,
        321.947998046875,
        435.47998046875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Brotiazolam*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        67.79999542236328,
        438.7200012207031,
        336.947998046875,
        453.1199951171875
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.25mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        438.7200012207031,
        336.947998046875,
        453.1199951171875
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Clonazepam",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        456.3599853515625,
        330.947998046875,
        470.7599792480469
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0.5mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        456.3599853515625,
        330.947998046875,
        470.7599792480469
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B. Non-benzodiazepine",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        61.79999923706055,
        474.0,
        197.3040008544922,
        488.3999938964844
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Non-benzodiazepine GABA modulator (z-class)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.79999542236328,
        488.3999938964844,
        356.5320129394531,
        502.79998779296875
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Zolpidem immediate-release*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        67.79999542236328,
        506.03997802734375,
        340.18798828125,
        520.4400024414062
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5-10mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        506.03997802734375,
        340.18798828125,
        520.4400024414062
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Zolpidem controlled-release*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        67.79999542236328,
        523.6799926757812,
        364.0679931640625,
        538.0800170898438
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6.25-12.5mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        523.6799926757812,
        364.0679931640625,
        538.0800170898438
      ],
      "page_num": 20,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Eszopiclone*",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        67.79999542236328,
        541.3200073242188,
        334.18798828125,
        555.7200317382812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1-3mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        541.3200073242188,
        334.18798828125,
        555.7200317382812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Antidepressant",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        558.9599609375,
        346.18798828125,
        591.0
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Trazodone",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        558.9599609375,
        346.18798828125,
        591.0
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25-50mg",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.79999542236328,
        558.9599609375,
        346.18798828125,
        591.0
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 식약처 허가된 제품",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        592.9199829101562,
        405.25201416015625,
        621.7200317382812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        592.9199829101562,
        405.25201416015625,
        621.7200317382812
      ],
      "page_num": 20,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 4. 국내 불면증에 사용되는 약물",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        184.44000244140625,
        323.1600036621094,
        404.4000549316406,
        338.7120056152344
      ],
      "page_num": 20,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 14 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마. 불면증 인지행동치료(CBT-I)의 임상적 권고 수준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        416.8800048828125,
        100.72968292236328
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권고한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        120.68296813964844,
        190.7296905517578
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단하였다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        137.8429718017578,
        250.72967529296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진료지침",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        113.63999938964844,
        318.47998046875,
        483.9599914550781,
        332.8799743652344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "권고등급",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        113.63999938964844,
        318.47998046875,
        483.9599914550781,
        332.8799743652344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거 수준",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        113.63999938964844,
        318.47998046875,
        483.9599914550781,
        332.8799743652344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ACP 진료지침(2016)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.5999984741211,
        342.7200012207031,
        480.5039978027344,
        357.1199951171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strong",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.5999984741211,
        342.7200012207031,
        480.5039978027344,
        357.1199951171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Moderate",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.5999984741211,
        342.7200012207031,
        480.5039978027344,
        357.1199951171875
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ESRS 진료지침(2017)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.75999450683594,
        365.6399841308594,
        467.98797607421875,
        380.03997802734375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strong",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.75999450683594,
        365.6399841308594,
        467.98797607421875,
        380.03997802734375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "High",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.75999450683594,
        365.6399841308594,
        467.98797607421875,
        380.03997802734375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "AASM 진료지침(2017)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        388.55999755859375,
        480.5039978027344,
        402.9599914550781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Strong",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        388.55999755859375,
        480.5039978027344,
        402.9599914550781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Moderate",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        388.55999755859375,
        480.5039978027344,
        402.9599914550781
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* ACP: American College of Physicians, ESRS: European Sleep Research Society,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        407.3999938964844,
        512.7119750976562,
        421.79998779296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "AASM: American Academy of Sleep Medicine",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        75.0,
        424.1999816894531,
        321.14398193359375,
        438.5999755859375
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        440.3999938964844,
        408.1319885253906,
        454.79998779296875
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 5. 진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        69.0,
        290.1600036621094,
        525.4805908203125,
        305.7120056152344
      ],
      "page_num": 21,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        498.90936279296875,
        545.9400024414062,
        514.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        528.9093627929688,
        546.0599975585938,
        544.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국내과학회(ACP, American College of Physician) 진료지침(2016)의",
      "font_size": 14.880475997924805,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        558.9093627929688,
        545.9409790039062,
        574.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        588.9093627929688,
        546.0599975585938,
        604.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        618.9093627929688,
        498.6600036621094,
        634.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유럽수면학회(European Sleep Research Society, ESRS) 진료지침",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        648.9093627929688,
        538.4400024414062,
        664.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        678.9093627929688,
        546.0599975585938,
        694.7296752929688
      ],
      "page_num": 21,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        708.9093627929688,
        529.5,
        724.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        738.9093627929688,
        538.5599975585938,
        754.7296752929688
      ],
      "page_num": 21,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 15 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Strong). 또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        538.5599975585938,
        160.7296905517578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        113.12296295166016,
        220.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있어 제한이 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        180.68296813964844,
        340.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        466.1999816894531,
        400.72967529296875
      ],
      "page_num": 22,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        414.90936279296875,
        538.5599975585938,
        430.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        546.0599975585938,
        490.72967529296875
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접근성이 수월하다 (Strom et al., 2004). 또한 디지털 기반 치료로,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        545.9400024414062,
        520.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        546.0599975585938,
        550.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료자 입장에서의 비용 대비 효용성도 증가된다. 따라서, 환자들이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        594.9093627929688,
        538.5599975585938,
        610.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        538.5599975585938,
        730.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되고 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        128.12295532226562,
        760.7296752929688
      ],
      "page_num": 22,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 16 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 23,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증하였다 (Felder et al., 2020). 실험군의 경우 6주 동안 모바일 기반",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 표준 치료를 제공받았다. 그 결과, 실험군의 주요 임상 지표인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상 불면증 심각도가 완화되었다. 또한, 치료 기간 종료 후 두 달 뒤에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효과가 유지되었다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        188.1229705810547,
        370.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        538.5599975585938,
        430.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019). 해당",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        538.4400024414062,
        490.72967529296875
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        538.5599975585938,
        520.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "육을 제공받았다. 그 결과, 디지털 불면증 인지행동치료를 수행한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        545.9400024414062,
        580.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        594.9093627929688,
        443.0029602050781,
        610.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        538.5599975585938,
        670.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        538.4400024414062,
        730.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 23,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 17 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 24,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교육(patient education)을 제공받았다. 해당 연구에서의 주요 임상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        538.5599975585938,
        130.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Sleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상 지표들이 모두 유의미한 차이를 보였다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        368.1229553222656,
        250.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CBT-I)의 효과를 검증하였다 (Freeman et al., 2017). 해당 연구에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        538.5599975585938,
        370.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "usual, TAU)를 제공받았다. 해당 연구에서는 불면 증상(insomnia), 편집",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        538.4400024414062,
        490.72967529296875
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "들이 유의하게 개선되었다. 이러한 결과를 바탕으로 디지털 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        545.9400024414062,
        520.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        495.5629577636719,
        580.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "et al., 2016). 해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        546.0599975585938,
        730.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 24,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 18 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 25,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로그램을 제공받았다. 연구 결과 6주간의 치료 후, 실험군의 우울",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다. 추가적으로,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "PHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보고되었다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        135.68296813964844,
        310.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        538.5599975585938,
        400.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대해선 아직 논란의 여지가 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        283.1629638671875,
        460.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        474.90936279296875,
        538.4400024414062,
        490.72967529296875
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        538.5599975585938,
        520.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        538.5599975585938,
        550.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        536.8200073242188,
        580.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        594.9093627929688,
        538.4400024414062,
        610.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        538.5599975585938,
        700.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        538.4400024414062,
        730.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되었다 (Bruin et al. 2016).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        246.05999755859375,
        760.7296752929688
      ],
      "page_num": 25,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 19 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 26,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        84.90937042236328,
        538.4400024414062,
        100.72968292236328
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Lancee et al., 2016). 이 결과는 각 군별 치료 순응도의 차이로부터",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        538.4400024414062,
        220.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각각 50%, 70%로 유의한 차이를 보였다. 따라서, 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        538.5599975585938,
        280.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        538.4400024414062,
        340.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        536.9400024414062,
        370.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Kim et al., 2020). 또한, 전통적인 불면증 인지행동치료(CBT-I)에서는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        546.0599975585938,
        490.72967529296875
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        545.9400024414062,
        520.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        545.9400024414062,
        580.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려해야 한다 (Lee, 2020).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        594.9093627929688,
        240.92295837402344,
        610.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        546.0599975585938,
        700.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용될 것으로 기대된다. 하지만, 국내에서 진행된 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        538.4400024414062,
        760.7296752929688
      ],
      "page_num": 26,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 20 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        538.4400024414062,
        130.72967529296875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배정 임상시험이 필요하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        240.68296813964844,
        160.7296905517578
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사. 불면증 개선 디지털치료기기의 국외 사례",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        365.03997802734375,
        220.72967529296875
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        477.3229675292969,
        280.72967529296875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연번",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        65.15999603271484,
        365.2799987792969,
        91.80057525634766,
        380.8320007324219
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품명(제조업체)",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        121.91999816894531,
        353.1600036621094,
        225.40174865722656,
        368.7120056152344
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 설명",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        361.79998779296875,
        365.2799987792969,
        422.1600341796875,
        380.8320007324219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 외형",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        143.52000427246094,
        377.5199890136719,
        203.8805694580078,
        393.0719909667969
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        75.83999633789062,
        538.3200073242188,
        81.83999633789062,
        552.7200317382812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Somryst",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        153.0,
        410.3999938964844,
        195.05999755859375,
        424.79998779296875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(PEAR Therapeutics)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        118.91999816894531,
        423.1199951171875,
        356.5199890136719,
        443.9999694824219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- FDA 510(k) 승인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        118.91999816894531,
        423.1199951171875,
        356.5199890136719,
        443.9999694824219
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* Classification: Computerized Behavioral Therapy",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        261.0,
        442.3199768066406,
        529.6319580078125,
        456.719970703125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Device For Psychiatric Disorders",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        349.91998291015625,
        461.5199890136719,
        524.0399780273438,
        475.91998291015625
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* Product code: PWE",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        261.0,
        480.7200012207031,
        377.1479797363281,
        495.1199951171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 22세 이상의 성인 불면증 환자에게 9주 동안 총",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        255.0,
        499.91998291015625,
        529.6799926757812,
        514.3200073242188
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6개의 코어 세션(Get ready, Sleep window, Behavior,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        519.1199951171875,
        529.7520141601562,
        533.52001953125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Thoughts, Education, Look Ahead)을 적용하는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        538.3200073242188,
        529.6799926757812,
        552.7200317382812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        557.5199584960938,
        529.6920166015625,
        571.9199829101562
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 매일 불면증 증상 확인을 위해 수면 일기를 입력",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        576.719970703125,
        526.6799926757812,
        591.1199951171875
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 일기는 모바일 화면에 터치 및 입력을 통해",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        595.9199829101562,
        529.6799926757812,
        610.3200073242188
      ],
      "page_num": 27,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "간편하게 입력할 수 있으며, 환자가 희망할 경우",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        615.1199951171875,
        529.6799926757812,
        629.52001953125
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Fitbit 등과 연동하여 자동적으로 야간 수면을 측정",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        634.3200073242188,
        529.6799926757812,
        648.7200317382812
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 웨어러블 데이터도 활용 가능",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        653.5199584960938,
        459.0,
        667.9199829101562
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(출처: peartherapeutics 홈페이지)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        103.43999481201172,
        611.6400146484375,
        244.6622314453125,
        624.8880004882812
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(https://peartherapeutics.com/",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        105.1199951171875,
        629.280029296875,
        242.9025115966797,
        642.5280151367188
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "products/somryst/)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        131.16000366210938,
        646.9199829101562,
        216.9430389404297,
        660.16796875
      ],
      "page_num": 27,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 6. 국외 불면증 개선 디지털치료기기 허가 제품 동향(2021. 06. 기준)",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        72.72000122070312,
        326.0400085449219,
        520.841796875,
        341.5920104980469
      ],
      "page_num": 27,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 21 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 28,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연번",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        65.15999603271484,
        103.79999542236328,
        91.80057525634766,
        119.35199737548828
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품명(제조업체)",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        121.91999816894531,
        91.68000030517578,
        225.40174865722656,
        107.23200225830078
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품 설명",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        361.79998779296875,
        103.79999542236328,
        422.1600341796875,
        119.35199737548828
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 외형",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        143.52000427246094,
        115.91999053955078,
        203.8805694580078,
        131.47198486328125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        75.83999633789062,
        269.7599792480469,
        81.83999633789062,
        284.15997314453125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Sleepio",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        155.0399932861328,
        149.87998962402344,
        193.0679931640625,
        164.2799835205078
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Big Health)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        143.0399932861328,
        169.0800018310547,
        204.97198486328125,
        183.47999572753906
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 18세 이상의 불면증 환자를 위한 스마트폰 앱",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        255.0,
        154.55999755859375,
        529.6799926757812,
        168.95999145507812
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기반의 불면증 인지행동치료(CBT-I)로 행동, 인지,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        173.75999450683594,
        529.6320190429688,
        188.1599884033203
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "교육 등의 파트로 구성된 약 20분 길의 총 6개",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        192.95999145507812,
        529.6799926757812,
        207.3599853515625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코어 세션 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        267.0,
        212.1599884033203,
        351.0,
        226.5599822998047
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 일기를 통해 개개인의 수면의 정보를 얻어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        231.36000061035156,
        529.6799926757812,
        245.75999450683594
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그래프로 제공하여 수면 질 분석 결과를 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        267.0,
        250.55999755859375,
        502.0799865722656,
        264.9599914550781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- Sleepio 사용 시작 시 개인의 수면 양상에 대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        269.7599792480469,
        529.6799926757812,
        284.15997314453125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설문을 통해 개인화된 치료를 제공하는데 초점을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        288.9599914550781,
        529.6799926757812,
        303.3599853515625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "맞추며, 이에 따라 달라지는 시각적 훈련을 통해",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        308.1600036621094,
        529.6799926757812,
        322.55999755859375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 효과를 꾀함",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        327.3599853515625,
        363.0,
        341.7599792480469
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 환자의 참여도를 높이기 위해 가상의 수면 전문가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        346.55999755859375,
        529.6799926757812,
        360.9599914550781
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "캐릭터가 강의와 질문 및 답변을 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        267.0,
        365.7599792480469,
        477.0,
        380.15997314453125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- CE 인증과 영국 NHS와 제휴",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        255.0,
        384.9599914550781,
        427.44000244140625,
        399.3599853515625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: bighealth 홈페이지)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        110.04000091552734,
        333.5999755859375,
        238.06222534179688,
        346.8479919433594
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[https://www.bighealth.com/",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        110.39999389648438,
        351.239990234375,
        237.7452850341797,
        364.4880065917969
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "sleepio]",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        156.1199951171875,
        368.7599792480469,
        191.91311645507812,
        382.00799560546875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        75.83999633789062,
        557.6400146484375,
        81.83999633789062,
        572.0400390625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Somino",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        154.55999755859375,
        425.2799987792969,
        193.54800415039062,
        439.67999267578125
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Mementor DEGmbH)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        126.47999572753906,
        444.47998046875,
        221.531982421875,
        458.8799743652344
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 불면증 환자를 위한 스마트폰 앱 기반의 불면증",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        480.8399963378906,
        529.6799926757812,
        495.239990234375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인지행동치료(CBT-I)를 기반으로 함",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        500.03997802734375,
        462.0,
        514.4400024414062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 30분 길이의 총 8개 세션이 8주 내에 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        255.0,
        519.239990234375,
        501.0,
        533.6400146484375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        255.0,
        538.4400024414062,
        529.6799926757812,
        552.8400268554688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등록되어 건강보험 지불",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        557.6400146484375,
        399.0,
        572.0400390625
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 독일은 의사가 PZN(Pharmazentralnumme, 중앙",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        255.0,
        576.8399658203125,
        529.6799926757812,
        591.239990234375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제약번호) 16898724와 제품명 Somnio를 처방하여",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        267.0,
        596.0399780273438,
        529.6799926757812,
        610.4400024414062
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환자가 건강보험에 처방전을 제출한 후 라이센스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        615.239990234375,
        529.6799926757812,
        629.6400146484375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코드를 받아 사용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        267.0,
        634.4400024414062,
        363.0,
        648.8400268554688
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: Somino 홈페이지,",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        113.39999389648438,
        616.5599975585938,
        234.6758270263672,
        629.8079833984375
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "teleclinic 홈페이지)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        127.91999816894531,
        634.0800170898438,
        220.06222534179688,
        647.3280029296875
      ],
      "page_num": 28,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[https://somn.io/en/],",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        127.31999969482422,
        651.7200317382812,
        220.75582885742188,
        664.968017578125
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[https://www.teleclinic.com/",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        111.5999984741211,
        669.3599853515625,
        236.42674255371094,
        682.6079711914062
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "app/somnio/]",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        144.0,
        686.8800048828125,
        204.1531219482422,
        700.1279907226562
      ],
      "page_num": 28,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 22 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아. 디지털치료기기의 정의와 국내 가이드라인별 적용 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        465.5999755859375,
        100.72968292236328
      ],
      "page_num": 29,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 디지털치료기기 정의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        238.79998779296875,
        130.72967529296875
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        144.9093780517578,
        538.5599975585938,
        160.7296905517578
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        538.4400024414062,
        220.72967529296875
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 소프트웨어 의료기기(SaMD)이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        234.90936279296875,
        356.96295166015625,
        250.72967529296875
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        106.68000030517578,
        263.1600036621094,
        525.6000366210938,
        278.7120056152344
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 국내 가이드라인별 적용 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        290.9493713378906,
        298.79998779296875,
        306.7696838378906
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        320.9493713378906,
        490.6875,
        336.7696838378906
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        350.9493713378906,
        546.0599975585938,
        366.7696838378906
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        380.9493713378906,
        546.0599975585938,
        396.7696838378906
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        410.9493713378906,
        546.0599975585938,
        426.7696838378906
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "목적으로 환자에게 적용되어야 한다. 또한, 치료 작용기전의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        440.9493713378906,
        546.0599975585938,
        456.7696838378906
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과학적(임상적) 근거에 해당하는 자료가 있어야 한다. 여기서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        470.9493713378906,
        546.0599975585938,
        486.7696838378906
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질병이란 국제질병분류코드(International Classification of Disease,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        500.9493408203125,
        546.0599975585938,
        516.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        530.9493408203125,
        546.0599975585938,
        546.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질환으로 정의한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        560.9493408203125,
        243.2029571533203,
        576.7696533203125
      ],
      "page_num": 29,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        590.9493408203125,
        538.4400024414062,
        606.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        620.9493408203125,
        546.0599975585938,
        636.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설치하여 제공하므로 소프트웨어 의료기기에 해당한다. 또한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        650.9493408203125,
        545.9400024414062,
        666.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한국표준질병사인분류에 따라 불면증을 의사에게 진단받은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        680.9493408203125,
        546.0599975585938,
        696.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자들을 대상으로 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        710.9493408203125,
        280.6429748535156,
        726.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        740.9493408203125,
        546.0599975585938,
        756.7696533203125
      ],
      "page_num": 29,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 23 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 30,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        84.90937042236328,
        538.4400024414062,
        100.72968292236328
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 시행하기를 권고하고 있다. 또한 다수의 동료검토 선행",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        114.90937042236328,
        538.4400024414062,
        130.72967529296875
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "al., 2017, Christensen et al., 2016).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        234.90936279296875,
        351.08294677734375,
        250.72967529296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        264.90936279296875,
        538.4400024414062,
        280.72967529296875
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        294.90936279296875,
        538.4400024414062,
        310.72967529296875
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료기기라고 판단할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        324.90936279296875,
        318.08294677734375,
        340.72967529296875
      ],
      "page_num": 30,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림 2. 디지털치료기기 대상여부 판단 기준 및 절차",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        140.52000427246094,
        699.3599853515625,
        468.9600524902344,
        714.9119873046875
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        90.36000061035156,
        717.5999755859375,
        519.8519897460938,
        732.0
      ],
      "page_num": 30,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 24 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 31,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        84.90937042236328,
        532.8074951171875,
        100.72968292236328
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하여 평가한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        204.90936279296875,
        243.2029571533203,
        220.72967529296875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허가되지 않은 용도로 사용되지 않아야 함을 의미하며,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파괴되지 않아야 함을 의미한다. 가용성은 개인의료정보가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "곳에서 필요한 형태로 존재하여야 함을 의미한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        384.90936279296875,
        453.08294677734375,
        400.72967529296875
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        444.90936279296875,
        538.4400024414062,
        460.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        474.90936279296875,
        546.0599975585938,
        490.72967529296875
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그에 따른 사이버 보안 요구사항을 적용한다. 일반적으로 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        534.9093627929688,
        538.4400024414062,
        550.7296752929688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        594.9093627929688,
        545.9400024414062,
        610.7296752929688
      ],
      "page_num": 31,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불가능하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        624.9093627929688,
        190.64295959472656,
        640.7296752929688
      ],
      "page_num": 31,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 25 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 32,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그림 3. 데이터 보호 및 보안성 영역 연구의 흐름",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        143.39999389648438,
        296.0400085449219,
        451.08056640625,
        311.5920104980469
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        360.78936767578125,
        528.1275024414062,
        376.60968017578125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        390.78936767578125,
        546.0599975585938,
        406.60968017578125
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        420.78936767578125,
        545.9400024414062,
        436.60968017578125
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "범위 내에서 개발 및 유지가 되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        450.78936767578125,
        400.52294921875,
        466.60968017578125
      ],
      "page_num": 32,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        480.78936767578125,
        538.5599975585938,
        496.60968017578125
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        510.78936767578125,
        546.0599975585938,
        526.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        540.7893676757812,
        538.4400024414062,
        556.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        570.7893676757812,
        538.4400024414062,
        586.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(evaluation of overal residual risk acceptability), 위험관리 보고서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        600.7893676757812,
        538.5599975585938,
        616.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(risk management report), 생산 및 생산 후 정보(production and",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        630.7893676757812,
        546.0599975585938,
        646.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "post-production information)로 구분한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        660.7893676757812,
        390.3229675292969,
        676.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        690.7893676757812,
        545.9400024414062,
        706.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        720.7893676757812,
        545.9400024414062,
        736.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        750.7893676757812,
        546.0599975585938,
        766.6096801757812
      ],
      "page_num": 32,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 26 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 33,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "B등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        114.90937042236328,
        538.5599975585938,
        130.72967529296875
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 구분한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        214.40296936035156,
        160.7296905517578
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        174.9093780517578,
        538.5599975585938,
        190.7296905517578
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        264.90936279296875,
        175.64295959472656,
        280.72967529296875
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그림 4. 소프트웨어의 안전성 평가 관련 연구의 흐름",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        132.95999145507812,
        521.2799682617188,
        461.52056884765625,
        536.8319702148438
      ],
      "page_num": 33,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        571.0293579101562,
        534.4874877929688,
        586.8496704101562
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털치료기기는 실사용증거(Real World Evidence, RWE)를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        601.0293579101562,
        546.0599975585938,
        616.8496704101562
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        631.0293579101562,
        545.9400024414062,
        646.8496704101562
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        661.0293579101562,
        545.9400024414062,
        676.8496704101562
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.1)",
      "font_size": 11.279999732971191,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        691.0293579101562,
        177.2849884033203,
        706.8496704101562
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인",
      "font_size": 8.759956359863281,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        733.1456298828125,
        542.7031860351562,
        742.6378173828125
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "용어이다. 실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익",
      "font_size": 8.759956359863281,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        67.55999755859375,
        747.5455932617188,
        542.8231811523438,
        757.0377807617188
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 위험성에 관한 임상적 근거를 말한다. 또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.",
      "font_size": 8.759956359863281,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        67.55999755859375,
        761.9456176757812,
        457.9380798339844,
        771.4378051757812
      ],
      "page_num": 33,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 27 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 34,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 객관적인 사항이 반드시 포함되어야 한다. 또한 실사용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        538.4400024414062,
        160.7296905517578
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 34,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제시해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        204.90936279296875,
        213.2029571533203,
        220.72967529296875
      ],
      "page_num": 34,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 28 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅱ",
      "font_size": 20.03999900817871,
      "font_name": "T9",
      "bbox": [
        68.4000015258789,
        91.31999969482422,
        288.3600158691406,
        115.36800384521484
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전성·성능 평가",
      "font_size": 20.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        68.4000015258789,
        91.31999969482422,
        288.3600158691406,
        115.36800384521484
      ],
      "page_num": 35,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 국내외 관련 규격 및 가이드라인",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        147.09996032714844,
        325.19940185546875,
        163.05996704101562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 국내외 규격",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        190.38937377929688,
        164.75999450683594,
        206.20968627929688
      ],
      "page_num": 35,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털치료기기 관련 국내외 규격은 <표 7>과 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        220.38937377929688,
        428.1229553222656,
        236.20968627929688
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연번",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.27999877929688,
        308.6399841308594,
        523.4400024414062,
        323.03997802734375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표준",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.27999877929688,
        308.6399841308594,
        523.4400024414062,
        323.03997802734375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격 명칭",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.27999877929688,
        308.6399841308594,
        523.4400024414062,
        323.03997802734375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 내용",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.27999877929688,
        308.6399841308594,
        523.4400024414062,
        323.03997802734375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.27999877929688,
        308.6399841308594,
        523.4400024414062,
        323.03997802734375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        359.3999938964844,
        158.51998901367188,
        373.79998779296875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ISO 13485",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        359.3999938964844,
        158.51998901367188,
        373.79998779296875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        206.51998901367188,
        330.6000061035156,
        290.760009765625,
        345.0
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "–Quality management",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        188.39999389648438,
        349.79998779296875,
        308.8199768066406,
        364.1999816894531
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "systems–Requirements",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        186.0,
        369.0,
        311.2799987792969,
        383.3999938964844
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "for regulatory purposes",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        187.0800018310547,
        388.1999816894531,
        310.20001220703125,
        402.5999755859375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 품질관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        361.3199768066406,
        340.1999816894531,
        463.3199768066406,
        354.5999755859375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Quality Management)에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        348.8399963378906,
        359.3999938964844,
        475.91998291015625,
        373.79998779296875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한 국제 규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        370.3199768066406,
        378.6000061035156,
        454.3199768066406,
        393.0
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        359.3999938964844,
        523.4400024414062,
        373.79998779296875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        436.0799865722656,
        158.51998901367188,
        450.47998046875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ISO 14971",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        436.0799865722656,
        158.51998901367188,
        450.47998046875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        206.51998901367188,
        416.8800048828125,
        290.760009765625,
        431.2799987792969
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "–Application of risk management",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.39999389648438,
        436.0799865722656,
        326.8199768066406,
        450.47998046875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "to medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        203.39999389648438,
        455.2799987792969,
        293.760009765625,
        469.67999267578125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 위험관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        361.3199768066406,
        416.8800048828125,
        463.3199768066406,
        431.2799987792969
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Risk Management)에 대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        340.32000732421875,
        436.0799865722656,
        484.44000244140625,
        450.47998046875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국제 규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        385.3199768066406,
        455.2799987792969,
        439.3199768066406,
        469.67999267578125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        436.0799865722656,
        523.4400024414062,
        450.47998046875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        74.87999725341797,
        505.91998291015625,
        312.5039978027344,
        529.9199829101562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IEC 62304",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        74.87999725341797,
        505.91998291015625,
        312.5039978027344,
        529.9199829101562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Medical device software",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        505.91998291015625,
        312.5039978027344,
        529.9199829101562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "–Software life cycle processes",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.75999450683594,
        525.1199951171875,
        326.5199890136719,
        539.52001953125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        349.32000732421875,
        486.7200012207031,
        475.3199768066406,
        501.1199951171875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발부터 유지보수를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        505.91998291015625,
        469.3199768066406,
        520.3200073242188
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포함하여 전주기에 대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        346.32000732421875,
        525.1199951171875,
        478.3199768066406,
        539.52001953125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국제 규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        385.3199768066406,
        544.3200073242188,
        439.3199768066406,
        558.7200317382812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        515.5199584960938,
        523.4400024414062,
        529.9199829101562
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        74.87999725341797,
        589.6799926757812,
        149.18399047851562,
        613.6799926757812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IEC/TR",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        589.6799926757812,
        149.18399047851562,
        613.6799926757812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80002-1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.04000091552734,
        608.8800048828125,
        151.44000244140625,
        623.280029296875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Medical device software–",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        178.8000030517578,
        570.47998046875,
        318.47998046875,
        584.8800048828125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Part 1: Guidance on the",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        182.87998962402344,
        589.6799926757812,
        314.4239807128906,
        604.0800170898438
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "application of ISO 14971",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        182.75999450683594,
        608.8800048828125,
        314.3999938964844,
        623.280029296875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "to medical device software",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        177.0,
        628.0799560546875,
        320.3039855957031,
        642.47998046875
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        349.32000732421875,
        580.0800170898438,
        475.3199768066406,
        594.4800415039062
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험관리 방법에 대한 국제",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        337.32000732421875,
        599.2799682617188,
        487.3199768066406,
        613.6799926757812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        400.3199768066406,
        618.47998046875,
        424.3199768066406,
        632.8800048828125
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        599.2799682617188,
        523.4400024414062,
        613.6799926757812
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        686.6400146484375,
        140.2679901123047,
        710.6400146484375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IEC",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        686.6400146484375,
        140.2679901123047,
        710.6400146484375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80001-1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        109.68000030517578,
        705.8399658203125,
        151.8000030517578,
        720.239990234375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Application of risk",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        201.239990234375,
        657.8399658203125,
        295.95599365234375,
        672.239990234375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "management for IT-networks",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        171.36000061035156,
        677.0399780273438,
        325.9200134277344,
        691.4400024414062
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "incorporating medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.51998901367188,
        696.239990234375,
        326.760009765625,
        710.6400146484375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "–Part 1: Roles, responsibilities,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.75999450683594,
        715.4400024414062,
        326.59197998046875,
        729.8400268554688
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "and activities",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        214.44000244140625,
        734.6399536132812,
        282.8399963378906,
        749.0399780273438
      ],
      "page_num": 35,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "네트워크로 연결되는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        677.0399780273438,
        469.3199768066406,
        691.4400024414062
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의 위험관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        696.239990234375,
        469.3199768066406,
        710.6400146484375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법에 대한 국제 규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        349.32000732421875,
        715.4400024414062,
        475.3199768066406,
        729.8400268554688
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        696.239990234375,
        523.4400024414062,
        710.6400146484375
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 7. 디지털치료기기 관련 국내외 규격",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        170.87998962402344,
        281.3999938964844,
        418.2005615234375,
        296.9519958496094
      ],
      "page_num": 35,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 29 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 국내외 가이드라인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        426.90936279296875,
        209.27999877929688,
        442.72967529296875
      ],
      "page_num": 36,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        456.90936279296875,
        473.1229553222656,
        472.72967529296875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        151.9199981689453,
        80.87999725341797,
        166.3199920654297
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IEC/TR",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.95999908447266,
        142.3199920654297,
        149.5439910888672,
        156.71998596191406
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80001-2-1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        103.55999755859375,
        161.51998901367188,
        157.9199981689453,
        175.91998291015625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Application of risk",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        201.239990234375,
        94.31999969482422,
        295.95599365234375,
        108.72000122070312
      ],
      "page_num": 36,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "management for IT-networks",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        171.36000061035156,
        113.5199966430664,
        325.9200134277344,
        127.91999816894531
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "incorporating medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.51998901367188,
        132.72000122070312,
        326.760009765625,
        147.1199951171875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "– Part 2-1: Step by step",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        178.0800018310547,
        151.9199981689453,
        319.1400146484375,
        166.3199920654297
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "risk management of medical",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        172.8000030517578,
        171.1199951171875,
        324.41998291015625,
        185.51998901367188
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IT-networks–Practical",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        189.83999633789062,
        190.3199920654297,
        307.3799743652344,
        204.71998596191406
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "applications and examples",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        178.44000244140625,
        209.51998901367188,
        318.8399963378906,
        223.91998291015625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크로 연결되는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        132.72000122070312,
        469.3199768066406,
        147.1199951171875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의 위험관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        151.9199981689453,
        469.3199768066406,
        166.3199920654297
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법에 대한 국제 규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        349.32000732421875,
        171.1199951171875,
        475.3199768066406,
        185.51998901367188
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        151.9199981689453,
        523.4400024414062,
        166.3199920654297
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        295.44000244140625,
        149.5439910888672,
        319.4399719238281
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IEC/TR",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.87999725341797,
        295.44000244140625,
        149.5439910888672,
        319.4399719238281
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "80001-2-2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        103.55999755859375,
        314.6399841308594,
        157.9199981689453,
        329.03997802734375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Application of risk",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        201.239990234375,
        237.83999633789062,
        295.95599365234375,
        252.239990234375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "management for IT-networks",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        171.36000061035156,
        257.0400085449219,
        325.9200134277344,
        271.44000244140625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "incorporating medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.51998901367188,
        276.239990234375,
        326.760009765625,
        290.6399841308594
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "–Part 2-2: Guidance for the",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.51998901367188,
        295.44000244140625,
        326.66400146484375,
        309.8399963378906
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "disclosure and",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        210.36000061035156,
        314.6399841308594,
        286.9320068359375,
        329.03997802734375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "communication of medical",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        179.51998901367188,
        333.8399963378906,
        317.6999816894531,
        348.239990234375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "device security needs, risks",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        174.83999633789062,
        353.03997802734375,
        322.44000244140625,
        367.4399719238281
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "and controls",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        216.0,
        372.239990234375,
        281.1600036621094,
        386.6399841308594
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크로 연결되는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        285.8399963378906,
        469.3199768066406,
        300.239990234375
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의 위험관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        355.3199768066406,
        305.03997802734375,
        469.3199768066406,
        319.4399719238281
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법에 대한 국제 규격",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        349.32000732421875,
        324.239990234375,
        475.3199768066406,
        338.6399841308594
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        499.44000244140625,
        305.03997802734375,
        523.4400024414062,
        319.4399719238281
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연번",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.5999984741211,
        546.719970703125,
        525.239990234375,
        561.1199951171875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인 명칭",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.5999984741211,
        546.719970703125,
        525.239990234375,
        561.1199951171875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 내용",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.5999984741211,
        546.719970703125,
        525.239990234375,
        561.1199951171875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비고",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.5999984741211,
        546.719970703125,
        525.239990234375,
        561.1199951171875
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        603.0,
        256.55999755859375,
        627.0
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "디지털치료기기 허가·심사",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        603.0,
        256.55999755859375,
        627.0
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드라인(민원인 안내서)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        112.91999816894531,
        622.2000122070312,
        257.6520080566406,
        636.6000366210938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "「의료기기법」 및 「의료기기법 시행",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        574.2000122070312,
        486.47998046875,
        588.6000366210938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규칙」,「의료기기 허가·신고·심사 등에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        593.3999633789062,
        486.5999755859375,
        607.7999877929688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        612.5999755859375,
        486.5999755859375,
        627.0
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규정」기반,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        612.5999755859375,
        486.5999755859375,
        627.0
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "디지털치료기기에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        612.5999755859375,
        486.5999755859375,
        627.0
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당하는 제품의 범위, 판단기준, 허가·",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        276.6000061035156,
        631.7999877929688,
        486.6119689941406,
        646.2000122070312
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심사 방안 등 제시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        651.0,
        378.6000061035156,
        665.4000244140625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        501.239990234375,
        612.5999755859375,
        525.239990234375,
        627.0
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        696.3599853515625,
        82.19999694824219,
        710.760009765625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        128.27999877929688,
        677.1599731445312,
        242.27999877929688,
        691.5599975585938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "밸리데이션 가이드라인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        122.27999877929688,
        696.3599853515625,
        248.27999877929688,
        710.760009765625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(민원인 안내서)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        142.9199981689453,
        715.5599975585938,
        227.65199279785156,
        729.9600219726562
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        677.1599731445312,
        486.5999755859375,
        691.5599975585938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        677.1599731445312,
        486.5999755859375,
        691.5599975585938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "밸리데이션에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        677.1599731445312,
        486.5999755859375,
        691.5599975585938
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대하여 알기 쉽게 설명하거나 식품",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        696.3599853515625,
        486.5999755859375,
        710.760009765625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의약품안전처의 입장을 기술",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        715.5599975585938,
        438.3599853515625,
        729.9600219726562
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        501.239990234375,
        696.3599853515625,
        525.239990234375,
        710.760009765625
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 8. 디지털치료기기 관련 국내외 가이드라인",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        152.63999938964844,
        518.0399780273438,
        440.8812561035156,
        533.5919799804688
      ],
      "page_num": 36,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 30 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 37,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.19999694824219,
        136.9199981689453,
        82.19999694824219,
        151.3199920654297
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        128.27999877929688,
        117.72000122070312,
        242.27999877929688,
        132.1199951171875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가·심사 가이드라인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        126.0,
        136.9199981689453,
        244.55999755859375,
        151.3199920654297
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(민원인 안내서)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        142.9199981689453,
        156.1199951171875,
        227.65199279785156,
        170.51998901367188
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어의 기술문서 작성",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        88.91999816894531,
        486.47998046875,
        103.31999969482422
      ],
      "page_num": 37,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법에 대하여 상세히 기술하고 ‘의료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        108.1199951171875,
        486.5999755859375,
        122.5199966430664
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기기 소프트웨어 적합성 확인 보고서’,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        127.31999206542969,
        486.5519714355469,
        141.71998596191406
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘의료기기 소프트웨어 검증 및 유효성",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        146.51998901367188,
        486.5999755859375,
        160.91998291015625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "확인’ 자료 등 허가·심사 시 제출해야 할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        165.72000122070312,
        486.5999755859375,
        180.1199951171875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨부자료에 대하여 제시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        184.9199981689453,
        408.6000061035156,
        199.3199920654297
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        501.239990234375,
        136.9199981689453,
        525.239990234375,
        151.3199920654297
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.19999694824219,
        231.36000061035156,
        82.19999694824219,
        245.75999450683594
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의 사이버 보안",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.27999877929688,
        212.1599884033203,
        251.27999877929688,
        226.5599822998047
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허가·심사 가이드라인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        126.0,
        231.36000061035156,
        244.55999755859375,
        245.75999450683594
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(민원인 안내서)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        142.9199981689453,
        250.55999755859375,
        227.65199279785156,
        264.9599914550781
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 허가·심사 시 사용자의 건강에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        202.55999755859375,
        486.5999755859375,
        216.95999145507812
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직접적인 영향을 미칠 수 있는 사이버",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        276.6000061035156,
        221.75999450683594,
        486.47998046875,
        236.1599884033203
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보안 위협에 대하여 적용할 수 있는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        240.95999145507812,
        486.47998046875,
        255.3599853515625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최소한의 권고사항 등 제시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        260.1600036621094,
        426.5999755859375,
        274.55999755859375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        501.239990234375,
        231.36000061035156,
        525.239990234375,
        245.75999450683594
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        297.0,
        82.19999694824219,
        311.3999938964844
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의 사이버 보안",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.27999877929688,
        277.79998779296875,
        251.27999877929688,
        292.1999816894531
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용방법 및 사례집",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        131.27999877929688,
        297.0,
        239.27999877929688,
        311.3999938964844
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(민원인 안내서)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        142.9199981689453,
        316.1999816894531,
        227.65199279785156,
        330.5999755859375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 사이버 보안 적용 방법과 허가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        287.3999938964844,
        486.47998046875,
        301.79998779296875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신청 시 제출하는 자료의 작성 예시를 제시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        306.6000061035156,
        484.67999267578125,
        321.0
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        501.239990234375,
        297.0,
        525.239990234375,
        311.3999938964844
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        343.44000244140625,
        82.19999694824219,
        357.8399963378906
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Off-The-Shelf Software Use",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        109.91999816894531,
        333.8399963378906,
        260.66400146484375,
        348.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "in Medical Devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        134.87998962402344,
        353.03997802734375,
        235.67999267578125,
        367.4399719238281
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기에서의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        333.8399963378906,
        486.5999755859375,
        348.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기성품",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        333.8399963378906,
        486.5999755859375,
        348.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        333.8399963378906,
        486.5999755859375,
        348.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용에 대한 가이던스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        343.44000244140625,
        525.239990234375,
        367.4399719238281
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        343.44000244140625,
        525.239990234375,
        367.4399719238281
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        418.67999267578125,
        82.19999694824219,
        433.0799865722656
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Information for Healthcare",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        116.5199966430664,
        370.67999267578125,
        253.94400024414062,
        385.0799865722656
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Organizations about FDA’S",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.04000091552734,
        389.8800048828125,
        257.47198486328125,
        404.2799987792969
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "“Guidance for Industry:",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        124.31999969482422,
        409.0799865722656,
        246.32400512695312,
        423.47998046875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cybersecurity for Networked",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.5199966430664,
        428.2799987792969,
        260.052001953125,
        442.67999267578125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Medical Devices Containing",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.95999908447266,
        447.47998046875,
        258.5879821777344,
        461.8799743652344
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Off-The-Shelf(OTS) Software”",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        105.5999984741211,
        466.67999267578125,
        264.8999938964844,
        481.0799865722656
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크를 활용하는 의료기기의 사이버",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        276.6000061035156,
        409.0799865722656,
        486.47998046875,
        423.47998046875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보안 가이던스에 대한 정보",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        428.2799987792969,
        426.5999755859375,
        442.67999267578125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        501.239990234375,
        418.67999267578125,
        525.239990234375,
        433.0799865722656
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.19999694824219,
        513.239990234375,
        82.19999694824219,
        527.6400146484375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Guidance for the Content of",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        109.31999969482422,
        484.44000244140625,
        261.17999267578125,
        498.8399963378906
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Premarket Submissions for",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.75999450683594,
        503.6400146484375,
        256.67999267578125,
        518.0400390625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Software Contained in",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        126.23999786376953,
        522.8399658203125,
        244.30799865722656,
        537.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Medical Devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        142.1999969482422,
        542.0399780273438,
        228.3599853515625,
        556.4400024414062
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        503.6400146484375,
        486.5999755859375,
        518.0400390625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포함하는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        503.6400146484375,
        486.5999755859375,
        518.0400390625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        503.6400146484375,
        486.5999755859375,
        518.0400390625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한 시판 전 제출에 대한 가이던스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        513.239990234375,
        525.239990234375,
        537.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        513.239990234375,
        525.239990234375,
        537.239990234375
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        578.8800048828125,
        82.19999694824219,
        593.280029296875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Deciding When to Submit a",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.39999389648438,
        559.6799926757812,
        260.0879821777344,
        574.0800170898438
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "510(k) for a Software Change",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        578.8800048828125,
        265.10400390625,
        593.280029296875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "to an Existing Device",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        127.68000030517578,
        598.0799560546875,
        242.78399658203125,
        612.47998046875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기내 소프트웨어 변경에 따른 지침",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        569.2799682617188,
        486.5999755859375,
        583.6799926757812
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이던스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        578.8800048828125,
        525.239990234375,
        602.8800048828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        578.8800048828125,
        525.239990234375,
        602.8800048828125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.19999694824219,
        634.9199829101562,
        85.19999694824219,
        649.3200073242188
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Postmarket Management of",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.95999908447266,
        615.719970703125,
        258.5400085449219,
        630.1199951171875
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cybersecurity in Medical",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        120.47999572753906,
        634.9199829101562,
        250.01998901367188,
        649.3200073242188
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        164.87998962402344,
        654.1199951171875,
        205.67999267578125,
        668.52001953125
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 사이버 보안의 시판 후 관리에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        625.3200073242188,
        486.47998046875,
        639.7200317382812
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한 가이던스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        634.9199829101562,
        525.239990234375,
        658.9199829101562
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미국",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        276.6000061035156,
        634.9199829101562,
        525.239990234375,
        658.9199829101562
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.19999694824219,
        687.0,
        85.19999694824219,
        701.4000244140625
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Guidance on Cybersecurity",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.5199966430664,
        677.3999633789062,
        256.99200439453125,
        691.7999877929688
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "for medical devices",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        133.55999755859375,
        687.0,
        525.239990234375,
        711.0
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 사이버 보안에 대한 가이드라인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        133.55999755859375,
        687.0,
        525.239990234375,
        711.0
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유럽",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        133.55999755859375,
        687.0,
        525.239990234375,
        711.0
      ],
      "page_num": 37,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 31 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 안전성 평가 항목",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        213.1199951171875,
        109.41996002197266
      ],
      "page_num": 38,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 소프트웨어 검증 및 유효성 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        136.74937438964844,
        305.7599792480469,
        152.56968688964844
      ],
      "page_num": 38,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 개요",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        166.74937438964844,
        126.36000061035156,
        182.56968688964844
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.95999908447266,
        196.74937438964844,
        538.4400024414062,
        212.56968688964844
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        226.74937438964844,
        546.0599975585938,
        242.56968688964844
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        256.7493591308594,
        538.4400024414062,
        272.5696716308594
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        286.7493591308594,
        176.48297119140625,
        302.5696716308594
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.95999908447266,
        316.7493591308594,
        545.9400024414062,
        332.5696716308594
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        346.7493591308594,
        538.4400024414062,
        362.5696716308594
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        376.7493591308594,
        545.9400024414062,
        392.5696716308594
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        406.7493591308594,
        493.282958984375,
        422.5696716308594
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 소프트웨어 개발 및 위험관리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        436.7493591308594,
        298.79998779296875,
        452.5696716308594
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.95999908447266,
        466.7493591308594,
        545.9400024414062,
        482.5696716308594
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        496.7493591308594,
        538.4400024414062,
        512.5697021484375
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        526.7493896484375,
        468.8999938964844,
        542.5697021484375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.95999908447266,
        556.7493896484375,
        538.5599975585938,
        572.5697021484375
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        586.7493896484375,
        537.3229370117188,
        602.5697021484375
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.95999908447266,
        616.7493896484375,
        538.5599975585938,
        632.5697021484375
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        646.7493896484375,
        538.4400024414062,
        662.5697021484375
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "로서의 사용목적을 달성할 수 있음을 증명해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        676.7493896484375,
        453.9229736328125,
        692.5697021484375
      ],
      "page_num": 38,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        99.95999908447266,
        706.7493286132812,
        538.5599975585938,
        722.5696411132812
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세스에 따른다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        736.7493286132812,
        191.48297119140625,
        752.5696411132812
      ],
      "page_num": 38,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 32 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 39,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        109.07999420166016,
        182.63999938964844,
        133.07998657226562
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IEC 62304",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        109.07999420166016,
        182.63999938964844,
        133.07998657226562
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "프로세스",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        128.0399932861328,
        128.27999877929688,
        177.83999633789062,
        142.67999267578125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 개발",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        249.36000061035156,
        118.67999267578125,
        519.9599609375,
        133.07998657226562
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 위험관리",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        249.36000061035156,
        118.67999267578125,
        519.9599609375,
        133.07998657226562
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        178.55999755859375,
        82.31999969482422,
        192.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        438.47998046875,
        141.47999572753906,
        524.8800048828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        438.47998046875,
        141.47999572753906,
        524.8800048828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        438.47998046875,
        141.47999572753906,
        524.8800048828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "프로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        438.47998046875,
        141.47999572753906,
        524.8800048828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        438.47998046875,
        141.47999572753906,
        524.8800048828125
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.75999450683594,
        169.55999755859375,
        202.0800018310547,
        201.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 계획",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        152.75999450683594,
        169.55999755859375,
        202.0800018310547,
        201.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 소프트웨어의 범위, 규모",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        151.55999755859375,
        380.6399841308594,
        219.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "및 소프트웨어 안전에 적합한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        151.55999755859375,
        380.6399841308594,
        219.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 활동을 위하여 소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        151.55999755859375,
        380.6399841308594,
        219.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발 계획을 수립한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        151.55999755859375,
        380.6399841308594,
        219.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        159.36000061035156,
        530.760009765625,
        173.75999450683594
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개발",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        159.36000061035156,
        530.760009765625,
        173.75999450683594
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계획",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        390.8399963378906,
        159.36000061035156,
        530.760009765625,
        173.75999450683594
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "을 수립하면서 동시에 위",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        178.55999755859375,
        530.760009765625,
        192.95999145507812
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "험관리 계획을 수립한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        197.75999450683594,
        525.7799682617188,
        212.1599884033203
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        306.0,
        82.31999969482422,
        320.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.87998962402344,
        288.0,
        201.83999633789062,
        320.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요구사항",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        152.87998962402344,
        288.0,
        201.83999633789062,
        320.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        165.36000061035156,
        324.0,
        189.36000061035156,
        338.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어가 어떤(what) 기능을,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        270.0,
        380.6399841308594,
        302.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "어떻게(how)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        270.0,
        380.6399841308594,
        302.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수행할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        270.0,
        380.6399841308594,
        302.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "것인지에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        270.0,
        380.6399841308594,
        302.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대하여 소프트웨어가 수행할 수",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        306.0,
        380.6399841308594,
        356.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있는 논리적이고 물리적인 표현",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        306.0,
        380.6399841308594,
        356.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 정의한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        306.0,
        380.6399841308594,
        356.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어의 정상 상태 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        238.79998779296875,
        530.760009765625,
        253.19998168945312
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        258.0,
        530.760009765625,
        272.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상태에서의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        258.0,
        530.760009765625,
        272.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잠재적",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        258.0,
        530.760009765625,
        272.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결함을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        277.1999816894531,
        530.760009765625,
        291.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "고려하여",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        390.8399963378906,
        277.1999816894531,
        530.760009765625,
        291.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        277.1999816894531,
        530.760009765625,
        291.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석하고, 해당 위험을 통제",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        296.3999938964844,
        530.760009765625,
        310.79998779296875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하기 위한 조치를 결정한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        315.6000061035156,
        530.7000122070312,
        330.0
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이 중 소프트웨어 설계에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        334.79998779296875,
        530.760009765625,
        349.1999816894531
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당하는 통제 조치를 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        354.0,
        530.760009765625,
        368.3999938964844
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 요구사항에 반영한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        373.1999816894531,
        529.1400146484375,
        387.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.31999969482422,
        463.1999816894531,
        201.83999633789062,
        495.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        463.1999816894531,
        201.83999633789062,
        495.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아키텍처",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        463.1999816894531,
        201.83999633789062,
        495.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 요구사항을 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        409.1999816894531,
        380.6399841308594,
        477.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 구조로 설명하며 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        409.1999816894531,
        380.6399841308594,
        477.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 항목(item)을 식별하는 아키",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        409.1999816894531,
        380.6399841308594,
        477.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "텍처로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        409.1999816894531,
        380.6399841308594,
        477.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변환한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        409.1999816894531,
        380.6399841308594,
        477.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        409.1999816894531,
        380.6399841308594,
        477.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항목과 소프트웨어 항목 외부의",
      "font_size": 11.939848899841309,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        481.1999816894531,
        380.6400451660156,
        513.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구성요소 간의 연계성과 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        481.1999816894531,
        380.6400451660156,
        513.5999755859375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 항목 간 연계성을 위한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        517.2000122070312,
        380.6399841308594,
        549.6000366210938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아키텍처를 개발한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        517.2000122070312,
        380.6399841308594,
        549.6000366210938
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 요구사항에 반영한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        443.3999938964844,
        530.760009765625,
        457.79998779296875
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험통제",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        462.5999755859375,
        530.760009765625,
        476.9999694824219
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조치가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        462.5999755859375,
        530.760009765625,
        476.9999694824219
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실현될",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        462.5999755859375,
        530.760009765625,
        476.9999694824219
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있도록 안전한 구조를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        481.79998779296875,
        530.760009765625,
        496.1999816894531
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "갖추어 설계한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        501.0,
        483.7799987792969,
        515.4000244140625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.31999969482422,
        647.6400146484375,
        202.0800018310547,
        680.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        647.6400146484375,
        202.0800018310547,
        680.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상세 설계",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        647.6400146484375,
        202.0800018310547,
        680.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 아키텍처를 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        566.6400146484375,
        380.6399841308594,
        617.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 유닛으로 표현할 수 있을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        566.6400146484375,
        380.6399841308594,
        617.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "때까지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        566.6400146484375,
        380.6399841308594,
        617.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분해하고,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        566.6400146484375,
        380.6399841308594,
        617.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        566.6400146484375,
        380.6399841308594,
        617.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유닛에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        566.6400146484375,
        380.6399841308594,
        617.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        620.6400146484375,
        380.5799865722656,
        635.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상세",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        620.6400146484375,
        380.5799865722656,
        635.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설계를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        620.6400146484375,
        380.5799865722656,
        635.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수행한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        620.6400146484375,
        380.5799865722656,
        635.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또한 소프트웨어 유닛 및 외부",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구성요인 사이의 연계성 및 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 유닛 사이의 연계성을 위한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상세",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설계를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수행한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상세",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        638.6400146484375,
        380.6399841308594,
        707.0400390625
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설계를 바탕으로 코딩을 하며",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        710.6399536132812,
        380.6399841308594,
        743.0399780273438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "코드는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        710.6399536132812,
        380.6399841308594,
        743.0399780273438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정확하고",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        710.6399536132812,
        380.6399841308594,
        743.0399780273438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구사항에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        710.6399536132812,
        380.6399841308594,
        743.0399780273438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부합한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        746.6399536132812,
        263.2200012207031,
        761.0399780273438
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어 위험통제 조치를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        618.239990234375,
        530.760009765625,
        632.6400146484375
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품에 구현한다. 이때 코드는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        637.4400024414062,
        530.760009765625,
        651.8400268554688
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험관리 프로세스에서 식별한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        656.6400146484375,
        530.760009765625,
        671.0400390625
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안전 요구사항을 정확하게",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        390.8399963378906,
        675.8399658203125,
        530.760009765625,
        690.239990234375
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실현할 수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        695.0399780273438,
        519.7799682617188,
        709.4400024414062
      ],
      "page_num": 39,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 9. 소프트웨어 개발 및 위험관리",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        187.3199920654297,
        86.04000091552734,
        407.4012145996094,
        101.59200286865234
      ],
      "page_num": 39,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 33 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 40,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        87.47999572753906,
        182.63999938964844,
        111.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "IEC 62304",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        87.47999572753906,
        182.63999938964844,
        111.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로세스",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        128.0399932861328,
        106.68000030517578,
        177.83999633789062,
        121.08000183105469
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 개발",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        249.36000061035156,
        97.07999420166016,
        519.9599609375,
        111.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어 위험관리",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        249.36000061035156,
        97.07999420166016,
        519.9599609375,
        111.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        158.39999389648438,
        82.31999969482422,
        172.79998779296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        104.5199966430664,
        202.0800018310547,
        142.3199920654297,
        216.47999572753906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.5199966430664,
        220.0800018310547,
        136.45199584960938,
        288.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "개발",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.5199966430664,
        220.0800018310547,
        136.45199584960938,
        288.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "프로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.5199966430664,
        220.0800018310547,
        136.45199584960938,
        288.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세스)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        110.5199966430664,
        220.0800018310547,
        136.45199584960938,
        288.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.75999450683594,
        149.39999389648438,
        202.0800018310547,
        181.79998779296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유닛 검증",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.75999450683594,
        149.39999389648438,
        202.0800018310547,
        181.79998779296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 유닛에 대한 코드를 검증하는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        131.39999389648438,
        530.760009765625,
        204.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것으로 코드 실행 전에 오류를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        131.39999389648438,
        530.760009765625,
        204.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "파악할 수 있는 “static test” 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        131.39999389648438,
        530.760009765625,
        204.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "“white-box” 방법으로 수행한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        131.39999389648438,
        530.760009765625,
        204.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어 요구사항에서",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        131.39999389648438,
        530.760009765625,
        204.47999572753906
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정의한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        209.27999877929688,
        530.760009765625,
        223.67999267578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험통제",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        209.27999877929688,
        530.760009765625,
        223.67999267578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조치가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        209.27999877929688,
        530.760009765625,
        223.67999267578125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실제 제품에 올바르게 반",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        228.47999572753906,
        530.760009765625,
        242.87998962402344
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "영되었으며, 위험이 효과적",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        247.67999267578125,
        530.760009765625,
        262.0799865722656
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 통제되어 잔여위험이",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        266.8800048828125,
        530.760009765625,
        281.2799987792969
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용 가능함을 검증한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        286.0799865722656,
        525.7799682617188,
        300.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        238.0800018310547,
        201.83999633789062,
        270.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        238.0800018310547,
        201.83999633789062,
        270.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통합 검증",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        238.0800018310547,
        201.83999633789062,
        270.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통합 계획에 따라 소프트웨어를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        220.0800018310547,
        380.6399841308594,
        252.47999572753906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통합하고",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        220.0800018310547,
        380.6399841308594,
        252.47999572753906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통합한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        220.0800018310547,
        380.6399841308594,
        252.47999572753906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        220.0800018310547,
        380.6399841308594,
        252.47999572753906
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항목이 의도한 대로 기능을 발휘",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        256.0799865722656,
        380.6399841308594,
        288.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는지 확인한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        256.0799865722656,
        380.6399841308594,
        288.47998046875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        326.7599792480469,
        82.31999969482422,
        341.15997314453125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.87998962402344,
        308.7599792480469,
        201.83999633789062,
        323.15997314453125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시스템",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        159.36000061035156,
        326.7599792480469,
        195.36000061035156,
        359.15997314453125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검증",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        159.36000061035156,
        326.7599792480469,
        195.36000061035156,
        359.15997314453125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체 소프트웨어 시스템이 요구",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.27999877929688,
        317.7599792480469,
        380.6399841308594,
        350.15997314453125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항을 충족하는지 확인한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        317.7599792480469,
        380.6399841308594,
        350.15997314453125
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.31999969482422,
        439.55999755859375,
        82.31999969482422,
        453.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        473.8799743652344,
        141.47999572753906,
        506.27996826171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        105.47999572753906,
        473.8799743652344,
        141.47999572753906,
        506.27996826171875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.47999572753906,
        509.8800048828125,
        135.47999572753906,
        578.280029296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활동",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.47999572753906,
        509.8800048828125,
        135.47999572753906,
        578.280029296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "프로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.47999572753906,
        509.8800048828125,
        135.47999572753906,
        578.280029296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "세스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        111.47999572753906,
        509.8800048828125,
        135.47999572753906,
        578.280029296875
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.75999450683594,
        430.55999755859375,
        202.0800018310547,
        462.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "형상 관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        152.75999450683594,
        430.55999755859375,
        202.0800018310547,
        462.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어의 출시 후에 발생",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        403.55999755859375,
        380.6399841308594,
        453.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 피드백에 적절히 대응하고,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        403.55999755859375,
        380.6399841308594,
        453.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        403.55999755859375,
        380.6399841308594,
        453.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항목의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        403.55999755859375,
        380.6399841308594,
        453.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일관성을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        403.55999755859375,
        380.6399841308594,
        453.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유지하면서 설계 변경 및 소프트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        457.55999755859375,
        380.6399841308594,
        489.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어 형상을 유지한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        457.55999755859375,
        380.6399841308594,
        489.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "새로운 위험의 발생 또는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기존에 식별한 위험평가의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변경이 필요한 경우, 소프",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "트웨어 형상의 변경이 위해",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요인이 될 수 있는 경우",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험관리 프로세스의 입력",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 식별한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        385.55999755859375,
        530.760009765625,
        507.9599914550781
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        587.3999633789062,
        201.83999633789062,
        619.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        587.3999633789062,
        201.83999633789062,
        619.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문제해결",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.31999969482422,
        587.3999633789062,
        201.83999633789062,
        619.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시판 후 소프트웨어에 문제가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        560.3999633789062,
        380.6399841308594,
        646.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발생하거나 개선의 필요성 때문에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        560.3999633789062,
        380.6399841308594,
        646.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품 또는 관련 문서가 수정되는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        560.3999633789062,
        380.6399841308594,
        646.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경우 문제점과 그 영향 등을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        560.3999633789062,
        380.6399841308594,
        646.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석하여 변경해야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.27999877929688,
        560.3999633789062,
        380.6399841308594,
        646.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시판 후 발견된 문제점을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        533.3999633789062,
        530.760009765625,
        565.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석하고",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        533.3999633789062,
        530.760009765625,
        565.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전과",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        533.3999633789062,
        530.760009765625,
        565.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련된",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        390.8399963378906,
        533.3999633789062,
        530.760009765625,
        565.7999877929688
      ],
      "page_num": 40,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항목은 위험관리 프로세스의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        569.3999633789062,
        530.8200073242188,
        673.7999877929688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입력으로 식별한다. 문제",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        569.3999633789062,
        530.8200073242188,
        673.7999877929688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해결 및 설계 변경은 위험",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        569.3999633789062,
        530.8200073242188,
        673.7999877929688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통제 조치가 될 수 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        569.3999633789062,
        530.8200073242188,
        673.7999877929688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요시 규제 당국에 안전성",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        569.3999633789062,
        530.8200073242188,
        673.7999877929688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관련 보고를 시행한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        390.8399963378906,
        569.3999633789062,
        530.8200073242188,
        673.7999877929688
      ],
      "page_num": 40,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 34 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 소프트웨어 안전성 등급",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        84.90937042236328,
        261.239990234375,
        100.72968292236328
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같이 분류한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        197.1229705810547,
        190.7296905517578
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등급",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        108.0,
        254.63998413085938,
        360.6000061035156,
        269.03997802734375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        108.0,
        254.63998413085938,
        360.6000061035156,
        269.03997802734375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "A등급",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        104.75999450683594,
        282.239990234375,
        437.6999816894531,
        296.6399841308594
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "부상이나 신체적 피해가 발생할 가능성이 없다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        104.75999450683594,
        282.239990234375,
        437.6999816894531,
        296.6399841308594
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "B등급",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        104.87999725341797,
        311.1600036621094,
        456.53997802734375,
        325.55999755859375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심각하지 않은 부상(경상)이 발생할 가능성이 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        104.87999725341797,
        311.1600036621094,
        456.53997802734375,
        325.55999755859375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "C등급",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        104.39999389648438,
        340.1999816894531,
        443.6999816894531,
        354.5999755859375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심각한 부상 또는 사망이 발생할 가능성이 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        104.39999389648438,
        340.1999816894531,
        443.6999816894531,
        354.5999755859375
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 10. 소프트웨어 안전성 등급",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        200.51998901367188,
        225.95999145507812,
        393.9605712890625,
        241.51199340820312
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        401.109375,
        546.0599975585938,
        416.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "토대로 분류할 수 있다. 이때, 발생 가능성은 안전성 등급 결정 시",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        431.109375,
        546.0599975585938,
        446.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하지 않는다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        461.109375,
        213.2029571533203,
        476.9296875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        491.109375,
        545.9400024414062,
        506.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다. 이때 전체",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        521.109375,
        546.0599975585938,
        536.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        551.109375,
        546.0599975585938,
        566.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "높은 등급이 된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        581.109375,
        220.64295959472656,
        596.9296875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 의료기기의 사이버 보안",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        641.109375,
        246.36000061035156,
        656.9296875
      ],
      "page_num": 41,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 개요",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        671.109375,
        126.36000061035156,
        686.9296875
      ],
      "page_num": 41,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        701.109375,
        545.9400024414062,
        716.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        731.109375,
        545.9400024414062,
        746.9296875
      ],
      "page_num": 41,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 35 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 42,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안에 대한 요구사항을 준수해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        84.90937042236328,
        433.97998046875,
        100.72968292236328
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안 필수원칙 체크리스트’를 제출해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        465.6600036621094,
        220.72967529296875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인(민원인 안내서)’에 따른다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        264.90936279296875,
        349.8829650878906,
        280.72967529296875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 사이버 보안 요구사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        294.90936279296875,
        246.36000061035156,
        310.72967529296875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        324.90936279296875,
        538.4400024414062,
        340.72967529296875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        354.90936279296875,
        538.5599975585938,
        370.72967529296875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 총 24개의 요구사항을 제시하고 있다. 본 요구사항은 제품의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        414.90936279296875,
        502.7629699707031,
        430.72967529296875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보안 적용 사항을 기재한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        474.90936279296875,
        288.0829772949219,
        490.72967529296875
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 사이버 보안 위험관리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        504.90936279296875,
        246.36000061035156,
        520.7296752929688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        564.9093627929688,
        538.5599975585938,
        580.7296752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리 결과가 검증되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        594.9093627929688,
        303.0829772949219,
        610.7296752929688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 위험분석",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        624.9093627929688,
        173.87998962402344,
        640.7296752929688
      ],
      "page_num": 42,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        714.9093627929688,
        546.0599975585938,
        730.7296752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해요인들에 대해 <표 11>과 같이 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        744.9093627929688,
        423.2029724121094,
        760.7296752929688
      ],
      "page_num": 42,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 36 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 43,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        114.90937042236328,
        505.52294921875,
        130.72967529296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위해요인",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        90.95999908447266,
        190.1999969482422,
        429.1199951171875,
        211.79998779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구체적인 예시",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        90.95999908447266,
        190.1999969482422,
        429.1199951171875,
        211.79998779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용자 또는 환자에게",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        90.95999908447266,
        190.1999969482422,
        429.1199951171875,
        211.79998779296875
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발생 가능한 손상",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        316.91998291015625,
        197.39999389648438,
        510.8399963378906,
        218.99998474121094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련 자료",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        316.91998291015625,
        197.39999389648438,
        510.8399963378906,
        218.99998474121094
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비 인가된",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        89.15999603271484,
        235.55999755859375,
        143.16000366210938,
        249.95999145507812
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용자의 접근",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        77.15999603271484,
        252.3599853515625,
        155.16000366210938,
        266.7599792480469
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비 인가된 사용자의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        174.1199951171875,
        227.1599884033203,
        282.1199951171875,
        258.3599853515625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접근으로 인해 환자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        174.1199951171875,
        227.1599884033203,
        282.1199951171875,
        258.3599853515625
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데이터 손실",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        195.1199951171875,
        260.7599792480469,
        261.1199951171875,
        275.15997314453125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오진, 잘못된 치료 수행",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        302.5199890136719,
        235.55999755859375,
        431.5199890136719,
        249.95999145507812
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 치료 기회 박탈",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        309.9599914550781,
        252.3599853515625,
        423.9599914550781,
        266.7599792480469
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "국내외",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        459.239990234375,
        235.55999755859375,
        507.239990234375,
        266.7599792480469
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상사례",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        459.239990234375,
        235.55999755859375,
        507.239990234375,
        266.7599792480469
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 11. 위해요인 식별 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        214.1999969482422,
        161.99998474121094,
        380.280029296875,
        177.55198669433594
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 위험평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        320.9493713378906,
        181.37998962402344,
        336.7696838378906
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        350.9493713378906,
        538.5599975585938,
        366.7696838378906
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용 기준을 사용하여 위험 감소가 필요한지 결정한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        380.9493713378906,
        493.1399841308594,
        396.7696838378906
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        410.9493713378906,
        545.9400024414062,
        426.7696838378906
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        440.9493713378906,
        545.9400024414062,
        456.7696838378906
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 가장 낮은 영역(As Low As Reasonably Practicable,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        470.9493713378906,
        546.0599975585938,
        486.7696838378906
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        500.9493408203125,
        546.0599975585938,
        516.7696533203125
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        530.9493408203125,
        546.0599975585938,
        546.7696533203125
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 영역(acceptable)’의 2단계로 구분할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        560.9493408203125,
        450.8029479980469,
        576.7696533203125
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험분석",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        225.83999633789062,
        637.9199829101562,
        514.199951171875,
        652.3200073242188
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험평가",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        225.83999633789062,
        637.9199829101562,
        514.199951171875,
        652.3200073242188
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위해",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요인",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발생 가능한 사례",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해상황",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발생",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심각성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험도",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        72.47999572753906,
        655.5599975585938,
        524.3999633789062,
        681.9600219726562
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        79.08000183105469,
        685.2000122070312,
        91.08000183105469,
        699.6000366210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인가된",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        64.68000030517578,
        702.0,
        105.47999572753906,
        750.0
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.68000030517578,
        702.0,
        105.47999572753906,
        750.0
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의 접근",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.68000030517578,
        702.0,
        105.47999572753906,
        750.0
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용자 구분을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        115.91999816894531,
        685.2000122070312,
        195.1199951171875,
        750.0
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하지 않고 누구나",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        115.91999816894531,
        685.2000122070312,
        195.1199951171875,
        750.0
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환자의 데이터에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        115.91999816894531,
        685.2000122070312,
        195.1199951171875,
        750.0
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접근하도록한경우",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        115.91999816894531,
        685.2000122070312,
        195.1199951171875,
        750.0
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조작된 환자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        205.55999755859375,
        685.2000122070312,
        270.9599914550781,
        733.2000122070312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과 데이터로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        205.55999755859375,
        685.2000122070312,
        270.9599914550781,
        733.2000122070312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전문의 진료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        205.55999755859375,
        685.2000122070312,
        270.9599914550781,
        733.2000122070312
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수행",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        226.1999969482422,
        735.5999755859375,
        250.1999969482422,
        750.0
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오진, 잘못된",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        281.2799987792969,
        693.5999755859375,
        349.44000244140625,
        741.6000366210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 수행 또는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        281.2799987792969,
        693.5999755859375,
        349.44000244140625,
        741.6000366210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 기회 박탈",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        281.2799987792969,
        693.5999755859375,
        349.44000244140625,
        741.6000366210938
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        372.9599914550781,
        710.3999633789062,
        530.9639892578125,
        724.7999877929688
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        372.9599914550781,
        710.3999633789062,
        530.9639892578125,
        724.7999877929688
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        372.9599914550781,
        710.3999633789062,
        530.9639892578125,
        724.7999877929688
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "ALARP",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        372.9599914550781,
        710.3999633789062,
        530.9639892578125,
        724.7999877929688
      ],
      "page_num": 43,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 12. 위험평가 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        231.47999572753906,
        612.1199340820312,
        363.840576171875,
        627.6719360351562
      ],
      "page_num": 43,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 37 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 44,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) 위험통제",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        84.90937042236328,
        181.37998962402344,
        100.72968292236328
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        114.90937042236328,
        538.4400024414062,
        130.72967529296875
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        538.5599975585938,
        160.7296905517578
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        234.90936279296875,
        145.40296936035156,
        250.72967529296875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험통제",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        76.79999542236328,
        306.47998046875,
        126.5999984741211,
        320.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조치",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        89.4000015258789,
        318.47998046875,
        114.0,
        332.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험통제",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        157.1999969482422,
        306.47998046875,
        207.0,
        332.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조치실행",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        157.1999969482422,
        306.47998046875,
        207.0,
        332.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔여위험평가",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        246.83999633789062,
        299.03997802734375,
        321.8399963378906,
        313.4399719238281
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        367.79998779296875,
        312.47998046875,
        392.3999938964844,
        326.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험/",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        417.0,
        300.47998046875,
        445.3559875488281,
        338.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이득",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        417.0,
        300.47998046875,
        445.3559875488281,
        338.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        417.0,
        300.47998046875,
        445.3559875488281,
        338.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "추가",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        458.7599792480469,
        300.47998046875,
        483.3599853515625,
        338.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발생",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        458.7599792480469,
        300.47998046875,
        483.3599853515625,
        338.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        458.7599792480469,
        300.47998046875,
        483.3599853515625,
        338.8799743652344
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통제",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        226.3199920654297,
        306.47998046875,
        521.760009765625,
        340.1999816894531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완료",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        226.3199920654297,
        306.47998046875,
        521.760009765625,
        340.1999816894531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발생",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        226.3199920654297,
        306.47998046875,
        521.760009765625,
        340.1999816894531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가능성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        226.3199920654297,
        306.47998046875,
        521.760009765625,
        340.1999816894531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "심각성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        226.3199920654297,
        306.47998046875,
        521.760009765625,
        340.1999816894531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험도",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        226.3199920654297,
        306.47998046875,
        521.760009765625,
        340.1999816894531
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설계 변경을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.63999938964844,
        350.5199890136719,
        138.36000061035156,
        398.5199890136719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통한 사용자별",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.63999938964844,
        350.5199890136719,
        138.36000061035156,
        398.5199890136719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접근통제 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.63999938964844,
        350.5199890136719,
        138.36000061035156,
        398.5199890136719
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인증 기능 구현",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.68000030517578,
        400.91998291015625,
        139.32000732421875,
        415.3199768066406
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        150.47999572753906,
        342.1199951171875,
        214.3199920654297,
        423.719970703125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검증 자료로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        150.47999572753906,
        342.1199951171875,
        214.3199920654297,
        423.719970703125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접근통제 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        150.47999572753906,
        342.1199951171875,
        214.3199920654297,
        423.719970703125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인증 기능",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        150.47999572753906,
        342.1199951171875,
        214.3199920654297,
        423.719970703125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구현 확인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        150.47999572753906,
        342.1199951171875,
        214.3199920654297,
        423.719970703125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        239.51998901367188,
        375.7200012207031,
        405.8639831542969,
        390.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        239.51998901367188,
        375.7200012207031,
        405.8639831542969,
        390.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        239.51998901367188,
        375.7200012207031,
        405.8639831542969,
        390.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Acceptable",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        239.51998901367188,
        375.7200012207031,
        405.8639831542969,
        390.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        419.5199890136719,
        358.91998291015625,
        443.5199890136719,
        373.3199768066406
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "<",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        428.03997802734375,
        375.7200012207031,
        435.0359802246094,
        390.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이득",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        419.5199890136719,
        392.5199890136719,
        443.5199890136719,
        406.91998291015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        459.3599853515625,
        358.91998291015625,
        483.3599853515625,
        406.91998291015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사항",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        459.3599853515625,
        358.91998291015625,
        483.3599853515625,
        406.91998291015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없음",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        459.3599853515625,
        358.91998291015625,
        483.3599853515625,
        406.91998291015625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        497.7599792480469,
        375.7200012207031,
        521.760009765625,
        390.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 13. 위험통제 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        227.27999877929688,
        276.0,
        359.76055908203125,
        291.552001953125
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 전체 잔여위험 허용 가능성 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        468.54937744140625,
        338.7599792480469,
        484.36968994140625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        498.54937744140625,
        546.0599975585938,
        514.3696899414062
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        528.5493774414062,
        545.9400024414062,
        544.3696899414062
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        558.5493774414062,
        546.0599975585938,
        574.3696899414062
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        588.5493774414062,
        170.2429656982422,
        604.3696899414062
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잔여위험평가",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        88.91999816894531,
        664.0799560546875,
        163.9199981689453,
        678.47998046875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        215.51998901367188,
        673.9199829101562,
        321.239990234375,
        696.7200317382812
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험/이득",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        215.51998901367188,
        673.9199829101562,
        321.239990234375,
        696.7200317382812
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "분석",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        282.239990234375,
        690.719970703125,
        306.8399963378906,
        705.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "추가 발생",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        332.7599792480469,
        673.9199829101562,
        381.1199951171875,
        688.3200073242188
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        344.6399841308594,
        690.719970703125,
        369.239990234375,
        705.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통제",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        393.0,
        673.9199829101562,
        417.6000061035156,
        705.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완료",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        393.0,
        673.9199829101562,
        417.6000061035156,
        705.1199951171875
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전체 잔여위험",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        438.5999755859375,
        665.5199584960938,
        519.5999755859375,
        679.9199829101562
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "허용 가능성 평가",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        429.239990234375,
        682.3200073242188,
        528.8399658203125,
        713.52001953125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(허용 가능/불가)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        429.239990234375,
        682.3200073242188,
        528.8399658203125,
        713.52001953125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발생",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.4000015258789,
        682.6799926757812,
        187.0800018310547,
        713.8800048828125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.4000015258789,
        682.6799926757812,
        187.0800018310547,
        713.8800048828125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "심각성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.4000015258789,
        682.6799926757812,
        187.0800018310547,
        713.8800048828125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험도",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        65.4000015258789,
        682.6799926757812,
        187.0800018310547,
        713.8800048828125
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        78.72000122070312,
        720.8399658203125,
        313.2359924316406,
        743.6400146484375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        78.72000122070312,
        720.8399658203125,
        313.2359924316406,
        743.6400146484375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        78.72000122070312,
        720.8399658203125,
        313.2359924316406,
        743.6400146484375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Acceptable",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        78.72000122070312,
        720.8399658203125,
        313.2359924316406,
        743.6400146484375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위험 <",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        78.72000122070312,
        720.8399658203125,
        313.2359924316406,
        743.6400146484375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이득",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        282.8399963378906,
        737.6399536132812,
        306.8399963378906,
        752.0399780273438
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당사항",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        333.239990234375,
        720.8399658203125,
        381.239990234375,
        735.239990234375
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없음",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        345.239990234375,
        729.239990234375,
        506.3999938964844,
        752.0399780273438
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "완료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        345.239990234375,
        729.239990234375,
        506.3999938964844,
        752.0399780273438
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "허용 가능",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        345.239990234375,
        729.239990234375,
        506.3999938964844,
        752.0399780273438
      ],
      "page_num": 44,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "표 14. 전체 잔여위험 허용 가능성 평가 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        156.1199951171875,
        639.5999755859375,
        437.28057861328125,
        655.1519775390625
      ],
      "page_num": 44,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 38 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 45,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 사이버 보안 적용 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        84.90937042236328,
        253.79998779296875,
        100.72968292236328
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        537.2029418945312,
        220.72967529296875
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하에서 해당 되는 것을 체크한다. 통신목적, 공용 네트워크 망의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 45,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용여부 등을 체크리스트를 이용하여 기술한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        294.90936279296875,
        430.6429443359375,
        310.72967529296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등급",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        108.47999572753906,
        374.03997802734375,
        361.0799865722656,
        388.4399719238281
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        108.47999572753906,
        374.03997802734375,
        361.0799865722656,
        388.4399719238281
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        115.07999420166016,
        405.1199951171875,
        127.07999420166016,
        419.5199890136719
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(major)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        103.31999969482422,
        419.5199890136719,
        138.73199462890625,
        433.91998291015625
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.0399932861328,
        402.7200012207031,
        527.83203125,
        417.1199951171875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.0399932861328,
        421.91998291015625,
        527.219970703125,
        436.3199768066406
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        115.07999420166016,
        454.44000244140625,
        127.07999420166016,
        468.8399963378906
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(moderate)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        93.36000061035156,
        468.8399963378906,
        148.69198608398438,
        483.239990234375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.0399932861328,
        452.03997802734375,
        528.0,
        466.4399719238281
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상해, 의학적 중재가 필요할 수 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.0399932861328,
        471.239990234375,
        373.97998046875,
        485.6399841308594
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        115.07999420166016,
        500.8800048828125,
        127.07999420166016,
        515.280029296875
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(minor)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        103.31999969482422,
        515.2799682617188,
        138.73199462890625,
        529.6799926757812
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.0399932861328,
        498.47998046875,
        527.8800048828125,
        512.8800048828125
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        170.0399932861328,
        517.6799926757812,
        525.7799682617188,
        532.0800170898438
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 15. 의료기기 사이버 보안 안전성 등급 분류",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        157.3199920654297,
        346.79998779296875,
        452.0400390625,
        362.35198974609375
      ],
      "page_num": 45,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 39 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 46,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "<예시> - 사이버보안 필수원칙 체크리스트",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        346.1999816894531,
        100.72968292236328
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "< 의료기기 사이버 보안 특성 기재 >",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        60.84000015258789,
        117.47999572753906,
        275.30401611328125,
        131.87998962402344
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 사이버 보안 안전성 등급 : □상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        72.83999633789062,
        136.67999267578125,
        349.1999816894531,
        151.07998657226562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■중",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        72.83999633789062,
        136.67999267578125,
        349.1999816894531,
        151.07998657226562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□하",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        72.83999633789062,
        136.67999267578125,
        349.1999816894531,
        151.07998657226562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 사용되는 통신 기술 : LAN, Wi-fi",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        72.83999633789062,
        155.87998962402344,
        267.41998291015625,
        170.2799835205078
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 통신 목적 :",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        72.83999633789062,
        175.0800018310547,
        421.1999816894531,
        189.47999572753906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "■ 환자의 생체정보 등의 개인의료정보 송수신",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        72.83999633789062,
        175.0800018310547,
        421.1999816894531,
        189.47999572753906
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 기기제어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        162.83999633789062,
        194.27999877929688,
        228.83999633789062,
        208.67999267578125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 펌웨어 또는 소프트웨어 업데이트 등 유지보수",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        162.83999633789062,
        213.47999572753906,
        438.8399963378906,
        227.87998962402344
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        72.83999633789062,
        232.67999267578125,
        355.1999816894531,
        247.07998657226562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버보안 필수원칙",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        118.19999694824219,
        287.1600036621094,
        349.67999267578125,
        318.3599853515625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당기기",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        118.19999694824219,
        287.1600036621094,
        349.67999267578125,
        318.3599853515625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용여부",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        118.19999694824219,
        287.1600036621094,
        349.67999267578125,
        318.3599853515625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적합성",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        362.7599792480469,
        278.7599792480469,
        399.9599914550781,
        293.15997314453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입증",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        369.1199951171875,
        295.55999755859375,
        393.7200012207031,
        326.7599792480469
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방법",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        369.1199951171875,
        295.55999755859375,
        393.7200012207031,
        326.7599792480469
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        426.9599914550781,
        278.7599792480469,
        451.55999755859375,
        293.15997314453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "법규 및",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        417.7200012207031,
        295.55999755859375,
        460.91998291015625,
        309.9599914550781
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "규격",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        426.9599914550781,
        312.3599853515625,
        451.55999755859375,
        326.7599792480469
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        490.79998779296875,
        270.3599853515625,
        515.4000244140625,
        284.7599792480469
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "첨부자료",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        478.1999816894531,
        287.1600036621094,
        528.0,
        301.55999755859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        490.79998779296875,
        303.9599914550781,
        515.4000244140625,
        318.3599853515625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문서번호",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        478.1999816894531,
        320.7599792480469,
        528.0,
        335.15997314453125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 식별 및 보호",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        61.79999923706055,
        339.47998046875,
        152.27999877929688,
        353.8799743652344
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.1 접근통제 및 인증",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        358.1999816894531,
        178.67999267578125,
        372.5999755859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식별 및 인증에 기반하여 사용자(의료기기)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        391.79998779296875,
        294.1319885253906,
        456.5999755859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "역할에 따른 접근 권한을 부여가 가능하고",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        391.79998779296875,
        294.1319885253906,
        456.5999755859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접근 권한에 따라 인가된 데이터에만 접근",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        391.79998779296875,
        294.1319885253906,
        456.5999755859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가능해야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        391.79998779296875,
        294.1319885253906,
        456.5999755859375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        393.1199951171875,
        392.760009765625,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        393.1199951171875,
        392.760009765625,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        393.1199951171875,
        392.760009765625,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        377.7599792480469,
        465.95947265625,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        377.7599792480469,
        465.95947265625,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        377.7599792480469,
        465.95947265625,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        423.9599914550781,
        457.16400146484375,
        437.2080078125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        393.1199951171875,
        530.2804565429688,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        393.1199951171875,
        530.2804565429688,
        421.8479919433594
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.2 다중접속 금지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        457.0799865722656,
        160.67999267578125,
        471.47998046875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동일 사용자가 다중으로 접속하지 않아야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        490.67999267578125,
        294.1199951171875,
        521.8800048828125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        490.67999267578125,
        294.1199951171875,
        521.8800048828125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        475.1999816894531,
        392.760009765625,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        475.1999816894531,
        392.760009765625,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        475.1999816894531,
        392.760009765625,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        459.8399658203125,
        465.95947265625,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        459.8399658203125,
        465.95947265625,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        459.8399658203125,
        465.95947265625,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        506.0400085449219,
        457.16400146484375,
        519.2880249023438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        475.1999816894531,
        530.2804565429688,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        475.1999816894531,
        530.2804565429688,
        503.8079833984375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.3 사용자(의료기기) 접속 인식",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        522.239990234375,
        233.51998901367188,
        536.6400146484375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비인가된",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        555.8399658203125,
        294.1199951171875,
        570.239990234375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용자(의료기기)가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        555.8399658203125,
        294.1199951171875,
        570.239990234375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접속될",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        555.8399658203125,
        294.1199951171875,
        570.239990234375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        555.8399658203125,
        294.1199951171875,
        570.239990234375
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이를 인식하여 구분할 수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.6400146484375,
        274.5,
        587.0400390625
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        540.3599853515625,
        392.760009765625,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        540.3599853515625,
        392.760009765625,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        540.3599853515625,
        392.760009765625,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        525.0,
        465.95947265625,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        525.0,
        465.95947265625,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        525.0,
        465.95947265625,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        571.2000122070312,
        457.16400146484375,
        584.447998046875
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        540.3599853515625,
        530.2804565429688,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        540.3599853515625,
        530.2804565429688,
        569.0880126953125
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.4 비인가된 사용자(의료기기) 접속 제한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        587.5199584960938,
        287.5199890136719,
        601.9199829101562
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비인가된 사용자(의료기기)의 접속 시 접",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        621.1199951171875,
        294.1199951171875,
        652.3200073242188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "속을 제한할 수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        621.1199951171875,
        294.1199951171875,
        652.3200073242188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        605.6400146484375,
        392.760009765625,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        605.6400146484375,
        392.760009765625,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        605.6400146484375,
        392.760009765625,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        590.280029296875,
        465.95947265625,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        590.280029296875,
        465.95947265625,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        590.280029296875,
        465.95947265625,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        636.47998046875,
        457.16400146484375,
        649.7279663085938
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        605.6400146484375,
        530.2804565429688,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        605.6400146484375,
        530.2804565429688,
        634.2479858398438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.5 비인가된 네트워크 통신 차단",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        652.6799926757812,
        244.67999267578125,
        667.0800170898438
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비인가된",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        686.2799682617188,
        294.1199951171875,
        700.6799926757812
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "네트워크",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        686.2799682617188,
        294.1199951171875,
        700.6799926757812
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통신",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        686.2799682617188,
        294.1199951171875,
        700.6799926757812
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "접속을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        686.2799682617188,
        294.1199951171875,
        700.6799926757812
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제한할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        686.2799682617188,
        294.1199951171875,
        700.6799926757812
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        703.0799560546875,
        148.74000549316406,
        717.47998046875
      ],
      "page_num": 46,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        670.7999877929688,
        392.760009765625,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        670.7999877929688,
        392.760009765625,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        670.7999877929688,
        392.760009765625,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        655.4400024414062,
        465.95947265625,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        655.4400024414062,
        465.95947265625,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        655.4400024414062,
        465.95947265625,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        701.6400146484375,
        457.16400146484375,
        714.8880004882812
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        670.7999877929688,
        530.2804565429688,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        670.7999877929688,
        530.2804565429688,
        699.5280151367188
      ],
      "page_num": 46,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 40 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.6 원격접속 차단",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        84.72000122070312,
        160.67999267578125,
        99.12000274658203
      ],
      "page_num": 47,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용자(의료기기)가 의료기관의 서버에 접속할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        183.1199951171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있는 경우, 사용자 계정 또는 의료기기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        183.1199951171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "도난 시 해당 계정(의료기기)이 서버에 접속할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        183.1199951171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 없도록 접근통제를 할 수 있어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        183.1199951171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        119.6399917602539,
        392.760009765625,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        119.6399917602539,
        392.760009765625,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        119.6399917602539,
        392.760009765625,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        104.15999603271484,
        465.95947265625,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        104.15999603271484,
        465.95947265625,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        104.15999603271484,
        465.95947265625,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        150.36000061035156,
        457.16400146484375,
        163.6079864501953
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        119.6399917602539,
        530.2804565429688,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        119.6399917602539,
        530.2804565429688,
        148.24798583984375
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.7 사용자(의료기기) 인증 관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        183.47999572753906,
        233.51998901367188,
        197.87998962402344
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용자(의료기기) 계정의 유효기간을 설정할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        217.0800018310547,
        294.1199951171875,
        265.0799865722656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수 있어야 하며, 설정된 유효기간 만료 시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        217.0800018310547,
        294.1199951171875,
        265.0799865722656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접근이 통제되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        217.0800018310547,
        294.1199951171875,
        265.0799865722656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        210.0,
        392.760009765625,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        210.0,
        392.760009765625,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        210.0,
        392.760009765625,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        194.63999938964844,
        465.95947265625,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        194.63999938964844,
        465.95947265625,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        194.63999938964844,
        465.95947265625,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        240.83999633789062,
        457.16400146484375,
        254.08798217773438
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        210.0,
        530.2804565429688,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        210.0,
        530.2804565429688,
        238.7279815673828
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.8 자동세션종료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        265.55999755859375,
        154.67999267578125,
        279.9599914550781
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정된 시간 이후에는 의료기기간의 통신",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        299.1600036621094,
        294.1199951171875,
        330.3599853515625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 접속이 종료되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        299.1600036621094,
        294.1199951171875,
        330.3599853515625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        283.67999267578125,
        392.760009765625,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        283.67999267578125,
        392.760009765625,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        283.67999267578125,
        392.760009765625,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        268.1999816894531,
        465.95947265625,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        268.1999816894531,
        465.95947265625,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        268.1999816894531,
        465.95947265625,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        314.3999938964844,
        457.16400146484375,
        327.64801025390625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        283.67999267578125,
        530.2804565429688,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        283.67999267578125,
        530.2804565429688,
        312.2879943847656
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.9 비밀번호 작성 규칙 강화",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        330.7200012207031,
        220.67999267578125,
        345.1199951171875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비밀번호 작성규칙은 ‘개인정보의 기술적·",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        364.3199768066406,
        294.1319885253906,
        395.5199890136719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관리적 보호조치 기준’을 만족하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        364.3199768066406,
        294.1319885253906,
        395.5199890136719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        348.8399963378906,
        392.760009765625,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        348.8399963378906,
        392.760009765625,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        348.8399963378906,
        392.760009765625,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        333.47998046875,
        465.95947265625,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        333.47998046875,
        465.95947265625,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        333.47998046875,
        465.95947265625,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        379.67999267578125,
        457.16400146484375,
        392.9280090332031
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        348.8399963378906,
        530.2804565429688,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        348.8399963378906,
        530.2804565429688,
        377.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.10 비밀번호 하드코딩 금지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        401.7599792480469,
        220.67999267578125,
        416.15997314453125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비밀번호를 하드코딩하지 않아야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        435.3599853515625,
        274.739990234375,
        449.7599792480469
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        411.47998046875,
        392.760009765625,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        411.47998046875,
        392.760009765625,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        411.47998046875,
        392.760009765625,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        396.1199951171875,
        465.95947265625,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        396.1199951171875,
        465.95947265625,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        396.1199951171875,
        465.95947265625,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        442.3199768066406,
        457.16400146484375,
        455.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        411.47998046875,
        530.2804565429688,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        411.47998046875,
        530.2804565429688,
        440.0880126953125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.11 비밀번호 노출 금지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        456.0,
        196.67999267578125,
        470.3999938964844
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비밀번호를 입력 시 ***와 같이 노출되지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        489.5999755859375,
        294.1199951171875,
        520.7999877929688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않는 형태로 사용되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        489.5999755859375,
        294.1199951171875,
        520.7999877929688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        474.1199951171875,
        392.760009765625,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        474.1199951171875,
        392.760009765625,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        474.1199951171875,
        392.760009765625,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        458.7599792480469,
        465.95947265625,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        458.7599792480469,
        465.95947265625,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        458.7599792480469,
        465.95947265625,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        504.9599914550781,
        457.16400146484375,
        518.2080078125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        474.1199951171875,
        530.2804565429688,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        474.1199951171875,
        530.2804565429688,
        502.7279968261719
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.12 펌웨어 또는 소프트웨어 업데이트의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        521.1599731445312,
        294.1199951171875,
        552.3599853515625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        521.1599731445312,
        294.1199951171875,
        552.3599853515625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "펌웨어 또는 소프트웨어 업데이트 시 관리자의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        571.5599975585938,
        294.1199951171875,
        653.1600341796875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인가를 요청 및 확인하는 절차가 있거나",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        571.5599975585938,
        294.1199951171875,
        653.1600341796875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관리자 또는 사용자가 인지할 수 있는 거리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        571.5599975585938,
        294.1199951171875,
        653.1600341796875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에서 보안이 보장되는 방법으로 수행되어야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        571.5599975585938,
        294.1199951171875,
        653.1600341796875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        571.5599975585938,
        294.1199951171875,
        653.1600341796875
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        572.8800048828125,
        392.760009765625,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        572.8800048828125,
        392.760009765625,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        572.8800048828125,
        392.760009765625,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        557.52001953125,
        465.95947265625,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        557.52001953125,
        465.95947265625,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        557.52001953125,
        465.95947265625,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        603.7200317382812,
        457.16400146484375,
        616.968017578125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        572.8800048828125,
        530.2804565429688,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        572.8800048828125,
        530.2804565429688,
        601.6079711914062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.13 펌웨어 또는 소프트웨어 업데이트의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        653.6400146484375,
        294.1199951171875,
        684.8400268554688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무결성 보장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        653.6400146484375,
        294.1199951171875,
        684.8400268554688
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "펌웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        704.0399780273438,
        294.1199951171875,
        718.4400024414062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        704.0399780273438,
        294.1199951171875,
        718.4400024414062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        704.0399780273438,
        294.1199951171875,
        718.4400024414062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "업데이트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        704.0399780273438,
        294.1199951171875,
        718.4400024414062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "파일",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        704.0399780273438,
        294.1199951171875,
        718.4400024414062
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배포 시 버전 식별이 가능하여야 하며, 파일에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        720.8399658203125,
        294.1199951171875,
        768.8400268554688
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 배포자 및 무결성을 검증할 수 있어야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        720.8399658203125,
        294.1199951171875,
        768.8400268554688
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        720.8399658203125,
        294.1199951171875,
        768.8400268554688
      ],
      "page_num": 47,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        696.9600219726562,
        392.760009765625,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        696.9600219726562,
        392.760009765625,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        696.9600219726562,
        392.760009765625,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        681.6000366210938,
        465.95947265625,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        681.6000366210938,
        465.95947265625,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        681.6000366210938,
        465.95947265625,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        727.7999877929688,
        457.16400146484375,
        741.0479736328125
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        696.9600219726562,
        530.2804565429688,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        696.9600219726562,
        530.2804565429688,
        725.5679931640625
      ],
      "page_num": 47,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 41 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.14 펌웨어 또는 소프트웨어 업데이트 시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        84.72000122070312,
        294.1199951171875,
        99.12000274658203
      ],
      "page_num": 48,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인증 방식 사용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.04000091552734,
        101.5199966430664,
        173.0399932861328,
        115.91999816894531
      ],
      "page_num": 48,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "펌웨어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        135.1199951171875,
        294.1199951171875,
        149.51998901367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        135.1199951171875,
        294.1199951171875,
        149.51998901367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트웨어의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        135.1199951171875,
        294.1199951171875,
        149.51998901367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "업데이트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        135.1199951171875,
        294.1199951171875,
        149.51998901367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        135.1199951171875,
        294.1199951171875,
        149.51998901367188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "코드 서명 확인 등 인증된 코드로 제한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        151.9199981689453,
        294.1199951171875,
        183.1199951171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        151.9199981689453,
        294.1199951171875,
        183.1199951171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        119.6399917602539,
        392.760009765625,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        119.6399917602539,
        392.760009765625,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        119.6399917602539,
        392.760009765625,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        104.15999603271484,
        465.95947265625,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        104.15999603271484,
        465.95947265625,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        104.15999603271484,
        465.95947265625,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        150.36000061035156,
        457.16400146484375,
        163.6079864501953
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        119.6399917602539,
        530.2804565429688,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        119.6399917602539,
        530.2804565429688,
        148.24798583984375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.15 네트워크상의 의료기기 제어정보 전송",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        183.47999572753906,
        294.1199951171875,
        197.87998962402344
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기밀성 및 무결성 보장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.04000091552734,
        200.27999877929688,
        215.0399932861328,
        214.67999267578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크를 통하여 의료기기 제어정보를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        233.87998962402344,
        294.1199951171875,
        298.67999267578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주고받을 경우 적절한 암호화 및 복호화",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        233.87998962402344,
        294.1199951171875,
        298.67999267578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방식을 활용하여 기밀성과 무결성을 보장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        233.87998962402344,
        294.1199951171875,
        298.67999267578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        233.87998962402344,
        294.1199951171875,
        298.67999267578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        226.8000030517578,
        392.760009765625,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        226.8000030517578,
        392.760009765625,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        226.8000030517578,
        392.760009765625,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        211.44000244140625,
        465.95947265625,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        211.44000244140625,
        465.95947265625,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        211.44000244140625,
        465.95947265625,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        257.6399841308594,
        457.16400146484375,
        270.88800048828125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        226.8000030517578,
        530.2804565429688,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        226.8000030517578,
        530.2804565429688,
        255.52798461914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.16 네트워크 상의 개인의료정보 전송",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        299.1600036621094,
        294.1199951171875,
        313.55999755859375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기밀성 및 무결성 보장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        88.79999542236328,
        315.9599914550781,
        218.75999450683594,
        330.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크를 통하여 개인의료정보를 주고",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        349.55999755859375,
        294.1199951171875,
        414.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "받을 경우 적절한 암호화 및 복호화 방식을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        349.55999755859375,
        294.1199951171875,
        414.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "활용하여 기밀성과 무결성을 보장하여야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        349.55999755859375,
        294.1199951171875,
        414.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        349.55999755859375,
        294.1199951171875,
        414.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        342.47998046875,
        392.760009765625,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        342.47998046875,
        392.760009765625,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        342.47998046875,
        392.760009765625,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        326.9999694824219,
        465.95947265625,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        326.9999694824219,
        465.95947265625,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        326.9999694824219,
        465.95947265625,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        373.1999816894531,
        457.16400146484375,
        386.447998046875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        342.47998046875,
        530.2804565429688,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        342.47998046875,
        530.2804565429688,
        371.0880126953125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.17 안전한 암호 알고리즘 사용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        414.7200012207031,
        238.67999267578125,
        429.1199951171875
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데이터 전송 및 저장 시 사용되는 암호",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        448.3199768066406,
        294.1199951171875,
        529.9199829101562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "알고리즘은 112비트 이상 보안강도를 가진",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        448.3199768066406,
        294.1199951171875,
        529.9199829101562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검증된 암호 알고리즘 또는 모듈을 사용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        448.3199768066406,
        294.1199951171875,
        529.9199829101562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여야 하며, 암호화 시 사용되는 암호키는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        448.3199768066406,
        294.1199951171875,
        529.9199829101562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전하게 관리되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        448.3199768066406,
        294.1199951171875,
        529.9199829101562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        458.03997802734375,
        392.760009765625,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        458.03997802734375,
        392.760009765625,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        458.03997802734375,
        392.760009765625,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        442.67999267578125,
        465.95947265625,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        442.67999267578125,
        465.95947265625,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        442.67999267578125,
        465.95947265625,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        488.8799743652344,
        457.16400146484375,
        502.12799072265625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        458.03997802734375,
        530.2804565429688,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        458.03997802734375,
        530.2804565429688,
        486.76800537109375
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.18 물리적인 통신포트 침해의 최소화",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        530.3999633789062,
        274.67999267578125,
        544.7999877929688
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통신포트의 침해를 최소화하기 위해 기기에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        564.0,
        294.1199951171875,
        595.2000122070312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "물리적인 잠금을 제공하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        564.0,
        294.1199951171875,
        595.2000122070312
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        548.52001953125,
        392.760009765625,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        548.52001953125,
        392.760009765625,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        548.52001953125,
        392.760009765625,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        533.0400390625,
        465.95947265625,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        533.0400390625,
        465.95947265625,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        533.0400390625,
        465.95947265625,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        579.239990234375,
        457.16400146484375,
        592.4879760742188
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        548.52001953125,
        530.2804565429688,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        548.52001953125,
        530.2804565429688,
        577.1279907226562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.19 불필요한 서비스 제거 또는 비활성화",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        595.5599975585938,
        292.67999267578125,
        609.9600219726562
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불필요한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        629.1599731445312,
        294.1199951171875,
        643.5599975585938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외부",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        629.1599731445312,
        294.1199951171875,
        643.5599975585938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접속",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        61.79999923706055,
        629.1599731445312,
        294.1199951171875,
        643.5599975585938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "포트",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        629.1599731445312,
        294.1199951171875,
        643.5599975585938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        629.1599731445312,
        294.1199951171875,
        643.5599975585938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서비스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        629.1599731445312,
        294.1199951171875,
        643.5599975585938
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비활성화를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        645.9599609375,
        294.1199951171875,
        660.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기본값으로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        645.9599609375,
        294.1199951171875,
        660.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설정하고,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        645.9599609375,
        294.1199951171875,
        660.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "외부",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        645.9599609375,
        294.1199951171875,
        660.3599853515625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "접속 포트를 사용할 경우 비밀번호 설정,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        662.760009765625,
        294.1199951171875,
        710.760009765625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IP 제한 등의 추가적인 보안 조치를 수행",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        662.760009765625,
        294.1199951171875,
        710.760009765625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        662.760009765625,
        294.1199951171875,
        710.760009765625
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        638.8800048828125,
        392.760009765625,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        638.8800048828125,
        392.760009765625,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        638.8800048828125,
        392.760009765625,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        623.52001953125,
        465.95947265625,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        623.52001953125,
        465.95947265625,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        623.52001953125,
        465.95947265625,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        669.7200317382812,
        457.16400146484375,
        682.968017578125
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        638.8800048828125,
        530.2804565429688,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        638.8800048828125,
        530.2804565429688,
        667.6079711914062
      ],
      "page_num": 48,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 42 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.20 개인의료정보 저장관리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        84.72000122070312,
        214.67999267578125,
        99.12000274658203
      ],
      "page_num": 49,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기관 외부에서 사용되는 측정기기 또는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        166.3199920654297
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "게이트웨이에는 개인의료정보를 저장하지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        166.3199920654297
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않는 것을 권고한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        118.31999206542969,
        294.1199951171875,
        166.3199920654297
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        111.23999786376953,
        392.760009765625,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        111.23999786376953,
        392.760009765625,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        111.23999786376953,
        392.760009765625,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        95.75999450683594,
        465.95947265625,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        95.75999450683594,
        465.95947265625,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        95.75999450683594,
        465.95947265625,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        141.9600067138672,
        457.16400146484375,
        155.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        111.23999786376953,
        530.2804565429688,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        111.23999786376953,
        530.2804565429688,
        139.84799194335938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 탐지, 대응, 복구",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        61.79999923706055,
        171.0,
        172.0800018310547,
        185.39999389648438
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.1 데이터 감사를 위한 시스템 로그 기록",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        190.0800018310547,
        292.67999267578125,
        204.47999572753906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용자의 의료기기에 접속 시 접속기록,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        223.67999267578125,
        294.1199951171875,
        271.67999267578125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "환자정보 조회, 데이터 생성, 변경, 삭제",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        223.67999267578125,
        294.1199951171875,
        271.67999267578125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "등과 같은 로그가 기록되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        223.67999267578125,
        294.1199951171875,
        271.67999267578125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        216.47999572753906,
        392.760009765625,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        216.47999572753906,
        392.760009765625,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        216.47999572753906,
        392.760009765625,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        201.1199951171875,
        465.95947265625,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        201.1199951171875,
        465.95947265625,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        201.1199951171875,
        465.95947265625,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        247.3199920654297,
        457.16400146484375,
        260.5679931640625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        216.47999572753906,
        530.2804565429688,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        216.47999572753906,
        530.2804565429688,
        245.20799255371094
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.2 주요 실행파일 및 설정파일에 대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        272.0400085449219,
        294.1199951171875,
        286.44000244140625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "무결성 검증 및 대응",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        288.8399963378906,
        200.63999938964844,
        303.239990234375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        322.44000244140625,
        294.1199951171875,
        336.8399963378906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        322.44000244140625,
        294.1199951171875,
        336.8399963378906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동작을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        322.44000244140625,
        294.1199951171875,
        336.8399963378906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보장하기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        322.44000244140625,
        294.1199951171875,
        336.8399963378906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위해",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        322.44000244140625,
        294.1199951171875,
        336.8399963378906
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 실행 파일 및 설정파일에 대한 무결성을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        339.239990234375,
        294.1199951171875,
        387.239990234375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검증하여야 하며, 무결성 오류 발생 시 대응",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        339.239990234375,
        294.1199951171875,
        387.239990234375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방안을 고려하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        339.239990234375,
        294.1199951171875,
        387.239990234375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        315.3599853515625,
        392.760009765625,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        315.3599853515625,
        392.760009765625,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        315.3599853515625,
        392.760009765625,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        299.9999694824219,
        465.95947265625,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        299.9999694824219,
        465.95947265625,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        299.9999694824219,
        465.95947265625,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        346.1999816894531,
        457.16400146484375,
        359.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        315.3599853515625,
        530.2804565429688,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        315.3599853515625,
        530.2804565429688,
        343.9679870605469
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.3 사이버 보안 위협 탐지 시 취해야 할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        387.7200012207031,
        294.0,
        402.1199951171875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대응책에 관한 정보 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        83.75999450683594,
        404.5199890136719,
        221.75999450683594,
        418.91998291015625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기의 사용 중 발생하는 사이버 보안",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        438.1199951171875,
        294.1199951171875,
        536.52001953125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사고에 대하여 긴급 연락처 및 기기의 제조자와",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        438.1199951171875,
        294.1199951171875,
        536.52001953125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상담을 할 수 있는 연락방식을 제공하여야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        438.1199951171875,
        294.1199951171875,
        536.52001953125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하며, 사이버 보안 위협 탐지 시 취해야 할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        438.1199951171875,
        294.1199951171875,
        536.52001953125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대응책을 수립하고 사용자에게 제공하여야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        438.1199951171875,
        294.1199951171875,
        536.52001953125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        438.1199951171875,
        294.1199951171875,
        536.52001953125
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "적용",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        447.719970703125,
        392.760009765625,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        447.719970703125,
        392.760009765625,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        447.719970703125,
        392.760009765625,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘IEC 62304’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        413.2799987792969,
        432.3599853515625,
        465.95947265625,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘스마트 의료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        432.3599853515625,
        465.95947265625,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        413.2799987792969,
        432.3599853515625,
        465.95947265625,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가이드’",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        422.03997802734375,
        478.5599670410156,
        457.16400146484375,
        491.8079833984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험보고서",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        447.719970703125,
        530.2804565429688,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(AB-1234)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        476.5199890136719,
        447.719970703125,
        530.2804565429688,
        476.447998046875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2.4 DDoS 공격에 대한 방어",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        539.1599731445312,
        215.51998901367188,
        553.5599975585938
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공용 네트워크망에 접속하여 의료기기를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.760009765625,
        294.1199951171875,
        671.1600341796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실시간으로 제어 또는 환자 생명과 직접적",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.760009765625,
        294.1199951171875,
        671.1600341796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로 연관될 수 있는 정보(예: 사이버 보안",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.760009765625,
        294.1199951171875,
        671.1600341796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "안전성 등급 ‘상’에 해당되는 정보 등)를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.760009765625,
        294.1199951171875,
        671.1600341796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실시간으로 송수신하는 장비의 경우 DDoS",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.760009765625,
        294.1199951171875,
        671.1600341796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "공격에 대한 대응책이 수립되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        61.79999923706055,
        572.760009765625,
        294.1199951171875,
        671.1600341796875
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        316.32000732421875,
        590.8800048828125,
        338.3999938964844,
        619.4879760742188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없음",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        316.32000732421875,
        590.8800048828125,
        338.3999938964844,
        619.4879760742188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단독",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        365.1600036621094,
        537.0,
        398.15966796875,
        611.8079833984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소프트",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        365.1600036621094,
        537.0,
        398.15966796875,
        611.8079833984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "웨어로",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        365.1600036621094,
        537.0,
        398.15966796875,
        611.8079833984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실시간",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        365.1600036621094,
        537.0,
        398.15966796875,
        611.8079833984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "감시",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        365.1600036621094,
        537.0,
        398.15966796875,
        611.8079833984375
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목적으로",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        360.7200012207031,
        614.0399780273438,
        402.7206115722656,
        642.6480102539062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용되지",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        360.7200012207031,
        614.0399780273438,
        402.7206115722656,
        642.6480102539062
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않는",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        365.1600036621094,
        644.760009765625,
        398.15966796875,
        673.4879760742188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제품임",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        365.1600036621094,
        644.760009765625,
        398.15966796875,
        673.4879760742188
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        436.44000244140625,
        597.9599609375,
        506.4960021972656,
        612.3599853515625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        436.44000244140625,
        597.9599609375,
        506.4960021972656,
        612.3599853515625
      ],
      "page_num": 49,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 43 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 성능 평가 항목",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        63.119998931884766,
        92.01995849609375,
        195.72000122070312,
        107.97996520996094
      ],
      "page_num": 50,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        134.94937133789062,
        546.0599975585938,
        150.76968383789062
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        164.94937133789062,
        545.9400024414062,
        180.76968383789062
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능한 정량적이고 구체적으로 작성한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        194.94937133789062,
        338.1229553222656,
        210.76968383789062
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        224.94937133789062,
        517.97998046875,
        240.76968383789062
      ],
      "page_num": 50,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 제품의 사용목적상 필요한 기능(능력) 요구사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        254.94937133789062,
        425.8800048828125,
        270.7696838378906
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 소프트웨어 기반 알람, 경고, 연산 메시지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        284.9493713378906,
        387.0,
        300.7696838378906
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 데이터베이스 요구사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        314.9493713378906,
        259.08001708984375,
        330.7696838378906
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 운영 방법 및 유지보수 방법과 관련된 요구사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        344.9493713378906,
        431.3999938964844,
        360.7696838378906
      ],
      "page_num": 50,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 44 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 51,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.68000030517578,
        97.31999969482422,
        527.5199584960938,
        111.72000122070312
      ],
      "page_num": 51,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다. 실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        65.15999603271484,
        121.31999206542969,
        527.5199584960938,
        135.71998596191406
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "작성하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.15999603271484,
        145.3199920654297,
        155.33999633789062,
        159.71998596191406
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        217.55430603027344,
        94.91999816894531,
        237.50547790527344
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연번",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        63.959999084472656,
        260.6399841308594,
        456.9599914550781,
        275.03997802734375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 항목",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        63.959999084472656,
        260.6399841308594,
        456.9599914550781,
        275.03997802734375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험 기준",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        63.959999084472656,
        260.6399841308594,
        456.9599914550781,
        275.03997802734375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험방법",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        63.959999084472656,
        260.6399841308594,
        456.9599914550781,
        275.03997802734375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        298.79998779296875,
        79.55999755859375,
        313.1999816894531
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "최소",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        125.63999938964844,
        289.1999816894531,
        149.63999938964844,
        303.5999755859375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "응답시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.63999938964844,
        308.3999938964844,
        161.63999938964844,
        322.79998779296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OO초 미만일 것",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        210.239990234375,
        298.79998779296875,
        300.239990234375,
        313.1999816894531
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OOO 기능이 구현되도록 입력값을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        289.1999816894531,
        529.2000122070312,
        303.5999755859375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입력한 후 그에 대한 응답시간을 측정",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        308.3999938964844,
        527.5199584960938,
        322.79998779296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        347.8800048828125,
        170.63999938964844,
        362.2799987792969
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "메모리 크기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        347.8800048828125,
        170.63999938964844,
        362.2799987792969
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "App memory size는 최소",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        186.95999145507812,
        338.2799987792969,
        323.5199890136719,
        352.67999267578125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OO MB 이상일 것",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        204.59999084472656,
        357.47998046875,
        305.8800048828125,
        371.8799743652344
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설치될 기기의 메모리 공간을 확인한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        338.2799987792969,
        528.4199829101562,
        352.67999267578125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(ex : 설정→애플리케이션→메모리)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        357.47998046875,
        525.2520141601562,
        371.8799743652344
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        73.55999755859375,
        395.6399841308594,
        170.63999938964844,
        410.03997802734375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경고 메시지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        395.6399841308594,
        170.63999938964844,
        410.03997802734375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‘OOOOO’ 경고 푸시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        200.0399932861328,
        386.03997802734375,
        310.44000244140625,
        400.4399719238281
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "알림이 발생할 것",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        207.239990234375,
        405.239990234375,
        303.239990234375,
        419.6399841308594
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "해당 알림이 발생하는 조건을 정하고,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        386.03997802734375,
        529.1520385742188,
        400.4399719238281
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실제 제품에 구현시킨다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        405.239990234375,
        470.3399963378906,
        419.6399841308594
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        73.55999755859375,
        454.55999755859375,
        79.55999755859375,
        468.9599914550781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데이터베이스",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        101.63999938964844,
        444.9599914550781,
        173.63999938964844,
        459.3599853515625
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "송수신",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.63999938964844,
        464.1600036621094,
        155.63999938964844,
        478.55999755859375
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "데이터베이스에 저장했던",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        186.239990234375,
        435.3599853515625,
        324.239990234375,
        449.7599792480469
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정보와 다시 호출한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        201.239990234375,
        454.55999755859375,
        309.239990234375,
        468.9599914550781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정보가 일치할 것",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        207.239990234375,
        473.7599792480469,
        303.239990234375,
        488.15997314453125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "네트워크 API를 통해 데이터베이스로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        435.3599853515625,
        529.2000122070312,
        449.7599792480469
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미리 정해진 데이터를 송신 및 저장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        454.55999755859375,
        529.2000122070312,
        468.9599914550781
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 후, 해당 데이터를 불러오기 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        473.7599792480469,
        528.0599975585938,
        488.15997314453125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        530.8800048828125,
        170.63999938964844,
        554.8800048828125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중복 로그인",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        530.8800048828125,
        170.63999938964844,
        554.8800048828125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        125.63999938964844,
        550.0800170898438,
        149.63999938964844,
        564.4800415039062
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다른 디바이스에서 같은",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        189.239990234375,
        502.08001708984375,
        321.239990234375,
        516.4800415039062
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "휴대폰 번호로 동시에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        195.239990234375,
        521.2799682617188,
        315.239990234375,
        535.6799926757812
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로그인을 시도했을 때,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        193.8000030517578,
        540.47998046875,
        316.7519836425781,
        554.8800048828125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기존 로그인되어 있던",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        195.239990234375,
        559.6799926757812,
        315.239990234375,
        574.0800170898438
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기기에서는 로그아웃될 것",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        188.51998901367188,
        578.8800048828125,
        321.9599914550781,
        593.280029296875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한 기기에 시험용 정보로 로그인을 한 후,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        521.2799682617188,
        529.1520385742188,
        535.6799926757812
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다른 기기에서 같은 정보로 로그인을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        540.47998046875,
        529.2000122070312,
        554.8800048828125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시도한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        559.6799926757812,
        386.3399963378906,
        574.0800170898438
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        625.3200073242188,
        164.63999938964844,
        649.3200073242188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 평가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.55999755859375,
        625.3200073242188,
        164.63999938964844,
        649.3200073242188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정확도",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.63999938964844,
        644.5199584960938,
        155.63999938964844,
        658.9199829101562
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 효율 예상값",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        207.239990234375,
        615.719970703125,
        303.239990234375,
        630.1199951171875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대비 결과값 차이는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        201.239990234375,
        634.9199829101562,
        309.239990234375,
        649.3200073242188
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "± 1% 이내일 것",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        210.0,
        654.1199951171875,
        300.47998046875,
        668.52001953125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 효율을 구하기 위해, 임의의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        606.1199951171875,
        529.2000122070312,
        620.52001953125
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험용 수명입력정보를 입력했을 때,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        625.3200073242188,
        529.1520385742188,
        639.7200317382812
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "산출되는 결과값과 예상값을 비교",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        644.5199584960938,
        529.2000122070312,
        658.9199829101562
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        335.3999938964844,
        663.719970703125,
        362.3399963378906,
        678.1199951171875
      ],
      "page_num": 51,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 45 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅲ",
      "font_size": 20.03999900817871,
      "font_name": "T9",
      "bbox": [
        68.4000015258789,
        97.07999420166016,
        508.32000732421875,
        121.12799835205078
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험계획서 작성 시 고려사항 및 예시",
      "font_size": 20.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        68.4000015258789,
        97.07999420166016,
        508.32000732421875,
        121.12799835205078
      ],
      "page_num": 52,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        162.3093719482422,
        545.9400024414062,
        178.1296844482422
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험계획서에 포함되어야 할 사항은 다음과 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        192.3093719482422,
        439.04296875,
        208.1296844482422
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 임상시험의 제목",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        222.2624969482422,
        195.0,
        235.93124389648438
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 임상시험기관의 명칭 및 소재지",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        243.1425018310547,
        285.9599914550781,
        256.8112487792969
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        263.9024963378906,
        448.4399719238281,
        277.5712585449219
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 임상시험용 의료기기를 관리하는 관리자의 성명 및 직명",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        284.6624755859375,
        435.4804992675781,
        298.33123779296875
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. 임상시험을 하려는 자의 성명 및 주소",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        305.54248046875,
        324.9599914550781,
        319.21124267578125
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. 임상시험의 목적 및 배경",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        326.302490234375,
        246.9600067138672,
        339.97125244140625
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7. 임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        347.0624694824219,
        503.2499694824219,
        360.7312316894531
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8. 임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        367.9424743652344,
        539.9999389648438,
        381.6112365722656
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        97.79999542236328,
        388.7024841308594,
        480.239990234375,
        402.3712463378906
      ],
      "page_num": 52,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 임상시험기간",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        409.46246337890625,
        175.56105041503906,
        423.1312255859375
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10. 임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        430.34246826171875,
        496.16998291015625,
        444.01123046875
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11. 관찰항목ㆍ임상검사항목 및 관찰검사방법",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        451.10247802734375,
        344.5205078125,
        464.771240234375
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12. 예측되는 부작용 및 사용 시 주의사항",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        471.86248779296875,
        324.96051025390625,
        485.53125
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "13. 중지ㆍ탈락 기준",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        492.7424621582031,
        195.1205291748047,
        506.4112243652344
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14. 유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        513.5025024414062,
        480.6899719238281,
        527.1712646484375
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15. 부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        534.262451171875,
        455.0404968261719,
        547.9312133789062
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16. 피험자동의서 서식",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        555.1424560546875,
        208.0800018310547,
        568.8112182617188
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17. 피해자 보상에 대한 규약",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        575.9024658203125,
        247.08053588867188,
        589.5712280273438
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18. 임상시험 후 피험자의 진료에 관한 사항",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        596.6624755859375,
        338.0404968261719,
        610.3312377929688
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19. 피험자의 안전보호에 관한 대책",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        617.54248046875,
        286.08050537109375,
        631.2112426757812
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20. 그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        61.68000030517578,
        638.302490234375,
        497.1601867675781,
        651.9712524414062
      ],
      "page_num": 52,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        70.08000183105469,
        689.1599731445312,
        531.359619140625,
        704.7119750976562
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        92.15999603271484,
        715.199951171875,
        531.3598022460938,
        730.751953125
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변경이 가능하다.",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        92.15999603271484,
        741.239990234375,
        196.3751983642578,
        756.7919921875
      ],
      "page_num": 52,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 46 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 53,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 임상시험의 제목",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        59.52000045776367,
        99.09996032714844,
        200.16000366210938,
        115.0599594116211
      ],
      "page_num": 53,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        78.1199951171875,
        155.2799835205078,
        529.9204711914062,
        170.8319854736328
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        65.15999603271484,
        181.3199920654297,
        428.335205078125,
        196.8719940185547
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        376.67431640625,
        94.91999816894531,
        396.62548828125
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        412.8693542480469,
        546.0599975585938,
        428.6896667480469
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        442.8693542480469,
        545.9400024414062,
        458.6896667480469
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전향적 무작위 확증 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        472.8693542480469,
        257.03997802734375,
        488.6896667480469
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증),",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        502.869384765625,
        508.1629638671875,
        518.689697265625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[G47.0] Disorders of initiating and maintaining sleep",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        182.75999450683594,
        532.869384765625,
        545.9400024414062,
        548.689697265625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[insomnias] (수면 개시 및 유지 장애[불면증])",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        182.75999450683594,
        562.869384765625,
        489.12750244140625,
        578.689697265625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        592.869384765625,
        512.760009765625,
        608.689697265625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        622.869384765625,
        494.2874755859375,
        638.689697265625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        652.869384765625,
        537.4874877929688,
        668.689697265625
      ],
      "page_num": 53,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        682.869384765625,
        522.719970703125,
        698.689697265625
      ],
      "page_num": 53,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 47 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 54,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 임상시험기관의 명칭 및 소재지",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        317.1596984863281,
        109.41996002197266
      ],
      "page_num": 54,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.55999755859375,
        148.44000244140625,
        528.1199951171875,
        162.83999633789062
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        172.44000244140625,
        528.1199951171875,
        186.83999633789062
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        196.44000244140625,
        528.1199951171875,
        210.83999633789062
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        220.4399871826172,
        409.5,
        234.83998107910156
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        291.9543151855469,
        94.91999816894531,
        311.9054870605469
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험기관",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        328.14935302734375,
        146.63999938964844,
        343.96966552734375
      ],
      "page_num": 54,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기관명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        100.07999420166016,
        363.6000061035156,
        488.1600036621094,
        378.0
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소재지",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        100.07999420166016,
        363.6000061035156,
        488.1600036621094,
        378.0
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        100.07999420166016,
        363.6000061035156,
        488.1600036621094,
        378.0
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팩스",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        100.07999420166016,
        363.6000061035156,
        488.1600036621094,
        378.0
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.04000091552734,
        384.1199951171875,
        521.280029296875,
        398.5199890136719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○시 ○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        89.04000091552734,
        384.1199951171875,
        521.280029296875,
        398.5199890136719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        89.04000091552734,
        384.1199951171875,
        521.280029296875,
        398.5199890136719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        89.04000091552734,
        384.1199951171875,
        521.280029296875,
        398.5199890136719
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        89.04000091552734,
        404.5199890136719,
        521.280029296875,
        418.91998291015625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○시 ○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        89.04000091552734,
        404.5199890136719,
        521.280029296875,
        418.91998291015625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        89.04000091552734,
        404.5199890136719,
        521.280029296875,
        418.91998291015625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        89.04000091552734,
        404.5199890136719,
        521.280029296875,
        418.91998291015625
      ],
      "page_num": 54,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 48 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. 임상시험 책임자·담당자 및 공동연구자의 성명 및 직명",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        501.1199951171875,
        109.41996002197266
      ],
      "page_num": 55,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.79999542236328,
        140.75999450683594,
        460.3800048828125,
        155.1599884033203
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.79999542236328,
        164.75999450683594,
        531.0,
        179.1599884033203
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.27999877929688,
        188.75999450683594,
        531.0,
        203.1599884033203
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하기에 충분한 경험이 있는 자가 선정되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.27999877929688,
        212.75999450683594,
        373.2599792480469,
        227.1599884033203
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.79999542236328,
        236.75999450683594,
        531.0,
        251.1599884033203
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.27999877929688,
        260.7599792480469,
        531.0,
        275.15997314453125
      ],
      "page_num": 55,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관여하는 사람을 말한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.27999877929688,
        284.7599792480469,
        222.17999267578125,
        299.15997314453125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.79999542236328,
        308.7599792480469,
        442.1399841308594,
        323.15997314453125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.79999542236328,
        332.7599792480469,
        531.1199951171875,
        347.15997314453125
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.27999877929688,
        356.7599792480469,
        528.7799682617188,
        371.15997314453125
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        395.3943176269531,
        94.91999816894531,
        415.3454895019531
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 시험책임자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        431.7093505859375,
        157.44000244140625,
        447.5296630859375
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        462.8399963378906,
        489.0,
        477.239990234375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소속기관명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        462.8399963378906,
        489.0,
        477.239990234375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        462.8399963378906,
        489.0,
        477.239990234375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직위",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        462.8399963378906,
        489.0,
        477.239990234375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        462.8399963378906,
        489.0,
        477.239990234375
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        477.7200012207031,
        522.1199951171875,
        492.1199951171875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        100.43999481201172,
        477.7200012207031,
        522.1199951171875,
        492.1199951171875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        477.7200012207031,
        522.1199951171875,
        492.1199951171875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        477.7200012207031,
        522.1199951171875,
        492.1199951171875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        477.7200012207031,
        522.1199951171875,
        492.1199951171875
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 시험담당자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        519.1893920898438,
        157.44000244140625,
        535.0097045898438
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        550.3200073242188,
        489.0,
        564.7200317382812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소속기관명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        550.3200073242188,
        489.0,
        564.7200317382812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        550.3200073242188,
        489.0,
        564.7200317382812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직위",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        550.3200073242188,
        489.0,
        564.7200317382812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.83999633789062,
        550.3200073242188,
        489.0,
        564.7200317382812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        565.2000122070312,
        522.1199951171875,
        579.6000366210938
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        100.43999481201172,
        565.2000122070312,
        522.1199951171875,
        579.6000366210938
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        565.2000122070312,
        522.1199951171875,
        579.6000366210938
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        565.2000122070312,
        522.1199951171875,
        579.6000366210938
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        100.43999481201172,
        565.2000122070312,
        522.1199951171875,
        579.6000366210938
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 공동연구자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        606.6693725585938,
        157.44000244140625,
        622.4896850585938
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        637.7999877929688,
        476.2799987792969,
        652.2000122070312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소속기관명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        637.7999877929688,
        476.2799987792969,
        652.2000122070312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        637.7999877929688,
        476.2799987792969,
        652.2000122070312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직위",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        637.7999877929688,
        476.2799987792969,
        652.2000122070312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        637.7999877929688,
        476.2799987792969,
        652.2000122070312
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        652.5599975585938,
        509.3999938964844,
        666.9600219726562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        99.0,
        652.5599975585938,
        509.3999938964844,
        666.9600219726562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        652.5599975585938,
        509.3999938964844,
        666.9600219726562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        652.5599975585938,
        509.3999938964844,
        666.9600219726562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        652.5599975585938,
        509.3999938964844,
        666.9600219726562
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 임상시험 조정자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        694.0293579101562,
        194.51998901367188,
        709.8496704101562
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        725.2799682617188,
        476.2799987792969,
        739.6799926757812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소속기관명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        725.2799682617188,
        476.2799987792969,
        739.6799926757812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        725.2799682617188,
        476.2799987792969,
        739.6799926757812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직위",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        725.2799682617188,
        476.2799987792969,
        739.6799926757812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        104.39999389648438,
        725.2799682617188,
        476.2799987792969,
        739.6799926757812
      ],
      "page_num": 55,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        740.0399780273438,
        509.3999938964844,
        754.4400024414062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        99.0,
        740.0399780273438,
        509.3999938964844,
        754.4400024414062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        740.0399780273438,
        509.3999938964844,
        754.4400024414062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        740.0399780273438,
        509.3999938964844,
        754.4400024414062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        99.0,
        740.0399780273438,
        509.3999938964844,
        754.4400024414062
      ],
      "page_num": 55,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 49 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 56,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. 임상시험용 의료기기를 관리하는 관리자의 성명 및 직명",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        501.1199951171875,
        109.41996002197266
      ],
      "page_num": 56,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.55999755859375,
        143.0399932861328,
        528.239990234375,
        157.4399871826172
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        167.0399932861328,
        528.239990234375,
        181.4399871826172
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        191.0399932861328,
        528.239990234375,
        205.4399871826172
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "할 경우 이를 함께 관리한다. 임상시험용 의료기기 관리자의 성명, 소속 기관명 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        215.0399932861328,
        528.239990234375,
        229.4399871826172
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직명 등 인적사항을 기재한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        239.0399932861328,
        226.25999450683594,
        253.4399871826172
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        310.0743103027344,
        94.91999816894531,
        330.0254821777344
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기 관리자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        346.3893737792969,
        169.0800018310547,
        362.2096862792969
      ],
      "page_num": 56,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        98.27999877929688,
        380.3999938964844,
        481.55999755859375,
        394.79998779296875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소속기관명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        98.27999877929688,
        380.3999938964844,
        481.55999755859375,
        394.79998779296875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전공",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        98.27999877929688,
        380.3999938964844,
        481.55999755859375,
        394.79998779296875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직위",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        98.27999877929688,
        380.3999938964844,
        481.55999755859375,
        394.79998779296875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        98.27999877929688,
        380.3999938964844,
        481.55999755859375,
        394.79998779296875
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        92.87999725341797,
        400.79998779296875,
        514.6799926757812,
        415.1999816894531
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○병원",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        92.87999725341797,
        400.79998779296875,
        514.6799926757812,
        415.1999816894531
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        92.87999725341797,
        400.79998779296875,
        514.6799926757812,
        415.1999816894531
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        92.87999725341797,
        400.79998779296875,
        514.6799926757812,
        415.1999816894531
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        92.87999725341797,
        400.79998779296875,
        514.6799926757812,
        415.1999816894531
      ],
      "page_num": 56,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 50 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. 임상시험을 하려는 자의 성명 및 주소",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        365.15997314453125,
        115.0599594116211
      ],
      "page_num": 57,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.79999542236328,
        154.67999267578125,
        533.760009765625,
        169.07998657226562
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 의료기기의 제조업자 또는 수입업자가 해당된다. 의뢰자는 임상시험 모니터",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        64.55999755859375,
        178.67999267578125,
        533.0399780273438,
        193.07998657226562
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요원을 지정하여야 한다. 임상시험 모니터요원의 선정, 자격기준, 수행임무 등에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        202.67999267578125,
        533.6400146484375,
        217.07998657226562
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        226.67999267578125,
        533.760009765625,
        241.07998657226562
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "머목(모니터링)에서 정하고 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        250.67999267578125,
        247.6199951171875,
        265.0799865722656
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        316.7943115234375,
        94.91999816894531,
        336.7454833984375
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 의뢰자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        352.9893798828125,
        127.68000030517578,
        368.8096923828125
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회사명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.04000091552734,
        387.0,
        456.239990234375,
        401.3999938964844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대표이사",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.04000091552734,
        387.0,
        456.239990234375,
        401.3999938964844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소재지",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.04000091552734,
        387.0,
        456.239990234375,
        401.3999938964844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.04000091552734,
        387.0,
        456.239990234375,
        401.3999938964844
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㈜○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.0,
        407.5199890136719,
        501.47998046875,
        421.91998291015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.0,
        407.5199890136719,
        501.47998046875,
        421.91998291015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○ ○○시 ○○구",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        90.0,
        407.5199890136719,
        501.47998046875,
        421.91998291015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○- ○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.0,
        407.5199890136719,
        501.47998046875,
        421.91998291015625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 모니터요원",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        451.8693542480469,
        157.44000244140625,
        467.6896667480469
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회사명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        485.7599792480469,
        456.47998046875,
        500.15997314453125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대표이사",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        485.7599792480469,
        456.47998046875,
        500.15997314453125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소재지",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        485.7599792480469,
        456.47998046875,
        500.15997314453125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        485.7599792480469,
        456.47998046875,
        500.15997314453125
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㈜○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.1199951171875,
        506.27996826171875,
        501.5999755859375,
        520.6799926757812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.1199951171875,
        506.27996826171875,
        501.5999755859375,
        520.6799926757812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○ ○○시 ○○구",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        90.1199951171875,
        506.27996826171875,
        501.5999755859375,
        520.6799926757812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○- ○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.1199951171875,
        506.27996826171875,
        501.5999755859375,
        520.6799926757812
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 임상시험 수탁업체",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        550.6293334960938,
        209.27999877929688,
        566.4496459960938
      ],
      "page_num": 57,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "회사명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        584.6400146484375,
        456.47998046875,
        599.0400390625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대표이사",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        584.6400146484375,
        456.47998046875,
        599.0400390625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소재지",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        584.6400146484375,
        456.47998046875,
        599.0400390625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        95.27999877929688,
        584.6400146484375,
        456.47998046875,
        599.0400390625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "㈜○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.1199951171875,
        605.0399780273438,
        501.5999755859375,
        619.4400024414062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.1199951171875,
        605.0399780273438,
        501.5999755859375,
        619.4400024414062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○○ ○○시 ○○구",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        90.1199951171875,
        605.0399780273438,
        501.5999755859375,
        619.4400024414062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○○- ○○-○○○○",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        90.1199951171875,
        605.0399780273438,
        501.5999755859375,
        619.4400024414062
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 임상시험",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        75.0,
        637.5599365234375,
        538.4395141601562,
        653.1119384765625
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수탁기관(Contact Research Organization, CRO)이",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        75.0,
        637.5599365234375,
        538.4395141601562,
        653.1119384765625
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 경우",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        75.0,
        637.5599365234375,
        538.4395141601562,
        653.1119384765625
      ],
      "page_num": 57,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 내용을 기재함",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        94.43999481201172,
        663.5999755859375,
        214.559814453125,
        679.1519775390625
      ],
      "page_num": 57,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 51 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6. 임상시험의 목적 및 배경",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        269.1600036621094,
        109.41996002197266
      ],
      "page_num": 58,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.68000030517578,
        139.9199981689453,
        530.8800048828125,
        154.3199920654297
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        163.9199981689453,
        530.8800048828125,
        178.3199920654297
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        187.9199981689453,
        530.8800048828125,
        202.3199920654297
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        211.9199981689453,
        530.8800048828125,
        226.3199920654297
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        235.9199981689453,
        117.41999816894531,
        250.3199920654297
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 임상시험의 목적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        299.58935546875,
        194.51998901367188,
        315.40966796875
      ],
      "page_num": 58,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        328.914306640625,
        94.91999816894531,
        348.865478515625
      ],
      "page_num": 58,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[목적]",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        365.2293701171875,
        110.64468383789062,
        381.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        395.2293701171875,
        536.6400146484375,
        411.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        425.2293701171875,
        536.6400146484375,
        441.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        485.2293701171875,
        546.0599975585938,
        501.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        515.2293701171875,
        538.4400024414062,
        531.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Straten et al., 2018). 임상에서 불면증 환자들에게 주로 사용되는 치료는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        545.2293701171875,
        546.0599975585938,
        561.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약물치료이다. 약물치료는 불면증의 단기 치료에 있어서 그 유용성이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        575.2293701171875,
        546.0599975585938,
        591.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        605.2293701171875,
        545.9400024414062,
        621.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증가 등의 부작용의 위험성이 있다. 또한, 최근의 연구들은 수면제의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        635.2293701171875,
        546.0599975585938,
        651.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        665.2293701171875,
        546.0599975585938,
        681.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        695.2293701171875,
        543.7799682617188,
        711.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        725.2293701171875,
        538.4400024414062,
        741.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(CBT-I)이다. 불면증 인지행동치료(CBT-I)는 단기적으로는 약물",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        755.2293701171875,
        538.5599975585938,
        771.0496826171875
      ],
      "page_num": 58,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 52 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 59,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        538.4400024414062,
        100.72968292236328
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        457.1399841308594,
        160.7296905517578
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "약물치료에 비해 현저히 낮다 (Riemann D et al., 2011). 불면증 인지행동",
      "font_size": 14.880475997924805,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        538.4429321289062,
        220.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        538.4400024414062,
        310.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        545.9400024414062,
        370.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이 현실이다. 셋째, 치료진 관점에서 약물치료에 비해 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        538.5599975585938,
        460.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        546.0599975585938,
        490.72967529296875
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선호도가 떨어지는 경향이 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        278.1229553222656,
        520.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        534.9093627929688,
        538.5599975585938,
        550.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료(Digital CBT-I)가 개발되고 있다. 디지털 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        538.4400024414062,
        580.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "받을 수 있도록 하는 것이다 (Strom et al. 2004). 이를 통해 환자들이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        538.5599975585938,
        760.7296752929688
      ],
      "page_num": 59,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 53 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        481.04296875,
        100.72968292236328
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다. 특히, 최근",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        538.5599975585938,
        220.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개념을 추구하고 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        210.68296813964844,
        310.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검증하고자 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        180.66000366210938,
        400.72967529296875
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 임상시험의 배경",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        194.51998901367188,
        460.72967529296875
      ],
      "page_num": 60,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        474.35430908203125,
        94.91999816894531,
        494.30548095703125
      ],
      "page_num": 60,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        510.54937744140625,
        545.9400024414062,
        526.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        540.5493774414062,
        546.0599975585938,
        556.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고도화된 소프트웨어 의료기기를 가리킨다.",
      "font_size": 15.0,
      "font_name": "Haansoft Batang",
      "bbox": [
        56.63999938964844,
        570.5493774414062,
        340.0199890136719,
        586.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        597.3900146484375,
        545.9400024414062,
        616.8900146484375
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        630.5493774414062,
        545.9400024414062,
        646.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상에서 사용되고 있다. Somryst™는 여러 무작위배정 임상시험을 통해 그",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        658.5899658203125,
        545.9400024414062,
        676.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        690.5493774414062,
        545.9400024414062,
        706.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        720.5493774414062,
        546.0599975585938,
        736.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바 있다. 아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        750.5493774414062,
        546.0599975585938,
        766.3696899414062
      ],
      "page_num": 60,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 54 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 61,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관련하여 수행한 임상시험의 선행연구 결과들이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        405.5629577636719,
        100.72968292236328
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        114.90937042236328,
        538.4400024414062,
        130.72967529296875
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al. 2016.).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        537.0829467773438,
        310.72967529296875
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그림 5. 불면증 개선 디지털치료기기 임상시험 선행연구 결과 1",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        98.87999725341797,
        521.3999633789062,
        495.6000061035156,
        536.9519653320312
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: Christensen et al., 2016.)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.63999938964844,
        541.0800170898438,
        382.5719909667969,
        555.4800415039062
      ],
      "page_num": 61,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        583.869384765625,
        545.9400024414062,
        599.689697265625
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        613.869384765625,
        545.9400024414062,
        629.689697265625
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        643.869384765625,
        546.0599975585938,
        659.689697265625
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        673.869384765625,
        546.0599975585938,
        689.689697265625
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인되었다 (Ritterband et al., 2017).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        703.869384765625,
        306.6829528808594,
        719.689697265625
      ],
      "page_num": 61,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 55 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 62,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그림 6. 불면증 개선 디지털치료기기 임상시험 선행연구 결과 2",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        106.43999481201172,
        579.9599609375,
        503.0400085449219,
        595.511962890625
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: Ritterband et al., 2017)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        219.36000061035156,
        599.5199584960938,
        390.76226806640625,
        615.0719604492188
      ],
      "page_num": 62,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        659.2293701171875,
        538.5599975585938,
        675.0496826171875
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그램과 다음과 같은 차이점을 가진다. 첫째, 일방향적인 콘텐츠 제공을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        689.2293701171875,
        545.9400024414062,
        705.0496826171875
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "넘어 쌍방향적인 피드백을 제공한다. 대상자의 수면에 대한 변수를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        719.2293701171875,
        545.9400024414062,
        735.0496826171875
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        749.2293701171875,
        545.9400024414062,
        765.0496826171875
      ],
      "page_num": 62,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 56 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 63,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "극대화시킨다. 이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다. 둘째,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자 맞춤형 콘텐츠 제공이 가능하다. 모든 콘텐츠를 같은 비율로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 집중적인 맞춤형 콘텐츠 제공이 가능하다. 셋째, 일정 시간 동안의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        234.90936279296875,
        510.53997802734375,
        250.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있어 치료 동기 부여에 긍정적으로 작용할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        413.0029602050781,
        400.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        414.90936279296875,
        538.5599975585938,
        430.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선택지를 열어주고자 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        240.68296813964844,
        550.7296752929688
      ],
      "page_num": 63,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 57 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 64,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "7. 임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)",
      "font_size": 14.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        524.1658935546875,
        115.0599594116211
      ],
      "page_num": 64,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 임상시험용 의료기기 사용목적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        143.46937561035156,
        290.8800048828125,
        159.28968811035156
      ],
      "page_num": 64,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.68000030517578,
        180.36000061035156,
        530.8800048828125,
        194.75999450683594
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적응증을 포함하도록 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        204.36000061035156,
        212.94000244140625,
        218.75999450683594
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        238.914306640625,
        94.91999816894531,
        258.865478515625
      ],
      "page_num": 64,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[사용목적]",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        275.2293701171875,
        126.24468231201172,
        291.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        305.2293701171875,
        546.0599975585938,
        321.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        335.2293701171875,
        538.4400024414062,
        351.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기기이다. 임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        365.2293701171875,
        545.9400024414062,
        381.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        395.2293701171875,
        546.0599975585938,
        411.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증상을 개선하는 것을 목표로 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        425.2293701171875,
        300.5629577636719,
        441.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        453.2699890136719,
        546.0599975585938,
        471.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        485.2293701171875,
        546.0599975585938,
        501.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기반으로 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        515.2293701171875,
        158.1229705810547,
        531.0496826171875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "*",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[F51.0]",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Nonorganic",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "insomnia(비기질성",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[G47.0]",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Disorders",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        71.63999938964844,
        543.47998046875,
        538.5043334960938,
        559.031982421875
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "initiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        87.1199951171875,
        569.3999633789062,
        535.2417602539062,
        584.9519653320312
      ],
      "page_num": 64,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 58 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 임상시험용 의료기기 정보",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        261.239990234375,
        100.72968292236328
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        78.47999572753906,
        121.80000305175781,
        532.5120239257812,
        136.1999969482422
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구조, 성능 등을 구체적으로 기재하도록 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        66.5999984741211,
        145.8000030517578,
        321.05999755859375,
        160.1999969482422
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        180.35430908203125,
        94.91999816894531,
        200.30548095703125
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상시험용 의료기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        216.54937744140625,
        238.79998779296875,
        232.36968994140625
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 시험기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        246.54937744140625,
        173.87998962402344,
        262.36968994140625
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        276.54937744140625,
        544.8599853515625,
        292.36968994140625
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 모델명: ○○○",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        306.54937744140625,
        218.1599884033203,
        322.36968994140625
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 제조회사: ㈜○○○",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        336.54937744140625,
        248.1599884033203,
        352.36968994140625
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        366.54937744140625,
        506.5274963378906,
        382.36968994140625
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        121.07999420166016,
        394.79998779296875,
        522.1205444335938,
        410.35198974609375
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        422.58935546875,
        519.8474731445312,
        438.40966796875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 성능: (임상시험용 의료기기의 성능 기술)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        452.58935546875,
        399.9674987792969,
        468.40966796875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 대조기기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        482.58935546875,
        173.87998962402344,
        498.40966796875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다. 대조",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        86.63999938964844,
        510.8399963378906,
        538.4400024414062,
        526.3919677734375
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        106.31999969482422,
        536.7599487304688,
        444.1752014160156,
        552.3119506835938
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 임상시험용 의료기기 사용 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        590.58935546875,
        298.32000732421875,
        606.40966796875
      ],
      "page_num": 65,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        619.914306640625,
        94.91999816894531,
        639.865478515625
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 사용 전 준비사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        656.2293701171875,
        216.36000061035156,
        672.0496826171875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        686.2293701171875,
        538.5599975585938,
        702.0496826171875
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료기기를 설치한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        91.55999755859375,
        716.2293701171875,
        238.1629638671875,
        732.0496826171875
      ],
      "page_num": 65,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 사용 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        746.2293701171875,
        163.8000030517578,
        762.0496826171875
      ],
      "page_num": 65,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 59 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) OOO 디지털치료기기를 실행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        84.90937042236328,
        344.96295166015625,
        100.72968292236328
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 회원가입 및 초기 수면 평가를 시행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        114.90937042236328,
        395.2429504394531,
        130.72967529296875
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        521.3399658203125,
        160.7296905517578
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        538.4400024414062,
        190.7296905517578
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        496.8074951171875,
        250.72967529296875
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        264.90936279296875,
        538.52294921875,
        280.72967529296875
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.39999389648438,
        294.90936279296875,
        538.5599975585938,
        310.72967529296875
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.39999389648438,
        324.90936279296875,
        535.6429443359375,
        340.72967529296875
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위한 행동 치료를 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        384.90936279296875,
        315.4429626464844,
        400.72967529296875
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.39999389648438,
        444.90936279296875,
        513.9229736328125,
        460.72967529296875
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 66,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        534.9093627929688,
        538.5599975585938,
        550.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 하였을 경우 일반적으로 수면 일기가 사용된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        564.9093627929688,
        493.5,
        580.7296752929688
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        594.9093627929688,
        509.1229553222656,
        610.7296752929688
      ],
      "page_num": 66,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각성 시간, 수면의 질. 이외 수면 후 개운함, 낮잠 여부,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        684.9093627929688,
        542.219970703125,
        700.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 사용할 수 있다. 이 경우 웨어러블 디바이스의 측정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 66,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 60 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 67,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정확도에 대한 표준화 근거를 제시하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        84.90937042236328,
        457.1629638671875,
        100.72968292236328
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        114.90937042236328,
        534.9229736328125,
        130.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        538.4400024414062,
        160.7296905517578
      ],
      "page_num": 67,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        538.4400024414062,
        190.7296905517578
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        484.1629638671875,
        220.72967529296875
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 수면에 대한 교육을 수행한다. 이 내용은 과학적 근거에 기반을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "두어야 하며 대표적으로 수면 위생이 있을 수 있다. 수면 위생은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "좋은 수면과 관련된 환경 및 생활 습관을 의미한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        294.90936279296875,
        470.2429504394531,
        310.72967529296875
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        324.90936279296875,
        538.5599975585938,
        340.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 67,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        113.87999725341797,
        444.90936279296875,
        147.92295837402344,
        460.72967529296875
      ],
      "page_num": 67,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 61 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8. 피험자의 선정 기준·제외 기준·인원 및 그 근거",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        453.1199951171875,
        115.0599594116211
      ],
      "page_num": 68,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 피험자의 선정·제외 기준, 인원 및 근거",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        159.239990234375,
        300.1199951171875,
        173.63998413085938
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        183.239990234375,
        533.6400146484375,
        197.63998413085938
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        207.239990234375,
        533.6400146484375,
        221.63998413085938
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "선정 기준과 제외 기준을 제시하여야 한다. 이 때 임상시험 참여와 연관된 이익을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        231.239990234375,
        533.6400146484375,
        245.63998413085938
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        84.23999786376953,
        255.239990234375,
        533.6400146484375,
        269.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        279.239990234375,
        533.6400146484375,
        293.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Vulnerable Subjects)는 선정대상에서 제외한다. 또한, 시험군과 대조군을 포함한 피험자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        303.239990234375,
        533.760009765625,
        317.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        327.239990234375,
        533.6400146484375,
        341.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        351.239990234375,
        533.760009765625,
        365.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        375.239990234375,
        533.6400146484375,
        389.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수가 확보되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        399.239990234375,
        199.97999572753906,
        413.6399841308594
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 피험자 수: 시험대상수 산출시 일반적인 고려사항",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        447.239990234375,
        355.55999755859375,
        461.6399841308594
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        471.239990234375,
        533.6400146484375,
        485.6399841308594
      ],
      "page_num": 68,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.4000015258789,
        495.239990234375,
        533.6400146484375,
        509.6399841308594
      ],
      "page_num": 68,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.4000015258789,
        519.239990234375,
        478.97998046875,
        533.6400146484375
      ],
      "page_num": 68,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 62 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        84.35431671142578,
        94.91999816894531,
        104.30548858642578
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 피험자 선정 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        120.54937744140625,
        201.83999633789062,
        136.36968994140625
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상자군 별로 제시된 선정 기준 모두를 만족하는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        150.54937744140625,
        435.0,
        166.36968994140625
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 만 19세 이상 성인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        180.54937744140625,
        223.79998779296875,
        196.36968994140625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        210.54937744140625,
        545.9400024414062,
        226.36968994140625
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        240.5493621826172,
        545.9400024414062,
        256.36968994140625
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        270.54937744140625,
        545.9400024414062,
        286.36968994140625
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "받은 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        300.54937744140625,
        148.8000030517578,
        316.36968994140625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        330.54937744140625,
        458.2799987792969,
        346.36968994140625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 한국어를 읽고 쓰는데 어려움이 없는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        360.54937744140625,
        373.79998779296875,
        376.36968994140625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        390.54937744140625,
        538.4400024414062,
        406.36968994140625
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "케이션을 사용하는 데에 어려움이 없는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        420.54937744140625,
        388.79998779296875,
        436.36968994140625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        450.54937744140625,
        546.0599975585938,
        466.36968994140625
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결정하고 주의사항을 준수하기로 서면 동의한 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        480.54937744140625,
        433.79998779296875,
        496.36968994140625
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 피험자 제외 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        540.5493774414062,
        201.83999633789062,
        556.3696899414062
      ],
      "page_num": 69,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        570.5493774414062,
        538.4400024414062,
        586.3696899414062
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험에서 배제",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        600.5493774414062,
        153.83999633789062,
        616.3696899414062
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        630.5493774414062,
        545.9400024414062,
        646.3696899414062
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        660.5493774414062,
        545.9400024414062,
        676.3696899414062
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진단받은 사람",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        690.5493774414062,
        193.8000030517578,
        706.3696899414062
      ],
      "page_num": 69,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        720.5493774414062,
        516.1199951171875,
        736.3696899414062
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        750.5493774414062,
        546.0599975585938,
        766.3696899414062
      ],
      "page_num": 69,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 63 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 70,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당하는 증상을 가진 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        114.90937042236328,
        268.79998779296875,
        130.72967529296875
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.23999786376953,
        174.9093780517578,
        538.4400024414062,
        190.7296905517578
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 제외",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.23999786376953,
        204.90936279296875,
        163.1999969482422,
        220.72967529296875
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의해 자살 고위험군으로 판단되는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        264.90936279296875,
        351.239990234375,
        280.72967529296875
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        294.90936279296875,
        538.4400024414062,
        310.72967529296875
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료가 있을 경우*",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        322.9499816894531,
        258.65997314453125,
        340.72967529296875
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.1199951171875,
        353.1600036621094,
        458.15997314453125,
        368.7120056152344
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 교대근무자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        380.9493713378906,
        178.86000061035156,
        396.7696838378906
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        410.9493713378906,
        472.91998291015625,
        426.7696838378906
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        440.9493713378906,
        433.67999267578125,
        456.7696838378906
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        470.9493713378906,
        538.4400024414062,
        486.7696838378906
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        500.9493408203125,
        545.9400024414062,
        516.7696533203125
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "졸음이 치명적인 결과를 가져올 수 있는 자)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        530.9493408203125,
        407.16748046875,
        546.7696533203125
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        560.9493408203125,
        498.8399963378906,
        576.7696533203125
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        590.9493408203125,
        546.0599975585938,
        606.7696533203125
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단한 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        620.9493408203125,
        171.36000061035156,
        636.7696533203125
      ],
      "page_num": 70,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        650.9493408203125,
        538.3200073242188,
        666.7696533203125
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        679.199951171875,
        538.439453125,
        694.751953125
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일할 경우 제외 기준에 해당하지 않는다. 즉, 수면제를 복용하는 중인",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        705.1199340820312,
        538.4400024414062,
        720.6719360351562
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        731.1599731445312,
        538.4400024414062,
        746.7119750976562
      ],
      "page_num": 70,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 64 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 71,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능하다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        83.15999603271484,
        173.335205078125,
        98.71199798583984
      ],
      "page_num": 71,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 65 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 목표 대상자 수 및 그 근거",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        268.44000244140625,
        100.72968292236328
      ],
      "page_num": 72,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.55999755859375,
        121.80000305175781,
        533.6400146484375,
        136.1999969482422
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다. 피험자 수를 결정",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        141.0,
        533.760009765625,
        155.39999389648438
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        160.1999969482422,
        527.0999755859375,
        174.59999084472656
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 연구가설",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.5199966430664,
        179.39999389648438,
        137.8800048828125,
        193.79998779296875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 유의수준",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        74.5199966430664,
        198.59999084472656,
        137.8800048828125,
        212.99998474121094
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 통계적 검정 방법",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.5199966430664,
        217.79998779296875,
        185.87998962402344,
        232.19998168945312
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.5199966430664,
        237.0,
        369.73199462890625,
        251.39999389648438
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.5199966430664,
        256.1999816894531,
        456.73199462890625,
        270.5999755859375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        322.7943115234375,
        94.91999816894531,
        342.7454833984375
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 목표 대상자 수: 총 50명",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        359.109375,
        265.32000732421875,
        374.9296875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        387.3599853515625,
        538.44140625,
        402.9119873046875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        413.2799987792969,
        538.4400024414062,
        428.8320007324219
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        439.32000732421875,
        538.4405517578125,
        454.87200927734375
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구 결과 및 참고 문헌을 기준으로 산출한다. 이때, 그 근거(가설, 변수,",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        465.3599853515625,
        538.5081787109375,
        480.9119873046875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성공 기준)를 함께 제시하여야 한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        491.2799987792969,
        332.6951904296875,
        506.8320007324219
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 목표 대상자 수 산정의 추정 공식 예시",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        545.109375,
        366.239990234375,
        560.9296875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 일차목적 및 가설",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        575.109375,
        235.44000244140625,
        590.9296875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        605.109375,
        545.9400024414062,
        620.9296875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        635.109375,
        538.4400024414062,
        650.9296875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다. 이에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        665.109375,
        545.9400024414062,
        680.9296875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        695.109375,
        545.9400024414062,
        710.9296875
      ],
      "page_num": 72,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통계학적으로 유의하면 임상시험 성공으로 평가한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        725.109375,
        475.6429443359375,
        740.9296875
      ],
      "page_num": 72,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 66 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "    ",
      "font_size": 10.199999809265137,
      "font_name": "HyhwpEQ",
      "bbox": [
        216.20489501953125,
        85.06827545166016,
        407.8427429199219,
        104.5082778930664
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "    ≠",
      "font_size": 10.199999809265137,
      "font_name": "HyhwpEQ",
      "bbox": [
        216.20489501953125,
        85.06827545166016,
        407.8427429199219,
        104.5082778930664
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": ": 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.5199966430664,
        119.02827453613281,
        525.8399658203125,
        136.67202758789062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량",
      "font_size": 12.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        80.5199966430664,
        149.26828002929688,
        526.5599975585938,
        166.91201782226562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        202.62936401367188,
        545.9400024414062,
        218.44967651367188
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        232.62936401367188,
        546.0599975585938,
        248.44967651367188
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        262.6293640136719,
        546.0599975585938,
        278.4496765136719
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        292.6293640136719,
        546.0599975585938,
        308.4496765136719
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1.13, 1.16으로 조사되었다. 이에 본 연구에서의 예상되는 effect",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        322.6293640136719,
        545.9400024414062,
        338.4496765136719
      ],
      "page_num": 73,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "size는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        352.6293640136719,
        538.5,
        368.4496765136719
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 정하고자 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        382.6293640136719,
        234.80296325683594,
        398.4496765136719
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선행 연구",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        465.5999755859375,
        521.8200073242188,
        489.5999755859375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대상",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        465.5999755859375,
        521.8200073242188,
        489.5999755859375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배정군",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        465.5999755859375,
        521.8200073242188,
        489.5999755859375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "N",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        465.5999755859375,
        521.8200073242188,
        489.5999755859375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Cohen’s d2)",
      "font_size": 7.679999828338623,
      "font_name": "T11",
      "bbox": [
        85.79999542236328,
        465.5999755859375,
        521.8200073242188,
        489.5999755859375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Effect",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        465.5999755859375,
        521.8200073242188,
        489.5999755859375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "size3)",
      "font_size": 7.679999828338623,
      "font_name": "T11",
      "bbox": [
        491.7599792480469,
        483.8399963378906,
        520.3180541992188,
        499.1999816894531
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ritterband",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        87.72000122070312,
        503.8800048828125,
        140.1719970703125,
        518.280029296875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "L.M.(2017)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        87.5999984741211,
        523.0800170898438,
        140.4119873046875,
        537.4800415039062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21-65세 만성",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        173.75999450683594,
        503.8800048828125,
        246.0,
        518.280029296875
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불면증 환자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        176.87998962402344,
        523.0800170898438,
        242.87998962402344,
        537.4800415039062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SHUTi1)",
      "font_size": 7.679999828338623,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        501.6000061035156,
        453.8399963378906,
        516.9600219726562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "133",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        270.239990234375,
        501.6000061035156,
        453.8399963378906,
        516.9600219726562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.90",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        501.6000061035156,
        453.8399963378906,
        516.9600219726562
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.13",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        495.5999755859375,
        513.47998046875,
        516.47998046875,
        527.8800048828125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Patient Education",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        523.7999877929688,
        453.8399963378906,
        538.2000122070312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "142",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        523.7999877929688,
        453.8399963378906,
        538.2000122070312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.77",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        523.7999877929688,
        453.8399963378906,
        538.2000122070312
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Christension",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        82.31999969482422,
        545.0399780273438,
        145.66799926757812,
        559.4400024414062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "H.(2016)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        93.0,
        564.239990234375,
        135.01199340820312,
        578.6400146484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18-64세 불면증,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        166.3199920654297,
        545.0399780273438,
        253.51199340820312,
        559.4400024414062
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "우울증 환자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        176.87998962402344,
        564.239990234375,
        242.87998962402344,
        578.6400146484375
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SHUTi",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        543.5999755859375,
        453.8399963378906,
        558.0
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "248",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        270.239990234375,
        543.5999755859375,
        453.8399963378906,
        558.0
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.79",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        543.5999755859375,
        453.8399963378906,
        558.0
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1.16",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        554.6400146484375,
        516.47998046875,
        577.7999877929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "HealthWatch",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        270.239990234375,
        554.6400146484375,
        516.47998046875,
        577.7999877929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "333",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        270.239990234375,
        554.6400146484375,
        516.47998046875,
        577.7999877929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "0.63",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        270.239990234375,
        554.6400146484375,
        516.47998046875,
        577.7999877929688
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) SHUTi: Sleep Healthy Using the Internet",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        83.4000015258789,
        582.239990234375,
        277.2197265625,
        594.1920166015625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        83.4000015258789,
        598.199951171875,
        514.6799926757812,
        610.1519775390625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        83.4000015258789,
        614.1599731445312,
        334.23876953125,
        626.1119995117188
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        78.36000061035156,
        630.239990234375,
        355.8382873535156,
        642.1920166015625
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 16. 치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        76.43999481201172,
        443.7599792480469,
        528.0,
        458.15997314453125
      ],
      "page_num": 73,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        685.7493896484375,
        545.9400024414062,
        701.5697021484375
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        715.7493286132812,
        538.5599975585938,
        731.5696411132812
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        745.7493286132812,
        546.0599975585938,
        761.5696411132812
      ],
      "page_num": 73,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 67 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 74,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25명)으로 결정하였다. 두 군의 평균 차이 검정에 대한 피험자 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "산출 공식은 아래와 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        273.0829772949219,
        190.7296905517578
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 40% 정도의 중도 탈락을 보였다. 그러나 본 연구에서는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "30%로 정하고자 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        294.90936279296875,
        282.9229736328125,
        310.72967529296875
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": " ",
      "font_size": 59.3115234375,
      "font_name": "HyhwpEQ",
      "bbox": [
        96.95999908447266,
        370.9893798828125,
        318.38189697265625,
        399.5882873535156
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "",
      "font_size": 10.199999809265137,
      "font_name": "HyhwpEQ",
      "bbox": [
        96.95999908447266,
        370.9893798828125,
        318.38189697265625,
        399.5882873535156
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "     ",
      "font_size": 10.199999809265137,
      "font_name": "HyhwpEQ",
      "bbox": [
        203.27999877929688,
        355.5520324707031,
        316.9800109863281,
        377.5082702636719
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "",
      "font_size": 58.88851547241211,
      "font_name": "HyhwpEQ",
      "bbox": [
        320.8800048828125,
        371.02825927734375,
        453.0352478027344,
        399.5882873535156
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "",
      "font_size": 10.199999809265137,
      "font_name": "HyhwpEQ",
      "bbox": [
        320.8800048828125,
        371.02825927734375,
        453.0352478027344,
        399.5882873535156
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": " ",
      "font_size": 10.199999809265137,
      "font_name": "HyhwpEQ",
      "bbox": [
        339.7200012207031,
        358.7920227050781,
        451.6199951171875,
        377.02825927734375
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": " ",
      "font_size": 15.0,
      "font_name": "HyhwpEQ",
      "bbox": [
        455.5199890136719,
        371.02825927734375,
        497.6999816894531,
        386.7482604980469
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 한 군당 필요한 피험자 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        413.8293762207031,
        330.6000061035156,
        429.6496887207031
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 제 1종 오류 0.05 (유의수준)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        443.8293762207031,
        344.8874816894531,
        459.6496887207031
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 제 2종 오류 0.1",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        473.8293762207031,
        259.0199890136719,
        489.6496887207031
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 군간 예상되는 effect size",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        503.829345703125,
        325.9715576171875,
        519.649658203125
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        561.8399658203125,
        538.4398803710938,
        577.3919677734375
      ],
      "page_num": 74,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려할 것을 권고한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        587.8799438476562,
        251.33518981933594,
        603.4319458007812
      ],
      "page_num": 74,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 68 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 75,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        246.35430908203125,
        94.91999816894531,
        266.30548095703125
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        282.54937744140625,
        546.0599975585938,
        298.36968994140625
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        312.54937744140625,
        545.9400024414062,
        328.36968994140625
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하도록 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        342.54937744140625,
        173.1229705810547,
        358.36968994140625
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 식품의약품안전처의 임상 계획 승인일로부터 00개월",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        372.54937744140625,
        456.3599853515625,
        388.36968994140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 대상자 모집 기간: 00개월",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        402.54937744140625,
        272.8800048828125,
        418.36968994140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 임상시험 수행 기간: 00개월",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        432.54937744140625,
        287.8800048828125,
        448.36968994140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 임상시험 수행 후 follow-up 기간: 6~12개월",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        462.54937744140625,
        396.1199951171875,
        478.36968994140625
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        490.79998779296875,
        538.4400024414062,
        506.35198974609375
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "권고한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        516.8399658203125,
        173.335205078125,
        532.3919677734375
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 통계 처리 및 결과보고서 작성 기간: 00개월",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        544.6293334960938,
        400.3199768066406,
        560.4496459960938
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 임상시험기간",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        181.1994171142578,
        109.41996002197266
      ],
      "page_num": 75,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        75.83999633789062,
        146.87998962402344,
        530.8800048828125,
        161.2799835205078
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        170.87998962402344,
        530.8800048828125,
        185.2799835205078
      ],
      "page_num": 75,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        194.87998962402344,
        395.94000244140625,
        209.2799835205078
      ],
      "page_num": 75,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 69 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10. 임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)",
      "font_size": 14.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        490.3258361816406,
        109.41996002197266
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가. 시험 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        272.8293762207031,
        157.5,
        288.6496887207031
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        302.2743225097656,
        94.91999816894531,
        322.2254943847656
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 시험기기 및 대조기기 정보",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        338.58935546875,
        283.79998779296875,
        354.40966796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        368.58935546875,
        477.8399963378906,
        384.40966796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        398.58935546875,
        538.4400024414062,
        414.40966796875
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        148.8000030517578,
        428.58935546875,
        538.4400024414062,
        444.40966796875
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        148.8000030517578,
        458.58935546875,
        535.6875,
        474.40966796875
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 대조기기: 위약 대조군(sham)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        488.58935546875,
        311.2875061035156,
        504.40966796875
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        518.58935546875,
        535.7999877929688,
        534.40966796875
      ],
      "page_num": 76,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        545.7599487304688,
        538.4400024414062,
        562.27197265625
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가능하다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        572.7599487304688,
        173.335205078125,
        588.3119506835938
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        111.5999984741211,
        598.7999877929688,
        538.4390258789062,
        614.3519897460938
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "군이다. 다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        123.36000061035156,
        624.719970703125,
        538.4405517578125,
        640.27197265625
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하며, 이에는 과학적인 근거가 있어야 한다. 불면증 인지행동치료를",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        123.36000061035156,
        650.7599487304688,
        538.4410400390625,
        666.3119506835938
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        123.36000061035156,
        676.7999877929688,
        538.4400024414062,
        692.3519897460938
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료 등이 이에 해당된다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        123.36000061035156,
        702.719970703125,
        276.0552062988281,
        718.27197265625
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        78.5999984741211,
        146.63999938964844,
        532.9199829101562,
        161.0399932861328
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        66.5999984741211,
        170.63999938964844,
        532.8720092773438,
        185.0399932861328
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "병용 요법 등을 기술한다. 임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        66.5999984741211,
        194.63999938964844,
        532.7999877929688,
        209.0399932861328
      ],
      "page_num": 76,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 절차 등을 상세히 시험 방법을 기술한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        66.5999984741211,
        218.63999938964844,
        321.5400085449219,
        233.0399932861328
      ],
      "page_num": 76,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 70 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 디지털치료기기 치료기간: 총 6주",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        84.90937042236328,
        325.32000732421875,
        100.72968292236328
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        478.2074890136719,
        160.7296905517578
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        173.1599884033203,
        538.5081787109375,
        188.7119903564453
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SNS 등을 통해 수집할 수 있다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        199.19998168945312,
        309.2951965332031,
        214.75198364257812
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        226.98936462402344,
        545.9400024414062,
        242.80967712402344
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "층화하여 층내 치료군, 위약군 1:1 배정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        214.44000244140625,
        256.9893798828125,
        484.91998291015625,
        272.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 시험 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        286.9893798828125,
        163.8000030517578,
        302.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 스크리닝, 선정·제외 기준 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        316.9893798828125,
        335.2799987792969,
        332.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        346.9893798828125,
        545.9400024414062,
        362.8096923828125
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구군을 선별한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        376.9893798828125,
        246.80296325683594,
        392.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 피험자 동의 및 준비",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        406.9893798828125,
        256.32000732421875,
        422.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        436.9893798828125,
        546.0599975585938,
        452.8096923828125
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        466.9893493652344,
        546.0599975585938,
        482.8096618652344
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        496.9893493652344,
        546.0599975585938,
        512.8096923828125
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참가의 동의를 문서로 받는다. 또한 동의를 서명한 연월일을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        526.9893798828125,
        545.9400024414062,
        542.8096923828125
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록한다. 또한 동의서 사본을 환자에게 제공하여 환자가 지속",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        556.9893798828125,
        538.5599975585938,
        572.8096923828125
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        586.9893798828125,
        535.6429443359375,
        602.8096923828125
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다) 인구학적 조사, 병력조사 요법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        616.9893798828125,
        320.2799987792969,
        632.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        646.9893798828125,
        545.9400024414062,
        662.8096923828125
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        676.9893798828125,
        545.9400024414062,
        692.8096923828125
      ],
      "page_num": 77,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "점검하고 증례기록서에 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        706.9893798828125,
        343.282958984375,
        722.8096923828125
      ],
      "page_num": 77,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        736.9893798828125,
        438.7200012207031,
        752.8096923828125
      ],
      "page_num": 77,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 71 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 78,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(2) 병력조사: 동반 질환 여부",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        84.90937042236328,
        300.7200012207031,
        100.72968292236328
      ],
      "page_num": 78,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(3) 병용 약물: 복용 여부 및 종류",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        114.90937042236328,
        330.3599853515625,
        130.72967529296875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 피험자 식별코드 부여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        144.9093780517578,
        263.760009765625,
        160.7296905517578
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        174.9093780517578,
        538.5599975585938,
        190.7296905517578
      ],
      "page_num": 78,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식별코드를 부여한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        234.90936279296875,
        270.9229736328125,
        250.72967529296875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 78,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        125.87999725341797,
        294.90936279296875,
        189.32296752929688,
        310.72967529296875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(3) 피험자 식별코드는 아래의 방법에 따라 기입한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        324.90936279296875,
        463.7629699707031,
        340.72967529296875
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 피험자 식별코드: 실시기관 코드 - 등록된 순",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        121.07999420166016,
        353.1600036621094,
        402.1199951171875,
        368.7120056152344
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 외래 방문마다 유효성 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        380.9493713378906,
        301.32000732421875,
        396.7696838378906
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 일차와 이차 유효성 평가 관련된 목록을 작성한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        410.9493713378906,
        461.84295654296875,
        426.7696838378906
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        440.9493713378906,
        443.5274963378906,
        456.7696838378906
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        470.9493713378906,
        545.9400024414062,
        486.7696838378906
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        498.989990234375,
        545.9400024414062,
        516.7696533203125
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        530.9493408203125,
        546.0599975585938,
        546.7696533203125
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Index, ISI)를 이용하도록 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        560.9493408203125,
        335.2429504394531,
        576.7696533203125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(2) 이차 유효성 평가지표",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        590.9493408203125,
        274.44000244140625,
        606.7696533203125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        620.9493408203125,
        538.5599975585938,
        636.7696533203125
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        650.9493408203125,
        545.9400024414062,
        666.7696533203125
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        680.9493408203125,
        242.00296020507812,
        696.7696533203125
      ],
      "page_num": 78,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        710.9493408203125,
        545.9400024414062,
        726.7696533203125
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "개선될 수 있다고 여겨진 영역에 한정한다. (수면 효율, 수면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        740.9493408203125,
        546.0599975585938,
        756.7696533203125
      ],
      "page_num": 78,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 72 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 79,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 79,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우울과 불안을 포함한 정신건강의학과적 증상 등)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        114.90937042236328,
        476.2874755859375,
        130.72967529296875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 관찰 시기를 표기한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        286.52294921875,
        160.7296905517578
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 79,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Follow-up, 6개월 후)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        149.52000427246094,
        204.90936279296875,
        294.9674987792969,
        220.72967529296875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "측정 도구",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.0,
        284.6399841308594,
        381.9599914550781,
        299.03997802734375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "설명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.0,
        284.6399841308594,
        381.9599914550781,
        299.03997802734375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 효율",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        106.19999694824219,
        311.7599792480469,
        160.1999969482422,
        326.15997314453125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Sleep efficiency)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        88.55999755859375,
        326.1600036621094,
        177.85198974609375,
        340.55999755859375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        309.3599853515625,
        527.760009765625,
        323.7599792480469
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(총 수면시간 대비 총 침상시간)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        328.55999755859375,
        387.0119934082031,
        342.9599914550781
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 침상시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        97.19999694824219,
        351.9599914550781,
        350.1600036621094,
        380.7599792480469
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Time in bed)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        97.19999694824219,
        351.9599914550781,
        350.1600036621094,
        380.7599792480469
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "잠자리에서 보낸 총 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        97.19999694824219,
        351.9599914550781,
        350.1600036621094,
        380.7599792480469
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 수면 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        97.19999694824219,
        389.6399841308594,
        169.1999969482422,
        404.03997802734375
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Total sleep time)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        86.75999450683594,
        396.8399963378906,
        413.1600036621094,
        418.4399719238281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 수면시간, 실제 수면을 취한 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        86.75999450683594,
        396.8399963378906,
        413.1600036621094,
        418.4399719238281
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면잠복기",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        103.19999694824219,
        427.3199768066406,
        163.1999969482422,
        441.719970703125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Sleep onset latency)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        77.15999603271484,
        434.5199890136719,
        440.1600036621094,
        456.1199951171875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "소등에서 수면이 시작되기까지 걸린 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        77.15999603271484,
        434.5199890136719,
        440.1600036621094,
        456.1199951171875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "입면 후 각성시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        85.19999694824219,
        465.0,
        181.1999969482422,
        479.3999938964844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Wake after sleep onset,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        67.31999969482422,
        479.3999938964844,
        199.15199279785156,
        493.79998779296875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WASO)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        114.0,
        493.79998779296875,
        152.53199768066406,
        508.1999816894531
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        469.79998779296875,
        518.1600341796875,
        484.1999816894531
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각성 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        489.0,
        266.15997314453125,
        503.3999938964844
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 중 각성 횟수",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        82.19999694824219,
        519.9599609375,
        184.1999969482422,
        534.3599853515625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Number of awakening, NOA)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        527.1599731445312,
        527.760009765625,
        548.760009765625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        527.1599731445312,
        527.760009765625,
        548.760009765625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PTB",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        122.15999603271484,
        560.5199584960938,
        144.34800720214844,
        574.9199829101562
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Duration from administration",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.04000091552734,
        574.9199829101562,
        201.46800231933594,
        589.3200073242188
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of pills to bedtime)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        589.3200073242188,
        183.4919891357422,
        603.7200317382812
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면제 복용 후 잠자리에 들 때까지 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        574.9199829101562,
        440.1600036621094,
        589.3200073242188
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PTS",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        122.15999603271484,
        612.5999755859375,
        144.4320068359375,
        627.0
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Duration from administration",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.79999542236328,
        627.0,
        201.73199462890625,
        655.7999877929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of pills to sleep onset time)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.79999542236328,
        627.0,
        201.73199462890625,
        655.7999877929688
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면제 복용 후 입면까지 걸리는 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        627.0,
        422.1600036621094,
        641.4000244140625
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PTW",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        120.47999572753906,
        664.7999877929688,
        145.96800231933594,
        679.2000122070312
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Duration from administration",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.04000091552734,
        679.2000122070312,
        201.46800231933594,
        708.0
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "of pills to wake up time)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.04000091552734,
        679.2000122070312,
        201.46800231933594,
        708.0
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면제 복용 후 아침 기상 시까지 걸리는 시간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        679.2000122070312,
        470.1600036621094,
        693.6000366210938
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "ESS",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        121.68000030517578,
        723.47998046875,
        144.79200744628906,
        737.8800048828125
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Epworth sleepiness score)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        65.15999603271484,
        737.8800048828125,
        201.3719940185547,
        752.280029296875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        721.0799560546875,
        527.760009765625,
        735.47998046875
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이루어진 자가 설문도구 (0-24; 정상<10)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        740.2799682617188,
        433.0920104980469,
        754.6799926757812
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 17. 불면 이차 유효성 평가지표 측정 도구 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        138.36000061035156,
        255.95997619628906,
        453.2405700683594,
        271.5119934082031
      ],
      "page_num": 79,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 73 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 80,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "DBAS",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        117.7199935913086,
        111.47999572753906,
        148.7519989013672,
        125.87999725341797
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Dysfunctional Beliefs and",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.79999542236328,
        125.87998962402344,
        201.6119842529297,
        140.2799835205078
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Attitudes about Sleep)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        74.63999938964844,
        140.27999877929688,
        191.89198303222656,
        154.67999267578125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        87.47999572753906,
        527.760009765625,
        101.87999725341797
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가 도구. 불면증의 원인과 결과에 대한 오류, 수면에 대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        106.68000030517578,
        527.8800048828125,
        121.08000183105469
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        125.87998962402344,
        527.760009765625,
        140.2799835205078
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제에 대한 태도를 측정. 30문항(original) 또는 16문항을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        145.0800018310547,
        527.760009765625,
        159.47999572753906
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(short scale) 통해 리커트 척도로 측정",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        164.27999877929688,
        421.0799865722656,
        178.67999267578125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "PSG",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        121.07999420166016,
        219.95999145507812,
        145.45199584960938,
        234.3599853515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Polysomnography)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.0,
        234.36000061035156,
        182.531982421875,
        248.75999450683594
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        179.1599884033203,
        527.8800048828125,
        193.5599822998047
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신경생리학 검사방법. 일반적으로 하루 밤 동안에 걸쳐 뇌파",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        198.36000061035156,
        527.760009765625,
        212.75999450683594
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        217.55999755859375,
        527.8800048828125,
        231.95999145507812
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        236.75999450683594,
        527.8319702148438,
        251.1599884033203
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        255.95999145507812,
        527.8800048828125,
        270.3599853515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Oxymeter)를 측정 및 기록",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        275.1600036621094,
        358.55999755859375,
        289.55999755859375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "QIDS",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        119.27999877929688,
        297.1199951171875,
        147.19200134277344,
        311.5199890136719
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Quick Inventory of",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        82.79999542236328,
        311.5199890136719,
        183.6599884033203,
        325.91998291015625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Depressive",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        104.63999938964844,
        325.91998291015625,
        161.90399169921875,
        340.3199768066406
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Symptomatology)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        88.79999542236328,
        340.32000732421875,
        177.6119842529297,
        354.7200012207031
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        289.91998291015625,
        527.760009765625,
        304.3199768066406
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        309.1199951171875,
        527.760009765625,
        323.5199890136719
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단축형 우울증상 평가척도. 각각의 항목은 0점에서 3점까지",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        328.32000732421875,
        527.760009765625,
        342.7200012207031
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "채점. 총점의 범위는 0점에서 27점",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        347.5199890136719,
        401.1600036621094,
        361.91998291015625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "BAI",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        124.19999694824219,
        374.3999938964844,
        142.27198791503906,
        388.79998779296875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Beck Anxiety Inventory)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        69.23999786376953,
        388.79998779296875,
        197.2919921875,
        403.1999816894531
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        362.3999938964844,
        527.8800048828125,
        376.79998779296875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "하는 설문도구. 환자의 주관적인 불안을 평가하기 위한 목적으로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        381.6000061035156,
        527.760009765625,
        396.0
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        400.79998779296875,
        527.760009765625,
        415.1999816894531
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "SF-36",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.27999877929688,
        468.3599853515625,
        146.16000366210938,
        482.7599792480469
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Short Form-36 Health",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        72.83999633789062,
        482.7599792480469,
        193.66799926757812,
        497.15997314453125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Survey)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        113.87999725341797,
        497.1600036621094,
        152.65199279785156,
        511.55999755859375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        415.55999755859375,
        527.760009765625,
        429.9599914550781
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        434.7599792480469,
        527.8200073242188,
        449.15997314453125
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        453.9599914550781,
        527.760009765625,
        468.3599853515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        473.1600036621094,
        527.760009765625,
        487.55999755859375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "구성. 점수 산정은 각각의 8개 하위 척도에 속하는 세부",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        492.3599853515625,
        527.760009765625,
        506.7599792480469
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        511.55999755859375,
        527.8800048828125,
        525.9600219726562
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        530.760009765625,
        527.760009765625,
        545.1600341796875
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "점은 가장 좋은 건강 상태를 의미",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        212.1599884033203,
        549.9599609375,
        398.1600036621094,
        564.3599853515625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "WPAI",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        118.68000030517578,
        617.6400146484375,
        147.7919921875,
        632.0400390625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Work Productivity and",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        73.31999969482422,
        632.0399780273438,
        193.2119903564453,
        646.4400024414062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Activity Impairment)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        82.19999694824219,
        646.4400024414062,
        184.3319854736328,
        660.8400268554688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산성 손실 점수",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        564.8399658203125,
        308.1600036621094,
        579.239990234375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        212.1599884033203,
        584.0399780273438,
        527.760009765625,
        598.4400024414062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문제로 인해 손실된 시간의 비율) × 건강 문제로 인해",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        225.72000122070312,
        603.239990234375,
        527.760009765625,
        617.6400146484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일하는 동안 발생한 장애(impairment) 비율]",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        225.72000122070312,
        622.4400024414062,
        460.1159973144531,
        636.8400268554688
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "= 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 +",
      "font_size": 12.0,
      "font_name": "T20",
      "bbox": [
        212.1599884033203,
        641.6400146484375,
        527.8560180664062,
        656.0400390625
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "실제 일한 시간) +",
      "font_size": 12.0,
      "font_name": "T20",
      "bbox": [
        224.39999389648438,
        660.8399658203125,
        527.7960205078125,
        675.239990234375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[(1 - 건강 문제로 일을 빠진 시간 /",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        224.39999389648438,
        660.8399658203125,
        527.7960205078125,
        675.239990234375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        224.39999389648438,
        680.0399780273438,
        527.760009765625,
        694.4400024414062
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        224.39999389648438,
        699.239990234375,
        524.5559692382812,
        713.6400146484375
      ],
      "page_num": 80,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        716.8800048828125,
        527.8200073242188,
        748.0800170898438
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "al., 2003, Beck at al., 1998, Jenkinson et al., 1993,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        716.8800048828125,
        527.8200073242188,
        748.0800170898438
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한국보건의료연구원, 2011)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        716.8800048828125,
        527.8200073242188,
        748.0800170898438
      ],
      "page_num": 80,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 74 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 81,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바) 순응도 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        84.90937042236328,
        196.3199920654297,
        100.72968292236328
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 치료 기간 동안 수면 일기 기록 여부를 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        114.90937042236328,
        454.4029541015625,
        130.72967529296875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사) 이상반응 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        144.9093780517578,
        211.3199920654297,
        160.7296905517578
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 81,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        538.4400024414062,
        220.72967529296875
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하고, 임상시험용 의료기기와의 인과관계에 대하여 증례",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 81,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록지에 내용을 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        264.90936279296875,
        301.7629699707031,
        280.72967529296875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아) 병용 약물 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        294.90936279296875,
        218.75999450683594,
        310.72967529296875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 외래 방문마다 병용 약물을 수집하여 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        324.90936279296875,
        439.6429443359375,
        340.72967529296875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자) 관찰 및 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        354.90936279296875,
        203.75999450683594,
        370.72967529296875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 81,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 기재한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        414.90936279296875,
        231.92295837402344,
        430.72967529296875
      ],
      "page_num": 81,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 75 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 설계 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        58.68000030517578,
        84.90937042236328,
        152.63999938964844,
        100.72968292236328
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        122.52000427246094,
        529.7999877929688,
        136.9199981689453
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다. 피험자 배정과 처리",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        63.71999740600586,
        146.51998901367188,
        529.7999877929688,
        160.91998291015625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        63.71999740600586,
        170.51998901367188,
        529.81201171875,
        184.91998291015625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전략이 잘 포함되어야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        63.71999740600586,
        194.51998901367188,
        216.66000366210938,
        208.91998291015625
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        246.83432006835938,
        94.91999816894531,
        266.7854919433594
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 대상자군",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        278.109375,
        156.36000061035156,
        293.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험군: 디지털 불면증 인지행동치료군",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        308.109375,
        383.03997802734375,
        323.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 대조군: 디지털 불면증 위약군(sham군)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        338.109375,
        381.48748779296875,
        353.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 무작위 배정 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        368.109375,
        215.1599884033203,
        383.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        398.109375,
        546.0599975585938,
        413.9296875
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        428.109375,
        545.9400024414062,
        443.9296875
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통해서 시험군 혹은 대조군으로 1:1 배정한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        458.109375,
        428.84295654296875,
        473.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        488.109375,
        546.0599975585938,
        503.9296875
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통계 패키지를 이용하여 층화 순열화 블록 무작위배정법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        518.109375,
        538.5599975585938,
        533.9296875
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(stratified permuted block randomization)을 이용하여 발행된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        548.109375,
        546.0599975585938,
        563.9296875
      ],
      "page_num": 82,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "난수표가 적용된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        578.109375,
        248.1229705810547,
        593.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        608.109375,
        429.72747802734375,
        623.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 맹검 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        638.109375,
        163.8000030517578,
        653.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        668.109375,
        545.9400024414062,
        683.9296875
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        698.109375,
        224.48297119140625,
        713.9296875
      ],
      "page_num": 82,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        728.109375,
        546.0599975585938,
        743.9296875
      ],
      "page_num": 82,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 76 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 83,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요시 피험자의 눈가림 해제 절차를 둘 수 있다. 이 경우,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 83,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해제 문서를 기록 및 보관한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        144.9093780517578,
        328.4029541015625,
        160.7296905517578
      ],
      "page_num": 83,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 77 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 84,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "11. 관찰항목·임상검사항목 및 관찰검사방법",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        398.5194091796875,
        115.0599594116211
      ],
      "page_num": 84,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        151.67999267578125,
        385.6199951171875,
        166.07998657226562
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        170.87998962402344,
        533.2799682617188,
        185.2799835205078
      ],
      "page_num": 84,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.5199966430664,
        190.0800018310547,
        533.2799682617188,
        204.47999572753906
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기술한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.5199966430664,
        209.27999877929688,
        134.4600067138672,
        223.67999267578125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        228.47999572753906,
        533.2799682617188,
        242.87998962402344
      ],
      "page_num": 84,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "명시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        247.67999267578125,
        133.97999572753906,
        262.0799865722656
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험 중 관찰 항목을 기술한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        266.8800048828125,
        277.739990234375,
        281.2799987792969
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험 후 이상반응 확인에 대해서 기술한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.55999755859375,
        286.0799865722656,
        343.739990234375,
        300.47998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        321.9543151855469,
        94.91999816894531,
        341.9054870605469
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 임상시험 일정표",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        358.2693786621094,
        194.27999877929688,
        374.0896911621094
      ],
      "page_num": 84,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "스크리닝 및",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        191.75999450683594,
        391.0799865722656,
        254.51998901367188,
        404.3280029296875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검사일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        206.0399932861328,
        403.1999816894531,
        240.2397003173828,
        416.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Screening)1)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        190.9199981689453,
        414.3600158691406,
        255.789306640625,
        428.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료시작일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        279.47998046875,
        397.0799865722656,
        336.7201843261719,
        422.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Baseline)",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        279.47998046875,
        397.0799865722656,
        336.7201843261719,
        422.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 기간 종료",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        356.6399841308594,
        391.0799865722656,
        438.189453125,
        428.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1주 후(6주+1주)",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        356.6399841308594,
        391.0799865722656,
        438.189453125,
        428.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Post-treatment)3)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        356.6399841308594,
        391.0799865722656,
        438.189453125,
        428.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(선택)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        477.0,
        384.9599914550781,
        505.3022155761719,
        398.2080078125
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 기간 종료",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        450.9599914550781,
        397.0799865722656,
        530.7601928710938,
        410.3280029296875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6개월 후",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        468.0,
        409.1999816894531,
        513.719970703125,
        422.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Follow up)4)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        458.7599792480469,
        420.4800109863281,
        523.5094604492188,
        434.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        103.19999694824219,
        436.5599670410156,
        504.9599914550781,
        449.8079833984375
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문1",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        103.19999694824219,
        436.5599670410156,
        504.9599914550781,
        449.8079833984375
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문2",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        103.19999694824219,
        436.5599670410156,
        504.9599914550781,
        449.8079833984375
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문3",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        103.19999694824219,
        436.5599670410156,
        504.9599914550781,
        449.8079833984375
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문4",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        103.19999694824219,
        436.5599670410156,
        504.9599914550781,
        449.8079833984375
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경과일수",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        97.43999481201172,
        453.239990234375,
        493.99871826171875,
        466.4880065917969
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D-28 이내",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        97.43999481201172,
        453.239990234375,
        493.99871826171875,
        466.4880065917969
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DAY1",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        453.239990234375,
        493.99871826171875,
        466.4880065917969
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        453.239990234375,
        493.99871826171875,
        466.4880065917969
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        453.239990234375,
        493.99871826171875,
        466.4880065917969
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관찰형태",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        97.43999481201172,
        474.47998046875,
        324.9599914550781,
        493.8479919433594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        474.47998046875,
        324.9599914550781,
        493.8479919433594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원과",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        474.47998046875,
        324.9599914550781,
        493.8479919433594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "애플리케이션",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        275.3999938964844,
        486.5999755859375,
        341.3999938964844,
        499.8479919433594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원과",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        381.1199951171875,
        474.47998046875,
        414.11968994140625,
        487.7279968261719
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "애플리케이션",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        364.67999267578125,
        486.5999755859375,
        430.67999267578125,
        499.8479919433594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원 또는",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        466.55999755859375,
        468.47998046875,
        515.7596435546875,
        481.7279968261719
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "애플리케이션,",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        457.1999816894531,
        480.5999755859375,
        525.19580078125,
        493.8479919433594
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이메일, 문자, SNS",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        449.03997802734375,
        492.719970703125,
        533.3414306640625,
        505.9679870605469
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구 참여",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        94.68000030517578,
        506.5199890136719,
        145.80023193359375,
        519.7680053710938
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동의서 취득",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        88.91999816894531,
        512.52001953125,
        493.99871826171875,
        531.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        88.91999816894531,
        512.52001953125,
        493.99871826171875,
        531.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        512.52001953125,
        493.99871826171875,
        531.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        512.52001953125,
        493.99871826171875,
        531.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        512.52001953125,
        493.99871826171875,
        531.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선정/제외 기준 확인",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        67.08000183105469,
        535.3200073242188,
        493.99871826171875,
        548.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        67.08000183105469,
        535.3200073242188,
        493.99871826171875,
        548.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        67.08000183105469,
        535.3200073242188,
        493.99871826171875,
        548.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        67.08000183105469,
        535.3200073242188,
        493.99871826171875,
        548.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        67.08000183105469,
        535.3200073242188,
        493.99871826171875,
        548.5679931640625
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인구학적 정보",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        83.04000091552734,
        554.760009765625,
        493.99871826171875,
        568.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        554.760009765625,
        493.99871826171875,
        568.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        554.760009765625,
        493.99871826171875,
        568.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        554.760009765625,
        493.99871826171875,
        568.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        554.760009765625,
        493.99871826171875,
        568.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과거병력 조사",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        83.04000091552734,
        574.2000122070312,
        493.99871826171875,
        587.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        574.2000122070312,
        493.99871826171875,
        587.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        574.2000122070312,
        493.99871826171875,
        587.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        574.2000122070312,
        493.99871826171875,
        587.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        574.2000122070312,
        493.99871826171875,
        587.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 의료기기 적용",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        64.55999755859375,
        592.7999877929688,
        493.99871826171875,
        607.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O5)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        592.7999877929688,
        493.99871826171875,
        607.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        592.7999877929688,
        493.99871826171875,
        607.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        592.7999877929688,
        493.99871826171875,
        607.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        592.7999877929688,
        493.99871826171875,
        607.0079956054688
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가지표 수집 및 분석2)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        612.3599853515625,
        495.34893798828125,
        626.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        612.3599853515625,
        495.34893798828125,
        626.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        612.3599853515625,
        495.34893798828125,
        626.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        612.3599853515625,
        495.34893798828125,
        626.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        612.3599853515625,
        495.34893798828125,
        626.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응 확인",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        83.04000091552734,
        632.6400146484375,
        495.34893798828125,
        645.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        632.6400146484375,
        495.34893798828125,
        645.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        632.6400146484375,
        495.34893798828125,
        645.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        632.6400146484375,
        495.34893798828125,
        645.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병용 약물 조사",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        80.4000015258789,
        652.2000122070312,
        495.34893798828125,
        665.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        652.2000122070312,
        495.34893798828125,
        665.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        652.2000122070312,
        495.34893798828125,
        665.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        652.2000122070312,
        495.34893798828125,
        665.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        652.2000122070312,
        495.34893798828125,
        665.447998046875
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순응도 조사",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        88.91999816894531,
        671.6400146484375,
        493.99871826171875,
        684.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        671.6400146484375,
        493.99871826171875,
        684.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        88.91999816894531,
        671.6400146484375,
        493.99871826171875,
        684.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        88.91999816894531,
        671.6400146484375,
        493.99871826171875,
        684.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        671.6400146484375,
        493.99871826171875,
        684.8880004882812
      ],
      "page_num": 84,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        689.8799438476562,
        517.3195190429688,
        745.8720092773438
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. (예: ISI는 스크리닝에도 수집함)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        689.8799438476562,
        517.3195190429688,
        745.8720092773438
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        689.8799438476562,
        517.3195190429688,
        745.8720092773438
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        689.8799438476562,
        517.3195190429688,
        745.8720092773438
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        689.8799438476562,
        517.3195190429688,
        745.8720092773438
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        77.4000015258789,
        744.9599609375,
        404.8001708984375,
        756.9119873046875
      ],
      "page_num": 84,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 78 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 임상시험 절차",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        179.51998901367188,
        100.72968292236328
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        114.35430908203125,
        94.91999816894531,
        134.30548095703125
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 방문 1 (스크리닝 및 검사일, Screening)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        150.54937744140625,
        369.12750244140625,
        166.36968994140625
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 임상시험 설명 및 동의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        180.54937744140625,
        271.32000732421875,
        196.36968994140625
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        210.54937744140625,
        545.9400024414062,
        226.36968994140625
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상자 또는 법정대리인에게 상세히 설명한다. 서명일 및 서명",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        240.5493621826172,
        545.9400024414062,
        256.36968994140625
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        270.54937744140625,
        545.9400024414062,
        286.36968994140625
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        300.54937744140625,
        546.0599975585938,
        316.36968994140625
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교부한다. 대상자에게 서명 동의를 받은 후 동의 취득 순서에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        330.54937744140625,
        545.9400024414062,
        346.36968994140625
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 스크리닝 번호를 부여한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        360.54937744140625,
        335.84295654296875,
        376.36968994140625
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 선정·제외 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        390.54937744140625,
        226.3199920654297,
        406.36968994140625
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        420.54937744140625,
        545.9400024414062,
        436.36968994140625
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위임자가 모든 선정 및 제외 기준을 검토해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        450.54937744140625,
        469.282958984375,
        466.36968994140625
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 인구학적 정보",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        480.54937744140625,
        211.3199920654297,
        496.36968994140625
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        510.54937744140625,
        546.0599975585938,
        526.3696899414062
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        540.5493774414062,
        545.9400024414062,
        556.3696899414062
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "특성에 대한 정보들을 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        570.5493774414062,
        335.84295654296875,
        586.3696899414062
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 과거 병력 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        600.5493774414062,
        218.75999450683594,
        616.3696899414062
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 병력 등을 문진과 과거 진료 기록을 통해 조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        630.5493774414062,
        469.282958984375,
        646.3696899414062
      ],
      "page_num": 85,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 병력 조사에 포함되어야 하는 내용은 다음과 같다. 치매, 인지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        660.5493774414062,
        545.9400024414062,
        676.3696899414062
      ],
      "page_num": 85,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        690.5493774414062,
        546.0599975585938,
        706.3696899414062
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "major depressive episode) 등 스크리닝 확인해야 할 질병군 등의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        720.5493774414062,
        546.0599975585938,
        736.3696899414062
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        750.5493774414062,
        545.9400024414062,
        766.3696899414062
      ],
      "page_num": 85,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 79 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 86,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        180.0829620361328,
        100.72968292236328
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 86,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        144.9093780517578,
        180.0829620361328,
        160.7296905517578
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        174.9093780517578,
        543.1799926757812,
        190.7296905517578
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        204.90936279296875,
        538.4400024414062,
        220.72967529296875
      ],
      "page_num": 86,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상 분량의 수면 일기를 작성한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        264.90936279296875,
        358.04296875,
        280.72967529296875
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        293.1600036621094,
        538.439453125,
        308.7120056152344
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        319.20001220703125,
        538.439453125,
        334.75201416015625
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용 가능할 수 있다. 단, 이때 임상시험 의료기기는 치료가 아닌 수면",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        345.1199951171875,
        538.4400024414062,
        360.6719970703125
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일기 작성만을 목적으로 사용한다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        371.1600036621094,
        322.7351989746094,
        386.7120056152344
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 불면증 심각도 척도(ISI) 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        398.9493713378906,
        310.79998779296875,
        414.7696838378906
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        428.9493713378906,
        538.1629638671875,
        444.7696838378906
      ],
      "page_num": 86,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사) 병용 약물 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        458.9493713378906,
        218.75999450683594,
        474.7696838378906
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        488.9493713378906,
        513.802978515625,
        504.7696838378906
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        518.9493408203125,
        538.5599975585938,
        534.7696533203125
      ],
      "page_num": 86,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        548.9493408203125,
        546.0599975585938,
        564.7696533203125
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여기간, 목적을 확인한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        578.9493408203125,
        302.72296142578125,
        594.7696533203125
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 방문 2 (치료 시작일, Baseline)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        638.9493408203125,
        306.48748779296875,
        654.7696533203125
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) Baseline 유효성 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        668.9493408203125,
        258.1199951171875,
        684.7696533203125
      ],
      "page_num": 86,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        698.9493408203125,
        546.0599975585938,
        714.7696533203125
      ],
      "page_num": 86,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        728.9493408203125,
        546.0599975585938,
        744.7696533203125
      ],
      "page_num": 86,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 80 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 87,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통해 정보를 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        114.90937042236328,
        276.5400085449219,
        130.72967529296875
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        450.9229736328125,
        190.7296905517578
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 수면 일기 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        204.90936279296875,
        218.75999450683594,
        220.72967529296875
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 87,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        294.90936279296875,
        538.5599975585938,
        310.72967529296875
      ],
      "page_num": 87,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 87,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통해 작성하도록 한다).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        354.90936279296875,
        281.2200012207031,
        370.72967529296875
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        414.90936279296875,
        536.0029296875,
        430.72967529296875
      ],
      "page_num": 87,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시작한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        474.90936279296875,
        188.8199920654297,
        490.72967529296875
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 임상시험 의료기기 시험 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        504.90936279296875,
        316.32000732421875,
        520.7296752929688
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- OOO 애플리케이션을 실행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        534.9093627929688,
        330.5629577636719,
        550.7296752929688
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        594.9093627929688,
        545.9400024414062,
        610.7296752929688
      ],
      "page_num": 87,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여부, 직업, 업무생산성).",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        624.9093627929688,
        281.72296142578125,
        640.7296752929688
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통한 불면증 치료를 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        684.9093627929688,
        320.96295166015625,
        700.7296752929688
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 대조군 검사 시험 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        714.9093627929688,
        271.32000732421875,
        730.7296752929688
      ],
      "page_num": 87,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        744.9093627929688,
        546.0599975585938,
        760.7296752929688
      ],
      "page_num": 87,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 81 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 88,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "애플리케이션을 실행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        291.3229675292969,
        100.72968292236328
      ],
      "page_num": 88,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 회원가입 및 초기 수면 평가를 시행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        114.90937042236328,
        395.1229553222656,
        130.72967529296875
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 88,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근거에 기반한 건강한 수면을 위한 가이드를 제공한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        491.60296630859375,
        190.7296905517578
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마) 이상반응 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        204.90936279296875,
        211.3199920654297,
        220.72967529296875
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 88,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 88,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 88,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        324.90936279296875,
        231.92295837402344,
        340.72967529296875
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        353.1600036621094,
        538.4402465820312,
        368.7120056152344
      ],
      "page_num": 88,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수집할 수 있다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        379.20001220703125,
        212.33518981933594,
        394.75201416015625
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바) 병용 약물 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        406.9893798828125,
        218.75999450683594,
        422.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        436.9893798828125,
        521.2429809570312,
        452.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        466.9893493652344,
        538.4400024414062,
        482.8096618652344
      ],
      "page_num": 88,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        496.9893493652344,
        546.0599975585938,
        512.8096923828125
      ],
      "page_num": 88,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여 기간, 목적을 확인한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        526.9893798828125,
        310.1629638671875,
        542.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사) 순응도 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        556.9893798828125,
        196.3199920654297,
        572.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        586.9893798828125,
        546.0599975585938,
        602.8096923828125
      ],
      "page_num": 88,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        616.9893798828125,
        181.282958984375,
        632.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 방문 3 (치료 기간 종료 1주 후, Post-treatment)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        676.9893798828125,
        426.9674987792969,
        692.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가) 치료 후 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        706.9893798828125,
        203.75999450683594,
        722.8096923828125
      ],
      "page_num": 88,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        736.9893798828125,
        538.4400024414062,
        752.8096923828125
      ],
      "page_num": 88,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 82 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 89,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        114.90937042236328,
        538.5599975585938,
        130.72967529296875
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하게 하거나, 애플리케이션을 통해 정보를 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        144.9093780517578,
        473.3629455566406,
        160.7296905517578
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 89,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후에 방문을 하여, 치료 후 평가를 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        421.4029541015625,
        250.72967529296875
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        264.90936279296875,
        521.2429809570312,
        280.72967529296875
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나) 이상반응 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        294.90936279296875,
        211.3199920654297,
        310.72967529296875
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 89,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        354.90936279296875,
        545.9400024414062,
        370.72967529296875
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        414.90936279296875,
        231.92295837402344,
        430.72967529296875
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        443.1600036621094,
        538.4402465820312,
        458.7120056152344
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수집할 수 있다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        469.20001220703125,
        212.33518981933594,
        484.75201416015625
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 병용 약물 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        496.9893493652344,
        218.75999450683594,
        512.8096923828125
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        526.9893798828125,
        521.2429809570312,
        542.8096923828125
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        556.9893798828125,
        538.5599975585938,
        572.8096923828125
      ],
      "page_num": 89,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        586.9893798828125,
        546.0599975585938,
        602.8096923828125
      ],
      "page_num": 89,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여 기간, 목적을 확인한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        616.9893798828125,
        310.1629638671875,
        632.8096923828125
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 순응도 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        646.9893798828125,
        196.3199920654297,
        662.8096923828125
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        676.9893798828125,
        546.0599975585938,
        692.8096923828125
      ],
      "page_num": 89,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        706.9893798828125,
        182.00296020507812,
        722.8096923828125
      ],
      "page_num": 89,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 83 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 90,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 방문 4 (치료 기간 종료 6개월 후, Follow up)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        84.90937042236328,
        408.24749755859375,
        100.72968292236328
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "가) 장기 효과 검증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        114.90937042236328,
        218.75999450683594,
        130.72967529296875
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 90,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        483.3229675292969,
        250.72967529296875
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        101.63999938964844,
        263.1600036621094,
        538.4400024414062,
        278.7120056152344
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수집할 수 있다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        121.19999694824219,
        289.20001220703125,
        215.33518981933594,
        304.75201416015625
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        316.9893798828125,
        534.9229736328125,
        332.8096923828125
      ],
      "page_num": 90,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나) 이상반응 확인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        346.9893798828125,
        211.3199920654297,
        362.8096923828125
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        376.9893798828125,
        545.9400024414062,
        392.8096923828125
      ],
      "page_num": 90,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        406.9893798828125,
        545.9400024414062,
        422.8096923828125
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        436.9893798828125,
        546.0599975585938,
        452.8096923828125
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        466.9893493652344,
        231.92295837402344,
        482.8096618652344
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        98.63999938964844,
        495.1199951171875,
        538.4402465820312,
        510.6719970703125
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수집할 수 있다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        118.19999694824219,
        521.1599731445312,
        212.33518981933594,
        536.7119750976562
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다) 병용 약물 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        548.9493408203125,
        218.75999450683594,
        564.7696533203125
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        578.9493408203125,
        521.2429809570312,
        594.7696533203125
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        608.9493408203125,
        538.4400024414062,
        624.7696533203125
      ],
      "page_num": 90,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        638.9493408203125,
        546.0599975585938,
        654.7696533203125
      ],
      "page_num": 90,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "투여 기간, 목적을 확인한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        668.9493408203125,
        310.1629638671875,
        684.7696533203125
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라) 순응도 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        86.63999938964844,
        698.9493408203125,
        196.3199920654297,
        714.7696533203125
      ],
      "page_num": 90,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        728.9493408203125,
        536.4829711914062,
        744.7696533203125
      ],
      "page_num": 90,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 84 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 91,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "12. 예측되는 부작용 및 사용 시 주의사항",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        374.5196838378906,
        115.0599594116211
      ],
      "page_num": 91,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        92.4000015258789,
        151.9199981689453,
        531.719970703125,
        166.3199920654297
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        79.55999755859375,
        175.9199981689453,
        163.6199951171875,
        190.3199920654297
      ],
      "page_num": 91,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        239.27430725097656,
        94.91999816894531,
        259.2254638671875
      ],
      "page_num": 91,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 예측되는 부작용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        275.4693603515625,
        194.51998901367188,
        291.2896728515625
      ],
      "page_num": 91,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        305.4693603515625,
        546.0599975585938,
        321.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "CBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        335.4693603515625,
        538.4400024414062,
        351.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        365.4693603515625,
        545.9400024414062,
        381.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        395.4693603515625,
        546.0599975585938,
        411.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        425.4693603515625,
        546.0599975585938,
        441.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        455.4693603515625,
        90.08296966552734,
        471.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        485.4693603515625,
        546.0599975585938,
        501.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        515.4693603515625,
        545.9400024414062,
        531.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        545.4693603515625,
        545.9400024414062,
        561.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        575.4693603515625,
        545.9400024414062,
        591.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제외한다. 이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        605.4693603515625,
        546.0599975585938,
        621.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        635.4693603515625,
        546.0599975585938,
        651.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        665.4693603515625,
        497.8199768066406,
        681.2896728515625
      ],
      "page_num": 91,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        695.4693603515625,
        546.0599975585938,
        711.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 일시적인 불안감 악화를 가져올 수 있다. 치료 시작 시점",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        725.4693603515625,
        538.5599975585938,
        741.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        755.4693603515625,
        545.9400024414062,
        771.2896728515625
      ],
      "page_num": 91,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 85 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 92,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연결이 가능하도록 조치한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        114.90937042236328,
        295.4029541015625,
        130.72967529296875
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        144.9093780517578,
        538.5599975585938,
        160.7296905517578
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "필요시 의료진 연결이 가능하도록 조치한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        294.90936279296875,
        400.282958984375,
        310.72967529296875
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        497.72296142578125,
        370.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 사용 시 주의사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        414.90936279296875,
        201.72000122070312,
        430.72967529296875
      ],
      "page_num": 92,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주의, 적용 상의 주의는 다음과 같다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        319.6199951171875,
        490.72967529296875
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 부작용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        504.90936279296875,
        136.32000732421875,
        520.7296752929688
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수는 없으며 이상반응 문제가 생길 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        564.9093627929688,
        408.05999755859375,
        580.7296752929688
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 일반적 주의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        594.9093627929688,
        173.75999450683594,
        610.7296752929688
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "번호로 연락하고 관리자가 조치할 때까지 대기한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        654.9093627929688,
        453.08294677734375,
        670.7296752929688
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 적용 상의 주의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        684.9093627929688,
        196.3199920654297,
        700.7296752929688
      ],
      "page_num": 92,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "요구한 사용 방법을 준수하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        744.9093627929688,
        355.6429748535156,
        760.7296752929688
      ],
      "page_num": 92,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 86 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "13. 중지·탈락 기준",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        214.44000244140625,
        115.0599594116211
      ],
      "page_num": 93,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        70.24079895019531,
        156.83999633789062,
        530.8800048828125,
        171.239990234375
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        180.83999633789062,
        530.83203125,
        195.239990234375
      ],
      "page_num": 93,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        204.83999633789062,
        530.8200073242188,
        219.239990234375
      ],
      "page_num": 93,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        228.83999633789062,
        530.8800048828125,
        243.239990234375
      ],
      "page_num": 93,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        252.83999633789062,
        530.3399658203125,
        267.239990234375
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        71.04000091552734,
        276.8399963378906,
        530.8800048828125,
        291.239990234375
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        300.8399963378906,
        530.8800048828125,
        315.239990234375
      ],
      "page_num": 93,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.23999786376953,
        324.8399963378906,
        488.5799865722656,
        339.239990234375
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        395.9942932128906,
        94.91999816894531,
        415.9454650878906
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 중지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        432.3093566894531,
        112.91999816894531,
        448.1296691894531
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 중지 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        462.3093566894531,
        163.8000030517578,
        478.1296691894531
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        492.3093566894531,
        546.0599975585938,
        508.1296691894531
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 일시중지 시킬 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        522.3093872070312,
        313.52294921875,
        538.1296997070312
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        552.3093872070312,
        545.9400024414062,
        568.1296997070312
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        582.3093872070312,
        545.9400024414062,
        598.1296997070312
      ],
      "page_num": 93,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        612.3093872070312,
        172.64295959472656,
        628.1296997070312
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 심각한 부작용 발생으로 조기 종료시킬 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        642.3093872070312,
        450.5629577636719,
        658.1296997070312
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 중지 처리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        672.3093872070312,
        163.8000030517578,
        688.1296997070312
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        702.3093872070312,
        546.0599975585938,
        718.1296997070312
      ],
      "page_num": 93,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 일시 중지 시킬 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        732.3093872070312,
        320.96295166015625,
        748.1296997070312
      ],
      "page_num": 93,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 87 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위한 통계 처리 시 삽입할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        114.90937042236328,
        358.04296875,
        130.72967529296875
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 94,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        538.4400024414062,
        220.72967529296875
      ],
      "page_num": 94,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하도록 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        202.282958984375,
        250.72967529296875
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "전면 파기한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        294.90936279296875,
        217.1629638671875,
        310.72967529296875
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 탈락",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        112.91999816894531,
        370.72967529296875
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 탈락 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        384.90936279296875,
        163.8000030517578,
        400.72967529296875
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 94,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "탈락시킬 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        444.90936279296875,
        220.64295959472656,
        460.72967529296875
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참여 동의를 철회하는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        504.90936279296875,
        302.2799987792969,
        520.7296752929688
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        534.9093627929688,
        544.9199829101562,
        550.7296752929688
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 94,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "담당자가 임상시험 수행이 불가능한 것으로 판단한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        594.9093627929688,
        502.55999755859375,
        610.7296752929688
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        654.9093627929688,
        495.1199951171875,
        670.7296752929688
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        684.9093627929688,
        546.0599975585938,
        700.7296752929688
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "영향을 줄 수 있는 약물의 사용량이 변경된 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        714.9093627929688,
        450.5999755859375,
        730.7296752929688
      ],
      "page_num": 94,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 94,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 88 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 95,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발견되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        213.239990234375,
        100.72968292236328
      ],
      "page_num": 95,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        114.90937042236328,
        487.67999267578125,
        130.72967529296875
      ],
      "page_num": 95,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 95,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중지해야 한다고 판단한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        315.8399963378906,
        190.7296905517578
      ],
      "page_num": 95,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 95,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예상되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        217.8000030517578,
        250.72967529296875
      ],
      "page_num": 95,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 탈락 처리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        264.90936279296875,
        163.8000030517578,
        280.72967529296875
      ],
      "page_num": 95,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 95,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 95,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기재한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        354.90936279296875,
        180.0829620361328,
        370.72967529296875
      ],
      "page_num": 95,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        384.90936279296875,
        546.0599975585938,
        400.72967529296875
      ],
      "page_num": 95,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 95,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통화를 하여 탈락의 주요 사유를 파악하도록 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        444.90936279296875,
        462.8029479980469,
        460.72967529296875
      ],
      "page_num": 95,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 89 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 96,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14. 유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)",
      "font_size": 14.039999961853027,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        524.0458374023438,
        109.41996002197266
      ],
      "page_num": 96,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        71.04000091552734,
        155.16000366210938,
        530.6400146484375,
        169.55999755859375
      ],
      "page_num": 96,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.95999908447266,
        179.1599884033203,
        530.6400146484375,
        193.5599822998047
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다. 그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.95999908447266,
        203.1599884033203,
        530.5199584960938,
        217.5599822998047
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.95999908447266,
        227.1599884033203,
        530.5199584960938,
        241.5599822998047
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.95999908447266,
        251.16000366210938,
        140.22000122070312,
        265.55999755859375
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        71.04000091552734,
        275.1600036621094,
        530.6400146484375,
        289.55999755859375
      ],
      "page_num": 96,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        85.31999969482422,
        299.1600036621094,
        505.8599853515625,
        313.55999755859375
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        71.04000091552734,
        323.1600036621094,
        530.4599609375,
        337.55999755859375
      ],
      "page_num": 96,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.47999572753906,
        347.1600036621094,
        530.6400146484375,
        361.55999755859375
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.47999572753906,
        371.1600036621094,
        530.5199584960938,
        385.55999755859375
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        84.47999572753906,
        395.1600036621094,
        453.41998291015625,
        409.55999755859375
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 유효성의 평가 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        468.1893615722656,
        216.72000122070312,
        484.0096740722656
      ],
      "page_num": 96,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        497.63427734375,
        94.91999816894531,
        517.58544921875
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[일차 유효성 평가변수]",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        533.9493408203125,
        236.8199920654297,
        549.7696533203125
      ],
      "page_num": 96,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        563.9493408203125,
        460.97998046875,
        579.7696533203125
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": (치료 6주 후 ISI 점수) – (치료 전 ISI 점수)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        90.0,
        593.9493408203125,
        396.9674987792969,
        609.7696533203125
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[이차 유효성 평가변수]",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        623.9493408203125,
        229.32467651367188,
        639.7696533203125
      ],
      "page_num": 96,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        653.9493408203125,
        473.2799987792969,
        669.7696533203125
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        683.9493408203125,
        459.8399963378906,
        699.7696533203125
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 치료 전 대비 6주 및 6개월 후 관해*율",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        711.989990234375,
        363.47998046875,
        729.7696533203125
      ],
      "page_num": 96,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        88.68000030517578,
        742.0799560546875,
        365.5199890136719,
        757.6319580078125
      ],
      "page_num": 96,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 90 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 97,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4) 치료 전 대비 6주 및 6개월 후 반응*률",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        82.94999694824219,
        363.47998046875,
        100.72968292236328
      ],
      "page_num": 97,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        88.68000030517578,
        113.15999603271484,
        538.440185546875,
        128.7119903564453
      ],
      "page_num": 97,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        168.95999145507812,
        139.1999969482422,
        502.7994384765625,
        154.7519989013672
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 삶의 질",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        166.98936462402344,
        148.8000030517578,
        182.80967712402344
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등)",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        196.98936462402344,
        429.92999267578125,
        212.80967712402344
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연번",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        263.2799987792969,
        471.1617431640625,
        278.8320007324219
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "측정 질문 (0∼10점, 시각 아날로그 척도 사용)",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        263.2799987792969,
        471.1617431640625,
        278.8320007324219
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        284.2799987792969,
        504.4151916503906,
        299.8320007324219
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        284.2799987792969,
        504.4151916503906,
        299.8320007324219
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        305.760009765625,
        495.4151916503906,
        321.31201171875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        305.760009765625,
        495.4151916503906,
        321.31201171875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        96.23999786376953,
        327.239990234375,
        513.295166015625,
        342.7919921875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        327.239990234375,
        513.295166015625,
        342.7919921875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 18. 사용자 반응 평가 지표 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        195.95999145507812,
        237.95999145507812,
        415.9200439453125,
        253.51199340820312
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        378.0299987792969,
        475.91998291015625,
        395.8096923828125
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.15999603271484,
        408.239990234375,
        423.5351867675781,
        423.7919921875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연번",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        472.32000732421875,
        354.7205810546875,
        487.87200927734375
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가 지표",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        85.79999542236328,
        472.32000732421875,
        354.7205810546875,
        487.87200927734375
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        494.760009765625,
        476.5614318847656,
        510.31201171875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        494.760009765625,
        476.5614318847656,
        510.31201171875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        514.7999877929688,
        449.3216247558594,
        545.9519653320312
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면에 대한 역기능적 신념 및 태도 척도",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        514.7999877929688,
        449.3216247558594,
        545.9519653320312
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Dysfunctional Beliefs and Attitudes about Sleep, DBAS)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        514.7999877929688,
        449.3216247558594,
        545.9519653320312
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        96.23999786376953,
        551.8799438476562,
        358.24176025390625,
        567.4319458007812
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 다원검사 (Polysomnography, PSG)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        551.8799438476562,
        358.24176025390625,
        567.4319458007812
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        96.23999786376953,
        573.3599853515625,
        444.76190185546875,
        604.511962890625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "단축형 우울증상 평가 척도",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        573.3599853515625,
        444.76190185546875,
        604.511962890625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Quick Inventory of Depressive Symptomatology, QIDS)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        573.3599853515625,
        444.76190185546875,
        604.511962890625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        608.9999389648438,
        391.240966796875,
        624.5519409179688
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Beck 불안 척도 (Beck Anxiety Inventory, BAI)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        608.9999389648438,
        391.240966796875,
        624.5519409179688
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        633.3599853515625,
        472.9622802734375,
        648.9119873046875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36항 건강수준 척도 (Short Form-36 Health Survey, SF-36)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        633.3599853515625,
        472.9622802734375,
        648.9119873046875
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        657.5999755859375,
        522.8814697265625,
        673.1519775390625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        657.5999755859375,
        522.8814697265625,
        673.1519775390625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        96.23999786376953,
        681.9599609375,
        368.15997314453125,
        697.511962890625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 일기를 통한 수면양상, 낮시간 졸음",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        96.23999786376953,
        681.9599609375,
        368.15997314453125,
        697.511962890625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        706.199951171875,
        319.3199768066406,
        721.751953125
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면, 우울, 불안 관련 증상 유무",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        96.23999786376953,
        706.199951171875,
        319.3199768066406,
        721.751953125
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        93.0,
        730.5599365234375,
        270.96051025390625,
        746.1119384765625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "직업적/사회적 기능 상태",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        93.0,
        730.5599365234375,
        270.96051025390625,
        746.1119384765625
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 19. 불면증 이차 유효성 평가 지표 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        170.75999450683594,
        447.1199951171875,
        438.2405700683594,
        462.6719970703125
      ],
      "page_num": 97,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 91 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 98,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 검사 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        150.0,
        100.72968292236328
      ],
      "page_num": 98,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        114.35430908203125,
        94.91999816894531,
        134.30548095703125
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 불면증 심각도 척도(Insomnia Severity Index, ISI)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        150.54937744140625,
        428.6474914550781,
        166.36968994140625
      ],
      "page_num": 98,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        180.54937744140625,
        545.9400024414062,
        196.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        210.54937744140625,
        538.4400024414062,
        226.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로 검증된 자가 보고식 설문이다(Morin, 1993). 불면증 심각도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        240.5493621826172,
        545.9400024414062,
        256.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        270.54937744140625,
        546.0599975585938,
        286.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "리커트 척도(0-4)로 이루어져 있다. 불면증 심각도 척도(ISI) 점수의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        300.54937744140625,
        546.0599975585938,
        316.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        330.54937744140625,
        546.0599975585938,
        346.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "불면증군, 22-28점을 중증도의 불면증군으로 분류한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        360.54937744140625,
        472.282958984375,
        376.36968994140625
      ],
      "page_num": 98,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        390.54937744140625,
        545.9400024414062,
        406.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        420.54937744140625,
        545.9400024414062,
        436.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설문을 수행할 예정이다. 단, 필요에 따라 방문 1(스크리닝 단계)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        450.54937744140625,
        538.447509765625,
        466.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        480.54937744140625,
        545.9400024414062,
        496.36968994140625
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지표로 활용할 수 있다. 방문 1의 경우 연구자가 직접 피험자와",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        510.54937744140625,
        545.9400024414062,
        526.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        540.5493774414062,
        546.0599975585938,
        556.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        570.5493774414062,
        545.9400024414062,
        586.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        600.5493774414062,
        546.0599975585938,
        616.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동일하게 진행될 예정이다. 다만 방문 2, 3의 경우 애플리케이션을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        630.5493774414062,
        546.0599975585938,
        646.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        660.5493774414062,
        545.9400024414062,
        676.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        690.5493774414062,
        546.0599975585938,
        706.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "뒤 회신받는 것으로 갈음할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        720.5493774414062,
        348.08294677734375,
        736.3696899414062
      ],
      "page_num": 98,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        750.5493774414062,
        546.0599975585938,
        766.3696899414062
      ],
      "page_num": 98,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 92 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 99,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제외되게 된다. 방문 3, 4의 설문 점수는 방문 1의 점수와 비교",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석되어 유효성에 대한 검증을 위해 사용될 예정이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        114.90937042236328,
        475.52294921875,
        130.72967529296875
      ],
      "page_num": 99,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 수면 효율(Sleep Efficiency, SE)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        144.9093780517578,
        310.8074951171875,
        160.7296905517578
      ],
      "page_num": 99,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시간의 비율을 말한다(단위: 퍼센트). 얼마나 효율적으로 수면을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하나이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        294.90936279296875,
        168.17999267578125,
        310.72967529296875
      ],
      "page_num": 99,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        324.90936279296875,
        545.9400024414062,
        340.72967529296875
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면 일기이다(Camey et al. 2012). 수면 일기의 세부적인 항목은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 99,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        414.90936279296875,
        213.2029571533203,
        430.72967529296875
      ],
      "page_num": 99,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 99,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        474.90936279296875,
        455.1600036621094,
        490.72967529296875
      ],
      "page_num": 99,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 93 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 100,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[수면 일기] # ＿",
      "font_size": 11.039999961853027,
      "font_name": "T20",
      "bbox": [
        95.75999450683594,
        111.95999908447266,
        522.359619140625,
        125.20800018310547
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이름:＿＿＿",
      "font_size": 11.039999961853027,
      "font_name": "T20",
      "bbox": [
        95.75999450683594,
        111.95999908447266,
        522.359619140625,
        125.20800018310547
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "요일",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "월",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "화",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "목",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "금",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "토",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        128.87998962402344,
        524.0400390625,
        140.83200073242188
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "날짜 (월/일)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        141.71998596191406,
        289.8401794433594,
        166.39199829101562
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        141.71998596191406,
        289.8401794433594,
        166.39199829101562
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(낮잠을 잤던 시간을 모두 표시)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        112.43999481201172,
        164.51998901367188,
        258.03875732421875,
        176.4720001220703
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 지난밤에, 약 ＿을(를) ＿mg 복용하였다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        177.3599853515625,
        296.3201904296875,
        189.31199645996094
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "또는 알코올 ＿을(를) ＿잔(병) 음주하였다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        112.43999481201172,
        187.3199920654297,
        306.1601867675781,
        199.27200317382812
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        200.1599884033203,
        365.5587463378906,
        263.35198974609375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 지난밤에, ＿:＿에 불을 끄고 잠을 청했다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        200.1599884033203,
        365.5587463378906,
        263.35198974609375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        200.1599884033203,
        365.5587463378906,
        263.35198974609375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 자다가 중간에 ＿번 깼다. (최종적으로 일어난 것 제외)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        200.1599884033203,
        365.5587463378906,
        263.35198974609375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. 한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        200.1599884033203,
        365.5587463378906,
        263.35198974609375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(각각 깼을 때마다 구분하여 표시)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        112.43999481201172,
        261.3600158691406,
        268.1187744140625,
        273.31201171875
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. 나는 오늘 최종적으로 ＿:＿에 일어났다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        274.20001220703125,
        328.00018310546875,
        311.8320007324219
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. 나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        274.20001220703125,
        328.00018310546875,
        311.8320007324219
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. 전날 밤 수면의 질:",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        274.20001220703125,
        328.00018310546875,
        311.8320007324219
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(매우 나쁨)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        309.8399963378906,
        304.478759765625,
        321.7919921875
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(보통)",
      "font_size": 9.960000038146973,
      "font_name": "T20",
      "bbox": [
        117.36000061035156,
        309.8399963378906,
        304.478759765625,
        321.7919921875
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(매우 좋음)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        309.8399963378906,
        304.478759765625,
        321.7919921875
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        319.9200134277344,
        307.3797607421875,
        331.87200927734375
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11. 잠에서 깨었을 때 개운함의 정도:",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        99.95999908447266,
        332.6400146484375,
        269.8200988769531,
        344.5920104980469
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(매우 불만족)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        342.7200012207031,
        309.3987731933594,
        354.6719970703125
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(보통)",
      "font_size": 9.960000038146973,
      "font_name": "T20",
      "bbox": [
        117.36000061035156,
        342.7200012207031,
        309.3987731933594,
        354.6719970703125
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(매우 만족)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        342.7200012207031,
        309.3987731933594,
        354.6719970703125
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        117.36000061035156,
        352.67999267578125,
        307.3797607421875,
        364.6319885253906
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "* 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다. (1, 3, 4, 8, 9번)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        101.27999877929688,
        365.27996826171875,
        466.0622253417969,
        378.5279846191406
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        95.75999450683594,
        376.3199768066406,
        524.2796020507812,
        389.5679931640625
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대해서도 함께 적습니다.",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        110.15999603271484,
        387.239990234375,
        233.82479858398438,
        400.4880065917969
      ],
      "page_num": 100,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "표 20. 수면 일기의 예시",
      "font_size": 12.960000038146973,
      "font_name": "T10",
      "bbox": [
        233.51998901367188,
        86.04000091552734,
        386.0405578613281,
        101.59200286865234
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        444.0693664550781,
        546.0599975585938,
        459.8896789550781
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치의 수면 일기를 수집할 예정이다. 방문 1의 경우 연구자가 직접",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        474.0693664550781,
        546.0599975585938,
        489.8896789550781
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        504.0693359375,
        545.9400024414062,
        519.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        534.0693359375,
        545.9400024414062,
        549.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일기 작성법을 5~10분에 걸쳐 교육할 것이다. 이때 일주일 치의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        564.0693359375,
        545.9400024414062,
        579.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        594.0693359375,
        538.4400024414062,
        609.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        624.0693359375,
        545.9400024414062,
        639.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "작성도를 확인할 것이다. 방문 3, 방문 4의 경우 미리 교육을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        654.0693359375,
        545.9400024414062,
        669.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        684.0693359375,
        545.9400024414062,
        699.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        714.0693359375,
        545.9400024414062,
        729.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        744.0693359375,
        545.9400024414062,
        759.8896484375
      ],
      "page_num": 100,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 94 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 101,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        160.6199951171875,
        160.7296905517578
      ],
      "page_num": 101,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1주일 중 3일 이하로 저조할 경우 연구에서 제외한다. 제외하지",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "baseline 지표로 활용한다. 방문 3, 방문 4에서 수거한 수면 일기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "비교 분석하여 유효성에 대한 검증을 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        324.90936279296875,
        423.08294677734375,
        340.72967529296875
      ],
      "page_num": 101,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        354.90936279296875,
        538.4400024414062,
        370.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이스 등을 통하여 갈음할 수 있다. 웨어러블 디바이스를 사용할",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "후까지 디바이스를 착용하고 있어야 한다. 이 때 사용되는 웨어",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        444.90936279296875,
        538.4400024414062,
        460.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        474.90936279296875,
        538.5599975585938,
        490.72967529296875
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정력을 보여주어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        534.9093627929688,
        288.17999267578125,
        550.7296752929688
      ],
      "page_num": 101,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 기타 이차 유효성 평가 변수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        564.9093627929688,
        298.739990234375,
        580.7296752929688
      ],
      "page_num": 101,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다. 자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        684.9093627929688,
        546.0599975585938,
        700.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정이 가능하다. 연구자와의 대면 인터뷰 또한 불면증 심각도",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        744.9093627929688,
        538.4400024414062,
        760.7296752929688
      ],
      "page_num": 101,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 95 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 102,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        84.90937042236328,
        490.52294921875,
        100.72968292236328
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        538.5599975585938,
        190.7296905517578
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정이 가능하다. 이외 기타 치료 관련 변수와 동일한 방식으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "측정이 가능하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        264.90936279296875,
        213.2029571533203,
        280.72967529296875
      ],
      "page_num": 102,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 통계 분석 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        187.0800018310547,
        340.72967529296875
      ],
      "page_num": 102,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        354.35430908203125,
        94.91999816894531,
        374.30548095703125
      ],
      "page_num": 102,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 분석 대상군",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        390.54937744140625,
        178.8000030517578,
        406.36968994140625
      ],
      "page_num": 102,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 모든 분석 대상자군(Full Analysis Set, FAS)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        420.54937744140625,
        408.60748291015625,
        436.36968994140625
      ],
      "page_num": 102,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.68000030517578,
        450.54937744140625,
        545.9400024414062,
        466.36968994140625
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        480.54937744140625,
        545.9400024414062,
        496.36968994140625
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        510.54937744140625,
        538.4400024414062,
        526.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        540.5493774414062,
        545.9400024414062,
        556.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유효성 평가자료가 전무한 경우는 제외한다. 1차/2차 유효성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        570.5493774414062,
        545.9400024414062,
        586.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        600.5493774414062,
        538.4400024414062,
        616.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석군으로 분석한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        630.5493774414062,
        261.2029724121094,
        646.3696899414062
      ],
      "page_num": 102,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 계획서 순응 임상시험대상자군(Per-protocol Set, PPS)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        660.5493774414062,
        479.5274963378906,
        676.3696899414062
      ],
      "page_num": 102,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        690.5493774414062,
        538.5599975585938,
        706.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        720.5493774414062,
        545.9400024414062,
        736.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없는 피험자로 정의한다. 1차/2차 유효성 평가는 계획서 순응",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        750.5493774414062,
        545.9400024414062,
        766.3696899414062
      ],
      "page_num": 102,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 96 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 103,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험대상자군(PPS)를 보조분석군으로 분석한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        84.90937042236328,
        449.60296630859375,
        100.72968292236328
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "⦁ 수면 관련한 약물을 복용한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        114.90937042236328,
        356.8800048828125,
        130.72967529296875
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        144.9093780517578,
        483.0,
        160.7296905517578
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        111.5999984741211,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판단되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        134.16000366210938,
        204.90936279296875,
        232.55999755859375,
        220.72967529296875
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 안전성 자료(Safety Set, SS)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        234.90936279296875,
        302.2875061035156,
        250.72967529296875
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자로 정의한다. 안전성 평가는 안전성 자료를 대상으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        324.90936279296875,
        162.44296264648438,
        340.72967529296875
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 일차 유효성 평가변수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        354.90936279296875,
        246.36000061035156,
        370.72967529296875
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        384.90936279296875,
        464.7599792480469,
        400.72967529296875
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "신뢰구간을 제시한다. 대조군 대비 시험군의 평균 변화량이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통계적으로 우월하다고 판단한다. 또한, 결과에 대한 임상적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        564.9093627929688,
        545.9400024414062,
        580.7296752929688
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가를 제시한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        594.9093627929688,
        233.1229705810547,
        610.7296752929688
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 이차 유효성 평가변수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        624.9093627929688,
        246.36000061035156,
        640.7296752929688
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 103,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "6개월 후 수면 효율(SE) 변화량",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        684.9093627929688,
        328.91998291015625,
        700.7296752929688
      ],
      "page_num": 103,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 103,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 97 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 104,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통계적 우월성을 평가한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        114.90937042236328,
        306.17999267578125,
        130.72967529296875
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        144.9093780517578,
        454.55999755859375,
        160.7296905517578
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "exact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        264.90936279296875,
        503.0029602050781,
        280.72967529296875
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 삶의 질",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        294.90936279296875,
        168.72000122070312,
        310.72967529296875
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 일차 유효성 평가변수와 동일한 방법을 적용한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        324.90936279296875,
        465.9229736328125,
        340.72967529296875
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 사용자 반응 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        354.90936279296875,
        235.44000244140625,
        370.72967529296875
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        384.90936279296875,
        538.4400024414062,
        400.72967529296875
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        414.90936279296875,
        537.5629272460938,
        430.72967529296875
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        444.90936279296875,
        523.7999877929688,
        460.72967529296875
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        474.90936279296875,
        538.4400024414062,
        490.72967529296875
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가를 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        534.9093627929688,
        231.92295837402344,
        550.7296752929688
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 수면양상 및 낮시간 졸음",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        564.9093627929688,
        287.3999938964844,
        580.7296752929688
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": ": 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "measured Mixed model) 혹은 일반화 추정 방정식(Generalized",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Estimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        684.9093627929688,
        546.0599975585938,
        700.7296752929688
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통계적 평가를 수행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        714.9093627929688,
        283.8829650878906,
        730.7296752929688
      ],
      "page_num": 104,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 결측값 처리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        744.9093627929688,
        178.8000030517578,
        760.7296752929688
      ],
      "page_num": 104,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 98 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 105,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Carried Forward, LOCF)으로 대치한다. 그 외 자료는 대치 처리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "없이 수집된 자료로 분석한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        204.90936279296875,
        305.2429504394531,
        220.72967529296875
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 이상치 처리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        234.90936279296875,
        178.8000030517578,
        250.72967529296875
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "각 변수에 대해 이상치는 별도로 고려하지 않는다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        264.90936279296875,
        463.04296875,
        280.72967529296875
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 하위 분석",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        294.90936279296875,
        163.8000030517578,
        310.72967529296875
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        354.90936279296875,
        505.52294921875,
        370.72967529296875
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 민감도 분석",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        384.90936279296875,
        178.8000030517578,
        400.72967529296875
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 105,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        474.90936279296875,
        535.4029541015625,
        490.72967529296875
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 105,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        116.63999938964844,
        534.9093627929688,
        542.8200073242188,
        550.7296752929688
      ],
      "page_num": 105,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8) 중간 분석",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        564.9093627929688,
        163.8000030517578,
        580.7296752929688
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 본 연구는 중간 분석을 수행하지 않는다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.63999938964844,
        594.9093627929688,
        395.1229553222656,
        610.7296752929688
      ],
      "page_num": 105,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 99 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        280.55999755859375,
        803.6103515625,
        314.625,
        813.5703125
      ],
      "page_num": 106,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "15. 부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        525.96044921875,
        115.0599594116211
      ],
      "page_num": 106,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.91999816894531,
        151.67999267578125,
        530.6400146484375,
        166.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        175.67999267578125,
        530.5199584960938,
        190.07998657226562
      ],
      "page_num": 106,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        199.67999267578125,
        530.6520385742188,
        214.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정도와",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기와의",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인과관계를",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "평가하여",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증례기록서에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        223.67999267578125,
        530.6400146484375,
        238.07998657226562
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여야",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        247.67999267578125,
        530.5199584960938,
        262.0799865722656
      ],
      "page_num": 106,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "한다. 따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        247.67999267578125,
        530.5199584960938,
        262.0799865722656
      ],
      "page_num": 106,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한 평가 기준을 제시하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        271.67999267578125,
        276.8999938964844,
        286.0799865722656
      ],
      "page_num": 106,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        335.6343078613281,
        94.91999816894531,
        355.5854797363281
      ],
      "page_num": 106,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 피험자 안전성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        371.8293762207031,
        179.63999938964844,
        387.6496887207031
      ],
      "page_num": 106,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        401.8293762207031,
        546.0599975585938,
        417.6496887207031
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다. 하지만,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        431.8293762207031,
        546.0599975585938,
        447.6496887207031
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        461.8293762207031,
        546.0599975585938,
        477.6496887207031
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        491.8293762207031,
        545.9400024414062,
        507.6496887207031
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        521.829345703125,
        545.9400024414062,
        537.649658203125
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        551.829345703125,
        538.4400024414062,
        567.649658203125
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 긴급 연락망과 방문을 통해 이상반응을 수집한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        581.829345703125,
        439.6429443359375,
        597.649658203125
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 시험자 안전성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        641.829345703125,
        179.63999938964844,
        657.649658203125
      ],
      "page_num": 106,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        671.829345703125,
        545.9400024414062,
        687.649658203125
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        701.829345703125,
        546.0599975585938,
        717.649658203125
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        731.829345703125,
        135.68296813964844,
        747.649658203125
      ],
      "page_num": 106,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 100 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 107,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 이상사례의 정의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        84.90937042236328,
        205.67999267578125,
        100.72968292236328
      ],
      "page_num": 107,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        104.75999450683594,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        104.75999450683594,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 것은 아니다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        104.75999450683594,
        204.90936279296875,
        228.80296325683594,
        220.72967529296875
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.5199966430664,
        264.90936279296875,
        538.5599975585938,
        280.72967529296875
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.5199966430664,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우를 말한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        101.5199966430664,
        324.90936279296875,
        203.00296020507812,
        340.72967529296875
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        354.90936279296875,
        465.8399963378906,
        370.72967529296875
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 이상사례의 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        429.1893615722656,
        205.67999267578125,
        445.0096740722656
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 임상시험용 의료기기와의 인과관계 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        459.1893615722656,
        378.7200012207031,
        475.0096740722656
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        489.1893615722656,
        546.0599975585938,
        505.0096740722656
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        104.04000091552734,
        519.1893920898438,
        538.5599975585938,
        535.0097045898438
      ],
      "page_num": 107,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        104.04000091552734,
        549.1893920898438,
        138.0829620361328,
        565.0097045898438
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 관련성이 명백함(Definitely related)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        579.1893920898438,
        358.2074890136719,
        595.0097045898438
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        609.1893310546875,
        546.0599975585938,
        625.0096435546875
      ],
      "page_num": 107,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "타당한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        639.1893310546875,
        202.0800018310547,
        655.0096435546875
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        669.1893310546875,
        546.0599975585938,
        685.0096435546875
      ],
      "page_num": 107,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의해 가장 개연성이 있게 설명되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        699.1893310546875,
        396.9599914550781,
        715.0096435546875
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 사용 중단으로 이상반응이 없어지는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        729.1893310546875,
        403.91998291015625,
        745.0096435546875
      ],
      "page_num": 107,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 101 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        84.90937042236328,
        533.2799682617188,
        100.72968292236328
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        144.9093780517578,
        512.8800048828125,
        160.7296905517578
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 관련성이 많음(Probably related)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        174.9093780517578,
        336.8475036621094,
        190.7296905517578
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기를 사용하였다는 증거가 있는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        204.90936279296875,
        501.47998046875,
        220.72967529296875
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "타당한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        264.90936279296875,
        202.0800018310547,
        280.72967529296875
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "더욱 개연성이 있게 설명되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        324.90936279296875,
        359.5199890136719,
        340.72967529296875
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        354.90936279296875,
        534.1199951171875,
        370.72967529296875
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "○ 관련성이 의심됨(Possibly related)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        384.90936279296875,
        346.0874938964844,
        400.72967529296875
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기를 사용하였다는 증거가 있는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        414.90936279296875,
        501.47998046875,
        430.72967529296875
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "타당한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        474.90936279296875,
        202.0800018310547,
        490.72967529296875
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        504.90936279296875,
        545.9400024414062,
        520.7296752929688
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 의료기기의 사용에 기인한다고 판단되는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.5199966430664,
        534.9093627929688,
        517.5599975585938,
        550.7296752929688
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        564.9093627929688,
        538.5599975585938,
        580.7296752929688
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응이 사라지는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.19999694824219,
        594.9093627929688,
        271.0799865722656,
        610.7296752929688
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 관련성이 적음(Probably not related)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        624.9093627929688,
        365.2875061035156,
        640.7296752929688
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기를 사용하였다는 증거가 있는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        654.9093627929688,
        501.47998046875,
        670.7296752929688
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이상반응에 대해 보다 가능성 있는 원인이 있는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        684.9093627929688,
        486.3599853515625,
        700.7296752929688
      ],
      "page_num": 108,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        714.9093627929688,
        538.4400024414062,
        730.7296752929688
      ],
      "page_num": 108,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이거나 모호한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        121.19999694824219,
        744.9093627929688,
        256.08001708984375,
        760.7296752929688
      ],
      "page_num": 108,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 102 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 109,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 109,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모호한 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.75999450683594,
        114.90937042236328,
        202.1999969482422,
        130.72967529296875
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 관련성이 없음(Definitely not related)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        144.9093780517578,
        371.6474914550781,
        160.7296905517578
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기를 사용하지 않은 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        174.9093780517578,
        418.91998291015625,
        190.7296905517578
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 109,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "타당하지 않은 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        234.90936279296875,
        254.51998901367188,
        250.72967529296875
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 이상반응에 대해 다른 명백한 원인이 있는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        264.90936279296875,
        448.91998291015625,
        280.72967529296875
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 평가 불가능(Unknown)",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        294.90936279296875,
        272.16748046875,
        310.72967529296875
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 109,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인할 수 없는 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.63999938964844,
        354.90936279296875,
        262.08001708984375,
        370.72967529296875
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "마. 안전성의 평가 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        414.90936279296875,
        228.1199951171875,
        430.72967529296875
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 109,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        474.90936279296875,
        538.4400024414062,
        490.72967529296875
      ],
      "page_num": 109,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응으로 분류한다. 예측되는 부작용도 이상반응으로 분류한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        504.90936279296875,
        502.1629638671875,
        520.7296752929688
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 이상사례 보고 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        564.9093627929688,
        228.1199951171875,
        580.7296752929688
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 이상사례 교육",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        594.9093627929688,
        198.72000122070312,
        610.7296752929688
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        624.9093627929688,
        538.5599975585938,
        640.7296752929688
      ],
      "page_num": 109,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.04000091552734,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 109,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.04000091552734,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 109,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교육을 실시한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.04000091552734,
        714.9093627929688,
        235.04296875,
        730.7296752929688
      ],
      "page_num": 109,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 중대한 의료기기이상반응 보고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        744.9093627929688,
        311.2799987792969,
        760.7296752929688
      ],
      "page_num": 109,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 103 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 110,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        95.5199966430664,
        83.15999603271484,
        538.4403076171875,
        98.71199798583984
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        116.75999450683594,
        109.19999694824219,
        436.6152038574219,
        124.75199890136719
      ],
      "page_num": 110,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        66.5999984741211,
        136.98936462402344,
        538.4400024414062,
        152.80967712402344
      ],
      "page_num": 110,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        166.98936462402344,
        545.9400024414062,
        182.80967712402344
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        196.98936462402344,
        538.5675048828125,
        212.80967712402344
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기이상반응으로 기록하고 사망을 초래하거나 생명을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        226.98936462402344,
        546.0599975585938,
        242.80967712402344
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        256.9893798828125,
        546.0599975585938,
        272.8096923828125
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        286.9893798828125,
        545.9400024414062,
        302.8096923828125
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "8일 이내에 추가로 보고 하여야 한다. 그 밖의 중대하거나 예상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        316.9893798828125,
        538.4400024414062,
        332.8096923828125
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        346.9893798828125,
        545.9400024414062,
        362.8096923828125
      ],
      "page_num": 110,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        119.15999603271484,
        376.9893798828125,
        528.5629272460938,
        392.8096923828125
      ],
      "page_num": 110,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 104 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 111,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16. 피험자 동의서 서식",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        238.44000244140625,
        109.41996002197266
      ],
      "page_num": 111,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.91999816894531,
        145.9199981689453,
        530.5199584960938,
        160.3199920654297
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        169.9199981689453,
        530.5199584960938,
        184.3199920654297
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식,",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        193.9199981689453,
        530.592041015625,
        208.3199920654297
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        217.9199981689453,
        530.5800170898438,
        232.3199920654297
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        241.9199981689453,
        530.6400146484375,
        256.32000732421875
      ],
      "page_num": 111,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[별표 3])에서 정하고 있다. 이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        265.91998291015625,
        530.6400146484375,
        280.3199768066406
      ],
      "page_num": 111,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        289.91998291015625,
        404.94000244140625,
        304.3199768066406
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        353.8742980957031,
        94.91999816894531,
        373.8254699707031
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 피험자 동의서에 반드시 포함되어야 하는 사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        390.1893615722656,
        402.1199951171875,
        406.0096740722656
      ],
      "page_num": 111,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상시험의 연구목적으로 수행된다는 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        420.1893615722656,
        388.79998779296875,
        436.0096740722656
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상시험의 목적",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        450.1893615722656,
        208.8000030517578,
        466.0096740722656
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        480.1893615722656,
        538.4400024414062,
        496.0096740722656
      ],
      "page_num": 111,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "배정 될 확률",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        510.18939208984375,
        186.36000061035156,
        526.0097045898438
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        540.1893920898438,
        546.0599975585938,
        556.0097045898438
      ],
      "page_num": 111,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "받게 될 각종 검사나 절차",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        570.1893920898438,
        276.239990234375,
        586.0097045898438
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 피험자가 준수하여야 할 사항",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        600.1893310546875,
        298.79998779296875,
        616.0096435546875
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 검증되지 않은 임상시험이라는 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        630.1893310546875,
        343.79998779296875,
        646.0096435546875
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 피험자에게 미칠 것으로 예상되는 위험이나 불편",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        660.1893310546875,
        433.79998779296875,
        676.0096435546875
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        690.1893310546875,
        545.9400024414062,
        706.0096435546875
      ],
      "page_num": 111,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        720.1893310546875,
        148.8000030517578,
        736.0096435546875
      ],
      "page_num": 111,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        750.1893310546875,
        545.9400024414062,
        766.0096435546875
      ],
      "page_num": 111,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 105 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 112,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법의 잠재적 위험과 이익",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        84.90937042236328,
        283.79998779296875,
        100.72968292236328
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보상이나 치료 방법",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        144.9093780517578,
        238.79998779296875,
        160.7296905517578
      ],
      "page_num": 112,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 조정될 것이라고 하는 것",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        234.90936279296875,
        313.79998779296875,
        250.72967529296875
      ],
      "page_num": 112,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12) 임상시험에 참여함으로써 피험자에게 예상되는 비용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        264.90936279296875,
        459.9599914550781,
        280.72967529296875
      ],
      "page_num": 112,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.83999633789062,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        102.83999633789062,
        354.90936279296875,
        536.5199584960938,
        370.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        384.90936279296875,
        538.4400024414062,
        400.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        414.90936279296875,
        546.0599975585938,
        430.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        504.90936279296875,
        545.9400024414062,
        520.7296752929688
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서명이 이러한 자료의 열람을 허용하게 된다는 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        534.9093627929688,
        463.79998779296875,
        550.7296752929688
      ],
      "page_num": 112,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        564.9093627929688,
        545.9400024414062,
        580.7296752929688
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이라는 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        624.9093627929688,
        201.36000061035156,
        640.7296752929688
      ],
      "page_num": 112,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        684.9093627929688,
        546.0599975585938,
        700.7296752929688
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "것이라는 사실",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        714.9093627929688,
        201.36000061035156,
        730.7296752929688
      ],
      "page_num": 112,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        744.9093627929688,
        546.0599975585938,
        760.7296752929688
      ],
      "page_num": 112,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 106 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 113,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 사람",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        114.90937042236328,
        171.36000061035156,
        130.72967529296875
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그 사유",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        103.91999816894531,
        174.9093780517578,
        156.36000061035156,
        190.7296905517578
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "19) 피험자의 임상시험 예상 참여 기간",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        204.90936279296875,
        343.79998779296875,
        220.72967529296875
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20) 임상시험에 참여하는 대략의 피험자 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        234.90936279296875,
        373.79998779296875,
        250.72967529296875
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 피험자 동의의 일반적 요건",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        294.90936279296875,
        268.67999267578125,
        310.72967529296875
      ],
      "page_num": 113,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Review Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        354.90936279296875,
        545.9400024414062,
        370.72967529296875
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기타 문서화된 정보의 사전 서면 승인을 받아야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        384.90936279296875,
        467.72296142578125,
        400.72967529296875
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        474.90936279296875,
        546.0599975585938,
        490.72967529296875
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        504.90936279296875,
        538.5599975585938,
        520.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        534.9093627929688,
        182.8429718017578,
        550.7296752929688
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대리인)에게 제공해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        594.9093627929688,
        285.0829772949219,
        610.7296752929688
      ],
      "page_num": 113,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제공하여 동의를 얻어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        744.9093627929688,
        302.84295654296875,
        760.7296752929688
      ],
      "page_num": 113,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 107 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 114,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        114.90937042236328,
        538.5599975585938,
        130.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 내용이 포함되어서는 안 된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        144.9093780517578,
        340.282958984375,
        160.7296905517578
      ],
      "page_num": 114,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "받아야 한다. 피험자의 지속적인 연구 참여 의지에 영향을 줄",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고지와 관련된 모든 사항을 문서화해야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        324.90936279296875,
        407.84295654296875,
        340.72967529296875
      ],
      "page_num": 114,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        354.90936279296875,
        545.9400024414062,
        370.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "입회자가 동의를 얻는 전 과정에 참석하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.23999786376953,
        384.90936279296875,
        441.5629577636719,
        400.72967529296875
      ],
      "page_num": 114,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        518.0399780273438,
        460.72967529296875
      ],
      "page_num": 114,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        474.90936279296875,
        546.0599975585938,
        490.72967529296875
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        564.9093627929688,
        518.0029296875,
        580.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        503.03997802734375,
        640.7296752929688
      ],
      "page_num": 114,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        538.4400024414062,
        700.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        714.9093627929688,
        546.0599975585938,
        730.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        744.9093627929688,
        545.9400024414062,
        760.7296752929688
      ],
      "page_num": 114,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 108 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 115,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "서명하고 자필로 날짜를 기재하여야 한다. 또한, 피험자의 대리인임을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        545.9400024414062,
        100.72968292236328
      ],
      "page_num": 115,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 115,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        450.5629577636719,
        160.7296905517578
      ],
      "page_num": 115,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 109 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 116,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "17. 피해자 보상에 대한 규약",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        278.5196838378906,
        115.0599594116211
      ],
      "page_num": 116,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        76.43999481201172,
        155.87998962402344,
        530.8800048828125,
        170.2799835205078
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 원칙과 절차를 수립하여 제시한다. 피해자 보상에 대한 규약에는 보상원칙과 보상이",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        179.87998962402344,
        530.8800048828125,
        194.2799835205078
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        203.87998962402344,
        425.4599914550781,
        218.2799835205078
      ],
      "page_num": 116,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        270.9543151855469,
        94.91999816894531,
        290.9054870605469
      ],
      "page_num": 116,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        307.2693786621094,
        538.5599975585938,
        323.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        337.2693786621094,
        538.4400024414062,
        353.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        367.2693786621094,
        545.9400024414062,
        383.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        397.2693786621094,
        435.5629577636719,
        413.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        427.2693786621094,
        545.9400024414062,
        443.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다. 그 외의 경우",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        457.2693786621094,
        538.4400024414062,
        473.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        487.2693786621094,
        545.9400024414062,
        503.0896911621094
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        517.2693481445312,
        546.0599975585938,
        533.0896606445312
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        547.2693481445312,
        546.0599975585938,
        563.0896606445312
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        577.2693481445312,
        450.5629577636719,
        593.0896606445312
      ],
      "page_num": 116,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 110 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 117,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18. 임상시험 후 피험자의 진료에 관한 사항",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        99.09996032714844,
        390.47998046875,
        115.0599594116211
      ],
      "page_num": 117,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.79999542236328,
        151.3199920654297,
        530.8800048828125,
        165.71998596191406
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        175.3199920654297,
        530.8800048828125,
        189.71998596191406
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하는 원칙과 절차를 수립하여 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        199.3199920654297,
        287.82000732421875,
        213.71998596191406
      ],
      "page_num": 117,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        261.9543151855469,
        94.91999816894531,
        281.9054870605469
      ],
      "page_num": 117,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        298.2693786621094,
        545.9400024414062,
        314.0896911621094
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        328.2693786621094,
        545.9400024414062,
        344.0896911621094
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "치료비는 피험자가 지불하여야 한다. 다만, 부작용 발생 시 임상시험에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        358.2693786621094,
        545.9400024414062,
        374.0896911621094
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        388.2693786621094,
        545.9400024414062,
        404.0896911621094
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        418.2693786621094,
        545.9400024414062,
        434.0896911621094
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "부작용이 소실될 때까지 치료비를 지불한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        448.2693786621094,
        360.5629577636719,
        464.0896911621094
      ],
      "page_num": 117,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 111 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 118,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19. 피험자의 안전보호에 대한 대책",
      "font_size": 15.960000038146973,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        326.5196838378906,
        109.41996002197266
      ],
      "page_num": 118,
      "block_type": "heading",
      "level": 7,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.08000183105469,
        148.9199981689453,
        533.760009765625,
        163.3199920654297
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        172.9199981689453,
        410.6999816894531,
        187.3199920654297
      ],
      "page_num": 118,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        238.7943115234375,
        94.91999816894531,
        258.7454833984375
      ],
      "page_num": 118,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 임상시험 실시기관",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        274.9893798828125,
        209.27999877929688,
        290.8096923828125
      ],
      "page_num": 118,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        304.9893798828125,
        546.0599975585938,
        320.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        334.9893798828125,
        545.9400024414062,
        350.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        364.9893798828125,
        546.0599975585938,
        380.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        394.9893798828125,
        90.68296813964844,
        410.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "나. 임상시험심사위원회",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        454.9893493652344,
        216.72000122070312,
        470.8096618652344
      ],
      "page_num": 118,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        484.9893493652344,
        546.0599975585938,
        500.8096618652344
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        514.9893798828125,
        538.4400024414062,
        530.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        544.9893798828125,
        546.0599975585938,
        560.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        574.9893798828125,
        475.282958984375,
        590.8096923828125
      ],
      "page_num": 118,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        604.9893798828125,
        538.4400024414062,
        620.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        634.9893798828125,
        545.9400024414062,
        650.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        664.9893798828125,
        538.5599975585938,
        680.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        694.9893798828125,
        545.9400024414062,
        710.8096923828125
      ],
      "page_num": 118,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        724.9893798828125,
        497.72296142578125,
        740.8096923828125
      ],
      "page_num": 118,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 112 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 119,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 시험자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        127.68000030517578,
        100.72968292236328
      ],
      "page_num": 119,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "말한다. 시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        144.9093780517578,
        538.5599975585938,
        160.7296905517578
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        174.9093780517578,
        538.5599975585938,
        190.7296905517578
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험을 실시하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        204.90936279296875,
        265.4029541015625,
        220.72967529296875
      ],
      "page_num": 119,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        95.87999725341797,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        95.87999725341797,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        95.87999725341797,
        324.90936279296875,
        546.0599975585938,
        340.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        95.87999725341797,
        354.90936279296875,
        536.4829711914062,
        370.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문제점을 적극적으로 대응한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        414.90936279296875,
        310.4029541015625,
        430.72967529296875
      ],
      "page_num": 119,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "라. 의뢰자",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        127.68000030517578,
        490.72967529296875
      ],
      "page_num": 119,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        504.90936279296875,
        546.0599975585938,
        520.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        534.9093627929688,
        538.5599975585938,
        550.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다)를 말한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        564.9093627929688,
        202.52296447753906,
        580.7296752929688
      ],
      "page_num": 119,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        594.9093627929688,
        538.4400024414062,
        610.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험계획서의 절차에 따라 이루어지도록 하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        624.9093627929688,
        467.84295654296875,
        640.7296752929688
      ],
      "page_num": 119,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        684.9093627929688,
        546.0599975585938,
        700.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        714.9093627929688,
        546.0599975585938,
        730.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "따라 결정되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        744.9093627929688,
        250.40296936035156,
        760.7296752929688
      ],
      "page_num": 119,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 113 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 120,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마. 모니터링",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        142.55999755859375,
        100.72968292236328
      ],
      "page_num": 120,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        174.9093780517578,
        546.0599975585938,
        190.7296905517578
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "활동을 말한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        204.90936279296875,
        197.8429718017578,
        220.72967529296875
      ],
      "page_num": 120,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        264.90936279296875,
        546.0599975585938,
        280.72967529296875
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "자료보관(연구파일) 등을 확인한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        324.90936279296875,
        334.7629699707031,
        340.72967529296875
      ],
      "page_num": 120,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        354.90936279296875,
        546.0599975585938,
        370.72967529296875
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문제가 있을 경우 시험자와 상의한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        384.90936279296875,
        355.282958984375,
        400.72967529296875
      ],
      "page_num": 120,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "바. 임상시험계획서의 변경",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        239.0399932861328,
        460.72967529296875
      ],
      "page_num": 120,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        474.90936279296875,
        538.5599975585938,
        490.72967529296875
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        504.90936279296875,
        538.5599975585938,
        520.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        564.9093627929688,
        545.9400024414062,
        580.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "식품의약품안전처장의 승인을 받아야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        594.9093627929688,
        392.84295654296875,
        610.7296752929688
      ],
      "page_num": 120,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "내용 등을 기록하여 보관하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        654.9093627929688,
        355.282958984375,
        670.7296752929688
      ],
      "page_num": 120,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        714.9093627929688,
        546.0599975585938,
        730.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        744.9093627929688,
        546.0599975585938,
        760.7296752929688
      ],
      "page_num": 120,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 114 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 121,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "안 된다. 만일 피험자에게 발생한 즉각적 위험 요소를 제거하기",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        114.90937042236328,
        538.4400024414062,
        130.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        144.9093780517578,
        545.9400024414062,
        160.7296905517578
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        174.9093780517578,
        538.4400024414062,
        190.7296905517578
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의약품안전처장에게 제출하여야 한다. 그리고 임상시험심사위원회",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        234.90936279296875,
        503.72296142578125,
        250.72967529296875
      ],
      "page_num": 121,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "반드시 필요한 것은 아니며 행정상 변경이 필요하다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        294.90936279296875,
        460.282958984375,
        310.72967529296875
      ],
      "page_num": 121,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "사. 피험자 동의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        354.90936279296875,
        164.75999450683594,
        370.72967529296875
      ],
      "page_num": 121,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        414.90936279296875,
        538.4400024414062,
        430.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "절차를 말한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        504.90936279296875,
        197.8429718017578,
        520.7296752929688
      ],
      "page_num": 121,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        534.9093627929688,
        545.9400024414062,
        550.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얻는 전 과정에 참석하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        594.9093627929688,
        325.282958984375,
        610.7296752929688
      ],
      "page_num": 121,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        654.9093627929688,
        546.0599975585938,
        670.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        684.9093627929688,
        545.9400024414062,
        700.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        714.9093627929688,
        538.5599975585938,
        730.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "해주어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        744.9093627929688,
        197.8429718017578,
        760.7296752929688
      ],
      "page_num": 121,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 115 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 122,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아. 피험자 기록의 비밀 보장",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        253.79998779296875,
        100.72968292236328
      ],
      "page_num": 122,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        546.0599975585938,
        130.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "유지한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        174.9093780517578,
        160.40296936035156,
        190.7296905517578
      ],
      "page_num": 122,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        204.90936279296875,
        545.9400024414062,
        220.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        234.90936279296875,
        545.9400024414062,
        250.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록을 열람할 수 있다. 시험자는 본 임상시험 계획서에 서명함",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        264.90936279296875,
        538.5599975585938,
        280.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        324.90936279296875,
        538.4400024414062,
        340.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        354.90936279296875,
        538.4400024414062,
        370.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "한다. 이러한 정보들은 기밀로 보관되어야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        384.90936279296875,
        426.8029479980469,
        400.72967529296875
      ],
      "page_num": 122,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        444.90936279296875,
        546.0599975585938,
        460.72967529296875
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "구분한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        474.90936279296875,
        160.40296936035156,
        490.72967529296875
      ],
      "page_num": 122,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "자. 기록의 보존",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        164.75999450683594,
        550.7296752929688
      ],
      "page_num": 122,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하여야 하며 보안을 유지하도록 한다. 제조허가/수입허가 또는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        594.9093627929688,
        546.0599975585938,
        610.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        624.9093627929688,
        545.9400024414062,
        640.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        654.9093627929688,
        545.9400024414062,
        670.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "날부터 3년간 보존하도록 한다. 다만, 식품의약품안전처장이 지시",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        684.9093627929688,
        538.5599975585938,
        700.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        714.9093627929688,
        545.9400024414062,
        730.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연장할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        744.9093627929688,
        205.40296936035156,
        760.7296752929688
      ],
      "page_num": 122,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 116 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 123,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "20. 그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항",
      "font_size": 15.0,
      "font_name": "H2hdrM",
      "bbox": [
        64.55999755859375,
        93.4599609375,
        523.3199462890625,
        109.41996002197266
      ],
      "page_num": 123,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        76.19999694824219,
        144.83999633789062,
        530.8800048828125,
        159.239990234375
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        168.83999633789062,
        530.8800048828125,
        183.239990234375
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        192.83999633789062,
        530.8800048828125,
        207.239990234375
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "취급에 관한 사항을 추가로 확보할 수 있다.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        216.83999633789062,
        300.17999267578125,
        231.239990234375
      ],
      "page_num": 123,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예시",
      "font_size": 15.0,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        279.59429931640625,
        94.91999816894531,
        299.54547119140625
      ],
      "page_num": 123,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "가. 자료 처리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        315.90936279296875,
        150.0,
        331.72967529296875
      ],
      "page_num": 123,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 근거 자료/문서의 직접 열람",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        345.90936279296875,
        288.47998046875,
        361.72967529296875
      ],
      "page_num": 123,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        375.90936279296875,
        545.9400024414062,
        391.72967529296875
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        405.90936279296875,
        545.9400024414062,
        421.72967529296875
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록을 열람할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        435.90936279296875,
        257.12298583984375,
        451.72967529296875
      ],
      "page_num": 123,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 증례기록서의 작성",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        465.90936279296875,
        223.79998779296875,
        481.72967529296875
      ],
      "page_num": 123,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        106.68000030517578,
        495.90936279296875,
        546.0599975585938,
        511.72967529296875
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        525.9093627929688,
        546.0599975585938,
        541.7296752929688
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        555.9093627929688,
        538.5599975585938,
        571.7296752929688
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기록서에 기록한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.5999984741211,
        585.9093627929688,
        228.2029571533203,
        601.7296752929688
      ],
      "page_num": 123,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "나. 법규 준수",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        645.9093627929688,
        150.0,
        661.7296752929688
      ],
      "page_num": 123,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        675.9093627929688,
        538.5599975585938,
        691.7296752929688
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        705.9093627929688,
        546.0599975585938,
        721.7296752929688
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        735.9093627929688,
        538.4400024414062,
        751.7296752929688
      ],
      "page_num": 123,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 117 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 124,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "하게 된다. 임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        546.0599975585938,
        100.72968292236328
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "교육 등 사전 조치를 취한다. 임상시험의 진행은 의료기기 임상시험 관리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        174.9093780517578,
        545.9400024414062,
        190.7296905517578
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "기준에 합당하게 진행한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        204.90936279296875,
        240.2029571533203,
        220.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "다. 임상시험 자료의 보관 및 열람",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        264.90936279296875,
        290.8800048828125,
        280.72967529296875
      ],
      "page_num": 124,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        294.90936279296875,
        546.0599975585938,
        310.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        324.90936279296875,
        536.6029663085938,
        340.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "라. 점검 및 실태 조사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        384.90936279296875,
        209.27999877929688,
        400.72967529296875
      ],
      "page_num": 124,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        414.90936279296875,
        545.9400024414062,
        430.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "문제점 등에 따라 결정된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        474.90936279296875,
        248.1229705810547,
        490.72967529296875
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "마. 임상시험용 의료기기의 사용 및 관리",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        534.9093627929688,
        335.3999938964844,
        550.7296752929688
      ],
      "page_num": 124,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        71.63999938964844,
        564.9093627929688,
        546.0599975585938,
        580.7296752929688
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리한다. 임상시험용 의료기기는 기재 사항에 기술되어 있는 대로",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        594.9093627929688,
        545.9400024414062,
        610.7296752929688
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다. 임상시험용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        624.9093627929688,
        546.0599975585938,
        640.7296752929688
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        654.9093627929688,
        538.4400024414062,
        670.7296752929688
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        684.9093627929688,
        499.52294921875,
        700.7296752929688
      ],
      "page_num": 124,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 118 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 125,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "바. 임상시험용 의료기기의 공급과 취급",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        327.9599914550781,
        100.72968292236328
      ],
      "page_num": 125,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        114.90937042236328,
        545.9400024414062,
        130.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        144.9093780517578,
        546.0599975585938,
        160.7296905517578
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "아니 된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        174.9093780517578,
        167.8429718017578,
        190.7296905517578
      ],
      "page_num": 125,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        204.90936279296875,
        546.0599975585938,
        220.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        234.90936279296875,
        546.0599975585938,
        250.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        264.90936279296875,
        545.9400024414062,
        280.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        294.90936279296875,
        545.9400024414062,
        310.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "포함된다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        324.90936279296875,
        160.40296936035156,
        340.72967529296875
      ],
      "page_num": 125,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        354.90936279296875,
        538.4400024414062,
        370.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        384.90936279296875,
        545.9400024414062,
        400.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "및 폐기에 관한 기록을 유지하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        414.90936279296875,
        377.84295654296875,
        430.72967529296875
      ],
      "page_num": 125,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        76.68000030517578,
        444.90936279296875,
        545.9400024414062,
        460.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        474.90936279296875,
        545.9400024414062,
        490.72967529296875
      ],
      "page_num": 125,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        96.36000061035156,
        504.90936279296875,
        505.282958984375,
        520.7296752929688
      ],
      "page_num": 125,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 119 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ⅳ",
      "font_size": 20.03999900817871,
      "font_name": "T9",
      "bbox": [
        68.4000015258789,
        97.07999420166016,
        198.35975646972656,
        121.12799835205078
      ],
      "page_num": 126,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "참고문헌",
      "font_size": 20.03999900817871,
      "font_name": "H2hdrM",
      "bbox": [
        68.4000015258789,
        97.07999420166016,
        198.35975646972656,
        121.12799835205078
      ],
      "page_num": 126,
      "block_type": "heading",
      "level": 4,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "1. 의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        145.28062438964844,
        472.31951904296875,
        155.78530883789062
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2. 한국판 불면증 임상진료지침. 대한신경정신의학회, 2019.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        161.36062622070312,
        327.404052734375,
        171.8653106689453
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3. IEC62304 (Medical device software-software life cycle processes)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        177.32061767578125,
        367.431884765625,
        187.82530212402344
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "4. ISO14971 (Medical devices — Application of risk management to medical devices)",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        193.28062438964844,
        443.6339111328125,
        203.78530883789062
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "5. Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        209.36062622070312,
        543.4212036132812,
        219.8653106689453
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "... & Mackinnon, A. J. (2016). Effectiveness of an online insomnia program (SHUTi) for prevention",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        225.32061767578125,
        543.419677734375,
        235.82530212402344
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "of depressive episodes (the GoodNight Study): a randomised controlled trial. The Lancet Psychiatry,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        241.28062438964844,
        543.4203491210938,
        251.78530883789062
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "3(4), 333-341.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        257.360595703125,
        130.9638214111328,
        267.86529541015625
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. Ström, L., Pettersson, R., & Andersson, G. (2004). Internet-based treatment for insomnia: a",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        273.32061767578125,
        543.4197387695312,
        283.8253173828125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "controlled evaluation. Journal of Consulting and Clinical Psychology, 72(1), 113-120.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        289.2806091308594,
        452.4438171386719,
        299.7853088378906
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "7. Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        305.360595703125,
        543.5404052734375,
        315.86529541015625
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(2017). The effects of improving sleep on mental health (OASIS): a randomised controlled trial with",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        321.32061767578125,
        543.539794921875,
        331.8253173828125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "mediation analysis. The Lancet Psychiatry, 4(10), 749-758.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        337.2806091308594,
        335.3238220214844,
        347.7853088378906
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "8. Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        353.360595703125,
        543.4207763671875,
        363.86529541015625
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(2019). Effect of digital cognitive behavioral therapy for insomnia on health, psychological",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        369.32061767578125,
        543.540283203125,
        379.8253173828125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "well-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry, 76(1),",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        385.2806091308594,
        543.4201049804688,
        395.7853088378906
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "21-30.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        401.360595703125,
        97.00428771972656,
        411.86529541015625
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "9. Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        417.32061767578125,
        543.4207763671875,
        427.8253173828125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "... & Morin, C. M. (2017). Effect of a web-based cognitive behavior therapy for insomnia",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        433.2806091308594,
        543.419189453125,
        443.7853088378906
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry, 74(1), 68-75.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        69.36000061035156,
        449.360595703125,
        501.5242919921875,
        459.86529541015625
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10. Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        465.3205871582031,
        543.540771484375,
        475.8252868652344
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(2020). Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        481.2806091308594,
        543.4187622070312,
        491.7853088378906
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "episode of psychosis: a case-control development and validation study. The Lancet Digital Health,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        497.360595703125,
        543.4197387695312,
        507.86529541015625
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2(5), e229-e239.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        513.3206176757812,
        146.4438934326172,
        523.8253173828125
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11. Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H. (2016). Guided Online or",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        529.2805786132812,
        543.4203491210938,
        539.7852783203125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Face-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        545.360595703125,
        543.5404052734375,
        555.8652954101562
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Trial. Sleep, 39(1), 183–191.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        561.3206176757812,
        199.36428833007812,
        571.8253173828125
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "12. Lee, E. (2020). Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia. Chronobiol",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        577.2805786132812,
        543.5406494140625,
        587.7852783203125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Med 2(1),10-15.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        593.360595703125,
        144.04513549804688,
        603.8652954101562
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "13. Kim, M., & Choi, H. J. (2021). Digital Therapeutics for Obesity and Eating-Related Problems.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        609.3206176757812,
        543.4209594726562,
        619.8253173828125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Endocrinology and Metabolism, 36(2), 220.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        625.2805786132812,
        265.48382568359375,
        635.7852783203125
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "14. Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A. (2020). Efficacy of digital",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        641.360595703125,
        543.2994995117188,
        651.8652954101562
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "cognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        657.3206176757812,
        543.540283203125,
        667.8253173828125
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "randomized clinical trial. JAMA Psychiatry, 77(5), 484-492.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        673.2805786132812,
        339.8838195800781,
        683.7852783203125
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "15. Ahn, D. H. (2013). 불면증: 원인과 진단. Hanyang Med Rev, 33, 203-209.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        689.360595703125,
        409.60382080078125,
        699.8652954101562
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16. 이은환, 이상훈, 임영현, & 김욱. (2018). 경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        705.3206176757812,
        543.5394897460938,
        715.8253173828125
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "정책방안. 경기연구원 연구보고서.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        721.2805786132812,
        229.72451782226562,
        731.7852783203125
      ],
      "page_num": 126,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "17. 우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠. (2011). 근로자의 수면문제에 따른 생산",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        737.360595703125,
        538.4395141601562,
        747.8652954101562
      ],
      "page_num": 126,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "성 시간 손실. 신경정신의학, 50(1), 62-68.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        753.3206176757812,
        266.3238220214844,
        763.8253173828125
      ],
      "page_num": 126,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 120 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "18. Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D. (2006). Cognitive behavioral treatment of",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        85.0406265258789,
        543.4198608398438,
        95.5453109741211
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "insomnia: A session-by-session guide (Vol. 1). Springer Science & Business Media.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        101.00062561035156,
        451.4834289550781,
        111.50531005859375
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "19. Jacobs, G. D. (2009). Say good night to insomnia: the six-week, drug-free program developed at",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        117.08062744140625,
        543.4192504882812,
        127.58531188964844
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Harvard Medical School. Macmillan.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        133.04061889648438,
        235.24363708496094,
        143.54530334472656
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "20. Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L. (2003). Primary insomnia: Diagnostic",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        149.00062561035156,
        543.4192504882812,
        159.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "issues, treatment and future directions. In: Perlis ML, Lichstein KL. Treating sleep disorders:",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        165.08062744140625,
        543.4203491210938,
        175.58531188964844
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "principles and practice of Behavioral Sleep Medicine. 1st ed. Hoboken: John Wiley & Sons, Inc,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        181.04061889648438,
        543.539306640625,
        191.54530334472656
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "2003;214-261.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        197.00062561035156,
        134.68370056152344,
        207.50531005859375
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "21. 의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        213.08062744140625,
        538.4395141601562,
        223.58531188964844
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "넷진흥원, 2018.05",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        229.04061889648438,
        154.62014770507812,
        239.54530334472656
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "22. 의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        245.00062561035156,
        407.3396911621094,
        255.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "23. 의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        261.0805969238281,
        407.3396911621094,
        271.5852966308594
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "24. 의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        277.0406188964844,
        527.3396606445312,
        287.5453186035156
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "25. 소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        293.0006103515625,
        477.3001403808594,
        303.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "26. 디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        309.0805969238281,
        447.3001403808594,
        319.5852966308594
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "27. 의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        325.0406188964844,
        412.3796691894531,
        335.5453186035156
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. (2018).",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        341.0006103515625,
        543.4198608398438,
        351.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Medicine",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        357.0805969238281,
        543.4203491210938,
        367.5852966308594
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "reviews, 38, 3–16.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        373.0406188964844,
        155.56405639648438,
        383.5453186035156
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "29. Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        389.0006103515625,
        543.420166015625,
        399.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Bégaud, B. (2014). Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        405.0805969238281,
        543.5396728515625,
        415.5852966308594
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(Clinical research ed.), 349, g5205.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        421.04058837890625,
        231.8843231201172,
        431.5452880859375
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "30. Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. (2004). Cognitive behavior therapy",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        437.0006103515625,
        543.5391235351562,
        447.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Archives of",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        453.0805969238281,
        543.5404052734375,
        463.5852966308594
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Internal Medicine, 164(17), 1888–1896.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        469.04058837890625,
        245.56405639648438,
        479.5452880859375
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "31. Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        485.0006103515625,
        543.5408325195312,
        495.50531005859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(2011). Chronic insomnia: clinical and research challenges--an agenda. Pharmacopsychiatry, 44(1), 1–",
      "font_size": 9.960000038146973,
      "font_name": "Haansoft Batang",
      "bbox": [
        74.27999877929688,
        501.0805969238281,
        538.409423828125,
        511.5852966308594
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "14.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        517.0405883789062,
        87.0440444946289,
        527.5452880859375
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "32. Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. (2001). Does",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        533.0006103515625,
        543.4202270507812,
        543.5053100585938
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "cognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?. Sleep, 24(5), 591–599.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        549.0806274414062,
        535.604248046875,
        559.5853271484375
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "33. Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        565.0405883789062,
        543.420166015625,
        575.5452880859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Ritterband, L. M. (2018). Cognitive mechanisms of sleep outcomes in a randomized clinical trial of",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        581.0006103515625,
        543.4203491210938,
        591.5053100585938
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "internet-based cognitive behavioral therapy for insomnia. Sleep Medicine, 47, 77–85.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        597.0806274414062,
        462.404052734375,
        607.5853271484375
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "34. Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        613.0405883789062,
        543.4212036132812,
        623.5452880859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Lidbetter, N., & Smith, K. (2017). Feasibility of a UK community-based, eTherapy mental health",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        629.0006103515625,
        543.5391235351562,
        639.5053100585938
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "service in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        645.0806274414062,
        543.420166015625,
        655.5853271484375
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Full Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'. BMJ Open, 7(7),",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        661.0405883789062,
        543.5408325195312,
        671.5452880859375
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "e016392.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        677.0006103515625,
        112.24384307861328,
        687.5053100585938
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "35. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012).",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        693.0806274414062,
        543.3008422851562,
        703.5853271484375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        709.0405883789062,
        543.5397338867188,
        719.5452880859375
      ],
      "page_num": 127,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "disorder delivered via an automated media-rich web application. Sleep, 35(6), 769–781.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        725.0006103515625,
        472.1242980957031,
        735.5053100585938
      ],
      "page_num": 127,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "36. Morin, C. M. (1993). Insomnia Severity Index.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        741.08056640625,
        280.72503662109375,
        751.5852661132812
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "37. Johns M. W. (1991). A new method for measuring daytime sleepiness: the Epworth sleepiness scale.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        757.0405883789062,
        543.419677734375,
        767.5452880859375
      ],
      "page_num": 127,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 121 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Sleep, 14(6), 540–545.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        85.0406265258789,
        171.28428649902344,
        95.5453109741211
      ],
      "page_num": 128,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "38. Morin, C. M., Vallières, A., & Ivers, H. (2007). Dysfunctional beliefs and attitudes about sleep",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        101.00062561035156,
        543.4203491210938,
        111.50531005859375
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "(DBAS): validation of a brief version (DBAS-16). Sleep, 30(11), 1547–1554.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        117.08062744140625,
        417.2999267578125,
        127.58531188964844
      ],
      "page_num": 128,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "39. Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA. Polysomnography for the",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        133.04061889648438,
        543.5396728515625,
        143.54530334472656
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "sleep technologist. St. Louis: Elsevier; 2014.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        149.00062561035156,
        274.48406982421875,
        159.50531005859375
      ],
      "page_num": 128,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "40. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        165.08062744140625,
        543.4204711914062,
        175.58531188964844
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "C., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B. (2003). The",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        181.04061889648438,
        543.4195556640625,
        191.54530334472656
      ],
      "page_num": 128,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        197.00062561035156,
        543.5398559570312,
        207.50531005859375
      ],
      "page_num": 128,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        213.08062744140625,
        543.419921875,
        223.58531188964844
      ],
      "page_num": 128,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Biological psychiatry, 54(5), 573–583.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        229.04061889648438,
        239.5642852783203,
        239.54530334472656
      ],
      "page_num": 128,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "41. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        245.00062561035156,
        543.5403442382812,
        255.50531005859375
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        261.0805969238281,
        331.8453674316406,
        271.5852966308594
      ],
      "page_num": 128,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "42. Jenkinson, C., Coulter, A., & Wright, L. (1993). Short form 36 (SF36) health survey questionnaire:",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        277.0406188964844,
        543.419921875,
        287.5453186035156
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "normative data for adults of working age. BMJ (Clinical research ed.), 306(6890), 1437–1440.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        293.0006103515625,
        498.6440734863281,
        303.50531005859375
      ],
      "page_num": 128,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "43. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        309.0805969238281,
        543.4193115234375,
        319.5852966308594
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "activity impairment instrument. Pharmacoeconomics. 1993 Nov;4(5):353-65.",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        74.27999877929688,
        325.0406188964844,
        414.1654357910156,
        335.5453186035156
      ],
      "page_num": 128,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "44. 한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법",
      "font_size": 9.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        341.0006103515625,
        353.15997314453125,
        351.50531005859375
      ],
      "page_num": 128,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "- 122 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 129,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[증례기록서 예시]",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        178.68467712402344,
        100.72968292236328
      ],
      "page_num": 129,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "증례기록서",
      "font_size": 20.03999900817871,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        247.55999755859375,
        194.818115234375,
        347.6397705078125,
        215.9540557861328
      ],
      "page_num": 129,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 실시기관 및 책임 연구자 (소속과/직위/성명)",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        145.3199920654297,
        424.55999755859375,
        464.9217529296875,
        440.11199951171875
      ],
      "page_num": 129,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "OOOO병원 OOO과/교수/OOO",
      "font_size": 12.960000038146973,
      "font_name": "T14",
      "bbox": [
        217.3199920654297,
        454.55999755859375,
        392.74700927734375,
        470.11199951171875
      ],
      "page_num": 129,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "Ver. 1.0",
      "font_size": 12.960000038146973,
      "font_name": "T11",
      "bbox": [
        282.47998046875,
        484.55999755859375,
        327.6000061035156,
        500.11199951171875
      ],
      "page_num": 129,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자 이니셜(영문)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        175.8000030517578,
        629.8800048828125,
        284.6520080566406,
        644.280029296875
      ],
      "page_num": 129,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자 식별번호",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        185.1599884033203,
        668.2799682617188,
        275.1600036621094,
        682.6799926757812
      ],
      "page_num": 129,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 123 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 130,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "Case Report Form 작성 지침",
      "font_size": 18.959999084472656,
      "font_name": "T10",
      "bbox": [
        169.67999267578125,
        90.72000122070312,
        439.5606994628906,
        113.47200012207031
      ],
      "page_num": 130,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "일반적인 지침 사항",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        248.63999938964844,
        122.03999328613281,
        360.8399963378906,
        136.4399871826172
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 검정색 볼펜을 사용하여 기록하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        161.75999450683594,
        298.00018310546875,
        173.71200561523438
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        181.79998779296875,
        398.5601806640625,
        193.7519989013672
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 정해진 칸 이외의 여백에 기록하지 마십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        201.71998596191406,
        300.4001770019531,
        213.6719970703125
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        80.15999603271484,
        221.75999450683594,
        395.2001647949219,
        233.71200561523438
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        241.79998779296875,
        529.9199829101562,
        253.7519989013672
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "같이 분명한 이유를 기록하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        93.5999984741211,
        261.7200012207031,
        266.68017578125,
        273.6719970703125
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        281.760009765625,
        408.1601867675781,
        293.7120056152344
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증례 기록서 수정 방법",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        239.39999389648438,
        322.67999267578125,
        370.1999816894531,
        337.0799865722656
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        362.3999938964844,
        529.7999877929688,
        374.35198974609375
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대하여 기록하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        93.72000122070312,
        382.44000244140625,
        216.1602020263672,
        394.3919982910156
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "11.6",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        195.1199951171875,
        402.3599853515625,
        327.8787536621094,
        414.3119812011719
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "10/03/30 홍길동(오기)",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        195.1199951171875,
        402.3599853515625,
        327.8787536621094,
        414.3119812011719
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예) Hb 8.6 → Hb 8.6",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        105.1199951171875,
        422.3999938964844,
        202.14035034179688,
        434.35198974609375
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        80.15999603271484,
        462.3599853515625,
        473.8001708984375,
        474.3119812011719
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증례기록서 작성에 대한 세부사항",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        207.83999633789062,
        503.39996337890625,
        401.6399841308594,
        517.7999877929688
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        542.9999389648438,
        455.440185546875,
        554.9519653320312
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        90.1199951171875,
        563.0399780273438,
        418.8401794433594,
        574.9920043945312
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        80.15999603271484,
        583.0799560546875,
        443.3201904296875,
        595.031982421875
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여",
      "font_size": 9.960000038146973,
      "font_name": "T14",
      "bbox": [
        80.15999603271484,
        602.9999389648438,
        529.9199829101562,
        614.9519653320312
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "주십시오.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        94.79999542236328,
        623.0399780273438,
        137.2001953125,
        634.9920043945312
      ],
      "page_num": 130,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 124 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 131,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자 이니셜(영문)",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        80.4000015258789,
        121.91999053955078,
        505.1187438964844,
        133.8719940185547
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자식별코드",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        80.4000015258789,
        121.91999053955078,
        505.1187438964844,
        133.8719940185547
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자 방문일 (YY/MM/DD)",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        80.4000015258789,
        121.91999053955078,
        505.1187438964844,
        133.8719940185547
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "스크리닝 및",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        191.75999450683594,
        180.9600067138672,
        254.51998901367188,
        194.20799255371094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "검사일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        206.0399932861328,
        193.0800018310547,
        240.2397003173828,
        206.32798767089844
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Screening)1)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        190.9199981689453,
        204.36000061035156,
        255.789306640625,
        218.44798278808594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료시작일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        279.47998046875,
        186.9600067138672,
        336.7201843261719,
        212.32798767089844
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Baseline)",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        279.47998046875,
        186.9600067138672,
        336.7201843261719,
        212.32798767089844
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 기간 종료",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        356.6399841308594,
        180.9600067138672,
        438.189453125,
        218.44798278808594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1주 후(6주+1주)",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        356.6399841308594,
        180.9600067138672,
        438.189453125,
        218.44798278808594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Post-treatment)3)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        356.6399841308594,
        180.9600067138672,
        438.189453125,
        218.44798278808594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(선택)",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        477.0,
        174.83999633789062,
        505.3022155761719,
        188.08798217773438
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료 기간 종료",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        450.9599914550781,
        186.9600067138672,
        530.7601928710938,
        200.20799255371094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6개월 후",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        468.0,
        199.0800018310547,
        513.719970703125,
        212.32798767089844
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Follow up)4)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        458.7599792480469,
        210.36000061035156,
        523.5094604492188,
        224.44798278808594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        103.19999694824219,
        236.39999389648438,
        504.9599914550781,
        249.64797973632812
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문1",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        103.19999694824219,
        236.39999389648438,
        504.9599914550781,
        249.64797973632812
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문2",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        103.19999694824219,
        236.39999389648438,
        504.9599914550781,
        249.64797973632812
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문3",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        103.19999694824219,
        236.39999389648438,
        504.9599914550781,
        249.64797973632812
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "방문4",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        103.19999694824219,
        236.39999389648438,
        504.9599914550781,
        249.64797973632812
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "경과일수",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        97.43999481201172,
        261.47998046875,
        493.99871826171875,
        274.7279968261719
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "D-28 이내",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        97.43999481201172,
        261.47998046875,
        493.99871826171875,
        274.7279968261719
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "DAY1",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        261.47998046875,
        493.99871826171875,
        274.7279968261719
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        261.47998046875,
        493.99871826171875,
        274.7279968261719
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        261.47998046875,
        493.99871826171875,
        274.7279968261719
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관찰형태",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        97.43999481201172,
        292.67999267578125,
        324.9599914550781,
        312.0480041503906
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        292.67999267578125,
        324.9599914550781,
        312.0480041503906
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원과",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        97.43999481201172,
        292.67999267578125,
        324.9599914550781,
        312.0480041503906
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "애플리케이션",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        275.3999938964844,
        304.79998779296875,
        341.3999938964844,
        318.0480041503906
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원과",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        381.1199951171875,
        292.67999267578125,
        414.11968994140625,
        305.9280090332031
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "애플리케이션",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        364.67999267578125,
        304.79998779296875,
        430.67999267578125,
        318.0480041503906
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "내원 또는",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        466.55999755859375,
        286.67999267578125,
        515.7596435546875,
        299.9280090332031
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "애플리케이션,",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        457.1999816894531,
        298.79998779296875,
        525.19580078125,
        312.0480041503906
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이메일, 문자, SNS",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        449.03997802734375,
        310.91998291015625,
        533.3414306640625,
        324.1679992675781
      ],
      "page_num": 131,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "연구 참여",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        94.68000030517578,
        335.9999694824219,
        145.80023193359375,
        349.24798583984375
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "동의서 취득",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        88.91999816894531,
        342.1199951171875,
        493.99871826171875,
        361.3680114746094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        88.91999816894531,
        342.1199951171875,
        493.99871826171875,
        361.3680114746094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        342.1199951171875,
        493.99871826171875,
        361.3680114746094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        342.1199951171875,
        493.99871826171875,
        361.3680114746094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        342.1199951171875,
        493.99871826171875,
        361.3680114746094
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "선정/제외 기준 확인",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        67.08000183105469,
        376.1999816894531,
        493.99871826171875,
        389.447998046875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        67.08000183105469,
        376.1999816894531,
        493.99871826171875,
        389.447998046875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        67.08000183105469,
        376.1999816894531,
        493.99871826171875,
        389.447998046875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        67.08000183105469,
        376.1999816894531,
        493.99871826171875,
        389.447998046875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        67.08000183105469,
        376.1999816894531,
        493.99871826171875,
        389.447998046875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인구학적 정보",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        83.04000091552734,
        406.91998291015625,
        493.99871826171875,
        420.1679992675781
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        406.91998291015625,
        493.99871826171875,
        420.1679992675781
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        406.91998291015625,
        493.99871826171875,
        420.1679992675781
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        406.91998291015625,
        493.99871826171875,
        420.1679992675781
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        406.91998291015625,
        493.99871826171875,
        420.1679992675781
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과거병력 조사",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        83.04000091552734,
        437.7599792480469,
        493.99871826171875,
        451.00799560546875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        437.7599792480469,
        493.99871826171875,
        451.00799560546875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        437.7599792480469,
        493.99871826171875,
        451.00799560546875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        437.7599792480469,
        493.99871826171875,
        451.00799560546875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        83.04000091552734,
        437.7599792480469,
        493.99871826171875,
        451.00799560546875
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 의료기기 적용",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        64.55999755859375,
        467.6400146484375,
        493.99871826171875,
        481.8479919433594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O5)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        467.6400146484375,
        493.99871826171875,
        481.8479919433594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        467.6400146484375,
        493.99871826171875,
        481.8479919433594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        467.6400146484375,
        493.99871826171875,
        481.8479919433594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        467.6400146484375,
        493.99871826171875,
        481.8479919433594
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "평가지표 수집 및 분석2)",
      "font_size": 7.079999923706055,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        498.4800109863281,
        495.34893798828125,
        512.5679931640625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        498.4800109863281,
        495.34893798828125,
        512.5679931640625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        498.4800109863281,
        495.34893798828125,
        512.5679931640625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        498.4800109863281,
        495.34893798828125,
        512.5679931640625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        64.55999755859375,
        498.4800109863281,
        495.34893798828125,
        512.5679931640625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응 확인",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        83.04000091552734,
        530.1600341796875,
        495.34893798828125,
        543.4080200195312
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        530.1600341796875,
        495.34893798828125,
        543.4080200195312
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        530.1600341796875,
        495.34893798828125,
        543.4080200195312
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        83.04000091552734,
        530.1600341796875,
        495.34893798828125,
        543.4080200195312
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병용 약물 조사",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        80.4000015258789,
        561.0,
        495.34893798828125,
        574.2479858398438
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        561.0,
        495.34893798828125,
        574.2479858398438
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        561.0,
        495.34893798828125,
        574.2479858398438
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        561.0,
        495.34893798828125,
        574.2479858398438
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        80.4000015258789,
        561.0,
        495.34893798828125,
        574.2479858398438
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "순응도 조사",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        88.91999816894531,
        591.7200317382812,
        493.99871826171875,
        604.968017578125
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        591.7200317382812,
        493.99871826171875,
        604.968017578125
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        88.91999816894531,
        591.7200317382812,
        493.99871826171875,
        604.968017578125
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "O",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        88.91999816894531,
        591.7200317382812,
        493.99871826171875,
        604.968017578125
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "-",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        88.91999816894531,
        591.7200317382812,
        493.99871826171875,
        604.968017578125
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        614.2799682617188,
        517.3195190429688,
        682.27197265625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. (예: ISI는 스크리닝에도 수집함)",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        614.2799682617188,
        517.3195190429688,
        682.27197265625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        614.2799682617188,
        517.3195190429688,
        682.27197265625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        614.2799682617188,
        517.3195190429688,
        682.27197265625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        614.2799682617188,
        517.3195190429688,
        682.27197265625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        77.4000015258789,
        684.239990234375,
        404.8001708984375,
        696.1920166015625
      ],
      "page_num": 131,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 125 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 132,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 방문 1 (스크리닝 및 검사일)",
      "font_size": 11.039999961853027,
      "font_name": "Batang",
      "bbox": [
        71.63999938964844,
        82.79999542236328,
        253.88156127929688,
        100.78499603271484
      ],
      "page_num": 132,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자에게 서면 동의를 받았습니까?",
      "font_size": 12.0,
      "font_name": "T21",
      "bbox": [
        80.15999603271484,
        138.72000122070312,
        466.3199768066406,
        153.1199951171875
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        80.15999603271484,
        138.72000122070312,
        466.3199768066406,
        153.1199951171875
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        80.15999603271484,
        138.72000122070312,
        466.3199768066406,
        153.1199951171875
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서면 동의 일자 (YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        80.15999603271484,
        166.9199981689453,
        243.13198852539062,
        181.3199920654297
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◈ 인구학적 정보",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        213.72000122070312,
        179.27999877929688,
        228.1199951171875
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "생년월일",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        108.23999786376953,
        231.36000061035156,
        158.0399932861328,
        245.75999450683594
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        98.5199966430664,
        250.55999755859375,
        167.89198303222656,
        264.9599914550781
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "성별",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        336.1199951171875,
        240.95999145507812,
        504.3599853515625,
        255.3599853515625
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        336.1199951171875,
        240.95999145507812,
        504.3599853515625,
        255.3599853515625
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "남",
      "font_size": 12.0,
      "font_name": "T20",
      "bbox": [
        336.1199951171875,
        240.95999145507812,
        504.3599853515625,
        255.3599853515625
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        336.1199951171875,
        240.95999145507812,
        504.3599853515625,
        255.3599853515625
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "여",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        336.1199951171875,
        240.95999145507812,
        504.3599853515625,
        255.3599853515625
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◈ 과거력",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        79.68000030517578,
        290.6399841308594,
        135.47999572753906,
        305.03997802734375
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "과거력",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        117.1199951171875,
        312.0,
        471.47998046875,
        326.3999938964844
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        117.1199951171875,
        312.0,
        471.47998046875,
        326.3999938964844
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있 음 (page",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        117.1199951171875,
        312.0,
        471.47998046875,
        326.3999938964844
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 기입)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        117.1199951171875,
        312.0,
        471.47998046875,
        326.3999938964844
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        117.1199951171875,
        312.0,
        471.47998046875,
        326.3999938964844
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없 음",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        117.1199951171875,
        312.0,
        471.47998046875,
        326.3999938964844
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "병용 약물 서식",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        92.15999603271484,
        333.3599853515625,
        471.47998046875,
        347.7599792480469
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        92.15999603271484,
        333.3599853515625,
        471.47998046875,
        347.7599792480469
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있 음 (page",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        92.15999603271484,
        333.3599853515625,
        471.47998046875,
        347.7599792480469
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "에 기입)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        92.15999603271484,
        333.3599853515625,
        471.47998046875,
        347.7599792480469
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        92.15999603271484,
        333.3599853515625,
        471.47998046875,
        347.7599792480469
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "없 음",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        92.15999603271484,
        333.3599853515625,
        471.47998046875,
        347.7599792480469
      ],
      "page_num": 132,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 126 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 133,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 무작위 번호",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        161.63999938964844,
        100.72968292236328
      ],
      "page_num": 133,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 무작위 번호",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.36000061035156,
        130.1999969482422,
        183.36000061035156,
        144.59999084472656
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◈ 임상시험 검사",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        217.62936401367188,
        176.63999938964844,
        233.44967651367188
      ],
      "page_num": 133,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 검사를 실시하였습니까",
      "font_size": 12.0,
      "font_name": "T21",
      "bbox": [
        105.1199951171875,
        253.19998168945312,
        463.3199768066406,
        267.5999755859375
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 예",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        105.1199951171875,
        253.19998168945312,
        463.3199768066406,
        267.5999755859375
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 아니오",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        105.1199951171875,
        253.19998168945312,
        463.3199768066406,
        267.5999755859375
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◈ 검사일(YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        105.1199951171875,
        279.47998046875,
        230.77198791503906,
        293.8799743652344
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◈ 이상 반응",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        357.1893615722656,
        146.63999938964844,
        373.0096740722656
      ],
      "page_num": 133,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 그 밖의 이상반응이",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        88.19999694824219,
        391.1999816894531,
        219.0,
        405.5999755859375
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발생하였습니까?",
      "font_size": 12.0,
      "font_name": "T21",
      "bbox": [
        107.5199966430664,
        398.1600036621094,
        421.55999755859375,
        419.3999938964844
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        107.5199966430664,
        398.1600036621094,
        421.55999755859375,
        419.3999938964844
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "예",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        107.5199966430664,
        398.1600036621094,
        421.55999755859375,
        419.3999938964844
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        107.5199966430664,
        398.1600036621094,
        421.55999755859375,
        419.3999938964844
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "아니오",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        107.5199966430664,
        398.1600036621094,
        421.55999755859375,
        419.3999938964844
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        94.19999694824219,
        432.8399963378906,
        427.1399841308594,
        447.239990234375
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서명 날짜(YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.23999786376953,
        709.2000122070312,
        459.239990234375,
        723.6000366210938
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연구자 성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.23999786376953,
        709.2000122070312,
        459.239990234375,
        723.6000366210938
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.23999786376953,
        709.2000122070312,
        459.239990234375,
        723.6000366210938
      ],
      "page_num": 133,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 127 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 134,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 임상시험 완료 평가",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        214.0800018310547,
        100.72968292236328
      ],
      "page_num": 134,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "◈ 임상시험 완료 여부",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.31999969482422,
        152.16000366210938,
        481.0799865722656,
        166.55999755859375
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        85.31999969482422,
        152.16000366210938,
        481.0799865722656,
        166.55999755859375
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "완 료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        85.31999969482422,
        152.16000366210938,
        481.0799865722656,
        166.55999755859375
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□",
      "font_size": 12.0,
      "font_name": "T13",
      "bbox": [
        85.31999969482422,
        152.16000366210938,
        481.0799865722656,
        166.55999755859375
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "미 완 료",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        85.31999969482422,
        152.16000366210938,
        481.0799865722656,
        166.55999755859375
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 완료일(YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        97.31999969482422,
        180.36000061035156,
        251.2919921875,
        194.75999450683594
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험 미 완료일(YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        97.31999969482422,
        206.87998962402344,
        269.2919921875,
        221.2799835205078
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "◈ 미완료 사유",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        85.31999969482422,
        368.3999938964844,
        172.3199920654297,
        382.79998779296875
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 이상반응 발생",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        184.67999267578125,
        272.3999938964844,
        280.67999267578125,
        286.79998779296875
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 중대한 계획서 위반",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        184.67999267578125,
        310.79998779296875,
        310.67999267578125,
        325.1999816894531
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(구체적 내용: _____________________________________)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        202.67999267578125,
        330.0,
        506.4119873046875,
        344.3999938964844
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 동의 철회 또는 피험자가 임상시험 중단 요구",
      "font_size": 12.0,
      "font_name": "T14",
      "bbox": [
        184.67999267578125,
        368.3999938964844,
        454.67999267578125,
        382.79998779296875
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(구체적 사유: _____________________________________)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        202.67999267578125,
        387.6000061035156,
        506.4119873046875,
        402.0
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 추적 관찰 실패",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        184.67999267578125,
        426.0,
        286.67999267578125,
        440.3999938964844
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 기타 (_____________________________________________)",
      "font_size": 12.0,
      "font_name": "T11",
      "bbox": [
        184.67999267578125,
        464.3999938964844,
        509.5320129394531,
        478.79998779296875
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서명 날짜(YY/MM/DD)",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.23999786376953,
        714.3599853515625,
        459.239990234375,
        728.760009765625
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "연구자 성명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.23999786376953,
        714.3599853515625,
        459.239990234375,
        728.760009765625
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서명",
      "font_size": 12.0,
      "font_name": "T10",
      "bbox": [
        96.23999786376953,
        714.3599853515625,
        459.239990234375,
        728.760009765625
      ],
      "page_num": 134,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 128 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 135,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "[이상반응 서식지 예시]",
      "font_size": 15.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        56.63999938964844,
        84.90937042236328,
        216.24468994140625,
        100.72968292236328
      ],
      "page_num": 135,
      "block_type": "paragraph",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "이상반응 서식지",
      "font_size": 21.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        226.3199920654297,
        302.8331298828125,
        383.8800048828125,
        324.9815673828125
      ],
      "page_num": 135,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(Special form)",
      "font_size": 21.0,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        239.1599884033203,
        370.0331115722656,
        370.88372802734375,
        392.1815490722656
      ],
      "page_num": 135,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 129 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 136,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "SPECIAL FORM 이상반응서식지",
      "font_size": 18.959999084472656,
      "font_name": "T10",
      "bbox": [
        155.16000366210938,
        90.72000122070312,
        453.958984375,
        113.47200012207031
      ],
      "page_num": 136,
      "block_type": "heading",
      "level": 5,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "□ ‘이상 의료기기’의 반응",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        107.87999725341797,
        150.71998596191406,
        233.04006958007812,
        162.6719970703125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        122.87999725341797,
        166.8000030517578,
        502.19970703125,
        177.60000610351562
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        122.87999725341797,
        181.1999969482422,
        502.1999816894531,
        192.0
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "다. 이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        122.87999725341797,
        195.59999084472656,
        441.04498291015625,
        206.39999389648438
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ ‘중증도’ 판정 참고기준",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        107.87999725341797,
        224.2799835205078,
        233.0392608642578,
        236.23199462890625
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 경증(mild)",
      "font_size": 9.0,
      "font_name": "T10",
      "bbox": [
        121.31999969482422,
        240.47999572753906,
        175.5692901611328,
        251.27999877929688
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며,",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        133.8000030517578,
        254.8800048828125,
        474.4139709472656,
        265.67999267578125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자가 쉽게 견딜 수 있는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        133.8000030517578,
        269.2799987792969,
        272.0400085449219,
        280.0799865722656
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 중증도(moderate)",
      "font_size": 9.0,
      "font_name": "T10",
      "bbox": [
        121.31999969482422,
        283.67999267578125,
        207.60870361328125,
        294.47998046875
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        133.8000030517578,
        298.0799865722656,
        480.7200012207031,
        308.8799743652344
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 중증(severe)",
      "font_size": 9.0,
      "font_name": "T10",
      "bbox": [
        121.31999969482422,
        312.47998046875,
        186.7296142578125,
        323.27996826171875
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        133.8000030517578,
        326.8800048828125,
        399.7200012207031,
        337.67999267578125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ ‘의료기기와의 관련성’ 판정 참고기준",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        107.87999725341797,
        355.55999755859375,
        301.19921875,
        367.5119934082031
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1) 평가 불가능(Unknown)",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        371.6399841308594,
        223.3278350830078,
        382.4399719238281
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        386.03997802734375,
        488.1600036621094,
        396.8399658203125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2) 관련성이 없음(Not related)",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        400.44000244140625,
        240.36781311035156,
        411.239990234375
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        414.8399963378906,
        459.1199951171875,
        425.6399841308594
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3) 관련성이 적음(Unlikely)",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        429.239990234375,
        225.96900939941406,
        440.03997802734375
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        443.6399841308594,
        502.1999816894531,
        454.4399719238281
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있을 것 같지 않은 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        458.03997802734375,
        231.36000061035156,
        468.8399658203125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4) 관련성이 의심됨(Possible)",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        472.44000244140625,
        237.72840881347656,
        483.239990234375
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        486.8399963378906,
        502.1999816894531,
        497.6399841308594
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        501.239990234375,
        502.1999816894531,
        512.0399780273438
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        515.6400146484375,
        405.1199951171875,
        526.4400024414062
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5) 관련성이 많음(Probable)",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        530.0399780273438,
        230.7687225341797,
        540.8399658203125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        133.8000030517578,
        544.4400024414062,
        502.1999816894531,
        555.239990234375
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        133.8000030517578,
        558.8399658203125,
        441.1199951171875,
        569.6399536132812
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6) 관련성이 명백함(Definite)",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        573.239990234375,
        234.12782287597656,
        584.0399780273438
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        587.6400146484375,
        502.1999816894531,
        598.4400024414062
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며,",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        602.0399780273438,
        502.25396728515625,
        612.8399658203125
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        132.83999633789062,
        616.4400024414062,
        490.364990234375,
        627.239990234375
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "□ 중대한 이상반응/ 이상 의료기기의 반응",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        107.87999725341797,
        645.1199340820312,
        314.280029296875,
        657.0719604492188
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 사망을 초래하거나 생명을 위협하는 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        661.2000122070312,
        301.44000244140625,
        672.0
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 입원 또는 입원 기간의 연장이 필요한 경우",
      "font_size": 9.0,
      "font_name": "T11",
      "bbox": [
        121.31999969482422,
        675.5999755859375,
        310.44000244140625,
        686.3999633789062
      ],
      "page_num": 136,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "- 130 -",
      "font_size": 9.960000038146973,
      "font_name": "Gulim",
      "bbox": [
        277.67999267578125,
        803.6103515625,
        317.5050048828125,
        813.5703125
      ],
      "page_num": 137,
      "block_type": "list_item",
      "level": 0,
      "table_info": null,
      "is_in_table": false
    },
    {
      "text": "피험자 이니셜(영문)",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        121.91999053955078,
        498.9987487792969,
        133.8719940185547
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자식별코드",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        121.91999053955078,
        498.9987487792969,
        133.8719940185547
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "피험자 방문일 (YY/MM/DD)",
      "font_size": 9.960000038146973,
      "font_name": "T10",
      "bbox": [
        66.72000122070312,
        121.91999053955078,
        498.9987487792969,
        133.8719940185547
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "참 고 코 드",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        272.2799987792969,
        196.44000244140625,
        334.44000244140625,
        209.68798828125
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증상의",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        65.76000213623047,
        218.75999450683594,
        99.84048461914062,
        232.0079803466797
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "범위",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        71.5199966430664,
        231.9600067138672,
        94.08000183105469,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증상의",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        112.91999816894531,
        218.75999450683594,
        147.11968994140625,
        232.0079803466797
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정도",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        118.68000030517578,
        231.9600067138672,
        141.35946655273438,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기와의",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        167.51998901367188,
        218.75999450683594,
        236.39999389648438,
        232.0079803466797
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련성",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        184.9199981689453,
        231.9600067138672,
        219.00045776367188,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기에",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        255.83999633789062,
        218.75999450683594,
        516.72021484375,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한 조치",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        255.83999633789062,
        218.75999450683594,
        516.72021484375,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        255.83999633789062,
        218.75999450683594,
        516.72021484375,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        255.83999633789062,
        218.75999450683594,
        516.72021484375,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중대성",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        255.83999633789062,
        218.75999450683594,
        516.72021484375,
        245.20799255371094
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 국소",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        289.55999755859375,
        100.31999969482422,
        302.8080139160156
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 전신",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        64.55999755859375,
        307.0799865722656,
        100.31999969482422,
        320.3280029296875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 경증",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        111.72000122070312,
        280.67999267578125,
        147.47999572753906,
        293.9280090332031
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 중등",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        111.72000122070312,
        298.3199768066406,
        147.47999572753906,
        311.5679931640625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 중증",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        111.72000122070312,
        315.9599914550781,
        147.47999572753906,
        329.2080078125
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 평가 불가능",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        159.0,
        254.28001403808594,
        233.15965270996094,
        267.52801513671875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 관련성이 없음",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        159.0,
        271.91998291015625,
        244.19998168945312,
        285.1679992675781
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 관련성이 적음",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        159.0,
        289.55999755859375,
        244.19998168945312,
        302.8080139160156
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 관련성이 의심됨",
      "font_size": 11.039999961853027,
      "font_name": "T20",
      "bbox": [
        159.0,
        307.0799865722656,
        245.0399932861328,
        320.3280029296875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "5. 관련성이 많음",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        159.0,
        324.719970703125,
        244.19998168945312,
        337.9679870605469
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "6. 관련성이 명백함",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        159.0,
        342.3599853515625,
        245.0399932861328,
        355.6080017089844
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 검사진행",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        255.72000122070312,
        289.55999755859375,
        313.4396667480469,
        302.8080139160156
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 검사중지",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        255.72000122070312,
        307.0799865722656,
        313.44000244140625,
        320.3280029296875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 치료하지 않음",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        324.1199951171875,
        271.91998291015625,
        402.1199951171875,
        285.1679992675781
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 약물치료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        324.1199951171875,
        289.55999755859375,
        381.8396911621094,
        302.8080139160156
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 비약물치료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        324.1199951171875,
        307.0799865722656,
        392.8796691894531,
        320.3280029296875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 수술적치료",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        324.1199951171875,
        324.719970703125,
        392.8796691894531,
        337.9679870605469
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 회복",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        412.3199768066406,
        271.91998291015625,
        448.0799865722656,
        285.1679992675781
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 진행중",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        412.3199768066406,
        289.55999755859375,
        459.1199951171875,
        302.8080139160156
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "3. 후유증",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        412.3199768066406,
        307.0799865722656,
        459.1199951171875,
        320.3280029296875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "4. 사망",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        412.3199768066406,
        324.719970703125,
        448.0799865722656,
        337.9679870605469
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "1. 중대하지",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        472.3199768066406,
        280.67999267578125,
        527.6399536132812,
        293.9280090332031
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "않음",
      "font_size": 11.039999961853027,
      "font_name": "T14",
      "bbox": [
        486.0,
        298.3199768066406,
        505.20001220703125,
        311.5679931640625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "2. 중대함",
      "font_size": 11.039999961853027,
      "font_name": "T11",
      "bbox": [
        472.3199768066406,
        315.9599914550781,
        516.1204223632812,
        329.2080078125
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "이상",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        76.31999969482422,
        394.1999816894531,
        98.88024139404297,
        407.447998046875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "반응명",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        70.55999755859375,
        407.3999938964844,
        104.6404800415039,
        420.64801025390625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발생일,",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        129.83999633789062,
        387.5999755859375,
        167.23582458496094,
        414.0480041503906
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "종료일",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        129.83999633789062,
        387.5999755859375,
        167.23582458496094,
        414.0480041503906
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(yy/mm/dd)",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        120.1199951171875,
        413.9999694824219,
        176.8618927001953,
        427.24798583984375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "지속시간",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        186.72000122070312,
        387.5999755859375,
        232.43992614746094,
        427.24798583984375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "(hours/",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        186.72000122070312,
        387.5999755859375,
        232.43992614746094,
        427.24798583984375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "minutes)",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        186.72000122070312,
        387.5999755859375,
        232.43992614746094,
        427.24798583984375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증상의",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        242.63999938964844,
        394.1999816894531,
        276.720458984375,
        407.447998046875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "범위",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        248.39999389648438,
        407.3999938964844,
        270.9599914550781,
        420.64801025390625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "증상의",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        284.5199890136719,
        394.1999816894531,
        318.7196960449219,
        407.447998046875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "정도",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        290.2799987792969,
        407.3999938964844,
        312.95947265625,
        420.64801025390625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기기와의",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        325.32000732421875,
        394.1999816894531,
        367.20001220703125,
        420.64801025390625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "관련성",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        325.32000732421875,
        394.1999816894531,
        367.20001220703125,
        420.64801025390625
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "기기에",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        379.1999816894531,
        387.5999755859375,
        413.39971923828125,
        400.8479919433594
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "대한",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        384.9599914550781,
        400.79998779296875,
        407.5202331542969,
        427.24798583984375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "조치",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        384.9599914550781,
        400.79998779296875,
        407.5202331542969,
        427.24798583984375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "치료",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        428.1600036621094,
        400.79998779296875,
        528.0001831054688,
        414.0480041503906
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "결과",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        428.1600036621094,
        400.79998779296875,
        528.0001831054688,
        414.0480041503906
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "중대성",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        428.1600036621094,
        400.79998779296875,
        528.0001831054688,
        414.0480041503906
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        444.4800109863281,
        158.85946655273438,
        456.4320068359375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        444.4800109863281,
        158.85946655273438,
        456.4320068359375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        460.55999755859375,
        158.85946655273438,
        472.5119934082031
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        460.55999755859375,
        158.85946655273438,
        472.5119934082031
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        493.20001220703125,
        158.85946655273438,
        505.1520080566406
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        493.20001220703125,
        158.85946655273438,
        505.1520080566406
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        509.1600036621094,
        158.85946655273438,
        521.1119995117188
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        509.1600036621094,
        158.85946655273438,
        521.1119995117188
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        541.7999877929688,
        158.85946655273438,
        553.7520141601562
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        541.7999877929688,
        158.85946655273438,
        553.7520141601562
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        557.7599487304688,
        158.85946655273438,
        569.7119750976562
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        557.7599487304688,
        158.85946655273438,
        569.7119750976562
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        590.3999633789062,
        158.85946655273438,
        602.3519897460938
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        590.3999633789062,
        158.85946655273438,
        602.3519897460938
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        606.47998046875,
        158.85946655273438,
        618.4320068359375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        606.47998046875,
        158.85946655273438,
        618.4320068359375
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        639.1199340820312,
        158.85946655273438,
        651.0719604492188
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        639.1199340820312,
        158.85946655273438,
        651.0719604492188
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        655.0799560546875,
        158.85946655273438,
        667.031982421875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "/",
      "font_size": 9.960000038146973,
      "font_name": "T11",
      "bbox": [
        138.59999084472656,
        655.0799560546875,
        158.85946655273438,
        667.031982421875
      ],
      "page_num": 137,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "불면증 개선 디지털치료기기 안전성·성능 평가 및",
      "font_size": 15.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        115.79999542236328,
        445.5894775390625,
        485.0106201171875,
        466.8175048828125
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "임상시험계획서 작성 가이드라인(민원인 안내서)",
      "font_size": 15.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        120.7199935913086,
        471.14947509765625,
        475.2722473144531,
        492.37750244140625
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        499.8797607421875,
        354.59857177734375,
        513.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        499.8797607421875,
        354.59857177734375,
        513.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처 식품의약품안전처 식품의약품안전평가원",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.91999816894531,
        499.8797607421875,
        354.59857177734375,
        513.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        526.8796997070312,
        248.27999877929688,
        540.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        526.8796997070312,
        248.27999877929688,
        540.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "일 2021년 12월 8일",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.91999816894531,
        526.8796997070312,
        248.27999877929688,
        540.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "발",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        553.8796997070312,
        199.6795196533203,
        567.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "행",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        553.8796997070312,
        199.6795196533203,
        567.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "인",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        553.8796997070312,
        199.6795196533203,
        567.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "서경원",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.91999816894531,
        553.8796997070312,
        199.6795196533203,
        567.1273193359375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편 집 위 원 장 이정림",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.91999816894531,
        580.7597045898438,
        199.6795196533203,
        594.00732421875
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "편",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        610.1597290039062,
        308.5204162597656,
        623.4073486328125
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "집",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        610.1597290039062,
        308.5204162597656,
        623.4073486328125
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "위",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        610.1597290039062,
        308.5204162597656,
        623.4073486328125
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "원",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        610.1597290039062,
        308.5204162597656,
        623.4073486328125
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "강영규, 한영민, 김미선, 박수지",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        64.91999816894531,
        610.1597290039062,
        308.5204162597656,
        623.4073486328125
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "문",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        690.19970703125,
        159.36000061035156,
        703.4473266601562
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        690.19970703125,
        159.36000061035156,
        703.4473266601562
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "처",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothicBold",
      "bbox": [
        64.91999816894531,
        690.19970703125,
        159.36000061035156,
        703.4473266601562
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28159 충북 청주시 흥덕구 오송읍 오송생명2로 187",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        169.67999267578125,
        642.19970703125,
        409.2854309082031,
        655.4473266601562
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오송보건의료행정타운",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        169.67999267578125,
        658.2797241210938,
        269.6385498046875,
        671.52734375
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처 식품의약품안전평가원",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        169.67999267578125,
        674.2396850585938,
        354.59857177734375,
        687.4873046875
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기심사부 첨단의료기기과(디지털헬스기기팀)",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        169.67999267578125,
        690.19970703125,
        400.7146911621094,
        703.4473266601562
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "전화: 043-719-3948",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        169.67999267578125,
        722.2396850585938,
        260.2435607910156,
        735.4873046875
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "팩스: 043-719-3940",
      "font_size": 9.960000038146973,
      "font_name": "MalgunGothic",
      "bbox": [
        169.67999267578125,
        738.19970703125,
        260.2435607910156,
        751.4473266601562
      ],
      "page_num": 138,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "28159 충북 청주시 흥덕구 오송읍 오송생명2로 187",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        144.83999633789062,
        399.86248779296875,
        450.36053466796875,
        413.53125
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "오송보건의료행정타운",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        232.55999755859375,
        420.6224670410156,
        362.5215759277344,
        434.2912292480469
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "식품의약품안전처 식품의약품안전평가원",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        177.36000061035156,
        441.3824768066406,
        417.841552734375,
        455.0512390136719
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "의료기기심사부 첨단의료기기과(디지털헬스기기팀)",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        147.239990234375,
        462.2624816894531,
        447.92999267578125,
        475.9312438964844
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "TEL : 043) 719-3948   FAX : 043) 719-3940",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        164.51998901367188,
        483.0224914550781,
        430.5610656738281,
        496.6912536621094
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "https://www.nifds.go.kr",
      "font_size": 12.960000038146973,
      "font_name": "ÈÞ¸Õ¸íÁ¶",
      "bbox": [
        231.83999633789062,
        503.782470703125,
        363.4131164550781,
        517.4512329101562
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "[부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.",
      "font_size": 11.039999961853027,
      "font_name": "T10",
      "bbox": [
        156.95999145507812,
        693.0,
        469.7447814941406,
        706.2479858398438
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    },
    {
      "text": "‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너",
      "font_size": 11.039999961853027,
      "font_name": "T20",
      "bbox": [
        156.95999145507812,
        710.6400146484375,
        512.0399780273438,
        723.8880004882812
      ],
      "page_num": 139,
      "block_type": "table_cell",
      "level": 0,
      "table_info": null,
      "is_in_table": true
    }
  ],
  "markdown_content": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021. 12.\n의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n**[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다. | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261. | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다. 이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다. | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오. | 기밀성 및 무결성 보장 | 3. 지난밤에, ＿:＿에 잠자리(침대)로 들어갔다. | 4. 지난밤에, ＿:＿에 불을 끄고 잠을 청했다. | 5. 불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다. | 6. 자다가 중간에 ＿번 깼다. (최종적으로 일어난 것 제외) | 7. 한번 깨고 나면 ＿분 동안 잠을 못 이뤘다. | (소프트 | SNS 등을 통해 수집할 수 있다. | Psychological | 지침서ㆍ안내서가 있습니까? | 신경생리학 검사방법. 일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다. | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다. | 활동을 말한다. | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다. | 없이 수집된 자료로 분석한다. | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다. | 고려하여 평가한다. | 제시해야 한다. | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다. | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다. | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다. | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다. | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오. | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10. 소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583. | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다. | 하는 소프트웨어 의료기기(SaMD)이다. | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016). | 한다. | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.) | 후에 방문을 하여, 치료 후 평가를 수행한다. | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다. | 하도록 한다. | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다. | 잠만 자야 한다. | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18. 사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다. | 제시한다. | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341. | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17. 불면 이차 유효성 평가지표 측정 도구 예시 | 1. 평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다. | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. | 같이 분명한 이유를 기록하여 주십시오. | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다. | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021. 12. 8. | - 임상시험 중 관찰 항목을 기술한다. | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다. | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다. | 측정이 가능하다. | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다. | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다. | 해당한다. | 기록지에 내용을 기록한다. | 이상 분량의 수면 일기를 작성한다. | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다. | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2. 관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1. 치료하지 않음 | 1. 회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8. 나는 오늘 최종적으로 ＿:＿에 일어났다. | 9. 나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다. | 10. 전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다. | (Oxymeter)를 측정 및 기록 | 표 13. 위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오. | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다. | ◈ 검사일(YY/MM/DD) | 1. 경증 | 의료기기의 사이버 보안 | 표 7. 디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1. 중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다. | 5) 시험 방법 | 관여하는 사람을 말한다. | 되어야 한다. | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다. | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다. | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5. 진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation. Journal of Consulting and Clinical Psychology, 72(1), 113-120. | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다. | 최소 | 소프트웨어 | 요구사항 | 3. 관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1. 검사진행 | 2. 약물치료 | 2. 진행중 |\n| 소프트웨어 | normative data for adults of working age. BMJ (Clinical research ed.), 306(6890), 1437–1440. | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다. | 반드시 필요한 것은 아니며 행정상 변경이 필요하다. | 사용여부 등을 체크리스트를 이용하여 기술한다. | 하나이다. | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다. | 전면 파기한다. | QIDS | 평가한다. | 적용방법 및 사례집 | 30%로 정하고자 한다. | 그림 3. 데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다. | 관리에 관한 규정 제2조) | 받은 자 | 2. 중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까? | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다. | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4. 관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다. | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2. 검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3. 비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3. 후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다. | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다. | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3. 중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2. 중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다. |\n| 표 6. 국외 불면증 개선 디지털치료기기 허가 제품 동향(2021. 06. 기준) | activity impairment instrument. Pharmacoeconomics. 1993 Nov;4(5):353-65. | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다. | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다. | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다. | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다. | 자료보관(연구파일) 등을 확인한다. | 포함된다. | 비교 분석하여 유효성에 대한 검증을 수행한다. | 분석한다. | 경우를 말한다. | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다. | - 외래 방문마다 병용 약물을 수집하여 기록한다. | Depressive | 치료기기라고 판단할 수 있다. | 내용을 기록한다. | : 일차 유효성 평가변수와 동일한 방법을 적용한다. | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5. 관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4. 국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4. 수술적치료 | 방법에 대한 국제 규격 | 4. 사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도. 각각의 항목은 0점에서 3점까지 |\n| mediation analysis. The Lancet Psychiatry, 4(10), 749-758. | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11. 잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다. | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6. 관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15. 의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점. 총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다. | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다. | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다). | 기재한다. | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1. 관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다. | 따라 스크리닝 번호를 부여한다. | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다. |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다. (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다. | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다. | 1) 평가 불가능(Unknown) | 내용입니까? | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16. | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다. | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오. | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다. | 수집할 수 있다. | 제품 외형 | 하는 설문도구. 환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다. | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다. | 문제가 있을 경우 시험자와 상의한다. | 한다. 이러한 정보들은 기밀로 보관되어야 한다. | 으로 정하고자 한다. | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다. | 곳에서 필요한 형태로 존재하여야 함을 의미한다. | 위한 행동 치료를 수행한다. | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까? | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다. | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30. | 수가 확보되어야 한다. | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까? | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다. | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다. |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다. | - 일차와 이차 유효성 평가 관련된 목록을 작성한다. | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다. | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다. | 및 폐기에 관한 기록을 유지하여야 한다. | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다. | 포함되어야 한다. | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다. | 내용을 기록한다. | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3. 불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed.), 349, g5205. | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다. | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다. | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오. | 기록을 열람할 수 있다. | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까? | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다. | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다. | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다. | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다. | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19. 불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial. JAMA Psychiatry, 74(1), 68-75. | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다. | 위임자가 모든 선정 및 제외 기준을 검토해야 한다. | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다. | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다. | 사) 병용 약물 조사 | 고려하지 않는다. | 통해서 시험군 혹은 대조군으로 1:1 배정한다. | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다. | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다. | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다. |\n| Internal Medicine, 164(17), 1888–1896. | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다. | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다. | 만든다. | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다. | 보안 적용 사항을 기재한다. | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다. | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver. 1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다. | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다. | 성공 기준)를 함께 제시하여야 한다. | 각성 시간 | 구성. 점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다. |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다. | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다. | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다. | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까? (공무원용) |\n| 2(5), e229-e239. | 14. | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다. | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다. | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다. | 그림 5. 불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다. | 수집할 수 있다. | 그림 4. 소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8. 디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다. | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다. | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M.(2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다. | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. | 투여 기간, 목적을 확인한다. | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다. | 하여야 한다. | 측정력을 보여주어야 한다. | - OOO 애플리케이션을 실행한다. | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다. | 평가를 수행한다. | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2. 불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.) | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오. | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까? (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다. | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial. Sleep, 39(1), 183–191. | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다. | 있는 영역(acceptable)’의 2단계로 구분할 수 있다. | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다. | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다. | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함. | H.(2016) | 한다)를 말한다. | 수는 없으며 이상반응 문제가 생길 수 있다. | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다. | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다. | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다. | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다. | - 일차목적 및 가설 | 가능하다. | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다. | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. | 510(k) for a Software Change | 그림 6. 불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다. | 투여기간, 목적을 확인한다. | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다. 이후 수면 위생에 대한 점검을 권유한다. | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오. | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다. | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다. | 고려할 것을 권고한다. | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15. | internet-based cognitive behavioral therapy for insomnia. Sleep Medicine, 47, 77–85. | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다. | 식품의약품안전처장의 승인을 받아야 한다. | 얻는 전 과정에 참석하여야 한다. | 관리 결과가 검증되어야 한다. | - 본 연구는 중간 분석을 수행하지 않는다. | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다. | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다. | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까? | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. 그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n상기 사항에 대하여 확인하였음.\n\n2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다. 또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2. 문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ. 개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1. 배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2. 적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3. 용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4. 현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ. 안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1. 국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2. 안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3. 성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ. 임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ. 참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1. 배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n<!-- PAGE_8 -->\n###### 2. 적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n- - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다. | 날짜 (월/일) | 1. 전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다. | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다. 피험자 배정과 처리 | 1. 국내외 관련 규격 및 가이드라인 | 작성하여야 한다. | 구조, 성능 등을 구체적으로 기재하도록 한다. | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다. | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다. | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다. | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다. | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다. | ⦁ 관찰 시기를 표기한다. | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다. | 조사한다. | 하게 하거나, 애플리케이션을 통해 정보를 수집한다. | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정. 30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다. | sleep technologist. St. Louis: Elsevier; 2014. | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다. | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다. | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오. | 80001-2-1 | therapy | 표 11. 위해요인 식별 예시 | 2 | E06060.02 | 웨어. 가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다. | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다. | 유지한다. | 아니 된다. | 같이 분류한다. | 산출 공식은 아래와 같다. | 2. 지난밤에, 약 ＿을(를) ＿mg 복용하였다. | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다. | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다. | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다. | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오. | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다. | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다. | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다.**\n| 적응증을 포함하도록 한다. | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다. | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다. 그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다. 임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다. | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다. | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다. | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다. | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다. | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다. | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다. | 하여야 | 한다. 따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다. | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다. | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어. 가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다. | 1. 국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1. 불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3. 용어 설명\n\n- 가. 소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n- 나. 디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다. 불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n- 라. 수면 위생(Sleep hygiene)\n- 마. 수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n- 바. 자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n- - 4 -\n- 사. 수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아. 불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자. 수면 효율(Sleep Efficiency, SE)\n- 차. 정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다. DSM-5는 2013년도의\n\n- 카. 국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n- - 5 -\n<!-- PAGE_12 -->\n###### 4. 현 황\n\n- 가. 불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다. 성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다. 일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다. 불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다. 2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다. 따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\nOECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다. 이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다. 이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n- 나. 불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n**[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다. | application of ISO 14971 | 표 12. 위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다. | 투여 기간, 목적을 확인한다. | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우. | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다. | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오. | 시험계획서의 절차에 따라 이루어지도록 하여야 한다. | 것이라는 사실 | and sleep diary) | 불가능하다. | 여부, 직업, 업무생산성). | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다. | (https://peartherapeutics.com/ | 분석군으로 분석한다. | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14. 전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n<그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다. 예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School. Macmillan. | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다. | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까? | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다. |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n그림 1. 불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다. 불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다. 따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다. 이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다. 선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다. 불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다. 수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다. 수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다. 이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n- - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다. 잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다. 잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라. 불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n<표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다. 물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다. 왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다. 잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다. 다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,.(2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다. 단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\nA. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마. 불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n* ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong). 또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n- 바. 디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004). 또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다. 따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n- - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020). 실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다. 그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다. 또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019). 해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다. 그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다. 해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017). 해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다. 해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다. 이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016). 해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다. 연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다. 추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al. 2016).\n\n- - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016). 이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다. 따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020). 또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다. 하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n- 사. 불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구. 불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다. | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16). Sleep, 30(11), 1547–1554. | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다. | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다. | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다. | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다. | - 회원가입 및 초기 수면 평가를 시행한다. | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다. | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다. | 위한 통계 처리 시 삽입할 수 있다. | 통계적 우월성을 평가한다. | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다. 실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다.**\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다. |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다. | 웨어 요구사항에 반영한다. |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마. 안전성의 평가 기준 |\n**라. 이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성. | 네트워크 API를 통해 데이터베이스로 |\n**표 16. 치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다.**\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다. 예측되는 부작용도 이상반응으로 분류한다.**\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다. |\n| 바. 이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220. | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아. 디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다. 또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다. 여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다. 또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다. 또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2. 디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다. 가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다. 일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다. 실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다. 또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n- - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다. 또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가. 국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다. | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다. | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다. | 번호로 연락하고 관리자가 조치할 때까지 대기한다. | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다. | PTW | 한다. | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다. | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다. | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다. | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다. | 비 | 통한 불면증 치료를 수행한다. | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다. | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다. | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다. | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다. | 조사한다. | 자료 등이 이에 해당된다. |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나. 국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial. JAMA Psychiatry, 77(5), 484-492. | e016392. |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2. 안전성 평가 항목\n\n- 가. 소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n- - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다. | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다. |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n제품에 구현한다. 이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9. 소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다. 문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n- - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다. 이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다. 이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나. 의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다. 본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n- - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다. | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다. | 교육을 실시한다. |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다. | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다. | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다. | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다. | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다. 통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다. | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2. 전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1. 식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다. |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다. |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다. |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다. | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다.**\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다. |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다. |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다. | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다. |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다. |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다. |\n| 이를 인식하여 구분할 수 있어야 한다. | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다. | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다. | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다. | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다. | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다. | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n- - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다. | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다. | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다. |\n**2. 탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다. |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다. |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다. |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다. |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n- - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3. 성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n- - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n- 1. 임상시험의 제목\n- 2. 임상시험기관의 명칭 및 소재지\n- 3. 임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4. 임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5. 임상시험을 하려는 자의 성명 및 주소\n- 6. 임상시험의 목적 및 배경\n- 7. 임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8. 임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9. 임상시험기간\n- 10. 임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11. 관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12. 예측되는 부작용 및 사용 시 주의사항\n- 13. 중지ㆍ탈락 기준\n- 14. 유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15. 부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16. 피험자동의서 서식\n- 17. 피해자 보상에 대한 규약\n- 18. 임상시험 후 피험자의 진료에 관한 사항\n- 19. 피험자의 안전보호에 관한 대책\n- 20. 그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n- - 46 -\n<!-- PAGE_53 -->\n###### 1. 임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2. 임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3. 임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가. 시험책임자\n- 나. 시험담당자\n- 다. 공동연구자\n- 라. 임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4. 임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5. 임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다. 의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다. 임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가. 의뢰자\n- 나. 모니터요원\n- 다. 임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6. 임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가. 임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018). 임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다. 약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다. 또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다. 불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011). 불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다. 셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다. 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al. 2004). 이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다. 특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n- 나. 임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다. Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다. 아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al. 2016.).\n\n또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n- - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다. 첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다. 대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다. 이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다. 둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다. 모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다. 셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n- - 57 -\n- 7. 임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가. 임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다. 임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n*\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나. 임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다. 대조\n\n- 다. 임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n: 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n- (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질. 이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다. 이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n- - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다. 이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다. 수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8. 피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다. 이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다. 또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가. 피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나. 피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다. 즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n- - 65 -\n- 다. 목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다. 피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다. 이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다. 이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다. 이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다. 두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다. 그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9. 임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10. 임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가. 시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다. 다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다. 불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다. 임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다. 또한 동의를 서명한 연월일을\n\n기록한다. 또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n- - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다. (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안. 경기연구원 연구보고서. | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application. Sleep, 35(6), 769–781.**\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나. 설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다. 이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11. 관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가. 임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n- - 78 -\n- 나. 임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다. 서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다. 대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다. 치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n- - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다. 단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n- - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n- - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n- - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n- - 84 -\n<!-- PAGE_91 -->\n###### 12. 예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가. 예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다. 이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다. 치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n- 나. 사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n- - 86 -\n<!-- PAGE_93 -->\n###### 13. 중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가. 중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나. 탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14. 유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n- 가. 유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나. 검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993). 불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다. 불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다. 단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다. 방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다. 다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다. 방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트). 얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al. 2012). 수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20. 수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다. 방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다. 이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다. 방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다. 제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다. 방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다. 웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다. 이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다. 자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다. 연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다. 이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다. 통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다. 1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다. 1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다. 안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다. 대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다. 또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n: 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다. 그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n- - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n- - 99 -\n<!-- PAGE_106 -->\n###### 15. 부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가. 피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다. 하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다. 긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n- 나. 시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n- - 100 -\n- 다. 이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다. 그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16. 피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다. 이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가. 피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나. 피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n- - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다. 피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다. 임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n- 라. 피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다. 또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n- - 109 -\n<!-- PAGE_116 -->\n###### 17. 피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다. 피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다. 본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다. 그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n- - 110 -\n<!-- PAGE_117 -->\n###### 18. 임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다. 다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n- - 111 -\n<!-- PAGE_118 -->\n###### 19. 피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가. 임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n- 나. 임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다. 임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다. 시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다. 시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라. 의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n- - 113 -\n- 마. 모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바. 임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다. 만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다. 그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사. 피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n- - 115 -\n- 아. 피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다. 시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자. 기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다. 제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다. 다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n- - 116 -\n- 20. 그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가. 자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나. 법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다. 임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다. 임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n- 다. 임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n- 라. 점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n- 마. 임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다. 임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다. 임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n- - 118 -\n- 바. 임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1. 의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2. 한국판 불면증 임상진료지침. 대한신경정신의학회, 2019.\n- 3. IEC62304 (Medical device software-software life cycle processes)\n- 4. ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5. Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J. (2016). Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial. The Lancet Psychiatry,\n\n- 6. Ström, L., Pettersson, R., & Andersson, G. (2004). Internet-based treatment for insomnia: a\n- 7. Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n- (2017). The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8. Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n- (2019). Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial. JAMA Psychiatry, 76(1),\n\n- 9. Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M. (2017). Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10. Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n- (2020). Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study. The Lancet Digital Health,\n\n- 11. Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H. (2016). Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12. Lee, E. (2020). Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia. Chronobiol\n- 13. Kim, M., & Choi, H. J. (2021). Digital Therapeutics for Obesity and Eating-Related Problems.\n- 14. Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A. (2020). Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15. Ahn, D. H. (2013). 불면증: 원인과 진단. Hanyang Med Rev, 33, 203-209.\n- 16. 이은환, 이상훈, 임영현, & 김욱. (2018). 경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17. 우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠. (2011). 근로자의 수면문제에 따른 생산\n성 시간 손실. 신경정신의학, 50(1), 62-68.\n\n- - 120 -\n- 18. Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D. (2006). Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol. 1). Springer Science & Business Media.\n\n- 19. Jacobs, G. D. (2009). Say good night to insomnia: the six-week, drug-free program developed at\n- 20. Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L. (2003). Primary insomnia: Diagnostic\nissues, treatment and future directions. In: Perlis ML, Lichstein KL. Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine. 1st ed. Hoboken: John Wiley & Sons, Inc,\n\n- 21. 의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22. 의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23. 의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24. 의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25. 소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26. 디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27. 의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. (2018).\nCognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. Sleep Medicine\n\n- 29. Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B. (2014). Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ\n\n- 30. Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. (2004). Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. Archives of\n\n- 31. Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n- (2011). Chronic insomnia: clinical and research challenges--an agenda. Pharmacopsychiatry, 44(1), 1–\n- 32. Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. (2001). Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?. Sleep, 24(5), 591–599.\n\n- 33. Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M. (2018). Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34. Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K. (2017). Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'. BMJ Open, 7(7),\n\n- 35. Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. (2012).\nA randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36. Morin, C. M. (1993). Insomnia Severity Index.\n- 37. Johns M. W. (1991). A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n- - 121 -\nSleep, 14(6), 540–545.\n\n- 38. Morin, C. M., Vallières, A., & Ivers, H. (2007). Dysfunctional beliefs and attitudes about sleep\n- 39. Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA. Polysomnography for the\n- 40. Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B. (2003). The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n- 41. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric\n- 42. Jenkinson, C., Coulter, A., & Wright, L. (1993). Short form 36 (SF36) health survey questionnaire:\n- 43. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and\n- 44. 한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -",
  "chunks": [
    {
      "chunk_id": "chunk_001",
      "text": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 0,
        "window_size": 3,
        "char_count": 121,
        "word_count": 24,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021.  12.\n 의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다. ",
        "original_sentence": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021. "
      }
    },
    {
      "chunk_id": "chunk_002",
      "text": "12.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 1,
        "window_text": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021.  12.\n 의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261. ",
        "original_sentence": "12.\n"
      }
    },
    {
      "chunk_id": "chunk_003",
      "text": "의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 2,
        "window_size": 3,
        "char_count": 145,
        "word_count": 32,
        "page_number": 3,
        "window_text": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021.  12.\n 의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261.  | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다. ",
        "original_sentence": "의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_004",
      "text": "**[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 3,
        "window_size": 3,
        "char_count": 40,
        "word_count": 8,
        "page_number": 45,
        "window_text": "<!-- PAGE_1 -->\n## 불면증 개선 디지털치료기기\n\n<!-- PAGE_1 -->\n## 안전성·성능 평가 및 임상시험계획서\n\n<!-- PAGE_1 -->\n## 작성 가이드라인(민원인 안내서)\n\n- 2021.  12.\n 의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261.  | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다.  이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다. ",
        "original_sentence": "**[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다. "
      }
    },
    {
      "chunk_id": "chunk_005",
      "text": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 4,
        "window_size": 3,
        "char_count": 233,
        "word_count": 60,
        "page_number": 3,
        "window_text": "12.\n 의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261.  | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다.  이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.  | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오. ",
        "original_sentence": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261. "
      }
    },
    {
      "chunk_id": "chunk_006",
      "text": "| 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 5,
        "window_size": 3,
        "char_count": 42,
        "word_count": 11,
        "page_number": 36,
        "window_text": "의 료 기 기 심 사 부\n\n<!-- PAGE_3 -->\n###### 지침서·안내서 제·개정 점검표\n\n명칭\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서 작성 가이\n\n드라인(민원인 안내서)\n\n아래에 해당하는 사항에 체크하여 주시기 바랍니다.\n\n **[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261.  | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다.  이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.  | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오.  | 기밀성 및 무결성 보장 | 3. ",
        "original_sentence": "| 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다. "
      }
    },
    {
      "chunk_id": "chunk_007",
      "text": "이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 6,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 36,
        "window_text": "**[표 시작]**\n\n| 또는 알코올 ＿을(를) ＿잔(병) 음주하였다.  | □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261.  | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다.  이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.  | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오.  | 기밀성 및 무결성 보장 | 3.  지난밤에, ＿:＿에 잠자리(침대)로 들어갔다. ",
        "original_sentence": "이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_008",
      "text": "| □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 7,
        "window_size": 3,
        "char_count": 128,
        "word_count": 40,
        "page_number": 43,
        "window_text": "| □ 이미 등록된 지침서ㆍ안내서 중 동일ㆍ유사한 내용의 | - 수면-각성 패턴, 낮잠을 자는지(수면일기 및 설문지를 통해 평가) | 치료시작일 | (Baseline) | □ 예 | ■ 아니오 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 위해요인 | 구체적인 예시 | 사용자 또는 환자에게 | 필요시 | IT-networks–Practical |\n| 2003;214-261.  | 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다.  이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.  | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오.  | 기밀성 및 무결성 보장 | 3.  지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.  | 4. ",
        "original_sentence": "| □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오. "
      }
    },
    {
      "chunk_id": "chunk_009",
      "text": "| 기밀성 및 무결성 보장 | 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 8,
        "window_size": 3,
        "char_count": 20,
        "word_count": 7,
        "page_number": 28,
        "window_text": "| 6) 사용자 반응 평가(순응도, 만족도, 난이도, 개선점 등) | 다.  이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.  | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오.  | 기밀성 및 무결성 보장 | 3.  지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.  | 4.  지난밤에, ＿:＿에 불을 끄고 잠을 청했다. ",
        "original_sentence": "| 기밀성 및 무결성 보장 | 3. "
      }
    },
    {
      "chunk_id": "chunk_010",
      "text": "지난밤에, ＿:＿에 잠자리(침대)로 들어갔다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 9,
        "window_size": 3,
        "char_count": 26,
        "word_count": 4,
        "page_number": 100,
        "window_text": "이용 가능한 임상시험용 의료기기 정보를 참고하여 인과관계를 평가한다.  | □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오.  | 기밀성 및 무결성 보장 | 3.  지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.  | 4.  지난밤에, ＿:＿에 불을 끄고 잠을 청했다.  | 5. ",
        "original_sentence": "지난밤에, ＿:＿에 잠자리(침대)로 들어갔다. "
      }
    },
    {
      "chunk_id": "chunk_011",
      "text": "| 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 10,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 35,
        "window_text": "| □ 기기제어 | 검사일 | 증례기록서 | 참 고 코 드 | 발생 가능한 손상 | 관련 자료 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2) 유의수준 | 3) 정해진 칸 이외의 여백에 기록하지 마십시오.  | 기밀성 및 무결성 보장 | 3.  지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.  | 4.  지난밤에, ＿:＿에 불을 끄고 잠을 청했다.  | 5.  불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다. ",
        "original_sentence": "| 4. "
      }
    },
    {
      "chunk_id": "chunk_012",
      "text": "지난밤에, ＿:＿에 불을 끄고 잠을 청했다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 11,
        "window_size": 3,
        "char_count": 25,
        "word_count": 6,
        "page_number": 100,
        "window_text": "| 기밀성 및 무결성 보장 | 3.  지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.  | 4.  지난밤에, ＿:＿에 불을 끄고 잠을 청했다.  | 5.  불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.  | 6. ",
        "original_sentence": "지난밤에, ＿:＿에 불을 끄고 잠을 청했다. "
      }
    },
    {
      "chunk_id": "chunk_013",
      "text": "| 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 12,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 35,
        "window_text": "지난밤에, ＿:＿에 잠자리(침대)로 들어갔다.  | 4.  지난밤에, ＿:＿에 불을 끄고 잠을 청했다.  | 5.  불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.  | 6.  자다가 중간에 ＿번 깼다. ",
        "original_sentence": "| 5. "
      }
    },
    {
      "chunk_id": "chunk_014",
      "text": "불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 13,
        "window_size": 3,
        "char_count": 29,
        "word_count": 8,
        "page_number": 100,
        "window_text": "| 4.  지난밤에, ＿:＿에 불을 끄고 잠을 청했다.  | 5.  불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.  | 6.  자다가 중간에 ＿번 깼다.  (최종적으로 일어난 것 제외) | 7. ",
        "original_sentence": "불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다. "
      }
    },
    {
      "chunk_id": "chunk_015",
      "text": "| 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 14,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 36,
        "window_text": "지난밤에, ＿:＿에 불을 끄고 잠을 청했다.  | 5.  불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.  | 6.  자다가 중간에 ＿번 깼다.  (최종적으로 일어난 것 제외) | 7.  한번 깨고 나면 ＿분 동안 잠을 못 이뤘다. ",
        "original_sentence": "| 6. "
      }
    },
    {
      "chunk_id": "chunk_016",
      "text": "자다가 중간에 ＿번 깼다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 15,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 45,
        "window_text": "| 5.  불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.  | 6.  자다가 중간에 ＿번 깼다.  (최종적으로 일어난 것 제외) | 7.  한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.  | (소프트 | SNS 등을 통해 수집할 수 있다. ",
        "original_sentence": "자다가 중간에 ＿번 깼다. "
      }
    },
    {
      "chunk_id": "chunk_017",
      "text": "(최종적으로 일어난 것 제외) | 7. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 16,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 36,
        "window_text": "불을 끈 다음, 잠들기까지 대략 ＿분 정도 걸렸다.  | 6.  자다가 중간에 ＿번 깼다.  (최종적으로 일어난 것 제외) | 7.  한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.  | (소프트 | SNS 등을 통해 수집할 수 있다.  | Psychological | 지침서ㆍ안내서가 있습니까? ",
        "original_sentence": "(최종적으로 일어난 것 제외) | 7. "
      }
    },
    {
      "chunk_id": "chunk_018",
      "text": "한번 깨고 나면 ＿분 동안 잠을 못 이뤘다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 17,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 100,
        "window_text": "| 6.  자다가 중간에 ＿번 깼다.  (최종적으로 일어난 것 제외) | 7.  한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.  | (소프트 | SNS 등을 통해 수집할 수 있다.  | Psychological | 지침서ㆍ안내서가 있습니까?  | 신경생리학 검사방법. ",
        "original_sentence": "한번 깨고 나면 ＿분 동안 잠을 못 이뤘다. "
      }
    },
    {
      "chunk_id": "chunk_019",
      "text": "| (소프트 | SNS 등을 통해 수집할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 18,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 39,
        "window_text": "자다가 중간에 ＿번 깼다.  (최종적으로 일어난 것 제외) | 7.  한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.  | (소프트 | SNS 등을 통해 수집할 수 있다.  | Psychological | 지침서ㆍ안내서가 있습니까?  | 신경생리학 검사방법.  일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다. ",
        "original_sentence": "| (소프트 | SNS 등을 통해 수집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_020",
      "text": "| Psychological | 지침서ㆍ안내서가 있습니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 19,
        "window_size": 3,
        "char_count": 33,
        "word_count": 5,
        "page_number": 3,
        "window_text": "(최종적으로 일어난 것 제외) | 7.  한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.  | (소프트 | SNS 등을 통해 수집할 수 있다.  | Psychological | 지침서ㆍ안내서가 있습니까?  | 신경생리학 검사방법.  일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다. ",
        "original_sentence": "| Psychological | 지침서ㆍ안내서가 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_021",
      "text": "| 신경생리학 검사방법. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 20,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 46,
        "window_text": "한번 깨고 나면 ＿분 동안 잠을 못 이뤘다.  | (소프트 | SNS 등을 통해 수집할 수 있다.  | Psychological | 지침서ㆍ안내서가 있습니까?  | 신경생리학 검사방법.  일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다.  | 활동을 말한다. ",
        "original_sentence": "| 신경생리학 검사방법. "
      }
    },
    {
      "chunk_id": "chunk_022",
      "text": "일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 21,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 39,
        "window_text": "| (소프트 | SNS 등을 통해 수집할 수 있다.  | Psychological | 지침서ㆍ안내서가 있습니까?  | 신경생리학 검사방법.  일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다.  | 활동을 말한다.  | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다. ",
        "original_sentence": "일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다. "
      }
    },
    {
      "chunk_id": "chunk_023",
      "text": "| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 22,
        "window_size": 3,
        "char_count": 119,
        "word_count": 36,
        "page_number": 9,
        "window_text": "| Psychological | 지침서ㆍ안내서가 있습니까?  | 신경생리학 검사방법.  일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다.  | 활동을 말한다.  | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다.  | 없이 수집된 자료로 분석한다. ",
        "original_sentence": "| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_024",
      "text": "| 활동을 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 23,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 40,
        "window_text": "| 신경생리학 검사방법.  일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다.  | 활동을 말한다.  | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다.  | 없이 수집된 자료로 분석한다.  | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다. ",
        "original_sentence": "| 활동을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_025",
      "text": "| 사이버 보안 필수원칙 체크리스트’를 제출해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 24,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 42,
        "window_text": "일반적으로 하루 밤 동안에 걸쳐 뇌파 | 험관리 계획을 수립한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다.  | 활동을 말한다.  | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다.  | 없이 수집된 자료로 분석한다.  | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다.  | 고려하여 평가한다. ",
        "original_sentence": "| 사이버 보안 필수원칙 체크리스트’를 제출해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_026",
      "text": "| 없이 수집된 자료로 분석한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 25,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 44,
        "window_text": "| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 6개월 후 |\n| 19) 피험자의 임상시험 예상 참여 기간 | 나) 수면 일기 확인 | 마) 이상반응 확인 | 에서 제외 | 시험을 실시하여야 한다.  | 활동을 말한다.  | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다.  | 없이 수집된 자료로 분석한다.  | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다.  | 고려하여 평가한다.  | 제시해야 한다. ",
        "original_sentence": "| 없이 수집된 자료로 분석한다. "
      }
    },
    {
      "chunk_id": "chunk_027",
      "text": "| 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 26,
        "window_size": 3,
        "char_count": 36,
        "word_count": 8,
        "page_number": 44,
        "window_text": "| 활동을 말한다.  | 사이버 보안 필수원칙 체크리스트’를 제출해야 한다.  | 없이 수집된 자료로 분석한다.  | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다.  | 고려하여 평가한다.  | 제시해야 한다.  | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다. ",
        "original_sentence": "| 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다. "
      }
    },
    {
      "chunk_id": "chunk_028",
      "text": "| 고려하여 평가한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 27,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 31,
        "window_text": "| 사이버 보안 필수원칙 체크리스트’를 제출해야 한다.  | 없이 수집된 자료로 분석한다.  | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다.  | 고려하여 평가한다.  | 제시해야 한다.  | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.  | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다. ",
        "original_sentence": "| 고려하여 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_029",
      "text": "| 제시해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 28,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 34,
        "window_text": "| 없이 수집된 자료로 분석한다.  | 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다.  | 고려하여 평가한다.  | 제시해야 한다.  | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.  | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다.  | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다. ",
        "original_sentence": "| 제시해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_030",
      "text": "| 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 29,
        "window_size": 3,
        "char_count": 32,
        "word_count": 9,
        "page_number": 13,
        "window_text": "| 임상시험 미 완료일(YY/MM/DD) | 하는 것은 아니다.  | 고려하여 평가한다.  | 제시해야 한다.  | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.  | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다.  | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다.  | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다. ",
        "original_sentence": "| 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_031",
      "text": "| control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 30,
        "window_size": 3,
        "char_count": 139,
        "word_count": 31,
        "page_number": 18,
        "window_text": "| 고려하여 평가한다.  | 제시해야 한다.  | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.  | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다.  | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다.  | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다.  | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오. ",
        "original_sentence": "| control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_032",
      "text": "| 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 31,
        "window_size": 3,
        "char_count": 218,
        "word_count": 59,
        "page_number": 19,
        "window_text": "| 제시해야 한다.  | 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.  | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다.  | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다.  | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다.  | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.  | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10. ",
        "original_sentence": "| 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_033",
      "text": "| □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 32,
        "window_size": 3,
        "char_count": 78,
        "word_count": 23,
        "page_number": 9,
        "window_text": "| 교정 및 기저 불안을 줄이는 내용이 포함되어야 한다.  | control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다.  | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다.  | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다.  | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.  | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10.  소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583. ",
        "original_sentence": "| □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다. "
      }
    },
    {
      "chunk_id": "chunk_034",
      "text": "| 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 33,
        "window_size": 3,
        "char_count": 56,
        "word_count": 16,
        "page_number": 28,
        "window_text": "| control | 판단되는 경우 | (Follow-up, 6개월 후) | - 수면-각성 주기가 불규칙하거나 일주기리듬 수면각성장애가 의심될 때 | (Screening)1) | 의료기기 허가·심사 시 사용자의 건강에 |\n| 심리평가 | 기술한다.  | 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다.  | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다.  | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.  | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10.  소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583.  | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. ",
        "original_sentence": "| 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오. "
      }
    },
    {
      "chunk_id": "chunk_035",
      "text": "| 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 34,
        "window_size": 3,
        "char_count": 304,
        "word_count": 87,
        "page_number": 39,
        "window_text": "| 의료기기의 사이버 보안 | 이완 요법 | applications and examples | 코어 세션 제공 | 적용 | 성능 | 시험 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | (Follow up)4) |\n| 활동기록계 | 1) 임상시험용 의료기기 | ◈ 인구학적 정보 | 제·개정번호 | 승인일자 | 주요 내용 | 하기에 충분한 경험이 있는 자가 선정되어야 한다.  | □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다.  | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.  | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10.  소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583.  | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다. ",
        "original_sentence": "| 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10. "
      }
    },
    {
      "chunk_id": "chunk_036",
      "text": "소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 35,
        "window_size": 3,
        "char_count": 100,
        "word_count": 22,
        "page_number": 9,
        "window_text": "| □ 펌웨어 또는 소프트웨어 업데이트 등 유지보수 | 적용 | 성능 | 시험 |\n| 디지털치료기기 관련 국내외 규격은 <표 7>과 같다.  | 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.  | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10.  소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583.  | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.  | 하는 소프트웨어 의료기기(SaMD)이다. ",
        "original_sentence": "소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583. "
      }
    },
    {
      "chunk_id": "chunk_037",
      "text": "| 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 36,
        "window_size": 3,
        "char_count": 112,
        "word_count": 30,
        "page_number": 9,
        "window_text": "| 3) 통계적 검정 방법 | 4) 증례 기록서 내에 기록하며, 모든 칸은 빈칸으로 두지 마십시오.  | 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10.  소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583.  | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.  | 하는 소프트웨어 의료기기(SaMD)이다.  | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016). ",
        "original_sentence": "| 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_038",
      "text": "| 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 37,
        "window_size": 3,
        "char_count": 168,
        "word_count": 43,
        "page_number": 3,
        "window_text": "| 웨어 | 개발 | 프로 | 세스) | 증상의 | PSG | ☞ 상기 질문에 ‘예’라고 답하신 경우 기존의 지침서ㆍ안내서의 개정을 우선적 | assessment | 의료기기와의 | 통합 계획에 따라 소프트웨어를 | 통합하고 | 통합한 | 소프트웨어 | 2 | E06050.01 | 의료기기에 | 대한 조치 | 치료 | 결과 | 중대성 | 직접적인 영향을 미칠 수 있는 사이버 |\n| □ ‘중증도’ 판정 참고기준 | therapy) | - 정량적으로 수면지표 등을 파악하고자 할 때 | 비 인가된 사용자의 | 접근으로 인해 환자 | 표 10.  소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583.  | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.  | 하는 소프트웨어 의료기기(SaMD)이다.  | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016).  | 한다. ",
        "original_sentence": "| 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다. "
      }
    },
    {
      "chunk_id": "chunk_039",
      "text": "| 하는 소프트웨어 의료기기(SaMD)이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 38,
        "window_size": 3,
        "char_count": 25,
        "word_count": 4,
        "page_number": 9,
        "window_text": "소프트웨어 안전성 등급 | 적용 | 성능 | 시험 |\n| 소프트웨어 | 범위 | 넷진흥원, 2018.05 | Biological psychiatry, 54(5), 573–583.  | 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.  | 하는 소프트웨어 의료기기(SaMD)이다.  | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016).  | 한다.  | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.) ",
        "original_sentence": "| 하는 소프트웨어 의료기기(SaMD)이다. "
      }
    },
    {
      "chunk_id": "chunk_040",
      "text": "| - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 39,
        "window_size": 3,
        "char_count": 116,
        "word_count": 29,
        "page_number": 9,
        "window_text": "| 4 | 생년월일 | 정도 | (Cognitive | 허가·심사 가이드라인 | 관련성 | 결정하는데 사용하기 위한 소프트웨어 | 국내 |\n| 사실관계 등에 따라 달리 적용될 수 있음을 알려드립니다.  | 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.  | 하는 소프트웨어 의료기기(SaMD)이다.  | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016).  | 한다.  | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)  | 후에 방문을 하여, 치료 후 평가를 수행한다. ",
        "original_sentence": "| - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016). "
      }
    },
    {
      "chunk_id": "chunk_041",
      "text": "| 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 40,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 44,
        "window_text": "| 4) 공용 네트워크 망 사용 여부 : 병원 내 네트워크 | 4) 사용될 통계적 분석 방법(즉, 연구디자인과도 관련) | 5) 이상치 처리 | 20) 임상시험에 참여하는 대략의 피험자 수 | (Polysomnography) | 비 인가된 | 위원장이나 간사가 승인한 문서를 의뢰자에게 보내야 한다.  | 하는 소프트웨어 의료기기(SaMD)이다.  | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016).  | 한다.  | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)  | 후에 방문을 하여, 치료 후 평가를 수행한다.  | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_042",
      "text": "| 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.) ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 41,
        "window_size": 3,
        "char_count": 36,
        "word_count": 11,
        "page_number": 46,
        "window_text": "| 하는 소프트웨어 의료기기(SaMD)이다.  | - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016).  | 한다.  | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)  | 후에 방문을 하여, 치료 후 평가를 수행한다.  | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.  | 하도록 한다. ",
        "original_sentence": "| 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.) "
      }
    },
    {
      "chunk_id": "chunk_043",
      "text": "| 후에 방문을 하여, 치료 후 평가를 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 42,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 39,
        "window_text": "| - 안전성 자료(Safety Set, SS) | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | 따라 조정될 것이라고 하는 것 | al., 2017, Christensen et al., 2016).  | 한다.  | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)  | 후에 방문을 하여, 치료 후 평가를 수행한다.  | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.  | 하도록 한다.  | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다. ",
        "original_sentence": "| 후에 방문을 하여, 치료 후 평가를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_044",
      "text": "| 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 43,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 44,
        "window_text": "| 한다.  | 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)  | 후에 방문을 하여, 치료 후 평가를 수행한다.  | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.  | 하도록 한다.  | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다.  | 잠만 자야 한다. ",
        "original_sentence": "| 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다. "
      }
    },
    {
      "chunk_id": "chunk_045",
      "text": "| 하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 44,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 44,
        "window_text": "| 시간, 수면의 질, 수면 후 개운함 등이 포함될 수 있다.)  | 후에 방문을 하여, 치료 후 평가를 수행한다.  | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.  | 하도록 한다.  | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다.  | 잠만 자야 한다.  | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18. ",
        "original_sentence": "| 하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_046",
      "text": "| 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 45,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 44,
        "window_text": "| 후에 방문을 하여, 치료 후 평가를 수행한다.  | 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.  | 하도록 한다.  | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다.  | 잠만 자야 한다.  | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18.  사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다. ",
        "original_sentence": "| 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다. "
      }
    },
    {
      "chunk_id": "chunk_047",
      "text": "| 잠만 자야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 46,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 18,
        "window_text": "| 애플리케이션, 이메일, 문자, SNS 등을 통해 수집한다.  | 하도록 한다.  | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다.  | 잠만 자야 한다.  | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18.  사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다.  | 제시한다. ",
        "original_sentence": "| 잠만 자야 한다. "
      }
    },
    {
      "chunk_id": "chunk_048",
      "text": "| 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 47,
        "window_size": 3,
        "char_count": 84,
        "word_count": 25,
        "page_number": 9,
        "window_text": "| 하도록 한다.  | 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다.  | 잠만 자야 한다.  | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18.  사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다.  | 제시한다.  | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341. ",
        "original_sentence": "| 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18. "
      }
    },
    {
      "chunk_id": "chunk_049",
      "text": "사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 48,
        "window_size": 3,
        "char_count": 166,
        "word_count": 49,
        "page_number": 35,
        "window_text": "| 예상되는 경우 | 타당하지 않은 경우 | 식별코드를 부여한다.  | 잠만 자야 한다.  | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18.  사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다.  | 제시한다.  | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341.  | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17. ",
        "original_sentence": "사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다. "
      }
    },
    {
      "chunk_id": "chunk_050",
      "text": "| 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 49,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 44,
        "window_text": "| 잠만 자야 한다.  | 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18.  사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다.  | 제시한다.  | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341.  | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17.  불면 이차 유효성 평가지표 측정 도구 예시 | 1. ",
        "original_sentence": "| 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_051",
      "text": "| (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 50,
        "window_size": 3,
        "char_count": 100,
        "word_count": 25,
        "page_number": 9,
        "window_text": "| 오진, 잘못된 치료 수행 | 국내외 | 이상사례 |\n| 6 | 소프트웨어 | 통합 검증 | 1) 경증(mild) | software | 표 18.  사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다.  | 제시한다.  | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341.  | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17.  불면 이차 유효성 평가지표 측정 도구 예시 | 1.  평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다. ",
        "original_sentence": "| (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341. "
      }
    },
    {
      "chunk_id": "chunk_052",
      "text": "| 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 51,
        "window_size": 3,
        "char_count": 139,
        "word_count": 38,
        "page_number": 7,
        "window_text": "사용자 반응 평가 지표 예시 | Application of risk | 보안 위협에 대하여 적용할 수 있는 | 성별 | □ | 남 | □ | 여 | 가이드’ |\n| 가) 시험기기 | - 주기성 사지운동증이나 수면무호즙증, 기면병 등이 의심되는 경우 | 가이드’ |\n| 사용자의 접근 | 명시한다.  | 제시한다.  | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341.  | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17.  불면 이차 유효성 평가지표 측정 도구 예시 | 1.  평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다.  | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties. ",
        "original_sentence": "| 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17. "
      }
    },
    {
      "chunk_id": "chunk_053",
      "text": "불면 이차 유효성 평가지표 측정 도구 예시 | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 52,
        "window_size": 3,
        "char_count": 29,
        "word_count": 9,
        "page_number": 7,
        "window_text": "| 제시한다.  | (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341.  | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17.  불면 이차 유효성 평가지표 측정 도구 예시 | 1.  평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다.  | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties.  J Consult Clin Psychol. ",
        "original_sentence": "불면 이차 유효성 평가지표 측정 도구 예시 | 1. "
      }
    },
    {
      "chunk_id": "chunk_054",
      "text": "평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 53,
        "window_size": 3,
        "char_count": 68,
        "word_count": 15,
        "page_number": 7,
        "window_text": "| (YY/MM/DD) | therapy plus | (민원인 안내서) | 그래프로 제공하여 수면 질 분석 결과를 제공 | 또는 치료 기회 박탈 |\n| 3(4), 333-341.  | 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17.  불면 이차 유효성 평가지표 측정 도구 예시 | 1.  평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다.  | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties.  J Consult Clin Psychol.  1988 Dec;56(6):893-7. ",
        "original_sentence": "평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_055",
      "text": "| 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 54,
        "window_size": 3,
        "char_count": 42,
        "word_count": 10,
        "page_number": 27,
        "window_text": "| 5) 선행연구 또는 문헌 리뷰를 통한 예상되는 효과 차이(및 표준편차) | ◈ 검사를 실시하였습니까 | □ 예 | □ 아니오 | 등급 | 설명 | 피험자의 정상적인 일상생활(또는 기능)을 저해하지 않고, 최소한의 불편을 야기하며, | 표 17.  불면 이차 유효성 평가지표 측정 도구 예시 | 1.  평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다.  | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties.  J Consult Clin Psychol.  1988 Dec;56(6):893-7.  | 같이 분명한 이유를 기록하여 주십시오. ",
        "original_sentence": "| 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties. "
      }
    },
    {
      "chunk_id": "chunk_056",
      "text": "J Consult Clin Psychol. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 55,
        "window_size": 3,
        "char_count": 24,
        "word_count": 4,
        "page_number": 128,
        "window_text": "불면 이차 유효성 평가지표 측정 도구 예시 | 1.  평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다.  | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties.  J Consult Clin Psychol.  1988 Dec;56(6):893-7.  | 같이 분명한 이유를 기록하여 주십시오.  | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다. ",
        "original_sentence": "J Consult Clin Psychol. "
      }
    },
    {
      "chunk_id": "chunk_057",
      "text": "1988 Dec;56(6):893-7. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 56,
        "window_size": 3,
        "char_count": 22,
        "word_count": 2,
        "page_number": 27,
        "window_text": "평가 불가능 | management for IT-networks | 항목이 의도한 대로 기능을 발휘 | 하는지 확인한다.  | 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties.  J Consult Clin Psychol.  1988 Dec;56(6):893-7.  | 같이 분명한 이유를 기록하여 주십시오.  | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다.  | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021. ",
        "original_sentence": "1988 Dec;56(6):893-7. "
      }
    },
    {
      "chunk_id": "chunk_058",
      "text": "| 같이 분명한 이유를 기록하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 57,
        "window_size": 3,
        "char_count": 24,
        "word_count": 6,
        "page_number": 45,
        "window_text": "| 층화하여 층내 치료군, 위약군 1:1 배정 |\n| properties.  J Consult Clin Psychol.  1988 Dec;56(6):893-7.  | 같이 분명한 이유를 기록하여 주십시오.  | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다.  | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021.  12. ",
        "original_sentence": "| 같이 분명한 이유를 기록하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_059",
      "text": "| 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 58,
        "window_size": 3,
        "char_count": 101,
        "word_count": 28,
        "page_number": 3,
        "window_text": "J Consult Clin Psychol.  1988 Dec;56(6):893-7.  | 같이 분명한 이유를 기록하여 주십시오.  | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다.  | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021.  12.  8. ",
        "original_sentence": "| 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다. "
      }
    },
    {
      "chunk_id": "chunk_060",
      "text": "| 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 59,
        "window_size": 3,
        "char_count": 48,
        "word_count": 12,
        "page_number": 3,
        "window_text": "1988 Dec;56(6):893-7.  | 같이 분명한 이유를 기록하여 주십시오.  | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다.  | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021.  12.  8.  | - 임상시험 중 관찰 항목을 기술한다. ",
        "original_sentence": "| 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021. "
      }
    },
    {
      "chunk_id": "chunk_061",
      "text": "12. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 60,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 1,
        "window_text": "| 같이 분명한 이유를 기록하여 주십시오.  | 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다.  | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021.  12.  8.  | - 임상시험 중 관찰 항목을 기술한다.  | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다. ",
        "original_sentence": "12. "
      }
    },
    {
      "chunk_id": "chunk_062",
      "text": "8. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 61,
        "window_size": 3,
        "char_count": 3,
        "word_count": 1,
        "page_number": 4,
        "window_text": "| 경과일수 | D-28 이내 | DAY1 | - | - | (각각 깼을 때마다 구분하여 표시) | Affective | 데이터 손실 | 상태에서의 걱정이 많고 과각성이 일어난다.  | 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021.  12.  8.  | - 임상시험 중 관찰 항목을 기술한다.  | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다.  | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다. ",
        "original_sentence": "8. "
      }
    },
    {
      "chunk_id": "chunk_063",
      "text": "| - 임상시험 중 관찰 항목을 기술한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 62,
        "window_size": 3,
        "char_count": 24,
        "word_count": 7,
        "page_number": 7,
        "window_text": "| 최소한의 권고사항 등 제시 | 가이드’ |\n| 안내서-1176-01 | 2021.  12.  8.  | - 임상시험 중 관찰 항목을 기술한다.  | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다.  | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다.  | 측정이 가능하다. ",
        "original_sentence": "| - 임상시험 중 관찰 항목을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_064",
      "text": "| 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 63,
        "window_size": 3,
        "char_count": 52,
        "word_count": 13,
        "page_number": 9,
        "window_text": "12.  8.  | - 임상시험 중 관찰 항목을 기술한다.  | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다.  | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다.  | 측정이 가능하다.  | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다. ",
        "original_sentence": "| 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다. "
      }
    },
    {
      "chunk_id": "chunk_065",
      "text": "| 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 64,
        "window_size": 3,
        "char_count": 82,
        "word_count": 20,
        "page_number": 27,
        "window_text": "8.  | - 임상시험 중 관찰 항목을 기술한다.  | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다.  | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다.  | 측정이 가능하다.  | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.  | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다. ",
        "original_sentence": "| 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_066",
      "text": "| 측정이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 65,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 45,
        "window_text": "| - 임상시험 중 관찰 항목을 기술한다.  | 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다.  | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다.  | 측정이 가능하다.  | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.  | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다.  | 해당한다. ",
        "original_sentence": "| 측정이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_067",
      "text": "| - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 66,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 36,
        "window_text": "| 2) 탈락 처리 | 12) 임상시험에 참여함으로써 피험자에게 예상되는 비용 | 설문이다.  | 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다.  | 측정이 가능하다.  | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.  | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다.  | 해당한다.  | 기록지에 내용을 기록한다. ",
        "original_sentence": "| - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_068",
      "text": "| ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 67,
        "window_size": 3,
        "char_count": 73,
        "word_count": 19,
        "page_number": 29,
        "window_text": "| 연번 | 측정 질문 (0∼10점, 시각 아날로그 척도 사용) | 의해 자살 고위험군으로 판단되는 자 | 가이드라인(민원인 안내서)’에 따른다.  | 측정이 가능하다.  | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.  | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다.  | 해당한다.  | 기록지에 내용을 기록한다.  | 이상 분량의 수면 일기를 작성한다. ",
        "original_sentence": "| ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_069",
      "text": "| 해당한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 68,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 33,
        "window_text": "| 측정이 가능하다.  | - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.  | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다.  | 해당한다.  | 기록지에 내용을 기록한다.  | 이상 분량의 수면 일기를 작성한다.  | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다. ",
        "original_sentence": "| 해당한다. "
      }
    },
    {
      "chunk_id": "chunk_070",
      "text": "| 기록지에 내용을 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 69,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 13,
        "window_text": "| - 디지털치료기기에 대한 사용자 반응 평가를 함께 수행한다.  | ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다.  | 해당한다.  | 기록지에 내용을 기록한다.  | 이상 분량의 수면 일기를 작성한다.  | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.  | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2. ",
        "original_sentence": "| 기록지에 내용을 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_071",
      "text": "| 이상 분량의 수면 일기를 작성한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 70,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 17,
        "window_text": "| ※ “예방, 관리”의 범위는 치료적 개입이 필요한 “환자”를 대상으로 함 | 각 변수에 대해 이상치는 별도로 고려하지 않는다.  | 해당한다.  | 기록지에 내용을 기록한다.  | 이상 분량의 수면 일기를 작성한다.  | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.  | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2.  관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1. ",
        "original_sentence": "| 이상 분량의 수면 일기를 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_072",
      "text": "| 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 71,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 35,
        "window_text": "| 해당한다.  | 기록지에 내용을 기록한다.  | 이상 분량의 수면 일기를 작성한다.  | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.  | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2.  관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1.  치료하지 않음 | 1. ",
        "original_sentence": "| 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_073",
      "text": "| 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 72,
        "window_size": 3,
        "char_count": 149,
        "word_count": 28,
        "page_number": 107,
        "window_text": "| 기록지에 내용을 기록한다.  | 이상 분량의 수면 일기를 작성한다.  | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.  | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2.  관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1.  치료하지 않음 | 1.  회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8. ",
        "original_sentence": "| 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2. "
      }
    },
    {
      "chunk_id": "chunk_074",
      "text": "관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 73,
        "window_size": 3,
        "char_count": 72,
        "word_count": 18,
        "page_number": 9,
        "window_text": "| 이상 분량의 수면 일기를 작성한다.  | 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.  | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2.  관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1.  치료하지 않음 | 1.  회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8.  나는 오늘 최종적으로 ＿:＿에 일어났다. ",
        "original_sentence": "관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1. "
      }
    },
    {
      "chunk_id": "chunk_075",
      "text": "치료하지 않음 | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 74,
        "window_size": 3,
        "char_count": 13,
        "word_count": 4,
        "page_number": 27,
        "window_text": "| 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.  | 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2.  관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1.  치료하지 않음 | 1.  회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8.  나는 오늘 최종적으로 ＿:＿에 일어났다.  | 9. ",
        "original_sentence": "치료하지 않음 | 1. "
      }
    },
    {
      "chunk_id": "chunk_076",
      "text": "회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 75,
        "window_size": 3,
        "char_count": 48,
        "word_count": 15,
        "page_number": 9,
        "window_text": "| 타당한 경우 | (사유 :                                                                ) | - 치료에 잘 반응하지 않는 불면증 |\n| 2 | relaxation | 피험자가 쉽게 견딜 수 있는 경우 | 2.  관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1.  치료하지 않음 | 1.  회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8.  나는 오늘 최종적으로 ＿:＿에 일어났다.  | 9.  나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다. ",
        "original_sentence": "회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8. "
      }
    },
    {
      "chunk_id": "chunk_077",
      "text": "나는 오늘 최종적으로 ＿:＿에 일어났다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 76,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 100,
        "window_text": "관련성이 없음 | □ 이상반응 발생 | 소프트웨어가 어떤(what) 기능을, | 어떻게(how) | 수행할 | 것인지에 | 1.  치료하지 않음 | 1.  회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8.  나는 오늘 최종적으로 ＿:＿에 일어났다.  | 9.  나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.  | 10. ",
        "original_sentence": "나는 오늘 최종적으로 ＿:＿에 일어났다. "
      }
    },
    {
      "chunk_id": "chunk_078",
      "text": "| 9. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 77,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 37,
        "window_text": "치료하지 않음 | 1.  회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8.  나는 오늘 최종적으로 ＿:＿에 일어났다.  | 9.  나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.  | 10.  전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다. ",
        "original_sentence": "| 9. "
      }
    },
    {
      "chunk_id": "chunk_079",
      "text": "나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 78,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 100,
        "window_text": "회복 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 해당 |\n| 8.  나는 오늘 최종적으로 ＿:＿에 일어났다.  | 9.  나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.  | 10.  전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다.  | (Oxymeter)를 측정 및 기록 | 표 13. ",
        "original_sentence": "나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다. "
      }
    },
    {
      "chunk_id": "chunk_080",
      "text": "| 10. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 79,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 27,
        "window_text": "나는 오늘 최종적으로 ＿:＿에 일어났다.  | 9.  나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.  | 10.  전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다.  | (Oxymeter)를 측정 및 기록 | 표 13.  위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오. ",
        "original_sentence": "| 10. "
      }
    },
    {
      "chunk_id": "chunk_081",
      "text": "전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 80,
        "window_size": 3,
        "char_count": 67,
        "word_count": 13,
        "page_number": 9,
        "window_text": "| 9.  나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.  | 10.  전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다.  | (Oxymeter)를 측정 및 기록 | 표 13.  위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.  | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다. ",
        "original_sentence": "전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다. "
      }
    },
    {
      "chunk_id": "chunk_082",
      "text": "| (Oxymeter)를 측정 및 기록 | 표 13. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 81,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 27,
        "window_text": "나는 오늘 ＿:＿에 잠자리(침대)에 빠져 나왔다.  | 10.  전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다.  | (Oxymeter)를 측정 및 기록 | 표 13.  위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.  | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다.  | ◈ 검사일(YY/MM/DD) | 1. ",
        "original_sentence": "| (Oxymeter)를 측정 및 기록 | 표 13. "
      }
    },
    {
      "chunk_id": "chunk_083",
      "text": "위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 82,
        "window_size": 3,
        "char_count": 61,
        "word_count": 16,
        "page_number": 3,
        "window_text": "| 10.  전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다.  | (Oxymeter)를 측정 및 기록 | 표 13.  위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.  | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다.  | ◈ 검사일(YY/MM/DD) | 1.  경증 | 의료기기의 사이버 보안 | 표 7. ",
        "original_sentence": "위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_084",
      "text": "| A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 83,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 9,
        "window_text": "전날 밤 수면의 질: | disorder | incorporating medical devices | 매회기 점검한다.  | (Oxymeter)를 측정 및 기록 | 표 13.  위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.  | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다.  | ◈ 검사일(YY/MM/DD) | 1.  경증 | 의료기기의 사이버 보안 | 표 7.  디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1. ",
        "original_sentence": "| A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다. "
      }
    },
    {
      "chunk_id": "chunk_085",
      "text": "| ◈ 검사일(YY/MM/DD) | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 84,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 27,
        "window_text": "| (Oxymeter)를 측정 및 기록 | 표 13.  위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.  | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다.  | ◈ 검사일(YY/MM/DD) | 1.  경증 | 의료기기의 사이버 보안 | 표 7.  디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1.  중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다. ",
        "original_sentence": "| ◈ 검사일(YY/MM/DD) | 1. "
      }
    },
    {
      "chunk_id": "chunk_086",
      "text": "경증 | 의료기기의 사이버 보안 | 표 7. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 85,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 36,
        "window_text": "위험통제 예시 |\n| 1) 대상자군 | 6) 서명은 반드시 시험책임자 혹은 시험 담당자가 서명하여 주십시오.  | A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다.  | ◈ 검사일(YY/MM/DD) | 1.  경증 | 의료기기의 사이버 보안 | 표 7.  디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1.  중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다.  | 5) 시험 방법 | 관여하는 사람을 말한다. ",
        "original_sentence": "경증 | 의료기기의 사이버 보안 | 표 7. "
      }
    },
    {
      "chunk_id": "chunk_087",
      "text": "디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 86,
        "window_size": 3,
        "char_count": 34,
        "word_count": 10,
        "page_number": 27,
        "window_text": "| A등급 | 부상이나 신체적 피해가 발생할 가능성이 없다.  | ◈ 검사일(YY/MM/DD) | 1.  경증 | 의료기기의 사이버 보안 | 표 7.  디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1.  중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다.  | 5) 시험 방법 | 관여하는 사람을 말한다.  | 되어야 한다. ",
        "original_sentence": "디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1. "
      }
    },
    {
      "chunk_id": "chunk_088",
      "text": "중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 87,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 44,
        "window_text": "| ◈ 검사일(YY/MM/DD) | 1.  경증 | 의료기기의 사이버 보안 | 표 7.  디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1.  중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다.  | 5) 시험 방법 | 관여하는 사람을 말한다.  | 되어야 한다.  | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다. ",
        "original_sentence": "중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_089",
      "text": "| 5) 시험 방법 | 관여하는 사람을 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 88,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 35,
        "window_text": "경증 | 의료기기의 사이버 보안 | 표 7.  디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1.  중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다.  | 5) 시험 방법 | 관여하는 사람을 말한다.  | 되어야 한다.  | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.  | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다. ",
        "original_sentence": "| 5) 시험 방법 | 관여하는 사람을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_090",
      "text": "| 되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 89,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 38,
        "window_text": "디지털치료기기 관련 국내외 규격 | 적합성 | 해당 | 1.  중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다.  | 5) 시험 방법 | 관여하는 사람을 말한다.  | 되어야 한다.  | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.  | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다.  | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5. ",
        "original_sentence": "| 되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_091",
      "text": "| 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 90,
        "window_size": 3,
        "char_count": 43,
        "word_count": 11,
        "page_number": 27,
        "window_text": "중대하지 |\n| - 임상시험 후 이상반응 확인에 대해서 기술한다.  | 5) 시험 방법 | 관여하는 사람을 말한다.  | 되어야 한다.  | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.  | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다.  | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5.  진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation. ",
        "original_sentence": "| 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다. "
      }
    },
    {
      "chunk_id": "chunk_092",
      "text": "| 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 91,
        "window_size": 3,
        "char_count": 231,
        "word_count": 56,
        "page_number": 3,
        "window_text": "| 5) 시험 방법 | 관여하는 사람을 말한다.  | 되어야 한다.  | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.  | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다.  | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5.  진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation.  Journal of Consulting and Clinical Psychology, 72(1), 113-120. ",
        "original_sentence": "| 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다. "
      }
    },
    {
      "chunk_id": "chunk_093",
      "text": "| □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 92,
        "window_size": 3,
        "char_count": 31,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| 되어야 한다.  | 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.  | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다.  | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5.  진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation.  Journal of Consulting and Clinical Psychology, 72(1), 113-120.  | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다. ",
        "original_sentence": "| □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5. "
      }
    },
    {
      "chunk_id": "chunk_094",
      "text": "진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 93,
        "window_size": 3,
        "char_count": 64,
        "word_count": 11,
        "page_number": 9,
        "window_text": "| 1 | 나는 디지털치료기기를 통해 불면증에 대한 이해도가 더 증가하였다.  | 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다.  | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5.  진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation.  Journal of Consulting and Clinical Psychology, 72(1), 113-120.  | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다.  | 최소 | 소프트웨어 | 요구사항 | 3. ",
        "original_sentence": "진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation. "
      }
    },
    {
      "chunk_id": "chunk_095",
      "text": "Journal of Consulting and Clinical Psychology, 72(1), 113-120. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 94,
        "window_size": 3,
        "char_count": 63,
        "word_count": 8,
        "page_number": 9,
        "window_text": "| 측정 도구 | 설명 | 사이버보안 필수원칙 | 해당기기 | 적용여부 | technique) | 2) 중증도(moderate) | □ 법령(법ㆍ시행령ㆍ시행규칙) 또는 행정규칙(고시ㆍ훈령ㆍ예 | - 직업적으로 불면증이 위험을 초래할 수 있는 경우(직업운전사 등) | 2 | E06070.01 | 의료기기 사이버 보안 적용 방법과 허가 | 적용 | 성능 | 시험 | 네트워크로 연결되는 | 허용 가능함을 검증한다.  | □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5.  진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation.  Journal of Consulting and Clinical Psychology, 72(1), 113-120.  | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다.  | 최소 | 소프트웨어 | 요구사항 | 3.  관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1. ",
        "original_sentence": "Journal of Consulting and Clinical Psychology, 72(1), 113-120. "
      }
    },
    {
      "chunk_id": "chunk_096",
      "text": "| 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 95,
        "window_size": 3,
        "char_count": 55,
        "word_count": 18,
        "page_number": 9,
        "window_text": "| □ 예 | ■ 아니오 | 내원 또는 |\n| 표 5.  진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation.  Journal of Consulting and Clinical Psychology, 72(1), 113-120.  | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다.  | 최소 | 소프트웨어 | 요구사항 | 3.  관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1.  검사진행 | 2. ",
        "original_sentence": "| 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_097",
      "text": "| 최소 | 소프트웨어 | 요구사항 | 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 96,
        "window_size": 3,
        "char_count": 25,
        "word_count": 8,
        "page_number": 3,
        "window_text": "진료지침별 불면증 인지행동치료(CBT-I)의 권고 등급 및 근거 수준 | controlled evaluation.  Journal of Consulting and Clinical Psychology, 72(1), 113-120.  | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다.  | 최소 | 소프트웨어 | 요구사항 | 3.  관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1.  검사진행 | 2.  약물치료 | 2. ",
        "original_sentence": "| 최소 | 소프트웨어 | 요구사항 | 3. "
      }
    },
    {
      "chunk_id": "chunk_098",
      "text": "관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 97,
        "window_size": 3,
        "char_count": 70,
        "word_count": 11,
        "page_number": 64,
        "window_text": "Journal of Consulting and Clinical Psychology, 72(1), 113-120.  | 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다.  | 최소 | 소프트웨어 | 요구사항 | 3.  관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1.  검사진행 | 2.  약물치료 | 2.  진행중 |\n| 소프트웨어 | normative data for adults of working age. ",
        "original_sentence": "관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1. "
      }
    },
    {
      "chunk_id": "chunk_099",
      "text": "검사진행 | 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 98,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 9,
        "window_text": "| 2) 국내 가이드라인별 적용 기준 | ◈ 과거력 | 무결성 검증 및 대응 | 수집할 수 있다.  | 최소 | 소프트웨어 | 요구사항 | 3.  관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1.  검사진행 | 2.  약물치료 | 2.  진행중 |\n| 소프트웨어 | normative data for adults of working age.  BMJ (Clinical research ed.",
        "original_sentence": "검사진행 | 2. "
      }
    },
    {
      "chunk_id": "chunk_100",
      "text": "약물치료 | 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 99,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 9,
        "window_text": "| 최소 | 소프트웨어 | 요구사항 | 3.  관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1.  검사진행 | 2.  약물치료 | 2.  진행중 |\n| 소프트웨어 | normative data for adults of working age.  BMJ (Clinical research ed. ), 306(6890), 1437–1440. ",
        "original_sentence": "약물치료 | 2. "
      }
    },
    {
      "chunk_id": "chunk_101",
      "text": "진행중 |\n| 소프트웨어 | normative data for adults of working age. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 100,
        "window_size": 3,
        "char_count": 58,
        "word_count": 12,
        "page_number": 9,
        "window_text": "관련성이 적음 | IDS(Inventory of Depressive Symptomatology)에서 DSM-5 상의 | 1.  검사진행 | 2.  약물치료 | 2.  진행중 |\n| 소프트웨어 | normative data for adults of working age.  BMJ (Clinical research ed. ), 306(6890), 1437–1440.  | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다. ",
        "original_sentence": "진행중 |\n| 소프트웨어 | normative data for adults of working age. "
      }
    },
    {
      "chunk_id": "chunk_102",
      "text": "BMJ (Clinical research ed.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 101,
        "window_size": 3,
        "char_count": 26,
        "word_count": 4,
        "page_number": 128,
        "window_text": "검사진행 | 2.  약물치료 | 2.  진행중 |\n| 소프트웨어 | normative data for adults of working age.  BMJ (Clinical research ed. ), 306(6890), 1437–1440.  | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다.  | 반드시 필요한 것은 아니며 행정상 변경이 필요하다. ",
        "original_sentence": "BMJ (Clinical research ed."
      }
    },
    {
      "chunk_id": "chunk_103",
      "text": "), 306(6890), 1437–1440. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 102,
        "window_size": 3,
        "char_count": 25,
        "word_count": 3,
        "page_number": 27,
        "window_text": "약물치료 | 2.  진행중 |\n| 소프트웨어 | normative data for adults of working age.  BMJ (Clinical research ed. ), 306(6890), 1437–1440.  | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다.  | 반드시 필요한 것은 아니며 행정상 변경이 필요하다.  | 사용여부 등을 체크리스트를 이용하여 기술한다. ",
        "original_sentence": "), 306(6890), 1437–1440. "
      }
    },
    {
      "chunk_id": "chunk_104",
      "text": "| 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 103,
        "window_size": 3,
        "char_count": 98,
        "word_count": 30,
        "page_number": 3,
        "window_text": "진행중 |\n| 소프트웨어 | normative data for adults of working age.  BMJ (Clinical research ed. ), 306(6890), 1437–1440.  | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다.  | 반드시 필요한 것은 아니며 행정상 변경이 필요하다.  | 사용여부 등을 체크리스트를 이용하여 기술한다.  | 하나이다. ",
        "original_sentence": "| 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다. "
      }
    },
    {
      "chunk_id": "chunk_105",
      "text": "| 반드시 필요한 것은 아니며 행정상 변경이 필요하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 104,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 14,
        "window_text": "BMJ (Clinical research ed. ), 306(6890), 1437–1440.  | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다.  | 반드시 필요한 것은 아니며 행정상 변경이 필요하다.  | 사용여부 등을 체크리스트를 이용하여 기술한다.  | 하나이다.  | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다. ",
        "original_sentence": "| 반드시 필요한 것은 아니며 행정상 변경이 필요하다. "
      }
    },
    {
      "chunk_id": "chunk_106",
      "text": "| 사용여부 등을 체크리스트를 이용하여 기술한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 105,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 3,
        "window_text": "), 306(6890), 1437–1440.  | 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다.  | 반드시 필요한 것은 아니며 행정상 변경이 필요하다.  | 사용여부 등을 체크리스트를 이용하여 기술한다.  | 하나이다.  | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다.  | 전면 파기한다. ",
        "original_sentence": "| 사용여부 등을 체크리스트를 이용하여 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_107",
      "text": "| 하나이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 106,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 45,
        "window_text": "| 7 | IEC/TR | 5 | 2) 사이버 보안 요구사항 | 6) 하위 분석 | 아) 병용 약물 조사 | 나) 이상반응 확인 | 필요시 의료진 연결이 가능하도록 조치한다.  | 반드시 필요한 것은 아니며 행정상 변경이 필요하다.  | 사용여부 등을 체크리스트를 이용하여 기술한다.  | 하나이다.  | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다.  | 전면 파기한다.  | QIDS | 평가한다. ",
        "original_sentence": "| 하나이다. "
      }
    },
    {
      "chunk_id": "chunk_108",
      "text": "| 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 107,
        "window_size": 3,
        "char_count": 58,
        "word_count": 19,
        "page_number": 40,
        "window_text": "| 반드시 필요한 것은 아니며 행정상 변경이 필요하다.  | 사용여부 등을 체크리스트를 이용하여 기술한다.  | 하나이다.  | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다.  | 전면 파기한다.  | QIDS | 평가한다.  | 적용방법 및 사례집 | 30%로 정하고자 한다. ",
        "original_sentence": "| 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_109",
      "text": "| 전면 파기한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 108,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 44,
        "window_text": "| 사용여부 등을 체크리스트를 이용하여 기술한다.  | 하나이다.  | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다.  | 전면 파기한다.  | QIDS | 평가한다.  | 적용방법 및 사례집 | 30%로 정하고자 한다.  | 그림 3. ",
        "original_sentence": "| 전면 파기한다. "
      }
    },
    {
      "chunk_id": "chunk_110",
      "text": "| QIDS | 평가한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 109,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| 하나이다.  | 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다.  | 전면 파기한다.  | QIDS | 평가한다.  | 적용방법 및 사례집 | 30%로 정하고자 한다.  | 그림 3.  데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다. ",
        "original_sentence": "| QIDS | 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_111",
      "text": "| 적용방법 및 사례집 | 30%로 정하고자 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 110,
        "window_size": 3,
        "char_count": 29,
        "word_count": 8,
        "page_number": 28,
        "window_text": "| 관찰형태 | 내원 | 내원과 | - 삶의 질 | 좋은 수면과 관련된 환경 및 생활 습관을 의미한다.  | 전면 파기한다.  | QIDS | 평가한다.  | 적용방법 및 사례집 | 30%로 정하고자 한다.  | 그림 3.  데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.  | 관리에 관한 규정 제2조) | 받은 자 | 2. ",
        "original_sentence": "| 적용방법 및 사례집 | 30%로 정하고자 한다. "
      }
    },
    {
      "chunk_id": "chunk_112",
      "text": "| 그림 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 111,
        "window_size": 3,
        "char_count": 8,
        "word_count": 3,
        "page_number": 28,
        "window_text": "| 전면 파기한다.  | QIDS | 평가한다.  | 적용방법 및 사례집 | 30%로 정하고자 한다.  | 그림 3.  데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.  | 관리에 관한 규정 제2조) | 받은 자 | 2.  중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까? ",
        "original_sentence": "| 그림 3. "
      }
    },
    {
      "chunk_id": "chunk_113",
      "text": "데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 112,
        "window_size": 3,
        "char_count": 137,
        "word_count": 38,
        "page_number": 9,
        "window_text": "| QIDS | 평가한다.  | 적용방법 및 사례집 | 30%로 정하고자 한다.  | 그림 3.  데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.  | 관리에 관한 규정 제2조) | 받은 자 | 2.  중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까?  | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다. ",
        "original_sentence": "데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_114",
      "text": "| 관리에 관한 규정 제2조) | 받은 자 | 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 113,
        "window_size": 3,
        "char_count": 29,
        "word_count": 10,
        "page_number": 5,
        "window_text": "| 적용방법 및 사례집 | 30%로 정하고자 한다.  | 그림 3.  데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.  | 관리에 관한 규정 제2조) | 받은 자 | 2.  중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까?  | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.  | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4. ",
        "original_sentence": "| 관리에 관한 규정 제2조) | 받은 자 | 2. "
      }
    },
    {
      "chunk_id": "chunk_115",
      "text": "중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 114,
        "window_size": 3,
        "char_count": 79,
        "word_count": 19,
        "page_number": 45,
        "window_text": "| 그림 3.  데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.  | 관리에 관한 규정 제2조) | 받은 자 | 2.  중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까?  | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.  | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4.  관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다. ",
        "original_sentence": "중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_116",
      "text": "| OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 115,
        "window_size": 3,
        "char_count": 156,
        "word_count": 47,
        "page_number": 9,
        "window_text": "데이터 보호 및 보안성 영역 연구의 흐름 | therapy | –Part 2-2: Guidance for the | 입증 | 방법 | 내원과 | 법규 및 | 국내 |\n| 1 | 시험군과 대조군간의 비교 분석 방법을 통계적으로 타당하게 제시한다.  | 관리에 관한 규정 제2조) | 받은 자 | 2.  중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까?  | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.  | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4.  관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다.  | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2. ",
        "original_sentence": "| OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_117",
      "text": "| - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 116,
        "window_size": 3,
        "char_count": 73,
        "word_count": 21,
        "page_number": 7,
        "window_text": "| 관리에 관한 규정 제2조) | 받은 자 | 2.  중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까?  | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.  | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4.  관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다.  | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2.  검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3. ",
        "original_sentence": "| - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4. "
      }
    },
    {
      "chunk_id": "chunk_118",
      "text": "관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 117,
        "window_size": 3,
        "char_count": 58,
        "word_count": 15,
        "page_number": 9,
        "window_text": "중등 | 피험자의 정상적인 일상생활(또는 기능)을 유의하게 저해하는 불편을 야기하는 경우 | 규)의 내용을 단순 편집 또는 나열한 것입니까?  | OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.  | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4.  관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다.  | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2.  검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3.  비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3. ",
        "original_sentence": "관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다. "
      }
    },
    {
      "chunk_id": "chunk_119",
      "text": "| 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 118,
        "window_size": 3,
        "char_count": 49,
        "word_count": 17,
        "page_number": 9,
        "window_text": "| OO초 미만일 것 | 잔여위험평가 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 위험/ | 이득 | 분석 | 애플리케이션, | 추가 | 발생 | 위험 | 않음 |\n| 2 | 위험통제 | 2 | 나는 다시 불면증이 심해지면, 이 디지털치료기기를 사용할 것이다.  | - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4.  관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다.  | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2.  검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3.  비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3.  후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다. ",
        "original_sentence": "| 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2. "
      }
    },
    {
      "chunk_id": "chunk_120",
      "text": "검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 119,
        "window_size": 3,
        "char_count": 45,
        "word_count": 13,
        "page_number": 28,
        "window_text": "| - 모델명: ○○○ | - 객관적인 수면지표와 주관적인 불면증 사이에 큰 차이가 있을 것으로 | 위험통제 | 조치실행 | 4.  관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다.  | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2.  검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3.  비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3.  후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.  | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다. ",
        "original_sentence": "검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3. "
      }
    },
    {
      "chunk_id": "chunk_121",
      "text": "비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 120,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 9,
        "window_text": "관련성이 의심됨 | 대하여 소프트웨어가 수행할 수 | 있는 논리적이고 물리적인 표현 | 으로 정의한다.  | 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2.  검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3.  비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3.  후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.  | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다.  | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3. ",
        "original_sentence": "비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3. "
      }
    },
    {
      "chunk_id": "chunk_122",
      "text": "후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 121,
        "window_size": 3,
        "char_count": 54,
        "word_count": 15,
        "page_number": 35,
        "window_text": "| 통제 | 완료 | 발생 | 가능성 | 심각성 | 위험도 | 이상반응 서식지 | 2.  검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3.  비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3.  후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.  | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다.  | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3.  중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2. ",
        "original_sentence": "후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다. "
      }
    },
    {
      "chunk_id": "chunk_123",
      "text": "| (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 122,
        "window_size": 3,
        "char_count": 84,
        "word_count": 19,
        "page_number": 46,
        "window_text": "검사중지 | 애플리케이션 | 신청 시 제출하는 자료의 작성 예시를 제시 | 3.  비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3.  후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.  | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다.  | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3.  중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2.  중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
        "original_sentence": "| (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다. "
      }
    },
    {
      "chunk_id": "chunk_124",
      "text": "| 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 123,
        "window_size": 3,
        "char_count": 279,
        "word_count": 84,
        "page_number": 46,
        "window_text": "비약물치료 | 소프트웨어를 포함 | 의료기기의 위험관리 | 애플리케이션 | 3.  후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.  | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다.  | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3.  중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2.  중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다. ",
        "original_sentence": "| 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3. "
      }
    },
    {
      "chunk_id": "chunk_125",
      "text": "중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 124,
        "window_size": 3,
        "char_count": 70,
        "word_count": 19,
        "page_number": 9,
        "window_text": "후유증 | 또는 | 국외 |\n| - 공동연구자는 의학통계 전문가, 의료기기 전문가 등을 말한다.  | (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다.  | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3.  중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2.  중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다.  |\n| 표 6. ",
        "original_sentence": "중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2. "
      }
    },
    {
      "chunk_id": "chunk_126",
      "text": "중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 125,
        "window_size": 3,
        "char_count": 158,
        "word_count": 50,
        "page_number": 3,
        "window_text": "| (Quick Inventory of | - 시험군: 디지털 불면증 인지행동치료군 | B등급 | 심각하지 않은 부상(경상)이 발생할 가능성이 있다.  | 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3.  중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2.  중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다.  |\n| 표 6.  국외 불면증 개선 디지털치료기기 허가 제품 동향(2021. ",
        "original_sentence": "중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_127",
      "text": "| □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 126,
        "window_size": 3,
        "char_count": 51,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 수면 효율 | 응답시간 | 과거력 | □ | 있 음 (page | 에 기입) | □ | 없 음 | (매우 나쁨) | (보통) | (매우 좋음) | 3) 중증(severe) | 소프트웨어 | □ 중대한 계획서 위반 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율 | 주요 우울장애 진단기준에 해당되는 16개의 항목만을 간추린 | 입력한 후 그에 대한 응답시간을 측정 | 결과 | 규격 |\n| 가) 스크리닝, 선정·제외 기준 확인 | 기밀성 및 무결성 보장 | 80001-2-2 | 3.  중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2.  중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다.  |\n| 표 6.  국외 불면증 개선 디지털치료기기 허가 제품 동향(2021.  06. ",
        "original_sentence": "| □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_128",
      "text": "|\n| 표 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 127,
        "window_size": 3,
        "char_count": 9,
        "word_count": 4,
        "page_number": 36,
        "window_text": "중증 | (민원인 안내서) | software | disclosure and | 적용 | 성능 | 시험 | 가이드’ | 2.  중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다.  |\n| 표 6.  국외 불면증 개선 디지털치료기기 허가 제품 동향(2021.  06.  기준) | activity impairment instrument. ",
        "original_sentence": "|\n| 표 6. "
      }
    },
    {
      "chunk_id": "chunk_129",
      "text": "국외 불면증 개선 디지털치료기기 허가 제품 동향(2021. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 128,
        "window_size": 3,
        "char_count": 33,
        "word_count": 7,
        "page_number": 1,
        "window_text": "중대함 |\n| 등록대상 | 가) 디지털치료기기 허가·심사 가이드라인(민원인 안내서) | 나) 위험평가 | 조치 | 진료지침 | 권고등급 | 근거 수준 | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | □ 단순한 사실을 대외적으로 알리는 공고의 내용입니까?  | □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다.  |\n| 표 6.  국외 불면증 개선 디지털치료기기 허가 제품 동향(2021.  06.  기준) | activity impairment instrument.  Pharmacoeconomics. ",
        "original_sentence": "국외 불면증 개선 디지털치료기기 허가 제품 동향(2021. "
      }
    },
    {
      "chunk_id": "chunk_130",
      "text": "06. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 129,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 27,
        "window_text": "| □ 예 | ■ 아니오 | 전체 소프트웨어 시스템이 요구 | 사항을 충족하는지 확인한다.  |\n| 표 6.  국외 불면증 개선 디지털치료기기 허가 제품 동향(2021.  06.  기준) | activity impairment instrument.  Pharmacoeconomics.  1993 Nov;4(5):353-65. ",
        "original_sentence": "06. "
      }
    },
    {
      "chunk_id": "chunk_131",
      "text": "기준) | activity impairment instrument. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 130,
        "window_size": 3,
        "char_count": 38,
        "word_count": 5,
        "page_number": 1,
        "window_text": "|\n| 표 6.  국외 불면증 개선 디지털치료기기 허가 제품 동향(2021.  06.  기준) | activity impairment instrument.  Pharmacoeconomics.  1993 Nov;4(5):353-65.  | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다. ",
        "original_sentence": "기준) | activity impairment instrument. "
      }
    },
    {
      "chunk_id": "chunk_132",
      "text": "Pharmacoeconomics. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 131,
        "window_size": 3,
        "char_count": 19,
        "word_count": 1,
        "page_number": 128,
        "window_text": "국외 불면증 개선 디지털치료기기 허가 제품 동향(2021.  06.  기준) | activity impairment instrument.  Pharmacoeconomics.  1993 Nov;4(5):353-65.  | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.  | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다. ",
        "original_sentence": "Pharmacoeconomics. "
      }
    },
    {
      "chunk_id": "chunk_133",
      "text": "1993 Nov;4(5):353-65. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 132,
        "window_size": 3,
        "char_count": 22,
        "word_count": 2,
        "page_number": 27,
        "window_text": "06.  기준) | activity impairment instrument.  Pharmacoeconomics.  1993 Nov;4(5):353-65.  | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.  | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.  | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다. ",
        "original_sentence": "1993 Nov;4(5):353-65. "
      }
    },
    {
      "chunk_id": "chunk_134",
      "text": "| 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 133,
        "window_size": 3,
        "char_count": 40,
        "word_count": 12,
        "page_number": 11,
        "window_text": "기준) | activity impairment instrument.  Pharmacoeconomics.  1993 Nov;4(5):353-65.  | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.  | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.  | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.  | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다. ",
        "original_sentence": "| 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다. "
      }
    },
    {
      "chunk_id": "chunk_135",
      "text": "| 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 134,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 44,
        "window_text": "Pharmacoeconomics.  1993 Nov;4(5):353-65.  | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.  | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.  | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.  | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다.  | 자료보관(연구파일) 등을 확인한다. ",
        "original_sentence": "| 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_136",
      "text": "| (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 135,
        "window_size": 3,
        "char_count": 66,
        "word_count": 15,
        "page_number": 18,
        "window_text": "1993 Nov;4(5):353-65.  | 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.  | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.  | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.  | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다.  | 자료보관(연구파일) 등을 확인한다.  | 포함된다. ",
        "original_sentence": "| (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_137",
      "text": "| 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 136,
        "window_size": 3,
        "char_count": 42,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| 7 | 잠자리에 누운 시간 대비 실제 수면을 취한 시간의 비율이다.  | 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.  | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.  | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다.  | 자료보관(연구파일) 등을 확인한다.  | 포함된다.  | 비교 분석하여 유효성에 대한 검증을 수행한다. ",
        "original_sentence": "| 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_138",
      "text": "| 자료보관(연구파일) 등을 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 137,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| 사유와 관련 임상자료의 처리 방법을 ‘탈락 처리’에 구체적으로 제시한다.  | (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.  | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다.  | 자료보관(연구파일) 등을 확인한다.  | 포함된다.  | 비교 분석하여 유효성에 대한 검증을 수행한다.  | 분석한다. ",
        "original_sentence": "| 자료보관(연구파일) 등을 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_139",
      "text": "| 포함된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 138,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 8,
        "window_text": "| (Sleep efficiency) | 3 | 나는 내 주변의 불면증 환자에게, 이 디지털치료기기를 추천할 것이다.  | 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다.  | 자료보관(연구파일) 등을 확인한다.  | 포함된다.  | 비교 분석하여 유효성에 대한 검증을 수행한다.  | 분석한다.  | 경우를 말한다. ",
        "original_sentence": "| 포함된다. "
      }
    },
    {
      "chunk_id": "chunk_140",
      "text": "| 비교 분석하여 유효성에 대한 검증을 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 139,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 39,
        "window_text": "| 행동치료가 있을 경우* | 고지와 관련된 모든 사항을 문서화해야 한다.  | 자료보관(연구파일) 등을 확인한다.  | 포함된다.  | 비교 분석하여 유효성에 대한 검증을 수행한다.  | 분석한다.  | 경우를 말한다.  | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다. ",
        "original_sentence": "| 비교 분석하여 유효성에 대한 검증을 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_141",
      "text": "| 분석한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 140,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 44,
        "window_text": "| 자료보관(연구파일) 등을 확인한다.  | 포함된다.  | 비교 분석하여 유효성에 대한 검증을 수행한다.  | 분석한다.  | 경우를 말한다.  | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다.  | - 외래 방문마다 병용 약물을 수집하여 기록한다. ",
        "original_sentence": "| 분석한다. "
      }
    },
    {
      "chunk_id": "chunk_142",
      "text": "| 경우를 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 141,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 44,
        "window_text": "| 포함된다.  | 비교 분석하여 유효성에 대한 검증을 수행한다.  | 분석한다.  | 경우를 말한다.  | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다.  | - 외래 방문마다 병용 약물을 수집하여 기록한다.  | Depressive | 치료기기라고 판단할 수 있다. ",
        "original_sentence": "| 경우를 말한다. "
      }
    },
    {
      "chunk_id": "chunk_143",
      "text": "| (3) 피험자 식별코드는 아래의 방법에 따라 기입한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 142,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 28,
        "window_text": "| 비교 분석하여 유효성에 대한 검증을 수행한다.  | 분석한다.  | 경우를 말한다.  | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다.  | - 외래 방문마다 병용 약물을 수집하여 기록한다.  | Depressive | 치료기기라고 판단할 수 있다.  | 내용을 기록한다. ",
        "original_sentence": "| (3) 피험자 식별코드는 아래의 방법에 따라 기입한다. "
      }
    },
    {
      "chunk_id": "chunk_144",
      "text": "| - 외래 방문마다 병용 약물을 수집하여 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 143,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 44,
        "window_text": "| 분석한다.  | 경우를 말한다.  | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다.  | - 외래 방문마다 병용 약물을 수집하여 기록한다.  | Depressive | 치료기기라고 판단할 수 있다.  | 내용을 기록한다.  | : 일차 유효성 평가변수와 동일한 방법을 적용한다. ",
        "original_sentence": "| - 외래 방문마다 병용 약물을 수집하여 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_145",
      "text": "| Depressive | 치료기기라고 판단할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 144,
        "window_size": 3,
        "char_count": 32,
        "word_count": 7,
        "page_number": 30,
        "window_text": "| 경우를 말한다.  | (3) 피험자 식별코드는 아래의 방법에 따라 기입한다.  | - 외래 방문마다 병용 약물을 수집하여 기록한다.  | Depressive | 치료기기라고 판단할 수 있다.  | 내용을 기록한다.  | : 일차 유효성 평가변수와 동일한 방법을 적용한다.  | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5. ",
        "original_sentence": "| Depressive | 치료기기라고 판단할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_146",
      "text": "| 내용을 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 145,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| (3) 피험자 식별코드는 아래의 방법에 따라 기입한다.  | - 외래 방문마다 병용 약물을 수집하여 기록한다.  | Depressive | 치료기기라고 판단할 수 있다.  | 내용을 기록한다.  | : 일차 유효성 평가변수와 동일한 방법을 적용한다.  | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5.  관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4. ",
        "original_sentence": "| 내용을 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_147",
      "text": "| : 일차 유효성 평가변수와 동일한 방법을 적용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 146,
        "window_size": 3,
        "char_count": 31,
        "word_count": 8,
        "page_number": 7,
        "window_text": "| - 외래 방문마다 병용 약물을 수집하여 기록한다.  | Depressive | 치료기기라고 판단할 수 있다.  | 내용을 기록한다.  | : 일차 유효성 평가변수와 동일한 방법을 적용한다.  | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5.  관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4.  국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4. ",
        "original_sentence": "| : 일차 유효성 평가변수와 동일한 방법을 적용한다. "
      }
    },
    {
      "chunk_id": "chunk_148",
      "text": "| 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 147,
        "window_size": 3,
        "char_count": 63,
        "word_count": 16,
        "page_number": 41,
        "window_text": "| Depressive | 치료기기라고 판단할 수 있다.  | 내용을 기록한다.  | : 일차 유효성 평가변수와 동일한 방법을 적용한다.  | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5.  관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4.  국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4.  수술적치료 | 방법에 대한 국제 규격 | 4. ",
        "original_sentence": "| 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5. "
      }
    },
    {
      "chunk_id": "chunk_149",
      "text": "관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 148,
        "window_size": 3,
        "char_count": 41,
        "word_count": 14,
        "page_number": 14,
        "window_text": "| 내용을 기록한다.  | : 일차 유효성 평가변수와 동일한 방법을 적용한다.  | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5.  관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4.  국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4.  수술적치료 | 방법에 대한 국제 규격 | 4.  사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도. ",
        "original_sentence": "관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4. "
      }
    },
    {
      "chunk_id": "chunk_150",
      "text": "국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 149,
        "window_size": 3,
        "char_count": 48,
        "word_count": 15,
        "page_number": 28,
        "window_text": "| : 일차 유효성 평가변수와 동일한 방법을 적용한다.  | 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5.  관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4.  국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4.  수술적치료 | 방법에 대한 국제 규격 | 4.  사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도.  각각의 항목은 0점에서 3점까지 |\n| mediation analysis. ",
        "original_sentence": "국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4. "
      }
    },
    {
      "chunk_id": "chunk_151",
      "text": "수술적치료 | 방법에 대한 국제 규격 | 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 150,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 35,
        "window_text": "| 더욱 개연성이 있게 설명되는 경우 | 피험자의 정상적인 일상생활(또는 기능)을 불가능하게 하는 경우 | 5.  관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4.  국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4.  수술적치료 | 방법에 대한 국제 규격 | 4.  사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도.  각각의 항목은 0점에서 3점까지 |\n| mediation analysis.  The Lancet Psychiatry, 4(10), 749-758. ",
        "original_sentence": "수술적치료 | 방법에 대한 국제 규격 | 4. "
      }
    },
    {
      "chunk_id": "chunk_152",
      "text": "사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 151,
        "window_size": 3,
        "char_count": 181,
        "word_count": 37,
        "page_number": 9,
        "window_text": "관련성이 많음 | 시스템 | 검증 | 정의 | 의심되는 경우 | 표 4.  국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4.  수술적치료 | 방법에 대한 국제 규격 | 4.  사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도.  각각의 항목은 0점에서 3점까지 |\n| mediation analysis.  The Lancet Psychiatry, 4(10), 749-758.  | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11. ",
        "original_sentence": "사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도. "
      }
    },
    {
      "chunk_id": "chunk_153",
      "text": "각각의 항목은 0점에서 3점까지 |\n| mediation analysis. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 152,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 7,
        "window_text": "국내 불면증에 사용되는 약물 | 증례 기록서 수정 방법 | 치료 효과를 꾀함 | 4.  수술적치료 | 방법에 대한 국제 규격 | 4.  사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도.  각각의 항목은 0점에서 3점까지 |\n| mediation analysis.  The Lancet Psychiatry, 4(10), 749-758.  | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11.  잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다. ",
        "original_sentence": "각각의 항목은 0점에서 3점까지 |\n| mediation analysis. "
      }
    },
    {
      "chunk_id": "chunk_154",
      "text": "The Lancet Psychiatry, 4(10), 749-758. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 153,
        "window_size": 3,
        "char_count": 39,
        "word_count": 5,
        "page_number": 27,
        "window_text": "수술적치료 | 방법에 대한 국제 규격 | 4.  사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도.  각각의 항목은 0점에서 3점까지 |\n| mediation analysis.  The Lancet Psychiatry, 4(10), 749-758.  | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11.  잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다.  | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6. ",
        "original_sentence": "The Lancet Psychiatry, 4(10), 749-758. "
      }
    },
    {
      "chunk_id": "chunk_155",
      "text": "| 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 154,
        "window_size": 3,
        "char_count": 59,
        "word_count": 23,
        "page_number": 132,
        "window_text": "사망 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3) 불면증 심각도 척도(ISI)에서 8점 이상을 만족하는 자 | (구체적 내용: _____________________________________) | Medical devices | (총 수면시간 대비 총 침상시간) | 단축형 우울증상 평가척도.  각각의 항목은 0점에서 3점까지 |\n| mediation analysis.  The Lancet Psychiatry, 4(10), 749-758.  | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11.  잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다.  | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6.  관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15. ",
        "original_sentence": "| 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11. "
      }
    },
    {
      "chunk_id": "chunk_156",
      "text": "잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 155,
        "window_size": 3,
        "char_count": 303,
        "word_count": 74,
        "page_number": 49,
        "window_text": "각각의 항목은 0점에서 3점까지 |\n| mediation analysis.  The Lancet Psychiatry, 4(10), 749-758.  | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11.  잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다.  | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6.  관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15.  의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점. ",
        "original_sentence": "잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다. "
      }
    },
    {
      "chunk_id": "chunk_157",
      "text": "| 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 156,
        "window_size": 3,
        "char_count": 47,
        "word_count": 16,
        "page_number": 9,
        "window_text": "The Lancet Psychiatry, 4(10), 749-758.  | 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11.  잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다.  | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6.  관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15.  의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점.  총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다. ",
        "original_sentence": "| 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6. "
      }
    },
    {
      "chunk_id": "chunk_158",
      "text": "관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 157,
        "window_size": 3,
        "char_count": 171,
        "word_count": 47,
        "page_number": 46,
        "window_text": "| 병용 약물 서식 | □ | 있 음 (page | 에 기입) | □ | 없 음 | 연구 참여 | 11.  잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다.  | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6.  관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15.  의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점.  총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다.  | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다. ",
        "original_sentence": "관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15. "
      }
    },
    {
      "chunk_id": "chunk_159",
      "text": "의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 158,
        "window_size": 3,
        "char_count": 180,
        "word_count": 45,
        "page_number": 9,
        "window_text": "잠에서 깨었을 때 개운함의 정도: | - 제조회사: ㈜○○○ | Off-The-Shelf Software Use | (출처: bighealth 홈페이지) | communication of medical | 의료기기에서의 | 기성품 | 소프트웨어 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 시험기기 및 대조기기 정보 | 여부 | - 대조군: 디지털 불면증 위약군(sham군) | Symptomatology) | 동의서 취득 | O | - | - | - | C등급 | 심각한 부상 또는 사망이 발생할 가능성이 있다.  | 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6.  관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15.  의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점.  총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다.  | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.  | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다). ",
        "original_sentence": "의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점. "
      }
    },
    {
      "chunk_id": "chunk_160",
      "text": "총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 159,
        "window_size": 3,
        "char_count": 70,
        "word_count": 19,
        "page_number": 7,
        "window_text": "| 소프트웨어 | 검증 자료로 | 접근통제 및 | 인증 기능 | 구현 확인 | 6.  관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15.  의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점.  총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다.  | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.  | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다).  | 기재한다. ",
        "original_sentence": "총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다. "
      }
    },
    {
      "chunk_id": "chunk_161",
      "text": "| 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 160,
        "window_size": 3,
        "char_count": 82,
        "word_count": 22,
        "page_number": 20,
        "window_text": "관련성이 명백함 | App memory size는 최소 | 적용 | 성능 | 시험 | 의료기기 품질관리 |\n| 6 | 1) 근거 자료/문서의 직접 열람 | ACP 진료지침(2016) | Strong | Moderate | 나) 이상반응 확인 | (매우 불만족) | (보통) | (매우 만족) | 표 15.  의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점.  총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다.  | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.  | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다).  | 기재한다.  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1. ",
        "original_sentence": "| 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_162",
      "text": "| - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 161,
        "window_size": 3,
        "char_count": 55,
        "word_count": 15,
        "page_number": 36,
        "window_text": "의료기기 사이버 보안 안전성 등급 분류 | 사용에 대한 가이던스 | 미국 | 가이드’ |\n| 2 | 메모리 크기 | 총 침상시간 | (Time in bed) | 잠자리에서 보낸 총 시간 | [https://www.bighealth.com/ | 종류 | 주로 사용되는 용량 | –Quality management | 채점.  총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다.  | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.  | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다).  | 기재한다.  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1.  관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다. ",
        "original_sentence": "| - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다). "
      }
    },
    {
      "chunk_id": "chunk_163",
      "text": "| 기재한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 162,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 44,
        "window_text": "총점의 범위는 0점에서 27점 | 적용 | 성능 | 시험 |\n| 2) 일차 유효성 평가변수 | 웨어 의료기기(SaMD)이다.  | 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.  | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다).  | 기재한다.  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1.  관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다.  | 따라 스크리닝 번호를 부여한다. ",
        "original_sentence": "| 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_164",
      "text": "| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 163,
        "window_size": 3,
        "char_count": 266,
        "word_count": 80,
        "page_number": 9,
        "window_text": "| 자) 관찰 및 평가 | * 불면증을 포함하여 다른 종류의 인지행동치료를 모두 포함 | 따라 차이가 있는지를 확인하기 위해 하위분석을 제시한다.  | - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다).  | 기재한다.  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1.  관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다.  | 따라 스크리닝 번호를 부여한다.  | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다. ",
        "original_sentence": "| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1. "
      }
    },
    {
      "chunk_id": "chunk_165",
      "text": "관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 164,
        "window_size": 3,
        "char_count": 104,
        "word_count": 28,
        "page_number": 27,
        "window_text": "| - 사용자 반응 평가 | □ ‘의료기기와의 관련성’ 판정 참고기준 | 통해 작성하도록 한다).  | 기재한다.  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1.  관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다.  | 따라 스크리닝 번호를 부여한다.  | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.  |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다. ",
        "original_sentence": "관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다. "
      }
    },
    {
      "chunk_id": "chunk_166",
      "text": "| 따라 스크리닝 번호를 부여한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 165,
        "window_size": 3,
        "char_count": 20,
        "word_count": 5,
        "page_number": 39,
        "window_text": "| 기재한다.  | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1.  관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다.  | 따라 스크리닝 번호를 부여한다.  | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.  |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다.  (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다. ",
        "original_sentence": "| 따라 스크리닝 번호를 부여한다. "
      }
    },
    {
      "chunk_id": "chunk_167",
      "text": "| 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 166,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 7,
        "window_text": "| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 확인할 수 없는 경우 | * 피험자 식별코드: 실시기관 코드 - 등록된 순 | 제품명(제조업체) | □ 1년 이내 한시적 적용 또는 일회성 지시ㆍ명령에 해당하는 | in Medical Devices | device security needs, risks |       | OO MB 이상일 것 | (ex : 설정→애플리케이션→메모리) | □ 예 | ■ 아니오 |\n| 1.  관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다.  | 따라 스크리닝 번호를 부여한다.  | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.  |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다.  (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다.  | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다. ",
        "original_sentence": "| 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다. "
      }
    },
    {
      "chunk_id": "chunk_168",
      "text": "|   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 167,
        "window_size": 3,
        "char_count": 161,
        "word_count": 41,
        "page_number": 35,
        "window_text": "관련 규정 | 1 | ISO 13485 | 4) 한국어를 읽고 쓰는데 어려움이 없는 자 | 1) 목표 대상자 수: 총 50명 | 불면증군, 22-28점을 중증도의 불면증군으로 분류한다.  | 따라 스크리닝 번호를 부여한다.  | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.  |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다.  (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다.  | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다.  | 1) 평가 불가능(Unknown) | 내용입니까? ",
        "original_sentence": "|   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다. "
      }
    },
    {
      "chunk_id": "chunk_169",
      "text": "(1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 168,
        "window_size": 3,
        "char_count": 81,
        "word_count": 20,
        "page_number": 27,
        "window_text": "| 따라 스크리닝 번호를 부여한다.  | 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.  |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다.  (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다.  | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다.  | 1) 평가 불가능(Unknown) | 내용입니까?  | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16. ",
        "original_sentence": "(1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다. "
      }
    },
    {
      "chunk_id": "chunk_170",
      "text": "| 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 169,
        "window_size": 3,
        "char_count": 154,
        "word_count": 41,
        "page_number": 9,
        "window_text": "| 차이가 있기 때문에 필수적으로 시행되는 요법은 아니다.  |   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다.  (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다.  | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다.  | 1) 평가 불가능(Unknown) | 내용입니까?  | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16.  | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다. ",
        "original_sentence": "| 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_171",
      "text": "| 1) 평가 불가능(Unknown) | 내용입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 170,
        "window_size": 3,
        "char_count": 30,
        "word_count": 6,
        "page_number": 3,
        "window_text": "|   | (Quality Management)에 | 위험 | 해당 | 사항 | 없음 | 국외 |\n| ESRS 진료지침(2017) | Strong | High | 기관명 | 소재지 | 전화 | 팩스 | * 시간을 표시할 때, 꼭 오전/오후를 구분해서 적습니다.  (1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다.  | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다.  | 1) 평가 불가능(Unknown) | 내용입니까?  | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16.  | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다.  | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오. ",
        "original_sentence": "| 1) 평가 불가능(Unknown) | 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_172",
      "text": "| sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 171,
        "window_size": 3,
        "char_count": 140,
        "word_count": 31,
        "page_number": 28,
        "window_text": "(1, 3, 4, 8, 9번) | - 원재료: (임상시험용 의료기기의 원재료에 대한 특성 기술) | 치료로서, 수면 효율을 증가시키는 치료이다.  | 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다.  | 1) 평가 불가능(Unknown) | 내용입니까?  | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16.  | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다.  | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다. ",
        "original_sentence": "| sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16. "
      }
    },
    {
      "chunk_id": "chunk_173",
      "text": "| 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 172,
        "window_size": 3,
        "char_count": 106,
        "word_count": 29,
        "page_number": 9,
        "window_text": "| 캐릭터가 강의와 질문 및 답변을 제공 | 제품 설명 |\n| 2) 무작위 배정 방법 | ◈ 미완료 사유 | 가) 시험기기: 디지털 불면증 인지행동치료 애플리케이션 |   |  | Information for Healthcare | 일기 작성만을 목적으로 사용한다.  | 1) 평가 불가능(Unknown) | 내용입니까?  | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16.  | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다.  | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다.  | 수집할 수 있다. ",
        "original_sentence": "| 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다. "
      }
    },
    {
      "chunk_id": "chunk_174",
      "text": "| BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 173,
        "window_size": 3,
        "char_count": 156,
        "word_count": 46,
        "page_number": 9,
        "window_text": "| 1) 평가 불가능(Unknown) | 내용입니까?  | sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16.  | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다.  | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다.  | 수집할 수 있다.  | 제품 외형 | 하는 설문도구. ",
        "original_sentence": "| BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_175",
      "text": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 174,
        "window_size": 3,
        "char_count": 60,
        "word_count": 18,
        "page_number": 44,
        "window_text": "| sleepio] | □ 동의 철회 또는 피험자가 임상시험 중단 요구 | systems–Requirements | and controls | (Special form) |  |  |   |\n| reviews, 38, 3–16.  | 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다.  | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다.  | 수집할 수 있다.  | 제품 외형 | 하는 설문도구.  환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다. ",
        "original_sentence": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_176",
      "text": "| 수집할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 175,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 88,
        "window_text": "| 1) 식품의약품안전처의 임상 계획 승인일로부터 00개월 | ** 2번에 해당되는 경우, 술의 종류와 마신 술의 양이 몇 잔인지 또는 몇 병인지에 | 등급 | 설명 | 연구군을 선별한다.  | BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다.  | 수집할 수 있다.  | 제품 외형 | 하는 설문도구.  환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다.  | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다. ",
        "original_sentence": "| 수집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_177",
      "text": "| 제품 외형 | 하는 설문도구. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 176,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 27,
        "window_text": "| BAI | 1 | 2 | 2 | Acceptable | 가이드’ | < | 완료 |\n| (1) 「의료기기법」 제2조 (정의) | 7) 교대근무자 | 7) 기타 이차 유효성 평가 변수*들의 치료 전 대비 변화량 | 마) 외래 방문마다 유효성 평가 | 대하여 기록하여 주십시오.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다.  | 수집할 수 있다.  | 제품 외형 | 하는 설문도구.  환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다.  | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다.  | 문제가 있을 경우 시험자와 상의한다. ",
        "original_sentence": "| 제품 외형 | 하는 설문도구. "
      }
    },
    {
      "chunk_id": "chunk_178",
      "text": "환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 177,
        "window_size": 3,
        "char_count": 237,
        "word_count": 61,
        "page_number": 7,
        "window_text": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 허용 기준을 사용하여 위험 감소가 필요한지 결정한다.  | 수집할 수 있다.  | 제품 외형 | 하는 설문도구.  환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다.  | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다.  | 문제가 있을 경우 시험자와 상의한다.  | 한다. ",
        "original_sentence": "환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_179",
      "text": "| 기타 문서화된 정보의 사전 서면 승인을 받아야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 178,
        "window_size": 3,
        "char_count": 32,
        "word_count": 9,
        "page_number": 44,
        "window_text": "| 수집할 수 있다.  | 제품 외형 | 하는 설문도구.  환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다.  | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다.  | 문제가 있을 경우 시험자와 상의한다.  | 한다.  이러한 정보들은 기밀로 보관되어야 한다. ",
        "original_sentence": "| 기타 문서화된 정보의 사전 서면 승인을 받아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_180",
      "text": "| 문제가 있을 경우 시험자와 상의한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 179,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 44,
        "window_text": "| 제품 외형 | 하는 설문도구.  환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다.  | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다.  | 문제가 있을 경우 시험자와 상의한다.  | 한다.  이러한 정보들은 기밀로 보관되어야 한다.  | 으로 정하고자 한다. ",
        "original_sentence": "| 문제가 있을 경우 시험자와 상의한다. "
      }
    },
    {
      "chunk_id": "chunk_181",
      "text": "| 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 180,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 44,
        "window_text": "환자의 주관적인 불안을 평가하기 위한 목적으로 | 대한 국제 규격 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 가이드’ |\n| 1) 탈락 기준 | 7) 민감도 분석 | Mental Disorders, Fifth Edition, DSM-5) | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 회사명 | 대표이사 | 소재지 | 전화 | 입회자가 동의를 얻는 전 과정에 참석하여야 한다.  | 기타 문서화된 정보의 사전 서면 승인을 받아야 한다.  | 문제가 있을 경우 시험자와 상의한다.  | 한다.  이러한 정보들은 기밀로 보관되어야 한다.  | 으로 정하고자 한다.  | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다. ",
        "original_sentence": "| 한다. "
      }
    },
    {
      "chunk_id": "chunk_182",
      "text": "이러한 정보들은 기밀로 보관되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 181,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 38,
        "window_text": "| 기타 문서화된 정보의 사전 서면 승인을 받아야 한다.  | 문제가 있을 경우 시험자와 상의한다.  | 한다.  이러한 정보들은 기밀로 보관되어야 한다.  | 으로 정하고자 한다.  | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다.  | 곳에서 필요한 형태로 존재하여야 함을 의미한다. ",
        "original_sentence": "이러한 정보들은 기밀로 보관되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_183",
      "text": "| 으로 정하고자 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 182,
        "window_size": 3,
        "char_count": 14,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| 문제가 있을 경우 시험자와 상의한다.  | 한다.  이러한 정보들은 기밀로 보관되어야 한다.  | 으로 정하고자 한다.  | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다.  | 곳에서 필요한 형태로 존재하여야 함을 의미한다.  | 위한 행동 치료를 수행한다. ",
        "original_sentence": "| 으로 정하고자 한다. "
      }
    },
    {
      "chunk_id": "chunk_184",
      "text": "| - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 183,
        "window_size": 3,
        "char_count": 53,
        "word_count": 15,
        "page_number": 36,
        "window_text": "| 한다.  이러한 정보들은 기밀로 보관되어야 한다.  | 으로 정하고자 한다.  | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다.  | 곳에서 필요한 형태로 존재하여야 함을 의미한다.  | 위한 행동 치료를 수행한다.  | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
        "original_sentence": "| - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다. "
      }
    },
    {
      "chunk_id": "chunk_185",
      "text": "| 곳에서 필요한 형태로 존재하여야 함을 의미한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 184,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 31,
        "window_text": "이러한 정보들은 기밀로 보관되어야 한다.  | 으로 정하고자 한다.  | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다.  | 곳에서 필요한 형태로 존재하여야 함을 의미한다.  | 위한 행동 치료를 수행한다.  | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다. ",
        "original_sentence": "| 곳에서 필요한 형태로 존재하여야 함을 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_186",
      "text": "| 위한 행동 치료를 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 185,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 39,
        "window_text": "| 으로 정하고자 한다.  | - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다.  | 곳에서 필요한 형태로 존재하여야 함을 의미한다.  | 위한 행동 치료를 수행한다.  | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.  | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30. ",
        "original_sentence": "| 위한 행동 치료를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_187",
      "text": "| 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 186,
        "window_size": 3,
        "char_count": 319,
        "word_count": 79,
        "page_number": 45,
        "window_text": "| - 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 대해서도 함께 적습니다.  | 곳에서 필요한 형태로 존재하여야 함을 의미한다.  | 위한 행동 치료를 수행한다.  | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.  | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30.  | 수가 확보되어야 한다. ",
        "original_sentence": "| 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까? "
      }
    },
    {
      "chunk_id": "chunk_188",
      "text": "| □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 187,
        "window_size": 3,
        "char_count": 238,
        "word_count": 53,
        "page_number": 3,
        "window_text": "| 곳에서 필요한 형태로 존재하여야 함을 의미한다.  | 위한 행동 치료를 수행한다.  | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.  | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30.  | 수가 확보되어야 한다.  | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까? ",
        "original_sentence": "| □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_189",
      "text": "| (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 188,
        "window_size": 3,
        "char_count": 194,
        "word_count": 53,
        "page_number": 46,
        "window_text": "| 위한 행동 치료를 수행한다.  | 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.  | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30.  | 수가 확보되어야 한다.  | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까?  | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다. ",
        "original_sentence": "| (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30. "
      }
    },
    {
      "chunk_id": "chunk_190",
      "text": "| 수가 확보되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 189,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 38,
        "window_text": "| 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나 확인할 수 없는 경우 | ‘OOOOO’ 경고 푸시 | - CE 인증과 영국 NHS와 제휴 | (선택) |\n| (Beck Anxiety Inventory) | 1) 분석 대상군 | AASM 진료지침(2017) | Strong | Moderate | 나) 선정·제외 기준 | ◈ 그 밖의 이상반응이 | 총 수면 시간 | 참여하는 사람(피험자)의 선정 기준ㆍ제외 기준ㆍ인원 및 그 근거 | Organizations about FDA’S | 발생일, | 종료일 | □ 외국 규정을 번역하거나 설명하는 내용입니까?  | □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.  | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30.  | 수가 확보되어야 한다.  | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까?  | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.  | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다. ",
        "original_sentence": "| 수가 확보되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_191",
      "text": "| 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 190,
        "window_size": 3,
        "char_count": 71,
        "word_count": 18,
        "page_number": 39,
        "window_text": "| □ 예 | ■ 아니오 | 지속시간 | (hours/ | minutes) | for regulatory purposes | 스크리닝 및 | (구체적 사유: _____________________________________) | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) | 기기에 |\n| 3 | 경고 메시지 | 이상 | 보정할 수 있는 경우는 이를 반영하여 분석 결과를 제시해야 한다.  | (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30.  | 수가 확보되어야 한다.  | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까?  | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.  | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다.  |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다. ",
        "original_sentence": "| 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까? "
      }
    },
    {
      "chunk_id": "chunk_192",
      "text": "| □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 191,
        "window_size": 3,
        "char_count": 352,
        "word_count": 96,
        "page_number": 9,
        "window_text": "| (Total sleep time) | 총 수면시간, 실제 수면을 취한 시간 | * 독립형 소프트웨어 제품은 소프트웨어 명칭, 버전, 운영환경 기재 | 증상의 | 치료시작일 | (Baseline) | 증상의 | 적용 | 성능 | 시험 | 기기와의 | 관련성 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | 이득 |\n| 21-30.  | 수가 확보되어야 한다.  | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까?  | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.  | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다.  |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.  | - 일차와 이차 유효성 평가 관련된 목록을 작성한다. ",
        "original_sentence": "| □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_193",
      "text": "| 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 192,
        "window_size": 3,
        "char_count": 107,
        "word_count": 32,
        "page_number": 9,
        "window_text": "| 수가 확보되어야 한다.  | 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까?  | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.  | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다.  |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.  | - 일차와 이차 유효성 평가 관련된 목록을 작성한다.  | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다. ",
        "original_sentence": "| 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다. "
      }
    },
    {
      "chunk_id": "chunk_194",
      "text": "|\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 193,
        "window_size": 3,
        "char_count": 117,
        "word_count": 34,
        "page_number": 37,
        "window_text": "| 바) 불면증 심각도 척도(ISI) 조사 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 발생하였습니까?  | □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.  | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다.  |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.  | - 일차와 이차 유효성 평가 관련된 목록을 작성한다.  | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다.  | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다. ",
        "original_sentence": "|\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다. "
      }
    },
    {
      "chunk_id": "chunk_195",
      "text": "| - 일차와 이차 유효성 평가 관련된 목록을 작성한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 194,
        "window_size": 3,
        "char_count": 32,
        "word_count": 9,
        "page_number": 7,
        "window_text": "| □ | 예 | □ | 아니오 | 2) 관련성이 없음(Not related) | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 11.6 | 10/03/30 홍길동(오기) | 사용되고 있으며 점수가 높을수록 불안감이 더 크다고 평가 | 대한 | 조치 |\n| 반응명 | (2) 「의료기기법」 제3조 (등급분류와 지정) | 2) 대상자 모집 기간: 00개월 | 인구학적 정보 | O | - | - | - | 대응책에 관한 정보 제공 | 나) 피험자 동의 및 준비 | 바) 병용 약물 조사 | ○○○병원 | ○○시 ○○ | ○○○-○○○○ | ○○○-○○○○ | 밸리데이션 가이드라인(민원인 안내서)’에 따라 수행한다.  | 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다.  |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.  | - 일차와 이차 유효성 평가 관련된 목록을 작성한다.  | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다.  | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다.  | 및 폐기에 관한 기록을 유지하여야 한다. ",
        "original_sentence": "| - 일차와 이차 유효성 평가 관련된 목록을 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_196",
      "text": "| “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 195,
        "window_size": 3,
        "char_count": 109,
        "word_count": 24,
        "page_number": 3,
        "window_text": "| 상 | 검사일 | 알림이 발생할 것 | 소프트웨어의 출시 후에 발생 | 하는 피드백에 적절히 대응하고, | 소프트웨어 | 항목의 | 일관성을 | 범위 | 정도 | 실제 제품에 구현시킨다.  |\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.  | - 일차와 이차 유효성 평가 관련된 목록을 작성한다.  | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다.  | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다.  | 및 폐기에 관한 기록을 유지하여야 한다.  | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다. ",
        "original_sentence": "| “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다. "
      }
    },
    {
      "chunk_id": "chunk_197",
      "text": "| 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 196,
        "window_size": 3,
        "char_count": 75,
        "word_count": 21,
        "page_number": 9,
        "window_text": "|\n| 8) 시청각 장애가 있거나 인지 장애(예: 치매 등)가 있는 자 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | * 기타 이차 유효성 평가 지표 예시는 <표 19>와 같다.  | - 일차와 이차 유효성 평가 관련된 목록을 작성한다.  | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다.  | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다.  | 및 폐기에 관한 기록을 유지하여야 한다.  | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.  | 포함되어야 한다. ",
        "original_sentence": "| 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다. "
      }
    },
    {
      "chunk_id": "chunk_198",
      "text": "| 및 폐기에 관한 기록을 유지하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 197,
        "window_size": 3,
        "char_count": 25,
        "word_count": 7,
        "page_number": 36,
        "window_text": "| - 일차와 이차 유효성 평가 관련된 목록을 작성한다.  | “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다.  | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다.  | 및 폐기에 관한 기록을 유지하여야 한다.  | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.  | 포함되어야 한다.  | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다. ",
        "original_sentence": "| 및 폐기에 관한 기록을 유지하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_199",
      "text": "| 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 198,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 9,
        "window_text": "| “Guidance for Industry: | Somryst | 소프트웨어 요구사항을 소프트 | 웨어 구조로 설명하며 소프트 | 웨어 항목(item)을 식별하는 아키 | 텍처로 | 변환한다.  | 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다.  | 및 폐기에 관한 기록을 유지하여야 한다.  | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.  | 포함되어야 한다.  | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다.  | 내용을 기록한다. ",
        "original_sentence": "| 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다. "
      }
    },
    {
      "chunk_id": "chunk_200",
      "text": "| 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 199,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 38,
        "window_text": "| 소프트웨어 | 네트워크를 활용하는 의료기기의 사이버 | 적용 | 성능 | 시험 | 6개월 후 |\n| 문제점을 적극적으로 대응한다.  | 및 폐기에 관한 기록을 유지하여야 한다.  | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.  | 포함되어야 한다.  | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다.  | 내용을 기록한다.  | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3. ",
        "original_sentence": "| 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_201",
      "text": "| : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 200,
        "window_size": 3,
        "char_count": 41,
        "word_count": 13,
        "page_number": 13,
        "window_text": "| 및 폐기에 관한 기록을 유지하여야 한다.  | 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.  | 포함되어야 한다.  | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다.  | 내용을 기록한다.  | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3.  불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed.",
        "original_sentence": "| : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_202",
      "text": "| 내용을 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 201,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 13,
        "window_text": "| 사이버 보안 안전성 등급 및 제품의 특성에 따라 적용한다.  | 포함되어야 한다.  | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다.  | 내용을 기록한다.  | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3.  불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed. ), 349, g5205. ",
        "original_sentence": "| 내용을 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_203",
      "text": "| (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 202,
        "window_size": 3,
        "char_count": 64,
        "word_count": 15,
        "page_number": 7,
        "window_text": "| 포함되어야 한다.  | : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다.  | 내용을 기록한다.  | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3.  불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed. ), 349, g5205.  | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다. ",
        "original_sentence": "| (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3. "
      }
    },
    {
      "chunk_id": "chunk_204",
      "text": "불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 203,
        "window_size": 3,
        "char_count": 129,
        "word_count": 27,
        "page_number": 27,
        "window_text": "| : 한 군당 필요한 피험자 수 | 문제 해결법 | 내용을 기재한다.  | 내용을 기록한다.  | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3.  불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed. ), 349, g5205.  | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.  | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다. ",
        "original_sentence": "불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed."
      }
    },
    {
      "chunk_id": "chunk_205",
      "text": "), 349, g5205. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 204,
        "window_size": 3,
        "char_count": 15,
        "word_count": 3,
        "page_number": 9,
        "window_text": "| 내용을 기록한다.  | (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3.  불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed. ), 349, g5205.  | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.  | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다.  | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오. ",
        "original_sentence": "), 349, g5205. "
      }
    },
    {
      "chunk_id": "chunk_206",
      "text": "| 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 205,
        "window_size": 3,
        "char_count": 165,
        "word_count": 41,
        "page_number": 7,
        "window_text": "| (yy/mm/dd) | 이상반응이 명백하게 피험자의 임상적 상태 또는 시험절차/조건에 기인한 경우 | 표 3.  불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed. ), 349, g5205.  | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.  | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다.  | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.  | 기록을 열람할 수 있다. ",
        "original_sentence": "| 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다. "
      }
    },
    {
      "chunk_id": "chunk_207",
      "text": "| 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 206,
        "window_size": 3,
        "char_count": 483,
        "word_count": 120,
        "page_number": 35,
        "window_text": "불면증 인지행동치료(CBT-I)의 구성 | (Screening)1) | Medical devices | 신체적 및 정신적 건강 관련 삶의 질에 대한 35개 문항과 | 의료기기 위험관리 |\n| (Clinical research ed. ), 349, g5205.  | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.  | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다.  | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.  | 기록을 열람할 수 있다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
        "original_sentence": "| 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_208",
      "text": "| 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 207,
        "window_size": 3,
        "char_count": 126,
        "word_count": 31,
        "page_number": 9,
        "window_text": "), 349, g5205.  | 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.  | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다.  | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.  | 기록을 열람할 수 있다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까? ",
        "original_sentence": "| 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_209",
      "text": "| 기록을 열람할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 208,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 93,
        "window_text": "| 7 | 1) 임상시험의 연구목적으로 수행된다는 사실 | 케이션을 사용하는 데에 어려움이 없는 자 | - 모든 분석 대상자군(Full Analysis Set, FAS) | (major) | 예) Hb 8.6 → Hb 8.6 | 신체기능의 영구적 장애, 신체구조의 영구적 손상의 가능성이 있다.  | 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다.  | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.  | 기록을 열람할 수 있다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까?  | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다. ",
        "original_sentence": "| 기록을 열람할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_210",
      "text": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 209,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 44,
        "window_text": "| 오송보건의료행정타운 | (Follow up)4) | 미국 |\n| AASM: American Academy of Sleep Medicine | - 모양 및 구조: (임상시험용 의료기기의 모양 및 구조 기술) | 수면잠복기 | (PEAR Therapeutics) | - FDA 510(k) 승인 | □ 신규 직원 교육을 위해 법령 또는 행정규칙을 알기 쉽게 | 임상시험 실시기관 및 책임 연구자 (소속과/직위/성명) | Somino | □ 추적 관찰 실패 | 가이드’ | □ 예 | ■ 아니오 |\n| (3) 「의료기기법」 제10조 (임상시험계획의 승인 등) | Cybersecurity for Networked | 수면 제한법 | 3) 관련성이 적음(Unlikely) | 소프트웨어 | 형상 관리 | 보안 가이던스에 대한 정보 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 2 | ISO 14971 | 성 인증을 통과한 제품을 사용해야 한다.  | 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.  | 기록을 열람할 수 있다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까?  | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다.  | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다. ",
        "original_sentence": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_211",
      "text": "| 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 210,
        "window_size": 3,
        "char_count": 257,
        "word_count": 71,
        "page_number": 9,
        "window_text": "| 2) 소프트웨어 개발 및 위험관리 | 3) 임상시험 수행 기간: 00개월 | (Sleep onset latency) | 소등에서 수면이 시작되기까지 걸린 시간 | ※ 이상반응 발생 시 이상반응 서식지에 기입하여 주십시오.  | 기록을 열람할 수 있다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까?  | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다.  | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다.  | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다. ",
        "original_sentence": "| 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까? "
      }
    },
    {
      "chunk_id": "chunk_212",
      "text": "| 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 211,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 46,
        "window_text": "| 기록을 열람할 수 있다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까?  | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다.  | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다.  | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다.  | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다. ",
        "original_sentence": "| 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_213",
      "text": "| 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 212,
        "window_size": 3,
        "char_count": 107,
        "word_count": 25,
        "page_number": 45,
        "window_text": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까?  | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다.  | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다.  | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다.  | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.  | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19. ",
        "original_sentence": "| 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다. "
      }
    },
    {
      "chunk_id": "chunk_214",
      "text": "| 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 213,
        "window_size": 3,
        "char_count": 59,
        "word_count": 15,
        "page_number": 1,
        "window_text": "| 방문일 | 방문1 | 방문2 | 방문3 | 방문4 | (Trouble | –Application of risk management | 데이터베이스에 저장했던 | (Risk Management)에 대한 | 국외 |\n| 8 | 9) 한국어를 듣고 쓰고 말하는 데 어려움이 있는 자 | 과거병력 조사 | O | - | - | - | (1) 일차 유효성 평가지표: 불면증 심각도 척도(ISI) | 소프트 | 웨어 | 개발 | 프로 | 세스 | 정리한 자료입니까?  | 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다.  | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다.  | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다.  | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.  | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19.  불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial. ",
        "original_sentence": "| 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_215",
      "text": "| 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 214,
        "window_size": 3,
        "char_count": 35,
        "word_count": 10,
        "page_number": 39,
        "window_text": "| 식품의약품안전처 식품의약품안전평가원 | 가이드’ |\n| 탈락시킬 수 있다.  | 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다.  | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다.  | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.  | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19.  불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial.  JAMA Psychiatry, 74(1), 68-75. ",
        "original_sentence": "| 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_216",
      "text": "| (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 215,
        "window_size": 3,
        "char_count": 85,
        "word_count": 22,
        "page_number": 28,
        "window_text": "| 데이터베이스 | - 수면/우울/불안 관련 증상 유무 및 직업적/사회적 기능 상태 | : 제 1종 오류 0.05 (유의수준) | Medical Devices Containing | 한다.  | 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다.  | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.  | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19.  불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial.  JAMA Psychiatry, 74(1), 68-75.  | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다. ",
        "original_sentence": "| (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19. "
      }
    },
    {
      "chunk_id": "chunk_217",
      "text": "불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 216,
        "window_size": 3,
        "char_count": 122,
        "word_count": 25,
        "page_number": 7,
        "window_text": "| 불면증 개선 디지털치료기기 안전성·성능 평가 및 | 통화를 하여 탈락의 주요 사유를 파악하도록 한다.  | 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.  | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19.  불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial.  JAMA Psychiatry, 74(1), 68-75.  | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다.  | 위임자가 모든 선정 및 제외 기준을 검토해야 한다. ",
        "original_sentence": "불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial. "
      }
    },
    {
      "chunk_id": "chunk_218",
      "text": "JAMA Psychiatry, 74(1), 68-75. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 217,
        "window_size": 3,
        "char_count": 31,
        "word_count": 4,
        "page_number": 27,
        "window_text": "| 시간 대비 실제 수면 시간을 늘리는 행동 치료를 수행한다.  | (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19.  불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial.  JAMA Psychiatry, 74(1), 68-75.  | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다.  | 위임자가 모든 선정 및 제외 기준을 검토해야 한다.  | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다. ",
        "original_sentence": "JAMA Psychiatry, 74(1), 68-75. "
      }
    },
    {
      "chunk_id": "chunk_219",
      "text": "| 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 218,
        "window_size": 3,
        "char_count": 40,
        "word_count": 12,
        "page_number": 7,
        "window_text": "| (Mementor DEGmbH) | 이상반응과 임상시험용 의료기기 간의 시간적 연관성으로 볼 때 어떠한 합리적인 관련도 | / | / | 표 19.  불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial.  JAMA Psychiatry, 74(1), 68-75.  | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다.  | 위임자가 모든 선정 및 제외 기준을 검토해야 한다.  | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.  | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다. ",
        "original_sentence": "| 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_220",
      "text": "| 위임자가 모든 선정 및 제외 기준을 검토해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 219,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 44,
        "window_text": "불면증 이차 유효성 평가 지표 예시 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| intervention with 1-year follow-up: a randomized clinical trial.  JAMA Psychiatry, 74(1), 68-75.  | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다.  | 위임자가 모든 선정 및 제외 기준을 검토해야 한다.  | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.  | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.  | 사) 병용 약물 조사 | 고려하지 않는다. ",
        "original_sentence": "| 위임자가 모든 선정 및 제외 기준을 검토해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_221",
      "text": "| (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 220,
        "window_size": 3,
        "char_count": 97,
        "word_count": 25,
        "page_number": 18,
        "window_text": "JAMA Psychiatry, 74(1), 68-75.  | 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다.  | 위임자가 모든 선정 및 제외 기준을 검토해야 한다.  | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.  | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.  | 사) 병용 약물 조사 | 고려하지 않는다.  | 통해서 시험군 혹은 대조군으로 1:1 배정한다. ",
        "original_sentence": "| (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다. "
      }
    },
    {
      "chunk_id": "chunk_222",
      "text": "| 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 221,
        "window_size": 3,
        "char_count": 244,
        "word_count": 64,
        "page_number": 9,
        "window_text": "| 2) 임상시험의 목적 | 범위 내에서 개발 및 유지가 되어야 한다.  | 위임자가 모든 선정 및 제외 기준을 검토해야 한다.  | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.  | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.  | 사) 병용 약물 조사 | 고려하지 않는다.  | 통해서 시험군 혹은 대조군으로 1:1 배정한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
        "original_sentence": "| 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다. "
      }
    },
    {
      "chunk_id": "chunk_223",
      "text": "| 사) 병용 약물 조사 | 고려하지 않는다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 222,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 41,
        "window_text": "| 위임자가 모든 선정 및 제외 기준을 검토해야 한다.  | (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.  | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.  | 사) 병용 약물 조사 | 고려하지 않는다.  | 통해서 시험군 혹은 대조군으로 1:1 배정한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
        "original_sentence": "| 사) 병용 약물 조사 | 고려하지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_224",
      "text": "| 통해서 시험군 혹은 대조군으로 1:1 배정한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 223,
        "window_size": 3,
        "char_count": 29,
        "word_count": 7,
        "page_number": 27,
        "window_text": "| (Sleep | 적용 | 성능 | 시험 |\n| (4) 「의료기기법 시행규칙」 제9조 (기술문서 등의 심사) | 디지털치료기기 관련 국내외 가이드라인은 <표 8>과 같다.  | 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.  | 사) 병용 약물 조사 | 고려하지 않는다.  | 통해서 시험군 혹은 대조군으로 1:1 배정한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다. ",
        "original_sentence": "| 통해서 시험군 혹은 대조군으로 1:1 배정한다. "
      }
    },
    {
      "chunk_id": "chunk_225",
      "text": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 224,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 4 | 경과일수 | D-28 이내 | DAY1 | - | - | - 성능: (임상시험용 의료기기의 성능 기술) | 중 | shooting) | 정보와 다시 호출한 | to medical devices | 건강 관련 삶의 질은 8개의 하부영역으로 구성되었고, 이는 | OOOO병원 OOO과/교수/OOO | 국제 규격 |\n| 1) 중지 기준 | 2) 잘못 기입된 글자를 overwrite 해서 고치거나 수정액을 사용하여서는 안 됩니다.  | 사) 병용 약물 조사 | 고려하지 않는다.  | 통해서 시험군 혹은 대조군으로 1:1 배정한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다.  | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다. ",
        "original_sentence": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다. "
      }
    },
    {
      "chunk_id": "chunk_226",
      "text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 225,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 사) 병용 약물 조사 | 고려하지 않는다.  | 통해서 시험군 혹은 대조군으로 1:1 배정한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다.  | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다.  | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다. ",
        "original_sentence": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다. "
      }
    },
    {
      "chunk_id": "chunk_227",
      "text": "| 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 226,
        "window_size": 3,
        "char_count": 87,
        "word_count": 23,
        "page_number": 36,
        "window_text": "| 통해서 시험군 혹은 대조군으로 1:1 배정한다.  | ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다.  | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다.  | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다.  |\n| Internal Medicine, 164(17), 1888–1896. ",
        "original_sentence": "| 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다. "
      }
    },
    {
      "chunk_id": "chunk_228",
      "text": "| 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 227,
        "window_size": 3,
        "char_count": 317,
        "word_count": 82,
        "page_number": 27,
        "window_text": "| ☞ 상기 사항 중 어느 하나라도 ‘예’에 해당되는 경우에 지침서ㆍ안내서 등록 대상이 아닙니다.  | 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다.  | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다.  | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다.  |\n| Internal Medicine, 164(17), 1888–1896.  | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다. ",
        "original_sentence": "| 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_229",
      "text": "| 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 228,
        "window_size": 3,
        "char_count": 88,
        "word_count": 11,
        "page_number": 18,
        "window_text": "| 지침서ㆍ안내서 제ㆍ개정 절차를 적용하실 필요는 없습니다.  | 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다.  | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다.  | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다.  |\n| Internal Medicine, 164(17), 1888–1896.  | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다.  | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다. ",
        "original_sentence": "| 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_230",
      "text": "|\n| Internal Medicine, 164(17), 1888–1896. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 229,
        "window_size": 3,
        "char_count": 43,
        "word_count": 6,
        "page_number": 27,
        "window_text": "| 있을 것 같지 않은 경우 | / | / | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 유지하면서 설계 변경 및 소프트 | 웨어 형상을 유지한다.  | 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다.  | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다.  |\n| Internal Medicine, 164(17), 1888–1896.  | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다.  | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다.  | 만든다. ",
        "original_sentence": "|\n| Internal Medicine, 164(17), 1888–1896. "
      }
    },
    {
      "chunk_id": "chunk_231",
      "text": "| 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 230,
        "window_size": 3,
        "char_count": 69,
        "word_count": 20,
        "page_number": 27,
        "window_text": "| 적용 | 성능 | 시험 | Device For Psychiatric Disorders | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 3 | 소프트웨어 | 아키텍처 | 4) 임상시험 수행 후 follow-up 기간: 6~12개월 | 2) 증례기록서의 작성 | 입면 후 각성시간 | 선행 연구 | 대상 | 배정군 | N | Cohen’s d2) | Effect | Off-The-Shelf(OTS) Software” | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 내용을 기록한다.  | 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다.  |\n| Internal Medicine, 164(17), 1888–1896.  | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다.  | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다.  | 만든다.  | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다. ",
        "original_sentence": "| 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_232",
      "text": "| 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 231,
        "window_size": 3,
        "char_count": 76,
        "word_count": 16,
        "page_number": 1,
        "window_text": "| 송수신 | restriction | □ 기타 (_____________________________________________) | 피드백을 제공한다.  |\n| Internal Medicine, 164(17), 1888–1896.  | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다.  | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다.  | 만든다.  | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다.  | 보안 적용 사항을 기재한다. ",
        "original_sentence": "| 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_233",
      "text": "| 만든다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 232,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 18,
        "window_text": "|\n| Internal Medicine, 164(17), 1888–1896.  | 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다.  | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다.  | 만든다.  | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다.  | 보안 적용 사항을 기재한다.  | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다. ",
        "original_sentence": "| 만든다. "
      }
    },
    {
      "chunk_id": "chunk_234",
      "text": "| 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 233,
        "window_size": 3,
        "char_count": 50,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 연번 | 평가 지표 | 라) 전체 잔여위험 허용 가능성 평가 | (moderate) | SF-36 | 수집할 수 있다.  | 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다.  | 만든다.  | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다.  | 보안 적용 사항을 기재한다.  | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다.  | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver. ",
        "original_sentence": "| 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다. "
      }
    },
    {
      "chunk_id": "chunk_235",
      "text": "| 보안 적용 사항을 기재한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 234,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 3,
        "window_text": "| 임상시험계획서 작성 가이드라인(민원인 안내서) | 4) 관련성이 의심됨(Possible) | 상해, 의학적 중재가 필요할 수 있다.  | 만든다.  | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다.  | 보안 적용 사항을 기재한다.  | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다.  | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver.  1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다. ",
        "original_sentence": "| 보안 적용 사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_236",
      "text": "| 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 235,
        "window_size": 3,
        "char_count": 54,
        "word_count": 18,
        "page_number": 9,
        "window_text": "| 만든다.  | 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다.  | 보안 적용 사항을 기재한다.  | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다.  | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver.  1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.  | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다. ",
        "original_sentence": "| 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다. "
      }
    },
    {
      "chunk_id": "chunk_237",
      "text": "| 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 236,
        "window_size": 3,
        "char_count": 527,
        "word_count": 138,
        "page_number": 39,
        "window_text": "| 총 기록시간에서 수면 잠복기를 뺀 시간 중에서 나타난 | 내원 또는 |\n| 구분한다.  | 보안 적용 사항을 기재한다.  | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다.  | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver.  1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.  | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.  | 성공 기준)를 함께 제시하여야 한다. ",
        "original_sentence": "| 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver. "
      }
    },
    {
      "chunk_id": "chunk_238",
      "text": "1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 237,
        "window_size": 3,
        "char_count": 81,
        "word_count": 20,
        "page_number": 9,
        "window_text": "| 보안 적용 사항을 기재한다.  | 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다.  | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver.  1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.  | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.  | 성공 기준)를 함께 제시하여야 한다.  | 각성 시간 | 구성. ",
        "original_sentence": "1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다. "
      }
    },
    {
      "chunk_id": "chunk_239",
      "text": "| Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 238,
        "window_size": 3,
        "char_count": 106,
        "word_count": 20,
        "page_number": 20,
        "window_text": "| 관찰형태 | 내원 | 내원과 | 소프트 | 웨어 | : 제 2종 오류 0.1 | 시작한다.  | 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver.  1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.  | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.  | 성공 기준)를 함께 제시하여야 한다.  | 각성 시간 | 구성.  점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다. ",
        "original_sentence": "| Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_240",
      "text": "| 성공 기준)를 함께 제시하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 239,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 44,
        "window_text": "| 시각, 자다가 깬 횟수, 자다가 깬 시간, 수면의 질 | 타당한 경우 | 정보가 일치할 것 | 신체적 건강 관련 삶의 질과 정신적 건강 관련 삶의 질로 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 | 내원과 |\n| (5) 「의료기기법 시행규칙」 제20조 (임상시험계획의 승인 등) | 다) 인구학적 정보 | 결정하고 주의사항을 준수하기로 서면 동의한 자 | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 항목과 소프트웨어 항목 외부의 | 구성요소 간의 연계성과 소프트 | * Product code: PWE | 가이드’ | 애플리케이션, |\n| (Short Form-36 Health | 나) 대조기기 | 회사명 | 대표이사 | 소재지 | 전화 | Guidance for the Content of | therapy) | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가지고 | TEL : 043) 719-3948   FAX : 043) 719-3940 | 애플리케이션 | Ver.  1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.  | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.  | 성공 기준)를 함께 제시하여야 한다.  | 각성 시간 | 구성.  점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다.  |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다. ",
        "original_sentence": "| 성공 기준)를 함께 제시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_241",
      "text": "| 각성 시간 | 구성. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 240,
        "window_size": 3,
        "char_count": 14,
        "word_count": 5,
        "page_number": 39,
        "window_text": "1.0 | 의료기기 소프트웨어의 | 애플리케이션 | size3) |\n| 하는 경우는 별도의 안전성과 성능 시험을 통과한 제품의 사용을 권고한다.  | Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.  | 성공 기준)를 함께 제시하여야 한다.  | 각성 시간 | 구성.  점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다.  |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다.  | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다. ",
        "original_sentence": "| 각성 시간 | 구성. "
      }
    },
    {
      "chunk_id": "chunk_242",
      "text": "점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 241,
        "window_size": 3,
        "char_count": 355,
        "word_count": 90,
        "page_number": 37,
        "window_text": "| Non-benzodiazepine GABA modulator (z-class) | 나) 대조기기: 위약 대조군(sham) | - 약물 복용력 등을 문진과 과거 진료기록을 통해 조사한다.  | 성공 기준)를 함께 제시하여야 한다.  | 각성 시간 | 구성.  점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다.  |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다.  | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다.  | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다. ",
        "original_sentence": "점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다. "
      }
    },
    {
      "chunk_id": "chunk_243",
      "text": "|\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 242,
        "window_size": 3,
        "char_count": 140,
        "word_count": 32,
        "page_number": 9,
        "window_text": "| 성공 기준)를 함께 제시하여야 한다.  | 각성 시간 | 구성.  점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다.  |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다.  | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다.  | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.  | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
        "original_sentence": "|\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다. "
      }
    },
    {
      "chunk_id": "chunk_244",
      "text": "| 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 243,
        "window_size": 3,
        "char_count": 94,
        "word_count": 25,
        "page_number": 36,
        "window_text": "| 각성 시간 | 구성.  점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다.  |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다.  | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다.  | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.  | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2(5), e229-e239. ",
        "original_sentence": "| 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다. "
      }
    },
    {
      "chunk_id": "chunk_245",
      "text": "| 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 244,
        "window_size": 3,
        "char_count": 34,
        "word_count": 8,
        "page_number": 36,
        "window_text": "점수 산정은 각각의 8개 하위 척도에 속하는 세부 | 가이드’ |\n| 다) 병용 약물 조사 | 1 | 주간 졸음 자가 평가 척도 (Epworth sleepiness score, ESS) | Survey) | WASO) | □ 내부적으로 행정사무의 통일을 기하기 위하여 반복적으로 행정 | / | / | □ 예(☞지침서) | ■ 아니오 |\n| (6) 「의료기기법 시행규칙」 제24조 (임상시험 실시기준 등) | 하 | 있으나, 해당 의료기기에서 알려진 이상반응과 직접적인 관련성이 없고, 피험자의 임상적 | 다른 디바이스에서 같은 | 인지행동치료(CBT-I)를 기반으로 함 | SHUTi1) | 133 | 1.90 | 갖추어 설계한다.  |\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다.  | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다.  | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.  | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2(5), e229-e239.  | 14. ",
        "original_sentence": "| 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_246",
      "text": "| : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 245,
        "window_size": 3,
        "char_count": 247,
        "word_count": 61,
        "page_number": 45,
        "window_text": "|\n| 1) 부작용 | 3 | IEC 62304 | Medical device software | 3) 사이버 보안 위험관리 | 1) 대상 질환 : [F51.0] Nonorganic insomnia (비기질성 불면증), | 새로운 업데이트 버전이다.  | 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다.  | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.  | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2(5), e229-e239.  | 14.  | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다. ",
        "original_sentence": "| : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_247",
      "text": "(공무원용) |\n| 2(5), e229-e239. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 246,
        "window_size": 3,
        "char_count": 28,
        "word_count": 5,
        "page_number": 9,
        "window_text": "| 다) 임상시험 의료기기 시험 방법 | Ritterband | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | 연구 참여 | 절차를 말한다.  | 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.  | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2(5), e229-e239.  | 14.  | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다.  | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다. ",
        "original_sentence": "(공무원용) |\n| 2(5), e229-e239. "
      }
    },
    {
      "chunk_id": "chunk_248",
      "text": "| 14. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 247,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 27,
        "window_text": "| 의료기기의 회수 체계를 확립하고 이를 문서화하여야 한다.  | : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2(5), e229-e239.  | 14.  | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다.  | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다.  | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다. ",
        "original_sentence": "| 14. "
      }
    },
    {
      "chunk_id": "chunk_249",
      "text": "| 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 248,
        "window_size": 3,
        "char_count": 134,
        "word_count": 35,
        "page_number": 9,
        "window_text": "| : 군간 예상되는 effect size | Premarket Submissions for | 참여 동의를 철회하는 경우 | 21-65세 만성 | 증례기록서 작성에 대한 세부사항 | https://www.nifds.go.kr | 소프트웨어를 | 포함하는 | 의료기기에 | 개발부터 유지보수를 | 가이드’ | 가이드’ |\n| 배정 될 확률 | 유지 | 활동 | 프로 | 세스 | / | / | 사무의 세부기준이나 절차를 제시하는 것입니까?  (공무원용) |\n| 2(5), e229-e239.  | 14.  | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다.  | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다.  | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.  | 그림 5. ",
        "original_sentence": "| 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다. "
      }
    },
    {
      "chunk_id": "chunk_250",
      "text": "| 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 249,
        "window_size": 3,
        "char_count": 70,
        "word_count": 19,
        "page_number": 7,
        "window_text": "(공무원용) |\n| 2(5), e229-e239.  | 14.  | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다.  | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다.  | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.  | 그림 5.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다. ",
        "original_sentence": "| 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다. "
      }
    },
    {
      "chunk_id": "chunk_251",
      "text": "| 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 250,
        "window_size": 3,
        "char_count": 97,
        "word_count": 30,
        "page_number": 27,
        "window_text": "| 14.  | 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다.  | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다.  | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.  | 그림 5.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다.  | 수집할 수 있다. ",
        "original_sentence": "| 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_252",
      "text": "| 그림 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 251,
        "window_size": 3,
        "char_count": 8,
        "word_count": 3,
        "page_number": 35,
        "window_text": "| 8 | 동의서 취득 | O | - | - | - | 2 | 수면에 대한 역기능적 신념 및 태도 척도 | (Dysfunctional Beliefs and Attitudes about Sleep, DBAS) | (minor) | 권고한다.  | 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다.  | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.  | 그림 5.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다.  | 수집할 수 있다.  | 그림 4. ",
        "original_sentence": "| 그림 5. "
      }
    },
    {
      "chunk_id": "chunk_253",
      "text": "불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 252,
        "window_size": 3,
        "char_count": 49,
        "word_count": 13,
        "page_number": 1,
        "window_text": "| 상태 또는 시험 절차/조건에 의해 발생하였을 가능성이 있는 경우 | 웨어 항목 간 연계성을 위한 | 아키텍처를 개발한다.  | 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.  | 그림 5.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다.  | 수집할 수 있다.  | 그림 4.  소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8. ",
        "original_sentence": "불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_254",
      "text": "| 수집할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 253,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 88,
        "window_text": "| 대한 시판 전 제출에 대한 가이던스 | 미국 | 1.13 | 국외 |\n| 수면 중 각성 횟수 | 상에 정확한 피험자 수의 결정방법, 근거에 대한 기술이 포함되어야 한다.  | 그림 5.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다.  | 수집할 수 있다.  | 그림 4.  소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8.  디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다. ",
        "original_sentence": "| 수집할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_255",
      "text": "| 그림 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 254,
        "window_size": 3,
        "char_count": 8,
        "word_count": 3,
        "page_number": 35,
        "window_text": "| 그림 5.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다.  | 수집할 수 있다.  | 그림 4.  소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8.  디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.  | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다. ",
        "original_sentence": "| 그림 4. "
      }
    },
    {
      "chunk_id": "chunk_256",
      "text": "소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 255,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 9,
        "window_text": "불면증 개선 디지털치료기기 임상시험 선행연구 결과 1 | 또는 일시중지 시킬 수 있다.  | 수집할 수 있다.  | 그림 4.  소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8.  디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.  | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다.  | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M.",
        "original_sentence": "소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8. "
      }
    },
    {
      "chunk_id": "chunk_257",
      "text": "디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 256,
        "window_size": 3,
        "char_count": 59,
        "word_count": 14,
        "page_number": 36,
        "window_text": "| 수집할 수 있다.  | 그림 4.  소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8.  디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.  | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다.  | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M. (2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다. ",
        "original_sentence": "디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_258",
      "text": "| 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 257,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 17,
        "window_text": "| 그림 4.  소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8.  디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.  | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다.  | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M. (2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
        "original_sentence": "| 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다. "
      }
    },
    {
      "chunk_id": "chunk_259",
      "text": "| - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 258,
        "window_size": 3,
        "char_count": 69,
        "word_count": 20,
        "page_number": 28,
        "window_text": "소프트웨어의 안전성 평가 관련 연구의 흐름 | 표 8.  디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.  | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다.  | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M. (2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 투여 기간, 목적을 확인한다. ",
        "original_sentence": "| - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M."
      }
    },
    {
      "chunk_id": "chunk_260",
      "text": "(2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 259,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 9,
        "window_text": "디지털치료기기 관련 국내외 가이드라인 | 중재 없이 가역적이거나 경미하고 단시간의 불편이 있을 수 있다.  | 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다.  | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M. (2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 투여 기간, 목적을 확인한다.  | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다. ",
        "original_sentence": "(2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_261",
      "text": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 260,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 44,
        "window_text": "| 휴대폰 번호로 동시에 | 이외 감별이 필요한 질환을 소개한다.  | - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M. (2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 투여 기간, 목적을 확인한다.  | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.  | 하여야 한다. ",
        "original_sentence": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_262",
      "text": "| 투여 기간, 목적을 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 261,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 7,
        "window_text": "| - 30분 길이의 총 8개 세션이 8주 내에 제공 |\n| (7) 「의료기기 허가·신고·심사 등에 관한 규정」 | L.M. (2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 투여 기간, 목적을 확인한다.  | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.  | 하여야 한다.  | 측정력을 보여주어야 한다. ",
        "original_sentence": "| 투여 기간, 목적을 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_263",
      "text": "| Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 262,
        "window_size": 3,
        "char_count": 361,
        "word_count": 95,
        "page_number": 37,
        "window_text": "(2017) | 웨어의 개발 및 유지를 위한 활동을 수행하여야 한다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 투여 기간, 목적을 확인한다.  | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.  | 하여야 한다.  | 측정력을 보여주어야 한다.  | - OOO 애플리케이션을 실행한다. ",
        "original_sentence": "| Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_264",
      "text": "| 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 263,
        "window_size": 3,
        "char_count": 10,
        "word_count": 3,
        "page_number": 44,
        "window_text": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 투여 기간, 목적을 확인한다.  | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.  | 하여야 한다.  | 측정력을 보여주어야 한다.  | - OOO 애플리케이션을 실행한다.  | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다. ",
        "original_sentence": "| 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_265",
      "text": "| 측정력을 보여주어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 264,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| 투여 기간, 목적을 확인한다.  | Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.  | 하여야 한다.  | 측정력을 보여주어야 한다.  | - OOO 애플리케이션을 실행한다.  | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.  | 평가를 수행한다. ",
        "original_sentence": "| 측정력을 보여주어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_266",
      "text": "| - OOO 애플리케이션을 실행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 265,
        "window_size": 3,
        "char_count": 22,
        "word_count": 5,
        "page_number": 44,
        "window_text": "| Software Contained in | –Software life cycle processes | 불면증 환자 | Patient Education | 142 | 0.77 | 포함하여 전주기에 대한 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | 중복 로그인 | 이상반응 확인 | O | O | O | 졸음이 치명적인 결과를 가져올 수 있는 자) | 정상 수면, | 5) 관련성이 많음(Probable) | □ 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 | 변환시키는데, 0점은 가장 나쁜 건강 상태를 의미하며, 100 |\n| 구분 | 질 좋은 수면을 위한 생활 습관 및 주변 환경의 정돈을 의미한다.  | 하여야 한다.  | 측정력을 보여주어야 한다.  | - OOO 애플리케이션을 실행한다.  | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.  | 평가를 수행한다.  | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2. ",
        "original_sentence": "| - OOO 애플리케이션을 실행한다. "
      }
    },
    {
      "chunk_id": "chunk_267",
      "text": "| 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 266,
        "window_size": 3,
        "char_count": 63,
        "word_count": 16,
        "page_number": 36,
        "window_text": "| 하여야 한다.  | 측정력을 보여주어야 한다.  | - OOO 애플리케이션을 실행한다.  | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.  | 평가를 수행한다.  | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2.  불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.) ",
        "original_sentence": "| 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_268",
      "text": "| 평가를 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 267,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 39,
        "window_text": "| 측정력을 보여주어야 한다.  | - OOO 애플리케이션을 실행한다.  | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.  | 평가를 수행한다.  | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2.  불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.)  | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오. ",
        "original_sentence": "| 평가를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_269",
      "text": "| 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 268,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 9,
        "window_text": "| - OOO 애플리케이션을 실행한다.  | 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.  | 평가를 수행한다.  | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2.  불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.)  | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.  | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까? ",
        "original_sentence": "| 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2. "
      }
    },
    {
      "chunk_id": "chunk_270",
      "text": "불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.) ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 269,
        "window_size": 3,
        "char_count": 132,
        "word_count": 34,
        "page_number": 7,
        "window_text": "| 서명이 이러한 자료의 열람을 허용하게 된다는 사실 | 시험용 의료기기가 설정되지 않았을 경우 생략 가능하다.  | 평가를 수행한다.  | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2.  불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.)  | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.  | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까?  (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다. ",
        "original_sentence": "불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.) "
      }
    },
    {
      "chunk_id": "chunk_271",
      "text": "| 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 270,
        "window_size": 3,
        "char_count": 142,
        "word_count": 42,
        "page_number": 3,
        "window_text": "| 평가를 수행한다.  | 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2.  불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.)  | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.  | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까?  (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial. ",
        "original_sentence": "| 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_272",
      "text": "| Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 271,
        "window_size": 3,
        "char_count": 115,
        "word_count": 24,
        "page_number": 36,
        "window_text": "| 임상시험용 의료기기의 사용에 기인한다고 판단되는 경우 | 표 2.  불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.)  | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.  | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까?  (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial.  Sleep, 39(1), 183–191. ",
        "original_sentence": "| Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까? "
      }
    },
    {
      "chunk_id": "chunk_273",
      "text": "(민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 272,
        "window_size": 3,
        "char_count": 139,
        "word_count": 35,
        "page_number": 9,
        "window_text": "불면증 진단적 평가 항목 권고표 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1 | / | / | Medical Devices | 로그인을 시도했을 때, | (출처: Christensen et al., 2016.)  | 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.  | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까?  (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial.  Sleep, 39(1), 183–191.  | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다. ",
        "original_sentence": "(민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다. "
      }
    },
    {
      "chunk_id": "chunk_274",
      "text": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 273,
        "window_size": 3,
        "char_count": 163,
        "word_count": 55,
        "page_number": 17,
        "window_text": "| 적용 | 성능 | 시험 | ■ 예(☞안내서) | □ 아니오 |\n| 2) 목표 대상자 수 산정의 추정 공식 예시 | 5) 통계 처리 및 결과보고서 작성 기간: 00개월 | 1) 피험자 이니셜과 피험자 번호를 모든 페이지에서 적절하게 기록하여 주십시오.  | Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까?  (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial.  Sleep, 39(1), 183–191.  | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다.  | 있는 영역(acceptable)’의 2단계로 구분할 수 있다. ",
        "original_sentence": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial. "
      }
    },
    {
      "chunk_id": "chunk_275",
      "text": "Sleep, 39(1), 183–191. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 274,
        "window_size": 3,
        "char_count": 23,
        "word_count": 3,
        "page_number": 27,
        "window_text": "| Christension | 이상반응이 임상시험용 의료기기 시술 시점으로부터 합리적인 시간적 연관성을 가지고 있 | 풀어서 설명하거나 특정한 사안에 대하여 식품의약품안전처의 | 입장을 기술하는 것입니까?  (민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial.  Sleep, 39(1), 183–191.  | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다.  | 있는 영역(acceptable)’의 2단계로 구분할 수 있다.  | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다. ",
        "original_sentence": "Sleep, 39(1), 183–191. "
      }
    },
    {
      "chunk_id": "chunk_276",
      "text": "| 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 275,
        "window_size": 3,
        "char_count": 111,
        "word_count": 33,
        "page_number": 27,
        "window_text": "(민원인용) | 18-64세 불면증, | SHUTi | 248 | 1.79 | 국제 규격 |\n| (8) 「의료기기 임상시험계획 승인에 관한 규정」 | 다) 병용 약물 조사 | 3 | 수면 다원검사 (Polysomnography, PSG) | 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial.  Sleep, 39(1), 183–191.  | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다.  | 있는 영역(acceptable)’의 2단계로 구분할 수 있다.  | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다.  | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다. ",
        "original_sentence": "| 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다. "
      }
    },
    {
      "chunk_id": "chunk_277",
      "text": "| 있는 영역(acceptable)’의 2단계로 구분할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 276,
        "window_size": 3,
        "char_count": 37,
        "word_count": 7,
        "page_number": 3,
        "window_text": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 수면 위생, | 방지 | 점은 가장 좋은 건강 상태를 의미 | 적용 | 성능 | 시험 |\n| 인구학적 정보 | O | - | - | - | 사) 순응도 조사 | 1.16 | HealthWatch | 333 | 0.63 |\n| Trial.  Sleep, 39(1), 183–191.  | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다.  | 있는 영역(acceptable)’의 2단계로 구분할 수 있다.  | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다.  | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함. ",
        "original_sentence": "| 있는 영역(acceptable)’의 2단계로 구분할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_278",
      "text": "| PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 277,
        "window_size": 3,
        "char_count": 74,
        "word_count": 19,
        "page_number": 36,
        "window_text": "Sleep, 39(1), 183–191.  | 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다.  | 있는 영역(acceptable)’의 2단계로 구분할 수 있다.  | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다.  | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.  | H.",
        "original_sentence": "| PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_279",
      "text": "| / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 278,
        "window_size": 3,
        "char_count": 45,
        "word_count": 14,
        "page_number": 28,
        "window_text": "| 3 | 11) 범용 장비(스마트폰 또는 태블릿PC 등) 사용이 어려운 자 | 병용 약물 조사 | O | O | O | O | Deciding When to Submit a | 질환으로 정의한다.  | 있는 영역(acceptable)’의 2단계로 구분할 수 있다.  | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다.  | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.  | H. (2016) | 한다)를 말한다. ",
        "original_sentence": "| / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다. "
      }
    },
    {
      "chunk_id": "chunk_280",
      "text": "| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 279,
        "window_size": 3,
        "char_count": 160,
        "word_count": 47,
        "page_number": 7,
        "window_text": "| 있는 영역(acceptable)’의 2단계로 구분할 수 있다.  | PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다.  | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.  | H. (2016) | 한다)를 말한다.  | 수는 없으며 이상반응 문제가 생길 수 있다. ",
        "original_sentence": "| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함. "
      }
    },
    {
      "chunk_id": "chunk_281",
      "text": "| H.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 280,
        "window_size": 3,
        "char_count": 4,
        "word_count": 2,
        "page_number": 1,
        "window_text": "| PTB | 으며, 해당 의료기기의 알려진 특징으로 합리적인 설명을 할 수 있는 경우 | Index, ISI)를 이용하도록 한다.  | / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.  | H. (2016) | 한다)를 말한다.  | 수는 없으며 이상반응 문제가 생길 수 있다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다. ",
        "original_sentence": "| H."
      }
    },
    {
      "chunk_id": "chunk_282",
      "text": "(2016) | 한다)를 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 281,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 9,
        "window_text": "| / | / | 기존 로그인되어 있던 | 등록되어 건강보험 지불 | 시도한다.  | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.  | H. (2016) | 한다)를 말한다.  | 수는 없으며 이상반응 문제가 생길 수 있다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다.  | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다. ",
        "original_sentence": "(2016) | 한다)를 말한다. "
      }
    },
    {
      "chunk_id": "chunk_283",
      "text": "| 수는 없으며 이상반응 문제가 생길 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 282,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 45,
        "window_text": "| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 평가 항목 | 내용 | 치료 전 대비 6주 후 불면증 심각도 척도(ISI) 변화량 | 3) 기타 이차 유효성 평가 변수 | 8) 중간 분석 | - 탈락 또는 임상시험이 중지된 피험자의 경우 실시된 visit까지 기록함.  | H. (2016) | 한다)를 말한다.  | 수는 없으며 이상반응 문제가 생길 수 있다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다.  | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다.  | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다. ",
        "original_sentence": "| 수는 없으며 이상반응 문제가 생길 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_284",
      "text": "| ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 283,
        "window_size": 3,
        "char_count": 85,
        "word_count": 24,
        "page_number": 45,
        "window_text": "| H. (2016) | 한다)를 말한다.  | 수는 없으며 이상반응 문제가 생길 수 있다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다.  | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다.  | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다.  | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다. ",
        "original_sentence": "| ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다. "
      }
    },
    {
      "chunk_id": "chunk_285",
      "text": "| 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 284,
        "window_size": 3,
        "char_count": 95,
        "word_count": 26,
        "page_number": 40,
        "window_text": "(2016) | 한다)를 말한다.  | 수는 없으며 이상반응 문제가 생길 수 있다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다.  | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다.  | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다.  | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.  | - 일차목적 및 가설 | 가능하다. ",
        "original_sentence": "| 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다. "
      }
    },
    {
      "chunk_id": "chunk_286",
      "text": "| 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 285,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 9,
        "window_text": "| 수는 없으며 이상반응 문제가 생길 수 있다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다.  | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다.  | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다.  | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.  | - 일차목적 및 가설 | 가능하다.  | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다. ",
        "original_sentence": "| 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다. "
      }
    },
    {
      "chunk_id": "chunk_287",
      "text": "| 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 286,
        "window_size": 3,
        "char_count": 167,
        "word_count": 42,
        "page_number": 9,
        "window_text": "| ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | - 수면양상 및 낮시간 졸음 | 으로 하였을 경우 일반적으로 수면 일기가 사용된다.  | 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다.  | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다.  | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.  | - 일차목적 및 가설 | 가능하다.  | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
        "original_sentence": "| 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_288",
      "text": "| - 일차목적 및 가설 | 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 287,
        "window_size": 3,
        "char_count": 22,
        "word_count": 7,
        "page_number": 7,
        "window_text": "| 우울증 환자 | [insomnias] (수면 개시 및 유지 장애[불면증]) | 생산성 손실 점수 |\n| 받게 될 각종 검사나 절차 | 특성에 대한 정보들을 수집한다.  | 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다.  | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.  | - 일차목적 및 가설 | 가능하다.  | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 510(k) for a Software Change | 그림 6. ",
        "original_sentence": "| - 일차목적 및 가설 | 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_289",
      "text": "| 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 288,
        "window_size": 3,
        "char_count": 181,
        "word_count": 48,
        "page_number": 36,
        "window_text": "| 수면 일기 | Medical device software– | 경우 누워있는 시간을 지속적으로 증진시킨다.  | 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.  | - 일차목적 및 가설 | 가능하다.  | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 510(k) for a Software Change | 그림 6.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다. ",
        "original_sentence": "| 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다. "
      }
    },
    {
      "chunk_id": "chunk_290",
      "text": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 289,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 44,
        "window_text": "| 의료기기내 소프트웨어 변경에 따른 지침 | 가이드’ |\n| 과거병력 조사 | O | - | - | - | 4 | 단축형 우울증상 평가 척도 | (Quick Inventory of Depressive Symptomatology, QIDS) | 경우에는 그 이유의 타당성을 면밀히 검토하여야 한다.  | - 일차목적 및 가설 | 가능하다.  | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 510(k) for a Software Change | 그림 6.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다.  | 투여기간, 목적을 확인한다. ",
        "original_sentence": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_291",
      "text": "| 510(k) for a Software Change | 그림 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 290,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 27,
        "window_text": "| - 일차목적 및 가설 | 가능하다.  | 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 510(k) for a Software Change | 그림 6.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다.  | 투여기간, 목적을 확인한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다. ",
        "original_sentence": "| 510(k) for a Software Change | 그림 6. "
      }
    },
    {
      "chunk_id": "chunk_292",
      "text": "불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 291,
        "window_size": 3,
        "char_count": 43,
        "word_count": 10,
        "page_number": 1,
        "window_text": "| 6) 관련성이 명백함(Definite) | 수면제 복용 후 잠자리에 들 때까지 시간 | - 매일 불면증 증상 확인을 위해 수면 일기를 입력 | 「의료기기법」 및 「의료기기법 시행 | 적용 | 성능 | 시험 |\n| 9 | 1) SHUTi: Sleep Healthy Using the Internet | 높은 등급이 된다.  | - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 510(k) for a Software Change | 그림 6.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다.  | 투여기간, 목적을 확인한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다.  이후 수면 위생에 대한 점검을 권유한다. ",
        "original_sentence": "불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다. "
      }
    },
    {
      "chunk_id": "chunk_293",
      "text": "| 투여기간, 목적을 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 292,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 7,
        "window_text": "| - 약물 복용력 등을 문진과 과거 진료 기록을 통해 조사한다.  | 510(k) for a Software Change | 그림 6.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다.  | 투여기간, 목적을 확인한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다.  이후 수면 위생에 대한 점검을 권유한다.  | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오. ",
        "original_sentence": "| 투여기간, 목적을 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_294",
      "text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 293,
        "window_size": 3,
        "char_count": 55,
        "word_count": 14,
        "page_number": 3,
        "window_text": "| 510(k) for a Software Change | 그림 6.  불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다.  | 투여기간, 목적을 확인한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다.  이후 수면 위생에 대한 점검을 권유한다.  | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.  | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다. ",
        "original_sentence": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_295",
      "text": "이후 수면 위생에 대한 점검을 권유한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 294,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 17,
        "window_text": "불면증 개선 디지털치료기기 임상시험 선행연구 결과 2 | 난수표가 적용된다.  | 투여기간, 목적을 확인한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다.  이후 수면 위생에 대한 점검을 권유한다.  | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.  | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다.  | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다. ",
        "original_sentence": "이후 수면 위생에 대한 점검을 권유한다. "
      }
    },
    {
      "chunk_id": "chunk_296",
      "text": "| 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 295,
        "window_size": 3,
        "char_count": 100,
        "word_count": 27,
        "page_number": 3,
        "window_text": "| 투여기간, 목적을 확인한다.  | □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다.  이후 수면 위생에 대한 점검을 권유한다.  | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.  | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다.  | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다.  | 고려할 것을 권고한다. ",
        "original_sentence": "| 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_297",
      "text": "| 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 296,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 44,
        "window_text": "| □ 상위 법령을 일탈하여 새로운 규제를 신설ㆍ강화하거나 | 기기에서는 로그아웃될 것 | 한다.  이후 수면 위생에 대한 점검을 권유한다.  | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.  | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다.  | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다.  | 고려할 것을 권고한다.  | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15. ",
        "original_sentence": "| 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_298",
      "text": "| - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 297,
        "window_size": 3,
        "char_count": 169,
        "word_count": 49,
        "page_number": 13,
        "window_text": "이후 수면 위생에 대한 점검을 권유한다.  | 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.  | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다.  | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다.  | 고려할 것을 권고한다.  | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15.  | internet-based cognitive behavioral therapy for insomnia. ",
        "original_sentence": "| - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_299",
      "text": "| 고려할 것을 권고한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 298,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 21,
        "window_text": "| 가이던스 | 미국 | 의료기기 소프트웨어의 | 가이드’ | □ 예 | ■ 아니오 |\n| 2) 방문이 누락된 경우에는 해당 visit의 방문일란에 “ND\"로 기록하여 주십시오.  | 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다.  | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다.  | 고려할 것을 권고한다.  | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15.  | internet-based cognitive behavioral therapy for insomnia.  Sleep Medicine, 47, 77–85. ",
        "original_sentence": "| 고려할 것을 권고한다. "
      }
    },
    {
      "chunk_id": "chunk_300",
      "text": "| 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 299,
        "window_size": 3,
        "char_count": 120,
        "word_count": 31,
        "page_number": 36,
        "window_text": "| 회사명 | 대표이사 | 소재지 | 전화 | 기록서에 기록한다.  | - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다.  | 고려할 것을 권고한다.  | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15.  | internet-based cognitive behavioral therapy for insomnia.  Sleep Medicine, 47, 77–85.  | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다. ",
        "original_sentence": "| 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15. "
      }
    },
    {
      "chunk_id": "chunk_301",
      "text": "| internet-based cognitive behavioral therapy for insomnia. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 300,
        "window_size": 3,
        "char_count": 60,
        "word_count": 7,
        "page_number": 9,
        "window_text": "| - 약물 사용력(약, 술, 커피, 담배, 불법적 약물 등) | = (건강 문제로 인해 손실된 시간의 비율) + [(1 - 건강 |\n| of pills to bedtime) | 순응도 조사 | - | O | O | - | (2) 이차 유효성 평가지표 | (Sleep education, | 기록한다.  | 고려할 것을 권고한다.  | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15.  | internet-based cognitive behavioral therapy for insomnia.  Sleep Medicine, 47, 77–85.  | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다.  | 식품의약품안전처장의 승인을 받아야 한다. ",
        "original_sentence": "| internet-based cognitive behavioral therapy for insomnia. "
      }
    },
    {
      "chunk_id": "chunk_302",
      "text": "Sleep Medicine, 47, 77–85. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 301,
        "window_size": 3,
        "char_count": 27,
        "word_count": 4,
        "page_number": 35,
        "window_text": "| 고려할 것을 권고한다.  | 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15.  | internet-based cognitive behavioral therapy for insomnia.  Sleep Medicine, 47, 77–85.  | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다.  | 식품의약품안전처장의 승인을 받아야 한다.  | 얻는 전 과정에 참석하여야 한다. ",
        "original_sentence": "Sleep Medicine, 47, 77–85. "
      }
    },
    {
      "chunk_id": "chunk_303",
      "text": "| 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 302,
        "window_size": 3,
        "char_count": 93,
        "word_count": 26,
        "page_number": 7,
        "window_text": "| 이상반응이 임상시험용 의료기기의 시술 시점으로부터 합리적인 시간적 연관성을 가 | / | / | Part 1: Guidance on the |\n| 기타 확인 | 2) 일반적 주의 | Med 2(1),10-15.  | internet-based cognitive behavioral therapy for insomnia.  Sleep Medicine, 47, 77–85.  | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다.  | 식품의약품안전처장의 승인을 받아야 한다.  | 얻는 전 과정에 참석하여야 한다.  | 관리 결과가 검증되어야 한다. ",
        "original_sentence": "| 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_304",
      "text": "| 식품의약품안전처장의 승인을 받아야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 303,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 44,
        "window_text": "| internet-based cognitive behavioral therapy for insomnia.  Sleep Medicine, 47, 77–85.  | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다.  | 식품의약품안전처장의 승인을 받아야 한다.  | 얻는 전 과정에 참석하여야 한다.  | 관리 결과가 검증되어야 한다.  | - 본 연구는 중간 분석을 수행하지 않는다. ",
        "original_sentence": "| 식품의약품안전처장의 승인을 받아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_305",
      "text": "| 얻는 전 과정에 참석하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 304,
        "window_size": 3,
        "char_count": 21,
        "word_count": 6,
        "page_number": 44,
        "window_text": "Sleep Medicine, 47, 77–85.  | 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다.  | 식품의약품안전처장의 승인을 받아야 한다.  | 얻는 전 과정에 참석하여야 한다.  | 관리 결과가 검증되어야 한다.  | - 본 연구는 중간 분석을 수행하지 않는다.  | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다. ",
        "original_sentence": "| 얻는 전 과정에 참석하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_306",
      "text": "| 관리 결과가 검증되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 305,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 38,
        "window_text": "| 2) 의료기기의 사용목적 : 환자의 불면 증상을 정량적으로 개선 | : (치료 6주 후 ISI 점수) – (치료 전 ISI 점수) | 대리인)에게 제공해야 한다.  | 식품의약품안전처장의 승인을 받아야 한다.  | 얻는 전 과정에 참석하여야 한다.  | 관리 결과가 검증되어야 한다.  | - 본 연구는 중간 분석을 수행하지 않는다.  | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.  | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다. ",
        "original_sentence": "| 관리 결과가 검증되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_307",
      "text": "| - 본 연구는 중간 분석을 수행하지 않는다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 306,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 43,
        "window_text": "| 식품의약품안전처장의 승인을 받아야 한다.  | 얻는 전 과정에 참석하여야 한다.  | 관리 결과가 검증되어야 한다.  | - 본 연구는 중간 분석을 수행하지 않는다.  | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.  | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다.  | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까? ",
        "original_sentence": "| - 본 연구는 중간 분석을 수행하지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_308",
      "text": "| ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 307,
        "window_size": 3,
        "char_count": 34,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| 얻는 전 과정에 참석하여야 한다.  | 관리 결과가 검증되어야 한다.  | - 본 연구는 중간 분석을 수행하지 않는다.  | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.  | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다.  | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까?  | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. ",
        "original_sentence": "| ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_309",
      "text": "| 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 308,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 3,
        "window_text": "| 관리 결과가 검증되어야 한다.  | - 본 연구는 중간 분석을 수행하지 않는다.  | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.  | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다.  | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까?  | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
        "original_sentence": "| 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_310",
      "text": "| 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 309,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 3,
        "window_text": "| - 본 연구는 중간 분석을 수행하지 않는다.  | ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.  | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다.  | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까?  | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n",
        "original_sentence": "| 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까? "
      }
    },
    {
      "chunk_id": "chunk_311",
      "text": "| 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 310,
        "window_size": 3,
        "char_count": 122,
        "word_count": 22,
        "page_number": 9,
        "window_text": "| ⦁ 수면 일기에는 다음과 같은 사항들이 포함되어야 한다.  | 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다.  | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까?  | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n",
        "original_sentence": "| 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다. "
      }
    },
    {
      "chunk_id": "chunk_312",
      "text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 311,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 3,
        "window_text": "| 담당자가 임상시험 수행이 불가능한 것으로 판단한 경우 | 평가를 제시한다.  | 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까?  | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n",
        "original_sentence": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_313",
      "text": "지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 312,
        "window_size": 3,
        "char_count": 85,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| 반응이 사라지는 경우 | 민원인을 구속하는 내용이 있습니까?  | 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다. ",
        "original_sentence": "지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_314",
      "text": "상기 사항에 대하여 확인하였음.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 313,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| 규칙」,「의료기기 허가·신고·심사 등에 |\n**2) Cohen’s d: 평균 변화량(기저시점 - Post-treatment 시점)을 기저시점의 표준편차로 나눈 값**\n\n**[표 끝]**\n\n으로 고려하시기 바랍니다.  그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다.  또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2. ",
        "original_sentence": "상기 사항에 대하여 확인하였음.\n\n"
      }
    },
    {
      "chunk_id": "chunk_315",
      "text": "2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 314,
        "window_size": 3,
        "char_count": 282,
        "word_count": 58,
        "page_number": 4,
        "window_text": "그럼에도 불구하고 동 지침서ㆍ안내서의 제정이\n\n필요한 경우 그 사유를 아래에 기재해 주시기 바랍니다.\n\n 지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다.  또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2.  문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ. ",
        "original_sentence": "2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_316",
      "text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 315,
        "window_size": 3,
        "char_count": 103,
        "word_count": 22,
        "page_number": 5,
        "window_text": "지침서ㆍ안내서\n\n사항\n\n☞ 상기 질문에 ‘예’라고 답하신 경우 상위법령 일탈 내용을 삭제하시고 지침서ㆍ\n\n안내서 제ㆍ개정 절차를 진행하시기 바랍니다.\n\n 상기 사항에 대하여 확인하였음.\n\n 2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다.  또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2.  문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ.  개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1. ",
        "original_sentence": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다. "
      }
    },
    {
      "chunk_id": "chunk_317",
      "text": "또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 316,
        "window_size": 3,
        "char_count": 191,
        "word_count": 42,
        "page_number": 9,
        "window_text": "상기 사항에 대하여 확인하였음.\n\n 2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다.  또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2.  문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ.  개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1.  배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2. ",
        "original_sentence": "또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_318",
      "text": "문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 317,
        "window_size": 3,
        "char_count": 154,
        "word_count": 27,
        "page_number": 7,
        "window_text": "2021년  12월  8일\n\n담당자\n\n한 영 민\n\n확  인(부서장)\n\n강 영 규\n\n<!-- PAGE_4 -->\n###### 제·개정 이력\n\n불면증 개선 디지털치료기기 안전성·성능 평가 및 임상시험계획서\n\n작성 가이드라인(민원인 안내서)\n\n불면증 개선 디지털치료기기 안전성·성능\n\n평가 및 임상시험계획서 작성 가이드라인\n\n(민원인 안내서) 제정\n\n이 안내서는 불면증 개선 디지털치료기기의 안전성·성능 평가 및 임상시험계획서\n\n작성에 대하여 알기 쉽게 설명하거나 식품의약품안전처의 입장을 기술한 것입니다.\n\n 본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다.  또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2.  문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ.  개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1.  배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2.  적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3. ",
        "original_sentence": "문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ. "
      }
    },
    {
      "chunk_id": "chunk_319",
      "text": "개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 318,
        "window_size": 3,
        "char_count": 127,
        "word_count": 9,
        "page_number": 7,
        "window_text": "본 안내서는 대외적으로 법적 효력을 가지는 것이 아니므로 본문의 기술방식\n\n(‘∼하여야 한다’ 등)에도 불구하고 민원인 여러분께서 반드시 준수하셔야 하는 사항이\n\n아님을 알려드립니다.  또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2.  문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ.  개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1.  배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2.  적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3.  용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4. ",
        "original_sentence": "개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_320",
      "text": "배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 319,
        "window_size": 3,
        "char_count": 119,
        "word_count": 10,
        "page_number": 7,
        "window_text": "또한, 본 안내서는 2021년 12월 현재의 과학적ㆍ기술적 사실\n\n및 유효한 법규를 토대로 작성되었으므로 이후 최신 개정법규 내용 및 구체적인\n\n※ “민원인 안내서”란 대내외적으로 법령 또는 고시ㆍ훈령ㆍ예규 등을 알기 쉽게 풀어서 설명하거나\n\n특정한 사안에 대하여 식품의약품안전처의 입장을 기술하는 것(식품의약품안전처 지침서 등의\n\n- 2.  문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ.  개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1.  배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2.  적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3.  용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4.  현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ. ",
        "original_sentence": "배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_321",
      "text": "적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 320,
        "window_size": 3,
        "char_count": 123,
        "word_count": 9,
        "page_number": 7,
        "window_text": "문의처\n식품의약품안전처 식품의약품안전평가원 의료기기심사부(디지털헬스기기팀)\n\n전화 : (043) 719-3948\n\nFAX : (043) 719-3940\n\n<!-- PAGE_7 -->\n# 목\n\n<!-- PAGE_7 -->\n# 차\n\n<!-- PAGE_7 -->\n###### Ⅰ.  개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1.  배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2.  적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3.  용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4.  현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ.  안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1. ",
        "original_sentence": "적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_322",
      "text": "용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 321,
        "window_size": 3,
        "char_count": 123,
        "word_count": 9,
        "page_number": 7,
        "window_text": "개 요 ····························································································· 1\n\n<!-- PAGE_7 -->\n###### 1.  배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2.  적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3.  용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4.  현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ.  안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1.  국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2. ",
        "original_sentence": "용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_323",
      "text": "현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 322,
        "window_size": 3,
        "char_count": 129,
        "word_count": 9,
        "page_number": 7,
        "window_text": "배경 및 목적 ················································································· 1\n\n<!-- PAGE_7 -->\n###### 2.  적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3.  용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4.  현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ.  안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1.  국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2.  안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3. ",
        "original_sentence": "현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ. "
      }
    },
    {
      "chunk_id": "chunk_324",
      "text": "안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 323,
        "window_size": 3,
        "char_count": 102,
        "word_count": 9,
        "page_number": 7,
        "window_text": "적용 범위 ······················································································· 1\n\n<!-- PAGE_7 -->\n###### 3.  용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4.  현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ.  안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1.  국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2.  안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3.  성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ. ",
        "original_sentence": "안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_325",
      "text": "국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 324,
        "window_size": 3,
        "char_count": 92,
        "word_count": 12,
        "page_number": 7,
        "window_text": "용어 설명 ······················································································· 3\n\n<!-- PAGE_7 -->\n###### 4.  현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ.  안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1.  국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2.  안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3.  성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ.  임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ. ",
        "original_sentence": "국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_326",
      "text": "안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 325,
        "window_size": 3,
        "char_count": 112,
        "word_count": 10,
        "page_number": 7,
        "window_text": "현 황 ······························································································· 5\n\n<!-- PAGE_7 -->\n###### Ⅱ.  안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1.  국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2.  안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3.  성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ.  임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ.  참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1. ",
        "original_sentence": "안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_327",
      "text": "성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 326,
        "window_size": 3,
        "char_count": 115,
        "word_count": 10,
        "page_number": 7,
        "window_text": "안전성·성능 평가 ····························································· 28\n\n<!-- PAGE_7 -->\n###### 1.  국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2.  안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3.  성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ.  임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ.  참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1.  배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n",
        "original_sentence": "성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ. "
      }
    },
    {
      "chunk_id": "chunk_328",
      "text": "임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 327,
        "window_size": 3,
        "char_count": 60,
        "word_count": 13,
        "page_number": 7,
        "window_text": "국내외 관련 규격 및 가이드라인 ··········································· 28\n\n<!-- PAGE_7 -->\n###### 2.  안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3.  성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ.  임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ.  참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1.  배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n 본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n",
        "original_sentence": "임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ. "
      }
    },
    {
      "chunk_id": "chunk_329",
      "text": "참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 328,
        "window_size": 3,
        "char_count": 176,
        "word_count": 23,
        "page_number": 8,
        "window_text": "안전성 평가 항목 ······································································· 31\n\n<!-- PAGE_7 -->\n###### 3.  성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ.  임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ.  참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1.  배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n 본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n <!-- PAGE_8 -->\n###### 2. ",
        "original_sentence": "참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_330",
      "text": "배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 329,
        "window_size": 3,
        "char_count": 119,
        "word_count": 29,
        "page_number": 7,
        "window_text": "성능 평가 항목 ··········································································· 43\n\n<!-- PAGE_7 -->\n###### Ⅲ.  임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ.  참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1.  배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n 본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n <!-- PAGE_8 -->\n###### 2.  적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n",
        "original_sentence": "배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_331",
      "text": "본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 330,
        "window_size": 3,
        "char_count": 112,
        "word_count": 26,
        "page_number": 1,
        "window_text": "임상시험계획서 작성 시 고려사항 및 예시 ······ 45\n\n<!-- PAGE_7 -->\n###### Ⅳ.  참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1.  배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n 본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n <!-- PAGE_8 -->\n###### 2.  적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n 단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n",
        "original_sentence": "본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_332",
      "text": "<!-- PAGE_8 -->\n###### 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 331,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 8,
        "window_text": "참고문헌 ················································································· 118\n\n- - 1 -\n<!-- PAGE_8 -->\n#### Ⅰ\n\n<!-- PAGE_8 -->\n#### 개 요\n\n<!-- PAGE_8 -->\n###### 1.  배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n 본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n <!-- PAGE_8 -->\n###### 2.  적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n 단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n - - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다. ",
        "original_sentence": "<!-- PAGE_8 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_333",
      "text": "적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 332,
        "window_size": 3,
        "char_count": 135,
        "word_count": 25,
        "page_number": 1,
        "window_text": "배경 및 목적\n\n식품의약품안전처는 정부 지원 과제 중 디지털치료기기에 특화된\n\n과제의 제품 설계부터 제품화에 필요한 안전성·성능 평가 및 임상시험\n\n계획서 작성 방법 제공을 통한 신속 제품화 지원을 하고 있다.\n\n 본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n <!-- PAGE_8 -->\n###### 2.  적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n 단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n - - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.  | 날짜 (월/일) | 1. ",
        "original_sentence": "적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_334",
      "text": "단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 333,
        "window_size": 3,
        "char_count": 145,
        "word_count": 26,
        "page_number": 7,
        "window_text": "본 가이드라인은 “불면증 개선 디지털치료기기”의 안전성 및 성능\n\n평가 방법, 임상시험계획서 작성 시 고려사항 및 예시를 구체적으로\n\n제시하여 신속 제품화를 위한 맞춤형 기술 지원을 목적으로 한다.\n\n <!-- PAGE_8 -->\n###### 2.  적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n 단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n - - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.  | 날짜 (월/일) | 1.  전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다. ",
        "original_sentence": "단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_335",
      "text": "- - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 334,
        "window_size": 3,
        "char_count": 86,
        "word_count": 20,
        "page_number": 7,
        "window_text": "<!-- PAGE_8 -->\n###### 2.  적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n 단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n - - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.  | 날짜 (월/일) | 1.  전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.  | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다. ",
        "original_sentence": "- - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_336",
      "text": "| 날짜 (월/일) | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 335,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 27,
        "window_text": "적용 범위\n\n본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 「의료기기\n\n품목 및 품목별 등급에 관한 규정(식약처 고시 제2021-83호)」의 품목\n\n분류에 따라 인지치료소프트웨어(2등급, E06060.02) 의료기기로 분류\n\n된다.\n\n 단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n - - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.  | 날짜 (월/일) | 1.  전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.  | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다.  피험자 배정과 처리 | 1. ",
        "original_sentence": "| 날짜 (월/일) | 1. "
      }
    },
    {
      "chunk_id": "chunk_337",
      "text": "전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 336,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 100,
        "window_text": "단, 추후 불면증 외 동반된 정신과적 증상에 대한 평가 또는 치료를\n\n동시에 목적으로 한다면 심리평가소프트웨어(2등급, E06050.01) 또는\n\n정서장애치료소프트웨어(2등급, E06070.01)의 의료기기 분류를 추가하여\n\n조합의료기기로 분류할 수 있다.\n\n - - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.  | 날짜 (월/일) | 1.  전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.  | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다.  피험자 배정과 처리 | 1.  국내외 관련 규격 및 가이드라인 | 작성하여야 한다. ",
        "original_sentence": "전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다. "
      }
    },
    {
      "chunk_id": "chunk_338",
      "text": "| IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 337,
        "window_size": 3,
        "char_count": 135,
        "word_count": 38,
        "page_number": 9,
        "window_text": "- - 2 -\n품목명\n\n영문명\n\n등급\n\n분류번호\n\n품목 정의\n\n**[표 시작]**\n\n| - 시험자는 시험책임자, 시험담당자, 임상시험 조정자를 포함한다.  | 날짜 (월/일) | 1.  전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.  | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다.  피험자 배정과 처리 | 1.  국내외 관련 규격 및 가이드라인 | 작성하여야 한다.  | 구조, 성능 등을 구체적으로 기재하도록 한다. ",
        "original_sentence": "| IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_339",
      "text": "피험자 배정과 처리 | 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 338,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 27,
        "window_text": "| 날짜 (월/일) | 1.  전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.  | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다.  피험자 배정과 처리 | 1.  국내외 관련 규격 및 가이드라인 | 작성하여야 한다.  | 구조, 성능 등을 구체적으로 기재하도록 한다.  | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다. ",
        "original_sentence": "피험자 배정과 처리 | 1. "
      }
    },
    {
      "chunk_id": "chunk_340",
      "text": "국내외 관련 규격 및 가이드라인 | 작성하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 339,
        "window_size": 3,
        "char_count": 30,
        "word_count": 8,
        "page_number": 35,
        "window_text": "전날 ＿:＿부터 ＿:＿까지 낮잠을 잤다.  | IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다.  피험자 배정과 처리 | 1.  국내외 관련 규격 및 가이드라인 | 작성하여야 한다.  | 구조, 성능 등을 구체적으로 기재하도록 한다.  | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다.  | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다. ",
        "original_sentence": "국내외 관련 규격 및 가이드라인 | 작성하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_341",
      "text": "| 구조, 성능 등을 구체적으로 기재하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 340,
        "window_size": 3,
        "char_count": 28,
        "word_count": 7,
        "page_number": 44,
        "window_text": "| IEC/TR | Cognitive | 인지기능을 개선하는데 사용하는 소프트 | 가이드’ |\n| --- | --- | --- | --- | --- | --- | --- |\n| 그 외 임상시험의 목적에 따라 다른 디자인을 사용할 수도 있다.  피험자 배정과 처리 | 1.  국내외 관련 규격 및 가이드라인 | 작성하여야 한다.  | 구조, 성능 등을 구체적으로 기재하도록 한다.  | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다.  | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다.  | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다. ",
        "original_sentence": "| 구조, 성능 등을 구체적으로 기재하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_342",
      "text": "| ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 341,
        "window_size": 3,
        "char_count": 169,
        "word_count": 33,
        "page_number": 36,
        "window_text": "피험자 배정과 처리 | 1.  국내외 관련 규격 및 가이드라인 | 작성하여야 한다.  | 구조, 성능 등을 구체적으로 기재하도록 한다.  | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다.  | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다.  | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다.  | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다. ",
        "original_sentence": "| ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다. "
      }
    },
    {
      "chunk_id": "chunk_343",
      "text": "| 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 342,
        "window_size": 3,
        "char_count": 52,
        "word_count": 15,
        "page_number": 13,
        "window_text": "국내외 관련 규격 및 가이드라인 | 작성하여야 한다.  | 구조, 성능 등을 구체적으로 기재하도록 한다.  | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다.  | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다.  | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다.  | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.  | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다. ",
        "original_sentence": "| 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다. "
      }
    },
    {
      "chunk_id": "chunk_344",
      "text": "| 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 343,
        "window_size": 3,
        "char_count": 61,
        "word_count": 12,
        "page_number": 28,
        "window_text": "| 구조, 성능 등을 구체적으로 기재하도록 한다.  | ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다.  | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다.  | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다.  | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.  | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다.  | ⦁ 관찰 시기를 표기한다. ",
        "original_sentence": "| 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_345",
      "text": "| - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 344,
        "window_size": 3,
        "char_count": 36,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| ○ 관련성이 없음(Definitely not related) | 임상시험용 의료기기 관리자는 임상시험기관에서 임상시험용 해당 의료기기를 | 2) 수면 효율(Sleep Efficiency, SE) | 시험책임자는 의료기기법 시행규칙 제24조 제1항 제4호의 규정에 따라 임상 | 증가시키는 치료이다.  | 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다.  | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다.  | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.  | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다.  | ⦁ 관찰 시기를 표기한다.  | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다. ",
        "original_sentence": "| - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_346",
      "text": "| - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 345,
        "window_size": 3,
        "char_count": 58,
        "word_count": 19,
        "page_number": 36,
        "window_text": "| 라) 피험자 식별코드 부여 | 사) 이상반응 조사 | 하는 내용이 포함되어서는 안 된다.  | 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다.  | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.  | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다.  | ⦁ 관찰 시기를 표기한다.  | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다.  | 조사한다. ",
        "original_sentence": "| - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다. "
      }
    },
    {
      "chunk_id": "chunk_347",
      "text": "| ⦁ 관찰 시기를 표기한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 346,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 44,
        "window_text": "| 방문 3(Post-treatment, 7주 후), 방문 4(Follow-up, 6개월 후) | 수 있다.  | - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.  | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다.  | ⦁ 관찰 시기를 표기한다.  | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다.  | 조사한다.  | 하게 하거나, 애플리케이션을 통해 정보를 수집한다. ",
        "original_sentence": "| ⦁ 관찰 시기를 표기한다. "
      }
    },
    {
      "chunk_id": "chunk_348",
      "text": "| ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 347,
        "window_size": 3,
        "char_count": 51,
        "word_count": 14,
        "page_number": 13,
        "window_text": "| - 초기 수면 평가에는 최소 다음의 사항이 포함되어야 한다.  | - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다.  | ⦁ 관찰 시기를 표기한다.  | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다.  | 조사한다.  | 하게 하거나, 애플리케이션을 통해 정보를 수집한다.  | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정. ",
        "original_sentence": "| ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다. "
      }
    },
    {
      "chunk_id": "chunk_349",
      "text": "| 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 348,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 44,
        "window_text": "| - 치료 전 대비 6주 후 및 6개월 후 관해율, 반응율 | 보상이나 치료 방법 | 으로 구분한다.  | ⦁ 관찰 시기를 표기한다.  | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다.  | 조사한다.  | 하게 하거나, 애플리케이션을 통해 정보를 수집한다.  | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정.  30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다. ",
        "original_sentence": "| 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_350",
      "text": "| 하게 하거나, 애플리케이션을 통해 정보를 수집한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 349,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 44,
        "window_text": "| ⦁ 관찰 시기를 표기한다.  | ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다.  | 조사한다.  | 하게 하거나, 애플리케이션을 통해 정보를 수집한다.  | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정.  30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.  | sleep technologist. ",
        "original_sentence": "| 하게 하거나, 애플리케이션을 통해 정보를 수집한다. "
      }
    },
    {
      "chunk_id": "chunk_351",
      "text": "| 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 350,
        "window_size": 3,
        "char_count": 50,
        "word_count": 15,
        "page_number": 39,
        "window_text": "| ⦁ 정신과적 전문치료를 시작한 것으로 판단되는 경우 | 해제 문서를 기록 및 보관한다.  | 조사한다.  | 하게 하거나, 애플리케이션을 통해 정보를 수집한다.  | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정.  30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.  | sleep technologist.  St. ",
        "original_sentence": "| 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정. "
      }
    },
    {
      "chunk_id": "chunk_352",
      "text": "30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 351,
        "window_size": 3,
        "char_count": 85,
        "word_count": 20,
        "page_number": 9,
        "window_text": "| 조사한다.  | 하게 하거나, 애플리케이션을 통해 정보를 수집한다.  | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정.  30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.  | sleep technologist.  St.  Louis: Elsevier; 2014. ",
        "original_sentence": "30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다. "
      }
    },
    {
      "chunk_id": "chunk_353",
      "text": "| sleep technologist. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 352,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 1,
        "window_text": "| 하게 하거나, 애플리케이션을 통해 정보를 수집한다.  | 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정.  30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.  | sleep technologist.  St.  Louis: Elsevier; 2014.  | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다. ",
        "original_sentence": "| sleep technologist. "
      }
    },
    {
      "chunk_id": "chunk_354",
      "text": "St. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 353,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 128,
        "window_text": "| 대해 이미 알려져 있는 정보와 일관된 양상을 보이는 경우 | 제에 대한 태도를 측정.  30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.  | sleep technologist.  St.  Louis: Elsevier; 2014.  | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다.  | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다. ",
        "original_sentence": "St. "
      }
    },
    {
      "chunk_id": "chunk_355",
      "text": "Louis: Elsevier; 2014. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 354,
        "window_size": 3,
        "char_count": 23,
        "word_count": 3,
        "page_number": 9,
        "window_text": "30문항(original) 또는 16문항을 | ‘의료기기 소프트웨어 검증 및 유효성 |\n| - 임상시험 전, 중, 후에 관찰해야 할 항목들을 나열한다.  | sleep technologist.  St.  Louis: Elsevier; 2014.  | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다.  | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.  | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오. ",
        "original_sentence": "Louis: Elsevier; 2014. "
      }
    },
    {
      "chunk_id": "chunk_356",
      "text": "| 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 355,
        "window_size": 3,
        "char_count": 425,
        "word_count": 109,
        "page_number": 9,
        "window_text": "| sleep technologist.  St.  Louis: Elsevier; 2014.  | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다.  | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.  | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오.  | 80001-2-1 | therapy | 표 11. ",
        "original_sentence": "| 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다. "
      }
    },
    {
      "chunk_id": "chunk_357",
      "text": "| 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 356,
        "window_size": 3,
        "char_count": 227,
        "word_count": 60,
        "page_number": 9,
        "window_text": "St.  Louis: Elsevier; 2014.  | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다.  | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.  | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오.  | 80001-2-1 | therapy | 표 11.  위해요인 식별 예시 | 2 | E06060.02 | 웨어. ",
        "original_sentence": "| 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다. "
      }
    },
    {
      "chunk_id": "chunk_358",
      "text": "| 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 357,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 27,
        "window_text": "Louis: Elsevier; 2014.  | 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다.  | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.  | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오.  | 80001-2-1 | therapy | 표 11.  위해요인 식별 예시 | 2 | E06060.02 | 웨어.  가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다. ",
        "original_sentence": "| 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_359",
      "text": "| 80001-2-1 | therapy | 표 11. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 358,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 9,
        "window_text": "| 인지치료 | 6 | 식약처장은 「의료법」에 따른 의료기관 중 임상시험에 필요한 시설, 인력 및 | 1) 방문 1 (스크리닝 및 검사일, Screening) | 1) 불면증 심각도 척도(Insomnia Severity Index, ISI) | : 대조군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | ◈ 임상시험 완료 여부 | □ | 완 료 | □ | 미 완 료 | (필수) | □ ‘이상 의료기기’의 반응 | 소프트웨어 | 유닛 검증 | - 근무시간(교대근무), 일주기리듬(자고 깨는 시간이 앞으로 당겨지거나 | Sleepio | – Part 2-1: Step by step | 개발 소프트웨어의 범위, 규모 | 및 소프트웨어 안전에 적합한 | 개발 활동을 위하여 소프트웨어 | 개발 계획을 수립한다.  | 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.  | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오.  | 80001-2-1 | therapy | 표 11.  위해요인 식별 예시 | 2 | E06060.02 | 웨어.  가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.  | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다. ",
        "original_sentence": "| 80001-2-1 | therapy | 표 11. "
      }
    },
    {
      "chunk_id": "chunk_360",
      "text": "위해요인 식별 예시 | 2 | E06060.02 | 웨어. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 359,
        "window_size": 3,
        "char_count": 33,
        "word_count": 9,
        "page_number": 9,
        "window_text": "| 의료기기의 위험관리 | 가이드’ | 가이드’ | 국외 |\n| 2) 사용되는 통신 기술 : LAN, Wi-fi | 임상시험용 ‘불면증 개선 디지털치료기기’의 안전성과 유효성을 증명하고자 | (민원인 안내서) | - 18세 이상의 불면증 환자를 위한 스마트폰 앱 |\n| ※ 피험자의 선정·제외 기준, 인원 및 근거 | 하기 위해서는 사전 정보가 필요한데, 여기에 포함되어야 할 필수 정보로는 다음이 있다.  | 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오.  | 80001-2-1 | therapy | 표 11.  위해요인 식별 예시 | 2 | E06060.02 | 웨어.  가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.  | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다.  | 유지한다. ",
        "original_sentence": "위해요인 식별 예시 | 2 | E06060.02 | 웨어. "
      }
    },
    {
      "chunk_id": "chunk_361",
      "text": "가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 360,
        "window_size": 3,
        "char_count": 597,
        "word_count": 137,
        "page_number": 39,
        "window_text": "| 5 | 1) 검정색 볼펜을 사용하여 기록하여 주십시오.  | 80001-2-1 | therapy | 표 11.  위해요인 식별 예시 | 2 | E06060.02 | 웨어.  가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.  | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다.  | 유지한다.  | 아니 된다. ",
        "original_sentence": "가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_362",
      "text": "| ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 361,
        "window_size": 3,
        "char_count": 108,
        "word_count": 27,
        "page_number": 36,
        "window_text": "| 80001-2-1 | therapy | 표 11.  위해요인 식별 예시 | 2 | E06060.02 | 웨어.  가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.  | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다.  | 유지한다.  | 아니 된다.  | 같이 분류한다. ",
        "original_sentence": "| ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_363",
      "text": "| 유지한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 362,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 40,
        "window_text": "위해요인 식별 예시 | 2 | E06060.02 | 웨어.  가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.  | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다.  | 유지한다.  | 아니 된다.  | 같이 분류한다.  | 산출 공식은 아래와 같다. ",
        "original_sentence": "| 유지한다. "
      }
    },
    {
      "chunk_id": "chunk_364",
      "text": "| 아니 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 363,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 8,
        "window_text": "가상ㆍ증강(VRㆍAR) 기반 소프트 |\n| 보관, 관리하는 임상의, 의료기사 또는 간호사 등으로 임상시험기관의 장이 지정한 | 1) 개요 | 5) 삶의 질 | 서면 동의 일자 (YY/MM/DD) | (낮잠을 잤던 시간을 모두 표시) | 자극 조절법 | 임상시험에 사용되는 임상시험용 의료기기에서 발생한, 모든 유해하고 의도되지 않은 반응으 | 뒤로 늦춰져 있지 않은지) | (short scale) 통해 리커트 척도로 측정 | 확인’ 자료 등 허가·심사 시 제출해야 할 |\n| 할당에 있어 편향(Bias)을 줄이기 위해 무작위배정(Randomization)과 눈가림(Blinding) | 기구를 갖춘 의료기관을 임상시험기관으로 지정하여 운영하고 있으며, 임상시험 | 시험을 시작하기 전에 피험자로부터 동의를 받고 이를 문서화할 때, 헬싱키 선언에 | 소프트웨어 | 인지치료, | (Big Health) | 소프트웨어 | 개발 계획 | risk management of medical | 방법에 대한 국제 규격 |\n| ‘의료기기 임상시험 관리기준’(의료기기법 시행규칙 [별표3])에 의거, 정한 기간 | 시험자, 의뢰자, 모니터링요원 등의 의무사항을 정하여 제시한다.  | ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다.  | 유지한다.  | 아니 된다.  | 같이 분류한다.  | 산출 공식은 아래와 같다.  | 2. ",
        "original_sentence": "| 아니 된다. "
      }
    },
    {
      "chunk_id": "chunk_365",
      "text": "| 같이 분류한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 364,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 41,
        "window_text": "| ○ 관련성이 많음(Probably related) | - 임상시험용 의료기기를 사용하지 않은 경우 | 3) 통신 목적 : | ■ 환자의 생체정보 등의 개인의료정보 송수신 | 등을 제시한다.  | 유지한다.  | 아니 된다.  | 같이 분류한다.  | 산출 공식은 아래와 같다.  | 2.  지난밤에, 약 ＿을(를) ＿mg 복용하였다. ",
        "original_sentence": "| 같이 분류한다. "
      }
    },
    {
      "chunk_id": "chunk_366",
      "text": "| 산출 공식은 아래와 같다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 365,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 74,
        "window_text": "| 유지한다.  | 아니 된다.  | 같이 분류한다.  | 산출 공식은 아래와 같다.  | 2.  지난밤에, 약 ＿을(를) ＿mg 복용하였다.  | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다. ",
        "original_sentence": "| 산출 공식은 아래와 같다. "
      }
    },
    {
      "chunk_id": "chunk_367",
      "text": "| 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 366,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 9,
        "window_text": "| 아니 된다.  | 같이 분류한다.  | 산출 공식은 아래와 같다.  | 2.  지난밤에, 약 ＿을(를) ＿mg 복용하였다.  | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.  | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다. ",
        "original_sentence": "| 2. "
      }
    },
    {
      "chunk_id": "chunk_368",
      "text": "지난밤에, 약 ＿을(를) ＿mg 복용하였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 367,
        "window_size": 3,
        "char_count": 25,
        "word_count": 5,
        "page_number": 45,
        "window_text": "| 같이 분류한다.  | 산출 공식은 아래와 같다.  | 2.  지난밤에, 약 ＿을(를) ＿mg 복용하였다.  | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.  | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다.  | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다. ",
        "original_sentence": "지난밤에, 약 ＿을(를) ＿mg 복용하였다. "
      }
    },
    {
      "chunk_id": "chunk_369",
      "text": "| 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 368,
        "window_size": 3,
        "char_count": 44,
        "word_count": 11,
        "page_number": 87,
        "window_text": "| 산출 공식은 아래와 같다.  | 2.  지난밤에, 약 ＿을(를) ＿mg 복용하였다.  | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.  | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다.  | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.  | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오. ",
        "original_sentence": "| 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_370",
      "text": "| 근거에 기반한 건강한 수면을 위한 가이드를 제공한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 369,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 44,
        "window_text": "| 2.  지난밤에, 약 ＿을(를) ＿mg 복용하였다.  | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.  | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다.  | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.  | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.  | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다. ",
        "original_sentence": "| 근거에 기반한 건강한 수면을 위한 가이드를 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_371",
      "text": "| 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 370,
        "window_size": 3,
        "char_count": 100,
        "word_count": 25,
        "page_number": 28,
        "window_text": "지난밤에, 약 ＿을(를) ＿mg 복용하였다.  | 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.  | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다.  | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.  | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.  | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다.  | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다. ",
        "original_sentence": "| 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다. "
      }
    },
    {
      "chunk_id": "chunk_372",
      "text": "| 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 371,
        "window_size": 3,
        "char_count": 76,
        "word_count": 21,
        "page_number": 9,
        "window_text": "| 그 사유 | 척도(ISI) 정보를 Baseline 지표로 활용할 수 있다.  | 근거에 기반한 건강한 수면을 위한 가이드를 제공한다.  | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.  | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.  | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다.  | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.  | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다.",
        "original_sentence": "| 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_373",
      "text": "| 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 372,
        "window_size": 3,
        "char_count": 302,
        "word_count": 71,
        "page_number": 41,
        "window_text": "| 근거에 기반한 건강한 수면을 위한 가이드를 제공한다.  | 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.  | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.  | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다.  | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.  | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다. **\n| 적응증을 포함하도록 한다. ",
        "original_sentence": "| 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_374",
      "text": "| 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 373,
        "window_size": 3,
        "char_count": 84,
        "word_count": 18,
        "page_number": 36,
        "window_text": "| 중지해야 한다고 판단한 경우 | 기반의 불면증 인지행동치료(CBT-I)로 행동, 인지, | (선택) |\n| 예시 | 하는 임상시험의 목적을 구체적으로 알 수 있도록 기입한다.  | 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.  | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다.  | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.  | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다. **\n| 적응증을 포함하도록 한다.  | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다. ",
        "original_sentence": "| 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다. "
      }
    },
    {
      "chunk_id": "chunk_375",
      "text": "| 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 374,
        "window_size": 3,
        "char_count": 103,
        "word_count": 28,
        "page_number": 45,
        "window_text": "| 1) 연구가설 | 1 | 1) 만 19세 이상 성인 | 2) 가능하면 약어의 사용을 피하고 Full term으로 기록하여 주십시오.  | 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다.  | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.  | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다. **\n| 적응증을 포함하도록 한다.  | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.  | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다. ",
        "original_sentence": "| 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다."
      }
    },
    {
      "chunk_id": "chunk_376",
      "text": "**\n| 적응증을 포함하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 375,
        "window_size": 3,
        "char_count": 20,
        "word_count": 5,
        "page_number": 44,
        "window_text": "| 가) 임상시험 설명 및 동의 | 임상시험 완료일(YY/MM/DD) | 로서, 임상시험에 사용되는 임상시험용 의료기기와의 인과관계를 배제할 수 없는 경우를 말한 | software | 스크리닝 및 | 수면상태의 생리적 변화를 연속으로 기록할 수 있는 임상 | 웨어를 포함 | 치료 기간 종료 | 1주 후(6주+1주) | (Post-treatment)3) |\n| (Stimulus | 첨부자료에 대하여 제시 |\n**자를 말하며, 임상시험용 의료기기와 비교하기 위하여 대조시험용 의료기기를 사용**\n| 2회기 | 전략이 잘 포함되어야 한다.  | 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.  | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다. **\n| 적응증을 포함하도록 한다.  | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.  | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다.  그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다. ",
        "original_sentence": "**\n| 적응증을 포함하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_377",
      "text": "| 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 376,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 39,
        "window_text": "| 기관은 「의료기기 임상시험기관 지정에 관한 규정(식약처 고시)」에 따라 식약처장 | 계획 승인일로부터 OO 개월”로 표시하고 근거자료를 제출한다.  | 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다. **\n| 적응증을 포함하도록 한다.  | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.  | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다.  그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다.  임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다. ",
        "original_sentence": "| 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다. "
      }
    },
    {
      "chunk_id": "chunk_378",
      "text": "| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 377,
        "window_size": 3,
        "char_count": 39,
        "word_count": 10,
        "page_number": 36,
        "window_text": "| 근거한 윤리적 원칙과 이 기준을 준수하여야 하며 피험자에게 주어지는 동의서 서식, | 교육 등의 파트로 구성된 약 20분 길의 총 6개 |\n**하는 원칙과 절차를 수립하여 제시한다. **\n| 적응증을 포함하도록 한다.  | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.  | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다.  그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다.  임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다.  | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다. ",
        "original_sentence": "| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_379",
      "text": "그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 378,
        "window_size": 3,
        "char_count": 105,
        "word_count": 29,
        "page_number": 7,
        "window_text": "**\n| 적응증을 포함하도록 한다.  | 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.  | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다.  그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다.  임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다.  | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.  | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다. ",
        "original_sentence": "그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다. "
      }
    },
    {
      "chunk_id": "chunk_380",
      "text": "임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 379,
        "window_size": 3,
        "char_count": 56,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 되지 않는 경우에 대한 원칙, 보상수준에 대한 기준을 포함한다.  | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다.  그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다.  임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다.  | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.  | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.  | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다. ",
        "original_sentence": "임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_381",
      "text": "| 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 380,
        "window_size": 3,
        "char_count": 57,
        "word_count": 12,
        "page_number": 9,
        "window_text": "| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 한다.  그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다.  임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다.  | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.  | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.  | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다.  | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다. ",
        "original_sentence": "| 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_382",
      "text": "| 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 381,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 41,
        "window_text": "그 밖에 임상시험 결과의 사용 범위에 따른 성능 평가를 위하여 이차 |\n| 의료인이 환자의 심리학적 상태를 평가, | 시험보고서 | (AB-1234) |\n| 할 경우 이를 함께 관리한다.  임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다.  | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.  | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.  | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다.  | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다.  | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다. ",
        "original_sentence": "| 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_383",
      "text": "| 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 382,
        "window_size": 3,
        "char_count": 39,
        "word_count": 12,
        "page_number": 7,
        "window_text": "임상시험용 의료기기 관리자의 성명, 소속 기관명 및 | 취급에 관한 사항을 추가로 확보할 수 있다.  | 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.  | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.  | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다.  | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다.  | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다.  | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다. ",
        "original_sentence": "| 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_384",
      "text": "| (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 383,
        "window_size": 3,
        "char_count": 159,
        "word_count": 41,
        "page_number": 45,
        "window_text": "| 시험보고서 | (AB-1234) |\n| 으로부터 의료기기 임상시험기관으로 지정받은 곳이어야 한다.  | 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.  | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다.  | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다.  | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다.  | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다.  | 하여야 | 한다. ",
        "original_sentence": "| (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_385",
      "text": "| (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 384,
        "window_size": 3,
        "char_count": 73,
        "word_count": 12,
        "page_number": 1,
        "window_text": "| 피험자 설명서 및 그 밖의 문서화된 정보는 심사위원회의 승인을 받아야 한다.  | 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다.  | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다.  | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다.  | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다.  | 하여야 | 한다.  따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다. ",
        "original_sentence": "| (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다. "
      }
    },
    {
      "chunk_id": "chunk_386",
      "text": "| 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 385,
        "window_size": 3,
        "char_count": 120,
        "word_count": 31,
        "page_number": 35,
        "window_text": "| 예시 | 증상의 | 평가 절차 등을 상세히 시험 방법을 기술한다.  | (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다.  | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다.  | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다.  | 하여야 | 한다.  따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.  | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다. ",
        "original_sentence": "| 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_387",
      "text": "| 하여야 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 386,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| (EEG), 안구운동(EOG), 하악 근전도(Chin EMG), 다리 근전도 |\n| 유효성 평가변수를 제시하여 각 임상 검사 항목 및 검사 방법에 대한 기준을 | 시험보고서 | (AB-1234) |\n| 4회기 | - 수면 일기를 통해 개개인의 수면의 정보를 얻어 |\n| 기재한다.  | (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다.  | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다.  | 하여야 | 한다.  따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.  | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다.  | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어. ",
        "original_sentence": "| 하여야 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_388",
      "text": "따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 387,
        "window_size": 3,
        "char_count": 77,
        "word_count": 18,
        "page_number": 36,
        "window_text": "| (Leg EMG), 심전도(EKG), 코골이(Snoring), 호흡(Respiratory |\n| 직명 등 인적사항을 기재한다.  | 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다.  | 하여야 | 한다.  따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.  | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다.  | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어.  가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다. ",
        "original_sentence": "따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_389",
      "text": "| Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 388,
        "window_size": 3,
        "char_count": 142,
        "word_count": 37,
        "page_number": 45,
        "window_text": "| 예시 | 예시 | 예시 | 5) 자료를 기록할 수 없는 경우 “실시하지 않음(ND: not done)”또는 “알 수 없음(UK: Unknown)”과 |\n| 예시 | 예시 |\n| 머목(모니터링)에서 정하고 있다.  | 하여야 | 한다.  따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.  | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다.  | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어.  가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.  | 1. ",
        "original_sentence": "| Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_390",
      "text": "| 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 389,
        "window_size": 3,
        "char_count": 105,
        "word_count": 26,
        "page_number": 28,
        "window_text": "| 하여야 | 한다.  따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.  | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다.  | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어.  가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.  | 1.  국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1. ",
        "original_sentence": "| 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어. "
      }
    },
    {
      "chunk_id": "chunk_391",
      "text": "가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 390,
        "window_size": 3,
        "char_count": 62,
        "word_count": 14,
        "page_number": 7,
        "window_text": "따라서 이상반응에 대한 임상시험용 의료기기와의 인과관계에 |\n| 피험자별 중지 사유를 포함한 관련 임상시험 자료의 처리 방법을 제시한다.  | Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다.  | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어.  가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.  | 1.  국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1.  불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3. ",
        "original_sentence": "가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_392",
      "text": "| 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 391,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 27,
        "window_text": "| Airflow), 호흡 운동(Respiratory Effort), 혈중 산소 포화 농도 |\n| 연번 | 시험 항목 | 시험 기준 | 시험방법 | 예시 |\n**- 이상반응에 대해 다른 명백한 원인이 있는 경우**\n| 대한 평가 기준을 제시하여야 한다.  | 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어.  가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.  | 1.  국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1.  불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3.  용어 설명\n\n- 가. ",
        "original_sentence": "| 1. "
      }
    },
    {
      "chunk_id": "chunk_393",
      "text": "국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 392,
        "window_size": 3,
        "char_count": 93,
        "word_count": 21,
        "page_number": 28,
        "window_text": "| 예시 | - Sleepio 사용 시작 시 개인의 수면 양상에 대한 | 정서장애(우울증 등)를 개선하는데 사용 |\n**정서장애치료**\n**예시**\n| 수면다원 검사 | 하는 소프트웨어.  가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.  | 1.  국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1.  불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3.  용어 설명\n\n- 가.  소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n",
        "original_sentence": "국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1. "
      }
    },
    {
      "chunk_id": "chunk_394",
      "text": "불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 393,
        "window_size": 3,
        "char_count": 264,
        "word_count": 61,
        "page_number": 10,
        "window_text": "가상ㆍ증강(VRㆍAR) 기반 | 첨부자료 |\n| 설명서에는 동 기준의 제7호 아목의 10)을 포함하여야 한다.  | 1.  국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1.  불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3.  용어 설명\n\n- 가.  소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n - 나. ",
        "original_sentence": "불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_395",
      "text": "용어 설명\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 394,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 41,
        "window_text": "| 1.  국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1.  불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3.  용어 설명\n\n- 가.  소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n - 나.  디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다. ",
        "original_sentence": "용어 설명\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_396",
      "text": "소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 395,
        "window_size": 3,
        "char_count": 119,
        "word_count": 20,
        "page_number": 9,
        "window_text": "국소 | 설문을 통해 개인화된 치료를 제공하는데 초점을 | OOO 기능이 구현되도록 입력값을 |\n**○ 평가 불가능(Unknown)**\n\n**[표 끝]**\n\n표 1.  불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3.  용어 설명\n\n- 가.  소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n - 나.  디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다.  불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n",
        "original_sentence": "소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_397",
      "text": "- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 396,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "불면증 개선 디지털치료기기 관련 의료기기 품목(식약처 고시 제2021-83호)\n\n※ 본 가이드라인에서 다루는 불면증 개선 디지털치료기기는 소프트웨어 의료기기로서,\n\n사용 시 필요한 범용 장비(스마트폰 또는 태블릿 PC 등)는 적용 범위에 포함되지\n\n않으나, 반드시 함께 병용해야 하기 때문에 전기용품 안전 인증과 전자파 적합\n\n※ 실생활 생활 습관을 추적 관찰하기 위해 기타 웨어러블 의료기기를 추가로 사용\n\n- - 3 -\n<!-- PAGE_10 -->\n###### 3.  용어 설명\n\n- 가.  소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n - 나.  디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다.  불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n - 라. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_398",
      "text": "디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 397,
        "window_size": 3,
        "char_count": 144,
        "word_count": 25,
        "page_number": 137,
        "window_text": "용어 설명\n\n- 가.  소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n - 나.  디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다.  불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n - 라.  수면 위생(Sleep hygiene)\n- 마. ",
        "original_sentence": "디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_399",
      "text": "불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 398,
        "window_size": 3,
        "char_count": 169,
        "word_count": 31,
        "page_number": 9,
        "window_text": "소프트웨어 의료기기(Software as a Medical Device, SaMD)\n하드웨어에 종속되지 않고 의료기기의 사용목적에 부합하는 기능을\n\n가지며 독립적인 형태의 소프트웨어만으로 이루어진 의료기기이다.\n\n - 나.  디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다.  불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n - 라.  수면 위생(Sleep hygiene)\n- 마.  수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n",
        "original_sentence": "불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_400",
      "text": "- 라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 399,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "- 나.  디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다.  불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n - 라.  수면 위생(Sleep hygiene)\n- 마.  수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n - 바. ",
        "original_sentence": "- 라. "
      }
    },
    {
      "chunk_id": "chunk_401",
      "text": "수면 위생(Sleep hygiene)\n- 마. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 400,
        "window_size": 3,
        "char_count": 26,
        "word_count": 5,
        "page_number": 18,
        "window_text": "디지털치료기기(Digital Therapeutics)\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인(민원인\n\n안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방, 관리, 치료\n\n하기 위해 환자에게 근거기반의 치료적 개입을 제공하는 소프트\n\n- 다.  불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n - 라.  수면 위생(Sleep hygiene)\n- 마.  수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n - 바.  자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n",
        "original_sentence": "수면 위생(Sleep hygiene)\n- 마. "
      }
    },
    {
      "chunk_id": "chunk_402",
      "text": "수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 401,
        "window_size": 3,
        "char_count": 134,
        "word_count": 34,
        "page_number": 17,
        "window_text": "불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia, CBT-I)\n불면증을 만성화시키는 인지적인 오류를 바로잡고, 불면증을\n\n고착화하는 잘못된 행동의 요소 즉, 잠을 잘 이루기 위해 환자들이\n\n취하는 잠에 관련된 잘못된 습관을 고치는 행동 치료적 기법이다.\n\n - 라.  수면 위생(Sleep hygiene)\n- 마.  수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n - 바.  자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n - - 4 -\n- 사. ",
        "original_sentence": "수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_403",
      "text": "- 바. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 402,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "- 라.  수면 위생(Sleep hygiene)\n- 마.  수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n - 바.  자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n - - 4 -\n- 사.  수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아. ",
        "original_sentence": "- 바. "
      }
    },
    {
      "chunk_id": "chunk_404",
      "text": "자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 403,
        "window_size": 3,
        "char_count": 88,
        "word_count": 16,
        "page_number": 9,
        "window_text": "수면 위생(Sleep hygiene)\n- 마.  수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n - 바.  자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n - - 4 -\n- 사.  수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아.  불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자. ",
        "original_sentence": "자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_405",
      "text": "- - 4 -\n- 사. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 404,
        "window_size": 3,
        "char_count": 13,
        "word_count": 6,
        "page_number": 11,
        "window_text": "수면 일기(Sleep diary)\n자리에 누운 시각, 입면 시각, 기상 시각, 침대에서 나온 시각, 깬\n\n횟수, 수면의 질, 낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부\n\n등 불면의 측정에 필요한 지수들의 자가 기록지를 의미한다.\n\n - 바.  자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n - - 4 -\n- 사.  수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아.  불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자.  수면 효율(Sleep Efficiency, SE)\n- 차. ",
        "original_sentence": "- - 4 -\n- 사. "
      }
    },
    {
      "chunk_id": "chunk_406",
      "text": "수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 405,
        "window_size": 3,
        "char_count": 76,
        "word_count": 15,
        "page_number": 9,
        "window_text": "- 바.  자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n - - 4 -\n- 사.  수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아.  불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자.  수면 효율(Sleep Efficiency, SE)\n- 차.  정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다. ",
        "original_sentence": "수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아. "
      }
    },
    {
      "chunk_id": "chunk_407",
      "text": "불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 406,
        "window_size": 3,
        "char_count": 115,
        "word_count": 26,
        "page_number": 39,
        "window_text": "자극 조절법(Stimulus control therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 잠자리와\n\n각성 자극을 분리시키는 치료이다.\n\n - - 4 -\n- 사.  수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아.  불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자.  수면 효율(Sleep Efficiency, SE)\n- 차.  정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다.  DSM-5는 2013년도의\n\n- 카. ",
        "original_sentence": "불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자. "
      }
    },
    {
      "chunk_id": "chunk_408",
      "text": "수면 효율(Sleep Efficiency, SE)\n- 차. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 407,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 7,
        "window_text": "- - 4 -\n- 사.  수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아.  불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자.  수면 효율(Sleep Efficiency, SE)\n- 차.  정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다.  DSM-5는 2013년도의\n\n- 카.  국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n",
        "original_sentence": "수면 효율(Sleep Efficiency, SE)\n- 차. "
      }
    },
    {
      "chunk_id": "chunk_409",
      "text": "정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 408,
        "window_size": 3,
        "char_count": 162,
        "word_count": 25,
        "page_number": 11,
        "window_text": "수면 제한법(Sleep restriction therapy)\n불면증 인지행동치료 중 행동 치료에 속하는 치료로서 수면 효율을\n\n- 아.  불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자.  수면 효율(Sleep Efficiency, SE)\n- 차.  정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다.  DSM-5는 2013년도의\n\n- 카.  국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n - - 5 -\n<!-- PAGE_12 -->\n###### 4. ",
        "original_sentence": "정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다. "
      }
    },
    {
      "chunk_id": "chunk_410",
      "text": "DSM-5는 2013년도의\n\n- 카. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 409,
        "window_size": 3,
        "char_count": 21,
        "word_count": 4,
        "page_number": 9,
        "window_text": "불면증 심각도 척도(Insomnia Severity Index, ISI)\n불면증의 증상 심각도에 대한 평가를 수행할 수 있으며 질환의\n\n호전 여부를 판단할 수 있는 과학적으로 검증된 자가 보고식\n\n- 자.  수면 효율(Sleep Efficiency, SE)\n- 차.  정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다.  DSM-5는 2013년도의\n\n- 카.  국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n - - 5 -\n<!-- PAGE_12 -->\n###### 4.  현 황\n\n- 가. ",
        "original_sentence": "DSM-5는 2013년도의\n\n- 카. "
      }
    },
    {
      "chunk_id": "chunk_411",
      "text": "국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 410,
        "window_size": 3,
        "char_count": 222,
        "word_count": 24,
        "page_number": 11,
        "window_text": "수면 효율(Sleep Efficiency, SE)\n- 차.  정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다.  DSM-5는 2013년도의\n\n- 카.  국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n - - 5 -\n<!-- PAGE_12 -->\n###### 4.  현 황\n\n- 가.  불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n",
        "original_sentence": "국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_412",
      "text": "- - 5 -\n<!-- PAGE_12 -->\n###### 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 411,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 12,
        "window_text": "정신질환의 진단 및 통계 편람(Diagnostic and Statistical Manual of\n미국정신의학협회(American Psychiatric Association, APA)에서\n\n발행한 정신질환의 신뢰할 만한 진단이 가능하도록 고안된 관련\n\n기준들을 통칭하는 정신질환 분류법이다.  DSM-5는 2013년도의\n\n- 카.  국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n - - 5 -\n<!-- PAGE_12 -->\n###### 4.  현 황\n\n- 가.  불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n 불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다. ",
        "original_sentence": "- - 5 -\n<!-- PAGE_12 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_413",
      "text": "현 황\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 412,
        "window_size": 3,
        "char_count": 10,
        "word_count": 4,
        "page_number": 49,
        "window_text": "DSM-5는 2013년도의\n\n- 카.  국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n - - 5 -\n<!-- PAGE_12 -->\n###### 4.  현 황\n\n- 가.  불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n 불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다.  성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다. ",
        "original_sentence": "현 황\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_414",
      "text": "불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 413,
        "window_size": 3,
        "char_count": 126,
        "word_count": 28,
        "page_number": 9,
        "window_text": "국제수면장애분류(International Classification of Sleep Disorder, ICSD-3)\n미국수면의학회(American Academy of Sleep Medicine, AASM)에서\n\n발행한 제3판 국제수면장애분류(International Classification of Sleep\n\nDisorders-3rd edition, ICSD-3)를 한국어로 발간한 버전이다.\n\n - - 5 -\n<!-- PAGE_12 -->\n###### 4.  현 황\n\n- 가.  불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n 불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다.  성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다.  일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n",
        "original_sentence": "불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_415",
      "text": "불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 414,
        "window_size": 3,
        "char_count": 84,
        "word_count": 21,
        "page_number": 12,
        "window_text": "- - 5 -\n<!-- PAGE_12 -->\n###### 4.  현 황\n\n- 가.  불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n 불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다.  성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다.  일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n 불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다. ",
        "original_sentence": "불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다. "
      }
    },
    {
      "chunk_id": "chunk_416",
      "text": "성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 415,
        "window_size": 3,
        "char_count": 76,
        "word_count": 16,
        "page_number": 27,
        "window_text": "현 황\n\n- 가.  불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n 불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다.  성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다.  일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n 불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다.  불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n",
        "original_sentence": "성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다. "
      }
    },
    {
      "chunk_id": "chunk_417",
      "text": "일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 416,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 12,
        "window_text": "불면증의 인구학적 특성\nDSM-5에서는 불면증(insomnia disorder)을 ① 잠들기가 어렵거나,\n\n- ② 잠을 유지하기가 어렵고, ③ 아침에 일찍 깨는 증상이 주 3회 이상\n3개월 이상 지속될 때로 정의하고 있다.\n\n 불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다.  성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다.  일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n 불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다.  불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n 수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다. ",
        "original_sentence": "일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_418",
      "text": "불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 417,
        "window_size": 3,
        "char_count": 49,
        "word_count": 9,
        "page_number": 12,
        "window_text": "불면증은 모든 수면장애 중 가장 발생 빈도가 높고, 간헐적인 단기\n\n불면증은 일반 성인 인구집단의 약 30~50%가 호소하는 매우 흔한 증상\n\n이다.  성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다.  일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n 불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다.  불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n 수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다.  2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다. ",
        "original_sentence": "불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다. "
      }
    },
    {
      "chunk_id": "chunk_419",
      "text": "불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 418,
        "window_size": 3,
        "char_count": 92,
        "word_count": 23,
        "page_number": 27,
        "window_text": "성인의 10~15%는 일상생활 기능의 손상을 경험할 수준의 불면을\n\n경험하는데, 치료가 필요한 군은 전체 인구의 6~10%로 추정된다.  일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n 불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다.  불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n 수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다.  2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다.  따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n",
        "original_sentence": "불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_420",
      "text": "수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 419,
        "window_size": 3,
        "char_count": 56,
        "word_count": 13,
        "page_number": 12,
        "window_text": "일반\n\n적으로 불면증은 남성보다는 여성에서 훨씬 높은 유병률을 보이고 연\n\n령대가 높을수록 더 흔하게 관찰되는 것으로 알려져 있다.\n\n 불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다.  불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n 수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다.  2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다.  따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다. ",
        "original_sentence": "수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_421",
      "text": "2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 420,
        "window_size": 3,
        "char_count": 93,
        "word_count": 18,
        "page_number": 9,
        "window_text": "불면증은 일시적으로 나타났다가 소실되기도 하지만, 만성적으로\n\n지속되는 경우도 흔하다.  불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n 수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다.  2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다.  따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다.  이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n",
        "original_sentence": "2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다. "
      }
    },
    {
      "chunk_id": "chunk_422",
      "text": "따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 421,
        "window_size": 3,
        "char_count": 76,
        "word_count": 18,
        "page_number": 12,
        "window_text": "불면증의 자연 경과에 관한 연구를 보면, 약\n\n70%의 환자가 1년 동안 지속적 증상을 보였고, 약 46%가 3년에 걸쳐\n\n지속적인 증상을 보인 것으로 나타났다.\n\n 수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다.  2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다.  따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다.  이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n 경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다. ",
        "original_sentence": "따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_423",
      "text": "OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 422,
        "window_size": 3,
        "char_count": 68,
        "word_count": 17,
        "page_number": 9,
        "window_text": "수면진정제의 사용 빈도를 통하여 각 인구집단의 불면증의 유병률을\n\n간접적으로 가늠해 볼 수도 있다.  2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다.  따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다.  이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n 경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다.  이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n",
        "original_sentence": "OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다. "
      }
    },
    {
      "chunk_id": "chunk_424",
      "text": "이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 423,
        "window_size": 3,
        "char_count": 142,
        "word_count": 34,
        "page_number": 45,
        "window_text": "2011년 국내 의료보험 자료를 이용한\n\n연구에서 일반 인구의 1.5%에서 수면진정제가 처방되었으며, 80~89세\n\n노인의 5.4%가 처방을 받은 것으로 보고되었다.  따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다.  이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n 경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다.  이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n - 나. ",
        "original_sentence": "이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_425",
      "text": "경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 424,
        "window_size": 3,
        "char_count": 124,
        "word_count": 27,
        "page_number": 13,
        "window_text": "따라서, 실제 국내\n\n에서는 유병률 대비 치료 환자의 비율이 적은 것으로 추론되고, 의료적\n\n접근성을 높이는 방안의 모색이 요구된다.\n\n OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다.  이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n 경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다.  이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n - 나.  불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n",
        "original_sentence": "경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다. "
      }
    },
    {
      "chunk_id": "chunk_426",
      "text": "이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 425,
        "window_size": 3,
        "char_count": 77,
        "word_count": 18,
        "page_number": 27,
        "window_text": "OECD 국가들과 비교 시, 한국은 2015년 기준 평균 수면시간 7시간\n\n- - 6 -\n49분으로 최하위를 기록하였다.  이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n 경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다.  이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n - 나.  불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n **[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다. ",
        "original_sentence": "이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_427",
      "text": "- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 426,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "이러한 수면 부족은 집중력 장애, 성\n\n기능 장애, 인지능력 저하 등의 정신신경학적 합병증, 고혈압, 부정맥,\n\n심장정지에 의한 급사와 같은 심혈관계 합병증, 뇌혈관계 합병증, 당뇨,\n\n비만과 같은 대사장애 등과 연관성이 높은 것으로 잘 알려져 있다.\n\n 경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다.  이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n - 나.  불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n **[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다.  | application of ISO 14971 | 표 12. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_428",
      "text": "불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 427,
        "window_size": 3,
        "char_count": 75,
        "word_count": 17,
        "page_number": 7,
        "window_text": "경기연구원이 작성한 ‘경기도 수면산업 육성을 위한 실태조사 및 정책\n\n방안’보고서에 따르면 인구집단의 수면 부족으로 인한 사회경제적\n\n손실은 상당하여, 수면 부족으로 인한 전국의 경제적 손실은 11조원\n\n으로 추산되었다.  이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n - 나.  불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n **[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다.  | application of ISO 14971 | 표 12.  위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다. ",
        "original_sentence": "불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_429",
      "text": "**[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 428,
        "window_size": 3,
        "char_count": 309,
        "word_count": 83,
        "page_number": 13,
        "window_text": "이는 생산성 손실과도 관련 있어, 근로자 평균 주당\n\n1시간 51분의 생산성 시간 손실이 불면증으로 인하여 발생하는 것으로\n\n추정된다.\n\n - 나.  불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n **[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다.  | application of ISO 14971 | 표 12.  위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다.  | 투여 기간, 목적을 확인한다. ",
        "original_sentence": "**[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_430",
      "text": "| application of ISO 14971 | 표 12. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 429,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 9,
        "window_text": "- 나.  불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n **[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다.  | application of ISO 14971 | 표 12.  위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다.  | 투여 기간, 목적을 확인한다.  | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우. ",
        "original_sentence": "| application of ISO 14971 | 표 12. "
      }
    },
    {
      "chunk_id": "chunk_431",
      "text": "위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 430,
        "window_size": 3,
        "char_count": 133,
        "word_count": 29,
        "page_number": 7,
        "window_text": "불면증의 진단 절차·과정\n불면증의 진단은 주로 환자가 호소하는 증상에 기초하여 이루어지며,\n\n진단적 평가 항목은 <표 2>와 같다.\n\n **[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다.  | application of ISO 14971 | 표 12.  위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다.  | 투여 기간, 목적을 확인한다.  | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.  | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다. ",
        "original_sentence": "위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_432",
      "text": "| 투여 기간, 목적을 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 431,
        "window_size": 3,
        "char_count": 19,
        "word_count": 5,
        "page_number": 7,
        "window_text": "**[표 시작]**\n\n| 병력 청취 | ㈜○○○ | ○○○ | ○○○ ○○시 ○○구 | ○○- ○○-○○○○ | / | / | - 신체검사 | 적용 | 성능 | 시험 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 5 | Beck 불안 척도 (Beck Anxiety Inventory, BAI) | (출처: peartherapeutics 홈페이지) | 80002-1 | ⦁ 층: 성별(남/여), 연령(oo세 미만, oo세 이상) | sleep hygiene | 수 있다.  | application of ISO 14971 | 표 12.  위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다.  | 투여 기간, 목적을 확인한다.  | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.  | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다.  | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오. ",
        "original_sentence": "| 투여 기간, 목적을 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_433",
      "text": "| PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 432,
        "window_size": 3,
        "char_count": 55,
        "word_count": 15,
        "page_number": 41,
        "window_text": "| application of ISO 14971 | 표 12.  위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다.  | 투여 기간, 목적을 확인한다.  | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.  | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다.  | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오.  | 시험계획서의 절차에 따라 이루어지도록 하여야 한다. ",
        "original_sentence": "| PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우. "
      }
    },
    {
      "chunk_id": "chunk_434",
      "text": "| 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 433,
        "window_size": 3,
        "char_count": 109,
        "word_count": 31,
        "page_number": 7,
        "window_text": "위험평가 예시 |\n| 3) Effect size: 두 군의 cohen’s d의 차 (치료군-위약군) | 다) 인구학적 조사, 병력조사 요법 | Postmarket Management of | (출처: Somino 홈페이지, | 조사한다.  | 투여 기간, 목적을 확인한다.  | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.  | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다.  | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오.  | 시험계획서의 절차에 따라 이루어지도록 하여야 한다.  | 것이라는 사실 | and sleep diary) | 불가능하다. ",
        "original_sentence": "| 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_435",
      "text": "| 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 434,
        "window_size": 3,
        "char_count": 64,
        "word_count": 17,
        "page_number": 13,
        "window_text": "| 투여 기간, 목적을 확인한다.  | PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.  | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다.  | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오.  | 시험계획서의 절차에 따라 이루어지도록 하여야 한다.  | 것이라는 사실 | and sleep diary) | 불가능하다.  | 여부, 직업, 업무생산성). ",
        "original_sentence": "| 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오. "
      }
    },
    {
      "chunk_id": "chunk_436",
      "text": "| 시험계획서의 절차에 따라 이루어지도록 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 435,
        "window_size": 3,
        "char_count": 31,
        "word_count": 7,
        "page_number": 7,
        "window_text": "| PTS | 피험자의 임상적 상태에 대하여 알려진 특징으로는 합리적인 설명을 할 수 없는 경우.  | 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다.  | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오.  | 시험계획서의 절차에 따라 이루어지도록 하여야 한다.  | 것이라는 사실 | and sleep diary) | 불가능하다.  | 여부, 직업, 업무생산성).  | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
        "original_sentence": "| 시험계획서의 절차에 따라 이루어지도록 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_437",
      "text": "| 것이라는 사실 | and sleep diary) | 불가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 436,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 17,
        "window_text": "| 수면 효율 예상값 | 관한 | 규정」기반, | 디지털치료기기에 | 목적으로 | 사용되지 |\n| 판단한 자 | 가이드라인(민원인 안내서) | WPAI | 대한 | 상세 | 설계를 | 수행한다.  | 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오.  | 시험계획서의 절차에 따라 이루어지도록 하여야 한다.  | 것이라는 사실 | and sleep diary) | 불가능하다.  | 여부, 직업, 업무생산성).  | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다.  | (https://peartherapeutics.com/ | 분석군으로 분석한다. ",
        "original_sentence": "| 것이라는 사실 | and sleep diary) | 불가능하다. "
      }
    },
    {
      "chunk_id": "chunk_438",
      "text": "| 여부, 직업, 업무생산성). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 437,
        "window_size": 3,
        "char_count": 18,
        "word_count": 4,
        "page_number": 3,
        "window_text": "| 일하는 동안 발생한 장애(impairment) 비율] | 규격 |\n| 및 검사 | 가) 위험분석 | 주십시오.  | 시험계획서의 절차에 따라 이루어지도록 하여야 한다.  | 것이라는 사실 | and sleep diary) | 불가능하다.  | 여부, 직업, 업무생산성).  | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다.  | (https://peartherapeutics.com/ | 분석군으로 분석한다.  | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14. ",
        "original_sentence": "| 여부, 직업, 업무생산성). "
      }
    },
    {
      "chunk_id": "chunk_439",
      "text": "| - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 438,
        "window_size": 3,
        "char_count": 214,
        "word_count": 47,
        "page_number": 19,
        "window_text": "| 시험계획서의 절차에 따라 이루어지도록 하여야 한다.  | 것이라는 사실 | and sleep diary) | 불가능하다.  | 여부, 직업, 업무생산성).  | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다.  | (https://peartherapeutics.com/ | 분석군으로 분석한다.  | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14.  전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n",
        "original_sentence": "| - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_440",
      "text": "| (https://peartherapeutics.com/ | 분석군으로 분석한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 439,
        "window_size": 3,
        "char_count": 47,
        "word_count": 5,
        "page_number": 27,
        "window_text": "| 것이라는 사실 | and sleep diary) | 불가능하다.  | 여부, 직업, 업무생산성).  | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다.  | (https://peartherapeutics.com/ | 분석군으로 분석한다.  | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14.  전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n 불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n",
        "original_sentence": "| (https://peartherapeutics.com/ | 분석군으로 분석한다. "
      }
    },
    {
      "chunk_id": "chunk_441",
      "text": "| 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 440,
        "window_size": 3,
        "char_count": 280,
        "word_count": 73,
        "page_number": 9,
        "window_text": "| 여부, 직업, 업무생산성).  | - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다.  | (https://peartherapeutics.com/ | 분석군으로 분석한다.  | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14.  전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n 불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n <그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n",
        "original_sentence": "| 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14. "
      }
    },
    {
      "chunk_id": "chunk_442",
      "text": "전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 441,
        "window_size": 3,
        "char_count": 341,
        "word_count": 82,
        "page_number": 9,
        "window_text": "| - 필요시, 혈액검사(blood count, thyroid, hepatic and renal parameters, | 수면제 복용 후 입면까지 걸리는 시간 | 의료기기 사이버 보안의 시판 후 관리에 |\n| (출처: Ritterband, L, et al., 2017, Christensen, H. et al., 2016) | - 병력 등을 문진과 과거 진료 기록을 통해 조사한다.  | (https://peartherapeutics.com/ | 분석군으로 분석한다.  | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14.  전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n 불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n <그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n 초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다. ",
        "original_sentence": "전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_443",
      "text": "불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 442,
        "window_size": 3,
        "char_count": 117,
        "word_count": 29,
        "page_number": 14,
        "window_text": "| (https://peartherapeutics.com/ | 분석군으로 분석한다.  | 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14.  전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n 불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n <그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n 초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다.  예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School. ",
        "original_sentence": "불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_444",
      "text": "<그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 443,
        "window_size": 3,
        "char_count": 85,
        "word_count": 20,
        "page_number": 14,
        "window_text": "| 피험자 이니셜(영문) | to medical device software | 해당하는 제품의 범위, 판단기준, 허가· |\n| 이상반응 확인 | O | O | O | 6 | 36항 건강수준 척도 (Short Form-36 Health Survey, SF-36) | Cybersecurity in Medical | teleclinic 홈페이지) | 대비 결과값 차이는 | 코드를 받아 사용 | 가이드’ |\n| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 타당한 경우 | / | / | 표 14.  전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n 불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n <그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n 초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다.  예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School.  Macmillan. ",
        "original_sentence": "<그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_445",
      "text": "초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 444,
        "window_size": 3,
        "char_count": 76,
        "word_count": 21,
        "page_number": 14,
        "window_text": "전체 잔여위험 허용 가능성 평가 예시 | 28159 충북 청주시 흥덕구 오송읍 오송생명2로 187 | 위험분석 | 위험평가 |\n| (필수) | □ 중대한 이상반응/ 이상 의료기기의 반응 | C-reactive protein, hemoglobin, ferritin, vitamin B12) 및 심전도, 뇌파, |\n\n**[표 끝]**\n\nCT/MRI, 생체리듬 마커(멜라토닌, 심부 체온 등)\n\n정신과적\n\n/심리학적 병력\n\n(필수)\n\n- - 이전과 현재의 정신장애\n- - 성격적 요인\n- - 직업 및 가족 상황\n- - 대인관계 갈등\n- - 7 -\n불면증의 진단을 위해서는 자세한 병력 청취가 무엇보다도 중요하다.\n\n 불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n <그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n 초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다.  예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School.  Macmillan.  | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다. ",
        "original_sentence": "초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다. "
      }
    },
    {
      "chunk_id": "chunk_446",
      "text": "예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 445,
        "window_size": 3,
        "char_count": 376,
        "word_count": 112,
        "page_number": 14,
        "window_text": "불면증의 발생 시기, 불면증의 양상, 잠이 들기가 어려운지, 중간에\n\n자주 잠에서 깨는 것인지, 불면증을 유발할 만한 최근의 스트레스 사건\n\n이나 동반 질환이 있는지 등에 대한 병력 청취를 실시하여야 한다.\n\n <그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n 초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다.  예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School.  Macmillan.  | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.  | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까? ",
        "original_sentence": "예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School. "
      }
    },
    {
      "chunk_id": "chunk_447",
      "text": "Macmillan. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 446,
        "window_size": 3,
        "char_count": 11,
        "word_count": 1,
        "page_number": 127,
        "window_text": "<그림 1>“불면증 진단 및 치료 흐름도”에서 볼 수 있듯이, 불면증을\n\n진단하는 과정에서는 다양한 기타 수면 양상 질환과의 감별 진단이\n\n필요하다.\n\n 초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다.  예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School.  Macmillan.  | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.  | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까?  | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다. ",
        "original_sentence": "Macmillan. "
      }
    },
    {
      "chunk_id": "chunk_448",
      "text": "| 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 447,
        "window_size": 3,
        "char_count": 82,
        "word_count": 16,
        "page_number": 28,
        "window_text": "초기 불면증 진단이 잘못되었을 경우 환자가 적절한 치료를 받지 못\n\n하고, 이에 따라 질환의 호전 및 관해가 지연될 수 있기 때문이다.  예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School.  Macmillan.  | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.  | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까?  | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다.  |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n",
        "original_sentence": "| 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다. "
      }
    },
    {
      "chunk_id": "chunk_449",
      "text": "| 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까? ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 448,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 35,
        "window_text": "예를\n\n들어 일주기리듬 수면각성장애는 수면각성 패턴 때문에 아직 잠이 오지\n\n않을 상황을 불면증으로 오인할 수 있고, 폐쇄성 수면무호흡증은 잠은\n\n쉽게 들지만 중간에 자주 깨고 잠을 깊게 못 자고 낮에 졸리다는 호소를\n\n할 수 있으며, 하지불안증후군은 환자가 잠을 잘 이루기 어렵다는 호소를\n\n**[표 시작]**\n\n| 수면 병력 | 요일 | 월 | 화 | 수 | 목 | 금 | 토 | 일 | ◈ 무작위 번호 | 자는 동안 숨이 멎는지 등) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 1) 사이버 보안 안전성 등급 : □상 | ■중 | □하 | Harvard Medical School.  Macmillan.  | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.  | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까?  | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다.  |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n 사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n",
        "original_sentence": "| 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까? "
      }
    },
    {
      "chunk_id": "chunk_450",
      "text": "| □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 449,
        "window_size": 3,
        "char_count": 60,
        "word_count": 18,
        "page_number": 3,
        "window_text": "Macmillan.  | 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.  | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까?  | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다.  |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n 사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n 그림 1. ",
        "original_sentence": "| □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다. "
      }
    },
    {
      "chunk_id": "chunk_451",
      "text": "|\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 450,
        "window_size": 3,
        "char_count": 165,
        "word_count": 37,
        "page_number": 14,
        "window_text": "| 3 | 허가·심사 가이드라인 | incorporating medical devices | 치료로서, 잠자리와 각성 자극을 분리시키는 치료이다.  | 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까?  | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다.  |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n 사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n 그림 1.  불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다. ",
        "original_sentence": "|\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_452",
      "text": "사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 451,
        "window_size": 3,
        "char_count": 127,
        "word_count": 30,
        "page_number": 15,
        "window_text": "| 네트워크로 연결되는 |\n| Attitudes about Sleep) | 피험자에게 서면 동의를 받았습니까?  | □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다.  |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n 사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n 그림 1.  불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다.  불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n",
        "original_sentence": "사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_453",
      "text": "그림 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 452,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 15,
        "window_text": "| □ 예 | □ 아니오 | 비율이 50% 이상인 경우 반응(호전)이 있는 것으로 평가 | 하는 치료이다.  |\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n 사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n 그림 1.  불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다.  불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n 불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n",
        "original_sentence": "그림 1. "
      }
    },
    {
      "chunk_id": "chunk_454",
      "text": "불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 453,
        "window_size": 3,
        "char_count": 69,
        "word_count": 16,
        "page_number": 9,
        "window_text": "|\n\n**[표 끝]**\n\n- - 수면장애의 병력(유발 요인 포함)\n- - 같이 자는 사람들로부터의 정보(자는 동안 주기적으로 다리를 차는지,\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 8 -\n주로 하기 때문에 수면개시장애를 평가할 때 감별해야 하는 질환이다.\n\n 사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n 그림 1.  불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다.  불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n 불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n 수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n",
        "original_sentence": "불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_455",
      "text": "불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 454,
        "window_size": 3,
        "char_count": 164,
        "word_count": 27,
        "page_number": 43,
        "window_text": "사건수면은 렘수면과 비렘수면 각성장애로 나뉘며 필요시 수면다원\n\n검사가 필요할 수 있으므로 감별을 요하고, 기면병 및 특발성 과다\n\n수면증은 낮졸림증을 주 호소로 내원하는 경우가 있으므로 진단 시 감별\n\n해야 하는 질환이다.\n\n 그림 1.  불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다.  불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n 불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n 수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n 하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다. ",
        "original_sentence": "불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_456",
      "text": "불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 455,
        "window_size": 3,
        "char_count": 169,
        "word_count": 32,
        "page_number": 9,
        "window_text": "그림 1.  불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다.  불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n 불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n 수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n 하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다.  따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n",
        "original_sentence": "불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_457",
      "text": "수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 456,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 16,
        "window_text": "불면증 진단 및 치료 흐름도\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n- - 9 -\n- 다.  불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n 불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n 수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n 하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다.  따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n 불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다. ",
        "original_sentence": "수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_458",
      "text": "하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 457,
        "window_size": 3,
        "char_count": 100,
        "word_count": 27,
        "page_number": 16,
        "window_text": "불면증의 비약물적 치료 (불면증 인지행동치료(CBT-I))\n불면증 인지행동치료(Cognitive-Behavioral Therapy for Insomnia,\n\nCBT-I)는 1980년대 말 다양한 연령의 불면증 환자를 대상으로 한 다양한\n\n비약물적 치료법이 소개된 이후 꾸준히 발전되어 왔다.\n\n 불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n 수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n 하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다.  따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n 불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다.  이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n",
        "original_sentence": "하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_459",
      "text": "따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 458,
        "window_size": 3,
        "char_count": 57,
        "word_count": 10,
        "page_number": 45,
        "window_text": "불면증 인지행동치료(CBT-I)의 효과는 2008년 미국수면학회에서\n\n발간한 성인 불면증의 평가 및 치료에 관한 임상지침에서 재확인\n\n되었으며, 2016년 이후 미국, 유럽, 호주에서 발표된 모든 수면장애\n\n치료 가이드라인은 불면증 인지행동치료(CBT-I)를 만성 불면증의 일차\n\n치료로 권장하였다.\n\n 수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n 하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다.  따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n 불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다.  이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n 일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n",
        "original_sentence": "따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_460",
      "text": "불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 459,
        "window_size": 3,
        "char_count": 131,
        "word_count": 28,
        "page_number": 16,
        "window_text": "수면제는 환자의 불면증을 매우 효과적이고 쉽게 해결하는 방법이다.\n\n 하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다.  따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n 불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다.  이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n 일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n 각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다. ",
        "original_sentence": "불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다. "
      }
    },
    {
      "chunk_id": "chunk_461",
      "text": "이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 460,
        "window_size": 3,
        "char_count": 106,
        "word_count": 24,
        "page_number": 45,
        "window_text": "하지만 수면제는 불면증의 근본적 치료가 아니라는 점과 장기간 사용 시\n\n치료 효과가 확인되지 않았다는 점, 낙상 등의 위험이 있다는 점과\n\n의존 및 남용의 문제가 있을 수 있다.  따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n 불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다.  이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n 일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n 각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다.  선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다. ",
        "original_sentence": "이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_462",
      "text": "일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 461,
        "window_size": 3,
        "char_count": 229,
        "word_count": 38,
        "page_number": 16,
        "window_text": "따라서 수면제를 사용하기 이전에\n\n불면증 인지행동치료(CBT-I)를 적절히 활용하는 것이 필요하다.\n\n 불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다.  이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n 일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n 각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다.  선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다.  불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n",
        "original_sentence": "일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_463",
      "text": "각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 462,
        "window_size": 3,
        "char_count": 92,
        "word_count": 20,
        "page_number": 17,
        "window_text": "불면증 인지행동치료(CBT-I)는 불면증을 만성화시키는 인지적인\n\n오류를 바로잡고, 불면증을 고착화하는 잘못된 행동의 요소 즉, 잠을\n\n잘 이루기 위해 환자들이 취하는 잠에 관련된 잘못된 습관을 고치는\n\n행동 치료적 기법을 사용한다.  이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n 일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n 각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다.  선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다.  불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n 구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다. ",
        "original_sentence": "각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_464",
      "text": "선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 463,
        "window_size": 3,
        "char_count": 112,
        "word_count": 22,
        "page_number": 45,
        "window_text": "이러한 불면증 인지행동치료(CBT-I)의\n\n치료 효과는 약물 치료와 동일하거나 보다 좋고, 치료 효과가 지속적\n\n이며, 치료 종료 후에도 6개월 이상 치료 효과가 지속되는 경우가\n\n많다.\n\n 일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n 각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다.  선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다.  불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n 구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다.  수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다. ",
        "original_sentence": "선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다. "
      }
    },
    {
      "chunk_id": "chunk_465",
      "text": "불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 464,
        "window_size": 3,
        "char_count": 40,
        "word_count": 7,
        "page_number": 17,
        "window_text": "일반적으로 불면증 인지행동치료(CBT-I)는 ① 정상 수면 및 수면\n\n위생에 대한 교육과 불면증 인지행동치료(CBT-I)의 목적 설명, ② 자극\n\n- - 10 -\n조절법(stimulus control therapy), ③ 수면 제한법(sleep restriction\n\ntherapy), ④ 이완 요법(relaxation technique), ⑤ 인지치료(cognitive\n\ntherapy) 등으로 구성된다.\n\n 각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다.  선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다.  불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n 구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다.  수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다.  수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다. ",
        "original_sentence": "불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_466",
      "text": "구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 465,
        "window_size": 3,
        "char_count": 109,
        "word_count": 27,
        "page_number": 3,
        "window_text": "각각의 요소를 조합하여 4~6회기 정도로 구성하고, 각 회기당\n\n40~60분의 시간을 배정하는 것이 일반적이며 각 병원이나 클리닉의\n\n상황에 맞게 조정이 가능하다.  선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다.  불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n 구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다.  수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다.  수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다.  이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n",
        "original_sentence": "구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_467",
      "text": "수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 466,
        "window_size": 3,
        "char_count": 68,
        "word_count": 20,
        "page_number": 17,
        "window_text": "선행연구에 의하면 단기 불면증 인지\n\n행동치료(CBT-I) 역시 효과적일 수 있으나, 과제 수행 여부가 치료\n\n결과에 영향을 미치므로 다회기의 불면증 인지행동치료(CBT-I)가\n\n일반적으로 권장된다.  불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n 구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다.  수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다.  수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다.  이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n - - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다. ",
        "original_sentence": "수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다. "
      }
    },
    {
      "chunk_id": "chunk_468",
      "text": "수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 467,
        "window_size": 3,
        "char_count": 117,
        "word_count": 32,
        "page_number": 17,
        "window_text": "불면증 인지행동치료(CBT-I)의 일반적 구성은\n\n<표 3>과 같다.\n\n 구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다.  수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다.  수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다.  이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n - - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다.  잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다. ",
        "original_sentence": "수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다. "
      }
    },
    {
      "chunk_id": "chunk_469",
      "text": "이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 468,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 14,
        "window_text": "구분\n\n제목\n\n내용\n\n1회기\n\n- - 불면증 인지행동치료를 본격적으로 시작하기에 앞서 정상\n수면에 대한 소개, 불면증의 기전 및 인지행동치료의 원리,\n\n- - 수면 위생에 대한 교육을 수행한다.  수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다.  수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다.  이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n - - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다.  잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다.  잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n",
        "original_sentence": "이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_470",
      "text": "- - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 469,
        "window_size": 3,
        "char_count": 178,
        "word_count": 46,
        "page_number": 18,
        "window_text": "수면 위생이란 질 좋은\n수면을 취하기 위한 생활 습관 및 주변 환경의 정돈을 의미\n\n- - 수면 일기 작성법을 교육한다.  수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다.  이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n - - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다.  잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다.  잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n 이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라. ",
        "original_sentence": "- - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다. "
      }
    },
    {
      "chunk_id": "chunk_471",
      "text": "잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 470,
        "window_size": 3,
        "char_count": 131,
        "word_count": 34,
        "page_number": 18,
        "window_text": "수면 일기란 자리에 누운 시각,\n입면 시각, 기상 시각, 침대에서 나온 시각, 깬 횟수, 수면의 질,\n\n낮잠 여부, 수면 전 카페인 혹은 알코올 섭취 여부 등 불면의\n\n측정에 필요한 지수들의 자가 기록지이다.  이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n - - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다.  잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다.  잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n 이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라.  불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n",
        "original_sentence": "잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다. "
      }
    },
    {
      "chunk_id": "chunk_472",
      "text": "잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 471,
        "window_size": 3,
        "char_count": 189,
        "word_count": 47,
        "page_number": 18,
        "window_text": "이후 불면증 인지\n\n행동치료가 종료될 때까지 꾸준히 기록하는 것이 필요하다.\n\n - - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다.  잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다.  잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n 이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라.  불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n <표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n",
        "original_sentence": "잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_473",
      "text": "이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 472,
        "window_size": 3,
        "char_count": 46,
        "word_count": 13,
        "page_number": 9,
        "window_text": "- - 11 -\n- - 자극 조절법이란 불면증 인지행동치료 중 행동치료에 속하는\n- - 수면을 취하는 장소에서 각성 상태에서 하는 행동(스마트폰\n사용, 독서, TV 시청, 혹은 잠이 오지 않더라도 누워있기 등)을\n\n반복할 경우, 잠자리와 각성 상태가 연관된 자극으로 기능\n\n하기 때문에 더욱 수면을 취하기 어려워진다.  잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다.  잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n 이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라.  불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n <표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n 임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다. ",
        "original_sentence": "이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_474",
      "text": "불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 473,
        "window_size": 3,
        "char_count": 87,
        "word_count": 18,
        "page_number": 19,
        "window_text": "잠자리에서는\n\n- - 이에 대한 원리 및 필요한 행동 교정에 대해 교육하고, 이후\n3회기\n\n­ 수면 제한법이란 불면증 인지행동치료 중 행동치료에 속하는\n\n­ 수면 효율이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율이다.  잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n 이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라.  불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n <표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n 임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다.  물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다. ",
        "original_sentence": "불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_475",
      "text": "<표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 474,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 19,
        "window_text": "잠을 제대로 자지 못하는데도 오래 누워\n\n있는 것은 자극 조절법의 측면에서도 부정적이며, 수면에\n\n대한 욕구를 오히려 감소시킴으로써 수면의 질을 나쁘게\n\n­ 현재까지 작성한 수면 일기를 기반으로 수면 효율을 계산\n\n하여, 수면 효율이 85% 미만일 경우 누워있는 시간을 감소\n\n시키는 지침을 주어 수면 효율을 증진할 수 있게 교육한다.\n\n 이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라.  불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n <표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n 임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다.  물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다.  왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다. ",
        "original_sentence": "<표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_476",
      "text": "임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 475,
        "window_size": 3,
        "char_count": 103,
        "word_count": 27,
        "page_number": 19,
        "window_text": "이후 매회기마다 확인하여, 수면 효율이 지속적으로 낮을\n\n- - 12 -\n- 라.  불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n <표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n 임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다.  물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다.  왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다.  잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n",
        "original_sentence": "임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다. "
      }
    },
    {
      "chunk_id": "chunk_477",
      "text": "물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 476,
        "window_size": 3,
        "char_count": 133,
        "word_count": 33,
        "page_number": 9,
        "window_text": "불면증의 약물 치료\n불면증 인지행동치료(CBT-I)를 적용하기가 어렵거나, 적용하더라도\n\n효과가 없을 경우 약물적 치료를 통해 불면증을 개선할 수 있다.\n\n <표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n 임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다.  물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다.  왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다.  잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n 이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다. ",
        "original_sentence": "물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다. "
      }
    },
    {
      "chunk_id": "chunk_478",
      "text": "왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 477,
        "window_size": 3,
        "char_count": 87,
        "word_count": 24,
        "page_number": 19,
        "window_text": "<표 4>는 국내에서 수면제로 주로 사용되는 약물들을 정리하였다.\n\n 임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다.  물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다.  왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다.  잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n 이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다.  다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n",
        "original_sentence": "왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다. "
      }
    },
    {
      "chunk_id": "chunk_479",
      "text": "잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 478,
        "window_size": 3,
        "char_count": 63,
        "word_count": 17,
        "page_number": 19,
        "window_text": "임상에서 불면증 양상을 크게 수면 개시 장애와 수면 유지 장애로\n\n나눌 경우, 각 상황에 맞는 약제를 적절히 선택하는 것은 약물의\n\n불필요한 사용을 줄인다는 측면에서 큰 도움이 된다.  물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다.  왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다.  잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n 이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다.  다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n ­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,.",
        "original_sentence": "잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_480",
      "text": "이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 479,
        "window_size": 3,
        "char_count": 64,
        "word_count": 15,
        "page_number": 19,
        "window_text": "물론 각 약물의\n\n­ 인지치료는 불면증 인지행동치료 중 인지치료에 속하는 치료\n\n로서, 불면과 관련된 불안을 감소시키고 왜곡된 인지를 교정\n\n­ 대다수의 만성 불면증 환자의 경우 잠과 관련된 불안이\n\n높으며, 왜곡된 인지를 가지고 있다.  왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다.  잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n 이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다.  다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n ­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,. (2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다. ",
        "original_sentence": "이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다. "
      }
    },
    {
      "chunk_id": "chunk_481",
      "text": "다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 480,
        "window_size": 3,
        "char_count": 110,
        "word_count": 27,
        "page_number": 19,
        "window_text": "왜곡된 인지에는 잠에\n\n대한 과도한 관심, 잠을 자지 못하였을 경우 나타날 수 있는\n\n영향에 대한 과대 평가, 잠을 자지 못할 것이라는 확신 등이\n\n있다.  잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n 이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다.  다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n ­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,. (2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다.  단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n",
        "original_sentence": "다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_482",
      "text": "­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 481,
        "window_size": 3,
        "char_count": 83,
        "word_count": 17,
        "page_number": 19,
        "window_text": "잠과 관련된 불안이 높을 경우 특히 잠자리에 누운\n\n­ 인지 교정에 덧붙여 이완 요법을 수행하는 경우가 있다.\n\n 이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다.  다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n ­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,. (2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다.  단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마. ",
        "original_sentence": "­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,."
      }
    },
    {
      "chunk_id": "chunk_483",
      "text": "(2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 482,
        "window_size": 3,
        "char_count": 114,
        "word_count": 30,
        "page_number": 9,
        "window_text": "이완 요법에는 심호흡법, 점진적 근육 이완법 등이 포함되며\n\n과각성된 자율 신경계를 이완시키는 것을 목표로 한다.  다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n ­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,. (2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다.  단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마.  불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n",
        "original_sentence": "(2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_484",
      "text": "단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 483,
        "window_size": 3,
        "char_count": 153,
        "word_count": 35,
        "page_number": 36,
        "window_text": "다만\n\n이완 요법의 불면증 인지행동치료에 대한 효과는 문헌별로\n\n5회기\n\n­ 치료의 마무리를 위해 상술한 치료들에 대한 복습을 수행\n\n하고, 향후 문제 상황이 생겼을 때 대비한 대책을 교육한다.\n\n ­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,. (2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다.  단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마.  불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n 권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n",
        "original_sentence": "단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_485",
      "text": "A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 484,
        "window_size": 3,
        "char_count": 360,
        "word_count": 44,
        "page_number": 20,
        "window_text": "­ 치료 중 환자의 호전 정도를 되새기게 하고 긍정적인\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019), Smith et al,. (2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다.  단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마.  불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n 권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n * ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n",
        "original_sentence": "A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마. "
      }
    },
    {
      "chunk_id": "chunk_486",
      "text": "불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 485,
        "window_size": 3,
        "char_count": 116,
        "word_count": 18,
        "page_number": 9,
        "window_text": "(2003))\n\n- - 13 -\n용량에 따라 효과가 달라질 수 있고, 수면 개시 장애와 수면 유지\n\n장애가 혼재되는 경우도 있기 때문에 각 임상 상황에 맞도록 임상의의\n\n적절한 판단하에 사용하여야 한다.  단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마.  불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n 권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n * ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n 미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n",
        "original_sentence": "불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_487",
      "text": "권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 486,
        "window_size": 3,
        "char_count": 52,
        "word_count": 7,
        "page_number": 9,
        "window_text": "단, 이는 본 가이드라인에서 다루는\n\n의료기기의 주요 부문이 아니므로 더 서술하지 않되, 사용 환자의\n\n맞춤형 수면 상태를 파악하고 개선한다는 점에서 약물 복용력을 고려\n\n하는 디지털치료기기라면 수면 개시와 유지 측면을 별도로 구분하여\n\n환자 상태를 파악하기를 권고한다.\n\n A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마.  불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n 권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n * ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n 미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n 유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n",
        "original_sentence": "권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_488",
      "text": "* ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 487,
        "window_size": 3,
        "char_count": 199,
        "word_count": 34,
        "page_number": 21,
        "window_text": "A. Benzodiazepine\n\nFlurazepam*\n\n15-30mg\n\nTriazolam*\n\n- 0.125-0.25mg\nFlunitrazepam*\n\n1mg\n\nBrotiazolam*\n\n- 0.25mg\nClonazepam\n\n- 0.5mg\nB. Non-benzodiazepine\n\nZolpidem immediate-release*\n\n5-10mg\n\nZolpidem controlled-release*\n\n- 6.25-12.5mg\nEszopiclone*\n\n1-3mg\n\nAntidepressant\n\nTrazodone\n\n25-50mg\n\n* 식약처 허가된 제품\n\n(출처: 대한신경정신의학회(2019), 한국판 불면증 임상진료지침)\n\n- - 14 -\n- 마.  불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n 권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n * ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n 미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n 유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n 미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong). ",
        "original_sentence": "* ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_489",
      "text": "미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 488,
        "window_size": 3,
        "char_count": 139,
        "word_count": 23,
        "page_number": 9,
        "window_text": "불면증 인지행동치료(CBT-I)의 임상적 권고 수준\n대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에 따르면,\n\n성인의 불면증에 불면증 인지행동치료(CBT-I)를 우선적으로 시행하기를\n\n권고한다.\n\n 권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n * ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n 미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n 유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n 미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong).  또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n",
        "original_sentence": "미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n"
      }
    },
    {
      "chunk_id": "chunk_490",
      "text": "유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 489,
        "window_size": 3,
        "char_count": 142,
        "word_count": 24,
        "page_number": 21,
        "window_text": "권고 등급은 강함(Strong)이고, 근거 수준은 중등도(Moderate)로\n\n판단하였다.\n\n * ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n 미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n 유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n 미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong).  또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n 다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n",
        "original_sentence": "유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n"
      }
    },
    {
      "chunk_id": "chunk_491",
      "text": "미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 490,
        "window_size": 3,
        "char_count": 157,
        "word_count": 26,
        "page_number": 21,
        "window_text": "* ACP: American College of Physicians, ESRS: European Sleep Research Society,\n\n(출처: 한국판 불면증 임상진료지침, 대한신경정신의학회(2019))\n\n위의 <표 5>에서 보듯이, 불면증 치료에 있어서 세 가지 지침 모두\n\n불면증 인지행동치료(CBT-I)를 불면증의 일차 치료로 제시하고 있다.\n\n 미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n 유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n 미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong).  또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n 다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n - 바. ",
        "original_sentence": "미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong). "
      }
    },
    {
      "chunk_id": "chunk_492",
      "text": "또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 491,
        "window_size": 3,
        "char_count": 84,
        "word_count": 17,
        "page_number": 9,
        "window_text": "미국내과학회(ACP, American College of Physician) 진료지침(2016)의\n\n경우 불면증 인지행동치료(CBT-I)를 성인의 만성 불면증 치료에 있어서\n\n가장 먼저 시행해야 할 것으로 제안하였다 (권고 등급, Strong).\n\n 유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n 미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong).  또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n 다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n - 바.  디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004). ",
        "original_sentence": "또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_493",
      "text": "다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 492,
        "window_size": 3,
        "char_count": 132,
        "word_count": 26,
        "page_number": 22,
        "window_text": "유럽수면학회(European Sleep Research Society, ESRS) 진료지침\n\n- (2017) 역시 연령과 관계없이 성인의 만성 불면증 치료에 있어서 불면증\n인지행동치료(CBT-I)를 일차 치료로 제안하였다 (권고 등급, Strong).\n\n 미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong).  또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n 다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n - 바.  디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004).  또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다. ",
        "original_sentence": "다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_494",
      "text": "- 바. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 493,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "미국수면학회(American Acedemy of Sleep Medicine, AASM) 진료\n\n- - 15 -\n지침(2008) 역시 불면증 인지행동치료(CBT-I)를 표준치료로 언급하였고,\n\n2017년 진료지침에서는 이를 수용하는 것으로 기술되었다 (권고 등급,\n\nStrong).  또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n 다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n - 바.  디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004).  또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다.  따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n",
        "original_sentence": "- 바. "
      }
    },
    {
      "chunk_id": "chunk_495",
      "text": "디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 494,
        "window_size": 3,
        "char_count": 188,
        "word_count": 36,
        "page_number": 49,
        "window_text": "또한 동일 단체에서 2006년에 제작된 불면증의 심리 및 행동\n\n치료 진료지침에서도 불면증 인지행동치료(CBT-I)를 표준치료로 제안한\n\n바 있다.\n\n 다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n - 바.  디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004).  또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다.  따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n 이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n",
        "original_sentence": "디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004). "
      }
    },
    {
      "chunk_id": "chunk_496",
      "text": "또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 495,
        "window_size": 3,
        "char_count": 79,
        "word_count": 18,
        "page_number": 22,
        "window_text": "다만, 불면증 인지행동치료(CBT-I)는 시간과 비용에 있어서 제약이\n\n있고, 불면증의 약물 치료에 비해서 효과가 상대적으로 늦기 때문에\n\n불면증 인지행동치료(CBT-I)를 모든 환자에게 일괄적으로 적용하는 데에\n\n있어 제한이 있다.\n\n - 바.  디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004).  또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다.  따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n 이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n - - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020). ",
        "original_sentence": "또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다. "
      }
    },
    {
      "chunk_id": "chunk_497",
      "text": "따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 496,
        "window_size": 3,
        "char_count": 134,
        "word_count": 27,
        "page_number": 22,
        "window_text": "- 바.  디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004).  또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다.  따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n 이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n - - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020).  실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다. ",
        "original_sentence": "따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_498",
      "text": "이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 497,
        "window_size": 3,
        "char_count": 91,
        "word_count": 20,
        "page_number": 22,
        "window_text": "디지털 불면증 인지행동치료(Digital CBT-I)의 선행 연구\n디지털 불면증 인지행동치료(Digital CBT-I)는 2004년에 처음 등장\n\n하였으며, 환자는 웹 또는 모바일 애플리케이션 등을 이용하여 병원에\n\n내원하지 않고도 불면증 인지행동치료를 시행 받게 되어 치료적\n\n접근성이 수월하다 (Strom et al., 2004).  또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다.  따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n 이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n - - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020).  실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다.  그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다. ",
        "original_sentence": "이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_499",
      "text": "- - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 498,
        "window_size": 3,
        "char_count": 157,
        "word_count": 33,
        "page_number": 23,
        "window_text": "또한 디지털 기반 치료로,\n\n환자가 대부분의 프로그램을 수행하고 피드백을 받을 수 있으므로\n\n치료자 입장에서의 비용 대비 효용성도 증가된다.  따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n 이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n - - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020).  실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다.  그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다.  또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n",
        "original_sentence": "- - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020). "
      }
    },
    {
      "chunk_id": "chunk_500",
      "text": "실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 499,
        "window_size": 3,
        "char_count": 82,
        "word_count": 16,
        "page_number": 18,
        "window_text": "따라서, 환자들이\n\n병원에 매주 내원해야 시행이 가능한 전통적인 불면증 인지행동치료\n\n(CBT-I)의 공간적 접근성과 시간 자원 여부에 따른 치료적 제약들을\n\n디지털 불면증 인지행동치료(Digital CBT-I)를 통해 개선할 수 있다.\n\n 이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n - - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020).  실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다.  그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다.  또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n 선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019). ",
        "original_sentence": "실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다. "
      }
    },
    {
      "chunk_id": "chunk_501",
      "text": "그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 500,
        "window_size": 3,
        "char_count": 83,
        "word_count": 18,
        "page_number": 39,
        "window_text": "이처럼 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도\n\n15년이 되어, 치료 효과에 대한 여러 연구 결과들이 현재 다수 발표\n\n되고 있다.\n\n - - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020).  실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다.  그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다.  또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n 선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019).  해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다. ",
        "original_sentence": "그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다. "
      }
    },
    {
      "chunk_id": "chunk_502",
      "text": "또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 501,
        "window_size": 3,
        "char_count": 82,
        "word_count": 18,
        "page_number": 46,
        "window_text": "- - 16 -\n연구에 따르면 시간과 장소적인 조건이 중요한 임산부 중 불면\n\n증상을 경험하고 있는 임산부들을 대상으로 무작위배정 임상시험을 한\n\n결과, 디지털 불면증 인지행동치료(Digital CBT-I) 프로그램의 효과성을\n\n검증하였다 (Felder et al., 2020).  실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다.  그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다.  또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n 선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019).  해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다.  그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n",
        "original_sentence": "또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_503",
      "text": "선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 502,
        "window_size": 3,
        "char_count": 128,
        "word_count": 24,
        "page_number": 23,
        "window_text": "실험군의 경우 6주 동안 모바일 기반\n\n디지털 불면증 인지행동치료 프로그램(Sleepio)을 제공받았고, 대조군의\n\n경우 표준 치료를 제공받았다.  그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다.  또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n 선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019).  해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다.  그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n 또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n",
        "original_sentence": "선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019). "
      }
    },
    {
      "chunk_id": "chunk_504",
      "text": "해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 503,
        "window_size": 3,
        "char_count": 97,
        "word_count": 21,
        "page_number": 23,
        "window_text": "그 결과, 실험군의 주요 임상 지표인\n\n불면증 심각도 척도(ISI)가 유의하게 개선되었으며, 대조군에 비해 2배\n\n이상 불면증 심각도가 완화되었다.  또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n 선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019).  해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다.  그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n 또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n 해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다. ",
        "original_sentence": "해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다. "
      }
    },
    {
      "chunk_id": "chunk_505",
      "text": "그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 504,
        "window_size": 3,
        "char_count": 99,
        "word_count": 25,
        "page_number": 43,
        "window_text": "또한, 치료 기간 종료 후 두 달 뒤에\n\n추적 평가를 시행했을 때도 디지털 불면증 인지행동치료(Digital CBT-I)의\n\n효과가 유지되었다.\n\n 선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019).  해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다.  그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n 또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n 해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다.  해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n",
        "original_sentence": "그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_506",
      "text": "또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 505,
        "window_size": 3,
        "char_count": 134,
        "word_count": 25,
        "page_number": 23,
        "window_text": "선행 연구에서는 불면증을 앓는 일반 성인들 1,711명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Espie, et al., 2019).  해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다.  그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n 또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n 해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다.  해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n 선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017). ",
        "original_sentence": "또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n"
      }
    },
    {
      "chunk_id": "chunk_507",
      "text": "해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 506,
        "window_size": 3,
        "char_count": 120,
        "word_count": 25,
        "page_number": 23,
        "window_text": "해당\n\n연구에서 실험군의 경우, 8주 동안 모바일 기반 디지털 불면증 인지\n\n행동치료(Sleepio)를 제공받았고, 대조군의 경우, 기존의 수면 위생 교\n\n육을 제공받았다.  그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n 또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n 해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다.  해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n 선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017).  해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다. ",
        "original_sentence": "해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다. "
      }
    },
    {
      "chunk_id": "chunk_508",
      "text": "해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 507,
        "window_size": 3,
        "char_count": 239,
        "word_count": 49,
        "page_number": 39,
        "window_text": "그 결과, 디지털 불면증 인지행동치료를 수행한\n\n실험군의 신체적 건강, 심리적 웰빙 및 수면 관련 삶의 질이 대조군에\n\n비해 유의한 수준으로 개선되는 것을 확인할 수 있었다.\n\n 또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n 해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다.  해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n 선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017).  해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다.  해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다. ",
        "original_sentence": "해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_509",
      "text": "선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 508,
        "window_size": 3,
        "char_count": 123,
        "word_count": 20,
        "page_number": 24,
        "window_text": "또 다른 선행연구에서는 만성 불면증을 앓는 성인 303명을 대상으로\n\n단일 맹검, 무작위배정 임상시험을 시행하여 디지털 불면증 인지행동\n\n치료(Digital CBT-I)의 효과를 검증하였다 (Ritterband et al., 2017).\n\n 해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다.  해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n 선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017).  해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다.  해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다.  이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n",
        "original_sentence": "선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017). "
      }
    },
    {
      "chunk_id": "chunk_510",
      "text": "해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 509,
        "window_size": 3,
        "char_count": 118,
        "word_count": 22,
        "page_number": 24,
        "window_text": "해당 연구에서 실험군의 경우, 9주 동안 웹 기반 디지털 불면증 인지\n\n행동치료(SHUTi)를 제공받았고, 대조군의 경우는 기존의 불면증 환자\n\n- - 17 -\n교육(patient education)을 제공받았다.  해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n 선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017).  해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다.  해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다.  이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n 또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016). ",
        "original_sentence": "해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다. "
      }
    },
    {
      "chunk_id": "chunk_511",
      "text": "해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 510,
        "window_size": 3,
        "char_count": 128,
        "word_count": 26,
        "page_number": 39,
        "window_text": "해당 연구에서의 주요 임상\n\n지표는 불면증 심각도 척도(Insomnia Severity Index, ISI), 수면 잠재기\n\n(Sleep Onset Latency, SOL), 입면 후 각성시간(Wake Time After\n\nSleep Onset, WASO)이었고, 치료 후 실험군의 모든 주요 임상 지표들이\n\n대조군에 비해 더 큰 폭으로 개선되었으며, 시간에 따른 양 군의 주요\n\n임상 지표들이 모두 유의미한 차이를 보였다.\n\n 선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017).  해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다.  해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다.  이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n 또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016).  해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다. ",
        "original_sentence": "해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다. "
      }
    },
    {
      "chunk_id": "chunk_512",
      "text": "이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 511,
        "window_size": 3,
        "char_count": 105,
        "word_count": 22,
        "page_number": 43,
        "window_text": "선행연구에서는 불면증을 앓는 대학생들 3,755명을 대상으로 다기관,\n\n무작위배정 임상시험을 시행하여 디지털 불면증 인지행동치료(Digital\n\nCBT-I)의 효과를 검증하였다 (Freeman et al., 2017).  해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다.  해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다.  이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n 또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016).  해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다.  연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다. ",
        "original_sentence": "이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_513",
      "text": "또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 512,
        "window_size": 3,
        "char_count": 140,
        "word_count": 26,
        "page_number": 24,
        "window_text": "해당 연구에서\n\n실험군의 경우, 10주 동안 모바일 기반 디지털 불면증 인지행동치료\n\n(Sleepio)를 제공받았고, 대조군의 경우 기존의 표준 치료(treatment as\n\nusual, TAU)를 제공받았다.  해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다.  이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n 또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016).  해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다.  연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다.  추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n",
        "original_sentence": "또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016). "
      }
    },
    {
      "chunk_id": "chunk_514",
      "text": "해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 513,
        "window_size": 3,
        "char_count": 174,
        "word_count": 40,
        "page_number": 36,
        "window_text": "해당 연구에서는 불면 증상(insomnia), 편집\n\n증상(paranoid), 그리고 환각 증상에 대한 지표들을 주요 임상 지표들로\n\n설정하였는데, 연구 결과 실험군이 대조군보다 모든 주요 임상 지표\n\n들이 유의하게 개선되었다.  이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n 또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016).  해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다.  연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다.  추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n 이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n",
        "original_sentence": "해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다. "
      }
    },
    {
      "chunk_id": "chunk_515",
      "text": "연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 514,
        "window_size": 3,
        "char_count": 102,
        "word_count": 26,
        "page_number": 36,
        "window_text": "이러한 결과를 바탕으로 디지털 불면증\n\n인지행동치료(Digital CBT-I)의 효과를 검증할 뿐만 아니라, 수면이 다른\n\n정신 건강 지표들과 밀접한 연관이 있다는 것 또한 검증하였다.\n\n 또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016).  해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다.  연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다.  추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n 이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n 지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n",
        "original_sentence": "연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다. "
      }
    },
    {
      "chunk_id": "chunk_516",
      "text": "추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 515,
        "window_size": 3,
        "char_count": 158,
        "word_count": 27,
        "page_number": 44,
        "window_text": "또 다른 선행 연구에서는 우울 성향이 높고 불면증을 가진 일반\n\n성인 1,149명을 대상으로 무작위배정 임상시험을 시행하여 디지털\n\n불면증 인지행동치료(Digital CBT-I)의 효과를 검증하였다 (Christensen\n\net al., 2016).  해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다.  연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다.  추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n 이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n 지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n 그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al. ",
        "original_sentence": "추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_517",
      "text": "이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 516,
        "window_size": 3,
        "char_count": 185,
        "word_count": 34,
        "page_number": 25,
        "window_text": "해당 연구에서 실험군의 경우 6주 동안 웹 기반 디지털\n\n불면증 인지행동치료(SHUTi)를 제공받았고, 대조군의 경우는 특정\n\n정신 건강 또는 수면 관련 콘텐츠를 전혀 포함하고 있지 않으며,\n\n- - 18 -\n우울증 개선을 위한 치료적 요소와도 전혀 연관성이 없는 HealthWatch\n\n프로그램을 제공받았다.  연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다.  추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n 이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n 지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n 그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al.  2016).\n\n",
        "original_sentence": "이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_518",
      "text": "지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 517,
        "window_size": 3,
        "char_count": 168,
        "word_count": 30,
        "page_number": 25,
        "window_text": "연구 결과 6주간의 치료 후, 실험군의 우울\n\n수준, 불안 수준, 불면 증상 등이 대조군에 비해 유의하게 개선되었으며,\n\n6개월 후 추적 평가 시에도 이러한 개선 효과는 지속되었다.  추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n 이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n 지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n 그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al.  2016).\n\n - - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016). ",
        "original_sentence": "지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_519",
      "text": "그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 518,
        "window_size": 3,
        "char_count": 213,
        "word_count": 49,
        "page_number": 25,
        "window_text": "추가적으로,\n\n해당 연구의 주요 임상 지표는 우울 수준(Patient Health Questionnaire-9,\n\nPHQ-9)이었는데, 디지털 불면증 인지행동치료(Digital CBT-I)를 수행한\n\n실험군의 우울 수준이 감소함에 따라 자살 사고 수준도 감소한 것이\n\n보고되었다.\n\n 이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n 지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n 그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al.  2016).\n\n - - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016).  이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다. ",
        "original_sentence": "그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al. "
      }
    },
    {
      "chunk_id": "chunk_520",
      "text": "2016).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 519,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "이렇듯 최근 선행 연구들의 결과에 따르면, 대부분 디지털 불면증\n\n인지행동치료(Digital CBT-I)가 효과적인 것으로 나타나지만, 환자가\n\n직접 클리닉에 방문하여 수행되는 전통적인 불면증 인지행동치료\n\n(CBT-I)와 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성 비교에\n\n대해선 아직 논란의 여지가 있다.\n\n 지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n 그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al.  2016).\n\n - - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016).  이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다.  따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n",
        "original_sentence": "2016).\n\n"
      }
    },
    {
      "chunk_id": "chunk_521",
      "text": "- - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 520,
        "window_size": 3,
        "char_count": 143,
        "word_count": 30,
        "page_number": 26,
        "window_text": "지금까지 진행된 대부분의 임상시험 연구들은 디지털 불면증 인지\n\n행동치료(Digital CBT-I)를 비처치대조군(waitlist) 또는 위약 대조군\n\n(sham)에 비교하여 효과를 검증하였고, 전통적인 불면증 인지행동치료\n\n(CBT-I)를 대조군으로 효과성을 검증한 연구들은 그 수가 많지 않다.\n\n 그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al.  2016).\n\n - - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016).  이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다.  따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n 그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020). ",
        "original_sentence": "- - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016). "
      }
    },
    {
      "chunk_id": "chunk_522",
      "text": "이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 521,
        "window_size": 3,
        "char_count": 138,
        "word_count": 28,
        "page_number": 7,
        "window_text": "그룹 불면증 인지행동치료(Group CBT-I) 및 디지털 불면증 인지\n\n행동치료(CBT-I)를 청소년 대상으로 시행하고 1년 뒤 치료 효과를\n\n살펴본 연구에 따르면, 그룹 불면증 인지행동 치료군에 비해 디지털\n\n치료군에서 유사한 효용성 대비 적은 사회적 및 의료 비용을 소요\n\n하였고, 전통적인 치료에 비해 높은 수준의 비용 대비 효용성이 확인\n\n되었다 (Bruin et al.  2016).\n\n - - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016).  이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다.  따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n 그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020).  또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n",
        "original_sentence": "이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다. "
      }
    },
    {
      "chunk_id": "chunk_523",
      "text": "따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 522,
        "window_size": 3,
        "char_count": 157,
        "word_count": 27,
        "page_number": 49,
        "window_text": "2016).\n\n - - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016).  이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다.  따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n 그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020).  또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n 종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다. ",
        "original_sentence": "따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n"
      }
    },
    {
      "chunk_id": "chunk_524",
      "text": "그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 523,
        "window_size": 3,
        "char_count": 131,
        "word_count": 29,
        "page_number": 26,
        "window_text": "- - 19 -\n한편 다른 한 선행연구에 따르면, 온라인 불면증 인지행동치료\n\n(CBT-I)가 비처치 대조군에 비해선 효과적이였으나, 전통적인 불면증\n\n인지행동 치료군에 비해선 효과성이 떨어지는 것으로 확인되었다\n\n(Lancee et al., 2016).  이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다.  따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n 그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020).  또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n 종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다.  하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n",
        "original_sentence": "그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020). "
      }
    },
    {
      "chunk_id": "chunk_525",
      "text": "또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 524,
        "window_size": 3,
        "char_count": 179,
        "word_count": 39,
        "page_number": 35,
        "window_text": "이 결과는 각 군별 치료 순응도의 차이로부터\n\n기인할 수 있는데, 해당 연구에서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I)의 치료 순응도는\n\n각각 50%, 70%로 유의한 차이를 보였다.  따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n 그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020).  또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n 종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다.  하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n - 사. ",
        "original_sentence": "또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n"
      }
    },
    {
      "chunk_id": "chunk_526",
      "text": "종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 525,
        "window_size": 3,
        "char_count": 172,
        "word_count": 38,
        "page_number": 26,
        "window_text": "따라서, 디지털 불면증 인지\n\n행동치료(Digital CBT-I)와 전통적인 불면증 인지행동치료(CBT-I) 효과성\n\n비교의 타당성을 높여 검증하기 위해서는 디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 치료 순응도를 보완할 필요성을 시사한다 (Lee, 2020).\n\n 그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020).  또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n 종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다.  하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n - 사.  불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n",
        "original_sentence": "종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다. "
      }
    },
    {
      "chunk_id": "chunk_527",
      "text": "하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 526,
        "window_size": 3,
        "char_count": 134,
        "word_count": 30,
        "page_number": 9,
        "window_text": "그리고 디지털 환경이 전통적인 면대면 환경의 경우보다 환자들의\n\n치료적 접근성이 높아지다 보니, 두 가지 환경에서의 치료적 효과성을\n\n검증하는데 있어서는 각각의 치료 기간도 고려해볼 필요성이 있다\n\n(Kim et al., 2020).  또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n 종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다.  하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n - 사.  불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n 연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구. ",
        "original_sentence": "하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_528",
      "text": "- 사. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 527,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "또한, 전통적인 불면증 인지행동치료(CBT-I)에서는\n\n치료사 한 명이 한 번에 4명에서 6명 정도의 환자들을 돌볼 수 있는\n\n반면에, 디지털 불면증 인지행동치료(Digital CBT-I)의 경우, 한 번에\n\n여러 환자를 돌볼 수 있다는 점을 바탕으로 치료 제공의 확장성 측면도\n\n고려해야 한다 (Lee, 2020).\n\n 종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다.  하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n - 사.  불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n 연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구.  불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다. ",
        "original_sentence": "- 사. "
      }
    },
    {
      "chunk_id": "chunk_529",
      "text": "불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 528,
        "window_size": 3,
        "char_count": 96,
        "word_count": 20,
        "page_number": 1,
        "window_text": "종합적으로 국외에서 시행된 여러 선행 임상 연구들을 통해 비처치\n\n대조군 대비 디지털 불면증 인지행동치료(Digital CBT-I)의 효과성이\n\n검증되고 있으며, 용이한 접근성, 시간 및 공간 자원의 절약, 치료진의\n\n시간 대비 효용의 증진으로 현대 사회의 불면 치료에 적극적으로\n\n사용될 것으로 기대된다.  하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n - 사.  불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n 연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구.  불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.  | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16). ",
        "original_sentence": "불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_530",
      "text": "연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 529,
        "window_size": 3,
        "char_count": 376,
        "word_count": 76,
        "page_number": 27,
        "window_text": "하지만, 국내에서 진행된 디지털 불면증 인지\n\n- - 20 -\n행동치료(Digital CBT-I)와 관련된 연구가 극히 드문 만큼 국내에서\n\n개발된 디지털 불면증 인지행동치료 기기의 효용성 검증을 위한 무작위\n\n배정 임상시험이 필요하다.\n\n - 사.  불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n 연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구.  불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.  | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16).  Sleep, 30(11), 1547–1554. ",
        "original_sentence": "연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구. "
      }
    },
    {
      "chunk_id": "chunk_531",
      "text": "불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 530,
        "window_size": 3,
        "char_count": 238,
        "word_count": 68,
        "page_number": 9,
        "window_text": "- 사.  불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n 연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구.  불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.  | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16).  Sleep, 30(11), 1547–1554.  | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다. ",
        "original_sentence": "불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다. "
      }
    },
    {
      "chunk_id": "chunk_532",
      "text": "| DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 531,
        "window_size": 3,
        "char_count": 98,
        "word_count": 23,
        "page_number": 37,
        "window_text": "불면증 개선 디지털치료기기의 국외 사례\n현재 국외에서 불면증 개선 디지털치료기기로서 허가된 제품 및\n\n불면증 인지행동치료(CBT-I)를 이용한 제품은 <표 6>과 같다.\n\n 연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구.  불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.  | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16).  Sleep, 30(11), 1547–1554.  | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다.  | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다. ",
        "original_sentence": "| DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16). "
      }
    },
    {
      "chunk_id": "chunk_533",
      "text": "Sleep, 30(11), 1547–1554. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 532,
        "window_size": 3,
        "char_count": 26,
        "word_count": 3,
        "page_number": 27,
        "window_text": "연번\n\n* Classification: Computerized Behavioral Therapy\n\n- - 22세 이상의 성인 불면증 환자에게 9주 동안 총\n6개의 코어 세션(Get ready, Sleep window, Behavior,\n\nThoughts, Education, Look Ahead)을 적용하는\n\n스마트폰 앱 기반의 불면증 인지행동치료(CBT-I)\n\n- - 수면 일기는 모바일 화면에 터치 및 입력을 통해\n간편하게 입력할 수 있으며, 환자가 희망할 경우\n\nFitbit 등과 연동하여 자동적으로 야간 수면을 측정\n\n하는 웨어러블 데이터도 활용 가능\n\nproducts/somryst/)\n\n- - 21 -\n**[표 시작]**\n\n| 연번 | 프로세스 | 평가 도구.  불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.  | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16).  Sleep, 30(11), 1547–1554.  | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다.  | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다.  | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다. ",
        "original_sentence": "Sleep, 30(11), 1547–1554. "
      }
    },
    {
      "chunk_id": "chunk_534",
      "text": "| 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 533,
        "window_size": 3,
        "char_count": 44,
        "word_count": 12,
        "page_number": 27,
        "window_text": "불면증의 원인과 결과에 대한 오류, 수면에 대한 | 제품 설명 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| 번호 | IEC 62304 | [수면 일기] # ＿ | 이름:＿＿＿ | 기준’ 제8호 러목(의료기기이상반응의 보고)에 따른다.  | DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16).  Sleep, 30(11), 1547–1554.  | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다.  | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다.  | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다.  | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다. ",
        "original_sentence": "| 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다. "
      }
    },
    {
      "chunk_id": "chunk_535",
      "text": "| 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 534,
        "window_size": 3,
        "char_count": 48,
        "word_count": 14,
        "page_number": 40,
        "window_text": "| DBAS | 방법에 대하여 상세히 기술하고 ‘의료 | 적용 | 성능 | 시험 |\n| (DBAS): validation of a brief version (DBAS-16).  Sleep, 30(11), 1547–1554.  | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다.  | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다.  | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다.  | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다.  | - 회원가입 및 초기 수면 평가를 시행한다. ",
        "original_sentence": "| 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다. "
      }
    },
    {
      "chunk_id": "chunk_536",
      "text": "| 분석되어 유효성에 대한 검증을 위해 사용될 예정이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 535,
        "window_size": 3,
        "char_count": 32,
        "word_count": 8,
        "page_number": 39,
        "window_text": "Sleep, 30(11), 1547–1554.  | 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다.  | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다.  | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다.  | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다.  | - 회원가입 및 초기 수면 평가를 시행한다.  | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다. ",
        "original_sentence": "| 분석되어 유효성에 대한 검증을 위해 사용될 예정이다. "
      }
    },
    {
      "chunk_id": "chunk_537",
      "text": "| (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 536,
        "window_size": 3,
        "char_count": 56,
        "word_count": 18,
        "page_number": 3,
        "window_text": "| 1) 디지털치료기기 정의 | 나) 회원가입 및 초기 수면 평가를 시행한다.  | 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다.  | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다.  | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다.  | - 회원가입 및 초기 수면 평가를 시행한다.  | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.  | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다. ",
        "original_sentence": "| (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다. "
      }
    },
    {
      "chunk_id": "chunk_538",
      "text": "| - 회원가입 및 초기 수면 평가를 시행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 537,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 44,
        "window_text": "| 가) 장기 효과 검증 | 해당하는 증상을 가진 자 | 연결이 가능하도록 조치한다.  | 분석되어 유효성에 대한 검증을 위해 사용될 예정이다.  | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다.  | - 회원가입 및 초기 수면 평가를 시행한다.  | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.  | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다.  | 위한 통계 처리 시 삽입할 수 있다. ",
        "original_sentence": "| - 회원가입 및 초기 수면 평가를 시행한다. "
      }
    },
    {
      "chunk_id": "chunk_539",
      "text": "| - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 538,
        "window_size": 3,
        "char_count": 75,
        "word_count": 22,
        "page_number": 45,
        "window_text": "| 분석되어 유효성에 대한 검증을 위해 사용될 예정이다.  | (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다.  | - 회원가입 및 초기 수면 평가를 시행한다.  | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.  | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다.  | 위한 통계 처리 시 삽입할 수 있다.  | 통계적 우월성을 평가한다. ",
        "original_sentence": "| - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다. "
      }
    },
    {
      "chunk_id": "chunk_540",
      "text": "| ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 539,
        "window_size": 3,
        "char_count": 37,
        "word_count": 11,
        "page_number": 44,
        "window_text": "| (3) 병용 약물: 복용 여부 및 종류 | - 치료 기간 동안 수면 일기 기록 여부를 수집한다.  | - 회원가입 및 초기 수면 평가를 시행한다.  | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.  | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다.  | 위한 통계 처리 시 삽입할 수 있다.  | 통계적 우월성을 평가한다.  | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다. ",
        "original_sentence": "| ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다. "
      }
    },
    {
      "chunk_id": "chunk_541",
      "text": "| 위한 통계 처리 시 삽입할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 540,
        "window_size": 3,
        "char_count": 23,
        "word_count": 8,
        "page_number": 46,
        "window_text": "| - 회원가입 및 초기 수면 평가를 시행한다.  | - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.  | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다.  | 위한 통계 처리 시 삽입할 수 있다.  | 통계적 우월성을 평가한다.  | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다.  실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다.",
        "original_sentence": "| 위한 통계 처리 시 삽입할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_542",
      "text": "| 통계적 우월성을 평가한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 541,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| - 피험자가 제때에 방문을 안 하며 연락이 안 되는 경우 | 하는 사람 | 사건들을 조합하여 각 위해요인에 대한 위험을 산정한다.  | ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다.  | 위한 통계 처리 시 삽입할 수 있다.  | 통계적 우월성을 평가한다.  | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다.  실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다. **\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다. ",
        "original_sentence": "| 통계적 우월성을 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_543",
      "text": "| 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 542,
        "window_size": 3,
        "char_count": 85,
        "word_count": 21,
        "page_number": 27,
        "window_text": "| ⦁ 수면 관련한 약물을 복용한 경우 | 통해 정보를 수집한다.  | 위한 통계 처리 시 삽입할 수 있다.  | 통계적 우월성을 평가한다.  | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다.  실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다. **\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.  |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다. ",
        "original_sentence": "| 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_544",
      "text": "실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 543,
        "window_size": 3,
        "char_count": 449,
        "word_count": 117,
        "page_number": 35,
        "window_text": "| 위한 통계 처리 시 삽입할 수 있다.  | 통계적 우월성을 평가한다.  | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다.  실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다. **\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.  |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.  | 웨어 요구사항에 반영한다. ",
        "original_sentence": "실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다."
      }
    },
    {
      "chunk_id": "chunk_545",
      "text": "**\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 544,
        "window_size": 3,
        "char_count": 145,
        "word_count": 38,
        "page_number": 28,
        "window_text": "| 통계적 우월성을 평가한다.  | 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다.  실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다. **\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.  |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.  | 웨어 요구사항에 반영한다.  |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마. ",
        "original_sentence": "**\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_546",
      "text": "|\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 545,
        "window_size": 3,
        "char_count": 142,
        "word_count": 41,
        "page_number": 3,
        "window_text": "| 모호한 경우 | 우울과 불안을 포함한 정신건강의학과적 증상 등) | 제품 외형 | management for IT-networks |\n| 수 있다.  실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다. **\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.  |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.  | 웨어 요구사항에 반영한다.  |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마.  안전성의 평가 기준 |\n**라. ",
        "original_sentence": "|\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다. "
      }
    },
    {
      "chunk_id": "chunk_547",
      "text": "| 웨어 요구사항에 반영한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 546,
        "window_size": 3,
        "char_count": 17,
        "word_count": 4,
        "page_number": 3,
        "window_text": "실제 시험규격에 대해 작성 시에는 신청 제품의 특성 및 주요 기능을 고려하여 | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | 피험자 이니셜(영문) | 피험자식별코드 | 피험자 방문일 (YY/MM/DD) | : 치료군의 치료 전 대비 post-treatment 6주 후 평균 불면증 심각도 척도(ISI) 변화량 | 의료기기 소프트웨어 | 일반적인 지침 사항 | 소프트웨어 개발 | 소프트웨어 위험관리 | 적용 | 성능 | 시험 | 적용 | 성능 | 시험 |\n| 통제감 상실 및 예측, 수면 필요에 대한 잘못된 기대, 수면 | 기기 소프트웨어 적합성 확인 보고서’, |\n**프로세스**\n**국내**\n| 연번 | 표준 | 규격 명칭 | 주요 내용 | 비고 | 맞추며, 이에 따라 달라지는 시각적 훈련을 통해 |\n**문서번호**\n**설치될 기기의 메모리 공간을 확인한다. **\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.  |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.  | 웨어 요구사항에 반영한다.  |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마.  안전성의 평가 기준 |\n**라.  이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성. ",
        "original_sentence": "| 웨어 요구사항에 반영한다. "
      }
    },
    {
      "chunk_id": "chunk_548",
      "text": "|\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 547,
        "window_size": 3,
        "char_count": 156,
        "word_count": 40,
        "page_number": 43,
        "window_text": "**\n**- 환자의 참여도를 높이기 위해 가상의 수면 전문가**\n| 설계 변경을 | 통한 사용자별 | 접근통제 및 |\n| ○ 의료기기의 오류(결함)로 인한 오진률 발생 가능성 | 의견을 조정하기 위하여 조정위원회를 설치하고 임상시험 조정자를 선정할 수 있다.  |\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.  | 웨어 요구사항에 반영한다.  |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마.  안전성의 평가 기준 |\n**라.  이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.  | 네트워크 API를 통해 데이터베이스로 |\n**표 16. ",
        "original_sentence": "|\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마. "
      }
    },
    {
      "chunk_id": "chunk_549",
      "text": "안전성의 평가 기준 |\n**라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 548,
        "window_size": 3,
        "char_count": 18,
        "word_count": 5,
        "page_number": 64,
        "window_text": "|\n| 다) 의료기기 소프트웨어 허가·심사 가이드라인(민원인 안내서) | 일주일 이상의 기간 동안에 발생한 불안 증상의 빈도를 분석 |\n| 선정/제외 기준 확인 | O | O | - | - | 사실을 보고 받거나 알게 된 날로부터 15일 이내 보고한다.  | 웨어 요구사항에 반영한다.  |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마.  안전성의 평가 기준 |\n**라.  이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.  | 네트워크 API를 통해 데이터베이스로 |\n**표 16.  치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다.",
        "original_sentence": "안전성의 평가 기준 |\n**라. "
      }
    },
    {
      "chunk_id": "chunk_550",
      "text": "이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 549,
        "window_size": 3,
        "char_count": 49,
        "word_count": 13,
        "page_number": 27,
        "window_text": "| 웨어 요구사항에 반영한다.  |\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마.  안전성의 평가 기준 |\n**라.  이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.  | 네트워크 API를 통해 데이터베이스로 |\n**표 16.  치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다. **\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다. ",
        "original_sentence": "이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성. "
      }
    },
    {
      "chunk_id": "chunk_551",
      "text": "| 네트워크 API를 통해 데이터베이스로 |\n**표 16. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 550,
        "window_size": 3,
        "char_count": 33,
        "word_count": 8,
        "page_number": 27,
        "window_text": "|\n| ○ 관련성이 의심됨(Possibly related) | 해당 알림이 발생하는 조건을 정하고, |\n| 치료 | 결과 | 중대성 |\n**의료기기 사이버 보안 침해로 인해 사용자의 심각한 상해 또는 사망,**\n| - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 | 마.  안전성의 평가 기준 |\n**라.  이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.  | 네트워크 API를 통해 데이터베이스로 |\n**표 16.  치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다. **\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다.  예측되는 부작용도 이상반응으로 분류한다.",
        "original_sentence": "| 네트워크 API를 통해 데이터베이스로 |\n**표 16. "
      }
    },
    {
      "chunk_id": "chunk_552",
      "text": "치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 551,
        "window_size": 3,
        "char_count": 165,
        "word_count": 35,
        "page_number": 39,
        "window_text": "안전성의 평가 기준 |\n**라.  이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.  | 네트워크 API를 통해 데이터베이스로 |\n**표 16.  치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다. **\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다.  예측되는 부작용도 이상반응으로 분류한다. **\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다. ",
        "original_sentence": "치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다."
      }
    },
    {
      "chunk_id": "chunk_553",
      "text": "**\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 552,
        "window_size": 3,
        "char_count": 116,
        "word_count": 27,
        "page_number": 49,
        "window_text": "이상사례의 평가**\n| 건강 상태 변화에 대한 1개 문항으로 총 36개 문항으로 구성.  | 네트워크 API를 통해 데이터베이스로 |\n**표 16.  치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다. **\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다.  예측되는 부작용도 이상반응으로 분류한다. **\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다.  |\n| 바. ",
        "original_sentence": "**\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다. "
      }
    },
    {
      "chunk_id": "chunk_554",
      "text": "예측되는 부작용도 이상반응으로 분류한다.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 553,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| 네트워크 API를 통해 데이터베이스로 |\n**표 16.  치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다. **\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다.  예측되는 부작용도 이상반응으로 분류한다. **\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다.  |\n| 바.  이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220. ",
        "original_sentence": "예측되는 부작용도 이상반응으로 분류한다."
      }
    },
    {
      "chunk_id": "chunk_555",
      "text": "**\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 554,
        "window_size": 3,
        "char_count": 310,
        "word_count": 90,
        "page_number": 7,
        "window_text": "치료 전 대비 Post-treatment 후 불면증 심각도 척도(ISI) 변화량 비교결과**\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적이고 경미한**\n**미리 정해진 데이터를 송신 및 저장**\n**1) 임상시험용 의료기기와의 인과관계 평가**\n**한 후, 해당 데이터를 불러오기 한다. **\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다.  예측되는 부작용도 이상반응으로 분류한다. **\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다.  |\n| 바.  이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220.  | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아. ",
        "original_sentence": "**\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_556",
      "text": "|\n| 바. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 555,
        "window_size": 3,
        "char_count": 7,
        "word_count": 3,
        "page_number": 1,
        "window_text": "**\n| (Wake after sleep onset, | - 불면증 환자를 위한 스마트폰 앱 기반의 불면증 |\n**의료기기 사이버 보안 침해로 인해 사용자의 일시적인 불편, 의학적**\n**반응으로 분류한다.  예측되는 부작용도 이상반응으로 분류한다. **\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다.  |\n| 바.  이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220.  | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아.  디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다. ",
        "original_sentence": "|\n| 바. "
      }
    },
    {
      "chunk_id": "chunk_557",
      "text": "이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 556,
        "window_size": 3,
        "char_count": 648,
        "word_count": 159,
        "page_number": 9,
        "window_text": "예측되는 부작용도 이상반응으로 분류한다. **\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다.  |\n| 바.  이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220.  | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아.  디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다.  또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다. ",
        "original_sentence": "이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220. "
      }
    },
    {
      "chunk_id": "chunk_558",
      "text": "| 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 557,
        "window_size": 3,
        "char_count": 235,
        "word_count": 42,
        "page_number": 1,
        "window_text": "**\n**항목들을 점수화한 뒤 합산하여 0점부터 100점 사이의 점수로**\n**한 기기에 시험용 정보로 로그인을 한 후,**\n| 선정/제외 기준 확인 | O | O | - | - | 단독 | 소프트 | 웨어로 | 실시간 | 감시 |\n| - CE 인증과 독일 디지털건강앱(DiGA) 디렉터리에 | 다른 기기에서 같은 정보로 로그인을 |\n| 연번 | 가이드라인 명칭 | 주요 내용 | 비고 |\n| 시판 후 소프트웨어에 문제가 | 발생하거나 개선의 필요성 때문에 | 제품 또는 관련 문서가 수정되는 | 경우 문제점과 그 영향 등을 | 분석하여 변경해야 한다.  |\n| 바.  이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220.  | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아.  디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다.  또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다.  여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다. ",
        "original_sentence": "| 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아. "
      }
    },
    {
      "chunk_id": "chunk_559",
      "text": "디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 558,
        "window_size": 3,
        "char_count": 256,
        "word_count": 51,
        "page_number": 36,
        "window_text": "|\n| 바.  이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220.  | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아.  디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다.  또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다.  여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다.  또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n",
        "original_sentence": "디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_560",
      "text": "또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 559,
        "window_size": 3,
        "char_count": 44,
        "word_count": 9,
        "page_number": 44,
        "window_text": "이상사례 보고 방법 | 소프트웨어 아키텍처를 소프트 | 웨어 유닛으로 표현할 수 있을 | 때까지 | 분해하고, | 각 | 유닛에 |\n**- 독일은 의사가 PZN(Pharmazentralnumme, 중앙**\n**○ 관련성이 명백함(Definitely related)**\n| 9 | 소프트웨어 | 문제해결 |\n| 4 | IEC/TR | 해당 | 없음 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 1) 이상사례 교육 | 제약번호) 16898724와 제품명 Somnio를 처방하여 |\n| 5) 피험자가 준수하여야 할 사항 | 라) 과거 병력 조사 | to an Existing Device | 지고 있으며, 해당 의료기기의 알려진 이상반응과 직접적인 연관성을 배제할 수 없으며, | (출처: Ritterband et al., 2017) | 위험관리 방법에 대한 국제 | - | - | 국외 |\n| 1 | 디지털치료기기 허가·심사 | 문제로 인해 손실된 시간의 비율) × 건강 문제로 인해 | 수면 효율을 구하기 위해, 임의의 | 가이드’ |\n| 환자가 건강보험에 처방전을 제출한 후 라이센스 | 국내 |\n| ○ 관련성이 적음(Probably not related) | Endocrinology and Metabolism, 36(2), 220.  | 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아.  디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다.  또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다.  여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다.  또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n 대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다. ",
        "original_sentence": "또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_561",
      "text": "여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 560,
        "window_size": 3,
        "char_count": 205,
        "word_count": 30,
        "page_number": 64,
        "window_text": "| 3) 임상시험용 의료기기 : 불면증 개선 디지털치료기기(OOO) | 3) 이차 유효성 평가변수 | 시험용 수명입력정보를 입력했을 때, |\n| (Work Productivity and | 6) 검증되지 않은 임상시험이라는 사실 |\n\n**[표 끝]**\n\n제품명(제조업체)\n\n[https://somn.io/en/],\n\n[https://www.teleclinic.com/\n\napp/somnio/]\n\n- - 22 -\n- 아.  디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다.  또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다.  여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다.  또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n 대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다.  또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2. ",
        "original_sentence": "여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다. "
      }
    },
    {
      "chunk_id": "chunk_562",
      "text": "또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 561,
        "window_size": 3,
        "char_count": 50,
        "word_count": 9,
        "page_number": 29,
        "window_text": "디지털치료기기의 정의와 국내 가이드라인별 적용 기준\n식품의약품안전처 ‘디지털치료기기 허가·심사 가이드라인\n\n(민원인 안내서)’ 기준을 준용하여 의학적 장애나 질병을 예방,\n\n관리, 치료하기 위해 환자에게 근거기반의 치료적 개입을 제공\n\n디지털치료기기는 「의료기기법」 제2조에 따른 사용목적에\n\n해당해야 하며, <그림 2>와 같이 소프트웨어 의료기기로써 범용\n\n하드웨어에 설치되고, 질병을 예방, 관리 또는 치료하기 위한\n\n목적으로 환자에게 적용되어야 한다.  또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다.  여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다.  또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n 대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다.  또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2.  디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다. ",
        "original_sentence": "또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_563",
      "text": "대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 562,
        "window_size": 3,
        "char_count": 98,
        "word_count": 19,
        "page_number": 9,
        "window_text": "또한, 치료 작용기전의\n\n과학적(임상적) 근거에 해당하는 자료가 있어야 한다.  여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다.  또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n 대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다.  또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2.  디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다.  가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n",
        "original_sentence": "대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_564",
      "text": "또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 563,
        "window_size": 3,
        "char_count": 248,
        "word_count": 47,
        "page_number": 45,
        "window_text": "여기서\n\n질병이란 국제질병분류코드(International Classification of Disease,\n\nICD)에 기반한 한국표준질병사인분류에 독립적으로 분류 가능한\n\n디지털 불면증 인지행동치료(Digital CBT-I)는 불면증 인지행동\n\n치료(CBT-I) 기반의 콘텐츠를 범용 스마트폰이나 태블릿 PC에\n\n설치하여 제공하므로 소프트웨어 의료기기에 해당한다.  또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n 대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다.  또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2.  디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다.  가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n 사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다. ",
        "original_sentence": "또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2. "
      }
    },
    {
      "chunk_id": "chunk_565",
      "text": "디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 564,
        "window_size": 3,
        "char_count": 370,
        "word_count": 59,
        "page_number": 3,
        "window_text": "또한\n\n한국표준질병사인분류에 따라 불면증을 의사에게 진단받은\n\n환자들을 대상으로 한다.\n\n 대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다.  또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2.  디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다.  가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n 사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다.  일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n",
        "original_sentence": "디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다. "
      }
    },
    {
      "chunk_id": "chunk_566",
      "text": "가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 565,
        "window_size": 3,
        "char_count": 159,
        "word_count": 36,
        "page_number": 31,
        "window_text": "대한신경정신의학회의 2019년 한국판 불면증 임상진료지침에\n\n- - 23 -\n따르면, 성인 불면증에 불면증 인지행동치료(CBT-I)를 우선적\n\n으로 시행하기를 권고하고 있다.  또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2.  디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다.  가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n 사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다.  일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n 의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n",
        "original_sentence": "가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_567",
      "text": "사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 566,
        "window_size": 3,
        "char_count": 61,
        "word_count": 13,
        "page_number": 9,
        "window_text": "또한 다수의 동료검토 선행\n\n연구(Peer-reviewed Journal)에서 임상시험을 통해 디지털 불면증\n\n인지행동치료의 치료 효과성이 입증된 바 있다 (Felder et al.,\n\n2020, Espie et al., 2019, Ritterband et al., 2017, Freeman et\n\n위와 같이 디지털 불면증 인지행동치료(Digital CBT-I)는 디지털\n\n치료기기 대상여부 판단 기준 및 절차를 충족하므로 디지털\n\n그림 2.  디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다.  가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n 사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다.  일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n 의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n 의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다. ",
        "original_sentence": "사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다. "
      }
    },
    {
      "chunk_id": "chunk_568",
      "text": "일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 567,
        "window_size": 3,
        "char_count": 469,
        "word_count": 74,
        "page_number": 7,
        "window_text": "디지털치료기기 대상여부 판단 기준 및 절차\n\n(출처: 식품의약품안전처(2020.08), 디지털치료기기 허가·심사 가이드라인(민원인 안내서))\n\n- - 24 -\n나) 의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)\n\n디지털치료기기는 식품의약품안전처‘의료기기의 사이버 보안\n\n허가·심사 가이드라인(민원인 안내서)’에 근거하여 보안성\n\n영역은 기밀성(confidentiality), 무결성(integrity), 가용성(availability)을\n\n기밀성은 개인의료정보가 허가되지 않은 사람에게 공개되거나,\n\n허가되지 않은 용도로 사용되지 않아야 함을 의미하며,\n\n무결성은 개인의료정보가 허가되지 않은 방법으로 변환되거나\n\n파괴되지 않아야 함을 의미한다.  가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n 사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다.  일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n 의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n 의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다.  실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다. ",
        "original_sentence": "일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_569",
      "text": "의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 568,
        "window_size": 3,
        "char_count": 70,
        "word_count": 16,
        "page_number": 9,
        "window_text": "가용성은 개인의료정보가\n\n승인된 사용자에게 즉시 제공되어야 하며, 필요한 때에 필요한\n\n사이버 보안 안전성 등급은 유·무선 통신이 가능한 의료기기의\n\n사이버 보안 침해로 발생할 수 있는 잠재적 결함으로부터 사용자\n\n에게 영향을 끼칠 수 있는 위해(harm)의 정도에 따라 결정된다.\n\n 사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다.  일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n 의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n 의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다.  실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다.  또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n",
        "original_sentence": "의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_570",
      "text": "의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 569,
        "window_size": 3,
        "char_count": 456,
        "word_count": 100,
        "page_number": 9,
        "window_text": "사이버 보안 안전성 등급은‘상’, ‘중’, ‘하’로 결정되고,\n\n그에 따른 사이버 보안 요구사항을 적용한다.  일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n 의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n 의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다.  실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다.  또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n - - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다. ",
        "original_sentence": "의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다. "
      }
    },
    {
      "chunk_id": "chunk_571",
      "text": "실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 570,
        "window_size": 3,
        "char_count": 91,
        "word_count": 20,
        "page_number": 33,
        "window_text": "일반적으로 디지털\n\n치료기기는 ‘치료’를 목적으로 하는 2등급 이상의 의료기기로\n\n품목 분류되므로 사이버 보안 안전성에서‘하’등급의 분류가\n\n- - 25 -\n소프트웨어 의료기기도 일반 의료기기와 마찬가지로 제조 및\n\n품질관리체계의 기준과 위험관리 프로세스가 조화를 이루는\n\n식품의약품안전처‘의료기기 소프트웨어 허가·심사 가이드라인\n\n(민원인 안내서)’를 기준으로 디지털치료기기의 위험성 관리\n\n프로세스는 의료기기에서 발생하는 위험분석(risk analysis), 위험\n\n평가(risk evaluation), 위험통제(risk control), 잔여위험 허용평가\n\n(evaluation of overal residual risk acceptability), 위험관리 보고서\n\n(risk management report), 생산 및 생산 후 정보(production and\n\npost-production information)로 구분한다.\n\n 의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n 의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다.  실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다.  또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n - - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다.  또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가. ",
        "original_sentence": "실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다. "
      }
    },
    {
      "chunk_id": "chunk_572",
      "text": "또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 571,
        "window_size": 3,
        "char_count": 35,
        "word_count": 8,
        "page_number": 33,
        "window_text": "의료기기 소프트웨어 안전성 등급은 고장 또는 잠재적 결함으로\n\n인해 환자나 사용자에게 미치는 위해의 영향에 따라 분류한다.\n\n 의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다.  실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다.  또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n - - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다.  또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가.  국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다. ",
        "original_sentence": "또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_573",
      "text": "- - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 572,
        "window_size": 3,
        "char_count": 103,
        "word_count": 28,
        "page_number": 9,
        "window_text": "의료기기 소프트웨어 사용으로 건강상의 상해 또는 손상이\n\n- - 26 -\n없는 경우 A등급, 심각하지 않은 상해의 가능성 있을 경우\n\nB등급, 심각한 상해 또는 사망의 가능성이 있는 경우 C등급\n\n의료기기 소프트웨어는 안전성 등급이 결정될 때까지 초기\n\n에는 C등급 요구사항이 적용되며, 소프트웨어 시스템의 실패가\n\n위험한 상황을 발생하지 않을 경우 안전성 등급은 A등급에\n\n라) 의료기기의 실사용증거(RWE) 적용에 대한 가이드라인(민원인 안내서)\n\n디지털치료기기는 실사용증거(Real World Evidence, RWE)를\n\n사용하여 의료기기의 사전 및 사후와 관련된 안전성 및 유효성\n\n입증 근거로 제시할 수 있으며, 이에 따른 기간 및 비용을 절약할\n\n수 있다.1)\n\n1) 실사용데이터(RWD)는 기존의 중재적 방법에 의한 임상시험으로부터 수집되지 않은 다양한 유형의 의료데이터에 대한 포괄적인\n\n용어이다.  실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다.  또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n - - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다.  또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가.  국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다.  | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다. ",
        "original_sentence": "- - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_574",
      "text": "또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 573,
        "window_size": 3,
        "char_count": 118,
        "word_count": 30,
        "page_number": 35,
        "window_text": "실사용증거(RWE)는 RWD를 분석하여 파생된 증거로써, RWD 분석을 통해 얻은 의료기기의 사용 결과나 잠재적 이익\n\n또는 위험성에 관한 임상적 근거를 말한다.  또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n - - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다.  또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가.  국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다.  | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다.  | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다. ",
        "original_sentence": "또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_575",
      "text": "국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 574,
        "window_size": 3,
        "char_count": 145,
        "word_count": 41,
        "page_number": 9,
        "window_text": "또한, 임상 문헌을 분석하여 파생된 새로운 증거도 포함한다.\n\n - - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다.  또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가.  국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다.  | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다.  | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다.  | 번호로 연락하고 관리자가 조치할 때까지 대기한다. ",
        "original_sentence": "국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_576",
      "text": "| 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 575,
        "window_size": 3,
        "char_count": 79,
        "word_count": 24,
        "page_number": 9,
        "window_text": "- - 27 -\n실사용증거 수집은 데이터의 타당성 및 신뢰성 확보를 위해\n\n품질, 수집 및 분석 방법, 수집한 인력의 역량을 입증할 수\n\n있는 객관적인 사항이 반드시 포함되어야 한다.  또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가.  국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다.  | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다.  | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다.  | 번호로 연락하고 관리자가 조치할 때까지 대기한다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다. ",
        "original_sentence": "| 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_577",
      "text": "| 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 576,
        "window_size": 3,
        "char_count": 215,
        "word_count": 70,
        "page_number": 39,
        "window_text": "또한 실사용\n\n증거는 적용 목적, 수집 및 분석 정보, 분석 결과에 대한 사항을\n\n- - 28 -\n<!-- PAGE_35 -->\n#### Ⅱ\n\n<!-- PAGE_35 -->\n#### 안전성·성능 평가\n\n- 가.  국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다.  | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다.  | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다.  | 번호로 연락하고 관리자가 조치할 때까지 대기한다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.  | PTW | 한다. ",
        "original_sentence": "| 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_578",
      "text": "| 번호로 연락하고 관리자가 조치할 때까지 대기한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 577,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 39,
        "window_text": "국내외 규격\n**[표 시작]**\n\n| ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| --- | --- | --- |\n| 3) 맹검 방법 | 2) 방문 2 (치료 시작일, Baseline) | - 심각한 부작용 발생으로 조기 종료시킬 수 있다.  | 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다.  | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다.  | 번호로 연락하고 관리자가 조치할 때까지 대기한다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.  | PTW | 한다.  | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다. ",
        "original_sentence": "| 번호로 연락하고 관리자가 조치할 때까지 대기한다. "
      }
    },
    {
      "chunk_id": "chunk_579",
      "text": "| ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 578,
        "window_size": 3,
        "char_count": 392,
        "word_count": 95,
        "page_number": 45,
        "window_text": "| 또한 소프트웨어 유닛 및 외부 | 구성요인 사이의 연계성 및 소프트 | 웨어 유닛 사이의 연계성을 위한 | 상세 | 설계를 | 수행한다.  | 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다.  | 번호로 연락하고 관리자가 조치할 때까지 대기한다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.  | PTW | 한다.  | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다.  | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다. ",
        "original_sentence": "| ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다. "
      }
    },
    {
      "chunk_id": "chunk_580",
      "text": "| PTW | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 579,
        "window_size": 3,
        "char_count": 12,
        "word_count": 4,
        "page_number": 44,
        "window_text": "| 상세 | 적용 | 성능 | 시험 |\n| Activity Impairment) | 라) 순응도 조사 | 정확도 | 않는 | 제품임 |\n| 4 | 소프트웨어 | 상세 설계 | 병용 약물 조사 | O | O | O | O | 심사 방안 등 제시 |\n| 1) 사용 전 준비사항 | 1) 치료 전 대비 6개월 후 불면증 심각도 척도(ISI) 변화량 | 내용 등을 기록하여 보관하여야 한다.  | 번호로 연락하고 관리자가 조치할 때까지 대기한다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.  | PTW | 한다.  | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다.  | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다.  | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다. ",
        "original_sentence": "| PTW | 한다. "
      }
    },
    {
      "chunk_id": "chunk_581",
      "text": "| 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 580,
        "window_size": 3,
        "char_count": 96,
        "word_count": 32,
        "page_number": 9,
        "window_text": "| 번호로 연락하고 관리자가 조치할 때까지 대기한다.  | ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.  | PTW | 한다.  | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다.  | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다.  | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다.  | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다. ",
        "original_sentence": "| 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다. "
      }
    },
    {
      "chunk_id": "chunk_582",
      "text": "| 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 581,
        "window_size": 3,
        "char_count": 108,
        "word_count": 30,
        "page_number": 28,
        "window_text": "| ○○○ | ○○병원 | ○○○ | ○○○ | ○○○-○○○○ | 영향을 줄 것으로 예상하는 약물을 임의로 복용한 경우 | / | / | Devices | ± 1% 이내일 것 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 7) 피험자에게 미칠 것으로 예상되는 위험이나 불편 | 7 | 생산성 손실 점수 (Work Productivity and Activity Impairment, WPAI) | - 계획서 순응 임상시험대상자군(Per-protocol Set, PPS) | - 사망을 초래하거나 생명을 위협하는 경우 | 오송보건의료행정타운 | Application of risk |\n| 잔여위험평가 | 해당 내용을 기재함 | 즉시 상담과 필요시 의료진 연결이 가능하도록 조치한다.  | PTW | 한다.  | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다.  | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다.  | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다.  | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.  | 비 | 통한 불면증 치료를 수행한다. ",
        "original_sentence": "| 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_583",
      "text": "| Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 582,
        "window_size": 3,
        "char_count": 231,
        "word_count": 57,
        "page_number": 37,
        "window_text": "| PTW | 한다.  | 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다.  | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다.  | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다.  | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.  | 비 | 통한 불면증 치료를 수행한다.  | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다. ",
        "original_sentence": "| Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_584",
      "text": "| 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 583,
        "window_size": 3,
        "char_count": 193,
        "word_count": 55,
        "page_number": 9,
        "window_text": "| 전체 잔여위험 |\n| 1) 개요 | 2) 중지 처리 | 가) Baseline 유효성 평가 | 순응도 조사 | - | O | O | - | 투여 기간, 목적을 확인한다.  | 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다.  | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다.  | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.  | 비 | 통한 불면증 치료를 수행한다.  | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.  | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다. ",
        "original_sentence": "| 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_585",
      "text": "| 비 | 통한 불면증 치료를 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 584,
        "window_size": 3,
        "char_count": 23,
        "word_count": 7,
        "page_number": 39,
        "window_text": "| 피험자 식별번호 | 적용 | 성능 | 시험 | 가이드’ |\n| 3) 방문 3 (치료 기간 종료 1주 후, Post-treatment) | 로서의 사용목적을 달성할 수 있음을 증명해야 한다.  | Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다.  | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.  | 비 | 통한 불면증 치료를 수행한다.  | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.  | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다.  | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다. ",
        "original_sentence": "| 비 | 통한 불면증 치료를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_586",
      "text": "| 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 585,
        "window_size": 3,
        "char_count": 128,
        "word_count": 31,
        "page_number": 36,
        "window_text": "| Guidance on Cybersecurity | - 입원 또는 입원 기간의 연장이 필요한 경우 | 의료기기 소프트웨어 | 식품의약품안전처 식품의약품안전평가원 | management for IT-networks | 결과 | 위험/이득 | 의료기기 | 소프트웨어 | 밸리데이션에 | 추가 발생 | 네트워크로 연결되는 | 통제 | 완료 |\n| 8 | 수면 일기를 통한 수면양상, 낮시간 졸음 | 사용할 수 있다.  | 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.  | 비 | 통한 불면증 치료를 수행한다.  | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.  | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다.  | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다.  | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다. ",
        "original_sentence": "| 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다. "
      }
    },
    {
      "chunk_id": "chunk_587",
      "text": "| incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 586,
        "window_size": 3,
        "char_count": 97,
        "word_count": 24,
        "page_number": 35,
        "window_text": "| 수면제 복용 후 아침 기상 시까지 걸리는 시간 | ‘IEC 62304’ | ‘스마트 의료 | 사이버 보안 |\n| 5 | IEC | 5) 임상시험 디자인 : 단일(다)기관, 무작위배정, 전향적 임상시험 | 2) 치료 전 대비 6주 및 6개월 후 수면 효율(SE) 변화량 | 임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.  | 비 | 통한 불면증 치료를 수행한다.  | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.  | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다.  | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다.  | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다.  | 조사한다. ",
        "original_sentence": "| incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_588",
      "text": "| 국외 |\n| 라) 순응도 조사 | 수행할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 587,
        "window_size": 3,
        "char_count": 31,
        "word_count": 11,
        "page_number": 35,
        "window_text": "| 비 | 통한 불면증 치료를 수행한다.  | 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.  | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다.  | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다.  | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다.  | 조사한다.  | 자료 등이 이에 해당된다. ",
        "original_sentence": "| 국외 |\n| 라) 순응도 조사 | 수행할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_589",
      "text": "| 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 588,
        "window_size": 3,
        "char_count": 102,
        "word_count": 30,
        "page_number": 37,
        "window_text": "| 6개월 후 수면 효율(SE) 변화량 |\n| 진단받은 사람 | 의료기기심사부 첨단의료기기과(디지털헬스기기팀) | 분석 | 위험 |\n| 2 | 밸리데이션 가이드라인 | [부패·공익신고 안내] ※ 신고자 및 신고내용은 보호됩니다.  | incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다.  | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다.  | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다.  | 조사한다.  | 자료 등이 이에 해당된다.  |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나. ",
        "original_sentence": "| 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다. "
      }
    },
    {
      "chunk_id": "chunk_590",
      "text": "| 조사한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 589,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 44,
        "window_text": "| incorporating medical devices | 대하여 알기 쉽게 설명하거나 식품 | 적용 | 성능 | 시험 | 의료기기의 위험관리 | 실현할 수 있어야 한다.  | 국외 |\n| 라) 순응도 조사 | 수행할 수 있다.  | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다.  | 조사한다.  | 자료 등이 이에 해당된다.  |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나.  국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial. ",
        "original_sentence": "| 조사한다. "
      }
    },
    {
      "chunk_id": "chunk_591",
      "text": "| 자료 등이 이에 해당된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 590,
        "window_size": 3,
        "char_count": 17,
        "word_count": 5,
        "page_number": 8,
        "window_text": "| 국외 |\n| 라) 순응도 조사 | 수행할 수 있다.  | 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다.  | 조사한다.  | 자료 등이 이에 해당된다.  |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나.  국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial.  JAMA Psychiatry, 77(5), 484-492. ",
        "original_sentence": "| 자료 등이 이에 해당된다. "
      }
    },
    {
      "chunk_id": "chunk_592",
      "text": "|\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 591,
        "window_size": 3,
        "char_count": 234,
        "word_count": 59,
        "page_number": 28,
        "window_text": "| 의해 가장 개연성이 있게 설명되는 경우 | 가이드’ |\n| 가) 치료 후 평가 | 9 | 수면, 우울, 불안 관련 증상 유무 | 80001-1 | 점검하고 증례기록서에 기록한다.  | 조사한다.  | 자료 등이 이에 해당된다.  |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나.  국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial.  JAMA Psychiatry, 77(5), 484-492.  | e016392. ",
        "original_sentence": "|\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_593",
      "text": "국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 592,
        "window_size": 3,
        "char_count": 320,
        "word_count": 78,
        "page_number": 35,
        "window_text": "| 조사한다.  | 자료 등이 이에 해당된다.  |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나.  국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial.  JAMA Psychiatry, 77(5), 484-492.  | e016392.  |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2. ",
        "original_sentence": "국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial. "
      }
    },
    {
      "chunk_id": "chunk_594",
      "text": "JAMA Psychiatry, 77(5), 484-492. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 593,
        "window_size": 3,
        "char_count": 33,
        "word_count": 4,
        "page_number": 9,
        "window_text": "| 자료 등이 이에 해당된다.  |\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나.  국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial.  JAMA Psychiatry, 77(5), 484-492.  | e016392.  |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2.  안전성 평가 항목\n\n- 가. ",
        "original_sentence": "JAMA Psychiatry, 77(5), 484-492. "
      }
    },
    {
      "chunk_id": "chunk_595",
      "text": "| e016392. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 594,
        "window_size": 3,
        "char_count": 11,
        "word_count": 2,
        "page_number": 9,
        "window_text": "|\n| 3) 치료 전 대비 6주 및 6개월 후 관해*율 | 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | ‣ 식약처 홈페이지 “국민소통 > 신고센터 > 부패·공익신고 상담”코너 |\n| 서명 날짜(YY/MM/DD) | 연구자 성명 | 서명 | –Part 1: Roles, responsibilities, | 방법에 대한 국제 규격 |\n\n**[표 끝]**\n\nand activities\n\n- - 29 -\n- 나.  국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial.  JAMA Psychiatry, 77(5), 484-492.  | e016392.  |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2.  안전성 평가 항목\n\n- 가.  소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n",
        "original_sentence": "| e016392. "
      }
    },
    {
      "chunk_id": "chunk_596",
      "text": "|\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 595,
        "window_size": 3,
        "char_count": 57,
        "word_count": 13,
        "page_number": 38,
        "window_text": "국내외 가이드라인\nApplication of risk\n\n**[표 시작]**\n\n| 대한 가이던스 | 미국 |\n| --- | --- |\n| for medical devices | 의료기기 사이버 보안에 대한 가이드라인 | 유럽 |\n**국내**\n**문제로 인해 일하는 동안 발생한 작업 능률 점수 / 10]**\n| (민원인 안내서) | 의약품안전처의 입장을 기술 |\n\n**[표 끝]**\n\n- - 30 -\n의료기기 소프트웨어의 기술문서 작성\n\n**[표 시작]**\n\n| 6 | 수면 평가 |\n| --- | --- |\n**10**\n| randomized clinical trial.  JAMA Psychiatry, 77(5), 484-492.  | e016392.  |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2.  안전성 평가 항목\n\n- 가.  소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n 제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n",
        "original_sentence": "|\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_597",
      "text": "안전성 평가 항목\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 596,
        "window_size": 3,
        "char_count": 16,
        "word_count": 5,
        "page_number": 7,
        "window_text": "JAMA Psychiatry, 77(5), 484-492.  | e016392.  |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2.  안전성 평가 항목\n\n- 가.  소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n 제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n - - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다. ",
        "original_sentence": "안전성 평가 항목\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_598",
      "text": "소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 597,
        "window_size": 3,
        "char_count": 386,
        "word_count": 86,
        "page_number": 9,
        "window_text": "| e016392.  |\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2.  안전성 평가 항목\n\n- 가.  소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n 제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n - - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다.  | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다. ",
        "original_sentence": "소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_599",
      "text": "제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 598,
        "window_size": 3,
        "char_count": 123,
        "word_count": 28,
        "page_number": 9,
        "window_text": "|\n**11**\n\n**[표 끝]**\n\n- - 31 -\n<!-- PAGE_38 -->\n###### 2.  안전성 평가 항목\n\n- 가.  소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n 제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n - - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다.  | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다.  |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n",
        "original_sentence": "제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_600",
      "text": "- - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 599,
        "window_size": 3,
        "char_count": 310,
        "word_count": 80,
        "page_number": 9,
        "window_text": "안전성 평가 항목\n\n- 가.  소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n 제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n - - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다.  | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다.  |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n 제품에 구현한다. ",
        "original_sentence": "- - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다. "
      }
    },
    {
      "chunk_id": "chunk_601",
      "text": "| 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 600,
        "window_size": 3,
        "char_count": 369,
        "word_count": 88,
        "page_number": 9,
        "window_text": "소프트웨어 검증 및 유효성 확인\n의료기기에 포함되는 소프트웨어 또는 의료기기 자체가 소프트\n\n웨어인 경우 ‘의료기기 제조 및 품질관리 기준’ 및 ‘의료기기\n\n위험관리 시스템’과 조화를 이루는 범위에서 개발, 유지되고 사용\n\n소프트웨어 검증 및 유효성확인은 의료기기로서의 소프트웨어의\n\n신뢰도를 높이고 환자 및 사용자에 대한 위험을 낮추기 위한 활동\n\n으로, 국제 표준 IEC 62304, ISO 14971 및 ‘의료기기 소프트웨어\n\n의료기기 제조업체는 ‘의료기기 제조 및 품질관리 기준’에\n\n규정된 바와 같이 수립된 품질시스템에서 관련 절차에 따라 소프트\n\n의료기기 소프트웨어의 위험관리는 소프트웨어 개발 활동의 일부\n\n이며, 동시에 의료기기의 전체 수명주기의 위험관리 일부로 수행한다.\n\n 제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n - - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다.  | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다.  |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n 제품에 구현한다.  이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9. ",
        "original_sentence": "| 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다. "
      }
    },
    {
      "chunk_id": "chunk_602",
      "text": "|\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 601,
        "window_size": 3,
        "char_count": 445,
        "word_count": 101,
        "page_number": 9,
        "window_text": "제조자는 소프트웨어 위험관리를 통해 의료기기에 포함된 소프트\n\n웨어 사용에 따른 허용 불가능한 위험이 발생하지 않고, 의료기기\n\n소프트웨어 개발 및 위험관리는 <표 9>와 같이 IEC 62304 프로\n\n세스에 따른다.\n\n - - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다.  | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다.  |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n 제품에 구현한다.  이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9.  소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n",
        "original_sentence": "|\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_603",
      "text": "제품에 구현한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 602,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 39,
        "window_text": "- - 32 -\n소프트웨어의\n\n개발\n\n계획\n\n**[표 시작]**\n\n| 대상으로 실시하며, 일차 유효성 평가변수의 근거되는 성능 평가 기준을 제시 | 을 수립하면서 동시에 위 |\n| --- | --- |\n| 정의한 | 위험통제 | 조치가 |\n**실제 제품에 올바르게 반**\n**소프트웨어의 정상 상태 및**\n**영되었으며, 위험이 효과적**\n| 고장 | 상태에서의 | 잠재적 |\n**으로 통제되어 잔여위험이**\n| 결함을 | 고려하여 | 위험을 |\n| 시험보고서 | (AB-1234) |\n**분석하고, 해당 위험을 통제**\n| 하기 위한 조치를 결정한다.  | 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다.  |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n 제품에 구현한다.  이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9.  소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n 소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다. ",
        "original_sentence": "제품에 구현한다. "
      }
    },
    {
      "chunk_id": "chunk_604",
      "text": "이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 603,
        "window_size": 3,
        "char_count": 45,
        "word_count": 10,
        "page_number": 3,
        "window_text": "| 시험보고서 | (AB-1234) |\n**이 중 소프트웨어 설계에**\n| 시험보고서 | (AB-1234) |\n**임상시험을 복수의 임상시험 기관에서 실시하는 경우에는 기관에 따라 임상시험**\n| 시험보고서 | (AB-1234) |\n**해당하는 통제 조치를 소프트**\n**1) 잘못 기입된 부분은 한 줄로 긋고, 수정날짜(YY/MM/DD)와 수정자 서명, 필요시 수정 사유에**\n**결과에 차이가 있는지에 대한 여부를 분석해야 하며, 기관에 따른 영향력 차이를**\n| 새로운 위험의 발생 또는 | 기존에 식별한 위험평가의 | 변경이 필요한 경우, 소프 | 트웨어 형상의 변경이 위해 | 요인이 될 수 있는 경우 | 위험관리 프로세스의 입력 | 으로 식별한다.  |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n 제품에 구현한다.  이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9.  소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n 소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다.  문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n",
        "original_sentence": "이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9. "
      }
    },
    {
      "chunk_id": "chunk_605",
      "text": "소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 604,
        "window_size": 3,
        "char_count": 150,
        "word_count": 34,
        "page_number": 9,
        "window_text": "|\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n**소프트웨어 요구사항에 반영한**\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 위험통제 | 조치가 | 실현될 |\n| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n**수 있도록 안전한 구조를**\n| 시판 후 발견된 문제점을 | 분석하고 | 안전과 | 관련된 |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 시험보고서 | (AB-1234) |\n| 3) 임상시험이 종료(완료, 탈락 또는 중지)된 피험자의 경우, 증례결론란에 세부내용을 기록하여 | 시험보고서 | (AB-1234) |\n**소프트웨어 위험통제 조치를**\n\n**[표 끝]**\n\n설계를 바탕으로 코딩을 하며\n\n코드는\n\n정확하고\n\n요구사항에\n\n부합한다.\n\n 제품에 구현한다.  이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9.  소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n 소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다.  문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n 필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n",
        "original_sentence": "소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_606",
      "text": "소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 605,
        "window_size": 3,
        "char_count": 41,
        "word_count": 7,
        "page_number": 3,
        "window_text": "제품에 구현한다.  이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9.  소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n 소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다.  문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n 필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n - - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다. ",
        "original_sentence": "소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다. "
      }
    },
    {
      "chunk_id": "chunk_607",
      "text": "문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 606,
        "window_size": 3,
        "char_count": 36,
        "word_count": 11,
        "page_number": 39,
        "window_text": "이때 코드는\n\n위험관리 프로세스에서 식별한\n\n안전 요구사항을 정확하게\n\n표 9.  소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n 소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다.  문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n 필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n - - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다.  이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다. ",
        "original_sentence": "문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_608",
      "text": "필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 607,
        "window_size": 3,
        "char_count": 30,
        "word_count": 7,
        "page_number": 19,
        "window_text": "소프트웨어 개발 및 위험관리\n\n- - 33 -\n번호\n\nIEC 62304\n\n소프트웨어 개발\n\n소프트웨어 위험관리\n\n각 유닛에 대한 코드를 검증하는\n\n것으로 코드 실행 전에 오류를\n\n파악할 수 있는 “static test” 및\n\n“white-box” 방법으로 수행한다.\n\n 소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다.  문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n 필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n - - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다.  이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다.  이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나. ",
        "original_sentence": "필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_609",
      "text": "- - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 608,
        "window_size": 3,
        "char_count": 146,
        "word_count": 36,
        "page_number": 9,
        "window_text": "소프트웨어 요구사항에서\n\n항목은 위험관리 프로세스의\n\n입력으로 식별한다.  문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n 필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n - - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다.  이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다.  이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나.  의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n",
        "original_sentence": "- - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_610",
      "text": "이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 609,
        "window_size": 3,
        "char_count": 90,
        "word_count": 24,
        "page_number": 9,
        "window_text": "문제\n\n해결 및 설계 변경은 위험\n\n통제 조치가 될 수 있다.\n\n 필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n - - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다.  이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다.  이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나.  의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n 제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다. ",
        "original_sentence": "이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_611",
      "text": "이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 610,
        "window_size": 3,
        "char_count": 47,
        "word_count": 13,
        "page_number": 9,
        "window_text": "필요시 규제 당국에 안전성\n\n관련 보고를 시행한다.\n\n - - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다.  이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다.  이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나.  의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n 제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다.  본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n",
        "original_sentence": "이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_612",
      "text": "의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 611,
        "window_size": 3,
        "char_count": 120,
        "word_count": 30,
        "page_number": 36,
        "window_text": "- - 34 -\n3) 소프트웨어 안전성 등급\n\n의료기기 소프트웨어의 고장 또는 잠재적 결함으로 인해 환자나\n\n사용자에게 미치는 위해의 영향에 따라 안전성 등급을 <표 10>과\n\n소프트웨어 안전성 등급은 위험통제 후 잔여위험의 심각도를\n\n토대로 분류할 수 있다.  이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다.  이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나.  의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n 제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다.  본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n - - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다. ",
        "original_sentence": "의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_613",
      "text": "제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 612,
        "window_size": 3,
        "char_count": 234,
        "word_count": 50,
        "page_number": 3,
        "window_text": "이때, 발생 가능성은 안전성 등급 결정 시\n\n소프트웨어가 여러 개의 독립적인 모듈이 모여서 구성된 경우\n\n각 모듈에 대해 별도로 안전성 등급을 부여할 수 있다.  이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나.  의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n 제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다.  본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n - - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다.  | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다. ",
        "original_sentence": "제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_614",
      "text": "본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 613,
        "window_size": 3,
        "char_count": 247,
        "word_count": 54,
        "page_number": 3,
        "window_text": "이때 전체\n\n소프트웨어의 안전성 등급은 개별 모듈의 안전성 등급 중 가장\n\n- 나.  의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n 제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다.  본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n - - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다.  | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다.  | 교육을 실시한다. ",
        "original_sentence": "본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_615",
      "text": "- - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 614,
        "window_size": 3,
        "char_count": 545,
        "word_count": 131,
        "page_number": 28,
        "window_text": "의료기기의 사이버 보안\n네트워크 또는 다른 의료기기와 연결하여 의료기기 제어 정보,\n\n환자 의료 정보 등을 송수신하는 목적으로 사용하는 제품의 경우\n\n- - 35 -\n사이버 보안에 대한 요구사항을 준수해야 한다.\n\n 제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다.  본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n - - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다.  | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다.  | 교육을 실시한다.  |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다. ",
        "original_sentence": "- - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다. "
      }
    },
    {
      "chunk_id": "chunk_616",
      "text": "| 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 615,
        "window_size": 3,
        "char_count": 55,
        "word_count": 16,
        "page_number": 94,
        "window_text": "제조사의 위험분석을 통해 요구사항 일부를 제외하거나 수정하여\n\n적용하는 경우에는 시험규격 및 그 설정 근거를 제출하여야\n\n하며 해당 자료로 ‘사이버 보안 위험관리문서’와 ‘의료기기\n\n사이버 보안 요구사항은 ‘의료기기의 사이버 보안 허가·심사\n\n‘의료기기의 사이버 보안 허가·심사 가이드라인(민원인 안내서)’\n\n에는 의료기기의 사용목적, 통신 방식, 송수신 정보 등을 바탕\n\n으로 총 24개의 요구사항을 제시하고 있다.  본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n - - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다.  | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다.  | 교육을 실시한다.  |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다.  | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다. ",
        "original_sentence": "| 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_617",
      "text": "| 교육을 실시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 616,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 44,
        "window_text": "본 요구사항은 제품의\n\n해당 가이드라인에 따라 제품에 적합한 통신 개략도와 사이버\n\n소프트웨어 위험관리에는 사이버 보안에 대한 위험관리 항목이\n\n포함되어야 하며, 소프트웨어 위험관리와 동일한 방식으로 위험\n\n‘위해요인 식별’에서는 관련 자료(규격, 가이드라인, 국내외\n\n이상 사례 등)에 근거하여 의료기기의 정상 및 고장상태에서\n\n이미 알고 있거나 예측 가능한 의료기기 사이버 보안 측면의\n\n위해요인들에 대해 <표 11>과 같이 기록한다.\n\n - - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다.  | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다.  | 교육을 실시한다.  |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다.  | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다. ",
        "original_sentence": "| 교육을 실시한다. "
      }
    },
    {
      "chunk_id": "chunk_618",
      "text": "|\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 617,
        "window_size": 3,
        "char_count": 64,
        "word_count": 22,
        "page_number": 9,
        "window_text": "- - 36 -\n‘위험산정’에서는 위해상황을 초래할 수 있는 예측 가능한\n\n식별한 각 위해요인에 대하여 위험관리 계획서에 정의한 위험\n\n식별한 모든 위험에 대하여 위험의 평가 결과를 ‘위험을\n\n허용할 수 없는 영역(unacceptable)’과‘합리적으로 실현할 수\n\n있는 가장 낮은 영역(As Low As Reasonably Practicable,\n\nALARP)’, ‘허용할 수 있는 영역(acceptable)’의 3단계 또는\n\n‘위험을 허용할 수 없는 영역(unacceptable)’과 ‘허용할 수\n\n위해\n\n요인\n\n발생 가능한 사례\n\n위해상황\n\n위해\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n결과\n\n인가된\n\n사용자\n\n의 접근\n\n**[표 시작]**\n\n| 사용자 구분을 | 하지 않고 누구나 | 환자의 데이터에 | 접근하도록한경우 | 조작된 환자 | 결과 데이터로 | 전문의 진료 |\n| --- | --- | --- | --- | --- | --- | --- |\n| 오진, 잘못된 | 치료 수행 또는 | 치료 기회 박탈 |\n| 라) 대조군 검사 시험 방법 | 치료기기를 설치한다.  | 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다.  | 교육을 실시한다.  |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다.  | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다.  | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다. ",
        "original_sentence": "|\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_619",
      "text": "| 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 618,
        "window_size": 3,
        "char_count": 62,
        "word_count": 15,
        "page_number": 3,
        "window_text": "| 것이라는 사실 | 영향을 줄 수 있는 약물의 사용량이 변경된 경우 | 통계적 평가를 수행한다.  | 교육을 실시한다.  |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다.  | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다.  | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다.  | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n",
        "original_sentence": "| 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_620",
      "text": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 619,
        "window_size": 3,
        "char_count": 58,
        "word_count": 16,
        "page_number": 45,
        "window_text": "| 교육을 실시한다.  |\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다.  | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다.  | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다.  | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n 사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다. ",
        "original_sentence": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다. "
      }
    },
    {
      "chunk_id": "chunk_621",
      "text": "| ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 620,
        "window_size": 3,
        "char_count": 49,
        "word_count": 16,
        "page_number": 27,
        "window_text": "|\n| 1 | 2 | 2 | Acceptable | 위험 < | 그 사실 | 뒤 회신받는 것으로 갈음할 수 있다.  | 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다.  | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다.  | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n 사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다.  통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다. ",
        "original_sentence": "| ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_622",
      "text": "| 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 621,
        "window_size": 3,
        "char_count": 555,
        "word_count": 125,
        "page_number": 9,
        "window_text": "| 전화: 043-719-3948 | 해당사항 |\n| 중지 명령 등 필요한 조치를 시험책임자에게 하여야 한다.  | 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다.  | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다.  | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n 사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다.  통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다.  | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2. ",
        "original_sentence": "| 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_623",
      "text": "사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 622,
        "window_size": 3,
        "char_count": 58,
        "word_count": 15,
        "page_number": 9,
        "window_text": "| 성명 | 소속기관명 | 전공 | 직위 | 전화 | 통계학적으로 유의하면 임상시험 성공으로 평가한다.  | ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다.  | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n 사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다.  통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다.  | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2.  전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1. ",
        "original_sentence": "사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다. "
      }
    },
    {
      "chunk_id": "chunk_624",
      "text": "통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 623,
        "window_size": 3,
        "char_count": 137,
        "word_count": 34,
        "page_number": 7,
        "window_text": "| ESS |\n| 10 | 직업적/사회적 기능 상태 | 또는 일시 중지 시킬 수 있다.  | 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n 사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다.  통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다.  | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2.  전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1.  식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다. ",
        "original_sentence": "통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_625",
      "text": "| 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 624,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 9,
        "window_text": "| 가이드’ |\n**수행**\n\n**[표 끝]**\n\n3\n\n2\n\n6\n\nALARP\n\n- - 37 -\n다) 위험통제\n\n제조자는 위험평가 결과 중 ‘위험을 허용할 수 없는 영역\n\n(unacceptable)’과‘합리적으로 실현할 수 있는 가장 낮은 영역\n\n(ALARP)’을 허용 가능한 수준까지 감소시키기 위하여 위험통제\n\n조치를 식별하고, <표 13>과 같이 위험통제 활동을 수행하여야\n\n인증 기능 구현\n\n모든 위험통제 조치를 실시하고 검증한 뒤 위험관리 계획에서\n\n정의한 위험허용 기준을 사용하여 해당 의료기기에서 식별한\n\n전체 잔여위험이 허용 가능한지 여부를 결정하고 <표 14>와 같이\n\n허용 가능성 평가\n\n(허용 가능/불가)\n\n발생\n\n가능성\n\n심각성\n\n위험도\n\n이득\n\n없음\n\n완료\n\n허용 가능\n\n- - 38 -\n4) 사이버 보안 적용 방법\n\n의료기기 사이버 보안 필수원칙 체크리스트는 「의료기기의 사이버\n\n보안 허가심사 가이드라인(민원인 안내서)」의 요구사항을 개발\n\n제품에 적용하였음을 점검하는 것으로 제조자는 체크리스트의\n\n질의 사항을 확인하여 요구사항의 적용여부 등을 확인할 수 있다.\n\n 사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다.  통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다.  | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2.  전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1.  식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다.  |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다. ",
        "original_sentence": "| 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2. "
      }
    },
    {
      "chunk_id": "chunk_626",
      "text": "전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 625,
        "window_size": 3,
        "char_count": 103,
        "word_count": 29,
        "page_number": 36,
        "window_text": "사이버 보안 안전성 등급은 <표 15>과 같이 분류되며, 상, 중,\n\n하에서 해당 되는 것을 체크한다.  통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다.  | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2.  전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1.  식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다.  |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다.  |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다. ",
        "original_sentence": "전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1. "
      }
    },
    {
      "chunk_id": "chunk_627",
      "text": "식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 626,
        "window_size": 3,
        "char_count": 78,
        "word_count": 23,
        "page_number": 39,
        "window_text": "통신목적, 공용 네트워크 망의\n\n- - 39 -\n<예시> - 사이버보안 필수원칙 체크리스트\n\n< 의료기기 사이버 보안 특성 기재 >\n\n**[표 시작]**\n\n**예시**\n| 설정된 시간 이후에는 의료기기간의 통신 | 또는 접속이 종료되어야 한다.  | 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2.  전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1.  식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다.  |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다.  |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다.  |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다. ",
        "original_sentence": "식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_628",
      "text": "|\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 627,
        "window_size": 3,
        "char_count": 80,
        "word_count": 21,
        "page_number": 45,
        "window_text": "| 1.16 네트워크 상의 개인의료정보 전송 | 예시 |\n**2.  전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1.  식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다.  |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다.  |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다.  |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다.  | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다.",
        "original_sentence": "|\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_629",
      "text": "|\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 628,
        "window_size": 3,
        "char_count": 83,
        "word_count": 21,
        "page_number": 27,
        "window_text": "전신**\n**예시**\n**예시**\n| 의료기기의 | 정상 | 동작을 | 보장하기 | 위해 | 예시 |\n**예시**\n| 1.9 비밀번호 작성 규칙 강화 | 예시 |\n**예시**\n| 1.  식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다.  |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다.  |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다.  |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다.  | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다. **\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다. ",
        "original_sentence": "|\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_630",
      "text": "|\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 629,
        "window_size": 3,
        "char_count": 96,
        "word_count": 25,
        "page_number": 36,
        "window_text": "식별 및 보호 | 주요 실행 파일 및 설정파일에 대한 무결성을 | 검증하여야 하며, 무결성 오류 발생 시 대응 | 방안을 고려하여야 한다.  |\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다.  |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다.  |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다.  | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다. **\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다.  |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다. ",
        "original_sentence": "|\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다. "
      }
    },
    {
      "chunk_id": "chunk_631",
      "text": "| 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 630,
        "window_size": 3,
        "char_count": 109,
        "word_count": 28,
        "page_number": 9,
        "window_text": "|\n| 네트워크를 통하여 개인의료정보를 주고 | 받을 경우 적절한 암호화 및 복호화 방식을 | 활용하여 기밀성과 무결성을 보장하여야 | 한다.  |\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다.  |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다.  | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다. **\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다.  |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다.  |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다. ",
        "original_sentence": "| 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다."
      }
    },
    {
      "chunk_id": "chunk_632",
      "text": "**\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 631,
        "window_size": 3,
        "char_count": 138,
        "word_count": 39,
        "page_number": 36,
        "window_text": "|\n| 예시 | 예시 |\n**1.1 접근통제 및 인증**\n| 비밀번호 작성규칙은 ‘개인정보의 기술적· | 관리적 보호조치 기준’을 만족하여야 한다.  |\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다.  | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다. **\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다.  |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다.  |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다.  | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다. ",
        "original_sentence": "**\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_633",
      "text": "|\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 632,
        "window_size": 3,
        "char_count": 152,
        "word_count": 40,
        "page_number": 3,
        "window_text": "|\n**예시**\n| 식별 및 인증에 기반하여 사용자(의료기기) | 역할에 따른 접근 권한을 부여가 가능하고 | 접근 권한에 따라 인가된 데이터에만 접근 | 가능해야 한다.  | 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다. **\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다.  |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다.  |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다.  | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다.  |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다. ",
        "original_sentence": "|\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_634",
      "text": "|\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 633,
        "window_size": 3,
        "char_count": 108,
        "word_count": 33,
        "page_number": 9,
        "window_text": "| 2.3 사이버 보안 위협 탐지 시 취해야 할 |\n| 예시 | 예시 |\n**1.10 비밀번호 하드코딩 금지**\n**1.17 안전한 암호 알고리즘 사용**\n**비밀번호를 하드코딩하지 않아야 한다. **\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다.  |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다.  |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다.  | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다.  |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다.  |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다. ",
        "original_sentence": "|\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_635",
      "text": "| 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 634,
        "window_size": 3,
        "char_count": 45,
        "word_count": 12,
        "page_number": 38,
        "window_text": "**\n| 의료기기의 사용 중 발생하는 사이버 보안 | 사고에 대하여 긴급 연락처 및 기기의 제조자와 | 상담을 할 수 있는 연락방식을 제공하여야 | 하며, 사이버 보안 위협 탐지 시 취해야 할 | 대응책을 수립하고 사용자에게 제공하여야 | 한다.  |\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다.  |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다.  | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다.  |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다.  |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다.  |\n| 이를 인식하여 구분할 수 있어야 한다. ",
        "original_sentence": "| 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_636",
      "text": "|\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 635,
        "window_size": 3,
        "char_count": 366,
        "word_count": 101,
        "page_number": 9,
        "window_text": "|\n**※ 피험자 수: 시험대상수 산출시 일반적인 고려사항**\n| 데이터 전송 및 저장 시 사용되는 암호 | 알고리즘은 112비트 이상 보안강도를 가진 | 검증된 암호 알고리즘 또는 모듈을 사용 | 하여야 하며, 암호화 시 사용되는 암호키는 | 안전하게 관리되어야 한다.  |\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다.  | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다.  |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다.  |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다.  |\n| 이를 인식하여 구분할 수 있어야 한다.  | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다. ",
        "original_sentence": "|\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_637",
      "text": "|\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 636,
        "window_size": 3,
        "char_count": 110,
        "word_count": 31,
        "page_number": 7,
        "window_text": "|\n| 1.2 다중접속 금지 | 1.11 비밀번호 노출 금지 |\n| 임상시험 의료기기 적용 | O5) | O | O | - |\n**예시**\n| 동일 사용자가 다중으로 접속하지 않아야 | 한다.  | 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다.  |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다.  |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다.  |\n| 이를 인식하여 구분할 수 있어야 한다.  | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다.  | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다. ",
        "original_sentence": "|\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다. "
      }
    },
    {
      "chunk_id": "chunk_638",
      "text": "|\n| 이를 인식하여 구분할 수 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 637,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 3,
        "window_text": "| 비밀번호를 입력 시 ***와 같이 노출되지 | 않는 형태로 사용되어야 한다.  |\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다.  |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다.  |\n| 이를 인식하여 구분할 수 있어야 한다.  | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다.  | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.  | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. ",
        "original_sentence": "|\n| 이를 인식하여 구분할 수 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_639",
      "text": "| 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 638,
        "window_size": 3,
        "char_count": 151,
        "word_count": 39,
        "page_number": 36,
        "window_text": "|\n| 평가지표 수집 및 분석2) | O | O | O | O | 예시 | 발 | 행 | 처 식품의약품안전처 식품의약품안전평가원 |\n| 1.3 사용자(의료기기) 접속 인식 | 1.12 펌웨어 또는 소프트웨어 업데이트의 | 인가 |\n| (Number of awakening, NOA) | 수면 시작한 시간부터 마지막 깨어나기 직전까지 깨어난 횟수 | 발 | 행 | 일 2021년 12월 8일 |\n**1.18 물리적인 통신포트 침해의 최소화**\n**2.4 DDoS 공격에 대한 방어**\n| 비인가된 | 사용자(의료기기)가 | 접속될 | 시 | 발 | 행 | 인 | 서경원 |\n| 통신포트의 침해를 최소화하기 위해 기기에 | 물리적인 잠금을 제공하여야 한다.  |\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다.  |\n| 이를 인식하여 구분할 수 있어야 한다.  | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다.  | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.  | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다. ",
        "original_sentence": "| 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_640",
      "text": "| (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 639,
        "window_size": 3,
        "char_count": 255,
        "word_count": 74,
        "page_number": 64,
        "window_text": "|\n| 펌웨어 또는 소프트웨어 업데이트 시 관리자의 | 인가를 요청 및 확인하는 절차가 있거나 | 관리자 또는 사용자가 인지할 수 있는 거리 | 에서 보안이 보장되는 방법으로 수행되어야 | 한다.  |\n| 이를 인식하여 구분할 수 있어야 한다.  | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다.  | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.  | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.  | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다. ",
        "original_sentence": "| (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다. "
      }
    },
    {
      "chunk_id": "chunk_641",
      "text": "| 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 640,
        "window_size": 3,
        "char_count": 37,
        "word_count": 10,
        "page_number": 9,
        "window_text": "|\n| 이를 인식하여 구분할 수 있어야 한다.  | 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다.  | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.  | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.  | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.  | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다. ",
        "original_sentence": "| 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. "
      }
    },
    {
      "chunk_id": "chunk_642",
      "text": "(예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 641,
        "window_size": 3,
        "char_count": 75,
        "word_count": 19,
        "page_number": 1,
        "window_text": "| 공용 네트워크망에 접속하여 의료기기를 | 실시간으로 제어 또는 환자 생명과 직접적 | 으로 연관될 수 있는 정보(예: 사이버 보안 | 안전성 등급 ‘상’에 해당되는 정보 등)를 | 실시간으로 송수신하는 장비의 경우 DDoS | 공격에 대한 대응책이 수립되어야 한다.  | (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.  | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.  | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.  | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다.  | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n",
        "original_sentence": "(예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_643",
      "text": "| 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 642,
        "window_size": 3,
        "char_count": 57,
        "word_count": 17,
        "page_number": 3,
        "window_text": "| (Duration from administration |\n**편 집 위 원 장 이정림**\n**1.4 비인가된 사용자(의료기기) 접속 제한**\n| 1.19 불필요한 서비스 제거 또는 비활성화 | 임상시험 의료기기 적용 | O5) | O | O | - |\n| 평가지표 수집 및 분석2) | O | O | O | O | 편 | 집 | 위 | 원 | 강영규, 한영민, 김미선, 박수지 |\n| 1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.  | 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.  | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.  | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다.  | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n - - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다. ",
        "original_sentence": "| 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_644",
      "text": "| 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 643,
        "window_size": 3,
        "char_count": 104,
        "word_count": 29,
        "page_number": 17,
        "window_text": "| 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.  | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.  | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다.  | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n - - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다.  | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다. ",
        "original_sentence": "| 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_645",
      "text": "| 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 644,
        "window_size": 3,
        "char_count": 466,
        "word_count": 126,
        "page_number": 46,
        "window_text": "(예: ISI는 스크리닝에도 수집함) | 3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.  | 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.  | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다.  | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n - - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다.  | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다.  | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다. ",
        "original_sentence": "| 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_646",
      "text": "- - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 645,
        "window_size": 3,
        "char_count": 142,
        "word_count": 38,
        "page_number": 7,
        "window_text": "| 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.  | 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다.  | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n - - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다.  | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다.  | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다.  |\n**2. ",
        "original_sentence": "- - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_647",
      "text": "| 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 646,
        "window_size": 3,
        "char_count": 62,
        "word_count": 14,
        "page_number": 45,
        "window_text": "| 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로 |\n| 비인가된 사용자(의료기기)의 접속 시 접 | 속을 제한할 수 있어야 한다.  | 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n - - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다.  | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다.  | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다.  |\n**2.  탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다. ",
        "original_sentence": "| 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다. "
      }
    },
    {
      "chunk_id": "chunk_648",
      "text": "| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 647,
        "window_size": 3,
        "char_count": 252,
        "word_count": 69,
        "page_number": 9,
        "window_text": "| 예시 |\n| (Duration from administration | of pills to sleep onset time) |\n| 불필요한 | 외부 | 접속 | 포트 | 등의 | 서비스 |\n| = 건강 문제로 일을 빠진 시간 / (건강 문제로 일을 빠진 시간 + | 시험보고서 | (AB-1234) |\n| 비활성화를 | 기본값으로 | 설정하고, | 외부 | 산출되는 결과값과 예상값을 비교 |\n| 1.5 비인가된 네트워크 통신 차단 | 1.13 펌웨어 또는 소프트웨어 업데이트의 | 무결성 보장 | - 임상시험용 의료기기를 사용하였다는 증거가 있는 경우 |\n| 실제 일한 시간) + | [(1 - 건강 문제로 일을 빠진 시간 / |\n| 시험보고서 | (AB-1234) |\n**(건강 문제로 일을 빠진 시간 + 실제 일한 시간)] × 건강**\n\n**[표 끝]**\n\n비인가된\n\n네트워크\n\n통신\n\n접속을\n\n제한할\n\n수 있어야 한다.\n\n - - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다.  | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다.  | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다.  |\n**2.  탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다.  |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다. ",
        "original_sentence": "| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_649",
      "text": "|\n**2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 648,
        "window_size": 3,
        "char_count": 7,
        "word_count": 2,
        "page_number": 9,
        "window_text": "- - 40 -\n- 1.6 원격접속 차단\n**[표 시작]**\n\n| 사용자(의료기기)가 의료기관의 서버에 접속할 | 수 있는 경우, 사용자 계정 또는 의료기기 | 도난 시 해당 계정(의료기기)이 서버에 접속할 | 수 없도록 접근통제를 할 수 있어야 한다.  | 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다.  | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다.  |\n**2.  탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다.  |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다.  |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다. ",
        "original_sentence": "|\n**2. "
      }
    },
    {
      "chunk_id": "chunk_650",
      "text": "탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 649,
        "window_size": 3,
        "char_count": 161,
        "word_count": 39,
        "page_number": 27,
        "window_text": "| 의료기관 외부에서 사용되는 측정기기 또는 | 게이트웨이에는 개인의료정보를 저장하지 | 않는 것을 권고한다.  | 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다.  |\n**2.  탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다.  |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다.  |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다.  |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다. ",
        "original_sentence": "탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_651",
      "text": "|\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 650,
        "window_size": 3,
        "char_count": 74,
        "word_count": 20,
        "page_number": 36,
        "window_text": "| 시험보고서 | (AB-1234) | 시험보고서 | (AB-1234) |\n| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |\n| (Dysfunctional Beliefs and | 임상시험 디자인에서 많이 사용되는 설계방법에 대한 내용을 참고하여 선택하고 |\n| 펌웨어 | 또는 | 소프트웨어의 | 업데이트 | 시 |\n| 코드 서명 확인 등 인증된 코드로 제한 | 하여야 한다.  |\n**2.  탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다.  |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다.  |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다.  |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다.  |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n",
        "original_sentence": "|\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_652",
      "text": "|\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 651,
        "window_size": 3,
        "char_count": 83,
        "word_count": 22,
        "page_number": 36,
        "window_text": "|\n**2.  탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다.  |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다.  |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다.  |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다.  |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n - - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3. ",
        "original_sentence": "|\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_653",
      "text": "|\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 652,
        "window_size": 3,
        "char_count": 105,
        "word_count": 27,
        "page_number": 9,
        "window_text": "탐지, 대응, 복구**\n| 1.7 사용자(의료기기) 인증 관리 | 1.15 네트워크상의 의료기기 제어정보 전송 |\n**2.1 데이터 감사를 위한 시스템 로그 기록**\n| 사용자(의료기기) 계정의 유효기간을 설정할 | 수 있어야 하며, 설정된 유효기간 만료 시 | 접근이 통제되어야 한다.  |\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다.  |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다.  |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다.  |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n - - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3.  성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n",
        "original_sentence": "|\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_654",
      "text": "|\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 653,
        "window_size": 3,
        "char_count": 251,
        "word_count": 69,
        "page_number": 64,
        "window_text": "|\n| 사용자의 의료기기에 접속 시 접속기록, | 환자정보 조회, 데이터 생성, 변경, 삭제 | 등과 같은 로그가 기록되어야 한다.  |\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다.  |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다.  |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n - - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3.  성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n 제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n",
        "original_sentence": "|\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_655",
      "text": "- - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 654,
        "window_size": 3,
        "char_count": 200,
        "word_count": 51,
        "page_number": 50,
        "window_text": "|\n| 네트워크를 통하여 의료기기 제어정보를 | 주고받을 경우 적절한 암호화 및 복호화 | 방식을 활용하여 기밀성과 무결성을 보장 | 하여야 한다.  |\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다.  |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n - - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3.  성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n 제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n - - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n",
        "original_sentence": "- - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_656",
      "text": "성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 655,
        "window_size": 3,
        "char_count": 110,
        "word_count": 26,
        "page_number": 1,
        "window_text": "|\n**1.8 자동세션종료**\n**2.2 주요 실행파일 및 설정파일에 대한**\n| 접속 포트를 사용할 경우 비밀번호 설정, | IP 제한 등의 추가적인 보안 조치를 수행 | 하여야 한다.  |\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n - - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3.  성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n 제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n - - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n - 1. ",
        "original_sentence": "성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_657",
      "text": "제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 656,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 50,
        "window_text": "|\n| (Duration from administration | of pills to wake up time) |\n| - 이상반응에 대해 보다 가능성 있는 원인이 있는 경우 | 3) 적용 상의 주의 |\n| 문 | 의 | 처 |\n| 시험보고서 | (AB-1234) |\n| 펌웨어 | 또는 | 소프트웨어 | 업데이트 | 파일 |\n\n**[표 끝]**\n\n배포 시 버전 식별이 가능하여야 하며, 파일에\n\n대한 배포자 및 무결성을 검증할 수 있어야\n\n한다.\n\n - - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3.  성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n 제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n - - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n - 1.  임상시험의 제목\n- 2. ",
        "original_sentence": "제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_658",
      "text": "- - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 657,
        "window_size": 3,
        "char_count": 310,
        "word_count": 75,
        "page_number": 52,
        "window_text": "- - 41 -\n- 1.14 펌웨어 또는 소프트웨어 업데이트 시\n인증 방식 사용\n\n- - 42 -\n- 1.20 개인의료정보 저장관리\n‘IEC 62304’\n\n‘스마트 의료\n\n사이버 보안\n\n**[표 시작]**\n\n| 시험보고서 | (AB-1234) |\n| --- | --- |\n\n**[표 끝]**\n\n- - 43 -\n<!-- PAGE_50 -->\n###### 3.  성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n 제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n - - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n - 1.  임상시험의 제목\n- 2.  임상시험기관의 명칭 및 소재지\n- 3. ",
        "original_sentence": "- - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_659",
      "text": "- 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 658,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 27,
        "window_text": "성능 평가 항목\n\n불면증 개선 디지털치료기기의 성능 평가 항목은 제품의 주요 기능을\n\n근거로 설정하며, 시험 기준 및 시험 방법은 제품의 특성을 고려하여\n\n가능한 정량적이고 구체적으로 작성한다.\n\n 제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n - - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n - 1.  임상시험의 제목\n- 2.  임상시험기관의 명칭 및 소재지\n- 3.  임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4. ",
        "original_sentence": "- 1. "
      }
    },
    {
      "chunk_id": "chunk_660",
      "text": "임상시험의 제목\n- 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 659,
        "window_size": 3,
        "char_count": 14,
        "word_count": 4,
        "page_number": 7,
        "window_text": "제품의 주요 기능 선정 시 아래 고려사항을 참고하여 선정한다.\n\n - - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n - 1.  임상시험의 제목\n- 2.  임상시험기관의 명칭 및 소재지\n- 3.  임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5. ",
        "original_sentence": "임상시험의 제목\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_661",
      "text": "임상시험기관의 명칭 및 소재지\n- 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 660,
        "window_size": 3,
        "char_count": 22,
        "word_count": 6,
        "page_number": 3,
        "window_text": "- - 제품의 사용목적상 필요한 기능(능력) 요구사항\n- - 소프트웨어 기반 알람, 경고, 연산 메시지\n- - 데이터베이스 요구사항\n- - 운영 방법 및 유지보수 방법과 관련된 요구사항\n- - 44 -\n본 예시는 이해를 돕기 위하여 작성된 것으로 실제 신청하려는 제품의 내용과 상이할\n\n- - 45 -\n<!-- PAGE_52 -->\n#### Ⅲ\n\n<!-- PAGE_52 -->\n#### 임상시험계획서 작성 시 고려사항 및 예시\n\n「의료기기법 시행규칙」제20조(임상시험계획의 승인 등) 제2항에 따라\n\n임상시험계획서에 포함되어야 할 사항은 다음과 같다.\n\n - 1.  임상시험의 제목\n- 2.  임상시험기관의 명칭 및 소재지\n- 3.  임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5.  임상시험을 하려는 자의 성명 및 주소\n- 6. ",
        "original_sentence": "임상시험기관의 명칭 및 소재지\n- 3. "
      }
    },
    {
      "chunk_id": "chunk_662",
      "text": "임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 661,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 3,
        "window_text": "- 1.  임상시험의 제목\n- 2.  임상시험기관의 명칭 및 소재지\n- 3.  임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5.  임상시험을 하려는 자의 성명 및 주소\n- 6.  임상시험의 목적 및 배경\n- 7. ",
        "original_sentence": "임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_663",
      "text": "임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 662,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 35,
        "window_text": "임상시험의 제목\n- 2.  임상시험기관의 명칭 및 소재지\n- 3.  임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5.  임상시험을 하려는 자의 성명 및 주소\n- 6.  임상시험의 목적 및 배경\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8. ",
        "original_sentence": "임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5. "
      }
    },
    {
      "chunk_id": "chunk_664",
      "text": "임상시험을 하려는 자의 성명 및 주소\n- 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 663,
        "window_size": 3,
        "char_count": 26,
        "word_count": 8,
        "page_number": 36,
        "window_text": "임상시험기관의 명칭 및 소재지\n- 3.  임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5.  임상시험을 하려는 자의 성명 및 주소\n- 6.  임상시험의 목적 및 배경\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8.  임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9. ",
        "original_sentence": "임상시험을 하려는 자의 성명 및 주소\n- 6. "
      }
    },
    {
      "chunk_id": "chunk_665",
      "text": "임상시험의 목적 및 배경\n- 7. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 664,
        "window_size": 3,
        "char_count": 19,
        "word_count": 6,
        "page_number": 7,
        "window_text": "임상시험의 책임자ㆍ담당자 및 공동연구자의 성명 및 직명\n- 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5.  임상시험을 하려는 자의 성명 및 주소\n- 6.  임상시험의 목적 및 배경\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8.  임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9.  임상시험기간\n- 10. ",
        "original_sentence": "임상시험의 목적 및 배경\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_666",
      "text": "임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 665,
        "window_size": 3,
        "char_count": 45,
        "word_count": 9,
        "page_number": 7,
        "window_text": "임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n- 5.  임상시험을 하려는 자의 성명 및 주소\n- 6.  임상시험의 목적 및 배경\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8.  임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9.  임상시험기간\n- 10.  임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11. ",
        "original_sentence": "임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8. "
      }
    },
    {
      "chunk_id": "chunk_667",
      "text": "임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 666,
        "window_size": 3,
        "char_count": 44,
        "word_count": 10,
        "page_number": 36,
        "window_text": "임상시험을 하려는 자의 성명 및 주소\n- 6.  임상시험의 목적 및 배경\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8.  임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9.  임상시험기간\n- 10.  임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11.  관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12. ",
        "original_sentence": "임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9. "
      }
    },
    {
      "chunk_id": "chunk_668",
      "text": "임상시험기간\n- 10. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 667,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 27,
        "window_text": "임상시험의 목적 및 배경\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8.  임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9.  임상시험기간\n- 10.  임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11.  관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12.  예측되는 부작용 및 사용 시 주의사항\n- 13. ",
        "original_sentence": "임상시험기간\n- 10. "
      }
    },
    {
      "chunk_id": "chunk_669",
      "text": "임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 668,
        "window_size": 3,
        "char_count": 41,
        "word_count": 5,
        "page_number": 27,
        "window_text": "임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증을 포함한다)\n- 8.  임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9.  임상시험기간\n- 10.  임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11.  관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12.  예측되는 부작용 및 사용 시 주의사항\n- 13.  중지ㆍ탈락 기준\n- 14. ",
        "original_sentence": "임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11. "
      }
    },
    {
      "chunk_id": "chunk_670",
      "text": "관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 669,
        "window_size": 3,
        "char_count": 27,
        "word_count": 5,
        "page_number": 3,
        "window_text": "임상시험용 의료기기의 적용 대상이 되거나 대조군에 포함되어 임상시험에\n- 9.  임상시험기간\n- 10.  임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11.  관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12.  예측되는 부작용 및 사용 시 주의사항\n- 13.  중지ㆍ탈락 기준\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15. ",
        "original_sentence": "관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12. "
      }
    },
    {
      "chunk_id": "chunk_671",
      "text": "예측되는 부작용 및 사용 시 주의사항\n- 13. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 670,
        "window_size": 3,
        "char_count": 27,
        "word_count": 8,
        "page_number": 3,
        "window_text": "임상시험기간\n- 10.  임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11.  관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12.  예측되는 부작용 및 사용 시 주의사항\n- 13.  중지ㆍ탈락 기준\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15.  부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16. ",
        "original_sentence": "예측되는 부작용 및 사용 시 주의사항\n- 13. "
      }
    },
    {
      "chunk_id": "chunk_672",
      "text": "중지ㆍ탈락 기준\n- 14. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 671,
        "window_size": 3,
        "char_count": 15,
        "word_count": 4,
        "page_number": 27,
        "window_text": "임상시험방법(사용량ㆍ사용방법ㆍ사용기간ㆍ병용요법 등을 포함한다)\n- 11.  관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12.  예측되는 부작용 및 사용 시 주의사항\n- 13.  중지ㆍ탈락 기준\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15.  부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16.  피험자동의서 서식\n- 17. ",
        "original_sentence": "중지ㆍ탈락 기준\n- 14. "
      }
    },
    {
      "chunk_id": "chunk_673",
      "text": "유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 672,
        "window_size": 3,
        "char_count": 42,
        "word_count": 8,
        "page_number": 27,
        "window_text": "관찰항목ㆍ임상검사항목 및 관찰검사방법\n- 12.  예측되는 부작용 및 사용 시 주의사항\n- 13.  중지ㆍ탈락 기준\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15.  부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16.  피험자동의서 서식\n- 17.  피해자 보상에 대한 규약\n- 18. ",
        "original_sentence": "유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15. "
      }
    },
    {
      "chunk_id": "chunk_674",
      "text": "부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 673,
        "window_size": 3,
        "char_count": 37,
        "word_count": 8,
        "page_number": 27,
        "window_text": "예측되는 부작용 및 사용 시 주의사항\n- 13.  중지ㆍ탈락 기준\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15.  부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16.  피험자동의서 서식\n- 17.  피해자 보상에 대한 규약\n- 18.  임상시험 후 피험자의 진료에 관한 사항\n- 19. ",
        "original_sentence": "부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16. "
      }
    },
    {
      "chunk_id": "chunk_675",
      "text": "피험자동의서 서식\n- 17. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 674,
        "window_size": 3,
        "char_count": 16,
        "word_count": 4,
        "page_number": 27,
        "window_text": "중지ㆍ탈락 기준\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15.  부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16.  피험자동의서 서식\n- 17.  피해자 보상에 대한 규약\n- 18.  임상시험 후 피험자의 진료에 관한 사항\n- 19.  피험자의 안전보호에 관한 대책\n- 20. ",
        "original_sentence": "피험자동의서 서식\n- 17. "
      }
    },
    {
      "chunk_id": "chunk_676",
      "text": "피해자 보상에 대한 규약\n- 18. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 675,
        "window_size": 3,
        "char_count": 20,
        "word_count": 6,
        "page_number": 27,
        "window_text": "유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 따른다)\n- 15.  부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16.  피험자동의서 서식\n- 17.  피해자 보상에 대한 규약\n- 18.  임상시험 후 피험자의 진료에 관한 사항\n- 19.  피험자의 안전보호에 관한 대책\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n",
        "original_sentence": "피해자 보상에 대한 규약\n- 18. "
      }
    },
    {
      "chunk_id": "chunk_677",
      "text": "임상시험 후 피험자의 진료에 관한 사항\n- 19. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 676,
        "window_size": 3,
        "char_count": 28,
        "word_count": 8,
        "page_number": 3,
        "window_text": "부작용을 포함한 안전성의 평가기준ㆍ평가방법 및 보고방법\n- 16.  피험자동의서 서식\n- 17.  피해자 보상에 대한 규약\n- 18.  임상시험 후 피험자의 진료에 관한 사항\n- 19.  피험자의 안전보호에 관한 대책\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n - - 46 -\n<!-- PAGE_53 -->\n###### 1. ",
        "original_sentence": "임상시험 후 피험자의 진료에 관한 사항\n- 19. "
      }
    },
    {
      "chunk_id": "chunk_678",
      "text": "피험자의 안전보호에 관한 대책\n- 20. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 677,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 9,
        "window_text": "피험자동의서 서식\n- 17.  피해자 보상에 대한 규약\n- 18.  임상시험 후 피험자의 진료에 관한 사항\n- 19.  피험자의 안전보호에 관한 대책\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n - - 46 -\n<!-- PAGE_53 -->\n###### 1.  임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2. ",
        "original_sentence": "피험자의 안전보호에 관한 대책\n- 20. "
      }
    },
    {
      "chunk_id": "chunk_679",
      "text": "그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 678,
        "window_size": 3,
        "char_count": 130,
        "word_count": 33,
        "page_number": 3,
        "window_text": "피해자 보상에 대한 규약\n- 18.  임상시험 후 피험자의 진료에 관한 사항\n- 19.  피험자의 안전보호에 관한 대책\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n - - 46 -\n<!-- PAGE_53 -->\n###### 1.  임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2.  임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3. ",
        "original_sentence": "그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_680",
      "text": "- - 46 -\n<!-- PAGE_53 -->\n###### 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 679,
        "window_size": 3,
        "char_count": 36,
        "word_count": 9,
        "page_number": 53,
        "window_text": "임상시험 후 피험자의 진료에 관한 사항\n- 19.  피험자의 안전보호에 관한 대책\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n - - 46 -\n<!-- PAGE_53 -->\n###### 1.  임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2.  임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3.  임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가. ",
        "original_sentence": "- - 46 -\n<!-- PAGE_53 -->\n###### 1. "
      }
    },
    {
      "chunk_id": "chunk_681",
      "text": "임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 680,
        "window_size": 3,
        "char_count": 247,
        "word_count": 48,
        "page_number": 54,
        "window_text": "피험자의 안전보호에 관한 대책\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n - - 46 -\n<!-- PAGE_53 -->\n###### 1.  임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2.  임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3.  임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가.  시험책임자\n- 나. ",
        "original_sentence": "임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2. "
      }
    },
    {
      "chunk_id": "chunk_682",
      "text": "임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 681,
        "window_size": 3,
        "char_count": 62,
        "word_count": 14,
        "page_number": 55,
        "window_text": "그 밖에 임상시험을 안전하고 과학적으로 실시하기 위하여 필요한 사항\n※ 본 장에서 제시한 항목 및 예시는 참고용으로 작성한 것으로 사안에\n\n따라 변경될 수 있으며, 제품의 특성에 따라 타당한 근거를 제시할 경우\n\n변경이 가능하다.\n\n - - 46 -\n<!-- PAGE_53 -->\n###### 1.  임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2.  임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3.  임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가.  시험책임자\n- 나.  시험담당자\n- 다. ",
        "original_sentence": "임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3. "
      }
    },
    {
      "chunk_id": "chunk_683",
      "text": "임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 682,
        "window_size": 3,
        "char_count": 260,
        "word_count": 63,
        "page_number": 3,
        "window_text": "- - 46 -\n<!-- PAGE_53 -->\n###### 1.  임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2.  임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3.  임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가.  시험책임자\n- 나.  시험담당자\n- 다.  공동연구자\n- 라. ",
        "original_sentence": "임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_684",
      "text": "시험책임자\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 683,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 46,
        "window_text": "임상시험의 제목\n\n비기질성 불면증 진단환자의 불면 증상을 정량적으로 개선하기 위해서\n\n사용되는 OOO 디지털치료기기의 안전성 및 유효성을 평가하기 위한\n\n전향적 무작위 확증 임상시험\n\n[G47.0] Disorders of initiating and maintaining sleep\n\n4) 임상시험 평가 내용 : 불면증 심각도 척도(Insomnia Severity Index)\n\n- - 47 -\n<!-- PAGE_54 -->\n###### 2.  임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3.  임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가.  시험책임자\n- 나.  시험담당자\n- 다.  공동연구자\n- 라.  임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4. ",
        "original_sentence": "시험책임자\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_685",
      "text": "시험담당자\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 684,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 3,
        "window_text": "임상시험기관의 명칭 및 소재지\n\n임상시험기관\n\n- - 48 -\n<!-- PAGE_55 -->\n###### 3.  임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가.  시험책임자\n- 나.  시험담당자\n- 다.  공동연구자\n- 라.  임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5. ",
        "original_sentence": "시험담당자\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_686",
      "text": "공동연구자\n- 라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 685,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 49,
        "window_text": "임상시험 책임자·담당자 및 공동연구자의 성명 및 직명\n\n- - 시험책임자는 임상시험기관에서 임상시험 수행에 대한 책임을 갖고 있는 사람\n으로서, 전문지식과 윤리적 소양을 갖추고 해당 의료기기의 임상시험을 실시\n\n- - 시험담당자는 시험책임자의 위임 및 감독 하에 임상시험과 관련된 업무를 담당\n하거나 필요한 사항을 결정하는 의사, 치과의사, 한의사 및 그 밖의 임상시험에\n\n- - 각 임상시험기관의 적절한 임상시험의 수행을 위하여 임상시험기관 및 시험자의\n- 가.  시험책임자\n- 나.  시험담당자\n- 다.  공동연구자\n- 라.  임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5.  임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다. ",
        "original_sentence": "공동연구자\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_687",
      "text": "임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 686,
        "window_size": 3,
        "char_count": 81,
        "word_count": 21,
        "page_number": 56,
        "window_text": "시험책임자\n- 나.  시험담당자\n- 다.  공동연구자\n- 라.  임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5.  임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다.  의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다. ",
        "original_sentence": "임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4. "
      }
    },
    {
      "chunk_id": "chunk_688",
      "text": "임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 687,
        "window_size": 3,
        "char_count": 77,
        "word_count": 18,
        "page_number": 57,
        "window_text": "시험담당자\n- 다.  공동연구자\n- 라.  임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5.  임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다.  의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다.  임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가. ",
        "original_sentence": "임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5. "
      }
    },
    {
      "chunk_id": "chunk_689",
      "text": "임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 688,
        "window_size": 3,
        "char_count": 97,
        "word_count": 23,
        "page_number": 39,
        "window_text": "공동연구자\n- 라.  임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5.  임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다.  의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다.  임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가.  의뢰자\n- 나. ",
        "original_sentence": "임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다. "
      }
    },
    {
      "chunk_id": "chunk_690",
      "text": "의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 689,
        "window_size": 3,
        "char_count": 29,
        "word_count": 6,
        "page_number": 44,
        "window_text": "임상시험 조정자\n- ○○○\n- ○○병원\n- ○○○\n- ○○○\n- ○○○-○○○○\n- - 49 -\n<!-- PAGE_56 -->\n###### 4.  임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5.  임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다.  의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다.  임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가.  의뢰자\n- 나.  모니터요원\n- 다. ",
        "original_sentence": "의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_691",
      "text": "임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 690,
        "window_size": 3,
        "char_count": 82,
        "word_count": 16,
        "page_number": 3,
        "window_text": "임상시험용 의료기기를 관리하는 관리자의 성명 및 직명\n\n의료기기 관리자\n\n- - 50 -\n<!-- PAGE_57 -->\n###### 5.  임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다.  의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다.  임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가.  의뢰자\n- 나.  모니터요원\n- 다.  임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6. ",
        "original_sentence": "임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_692",
      "text": "의뢰자\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 691,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 49,
        "window_text": "임상시험을 하려는 자의 성명 및 주소\n\n임상시험 의뢰자는 임상시험의 계획, 관리, 재정 등에 관련된 책임이 있는 자로서\n\n해당 의료기기의 제조업자 또는 수입업자가 해당된다.  의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다.  임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가.  의뢰자\n- 나.  모니터요원\n- 다.  임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6.  임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가. ",
        "original_sentence": "의뢰자\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_693",
      "text": "모니터요원\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 692,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 49,
        "window_text": "의뢰자는 임상시험 모니터\n\n요원을 지정하여야 한다.  임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가.  의뢰자\n- 나.  모니터요원\n- 다.  임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6.  임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가.  임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018). ",
        "original_sentence": "모니터요원\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_694",
      "text": "임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 693,
        "window_size": 3,
        "char_count": 104,
        "word_count": 19,
        "page_number": 58,
        "window_text": "임상시험 모니터요원의 선정, 자격기준, 수행임무 등에\n\n대한 사항은 「의료기기법 시행규칙」별표3 “의료기기의 임상시험 관리기준” 제8호\n\n- 가.  의뢰자\n- 나.  모니터요원\n- 다.  임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6.  임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가.  임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018).  임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다. ",
        "original_sentence": "임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6. "
      }
    },
    {
      "chunk_id": "chunk_695",
      "text": "임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 694,
        "window_size": 3,
        "char_count": 199,
        "word_count": 47,
        "page_number": 7,
        "window_text": "의뢰자\n- 나.  모니터요원\n- 다.  임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6.  임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가.  임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018).  임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다.  약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다. ",
        "original_sentence": "임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_696",
      "text": "임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 695,
        "window_size": 3,
        "char_count": 186,
        "word_count": 41,
        "page_number": 7,
        "window_text": "모니터요원\n- 다.  임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6.  임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가.  임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018).  임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다.  약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다.  또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n",
        "original_sentence": "임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018). "
      }
    },
    {
      "chunk_id": "chunk_697",
      "text": "임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 696,
        "window_size": 3,
        "char_count": 36,
        "word_count": 7,
        "page_number": 45,
        "window_text": "임상시험 수탁업체\n※ 임상시험\n\n수탁기관(Contact Research Organization, CRO)이\n\n있는 경우\n\n- - 51 -\n<!-- PAGE_58 -->\n###### 6.  임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가.  임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018).  임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다.  약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다.  또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n 이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다. ",
        "original_sentence": "임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다. "
      }
    },
    {
      "chunk_id": "chunk_698",
      "text": "약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 697,
        "window_size": 3,
        "char_count": 93,
        "word_count": 22,
        "page_number": 45,
        "window_text": "임상시험의 목적 및 배경\n\n임상시험의 목적은 해당 의료기기의 안전성과 유효성 평가에 대하여 구체적으로\n\n기술하는 것을 말하며, 임상시험의 배경은 임상시험을 실시하게 된 동기로서 제품의\n\n일반적인 사항, 해당 제품의 개발경위 및 임상시험용 의료기기의 작동원리, 설계\n\n또는 디자인 특성, 원자재 및 성능, 새로운 제조방법 등에 대한 특이성을 함께\n\n- 가.  임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018).  임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다.  약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다.  또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n 이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다.  불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n",
        "original_sentence": "약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다. "
      }
    },
    {
      "chunk_id": "chunk_699",
      "text": "또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 698,
        "window_size": 3,
        "char_count": 114,
        "word_count": 24,
        "page_number": 28,
        "window_text": "임상시험의 목적\n[목적]\n\n1) 임상시험용 디지털치료기기의 불면증 치료에 대한 안전성 평가\n\n2) 임상시험용 디지털치료기기의 불면증 치료에 대한 유효성 평가\n\n최근 불면증으로 치료받는 환자의 숫자가 급격히 증가하고 있는\n\n추세로 불면증을 치료하기 위한 방법들 또한 많은 주목을 받고 있다\n\n(Straten et al., 2018).  임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다.  약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다.  또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n 이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다.  불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n 하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011). ",
        "original_sentence": "또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n"
      }
    },
    {
      "chunk_id": "chunk_700",
      "text": "이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 699,
        "window_size": 3,
        "char_count": 52,
        "word_count": 10,
        "page_number": 49,
        "window_text": "임상에서 불면증 환자들에게 주로 사용되는 치료는\n\n약물치료이다.  약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다.  또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n 이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다.  불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n 하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011).  불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n",
        "original_sentence": "이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다. "
      }
    },
    {
      "chunk_id": "chunk_701",
      "text": "불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 700,
        "window_size": 3,
        "char_count": 171,
        "word_count": 37,
        "page_number": 9,
        "window_text": "약물치료는 불면증의 단기 치료에 있어서 그 유용성이\n\n확립되어 있으나 어지러움, 낙상, 의존, 내성, 인지기능 저하 및 사망률의\n\n증가 등의 부작용의 위험성이 있다.  또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n 이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다.  불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n 하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011).  불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n 둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다. ",
        "original_sentence": "불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n"
      }
    },
    {
      "chunk_id": "chunk_702",
      "text": "하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 701,
        "window_size": 3,
        "char_count": 83,
        "word_count": 16,
        "page_number": 43,
        "window_text": "또한, 최근의 연구들은 수면제의\n\n복용, 특히 3개월 이상의 장기적인 사용이나 고용량을 복용할 경우\n\n치매의 위험이 더욱 증가한다고 보고하였다 (Billioti de Gage et al., 2014).\n\n 이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다.  불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n 하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011).  불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n 둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다.  셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n",
        "original_sentence": "하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011). "
      }
    },
    {
      "chunk_id": "chunk_703",
      "text": "불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 702,
        "window_size": 3,
        "char_count": 171,
        "word_count": 38,
        "page_number": 43,
        "window_text": "이러한 약물치료의 단점들을 보완해줄 수 있는 치료는 불면증 인지\n\n행동치료(CBT-I)이다.  불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n 하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011).  불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n 둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다.  셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n 이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다. ",
        "original_sentence": "불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_704",
      "text": "둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 703,
        "window_size": 3,
        "char_count": 128,
        "word_count": 28,
        "page_number": 59,
        "window_text": "불면증 인지행동치료(CBT-I)는 단기적으로는 약물\n\n- - 52 -\n치료와 그 효과가 유사하며 장기적인 효과는 약물치료보다 우수한 것\n\n으로 밝혀져 있으며, 이러한 효과의 입증을 통해 불면증의 일차 치료로\n\n권장되고 있다 (Jacobs et al., 2004, Edinger et al., 2001).\n\n 하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011).  불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n 둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다.  셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n 이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다.  디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al. ",
        "original_sentence": "둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다. "
      }
    },
    {
      "chunk_id": "chunk_705",
      "text": "셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 704,
        "window_size": 3,
        "char_count": 90,
        "word_count": 19,
        "page_number": 43,
        "window_text": "하지만 실제 임상에서 불면증 인지행동치료(CBT-I)가 처방되는 비율은\n\n약물치료에 비해 현저히 낮다 (Riemann D et al., 2011).  불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n 둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다.  셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n 이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다.  디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al.  2004). ",
        "original_sentence": "셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_706",
      "text": "이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 705,
        "window_size": 3,
        "char_count": 65,
        "word_count": 12,
        "page_number": 43,
        "window_text": "불면증 인지행동\n\n치료(CBT-I)가 약물치료에 비해 많은 장점이 있음에도 널리 시행되지\n\n않는 이유는 첫째, 불면증 인지행동치료(CBT-I)를 위해 환자들이 병원에\n\n매주 내원하여야 하므로 병원에의 공간적 접근성, 치료를 위해 확보\n\n할 수 있는 시간 자원 여부에 따른 치료적 제약이 생기기 때문이다.\n\n 둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다.  셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n 이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다.  디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al.  2004).  이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n",
        "original_sentence": "이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다. "
      }
    },
    {
      "chunk_id": "chunk_707",
      "text": "디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 706,
        "window_size": 3,
        "char_count": 134,
        "word_count": 25,
        "page_number": 9,
        "window_text": "둘째, 특히 고령 환자이거나, 기타 내과적 질환으로 인해 이동이 힘든\n\n환자들의 경우, 혹은 직장인이라 매주 시간을 내기 어려운 환자들의\n\n경우 본인들이 원하더라도 불면증 인지행동치료(CBT-I)를 받기 어려운\n\n것이 현실이다.  셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n 이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다.  디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al.  2004).  이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다. ",
        "original_sentence": "디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al. "
      }
    },
    {
      "chunk_id": "chunk_708",
      "text": "2004). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 707,
        "window_size": 3,
        "char_count": 7,
        "word_count": 1,
        "page_number": 9,
        "window_text": "셋째, 치료진 관점에서 약물치료에 비해 불면증 인지\n\n행동치료(CBT-I)를 시행하는 것이 시간 대비 효용성이 높지 않으므로\n\n선호도가 떨어지는 경향이 있다.\n\n 이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다.  디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al.  2004).  이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다.  특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n",
        "original_sentence": "2004). "
      }
    },
    {
      "chunk_id": "chunk_709",
      "text": "이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 708,
        "window_size": 3,
        "char_count": 172,
        "word_count": 44,
        "page_number": 45,
        "window_text": "이러한 단점들을 보완하기 위해 디지털로 수행하는 불면증 인지\n\n행동치료(Digital CBT-I)가 개발되고 있다.  디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al.  2004).  이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다.  특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n 본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n",
        "original_sentence": "이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_710",
      "text": "디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 709,
        "window_size": 3,
        "char_count": 79,
        "word_count": 17,
        "page_number": 27,
        "window_text": "디지털 불면증 인지행동치료\n\n(Digital CBT-I)의 개념은 2004년에 처음으로 등장하였으며, 인터넷을\n\n이용하여 병원에 내원하지 않고도 불면증 인지행동치료(CBT-I)를 시행\n\n받을 수 있도록 하는 것이다 (Strom et al.  2004).  이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다.  특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n 본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n - 나. ",
        "original_sentence": "디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다. "
      }
    },
    {
      "chunk_id": "chunk_711",
      "text": "특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 710,
        "window_size": 3,
        "char_count": 192,
        "word_count": 36,
        "page_number": 49,
        "window_text": "2004).  이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다.  특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n 본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n - 나.  임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n",
        "original_sentence": "특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_712",
      "text": "본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 711,
        "window_size": 3,
        "char_count": 104,
        "word_count": 17,
        "page_number": 39,
        "window_text": "이를 통해 환자들이\n\n직접 집에서 컴퓨터, 혹은 스마트폰을 이용하여 치료를 시행 받을 수\n\n있으므로 시공간의 제약에서 자유롭게 될 것이며, 치료 대부분을 환자가\n\n프로그램을 통해 수행하고 피드백을 받을 수 있으므로 치료자 입장\n\n- - 53 -\n에서의 비용 대비 효용성 또한 증가하게 될 것으로 기대된다.\n\n 디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다.  특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n 본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n - 나.  임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n 미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다. ",
        "original_sentence": "본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_713",
      "text": "- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 712,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "디지털 불면증 인지행동치료(Digital CBT-I)가 등장한 지도 약 15년이\n\n되어 치료 효과에 대한 여러 연구 결과들이 발표되고 있다.  특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n 본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n - 나.  임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n 미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다.  Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_714",
      "text": "임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 713,
        "window_size": 3,
        "char_count": 135,
        "word_count": 21,
        "page_number": 43,
        "window_text": "특히, 최근\n\n연구들은 단순히 불면증 인지행동치료(CBT-I)를 디지털 환경으로 옮기는\n\n것에서 발전하여, 애플리케이션을 통하여 환자에게 바로 피드백을 제공\n\n함으로써 의사나 치료자가 직접적인 가이드를 주지 않더라도 치료\n\n효과를 볼 수 있게 하는 “디지털치료기기(Digital Therapeutics, DTx)”의\n\n개념을 추구하고 있다.\n\n 본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n - 나.  임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n 미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다.  Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다.  아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n",
        "original_sentence": "임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_715",
      "text": "미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 714,
        "window_size": 3,
        "char_count": 104,
        "word_count": 21,
        "page_number": 60,
        "window_text": "본 임상시험을 통해 불면증이 있는 환자들을 대상으로 개발된 불면증 개선\n\n디지털치료기기의 작용기전에 대한 안전성(safety)과 유효성(effectiveness)을\n\n검증하고자 한다.\n\n - 나.  임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n 미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다.  Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다.  아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n 선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al. ",
        "original_sentence": "미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다. "
      }
    },
    {
      "chunk_id": "chunk_716",
      "text": "Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 715,
        "window_size": 3,
        "char_count": 118,
        "word_count": 29,
        "page_number": 27,
        "window_text": "- 나.  임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n 미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다.  Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다.  아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n 선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al.  2016.).\n\n",
        "original_sentence": "Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다. "
      }
    },
    {
      "chunk_id": "chunk_717",
      "text": "아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 716,
        "window_size": 3,
        "char_count": 74,
        "word_count": 17,
        "page_number": 1,
        "window_text": "임상시험의 배경\n디지털치료기기란 질병이나 장애를 예방, 관리, 치료하기 위해 환자에게\n\n근거 기반의 치료적 중재(evidence-based therapeutic intervention)를 제공하는\n\n고도화된 소프트웨어 의료기기를 가리킨다.\n\n 미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다.  Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다.  아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n 선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al.  2016.).\n\n 또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n",
        "original_sentence": "아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_718",
      "text": "선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 717,
        "window_size": 3,
        "char_count": 324,
        "word_count": 57,
        "page_number": 27,
        "window_text": "미국 Pear therapeutics 社에서 제공하는 Somryst™는 FDA 승인을 받은\n\n불면증 개선 디지털치료기기로서 의사가 처방을 내릴 수 있으며 실제\n\n임상에서 사용되고 있다.  Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다.  아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n 선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al.  2016.).\n\n 또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n - - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다. ",
        "original_sentence": "선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al. "
      }
    },
    {
      "chunk_id": "chunk_719",
      "text": "2016.).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 718,
        "window_size": 3,
        "char_count": 9,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Somryst™는 여러 무작위배정 임상시험을 통해 그\n\n효용성 또한 입증된 바 있으며, 수면에 관련된 변수들을 포함하여 신체적\n\n건강, 심리적 웰빙 및 우울 관련 지표 또한 호전되었다는 것이 밝혀진\n\n바 있다.  아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n 선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al.  2016.).\n\n 또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n - - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다.  첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다. ",
        "original_sentence": "2016.).\n\n"
      }
    },
    {
      "chunk_id": "chunk_720",
      "text": "또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 719,
        "window_size": 3,
        "char_count": 207,
        "word_count": 39,
        "page_number": 9,
        "window_text": "아래의 <그림 5>와 <그림 6>은 불면증 개선 디지털치료기기와\n\n- - 54 -\n관련하여 수행한 임상시험의 선행연구 결과들이다.\n\n 선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al.  2016.).\n\n 또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n - - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다.  첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다.  대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다. ",
        "original_sentence": "또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n"
      }
    },
    {
      "chunk_id": "chunk_721",
      "text": "- - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 720,
        "window_size": 3,
        "char_count": 66,
        "word_count": 17,
        "page_number": 35,
        "window_text": "선행 연구에서는 18세 이상 불면증과 우울 증상이 있는 사람을 대상\n\n으로 디지털 불면증 인지행동치료기기(SHUTi)를 활용한 임상시험 결과,\n\n대조군(HealthWatch)에 비해 디지털 불면증 인지행동치료기기를 사용한\n\n시험군에서 우울증 선별도구(Patient Health Questionnaire-9, PHQ-9)로\n\n측정한 우울 증상이 6주 및 6개월 후 유의하게 낮아졌으며, 정신과적\n\n증상 빈도 척도(Psychiatric Symptom Frequency scale, PSF)로 측정한\n\n불안과 우울 증상도 6주 후 유의하게 낮아졌다 (Christensen et al.  2016.).\n\n 또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n - - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다.  첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다.  대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다.  이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다. ",
        "original_sentence": "- - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다. "
      }
    },
    {
      "chunk_id": "chunk_722",
      "text": "첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 721,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 19,
        "window_text": "2016.).\n\n 또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n - - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다.  첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다.  대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다.  이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다.  둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다. ",
        "original_sentence": "첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다. "
      }
    },
    {
      "chunk_id": "chunk_723",
      "text": "대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 722,
        "window_size": 3,
        "char_count": 74,
        "word_count": 18,
        "page_number": 7,
        "window_text": "또 다른 선행연구에서는 21세 이상 만성 불면증 환자를 대상으로\n\n인터넷 기반 불면증 인지행동치료(Web-based CBT-I) 효과 임상시험\n\n결과, 대조군(Patient education)에 비해 시험군(SHUTi)에서 불면 심각도\n\n척도, 수면 잠재기, 입면 후 각성 시간 지표에서 모두 개선된 효과가\n\n확인되었다 (Ritterband et al., 2017).\n\n - - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다.  첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다.  대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다.  이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다.  둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다.  모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다. ",
        "original_sentence": "대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다. "
      }
    },
    {
      "chunk_id": "chunk_724",
      "text": "이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 723,
        "window_size": 3,
        "char_count": 66,
        "word_count": 16,
        "page_number": 43,
        "window_text": "- - 55 -\n이러한 디지털치료기기는 기존의 불면증 개선을 위한 웰니스 프로\n\n그램과 다음과 같은 차이점을 가진다.  첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다.  대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다.  이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다.  둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다.  모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다.  셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n",
        "original_sentence": "이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_725",
      "text": "둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 724,
        "window_size": 3,
        "char_count": 27,
        "word_count": 6,
        "page_number": 45,
        "window_text": "첫째, 일방향적인 콘텐츠 제공을\n\n넘어 쌍방향적인 피드백을 제공한다.  대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다.  이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다.  둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다.  모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다.  셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n 일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n",
        "original_sentence": "둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_726",
      "text": "모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 725,
        "window_size": 3,
        "char_count": 82,
        "word_count": 19,
        "page_number": 43,
        "window_text": "대상자의 수면에 대한 변수를\n\n지속적으로 수집하고, 이에 대해 다음 목표를 제시함으로써 치료 효과를\n\n- - 56 -\n극대화시킨다.  이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다.  둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다.  모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다.  셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n 일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n 이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n",
        "original_sentence": "모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_727",
      "text": "셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 726,
        "window_size": 3,
        "char_count": 51,
        "word_count": 12,
        "page_number": 39,
        "window_text": "이 과정에서 피험자는 단순히 콘텐츠를 소비하는 것을\n\n넘어서, 스스로 콘텐츠에 참여하고 있다는 느낌을 받을 수 있다.  둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다.  모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다.  셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n 일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n 이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n 본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n",
        "original_sentence": "셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_728",
      "text": "일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 727,
        "window_size": 3,
        "char_count": 75,
        "word_count": 17,
        "page_number": 7,
        "window_text": "둘째,\n\n피험자 맞춤형 콘텐츠 제공이 가능하다.  모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다.  셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n 일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n 이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n 본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n - - 57 -\n- 7. ",
        "original_sentence": "일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_729",
      "text": "이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 728,
        "window_size": 3,
        "char_count": 108,
        "word_count": 26,
        "page_number": 45,
        "window_text": "모든 콘텐츠를 같은 비율로\n\n제공하는 것에 그치지 않고 피험자의 정보를 수집함으로써 취약한 부분에\n\n대한 집중적인 맞춤형 콘텐츠 제공이 가능하다.  셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n 일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n 이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n 본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n - - 57 -\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가. ",
        "original_sentence": "이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_730",
      "text": "본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 729,
        "window_size": 3,
        "char_count": 164,
        "word_count": 38,
        "page_number": 36,
        "window_text": "셋째, 일정 시간 동안의\n\n꾸준한 사용을 독려하며 치료 효과에 대한 모니터링이 가능하다.\n\n 일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n 이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n 본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n - - 57 -\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가.  임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다. ",
        "original_sentence": "본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_731",
      "text": "- - 57 -\n- 7. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 730,
        "window_size": 3,
        "char_count": 14,
        "word_count": 6,
        "page_number": 35,
        "window_text": "일반적으로 디지털치료기기는 모든 콘텐츠를 한 번에 제공하지 않고\n\n일정 기간 순차적인 콘텐츠 제공을 함으로써 사용 기간을 조정한다.\n\n 이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n 본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n - - 57 -\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가.  임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다.  임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n",
        "original_sentence": "- - 57 -\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_732",
      "text": "임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 731,
        "window_size": 3,
        "char_count": 42,
        "word_count": 9,
        "page_number": 7,
        "window_text": "이에 따라 피험자들은 치료 기간 중 스스로의 수면이 어떻게 변화하는지\n\n실제 체감하고, 또한 디지털치료기기를 통한 모니터링을 제공받을 수\n\n있어 치료 동기 부여에 긍정적으로 작용할 수 있다.\n\n 본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n - - 57 -\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가.  임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다.  임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n 본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n",
        "original_sentence": "임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_733",
      "text": "임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 732,
        "window_size": 3,
        "char_count": 149,
        "word_count": 30,
        "page_number": 7,
        "window_text": "본 연구에서는 국내에서 개발된 디지털 불면증 인지행동치료 애플리\n\n케이션을 무작위 배정 임상시험을 통해 효과성과 안전성 검증을\n\n함으로써 해당 애플리케이션을 실제 국내 임상에서 활용할 수 있는지\n\n여부 확인을 할 수 있겠으며 국내 불면증 환자들에게 새로운 치료의\n\n선택지를 열어주고자 한다.\n\n - - 57 -\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가.  임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다.  임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n 본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n *\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나. ",
        "original_sentence": "임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다. "
      }
    },
    {
      "chunk_id": "chunk_734",
      "text": "임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 733,
        "window_size": 3,
        "char_count": 97,
        "word_count": 20,
        "page_number": 17,
        "window_text": "- - 57 -\n- 7.  임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가.  임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다.  임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n 본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n *\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나.  임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다. ",
        "original_sentence": "임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_735",
      "text": "본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 734,
        "window_size": 3,
        "char_count": 86,
        "word_count": 19,
        "page_number": 36,
        "window_text": "임상시험용 의료기기의 개요(사용목적, 대상질환 또는 적응증 포함)\n- 가.  임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다.  임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n 본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n *\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나.  임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다.  대조\n\n- 다. ",
        "original_sentence": "본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_736",
      "text": "*\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 735,
        "window_size": 3,
        "char_count": 154,
        "word_count": 25,
        "page_number": 27,
        "window_text": "임상시험용 의료기기 사용목적\n해당 의료기기의 사용목적과 그 사용범위를 구체적으로 기재하며 대상질환 또는\n\n[사용목적]\n\n모바일 애플리케이션 형태의 불면증 인지행동치료 기반 콘텐츠를\n\n범용 장비(스마트폰 또는 태블릿 PC)를 통해 제공하는 소프트웨어 의료\n\n기기이다.  임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n 본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n *\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나.  임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다.  대조\n\n- 다.  임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n",
        "original_sentence": "*\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_737",
      "text": "임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 736,
        "window_size": 3,
        "char_count": 150,
        "word_count": 27,
        "page_number": 7,
        "window_text": "임상시험용 기기는 불면증 인지행동치료(CBT-I)를 제공하여\n\n대조군(수면 일기 작성 권고 및 간단한 수면위생교육 제공) 대비 불면증\n\n증상을 개선하는 것을 목표로 한다.\n\n 본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n *\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나.  임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다.  대조\n\n- 다.  임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n : 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n",
        "original_sentence": "임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다. "
      }
    },
    {
      "chunk_id": "chunk_738",
      "text": "대조\n\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 737,
        "window_size": 3,
        "char_count": 9,
        "word_count": 3,
        "page_number": 49,
        "window_text": "본 의료기기는 불면증*을 의사에게 진단받은 환자들을 대상으로 하며,\n\n추후 추가적인 적응증 확대는 가능하나 불면증에 대한 의사 진단을\n\n기반으로 한다.\n\n *\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나.  임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다.  대조\n\n- 다.  임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n : 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n",
        "original_sentence": "대조\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_739",
      "text": "임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 738,
        "window_size": 3,
        "char_count": 99,
        "word_count": 24,
        "page_number": 36,
        "window_text": "*\n\n[F51.0]\n\nNonorganic\n\ninsomnia(비기질성\n\n불면증)\n\n또는\n\n[G47.0]\n\nDisorders\n\nof\n\ninitiating and maintaining sleep [insomnias](수면 개시 및 유지 장애 [불면증])\n\n- - 58 -\n- 나.  임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다.  대조\n\n- 다.  임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n : 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n - (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질. ",
        "original_sentence": "임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_740",
      "text": ": 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 739,
        "window_size": 3,
        "char_count": 115,
        "word_count": 30,
        "page_number": 3,
        "window_text": "임상시험용 의료기기 정보\n해당 임상시험용 의료기기 및 대조시험용 의료기기의 품목명, 제조회사, 원재료, 모양,\n\n- - 품목명(품목분류번호, 등급): 인지치료소프트웨어(E06060.02, 2등급)\n※ 대조시험용 의료기기의 구체적인 정보를 ‘가)’를 참고하여 작성한다.  대조\n\n- 다.  임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n : 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n - (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질.  이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n",
        "original_sentence": ": 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_741",
      "text": "이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 740,
        "window_size": 3,
        "char_count": 75,
        "word_count": 16,
        "page_number": 13,
        "window_text": "대조\n\n- 다.  임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n : 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n - (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질.  이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n ⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다. ",
        "original_sentence": "이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_742",
      "text": "- (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 741,
        "window_size": 3,
        "char_count": 244,
        "word_count": 65,
        "page_number": 9,
        "window_text": "임상시험용 의료기기 사용 방법\n치료에 앞서 범용 장비(스마트폰, 태블릿, PC 등)에 OOO 디지털\n\n2) 사용 방법\n\n- - 59 -\n가) OOO 디지털치료기기를 실행한다.\n\n : 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n - (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질.  이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n ⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다.  이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n",
        "original_sentence": "- (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질. "
      }
    },
    {
      "chunk_id": "chunk_743",
      "text": "이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 742,
        "window_size": 3,
        "char_count": 56,
        "word_count": 16,
        "page_number": 3,
        "window_text": ": 성별, 연령, 수면제 복용 여부, 불면 증상에 대한 기초 평가\n\n(입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후 각성\n\n다) 디지털치료기기를 통한 불면과 관련된 행동의 교정을 수행한다.\n\n 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n - (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질.  이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n ⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다.  이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n 라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n",
        "original_sentence": "이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_744",
      "text": "⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 743,
        "window_size": 3,
        "char_count": 47,
        "word_count": 14,
        "page_number": 17,
        "window_text": "이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동치료\n\n(CBT-I)를 기반으로 하였을 경우 다음 사항이 포함되어야 한다.\n\n - (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질.  이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n ⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다.  이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n 라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n - - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다. ",
        "original_sentence": "⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_745",
      "text": "이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 744,
        "window_size": 3,
        "char_count": 56,
        "word_count": 15,
        "page_number": 35,
        "window_text": "- (1) 자극 조절법: 잠자리와 각성 자극이 연관된 상태를 해소하기\n- (2) 수면 제한법: 수면 효율을 증가시킬 수 있도록 침대에 누워 있는\n- (3) 수면 일기 및 동등한 수준으로 수면에 대한 평가가 가능한 도구:\n수면 효율에 대한 평가 및 피드백이 가능하기 위해 수면에\n\n대한 평가를 해야 하며, 불면증 인지행동치료(CBT-I)를 기반\n\n: 입면 시간, 기상 시각, 총 수면시간, 수면 효율, 입면 후\n\n각성 시간, 수면의 질.  이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n ⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다.  이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n 라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n - - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다.  이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다. ",
        "original_sentence": "이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_746",
      "text": "라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 745,
        "window_size": 3,
        "char_count": 38,
        "word_count": 8,
        "page_number": 67,
        "window_text": "이외 수면 후 개운함, 낮잠 여부,\n\n알코올 및 카페인 섭취 여부에 대한 내용이 포함될 수 있다.\n\n ⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다.  이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n 라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n - - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다.  이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다.  수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8. ",
        "original_sentence": "라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_747",
      "text": "- - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 746,
        "window_size": 3,
        "char_count": 90,
        "word_count": 23,
        "page_number": 13,
        "window_text": "⦁ 수면 일기 외 수면을 측정할 수 있는 웨어러블 디바이스\n\n등을 사용할 수 있다.  이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n 라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n - - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다.  이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다.  수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8.  피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다. ",
        "original_sentence": "- - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다. "
      }
    },
    {
      "chunk_id": "chunk_748",
      "text": "이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 747,
        "window_size": 3,
        "char_count": 48,
        "word_count": 13,
        "page_number": 13,
        "window_text": "이 경우 웨어러블 디바이스의 측정\n\n- - 60 -\n정확도에 대한 표준화 근거를 제시하여야 한다.\n\n 라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n - - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다.  이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다.  수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8.  피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다.  이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다. ",
        "original_sentence": "이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_749",
      "text": "수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 748,
        "window_size": 3,
        "char_count": 189,
        "word_count": 47,
        "page_number": 68,
        "window_text": "라) 디지털치료기기를 통한 불면과 관련된 인지의 교정을 수행한다.\n\n - - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다.  이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다.  수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8.  피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다.  이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다.  또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가. ",
        "original_sentence": "수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8. "
      }
    },
    {
      "chunk_id": "chunk_750",
      "text": "피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 749,
        "window_size": 3,
        "char_count": 148,
        "word_count": 32,
        "page_number": 45,
        "window_text": "- - 이 내용은 과학적 근거에 기반하여야 하며, 불면증 인지행동\n치료를 기반으로 하였을 경우 불면과 관련된 왜곡된 인지의\n\n마) 수면에 대한 교육을 수행한다.  이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다.  수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8.  피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다.  이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다.  또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가.  피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나. ",
        "original_sentence": "피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_751",
      "text": "이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 750,
        "window_size": 3,
        "char_count": 147,
        "word_count": 32,
        "page_number": 45,
        "window_text": "이 내용은 과학적 근거에 기반을\n\n두어야 하며 대표적으로 수면 위생이 있을 수 있다.  수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8.  피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다.  이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다.  또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가.  피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나.  피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다. ",
        "original_sentence": "이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_752",
      "text": "또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 751,
        "window_size": 3,
        "char_count": 272,
        "word_count": 67,
        "page_number": 36,
        "window_text": "수면 위생은\n\n바) 상술한 치료의 경우 환자의 순응도를 높이기 위한 전략이 포함\n\n되어야 하며(콘텐츠 제공 방식의 다양화, 알림 제공, 보상 방안\n\n등을 포함) 환자가 입력한 정보에 따른 피드백이 제공되어야\n\n하고 환자가 스스로 입력한 정보를 모니터링할 수 있도록 하여야\n\n- - 61 -\n<!-- PAGE_68 -->\n###### 8.  피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다.  이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다.  또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가.  피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나.  피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다.  즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n",
        "original_sentence": "또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_753",
      "text": "피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 752,
        "window_size": 3,
        "char_count": 251,
        "word_count": 57,
        "page_number": 9,
        "window_text": "피험자의 선정 기준·제외 기준·인원 및 그 근거\n\n- - 피험자(Subject)란 임상시험에 참여하는 임상시험용 또는 대조시험용 의료기기의\n적용 대상이 되는 사람을 말하며, 시험디자인에 적합한 구체적이고 엄격한 피험자의\n\n선정 기준과 제외 기준을 제시하여야 한다.  이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다.  또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가.  피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나.  피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다.  즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n - - 65 -\n- 다. ",
        "original_sentence": "피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_754",
      "text": "피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 753,
        "window_size": 3,
        "char_count": 643,
        "word_count": 171,
        "page_number": 7,
        "window_text": "이 때 임상시험 참여와 연관된 이익을\n\n기대하거나, 참여를 거부할 경우 조직의 상급자에게서 받게 될 불이익을 우려하여\n\n자발적인 참여 결정에 영향을 받을 소지가 있는 등 취약한 환경에 있는 피험자\n\n(Vulnerable Subjects)는 선정대상에서 제외한다.  또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가.  피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나.  피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다.  즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n - - 65 -\n- 다.  목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다. ",
        "original_sentence": "피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다. "
      }
    },
    {
      "chunk_id": "chunk_755",
      "text": "즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 754,
        "window_size": 3,
        "char_count": 74,
        "word_count": 19,
        "page_number": 28,
        "window_text": "또한, 시험군과 대조군을 포함한 피험자\n\n수는 해당 의료기기의 특성, 임상시험디자인, 근거를 통한 시험에서 기대하는\n\n연구결과의 사전 예측, 통계적 유의성, 검정 방법, 탈락률 등을 반영하여 통계학\n\n적으로 타당하게 제시되어야 하며, 임상시험의 효능 및 안전성 입증에 필요한 충분한\n\n- - 임상연구에서 피험자의 수는 연구 목적을 달성할 수 있을 정도의 충분한 수가 보장\n되어야 하며, 일반적으로 1차 유효성 평가변수를 기준으로 정해지고, 연구 계획서\n\n- - 62 -\n예시\n\n- 가.  피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나.  피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다.  즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n - - 65 -\n- 다.  목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다.  피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다. ",
        "original_sentence": "즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_756",
      "text": "- - 65 -\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 755,
        "window_size": 3,
        "char_count": 14,
        "word_count": 6,
        "page_number": 35,
        "window_text": "피험자 선정 기준\n대상자군 별로 제시된 선정 기준 모두를 만족하는 자\n\n2) DSM-5의 비기질적 불면증 진단 기준을 만족하거나 국제수면장애\n\n분류 제3판의 불면증 진단 기준을 만족하여 ICD-10의 비기질적\n\n불면증 진단(F51.0), 수면 개시 및 유지 장애(불면증) 진단(G47.0)을\n\n5) 범용 장비(스마트폰 또는 태블릿PC 등)를 이용하여 모바일 애플리\n\n6) 본 임상시험에 대해 충분한 설명을 듣고 이해한 후, 자의로 참여를\n\n- 나.  피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다.  즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n - - 65 -\n- 다.  목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다.  피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다.  이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다. ",
        "original_sentence": "- - 65 -\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_757",
      "text": "목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 756,
        "window_size": 3,
        "char_count": 97,
        "word_count": 24,
        "page_number": 7,
        "window_text": "피험자 제외 기준\n제외 기준 중 어느 하나라도 해당하는 항목이 있는 경우 본 임상\n\n시험에서 배제\n\n1) 불면증 이외 다른 DSM-5의 수면 각성 장애(과다 수면장애, 기면증,\n\n호흡 관련 수면 장애, 일주기리듬 수면 각성장애, 사건 수면)를\n\n2) 신체 질환 또는 복용 중인 약물로 인한 불면 증상을 가진 자\n\n3) 기초 평가 시점에서 조현병 스펙트럼 장애진단에 해당하는 증상을\n\n- - 63 -\n가진 자 또는 양극성 장애로 진단에 해당하거나, 주요 우울 삽화에\n\n4) 치료 시작 1주일 간 수면 일기 작성을 통한 순응도를 평가하여,\n\n1주일 동안 3일 이하의 수면 일기를 작성하였을 경우 연구 대상\n\n5) 최근 3개월 이내에 자살 시도를 한 바 있으며, 정신과 전문의에\n\n6) 최근 3개월 이내에 새롭게 시작하였거나, 진행 중인 다른 인지\n\n10) 수면 제한 치료의 금기 사항에 해당되는 자(임산부, 수험생, 뇌전\n\n증, 트럭 운전수나 장거리 버스 기사, 중장비 기사 등 낮 시간\n\n12) 기타 사유로 인하여 시험자가 임상시험 참여에 부적합하다고\n\n13) 최근 3개월 이내 사용하는 약물의 종류 및 용량에 변화가 있는 자\n\n※ 최근 3개월 이내 (필요시 처방을 포함하여) 복용 약물의 종류 및 용량이\n\n동일할 경우 제외 기준에 해당하지 않는다.  즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n - - 65 -\n- 다.  목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다.  피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다.  이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다.  이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다. ",
        "original_sentence": "목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다. "
      }
    },
    {
      "chunk_id": "chunk_758",
      "text": "피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 757,
        "window_size": 3,
        "char_count": 159,
        "word_count": 43,
        "page_number": 43,
        "window_text": "즉, 수면제를 복용하는 중인\n\n환자도 3개월간 안정적인 약물 치료를 수행 중인 경우, 임상시험 참여가\n\n- - 64 -\n가능하다.\n\n - - 65 -\n- 다.  목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다.  피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다.  이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다.  이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다.  이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n",
        "original_sentence": "피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다. "
      }
    },
    {
      "chunk_id": "chunk_759",
      "text": "이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 758,
        "window_size": 3,
        "char_count": 129,
        "word_count": 28,
        "page_number": 7,
        "window_text": "- - 65 -\n- 다.  목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다.  피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다.  이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다.  이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다.  이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n 이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다. ",
        "original_sentence": "이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다. "
      }
    },
    {
      "chunk_id": "chunk_760",
      "text": "이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 759,
        "window_size": 3,
        "char_count": 275,
        "word_count": 60,
        "page_number": 7,
        "window_text": "목표 대상자 수 및 그 근거\n피험자 수는 임상시험 방법에 따라 식약처의 ‘의료기기 임상시험 관련 통계기법\n\n가이드라인’을 참고하여 임상시험 피험자 수 산출 방식을 적용한다.  피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다.  이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다.  이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다.  이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n 이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다.  두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다. ",
        "original_sentence": "이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다. "
      }
    },
    {
      "chunk_id": "chunk_761",
      "text": "이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 760,
        "window_size": 3,
        "char_count": 225,
        "word_count": 54,
        "page_number": 43,
        "window_text": "피험자 수를 결정\n\n※ 본 가이드라인에 작성된 산출 방법은 공개된 선행 연구 결과를 기반으로\n\n작성된 예시이며, 목표 대상자 수는 개발 제품 특성과 탐색 임상시험 등\n\n각 제품별 선행 연구 결과에 따라 다르기 때문에, 개발 제품의 선행\n\n연구 결과 및 참고 문헌을 기준으로 산출한다.  이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다.  이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다.  이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n 이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다.  두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다.  그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n",
        "original_sentence": "이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_762",
      "text": "이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 761,
        "window_size": 3,
        "char_count": 54,
        "word_count": 12,
        "page_number": 7,
        "window_text": "이때, 그 근거(가설, 변수,\n\n본 시험의 일차목적: 불면증 진단환자에서 시험군이 대조군에\n\n비해 치료 전 대비 post-treatment 6주 후 불면증 심각도 척도\n\n(ISI)의 변화량이 우월하게 개선될 것을 확증하는 것이다.  이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다.  이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n 이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다.  두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다.  그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n ※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9. ",
        "original_sentence": "이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다. "
      }
    },
    {
      "chunk_id": "chunk_763",
      "text": "두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 762,
        "window_size": 3,
        "char_count": 87,
        "word_count": 24,
        "page_number": 7,
        "window_text": "이에\n\n대한 가설은 다음과 같으며 이 가설의 평균 차이 검정에서\n\n- - 66 -\n    \n\n    ≠\n\n19세 이상 불면증 환자를 대상으로 한 국외 인터넷 기반 불면증\n\n인지행동치료(Web-based CBT-I) 선행연구를 검토한 결과, 대조군\n\n대비 인터넷 기반 불면증 인지행동치료(Web-based CBT-I)의 치료\n\n전 대비 Post-treatment 후 불면증 심각도 척도(ISI)의 effect size는\n\n- 1.13, 1.16으로 조사되었다.  이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n 이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다.  두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다.  그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n ※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9.  임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10. ",
        "original_sentence": "두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다. "
      }
    },
    {
      "chunk_id": "chunk_764",
      "text": "그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 763,
        "window_size": 3,
        "char_count": 191,
        "word_count": 50,
        "page_number": 45,
        "window_text": "이에 본 연구에서의 예상되는 effect\nsize는 보수적으로 조사된 결과 중 작은 수치에 해당하는 1.13\n\n본 연구에서는 가설의 평균 변화량 차이 검정에 대해 최소\n\n필요한 피험자 수를 산출하기 위해 effect size는 1.13을 가정하\n\n였고, 양측 유의수준 5%, 검정력 90%를 만족하기 위해 필요한\n\n- - 67 -\n피험자 수(군당 1:1 배정)를 산출한 결과, 한 군당 17명이었다.\n\n 이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다.  두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다.  그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n ※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9.  임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10.  임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가. ",
        "original_sentence": "그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_765",
      "text": "※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 764,
        "window_size": 3,
        "char_count": 69,
        "word_count": 16,
        "page_number": 75,
        "window_text": "이에 중도 탈락율 30%를 고려하여 목표 피험자 수는 총 50명(군당\n\n25명)으로 결정하였다.  두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다.  그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n ※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9.  임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10.  임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가.  시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다. ",
        "original_sentence": "※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9. "
      }
    },
    {
      "chunk_id": "chunk_766",
      "text": "임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 765,
        "window_size": 3,
        "char_count": 123,
        "word_count": 31,
        "page_number": 43,
        "window_text": "두 군의 평균 차이 검정에 대한 피험자 수\n\n⦁ 기존 SHUTi 연구에서는 병원 방문 없이 온라인 수집으로만 한\n\n경우 40% 정도의 중도 탈락을 보였다.  그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n ※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9.  임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10.  임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가.  시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다.  다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다. ",
        "original_sentence": "임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10. "
      }
    },
    {
      "chunk_id": "chunk_767",
      "text": "임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 766,
        "window_size": 3,
        "char_count": 37,
        "word_count": 5,
        "page_number": 45,
        "window_text": "그러나 본 연구에서는\n\n병원 방문으로 이보다는 더 적게 탈락될 것으로 예상하여\n\n※ 본 임상시험의 경우 임상시험 설계 시 중도 탈락율은 약 10∼30% 범위로\n\n- - 68 -\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 분석 기간,\n\n결과보고서 작성 기간, 임상시험심사위원회 심사 기간 등 충분한 기간을\n\n고려하도록 한다.\n\n ※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9.  임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10.  임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가.  시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다.  다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다.  불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다. ",
        "original_sentence": "임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_768",
      "text": "시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 767,
        "window_size": 3,
        "char_count": 273,
        "word_count": 59,
        "page_number": 9,
        "window_text": "※ 본 임상시험의 경우 임상시험 수행 후 6〜12개월 추적 관찰하는 것을\n\n<!-- PAGE_75 -->\n###### 9.  임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10.  임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가.  시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다.  다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다.  불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다.  임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다. ",
        "original_sentence": "시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다. "
      }
    },
    {
      "chunk_id": "chunk_769",
      "text": "다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 768,
        "window_size": 3,
        "char_count": 58,
        "word_count": 13,
        "page_number": 40,
        "window_text": "임상시험기간\n\n피험자의 모집 기간, 임상 관찰 및 시험 수행 기간, 통계 처리 기간, 결과보고서 작성\n\n기간, 임상시험심사위원회 심사 기간 등 충분한 기간을 고려하여 “식품의약품안전처의 임상\n\n- - 69 -\n- 10.  임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가.  시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다.  다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다.  불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다.  임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다.  또한 동의를 서명한 연월일을\n\n기록한다. ",
        "original_sentence": "다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_770",
      "text": "불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 769,
        "window_size": 3,
        "char_count": 160,
        "word_count": 41,
        "page_number": 76,
        "window_text": "임상시험방법(사용량·사용방법·사용기간·병용요법 등 포함)\n- 가.  시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다.  다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다.  불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다.  임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다.  또한 동의를 서명한 연월일을\n\n기록한다.  또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n",
        "original_sentence": "불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다. "
      }
    },
    {
      "chunk_id": "chunk_771",
      "text": "임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 770,
        "window_size": 3,
        "char_count": 382,
        "word_count": 89,
        "page_number": 7,
        "window_text": "시험 방법\n- (예) 무작위배정 이후, 12주 동안 치료 기간이 종결된 직후에 방문\n(Post-treatment)하여 임상 평가를 받고, 디지털 불면증 인지\n\n행동치료를 처방받아 치료를 수행하는 군 (Lancee et al., 2016)\n\n- (예) 수면 일기 기능과 기록 알림 기능만 탑재된 애플리케이션 등\n※ 단, 본 연구에서는 연구설계에 따라 비처치대조군(waitlist)*의 적용도\n\n* 비처치대조군(waitlist): 치료 기간 동안 아무런 처치를 받지 않고 대기하는\n\n군이다.  다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다.  불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다.  임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다.  또한 동의를 서명한 연월일을\n\n기록한다.  또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n - - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다. ",
        "original_sentence": "임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다. "
      }
    },
    {
      "chunk_id": "chunk_772",
      "text": "또한 동의를 서명한 연월일을\n\n기록한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 771,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 44,
        "window_text": "다만, 맹검을 유지하는 수준의 최소한의 치료가 제공되어야\n\n하며, 이에는 과학적인 근거가 있어야 한다.  불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다.  임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다.  또한 동의를 서명한 연월일을\n\n기록한다.  또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n - - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다.  (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안. ",
        "original_sentence": "또한 동의를 서명한 연월일을\n\n기록한다. "
      }
    },
    {
      "chunk_id": "chunk_773",
      "text": "또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 772,
        "window_size": 3,
        "char_count": 64,
        "word_count": 16,
        "page_number": 3,
        "window_text": "불면증 인지행동치료를\n\n기반으로 한 디지털치료기기의 경우 서면 형태로 된 수면위생 교육\n\n임상시험 방법은 해당 의료기기에 대한 모양, 구조 및 사용 전 준비사항, 피험자에\n\n대한 준비 등 임상시험을 위한 준비 절차와 사용 단계 절차의 각 단계별 조작 순서,\n\n병용 요법 등을 기술한다.  임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다.  또한 동의를 서명한 연월일을\n\n기록한다.  또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n - - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다.  (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안.  경기연구원 연구보고서. ",
        "original_sentence": "또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_774",
      "text": "- - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 773,
        "window_size": 3,
        "char_count": 493,
        "word_count": 126,
        "page_number": 7,
        "window_text": "임상시험을 위한 피험자 동의 및 준비, 치료 절차, 관찰 및\n\n- - 70 -\n2) 디지털치료기기 치료기간: 총 6주\n\n3) 총 4회의 외래방문을 통한 조사: 방문 1(Screening), 방문 2(Baseline),\n\n※ 방문 4(Follow-up, 6개월 후)는 필요시 애플리케이션, 이메일, 문자,\n\n4) 층화 무작위배정: 기관별 성별(남/여), 연령(oo세 미만, oo세 이상)을\n\n- - 각 기관별로 내원한 환자들 중 선정·제외 기준에 따라 적합한\n- - 본 임상시험을 실시하기에 앞서, 시험자는 임상시험에 관한\n내용을 피험자 본인 및 대리인에게 설명하고, 피험자 및 대리인이\n\n내용을 잘 이해한 것을 확인한 다음, 자유의사에 따른 임상시험\n\n참가의 동의를 문서로 받는다.  또한 동의를 서명한 연월일을\n\n기록한다.  또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n - - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다.  (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안.  경기연구원 연구보고서.  | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application. ",
        "original_sentence": "- - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다. "
      }
    },
    {
      "chunk_id": "chunk_775",
      "text": "(수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 774,
        "window_size": 3,
        "char_count": 129,
        "word_count": 31,
        "page_number": 9,
        "window_text": "또한 동의를 서명한 연월일을\n\n기록한다.  또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n - - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다.  (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안.  경기연구원 연구보고서.  | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application.  Sleep, 35(6), 769–781.",
        "original_sentence": "(수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안. "
      }
    },
    {
      "chunk_id": "chunk_776",
      "text": "경기연구원 연구보고서. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 775,
        "window_size": 3,
        "char_count": 13,
        "word_count": 2,
        "page_number": 126,
        "window_text": "또한 동의서 사본을 환자에게 제공하여 환자가 지속\n\n적으로 임상시험에 대한 사항을 확인할 수 있도록 해야 한다.\n\n - - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다.  (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안.  경기연구원 연구보고서.  | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application.  Sleep, 35(6), 769–781. **\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나. ",
        "original_sentence": "경기연구원 연구보고서. "
      }
    },
    {
      "chunk_id": "chunk_777",
      "text": "| 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 776,
        "window_size": 3,
        "char_count": 115,
        "word_count": 23,
        "page_number": 37,
        "window_text": "- - 임상시험에 들어가기 전에 피험자의 인구학적 조사 및 병력\n등에 대하여 차트 확인 및 애플리케이션 내 질문 등을 통하여\n\n- (1) 인구학적 정보: 성별, 연령, 직업, 업무 생산성\n- - 71 -\n- (2) 병력조사: 동반 질환 여부\n- (1) 피험자에게 서명 동의를 받은 후 동의 취득 순서에 따라 스크\n리닝 번호를 부여하며 피험자가 참여를 종료할 때까지 피험자\n\n- (2) 피험자 적합성 평가: 피험자 선정 및 제외 기준에 적합한지\n⦁ 일차 유효성 평가지표로는 불면증의 증상 개선을 확인하고자\n\n하는 연구에서 널리 사용되며, FDA 승인을 받은 Somryst™에서\n\n사용한 변수이기도 한 불면증 심각도 척도(Insomnia Severity\n\n⦁ 일차 유효성 평가지표를 통해 유효성을 검증하는 것이 기본\n\n적인 원칙이나, 이외 필요시 변수를 이차 유효성 평가지표로\n\n⦁ 과학적인 근거를 가진 변수이되, 기존 불면 개선 시 함께\n\n개선될 수 있다고 여겨진 영역에 한정한다.  (수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안.  경기연구원 연구보고서.  | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application.  Sleep, 35(6), 769–781. **\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나.  설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다. ",
        "original_sentence": "| 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application. "
      }
    },
    {
      "chunk_id": "chunk_778",
      "text": "Sleep, 35(6), 769–781.",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 777,
        "window_size": 3,
        "char_count": 22,
        "word_count": 3,
        "page_number": 27,
        "window_text": "(수면 효율, 수면\n\n- - 72 -\n양상, 낮 시간 졸음, 삶의 질, 직업적 혹은 사회적 기능,\n\n- - 방문 2(Baseline), 방문 3(Post-treatment, 7주 후), 방문 4\n**[표 시작]**\n\n| 정책방안.  경기연구원 연구보고서.  | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application.  Sleep, 35(6), 769–781. **\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나.  설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다.  이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11. ",
        "original_sentence": "Sleep, 35(6), 769–781."
      }
    },
    {
      "chunk_id": "chunk_779",
      "text": "**\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 778,
        "window_size": 3,
        "char_count": 484,
        "word_count": 110,
        "page_number": 45,
        "window_text": "경기연구원 연구보고서.  | 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application.  Sleep, 35(6), 769–781. **\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나.  설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다.  이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11.  관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가. ",
        "original_sentence": "**\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_780",
      "text": "설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 779,
        "window_size": 3,
        "char_count": 333,
        "word_count": 73,
        "page_number": 46,
        "window_text": "| 주간 과다 수면증을 평가하기 위한 도구로 8개 문항으로 |\n| --- | --- |\n**disorder delivered via an automated media-rich web application.  Sleep, 35(6), 769–781. **\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나.  설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다.  이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11.  관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가.  임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n",
        "original_sentence": "설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_781",
      "text": "이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 780,
        "window_size": 3,
        "char_count": 79,
        "word_count": 20,
        "page_number": 84,
        "window_text": "Sleep, 35(6), 769–781. **\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나.  설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다.  이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11.  관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가.  임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. ",
        "original_sentence": "이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11. "
      }
    },
    {
      "chunk_id": "chunk_782",
      "text": "관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 781,
        "window_size": 3,
        "char_count": 176,
        "word_count": 45,
        "page_number": 3,
        "window_text": "**\n**- 사용 중단으로 이상반응이 없어지는 경우**\n| (Epworth sleepiness score) | 팩스: 043-719-3940 | 이루어진 자가 설문도구 (0-24; 정상<10) |\n\n**[표 끝]**\n\n- - 73 -\n수면에 대한 역기능적 신념 및 태도를 평가하는데 사용되는\n\n(출처: 불면증 임상지료지침, 2019, Morin et al., 2007, Robertson　et al., 2014, Rush et\n\nal., 2003, Beck at al., 1998, Jenkinson et al., 1993,\n\n한국보건의료연구원, 2011)\n\n- - 74 -\n바) 순응도 조사\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰\n\n하고, 임상시험용 의료기기와의 인과관계에 대하여 증례\n\n- - 각 관찰 항목에 대한 평가 도구 및 평가 방법에 대한 자세한\n- - 75 -\n- 나.  설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다.  이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11.  관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가.  임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n",
        "original_sentence": "관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_783",
      "text": "임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 782,
        "window_size": 3,
        "char_count": 99,
        "word_count": 22,
        "page_number": 45,
        "window_text": "설계 방법\n- - 연구자는 선정·제외 기준을 합격한 피험자의 순서대로 배정일에\n쌍방향 웹반응시스템(Interactive Web Response System, IWARS)을\n\n- - 쌍방향 웹반응시스템은 본 연구와 독립된 통계학자가 SAS\n통계 패키지를 이용하여 층화 순열화 블록 무작위배정법\n\n(stratified permuted block randomization)을 이용하여 발행된\n\n- - 연구의 특성상 단일 맹검을 지향하되, 필요시 비맹검 임상시험을\n- - 단일 맹검인 경우, 임상시험 도중 응급 상황 발생 등으로 인하여\n- - 76 -\n필요시 피험자의 눈가림 해제 절차를 둘 수 있다.  이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11.  관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가.  임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n",
        "original_sentence": "임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_784",
      "text": "2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 783,
        "window_size": 3,
        "char_count": 35,
        "word_count": 9,
        "page_number": 9,
        "window_text": "이 경우,\n\n사유와 해제일, 열람자, 해제 후 조치사항 등에 대한 눈가림\n\n- - 77 -\n<!-- PAGE_84 -->\n###### 11.  관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가.  임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n",
        "original_sentence": "2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다. "
      }
    },
    {
      "chunk_id": "chunk_785",
      "text": "(예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 784,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 1,
        "window_text": "관찰항목·임상검사항목 및 관찰검사방법\n\n- - 임상시험 전 피험자 선정 과정에서의 확인해야 할 사항, 임상검사, 피험자 동의서\n유/무, 피험자 기초정보, 병력조사, 선정 및 제외 기준, 식별코드 부여 등에 대해서\n\n- - 피험자의 방문일에 따른 관찰 시기별 관찰 항목, 임상 검사 항목과 관찰 검사 방법을\n- 가.  임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n - - 78 -\n- 나. ",
        "original_sentence": "(예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_786",
      "text": "4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 785,
        "window_size": 3,
        "char_count": 56,
        "word_count": 16,
        "page_number": 3,
        "window_text": "임상시험 일정표\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n1) 스크리닝 및 검사일은 치료 시작일 전 28일 이내에 시작한다.\n\n 2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n - - 78 -\n- 나.  임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다. ",
        "original_sentence": "4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_787",
      "text": "5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 786,
        "window_size": 3,
        "char_count": 97,
        "word_count": 25,
        "page_number": 17,
        "window_text": "2) 수집하는 지표에 따라 수집이 다를 경우 나누어 표현한다.  (예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n - - 78 -\n- 나.  임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다.  서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다. ",
        "original_sentence": "5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_788",
      "text": "- - 78 -\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 787,
        "window_size": 3,
        "char_count": 14,
        "word_count": 6,
        "page_number": 36,
        "window_text": "(예: ISI는 스크리닝에도 수집함)\n\n3) 불면증 개선 디지털치료기기 제품의 치료 기간에 따라 전체 치료 기간은 변경될 수 있다.\n\n 4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n - - 78 -\n- 나.  임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다.  서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다.  대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다. ",
        "original_sentence": "- - 78 -\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_789",
      "text": "임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 788,
        "window_size": 3,
        "char_count": 75,
        "word_count": 18,
        "page_number": 7,
        "window_text": "4) 임상시험 설계에 따른 선택 사항이므로 치료 기간 종료 후 추적 관찰 기간은 변경될 수 있다.\n\n 5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n - - 78 -\n- 나.  임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다.  서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다.  대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다.  치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n",
        "original_sentence": "임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다. "
      }
    },
    {
      "chunk_id": "chunk_790",
      "text": "서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 789,
        "window_size": 3,
        "char_count": 83,
        "word_count": 18,
        "page_number": 45,
        "window_text": "5) 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮은 경우 제외시킬 목적으로\n\n임상시험 의료기기를 치료 시작일 이전 시점에도 사용 가능할 수 있다.\n\n - - 78 -\n- 나.  임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다.  서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다.  대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다.  치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n - - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다. ",
        "original_sentence": "서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다. "
      }
    },
    {
      "chunk_id": "chunk_791",
      "text": "대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 790,
        "window_size": 3,
        "char_count": 172,
        "word_count": 47,
        "page_number": 45,
        "window_text": "- - 78 -\n- 나.  임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다.  서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다.  대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다.  치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n - - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다.  단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n",
        "original_sentence": "대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다. "
      }
    },
    {
      "chunk_id": "chunk_792",
      "text": "치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 791,
        "window_size": 3,
        "char_count": 151,
        "word_count": 38,
        "page_number": 85,
        "window_text": "임상시험 절차\n예시\n\n- - 임상시험에 들어가기 전, 본 임상시험의 목적과 내용에 대하여\n대상자 또는 법정대리인에게 상세히 설명한다.  서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다.  대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다.  치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n - - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다.  단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n - - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n",
        "original_sentence": "치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_793",
      "text": "- - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 792,
        "window_size": 3,
        "char_count": 257,
        "word_count": 69,
        "page_number": 17,
        "window_text": "서명일 및 서명\n\n일자를 정확히 기재하여야 하며, 작성된 서명 동의서의 원본은\n\n시험자가 보관하고 사본은 시험대상자 또는 법정대리인에게\n\n교부한다.  대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다.  치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n - - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다.  단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n - - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n 애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n",
        "original_sentence": "- - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_794",
      "text": "단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 793,
        "window_size": 3,
        "char_count": 69,
        "word_count": 17,
        "page_number": 36,
        "window_text": "대상자에게 서명 동의를 받은 후 동의 취득 순서에\n\n- - 대상자가 본 시험에 적합함을 보증하기 위해 시험자 또는 그\n- - 인구학적 정보로 대상자 이니셜, 만 나이, 성별, 직업, 그리고\n업무 생산성을 조사하며 기초 문진에 필요한 환자들의 의학적\n\n- - 병력 조사에 포함되어야 하는 내용은 다음과 같다.  치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n - - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다.  단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n - - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n 애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n - - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n",
        "original_sentence": "단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n"
      }
    },
    {
      "chunk_id": "chunk_795",
      "text": "- - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 794,
        "window_size": 3,
        "char_count": 275,
        "word_count": 68,
        "page_number": 28,
        "window_text": "치매, 인지\n기능 장애, 정신증, 양극성 장애 및 현재 주요 우울 삽화(current\n\nmajor depressive episode) 등 스크리닝 확인해야 할 질병군 등의\n\n과거력 및 현 병력, 발생 시기, 치료와 진행 여부 및 내용 등을\n\n- - 79 -\n기재한다.\n\n - - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다.  단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n - - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n 애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n - - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n - - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n",
        "original_sentence": "- - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n"
      }
    },
    {
      "chunk_id": "chunk_796",
      "text": "애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 795,
        "window_size": 3,
        "char_count": 180,
        "word_count": 41,
        "page_number": 45,
        "window_text": "- - 동의서 취득일 기준으로 최근 5년 이내 과거 및 현재 병력을\n마) 수면 일기 작성(웨어러블 디바이스 등을 통한 수면의 평가로 대체 가능)\n\n- - 환자의 기초 수면 평가 및 일차성 유효 지표의 객관적인 수면 지표\n(예: 수면 효율[SE])를 측정하기 위해 피험자에게 최소 1주일\n\n※ 수면 시간, 수면 일기 등을 통해 순응 정도를 파악하고, 순응도가 낮을\n\n경우 제외시킬 목적으로 임상시험 의료기기를 치료 시작일 이전 시점에도\n\n사용 가능할 수 있다.  단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n - - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n 애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n - - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n - - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n - - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n",
        "original_sentence": "애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_797",
      "text": "- - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 796,
        "window_size": 3,
        "char_count": 216,
        "word_count": 57,
        "page_number": 45,
        "window_text": "단, 이때 임상시험 의료기기는 치료가 아닌 수면\n\n- - 피험자 선정을 위한 불면증 심각도 척도(ISI) 정보를 수집한다.\n - - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n 애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n - - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n - - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n - - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n - - 84 -\n<!-- PAGE_91 -->\n###### 12. ",
        "original_sentence": "- - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_798",
      "text": "- - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 797,
        "window_size": 3,
        "char_count": 978,
        "word_count": 257,
        "page_number": 13,
        "window_text": "- - 병용약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - Baseline의 일차 유효성 평가지표, 이차 임상 변수를 평가하기\n위해 불면증 심각도 척도(ISI) 및 수면 일기(애플리케이션 또는\n\n- - 80 -\n서면 형태)를 작성하도록 하여 지참하게 하거나, 애플리케이션을\n\n- - 필요에 따라 방문 1(스크리닝 단계)에서 측정한 불면증 심각도\n- - 수면 일기를 1주일간 작성하여 평가한 후 치료를 시작한다.\n 애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n - - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n - - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n - - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n - - 84 -\n<!-- PAGE_91 -->\n###### 12.  예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가. ",
        "original_sentence": "- - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n"
      }
    },
    {
      "chunk_id": "chunk_799",
      "text": "- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 798,
        "window_size": 3,
        "char_count": 267,
        "word_count": 66,
        "page_number": 3,
        "window_text": "애플리케이션을 통하여 작성하는 것이 가능하나, 이 경우 시험군과\n\n대조군이 동일한 형태의 입력 방식을 사용하여야 한다(애플리\n\n케이션을 통해 작성하도록 한다면 대조군 역시 애플리케이션을\n\n- - 수면 일기 작성도를 통한 순응도를 평가하여, 1주일 동안 3일\n이하의 수면 일기를 작성하였을 경우 연구 대상에서 제외시킨다.\n\n - - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n - - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n - - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n - - 84 -\n<!-- PAGE_91 -->\n###### 12.  예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가.  예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n",
        "original_sentence": "- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n"
      }
    },
    {
      "chunk_id": "chunk_800",
      "text": "- - 84 -\n<!-- PAGE_91 -->\n###### 12. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 799,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 91,
        "window_text": "- - 랜덤 배정을 통해 치료군 혹은 대조군에 배치하여 치료를\n- - 회원가입 및 초기 수면 평가를 시행한다(7가지 기본 입력 정보:\n성별, 연령, 불면 증상의 정도, 불면 증상의 양상, 동반증상\n\n- - 정해진 기간 동안 상술된 방식으로 디지털치료기기 콘텐츠를\n- - 수면 위생 교육 또는 수면 일기(예: Sham, 대면교육, 교육책자 등)\n- - 81 -\n애플리케이션을 실행한다.\n\n - - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n - - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n - - 84 -\n<!-- PAGE_91 -->\n###### 12.  예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가.  예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n 다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n",
        "original_sentence": "- - 84 -\n<!-- PAGE_91 -->\n###### 12. "
      }
    },
    {
      "chunk_id": "chunk_801",
      "text": "예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 800,
        "window_size": 3,
        "char_count": 67,
        "word_count": 19,
        "page_number": 3,
        "window_text": "- - 정해진 기간 동안 환자에게 해가 되지 않는 내용의 과학적\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 치료 후 평가 및 일차 유효성 평가지표, 이차 유효성 평가\n- - 82 -\n지표의 변화를 검증하기 위해 불면증 심각도 척도 및 수면\n\n일기(애플리케이션 또는 서면 형태)를 작성하도록 하여 지참\n\n- - 00주 치료 후 수면 일기를 작성하기 시작하여 1주일 치의 수면\n일기를 통하여 치료 효과를 검증하기 위해 치료 기간 종료 1주\n\n- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과 관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를\n- - 83 -\n4) 방문 4 (치료 기간 종료 6개월 후, Follow up)\n\n- - 장기 효과 확인을 위한 일차 유효성 평가지표, 이차 유효성\n평가지표의 변화를 검증하기 위해 불면증 심각도 척도 및\n\n일주일 치의 수면 일기를 작성하도록 하여 지참하게 하거나,\n\n※ 내원은 필수가 아니며 애플리케이션, 이메일, 문자, SNS 등을 통해\n\n- - 디지털치료기기에 대한 장기 사용자 반응 평가를 함께 수행한다.\n - - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n - - 84 -\n<!-- PAGE_91 -->\n###### 12.  예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가.  예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n 다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n 1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다. ",
        "original_sentence": "예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_802",
      "text": "예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 801,
        "window_size": 3,
        "char_count": 128,
        "word_count": 29,
        "page_number": 45,
        "window_text": "- - 시험자는 임상시험에 사용되는 의료기기 사용 후 나타나는\n이상반응 여부를 방문일에 피험자에 대한 진찰을 통해 관찰하고,\n\n임상시험용 의료기기와의 인과관계에 대하여 증례 기록지에\n\n※ 단, 이상반응 여부는 필요시 온라인(앱, 이메일, 문자, SNS 등)으로 대체\n\n- - 병용 약물은 동의서 취득일 기준으로 최근 3개월 이내에 복용\n하였거나 유지 중인 약물에 대해 조사하며 성분명, 용법, 용량,\n\n- - 치료 기간 동안 수면 일기 기록 여부를 수집하여 순응도를 조사한다.\n - - 84 -\n<!-- PAGE_91 -->\n###### 12.  예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가.  예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n 다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n 1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다.  이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다. ",
        "original_sentence": "예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_803",
      "text": "다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 802,
        "window_size": 3,
        "char_count": 87,
        "word_count": 19,
        "page_number": 43,
        "window_text": "- - 84 -\n<!-- PAGE_91 -->\n###### 12.  예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가.  예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n 다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n 1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다.  이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다.  치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n",
        "original_sentence": "다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_804",
      "text": "1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 803,
        "window_size": 3,
        "char_count": 157,
        "word_count": 41,
        "page_number": 27,
        "window_text": "예측되는 부작용 및 사용 시 주의사항\n\n임상시험을 실시하는 동안 발생할 수 있는 부작용 및 사용 시 주의사항\n\n- 가.  예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n 다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n 1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다.  이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다.  치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n 해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n",
        "original_sentence": "1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다. "
      }
    },
    {
      "chunk_id": "chunk_805",
      "text": "이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 804,
        "window_size": 3,
        "char_count": 134,
        "word_count": 33,
        "page_number": 9,
        "window_text": "예측되는 부작용\n본 연구에서 적용하는 치료인 디지털 불면증 인지행동치료(Digital\n\nCBT-I)는 행동 요법 및 인지요법을 포함한 교육 이외 기타 침습적\n\n이거나, 환자에게 유해를 끼칠 수 있는 내용은 포함되어 있지 않다.\n\n 다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n 1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다.  이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다.  치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n 해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n - 나. ",
        "original_sentence": "이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_806",
      "text": "치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 805,
        "window_size": 3,
        "char_count": 252,
        "word_count": 61,
        "page_number": 9,
        "window_text": "다만, 일반적인 불면증 인지행동치료(CBT-I)의 부작용에 준하는 부작용\n\n또는 범용 장비 사용으로 인한 부작용을 예상할 수 있고, 이는 다음과\n\n같다.\n\n 1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다.  이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다.  치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n 해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n - 나.  사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n",
        "original_sentence": "치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_807",
      "text": "해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 806,
        "window_size": 3,
        "char_count": 109,
        "word_count": 27,
        "page_number": 9,
        "window_text": "1) 불면증 인지행동치료(CBT-I)의 행동 요법 중 수면 제한 치료의\n\n경우, 일시적인 낮 시간 졸음의 증가 및 피로도 증가, 낮 시간의\n\n집중 저하를 불러일으킬 수 있어 트럭 운전사 등 낮 시간 졸음이\n\n큰 피해를 가져올 수 있는 직업군의 환자의 경우 임상시험에서\n\n제외한다.  이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다.  치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n 해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n - 나.  사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n 본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n",
        "original_sentence": "해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_808",
      "text": "- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 807,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "이외에도 치료 시작 시점에서 낮 시간 졸음이 악화될\n\n수 있음을 알리고, 24시간 연락 가능한 연구자 번호를 통하여\n\n2) 불면증 인지행동치료(CBT-I)의 인지 요법 중 왜곡된 인지 교정의\n\n경우 일시적인 불안감 악화를 가져올 수 있다.  치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n 해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n - 나.  사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n 본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n - - 86 -\n<!-- PAGE_93 -->\n###### 13. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_809",
      "text": "사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 808,
        "window_size": 3,
        "char_count": 71,
        "word_count": 17,
        "page_number": 1,
        "window_text": "치료 시작 시점\n\n에서 일시적인 불안감 악화가 나타날 수 있음을 알리고, 24시간\n\n- - 85 -\n연락 가능한 연구자 번호를 통하여 즉시 상담과 필요시 의료진\n\n3) 디지털 불면증 인지행동치료(Digital CBT-I)를 위한 범용 장비\n\n(스마트폰 또는 태블릿PC 등) 사용으로 두통, 눈의 피로, 눈 또는\n\n근육경련, 눈의 불수의운동, 메스꺼움, 어지럼증, 머리 또는 눈의\n\n불쾌감 또는 통증, 졸림, 피로감과 같은 부작용이 발생할 수 있다.\n\n 해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n - 나.  사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n 본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n - - 86 -\n<!-- PAGE_93 -->\n###### 13.  중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n",
        "original_sentence": "사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_810",
      "text": "본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 809,
        "window_size": 3,
        "char_count": 129,
        "word_count": 35,
        "page_number": 39,
        "window_text": "해당 경우 24시간 연락 가능한 연구자 번호를 통하여 즉시 상담과\n\n본 연구에서 진행되는 평가는 자가 보고 설문지, 면담 등 모두\n\n비침습적인 검사로 이루어져 있으므로 예측되는 부작용은 없다.\n\n - 나.  사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n 본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n - - 86 -\n<!-- PAGE_93 -->\n###### 13.  중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n ‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가. ",
        "original_sentence": "본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_811",
      "text": "- - 86 -\n<!-- PAGE_93 -->\n###### 13. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 810,
        "window_size": 3,
        "char_count": 37,
        "word_count": 9,
        "page_number": 93,
        "window_text": "- 나.  사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n 본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n - - 86 -\n<!-- PAGE_93 -->\n###### 13.  중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n ‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가.  중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나. ",
        "original_sentence": "- - 86 -\n<!-- PAGE_93 -->\n###### 13. "
      }
    },
    {
      "chunk_id": "chunk_812",
      "text": "중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 811,
        "window_size": 3,
        "char_count": 150,
        "word_count": 37,
        "page_number": 43,
        "window_text": "사용 시 주의사항\n본 연구에서 적용하는 불면증 개선 디지털치료기기의 부작용, 일반적\n\n주의, 적용 상의 주의는 다음과 같다.\n\n 본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n - - 86 -\n<!-- PAGE_93 -->\n###### 13.  중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n ‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가.  중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나.  탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14. ",
        "original_sentence": "중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_813",
      "text": "‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 812,
        "window_size": 3,
        "char_count": 145,
        "word_count": 40,
        "page_number": 3,
        "window_text": "본 제품을 사용한 후 제품에 대한 부적합 반응이 전부 배제될\n\n사이버 보안과 관련된 사고 발생 시 임상시험 관리자 긴급\n\n사용 시간, 사용 횟수, 결과 작성 등 임상시험 책임자 및 담당자가\n\n요구한 사용 방법을 준수하여야 한다.\n\n - - 86 -\n<!-- PAGE_93 -->\n###### 13.  중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n ‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가.  중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나.  탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n",
        "original_sentence": "‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_814",
      "text": "중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 813,
        "window_size": 3,
        "char_count": 339,
        "word_count": 88,
        "page_number": 45,
        "window_text": "- - 86 -\n<!-- PAGE_93 -->\n###### 13.  중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n ‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가.  중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나.  탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n - 가. ",
        "original_sentence": "중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_815",
      "text": "탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 814,
        "window_size": 3,
        "char_count": 512,
        "word_count": 137,
        "page_number": 45,
        "window_text": "중지·탈락 기준\n\n- - 부작용, 이상반응 발생 등으로 인하여 임상시험을 진행할 수 없거나 임상\n시험의 진행이 피험자의 안전 보호를 위협하여 그 진행을 멈추는 것을 ‘중지’라 하며,\n\n임상시험 개시에서 완료까지 중지될 수 있는 세부 사항을 ‘중지 기준’에 제시한다.\n\n ‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가.  중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나.  탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n - 가.  유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나. ",
        "original_sentence": "탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14. "
      }
    },
    {
      "chunk_id": "chunk_816",
      "text": "유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 815,
        "window_size": 3,
        "char_count": 168,
        "word_count": 42,
        "page_number": 36,
        "window_text": "‘중지 처리’에는 각 중지 기준에 대한 유효성 평가 통계 처리 시 그 산입 여부와\n\n- - ‘탈락’ 이란 피험자의 요구 또는 중대한 임상시험 계획서 위반 등의 이유로 임상\n시험이 완료되지 못한 경우를 말하며, 그 분류기준을 ‘탈락 기준’에, 탈락의\n\n- 가.  중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나.  탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n - 가.  유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나.  검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993). ",
        "original_sentence": "유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n"
      }
    },
    {
      "chunk_id": "chunk_817",
      "text": "- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 816,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "중지\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 임상시험 진행 중 관찰되는 상황이 임상시험을 계속 진행하는\n것에 무리가 있다고 판단되는 경우에는 임상시험을 중지할\n\n- - 임상시험은 시험책임자, 임상시험심사위원회에 의해 조기 종료\n- - 87 -\n- - 중지 시점까지의 검사 결과 관련 자료는 성능과 안전성 평가를\n- - 임상시험을 통해 얻어진 자료는 성능 및 안전성 분석을 위한\n데이터가 정해져야 하며, 만약 자료에 결함이 생기면 적절한\n\n보정 방법을 임상시험계획서에 제시하고 보정 후 분석을 시행\n\n- - 동의를 철회한 경우 해당 시점까지 수집된 피험자의 정보는\n- 나.  탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n - 가.  유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나.  검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993).  불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다. ",
        "original_sentence": "- 가. "
      }
    },
    {
      "chunk_id": "chunk_818",
      "text": "유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 817,
        "window_size": 3,
        "char_count": 173,
        "word_count": 47,
        "page_number": 7,
        "window_text": "탈락\n시험자는 다음과 같은 경우에 연구참여 대상자를 시험에서\n\n- - 피험자가 임상시험 중 임상시험 참여 중단을 요구하거나 시험\n- - 피험자의 부작용(예: 두통, 눈의 피로, 눈 또는 근육경련, 눈의 불수의\n운동, 메스꺼움, 어지럼증 등)으로 인하여 임상시험 책임자 또는\n\n- - 피험자가 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 피험자의 임상시험 중 임상시험용 의료기기 비교 평가하는데\n- - 임상시험 중 선정/제외 기준 위반 등 중대한 계획서 위반 사항이\n- - 88 -\n발견되는 경우\n\n- - 기타 사유로 인하여 임상시험 책임자 또는 담당자가 임상시험을\n- - 불면 증상이 지나치게 악화되어 다른 건강 결과 악화가\n- - 중도 탈락 시, 시험자는 대상자의 임상시험 조기 탈락의 주요\n사유를 평가하여 증례기록서의 임상시험 완료 란에 해당 정보를\n\n- - 참여 중단 의사를 밝히지 않고 방문에 출석하지 않아 현재\n상태가 불분명한 대상자의 경우에 시험자는 대상자와 전화\n\n- - 89 -\n- 14.  유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n - 가.  유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나.  검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993).  불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다.  불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다. ",
        "original_sentence": "유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_819",
      "text": "검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 818,
        "window_size": 3,
        "char_count": 116,
        "word_count": 27,
        "page_number": 39,
        "window_text": "유효성의 평가기준, 평가방법 및 해석방법(통계분석방법에 의함)\n- - 해당 의료기기의 임상시험에 따른 유효성 평가는 사용된 모든 의료기기를\n- - 성능 평가 방법은 임상시험 기간 동안 일차/이차 유효성 평가변수에 대한\n- - 통계 분석 방법에 따른 통계적 유의성에 대한 평가 방법과 기준을 제시한다.\n - 가.  유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나.  검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993).  불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다.  불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다.  단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다. ",
        "original_sentence": "검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993). "
      }
    },
    {
      "chunk_id": "chunk_820",
      "text": "불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 819,
        "window_size": 3,
        "char_count": 70,
        "word_count": 15,
        "page_number": 35,
        "window_text": "- 가.  유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나.  검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993).  불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다.  불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다.  단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다.  방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다. ",
        "original_sentence": "불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다. "
      }
    },
    {
      "chunk_id": "chunk_821",
      "text": "불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 820,
        "window_size": 3,
        "char_count": 157,
        "word_count": 36,
        "page_number": 27,
        "window_text": "유효성의 평가 기준\n[일차 유효성 평가변수]\n\n[이차 유효성 평가변수]\n\n* 관해 정의: 불면증 심각도 척도(ISI) 7점 이하\n\n- - 90 -\n4) 치료 전 대비 6주 및 6개월 후 반응*률\n\n* 반응 정의: 기저점 대비 일차 유효성 변수(불면증 심각도 척도[ISI]) 변화량의\n\n- - 91 -\n- 나.  검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993).  불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다.  불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다.  단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다.  방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다.  다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다. ",
        "original_sentence": "불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다. "
      }
    },
    {
      "chunk_id": "chunk_822",
      "text": "단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 821,
        "window_size": 3,
        "char_count": 82,
        "word_count": 19,
        "page_number": 27,
        "window_text": "검사 방법\n예시\n\n불면증 심각도 척도(ISI)는 불면증의 증상 심각도에 대한 평가를\n\n수행할 수 있으며 질환의 호전 여부를 판단할 수 있는 과학적\n\n으로 검증된 자가 보고식 설문이다(Morin, 1993).  불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다.  불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다.  단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다.  방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다.  다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다.  방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트). ",
        "original_sentence": "단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_823",
      "text": "방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 822,
        "window_size": 3,
        "char_count": 149,
        "word_count": 35,
        "page_number": 27,
        "window_text": "불면증 심각도\n\n척도(ISI)는 총 7개의 문항으로 구성되어 있고, 각 문항은 5점\n\n리커트 척도(0-4)로 이루어져 있다.  불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다.  단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다.  방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다.  다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다.  방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트).  얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al. ",
        "original_sentence": "방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다. "
      }
    },
    {
      "chunk_id": "chunk_824",
      "text": "다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 823,
        "window_size": 3,
        "char_count": 158,
        "word_count": 39,
        "page_number": 9,
        "window_text": "불면증 심각도 척도(ISI) 점수의\n\n0-7점을 정상군, 8-14점을 경도의 불면증군, 15-21점을 중등도의\n\n본 연구에서는 일차 유효성 지표에 대한 검증을 위해 방문 1,\n\n방문 2, 방문 3, 방문 4에 각각 불면증 심각도 척도(ISI) 자가 보고\n\n설문을 수행할 예정이다.  단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다.  방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다.  다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다.  방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트).  얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al.  2012). ",
        "original_sentence": "다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다. "
      }
    },
    {
      "chunk_id": "chunk_825",
      "text": "방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 824,
        "window_size": 3,
        "char_count": 89,
        "word_count": 22,
        "page_number": 27,
        "window_text": "단, 필요에 따라 방문 1(스크리닝 단계)\n\n에서 측정한 불면증 심각도 척도(ISI) 정보를 방문 2의 baseline\n\n지표로 활용할 수 있다.  방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다.  다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다.  방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트).  얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al.  2012).  수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20. ",
        "original_sentence": "방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트). "
      }
    },
    {
      "chunk_id": "chunk_826",
      "text": "얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 825,
        "window_size": 3,
        "char_count": 144,
        "word_count": 31,
        "page_number": 3,
        "window_text": "방문 1의 경우 연구자가 직접 피험자와\n\n대면하여 연구에 대한 설명을 수행하고 서면 동의를 얻은 뒤,\n\n독립된 방에서 설문지를 제공하고 피험자가 스스로 설문에 답하게\n\n5~10분간의 시간을 제공할 예정이며, 이는 방문 2, 3, 4에서도\n\n동일하게 진행될 예정이다.  다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다.  방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트).  얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al.  2012).  수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20.  수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다. ",
        "original_sentence": "얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al. "
      }
    },
    {
      "chunk_id": "chunk_827",
      "text": "2012). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 826,
        "window_size": 3,
        "char_count": 7,
        "word_count": 1,
        "page_number": 9,
        "window_text": "다만 방문 2, 3의 경우 애플리케이션을\n\n통해 불면증 심각도 척도(ISI) 정보를 수집할 수 있으며, 방문 4는\n\n내원, 애플리케이션, 이메일, 문자, SNS를 이용하여 설문지를 제공한\n\n방문 1의 설문에서 7점 이하를 기록할 경우 연구 대상에서\n\n- - 92 -\n제외되게 된다.  방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트).  얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al.  2012).  수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20.  수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다.  방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다. ",
        "original_sentence": "2012). "
      }
    },
    {
      "chunk_id": "chunk_828",
      "text": "수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 827,
        "window_size": 3,
        "char_count": 109,
        "word_count": 31,
        "page_number": 7,
        "window_text": "방문 3, 4의 설문 점수는 방문 1의 점수와 비교\n\n수면 효율(SE)이란 잠자리에 누운 시간 대비 실제 수면을 취한\n\n시간의 비율을 말한다(단위: 퍼센트).  얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al.  2012).  수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20.  수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다.  방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다.  이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다. ",
        "original_sentence": "수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20. "
      }
    },
    {
      "chunk_id": "chunk_829",
      "text": "수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 828,
        "window_size": 3,
        "char_count": 72,
        "word_count": 20,
        "page_number": 9,
        "window_text": "얼마나 효율적으로 수면을\n\n취하였는지 여부를 확인할 수 있으며, 불면증의 정도를 평가하고\n\n치료 경과를 확인하는 데에 사용되는 의학적으로 검증된 지표 중\n\n수면 효율(SE)을 평가하기 위해서 일반적으로 사용되는 도구는\n\n수면 일기이다(Camey et al.  2012).  수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20.  수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다.  방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다.  이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다.  방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n",
        "original_sentence": "수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다. "
      }
    },
    {
      "chunk_id": "chunk_830",
      "text": "방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 829,
        "window_size": 3,
        "char_count": 116,
        "word_count": 29,
        "page_number": 27,
        "window_text": "2012).  수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20.  수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다.  방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다.  이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다.  방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n 다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다. ",
        "original_sentence": "방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_831",
      "text": "이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 830,
        "window_size": 3,
        "char_count": 95,
        "word_count": 24,
        "page_number": 17,
        "window_text": "수면 일기의 세부적인 항목은\n\n치료자의 필요성에 따라 달라질 수 있으나 최소한 이하의 항목은\n\n- - 잠자리에 든 시각, 잠이 든 시각, 깨어난 시각, 잠자리에서 나온\n- - 93 -\n표 20.  수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다.  방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다.  이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다.  방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n 다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다.  제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다. ",
        "original_sentence": "이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다. "
      }
    },
    {
      "chunk_id": "chunk_832",
      "text": "방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 831,
        "window_size": 3,
        "char_count": 94,
        "word_count": 26,
        "page_number": 28,
        "window_text": "수면 일기의 예시\n\n본 연구에서는 방문 1, 방문 2, 방문 3, 방문 4에서 각각 일주일\n\n치의 수면 일기를 수집할 예정이다.  방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다.  이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다.  방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n 다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다.  제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다.  방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다. ",
        "original_sentence": "방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_833",
      "text": "다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 832,
        "window_size": 3,
        "char_count": 187,
        "word_count": 48,
        "page_number": 9,
        "window_text": "방문 1의 경우 연구자가 직접\n\n피험자와 대면하여 연구에 대한 설명을 수행하고 서면 동의를\n\n얻은 뒤, 독립된 방에서 수면 일기에 대한 작성 예시를 보여주고\n\n일기 작성법을 5~10분에 걸쳐 교육할 것이다.  이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다.  방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n 다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다.  제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다.  방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다.  웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다. ",
        "original_sentence": "다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_834",
      "text": "제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 833,
        "window_size": 3,
        "char_count": 61,
        "word_count": 13,
        "page_number": 45,
        "window_text": "이때 일주일 치의\n\n수면 일기를 기록할 수 있도록 서면 기록지 제공, 혹은 애플리\n\n케이션의 설치를 수행할 예정이며, 방문 2에서 수면 일기의\n\n작성도를 확인할 것이다.  방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n 다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다.  제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다.  방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다.  웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다.  이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다. ",
        "original_sentence": "제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다. "
      }
    },
    {
      "chunk_id": "chunk_835",
      "text": "방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 834,
        "window_size": 3,
        "char_count": 117,
        "word_count": 33,
        "page_number": 17,
        "window_text": "방문 3, 방문 4의 경우 미리 교육을\n\n해야 할 필요성이 없기 때문에 피험자에게 일주일 치의 수면\n\n일기를 작성하게 한 뒤 방문 시 지참하도록 하여 확인할 것이다.\n\n 다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다.  제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다.  방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다.  웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다.  이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다.  자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다. ",
        "original_sentence": "방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_836",
      "text": "웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 835,
        "window_size": 3,
        "char_count": 75,
        "word_count": 16,
        "page_number": 39,
        "window_text": "다만 방문 2, 3의 경우 애플리케이션을 통해 수면 일기 정보를\n\n- - 94 -\n수집할 수 있으며, 방문 4는 내원, 애플리케이션, 이메일, 문자,\n\nSNS를 이용하여 설문지를 제공한 뒤 회신받는 것으로 갈음할\n\n방문 1에서 교육하여 방문 2에서 수거한 수면 일기의 순응도가\n\n1주일 중 3일 이하로 저조할 경우 연구에서 제외한다.  제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다.  방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다.  웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다.  이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다.  자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다.  연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n",
        "original_sentence": "웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_837",
      "text": "이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 836,
        "window_size": 3,
        "char_count": 191,
        "word_count": 49,
        "page_number": 39,
        "window_text": "제외하지\n\n않은 피험자들의 경우 일주일의 평균 수면 효율을 계산하여 이를\n\nbaseline 지표로 활용한다.  방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다.  웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다.  이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다.  자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다.  연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n 사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n",
        "original_sentence": "이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_838",
      "text": "자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 837,
        "window_size": 3,
        "char_count": 51,
        "word_count": 11,
        "page_number": 39,
        "window_text": "방문 3, 방문 4에서 수거한 수면 일기\n\n역시 일주일의 평균 수면 효율을 계산한 뒤 방문 1의 수면 효율과\n\n수면 효율의 측정에 수면 일기를 사용하지 않고 웨어러블 디바\n\n이스 등을 통하여 갈음할 수 있다.  웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다.  이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다.  자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다.  연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n 사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n 여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다. ",
        "original_sentence": "자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_839",
      "text": "연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 838,
        "window_size": 3,
        "char_count": 105,
        "word_count": 26,
        "page_number": 39,
        "window_text": "웨어러블 디바이스를 사용할\n\n경우, 반드시 피험자가 잠자리에 눕기 전부터 잠자리에서 일어난\n\n후까지 디바이스를 착용하고 있어야 한다.  이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다.  자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다.  연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n 사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n 여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다.  이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다. ",
        "original_sentence": "연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_840",
      "text": "사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 839,
        "window_size": 3,
        "char_count": 70,
        "word_count": 17,
        "page_number": 28,
        "window_text": "이 때 사용되는 웨어\n\n러블 디바이스는 의학적으로 수면 효율 측정에 검증된 바가 있\n\n거나, 혹은 이미 검증된 기기와의 비교 분석상 동등한 수준의\n\n삶의 질, 수면/우울/불안 관련 증상 유무, 직업적/사회적 기능\n\n상태, 수면 양상, 낮 시간 졸음 등의 항목에 있어서는 자가 보고\n\n설문 혹은 연구자와의 대면 인터뷰를 통해 측정이 가능하다.  자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다.  연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n 사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n 여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다.  이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다.  통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다. ",
        "original_sentence": "사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_841",
      "text": "여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 840,
        "window_size": 3,
        "char_count": 83,
        "word_count": 20,
        "page_number": 43,
        "window_text": "자가\n\n보고 설문의 경우 불면증 심각도 척도(ISI)와 동등한 방식으로\n\n측정이 가능하다.  연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n 사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n 여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다.  이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다.  통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다.  1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다. ",
        "original_sentence": "여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다. "
      }
    },
    {
      "chunk_id": "chunk_842",
      "text": "이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 841,
        "window_size": 3,
        "char_count": 31,
        "word_count": 9,
        "page_number": 49,
        "window_text": "연구자와의 대면 인터뷰 또한 불면증 심각도\n\n척도(ISI)와 유사한 방식으로 하되, 자가 보고 설문 대신 연구자\n\n- - 95 -\n와의 인터뷰를 통해 진행되는 방식으로 측정이 가능하다.\n\n 사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n 여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다.  이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다.  통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다.  1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다.  1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n",
        "original_sentence": "이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_843",
      "text": "통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 842,
        "window_size": 3,
        "char_count": 188,
        "word_count": 41,
        "page_number": 44,
        "window_text": "사용자 반응 평가에 대해서는 애플리케이션 사용 후 측정이\n\n진행되어야 하므로 방문 3, 방문 4에 측정을 수행하여야 한다.\n\n 여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다.  이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다.  통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다.  1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다.  1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n ⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다. ",
        "original_sentence": "통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다. "
      }
    },
    {
      "chunk_id": "chunk_844",
      "text": "1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 843,
        "window_size": 3,
        "char_count": 141,
        "word_count": 28,
        "page_number": 7,
        "window_text": "여기에는 사용자의 순응도, 만족도, 난이도, 개선점 등이 포함되\n\n어야 하며 자가 보고 설문 혹은 연구자와의 대면 인터뷰를 통해\n\n측정이 가능하다.  이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다.  통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다.  1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다.  1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n ⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다.  안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다. ",
        "original_sentence": "1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다. "
      }
    },
    {
      "chunk_id": "chunk_845",
      "text": "1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 844,
        "window_size": 3,
        "char_count": 61,
        "word_count": 12,
        "page_number": 7,
        "window_text": "이외 기타 치료 관련 변수와 동일한 방식으로\n\n- 다.  통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다.  1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다.  1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n ⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다.  안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다.  대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다. ",
        "original_sentence": "1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_846",
      "text": "⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 845,
        "window_size": 3,
        "char_count": 78,
        "word_count": 18,
        "page_number": 1,
        "window_text": "통계 분석 방법\n배정된 대로 분석(Intention-to-treat, ITT) 원칙을 따르며, 무작위\n\n배정된 모든 피험자군 중 주요한 선정 기준을 위배하거나 무작위\n\n배정된 후 불면증 개선 디지털치료기기를 로그인하여, 한 번\n\n이라도 사용한 로그가 존재하지 않거나, 무작위 배정 이후 일차\n\n유효성 평가자료가 전무한 경우는 제외한다.  1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다.  1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n ⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다.  안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다.  대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다.  또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n",
        "original_sentence": "⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다. "
      }
    },
    {
      "chunk_id": "chunk_847",
      "text": "안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 846,
        "window_size": 3,
        "char_count": 145,
        "word_count": 31,
        "page_number": 7,
        "window_text": "1차/2차 유효성\n\n평가는 모든 분석 대상자군(Full Analysis Set, FAS)를 주요\n\n모든 분석 대상자군(FAS)에 속한 피험자이면서 임상시험 일정\n\n대로 모든 수행을 완료하고, 아래의 주요한 임상시험계획 위반이\n\n없는 피험자로 정의한다.  1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n ⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다.  안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다.  대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다.  또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n : 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다. ",
        "original_sentence": "안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_848",
      "text": "대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 847,
        "window_size": 3,
        "char_count": 76,
        "word_count": 15,
        "page_number": 35,
        "window_text": "1차/2차 유효성 평가는 계획서 순응\n\n- - 96 -\n임상시험대상자군(PPS)를 보조분석군으로 분석한다.\n\n ⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다.  안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다.  대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다.  또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n : 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다.  그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n",
        "original_sentence": "대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다. "
      }
    },
    {
      "chunk_id": "chunk_849",
      "text": "또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 848,
        "window_size": 3,
        "char_count": 375,
        "word_count": 91,
        "page_number": 36,
        "window_text": "⦁ 임상시험 참여중 심적/신체적 환경 변화로 있는 것으로\n\n불면증 개선 디지털치료기기로 한 번이라도 치료를 받은 모든\n\n피험자로 정의한다.  안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다.  대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다.  또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n : 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다.  그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n - - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n",
        "original_sentence": "또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_850",
      "text": ": 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 849,
        "window_size": 3,
        "char_count": 416,
        "word_count": 79,
        "page_number": 19,
        "window_text": "안전성 평가는 안전성 자료를 대상으로\n\n: 일차 유효성 평가변수에 대해 배정군, 기저치, 성, 연령을\n\n포함한 공분산분석(ANCOVA)을 적용하여 다른 변수를 통제한 후\n\n배정군간 평균 변화량 차이가 있는지 P-value와 양측 95%\n\n신뢰구간을 제시한다.  대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다.  또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n : 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다.  그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n - - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n - - 99 -\n<!-- PAGE_106 -->\n###### 15. ",
        "original_sentence": ": 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다. "
      }
    },
    {
      "chunk_id": "chunk_851",
      "text": "그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 850,
        "window_size": 3,
        "char_count": 161,
        "word_count": 42,
        "page_number": 7,
        "window_text": "대조군 대비 시험군의 평균 변화량이\n\n우월한 방향에 있고 P-value가 유의수준 0.05에서 작으면\n\n통계적으로 우월하다고 판단한다.  또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n : 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다.  그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n - - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n - - 99 -\n<!-- PAGE_106 -->\n###### 15.  부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가. ",
        "original_sentence": "그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_852",
      "text": "- - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 851,
        "window_size": 3,
        "char_count": 71,
        "word_count": 19,
        "page_number": 43,
        "window_text": "또한, 결과에 대한 임상적\n\n- - 치료 전 대비 6개월 후 불면증 심각도 척도(ISI), 6주 후 및\n: 각 유효성 평가변수의 각 시점의 변화량에 대해 기저치, 성,\n\n연령을 포함한 공분산분석을 적용하여 다른 변수를 통제한 후\n\n- - 97 -\n배정군간 평균 변화량 차이가 있는지 양측 유의수준 0.05에서\n\n: 치료 전 대비 치료 후 각 시점에서 군간 관해율 및 반응율 차이는\n\n카이제곱검정(Chi-square test) 혹은 피셔정확검정(Fisher’s\n\nexact test; 전체 셀의 20% 이상에서 기대빈도 5 미만인 경우)을\n\n: 각 시점에서 군간 답변 차이는 카이제곱검정 혹은 피셔정확\n\n검정을 통해 양측 유의수준 0.05에서 통계적 우월성을 평가한다.\n\n : 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다.  그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n - - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n - - 99 -\n<!-- PAGE_106 -->\n###### 15.  부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가.  피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다. ",
        "original_sentence": "- - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_853",
      "text": "- - 99 -\n<!-- PAGE_106 -->\n###### 15. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 852,
        "window_size": 3,
        "char_count": 38,
        "word_count": 9,
        "page_number": 106,
        "window_text": ": 각 시점에서 군간 응답 빈도와 비율을 제시하고 필요시 카이\n\n제곱검정 혹은 피셔정확검정을 통해 유의수준 0.05에서 통계적\n\n: 피험자 집단별 치료기간 동안 수면양상 및 낮시간 졸음의\n\n빈도와 비율을 제시하고 필요시 반복측정혼합모형(Repeated\n\nmeasured Mixed model) 혹은 일반화 추정 방정식(Generalized\n\nEstimating Equations, GEE) 모형을 적용하여 유의수준 0.05에서\n\n4) 결측값 처리\n\n- - 98 -\n모든 분석 대상자군(Full Analysis Set, FAS)에서 중도탈락 등의\n\n사유로 치료 후 시점에서 발생하는 결측치는 일차/이차 유효성\n\n평가변수에 대해서는 마지막 관측값 선행 대체법(Last Observation\n\nCarried Forward, LOCF)으로 대치한다.  그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n - - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n - - 99 -\n<!-- PAGE_106 -->\n###### 15.  부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가.  피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다.  하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다. ",
        "original_sentence": "- - 99 -\n<!-- PAGE_106 -->\n###### 15. "
      }
    },
    {
      "chunk_id": "chunk_854",
      "text": "부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 853,
        "window_size": 3,
        "char_count": 169,
        "word_count": 32,
        "page_number": 36,
        "window_text": "그 외 자료는 대치 처리\n\n1차 유효성 평가 결과가 피험자의 하위집단(성별, 연령별 등)에\n\n- - 1차 유효성 평가 결과가 기관에 따라 차이가 있는지를 확인하기\n위해 기관 및 기관과 그룹 간 상호작용을 공분산 분석 모형에\n\n포함하여 기관에 따른 군간 차이가 있는지 분석하여 제시한다.\n\n - - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n - - 99 -\n<!-- PAGE_106 -->\n###### 15.  부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가.  피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다.  하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다.  긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n",
        "original_sentence": "부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_855",
      "text": "피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 854,
        "window_size": 3,
        "char_count": 84,
        "word_count": 17,
        "page_number": 36,
        "window_text": "- - 대치 처리하지 않고 결측치를 고려한 반복 측정 혼합 모형\n등을 적용하여 주요 결과와 차이가 있는지 분석하여 제시한다.\n\n - - 99 -\n<!-- PAGE_106 -->\n###### 15.  부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가.  피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다.  하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다.  긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n - 나. ",
        "original_sentence": "피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다. "
      }
    },
    {
      "chunk_id": "chunk_856",
      "text": "하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 855,
        "window_size": 3,
        "char_count": 180,
        "word_count": 43,
        "page_number": 43,
        "window_text": "- - 99 -\n<!-- PAGE_106 -->\n###### 15.  부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가.  피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다.  하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다.  긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n - 나.  시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n",
        "original_sentence": "하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다. "
      }
    },
    {
      "chunk_id": "chunk_857",
      "text": "긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 856,
        "window_size": 3,
        "char_count": 28,
        "word_count": 6,
        "page_number": 44,
        "window_text": "부작용을 포함한 안전성의 평가기준·평가방법 및 보고방법\n\n이상사례(의료기기이상반응, 중대한 이상반응/의료기기이상반응 포함)의 발생 시\n\n내에 가능한 신속한 보고가 되어야 하며, 이상반응 등에 대한 의학적 소견·\n\n정도와\n\n임상시험용\n\n의료기기와의\n\n인과관계를\n\n평가하여\n\n증례기록서에\n\n기록\n\n- 가.  피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다.  하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다.  긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n - 나.  시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n - - 100 -\n- 다. ",
        "original_sentence": "긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_858",
      "text": "- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 857,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "피험자 안전성\n본 임상시험은 저위험(low-risk) 치료용 의료기기의 임상적 평가이므로\n\n피험자가 직접적으로 받는 인체의 위해도가 없을 수도 있다.  하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다.  긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n - 나.  시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n - - 100 -\n- 다.  이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_859",
      "text": "시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 858,
        "window_size": 3,
        "char_count": 91,
        "word_count": 21,
        "page_number": 9,
        "window_text": "하지만,\n\n치료 도중 피험자에게 문제(예: 낮 시간 졸음이 과도한 현상 등)가 발생할\n\n경우 임상시험 담당 연구진에게 연락할 수 있는 긴급 연락망을 제공하고,\n\n디지털기기(애플리케이션) 사용 관련한 문제(예: 버그 문제, 로그인 실패 등)가\n\n발생할 경우 회사 측 고객센터로 연락할 수 있는 별도의 연락망을 제공\n\n한다.  긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n - 나.  시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n - - 100 -\n- 다.  이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다.  그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16. ",
        "original_sentence": "시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_860",
      "text": "- - 100 -\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 859,
        "window_size": 3,
        "char_count": 15,
        "word_count": 6,
        "page_number": 27,
        "window_text": "긴급 연락망과 방문을 통해 이상반응을 수집한다.\n\n - 나.  시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n - - 100 -\n- 다.  이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다.  그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16.  피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다. ",
        "original_sentence": "- - 100 -\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_861",
      "text": "이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 860,
        "window_size": 3,
        "char_count": 1332,
        "word_count": 306,
        "page_number": 27,
        "window_text": "- 나.  시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n - - 100 -\n- 다.  이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다.  그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16.  피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다.  이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가. ",
        "original_sentence": "이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_862",
      "text": "그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 861,
        "window_size": 3,
        "char_count": 86,
        "word_count": 21,
        "page_number": 111,
        "window_text": "시험자 안전성\n해당 임상시험용 의료기기는 소프트웨어에 속하며 비침습적이며 짧은\n\n기간 동안 임상시험에 참여하기 때문에 안전에 대한 위험은 없다고\n\n할 수 있다.\n\n - - 100 -\n- 다.  이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다.  그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16.  피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다.  이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가.  피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나. ",
        "original_sentence": "그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16. "
      }
    },
    {
      "chunk_id": "chunk_863",
      "text": "피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 862,
        "window_size": 3,
        "char_count": 75,
        "word_count": 15,
        "page_number": 3,
        "window_text": "- - 100 -\n- 다.  이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다.  그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16.  피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다.  이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가.  피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나.  피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n",
        "original_sentence": "피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다. "
      }
    },
    {
      "chunk_id": "chunk_864",
      "text": "이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 863,
        "window_size": 3,
        "char_count": 38,
        "word_count": 10,
        "page_number": 45,
        "window_text": "이상사례의 정의\n1) 이상사례(Adverse Event, AE)란 임상시험 중 피험자에게\n\n발생한 모든 의도하지 않은 증후(sign), 증상(symptom) 또는 질병을\n\n말하며, 해당 임상시험용 의료기기와 반드시 인과관계를 가져야\n\n2) 의료기기이상반응(Adverse Device Effect, ADE)이란 임상시험용\n\n의료기기로 인하여 발생한 모든 유해하고 의도하지 않은 반응\n\n으로서 임상시험용 의료기기와의 인과관계를 부정할 수 없는\n\n이상사례 발현 시 임상시험용 의료기기와의 관련성 여부는\n\n시험자가 다음 기준에 의하여 평가하며, 시험자의 의견을 기술\n\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 어떤 이유보다 임상시험용 의료기기의 사용에\n- - 101 -\n- - 재사용(재사용이 가능한 경우에만 실시) 결과가 양성인 경우\n- - 이상반응이 임상시험용 의료기기 또는 동일 계열의 의료기기에\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 원인보다 임상시험용 의료기기의 사용에 의해\n- - 임상시험용 의료기기의 사용 중단으로 이상반응이 사라지는 경우\n- - 임상시험용 의료기기의 사용과 이상반응 발현의 시간적 순서가\n- - 이상반응이 다른 가능성이 있는 원인들과 같은 수준으로\n- - 임상시험용 의료기기의 사용의 중단으로(실시된 경우) 이상\n- - 임상시험용 의료기기의 사용 중단 결과(실시된 경우)가 음성\n이거나 모호한 경우\n\n- - 102 -\n- - 임상시험용 의료기기의 재사용(실시된 경우) 결과가 음성이거나\n- - 임상시험용 의료기기의 사용과 이상반응 발현과의 시간적 순서가\n- - 정보가 불충분하거나 상충되어 판단할 수 없고 이를 보완하거나\n본 임상시험에서 이상반응은 임상시험 시작 전에 관찰되지 않은\n\n증상이 발생하는 모든 바람직하지 않은 의학적ㆍ물리적 소견을 이상\n\n- ○ 시험책임자는 시험담당자 및 임상의 등에게 임상시험용 의료기\n기 사용 후 나타날 수 있는 모든 이상사례에 대하여 교육을\n\n실시하고 사용 후 나타나는 모든 현상에 대하여 보고하도록\n\n2) 중대한 의료기기이상반응 보고\n\n- - 103 -\n※ 본 내용은「의료기기법 시행규칙」별표 3 ‘의료기기 임상시험 관리\n\n- ○ 이외에도 시험자가 중대하다고 간주하거나, 임상시험용 의료\n기기와의 사용과 연관 지을 수 있는 유의한 위험, 금기,\n\n부작용, 주의사항을 시사하는 사건 등도 중대한 이상사례/\n\n의료기기이상반응으로 기록하고 사망을 초래하거나 생명을\n\n위협하는 경우에는 의뢰자가 이 사실을 보고받거나 알게된\n\n날로부터 7일 이내, 이 경우 상세한 정보를 최초 보고일로부터\n\n8일 이내에 추가로 보고 하여야 한다.  그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16.  피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다.  이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가.  피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나.  피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n - - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다. ",
        "original_sentence": "이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_865",
      "text": "피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 864,
        "window_size": 3,
        "char_count": 897,
        "word_count": 217,
        "page_number": 3,
        "window_text": "그 밖의 중대하거나 예상\n\n하지 못한 모든 이상반응이 나타난 경우에는 의뢰자가 이\n\n- - 104 -\n<!-- PAGE_111 -->\n###### 16.  피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다.  이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가.  피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나.  피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n - - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다.  피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다. ",
        "original_sentence": "피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_866",
      "text": "피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 865,
        "window_size": 3,
        "char_count": 451,
        "word_count": 98,
        "page_number": 27,
        "window_text": "피험자 동의서 서식\n\n피험자 동의와 관련한 준수사항은 의료기기 임상시험 관리기준(의료기기법 시행규칙\n\n[별표 3])에서 정하고 있다.  이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가.  피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나.  피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n - - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다.  피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다.  임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n",
        "original_sentence": "피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_867",
      "text": "- - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 866,
        "window_size": 3,
        "char_count": 202,
        "word_count": 52,
        "page_number": 27,
        "window_text": "이에 따른 피험자 동의서 서식을 제시하여야 하며, 피험자\n\n- 가.  피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나.  피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n - - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다.  피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다.  임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n - 라. ",
        "original_sentence": "- - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다. "
      }
    },
    {
      "chunk_id": "chunk_868",
      "text": "피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 867,
        "window_size": 3,
        "char_count": 109,
        "word_count": 29,
        "page_number": 46,
        "window_text": "피험자 동의서에 반드시 포함되어야 하는 사항\n3) 임상시험용 의료기기에 관한 정보 및 시험군 또는 대조군에 무작위\n\n4) 침습적 시술(invasive procedure)을 포함하여 임상시험에서 피험자가\n\n8) 기대되는 이익이 있거나 피험자에게 기대되는 이익이 없을 경우\n\n9) 피험자가 선택할 수 있는 다른 치료 방법이나 종류 및 그 치료\n\n- - 105 -\n방법의 잠재적 위험과 이익\n\n10) 임상시험과 관련한 손상이 발생하였을 경우 피험자에게 주어질\n\n11) 피험자가 임상시험에 참여함으로써 받게 될 금전적 보상이 있는\n\n경우 예상 금액 및 이 금액이 임상시험 참여의 정도나 기간에\n\n13) 피험자의 임상시험 참여 여부 결정은 자발적이어야 하며, 피험자가\n\n원래 받을 수 있는 이익에 대한 손실 없이 임상시험의 참여를\n\n거부하거나 임상시험 도중 언제라도 참여를 포기할 수 있다는 사실\n\n14) 제8호 항목에 따른 모니터 요원, 제8호 항목에 따른 점검을 실시\n\n하는 자, 임상시험심사위원회 및 식품의약품안전처장이 관계\n\n법령에 따라 임상시험의 실시 절차와 자료의 품질을 검증하기\n\n위하여 피험자의 신상에 관한 비밀이 보호되는 범위에서 피험자의\n\n의무기록을 열람할 수 있다는 사실과 피험자 또는 피험자 대리인의\n\n15) 피험자의 신상을 파악할 수 있는 기록은 비밀로 보호될 것이며\n\n임상시험의 결과가 출관될 경우 피험자의 신상은 비밀로 보호될\n\n16) 피험자의 임상시험 계속 참여 여부에 영향을 줄 수 있는 새로운\n\n정보를 취득하면 적시에 피험자 또는 피험자의 대리인에게 알릴\n\n17) 임상시험과 피험자의 권익에 관하여 추가적인 정보를 얻고자\n\n- - 106 -\n하거나 임상시험과 관련이 있는 손상이 발생한 경우에 연락해야\n\n18) 임상시험 도중 피험자의 임상시험 참여가 중지되는 경우 및\n\n- 나.  피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n - - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다.  피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다.  임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n - 라.  피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다. ",
        "original_sentence": "피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_869",
      "text": "임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 868,
        "window_size": 3,
        "char_count": 185,
        "word_count": 41,
        "page_number": 41,
        "window_text": "피험자 동의의 일반적 요건\n1) 연구자는 연구를 시작하기 전에 임상시험심사위원회(Institutional\n\nReview Board, IRB)로부터 피험자에게 제공될 설명서 및 동의서,\n\n2) 연구자는 임상시험심사위원회 승인 직인이 찍힌 동의서 등을\n\n피험자 또는 피험자의 대리인에게 제공해야 하며, 피험자(또는\n\n대리인)와 동의를 받은 책임연구자(또는 책임연구자의 위임을\n\n받은 자)는 동의서 서식에 서명하고, 자필로 해당 날짜를 기재\n\n3) 연구자는 서명된 동의서를 보관해야 하며, 사본을 피험자(또는\n\n4) 동의서를 받는 과정에서 연구자는 피험자 또는 대리인에게 강제나\n\n부당한 영향을 미치지 않아야 하며, 피험자 또는 대리인이 연구의\n\n모든 정보를 이해할 수 있는 용어 및 언어로 작성된 동의서 등을\n\n제공하여 설명하고 질문에 대하여 대답한 후 충분히 생각할 기회를\n\n제공하여 동의를 얻어야 한다.\n\n - - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다.  피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다.  임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n - 라.  피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다.  또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n",
        "original_sentence": "임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_870",
      "text": "- 라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 869,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "- - 107 -\n5) 피험자 동의서에는 피험자 또는 대리인의 법적 권리를 포기나\n\n제한, 연구자/의뢰자/기관 및 기관장의 과실 책임의 면제를 암시\n\n6) 피험자의 동의에 영향을 줄 수 있는 새로운 연구 관련 정보가\n\n수집되면 동의서 서식, 피험자 설명서 및 기타 문서화된 정보는\n\n이에 따라 수정되어야 하며, 사용 전에 반드시 위원회의 승인을\n\n받아야 한다.  피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다.  임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n - 라.  피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다.  또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n - - 109 -\n<!-- PAGE_116 -->\n###### 17. ",
        "original_sentence": "- 라. "
      }
    },
    {
      "chunk_id": "chunk_871",
      "text": "피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 870,
        "window_size": 3,
        "char_count": 216,
        "word_count": 53,
        "page_number": 45,
        "window_text": "피험자의 지속적인 연구 참여 의지에 영향을 줄\n\n경우 연구 책임자는 피험자 또는 대리인에게 즉시 알리고, 이러한\n\n7) 피험자 또는 대리인이 동의서 등을 읽을 수 없는 경우에는 공정한\n\n- 다.  임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n - 라.  피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다.  또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n - - 109 -\n<!-- PAGE_116 -->\n###### 17.  피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다. ",
        "original_sentence": "피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_872",
      "text": "또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 871,
        "window_size": 3,
        "char_count": 87,
        "word_count": 21,
        "page_number": 41,
        "window_text": "임상시험 실시 도중 피험자 설명문 등이 변경되었을 때 재동의\n임상시험 실시 도중 동의서 서식이 변경되거나, 피험자에게 제공된\n\n문서 정보의 변경이 있는 경우에는 변경일 기준 다음 방문일에 변경\n\n내용을 피험자에게 충분히 설명하고, 시험책임자(또는 시험담당의사)와\n\n피험자는 변경동의서에 서명하고 해당 날짜를 자필로 적어야 한다.\n\n - 라.  피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다.  또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n - - 109 -\n<!-- PAGE_116 -->\n###### 17.  피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다.  피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다. ",
        "original_sentence": "또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_873",
      "text": "- - 109 -\n<!-- PAGE_116 -->\n###### 17. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 872,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 116,
        "window_text": "- 라.  피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다.  또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n - - 109 -\n<!-- PAGE_116 -->\n###### 17.  피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다.  피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다.  본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n",
        "original_sentence": "- - 109 -\n<!-- PAGE_116 -->\n###### 17. "
      }
    },
    {
      "chunk_id": "chunk_874",
      "text": "피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 873,
        "window_size": 3,
        "char_count": 83,
        "word_count": 21,
        "page_number": 39,
        "window_text": "피험자의 대리인이 피험자를 대신하여 임상시험 참여에 동의\n피험자의 이해능력, 의사표현능력의 결여 등의 사유로 동의를 받을\n\n수 없는 경우에는 대리인의 동의를 받을 수 있으며, 이와 같은 경우\n\n에도 피험자는 피험자 자신이 이해할 수 있는 정도까지 임상시험에\n\n관한 정보를 제공 받아야 하며, 가능하다면 피험자는 동의서 서식에\n\n- - 108 -\n서명하고 자필로 날짜를 기재하여야 한다.  또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n - - 109 -\n<!-- PAGE_116 -->\n###### 17.  피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다.  피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다.  본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n 예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다. ",
        "original_sentence": "피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다. "
      }
    },
    {
      "chunk_id": "chunk_875",
      "text": "피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 874,
        "window_size": 3,
        "char_count": 107,
        "word_count": 25,
        "page_number": 36,
        "window_text": "또한, 피험자의 대리인임을\n\n확인할 수 있는 근거 자료 등을 확보하고, 피험자 동의 설명서 등에\n\n대리인의 동의 사유를 구체적으로 기술할 것을 권장한다.\n\n - - 109 -\n<!-- PAGE_116 -->\n###### 17.  피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다.  피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다.  본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n 예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다.  그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n",
        "original_sentence": "피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다. "
      }
    },
    {
      "chunk_id": "chunk_876",
      "text": "본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 875,
        "window_size": 3,
        "char_count": 68,
        "word_count": 16,
        "page_number": 43,
        "window_text": "- - 109 -\n<!-- PAGE_116 -->\n###### 17.  피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다.  피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다.  본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n 예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다.  그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n 당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n",
        "original_sentence": "본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_877",
      "text": "예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 876,
        "window_size": 3,
        "char_count": 71,
        "word_count": 17,
        "page_number": 36,
        "window_text": "피해자 보상에 대한 규약\n\n임상시험과 관련하여 발생한 손상에 대한 피험자의 치료비 및 치료 방법 등을 제공\n\n하는 원칙과 절차를 수립하여 제시한다.  피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다.  본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n 예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다.  그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n 당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n - - 110 -\n<!-- PAGE_117 -->\n###### 18. ",
        "original_sentence": "예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다. "
      }
    },
    {
      "chunk_id": "chunk_878",
      "text": "그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 877,
        "window_size": 3,
        "char_count": 87,
        "word_count": 23,
        "page_number": 45,
        "window_text": "피해자 보상에 대한 규약에는 보상원칙과 보상이\n\n임상시험용 의료기기가 직접적 원인이 되어 피험자에게 손상이 발생\n\n하여 응급 조치가 필요한 경우 시험책임자가 가입한 보험에 의해 보상\n\n한다.  본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n 예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다.  그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n 당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n - - 110 -\n<!-- PAGE_117 -->\n###### 18.  임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다. ",
        "original_sentence": "그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_879",
      "text": "당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 878,
        "window_size": 3,
        "char_count": 70,
        "word_count": 17,
        "page_number": 45,
        "window_text": "본 임상시험과 관련이 없는 부작용이 발생한 경우에도 해당 과와의\n\n긴밀한 협조를 통하여 신속한 검사와 처치를 시행한다.\n\n 예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다.  그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n 당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n - - 110 -\n<!-- PAGE_117 -->\n###### 18.  임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다.  다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n",
        "original_sentence": "당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_880",
      "text": "- - 110 -\n<!-- PAGE_117 -->\n###### 18. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 879,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 117,
        "window_text": "예상된 의료기기이상반응에 대하여 당사자들 간에 미리 합의한 보상액\n\n또는 조치가 있는 경우, 당해 기준에 따라 이를 보상한다.  그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n 당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n - - 110 -\n<!-- PAGE_117 -->\n###### 18.  임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다.  다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n - - 111 -\n<!-- PAGE_118 -->\n###### 19. ",
        "original_sentence": "- - 110 -\n<!-- PAGE_117 -->\n###### 18. "
      }
    },
    {
      "chunk_id": "chunk_881",
      "text": "임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 880,
        "window_size": 3,
        "char_count": 211,
        "word_count": 51,
        "page_number": 3,
        "window_text": "그 외의 경우\n\n에는 신체 손상의 정도, 성격, 지속 기간, 유사 사례 등을 종합적으로\n\n고려하여 당사자들 간에 합의한 보상 방법에 따라 이를 보상한다.\n\n 당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n - - 110 -\n<!-- PAGE_117 -->\n###### 18.  임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다.  다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n - - 111 -\n<!-- PAGE_118 -->\n###### 19.  피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가. ",
        "original_sentence": "임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_882",
      "text": "다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 881,
        "window_size": 3,
        "char_count": 122,
        "word_count": 27,
        "page_number": 36,
        "window_text": "당사자들 간에 전항의 합의가 이루어지지 아니한 경우에는, 법원의\n\n판결 및 이에 준하는 결정의 확정 내용에 따라 보상한다.\n\n - - 110 -\n<!-- PAGE_117 -->\n###### 18.  임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다.  다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n - - 111 -\n<!-- PAGE_118 -->\n###### 19.  피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가.  임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n",
        "original_sentence": "다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_883",
      "text": "- - 111 -\n<!-- PAGE_118 -->\n###### 19. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 882,
        "window_size": 3,
        "char_count": 39,
        "word_count": 9,
        "page_number": 118,
        "window_text": "- - 110 -\n<!-- PAGE_117 -->\n###### 18.  임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다.  다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n - - 111 -\n<!-- PAGE_118 -->\n###### 19.  피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가.  임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n - 나. ",
        "original_sentence": "- - 111 -\n<!-- PAGE_118 -->\n###### 19. "
      }
    },
    {
      "chunk_id": "chunk_884",
      "text": "피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 883,
        "window_size": 3,
        "char_count": 69,
        "word_count": 15,
        "page_number": 39,
        "window_text": "임상시험 후 피험자의 진료에 관한 사항\n\n임상시험이 종료된 후 피험자에게 발생한 부작용 및 이상반응 등에 대하여 임상\n\n시험용 의료기기와의 인과관계에 따른 피험자에 대한 보상 및 치료 방법 등을 제공\n\n본 임상시험이 종료된 후 피험자는 이후의 진료에 대하여 OO병원에서\n\n진행하던 치료 절차가 임상시험 참여 전과 다름없이 진행되며, 이후의\n\n치료비는 피험자가 지불하여야 한다.  다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n - - 111 -\n<!-- PAGE_118 -->\n###### 19.  피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가.  임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n - 나.  임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다. ",
        "original_sentence": "피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_885",
      "text": "임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 884,
        "window_size": 3,
        "char_count": 132,
        "word_count": 33,
        "page_number": 44,
        "window_text": "다만, 부작용 발생 시 임상시험에\n\n사용된 의료기기와의 인과관계 유무를 확인한 후, 본 임상시험에 사용된\n\n의료기기로 인하여 부작용이 발생한 경우 ㈜OOO에서 치료에 관한\n\n부작용이 소실될 때까지 치료비를 지불한다.\n\n - - 111 -\n<!-- PAGE_118 -->\n###### 19.  피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가.  임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n - 나.  임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다.  임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다. ",
        "original_sentence": "임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_886",
      "text": "- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 885,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "- - 111 -\n<!-- PAGE_118 -->\n###### 19.  피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가.  임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n - 나.  임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다.  임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다.  시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다. ",
        "original_sentence": "- 나. "
      }
    },
    {
      "chunk_id": "chunk_887",
      "text": "임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 886,
        "window_size": 3,
        "char_count": 51,
        "word_count": 9,
        "page_number": 27,
        "window_text": "피험자의 안전보호에 대한 대책\n\n피험자의 안전보호를 위한 임상시험 실시기관 및 임상시험심사위원회, 시험책임자 및\n\n- 가.  임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n - 나.  임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다.  임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다.  시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다.  시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n",
        "original_sentence": "임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다. "
      }
    },
    {
      "chunk_id": "chunk_888",
      "text": "임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 887,
        "window_size": 3,
        "char_count": 222,
        "word_count": 48,
        "page_number": 45,
        "window_text": "임상시험 실시기관\n임상시험 실시기관의 장은 해당 임상시험의 실시에 필요한 임상 시험실,\n\n설비와 전문 인력을 갖추어야 하고, 긴급 시 필요한 조치를 취할 수\n\n있도록 하는 등 해당 임상시험을 적절하게 실시할 수 있도록 하여야\n\n한다.\n\n - 나.  임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다.  임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다.  시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다.  시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n 3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라. ",
        "original_sentence": "임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다. "
      }
    },
    {
      "chunk_id": "chunk_889",
      "text": "시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 888,
        "window_size": 3,
        "char_count": 55,
        "word_count": 7,
        "page_number": 3,
        "window_text": "- 나.  임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다.  임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다.  시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다.  시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n 3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라.  의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n",
        "original_sentence": "시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다. "
      }
    },
    {
      "chunk_id": "chunk_890",
      "text": "시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 889,
        "window_size": 3,
        "char_count": 249,
        "word_count": 56,
        "page_number": 45,
        "window_text": "임상시험심사위원회\n1) 임상시험심사위원회는 국내 법규/관례에 따라 구성되어 있어야\n\n한다.  임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다.  시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다.  시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n 3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라.  의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n - - 113 -\n- 마. ",
        "original_sentence": "시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_891",
      "text": "3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 890,
        "window_size": 3,
        "char_count": 45,
        "word_count": 11,
        "page_number": 28,
        "window_text": "임상시험심사위원회는 피험자의 권리, 안전, 복지를 보호\n\n해야 하며, 취약한 환경에 있는 피험자가 임상시험에 참여하는\n\n2) 임상시험심사위원회는 임무를 수행함에 있어 피험자의 시험참가\n\n동의가 적절하게 얻어지지 않았거나 임상시험이 임상시험계획서에\n\n따라 진행되지 않은 경우 또는 중대한 이상반응/의료기기이상\n\n반응이 나타난 경우에는 임상시험의 일부 또는 전부에 대하여\n\n- - 112 -\n- 다.  시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다.  시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n 3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라.  의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n - - 113 -\n- 마.  모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n",
        "original_sentence": "3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라. "
      }
    },
    {
      "chunk_id": "chunk_892",
      "text": "의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 891,
        "window_size": 3,
        "char_count": 243,
        "word_count": 59,
        "page_number": 27,
        "window_text": "시험자\n1) 시험자(Investigator)란 시험책임자, 시험담당자, 임상시험조정자를\n\n말한다.  시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n 3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라.  의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n - - 113 -\n- 마.  모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n 방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바. ",
        "original_sentence": "의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_893",
      "text": "- - 113 -\n- 마. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 892,
        "window_size": 3,
        "char_count": 15,
        "word_count": 6,
        "page_number": 27,
        "window_text": "시험자는 의뢰자와 합의되고 임상시험심사위원회 및 식품\n\n의약품안전처장의 승인을 득한 임상시험 계획서를 준수하여 임상\n\n2) 임상시험 중 또는 임상시험 이후에도, 시험자는 임상적으로 의미\n\n있는 시험실적 검사치의 이상을 포함하여 임상시험에서 발생한\n\n모든 이상반응에 대해 피험자가 적절한 의학적 처치를 받을 수\n\n있도록 조치하여야 하고, 시험자가 알게 된 피험자의 병발 질환에\n\n대해 의학적 처치가 필요한 경우 이를 피험자에게 알려주어야 한다.\n\n 3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라.  의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n - - 113 -\n- 마.  모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n 방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바.  임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다. ",
        "original_sentence": "- - 113 -\n- 마. "
      }
    },
    {
      "chunk_id": "chunk_894",
      "text": "모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 893,
        "window_size": 3,
        "char_count": 191,
        "word_count": 37,
        "page_number": 27,
        "window_text": "3) 시험자는 임상시험계획을 정확히 분석 및 숙지하고, 대상 피험자의\n\n- 라.  의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n - - 113 -\n- 마.  모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n 방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바.  임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다.  만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다. ",
        "original_sentence": "모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_895",
      "text": "방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 894,
        "window_size": 3,
        "char_count": 81,
        "word_count": 20,
        "page_number": 28,
        "window_text": "의뢰자\n1) 임상 연구의 계획, 관리, 재정 등에 관련된 책임을 갖고 있는 자로\n\n통상 의료기기 임상시험의 경우 의료기기 제조업자(수입자를 포함\n\n2) 임상시험 대상, 시험 방법, 증례보고서의 서식과 내용 등이 임상\n\n3) 의뢰자의 점검 계획과 절차는 임상시험의 중요도, 피험자 수,\n\n임상시험의 종류와 복잡성, 피험자에게 미칠 수 있는 잠재적인\n\n위험의 정도 및 이미 확인된 임상시험 실시상의 문제점 등에\n\n따라 결정되어야 한다.\n\n - - 113 -\n- 마.  모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n 방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바.  임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다.  만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다.  그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사. ",
        "original_sentence": "방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바. "
      }
    },
    {
      "chunk_id": "chunk_896",
      "text": "임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 895,
        "window_size": 3,
        "char_count": 316,
        "word_count": 65,
        "page_number": 27,
        "window_text": "- - 113 -\n- 마.  모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n 방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바.  임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다.  만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다.  그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사.  피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n",
        "original_sentence": "임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다. "
      }
    },
    {
      "chunk_id": "chunk_897",
      "text": "만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 896,
        "window_size": 3,
        "char_count": 156,
        "word_count": 32,
        "page_number": 39,
        "window_text": "모니터링\n1) 모니터링(Monitoring)이란 임상시험 진행 과정을 감독하고, 해당\n\n임상시험이 임상시험계획서, 표준작업지침서, 임상시험 실시 기준\n\n및 관련 규정에 따라 실시, 기록되는지 여부를 검토, 확인하는\n\n2) 임상시험에 대한 모니터링은 임상시험모니터요원의 정기적인\n\n임상시험 실시기관 방문과 전화 등을 통해서 이루어질 것이다.\n\n 방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바.  임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다.  만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다.  그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사.  피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n - - 115 -\n- 아. ",
        "original_sentence": "만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다. "
      }
    },
    {
      "chunk_id": "chunk_898",
      "text": "그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 897,
        "window_size": 3,
        "char_count": 57,
        "word_count": 13,
        "page_number": 35,
        "window_text": "방문 시 모니터는 환자기록 원본, 임상시험용 의료기기 관리 기록,\n\n3) 또한 임상시험모니터 요원은 임상시험 진행 과정을 잘 살피고,\n\n- 바.  임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다.  만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다.  그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사.  피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n - - 115 -\n- 아.  피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다. ",
        "original_sentence": "그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사. "
      }
    },
    {
      "chunk_id": "chunk_899",
      "text": "피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 898,
        "window_size": 3,
        "char_count": 389,
        "word_count": 94,
        "page_number": 27,
        "window_text": "임상시험계획서의 변경\n1) 임상시험계획서를 임상시험심사위원회 및 식품의약품안전처장\n\n으로부터 승인받은 후, 시험절차가 광범위해지거나 위험도가 높아\n\n지거나 피험자 선정 기준에 변화가 있거나 추가적인 안전성 정보로\n\n인해 임상시험계획서를 변경하는 경우에는 임상시험심사위원회 및\n\n2) 임상시험계획서를 수정할 때에는 개정 일자, 개정 이유, 개정\n\n3) 시험자는 피험자에게 발생한 즉각적 위험 요소의 제거가 필요한\n\n경우를 제외하고는, 임상시험심사위원회 및 식품의약품안전처장의\n\n변경 승인 이전에는 계획서와 다르게 임상시험을 실시하여서는\n\n- - 114 -\n안 된다.  만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다.  그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사.  피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n - - 115 -\n- 아.  피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다.  시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자. ",
        "original_sentence": "피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_900",
      "text": "- - 115 -\n- 아. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 899,
        "window_size": 3,
        "char_count": 15,
        "word_count": 6,
        "page_number": 27,
        "window_text": "만일 피험자에게 발생한 즉각적 위험 요소를 제거하기\n\n위해 임상시험심사위원회의 승인을 얻기 전에 이러한 임상시험\n\n계획서의 변경을 적용하게 되는 경우, 가능한 한 빨리 변경에\n\n대하여 임상시험심사위원회(사후검토 승인을 위함), 의뢰자, 식품\n\n의약품안전처장에게 제출하여야 한다.  그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사.  피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n - - 115 -\n- 아.  피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다.  시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자.  기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다. ",
        "original_sentence": "- - 115 -\n- 아. "
      }
    },
    {
      "chunk_id": "chunk_901",
      "text": "피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 900,
        "window_size": 3,
        "char_count": 178,
        "word_count": 45,
        "page_number": 27,
        "window_text": "그리고 임상시험심사위원회\n\n4) 임상시험에 영향을 주지 않는 사소한 수정이나 명시는 승인이\n\n- 사.  피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n - - 115 -\n- 아.  피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다.  시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자.  기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다.  제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다. ",
        "original_sentence": "피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다. "
      }
    },
    {
      "chunk_id": "chunk_902",
      "text": "시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 901,
        "window_size": 3,
        "char_count": 203,
        "word_count": 47,
        "page_number": 36,
        "window_text": "피험자 동의\n1) 피험자 동의(Informed consent)라 함은 피험자가 임상시험 참여\n\n유무를 결정하기 전에 피험자를 위한 설명서를 통해 해당 임상\n\n시험과 관련된 모든 정보를 제공받고, 서명과 서명 날짜가 포함된\n\n문서를 통해 본인이 자발적으로 임상시험에 참여함을 확인하는\n\n2) 피험자 본인 또는 대리인이 동의서 서식, 피험자 설명서 및 기타\n\n문서화된 정보를 읽을 수 없는 경우에는 공정한 입회자가 동의를\n\n3) 동의를 얻기 전에 시험자는 피험자 또는 대리인이 임상시험의\n\n세부 사항에 대해 질문하고 해당 임상시험의 참여 여부를 결정할\n\n수 있도록 충분한 시간과 기회를 주어야 하며, 모든 임상시험\n\n관련 질문에 대해 피험자 또는 대리인이 만족할 수 있도록 대답\n\n해주어야 한다.\n\n - - 115 -\n- 아.  피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다.  시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자.  기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다.  제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다.  다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n",
        "original_sentence": "시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자. "
      }
    },
    {
      "chunk_id": "chunk_903",
      "text": "기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 902,
        "window_size": 3,
        "char_count": 65,
        "word_count": 17,
        "page_number": 27,
        "window_text": "- - 115 -\n- 아.  피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다.  시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자.  기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다.  제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다.  다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n - - 116 -\n- 20. ",
        "original_sentence": "기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_904",
      "text": "제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 903,
        "window_size": 3,
        "char_count": 105,
        "word_count": 24,
        "page_number": 28,
        "window_text": "피험자 기록의 비밀 보장\n1) 피험자의 신원을 파악할 수 있는 기록은 비밀로 보장될 것이며,\n\n임상시험의 결과가 출관될 경우에도 피험자의 신원을 비밀 상태로\n\n2) 본 임상시험에 관련된 의뢰자, 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 피험자의\n\n기록을 열람할 수 있다.  시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자.  기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다.  제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다.  다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n - - 116 -\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가. ",
        "original_sentence": "제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다. "
      }
    },
    {
      "chunk_id": "chunk_905",
      "text": "다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 904,
        "window_size": 3,
        "char_count": 64,
        "word_count": 13,
        "page_number": 45,
        "window_text": "시험자는 본 임상시험 계획서에 서명함\n\n으로써, 국내의 법규와 윤리적 측면에서 임상시험 의뢰자 또는\n\n모니터 및 점검자가 피험자의 차트와 증례기록서 기록을 검증\n\n하기 위하여 해당 문서를 검토하거나 복사할 수도 있음을 인정\n\n3) 증례기록서 등 임상시험에 관련된 모든 서류에는 피험자 이름이\n\n아닌 피험자 식별코드(일반적으로 피험자 이니셜)로 기록하고\n\n- 자.  기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다.  제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다.  다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n - - 116 -\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가.  자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나. ",
        "original_sentence": "다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_906",
      "text": "- - 116 -\n- 20. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 905,
        "window_size": 3,
        "char_count": 16,
        "word_count": 6,
        "page_number": 9,
        "window_text": "기록의 보존\n1) 임상시험 실시와 관련된 각종 자료 및 기록을 잘 보존하도록\n\n하여야 하며 보안을 유지하도록 한다.  제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다.  다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n - - 116 -\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가.  자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나.  법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다. ",
        "original_sentence": "- - 116 -\n- 20. "
      }
    },
    {
      "chunk_id": "chunk_907",
      "text": "그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 906,
        "window_size": 3,
        "char_count": 192,
        "word_count": 42,
        "page_number": 3,
        "window_text": "제조허가/수입허가 또는\n\n그 변경 허가를 위한 임상시험 관련 자료는 허가일로부터 3년간\n\n보존하도록 하고, 그 밖의 임상시험 관련 자료는 임상시험이 끝난\n\n날부터 3년간 보존하도록 한다.  다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n - - 116 -\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가.  자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나.  법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다.  임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다. ",
        "original_sentence": "그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가. "
      }
    },
    {
      "chunk_id": "chunk_908",
      "text": "자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 907,
        "window_size": 3,
        "char_count": 187,
        "word_count": 45,
        "page_number": 40,
        "window_text": "다만, 식품의약품안전처장이 지시\n\n하거나 시험책임자가 필요하다고 판단한 경우에는 보관 기간을\n\n연장할 수 있다.\n\n - - 116 -\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가.  자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나.  법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다.  임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다.  임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n",
        "original_sentence": "자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나. "
      }
    },
    {
      "chunk_id": "chunk_909",
      "text": "법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 908,
        "window_size": 3,
        "char_count": 138,
        "word_count": 35,
        "page_number": 36,
        "window_text": "- - 116 -\n- 20.  그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가.  자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나.  법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다.  임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다.  임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n - 다. ",
        "original_sentence": "법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다. "
      }
    },
    {
      "chunk_id": "chunk_910",
      "text": "임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 909,
        "window_size": 3,
        "char_count": 129,
        "word_count": 31,
        "page_number": 3,
        "window_text": "그 밖에 임상시험을 안전하고 과학적으로 하기 위하여 필요한 사항\n임상시험을 안전하고 과학적으로 실시하기 위하여 그 밖에 필요한 서류로 증례기록서\n\n(Case Report Form, CRF), 의뢰자와 임상시험기관 장과의 계약서, 시험책임자의 이력\n\n사항 및 임상시험용 의료기기의 사용 및 관리, 임상시험에 사용되는 의료기기의 공급과\n\n- 가.  자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나.  법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다.  임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다.  임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n - 다.  임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n",
        "original_sentence": "임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다. "
      }
    },
    {
      "chunk_id": "chunk_911",
      "text": "임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 910,
        "window_size": 3,
        "char_count": 40,
        "word_count": 8,
        "page_number": 36,
        "window_text": "자료 처리\n본 임상시험에 관련된 모니터 및 점검자는 본 임상시험의\n\n모니터링과 점검 및 진행 사항 관리를 위한 목적으로 대상자의\n\n임상시험용 의료기기와 연관된 유의한 위험, 금기, 부작용,\n\n주의사항을 시사하는 사건 등을 포함하며, 발생 시간, 정도, 처치,\n\n경과, 임상시험용 의료기기와의 인과관계 등에 대한 정보를 증례\n\n- 나.  법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다.  임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다.  임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n - 다.  임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n - 라. ",
        "original_sentence": "임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_912",
      "text": "- 다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 911,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "법규 준수\n시험자는 서명록에 서명함으로써, 본 임상시험계획서, 의료기기 임상\n\n시험 관리 기준, 국내의 모든 관련 법규와 임상시험 수행에 관련된\n\n규칙 및 규정에 따라서 효과적이고 성실하게 연구를 수행할 것에 동의\n\n- - 117 -\n하게 된다.  임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다.  임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n - 다.  임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n - 라.  점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n",
        "original_sentence": "- 다. "
      }
    },
    {
      "chunk_id": "chunk_913",
      "text": "임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 912,
        "window_size": 3,
        "char_count": 97,
        "word_count": 25,
        "page_number": 45,
        "window_text": "임상시험 담당자 및 참여 연구진은 임상시험계획을 정확히\n\n분석, 숙지하도록 하며 시험책임자는 예기치 않은 이상반응 등의 출현에\n\n대한 충분한 대처와 필요에 따른 보고, 시험참여 연구진에 대한 충분한\n\n교육 등 사전 조치를 취한다.  임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n - 다.  임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n - 라.  점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n - 마. ",
        "original_sentence": "임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_914",
      "text": "- 라. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 913,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "임상시험의 진행은 의료기기 임상시험 관리\n\n기준에 합당하게 진행한다.\n\n - 다.  임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n - 라.  점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n - 마.  임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다. ",
        "original_sentence": "- 라. "
      }
    },
    {
      "chunk_id": "chunk_915",
      "text": "점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 914,
        "window_size": 3,
        "char_count": 108,
        "word_count": 27,
        "page_number": 20,
        "window_text": "- 다.  임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n - 라.  점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n - 마.  임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다.  임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다. ",
        "original_sentence": "점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_916",
      "text": "- 마. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 915,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 49,
        "window_text": "임상시험 자료의 보관 및 열람\n임상시험 자료는 기밀로 보관되고 열람은 본 임상시험의 모니터링과\n\n점검 및 진행 사항 관리를 위한 목적으로 대상자의 기록을 열람할 수 있다.\n\n - 라.  점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n - 마.  임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다.  임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다.  임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n",
        "original_sentence": "- 마. "
      }
    },
    {
      "chunk_id": "chunk_917",
      "text": "임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 916,
        "window_size": 3,
        "char_count": 62,
        "word_count": 13,
        "page_number": 36,
        "window_text": "- 라.  점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n - 마.  임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다.  임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다.  임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n - - 118 -\n- 바. ",
        "original_sentence": "임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다. "
      }
    },
    {
      "chunk_id": "chunk_918",
      "text": "임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 917,
        "window_size": 3,
        "char_count": 63,
        "word_count": 13,
        "page_number": 3,
        "window_text": "점검 및 실태 조사\n임상시험의 중요도, 대상자 수, 임상시험의 종류와 복잡성, 대상자에게\n\n미칠 수 있는 잠재적인 위험의 정도 및 이미 확인된 임상시험 실시상의\n\n문제점 등에 따라 결정된다.\n\n - 마.  임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다.  임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다.  임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n - - 118 -\n- 바.  임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1. ",
        "original_sentence": "임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다. "
      }
    },
    {
      "chunk_id": "chunk_919",
      "text": "임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 918,
        "window_size": 3,
        "char_count": 82,
        "word_count": 18,
        "page_number": 36,
        "window_text": "- 마.  임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다.  임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다.  임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n - - 118 -\n- 바.  임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1.  의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2. ",
        "original_sentence": "임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n"
      }
    },
    {
      "chunk_id": "chunk_920",
      "text": "- - 118 -\n- 바. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 919,
        "window_size": 3,
        "char_count": 15,
        "word_count": 6,
        "page_number": 27,
        "window_text": "임상시험용 의료기기의 사용 및 관리\n임상시험용 의료기기는 해당 임상시험실시기관의 장이 지정한 자가\n\n관리한다.  임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다.  임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n - - 118 -\n- 바.  임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1.  의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2.  한국판 불면증 임상진료지침. ",
        "original_sentence": "- - 118 -\n- 바. "
      }
    },
    {
      "chunk_id": "chunk_921",
      "text": "임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 920,
        "window_size": 3,
        "char_count": 449,
        "word_count": 97,
        "page_number": 126,
        "window_text": "임상시험용 의료기기는 기재 사항에 기술되어 있는 대로\n\n취급, 저장하며 “임상시험용”이라는 문구가 있어야 한다.  임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n - - 118 -\n- 바.  임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1.  의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2.  한국판 불면증 임상진료지침.  대한신경정신의학회, 2019.\n",
        "original_sentence": "임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1. "
      }
    },
    {
      "chunk_id": "chunk_922",
      "text": "의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 921,
        "window_size": 3,
        "char_count": 59,
        "word_count": 11,
        "page_number": 9,
        "window_text": "임상시험용\n\n의료기기 관리자는 임상시험에 사용되는 의료기기에 대해 인수, 재고\n\n관리, 반납 등의 업무를 수행하고 관련 기록을 유지하여야 한다.\n\n - - 118 -\n- 바.  임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1.  의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2.  한국판 불면증 임상진료지침.  대한신경정신의학회, 2019.\n - 3. ",
        "original_sentence": "의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2. "
      }
    },
    {
      "chunk_id": "chunk_923",
      "text": "한국판 불면증 임상진료지침. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 922,
        "window_size": 3,
        "char_count": 16,
        "word_count": 3,
        "page_number": 21,
        "window_text": "- - 118 -\n- 바.  임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1.  의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2.  한국판 불면증 임상진료지침.  대한신경정신의학회, 2019.\n - 3.  IEC62304 (Medical device software-software life cycle processes)\n- 4. ",
        "original_sentence": "한국판 불면증 임상진료지침. "
      }
    },
    {
      "chunk_id": "chunk_924",
      "text": "대한신경정신의학회, 2019.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 923,
        "window_size": 3,
        "char_count": 17,
        "word_count": 2,
        "page_number": 9,
        "window_text": "임상시험용 의료기기의 공급과 취급\n1) 의뢰자는 임상시험계획서에 대한 심사위원회와 처장의 승인을\n\n얻기 이전에는 임상시험용 의료기기를 관리자 등에게 공급해서는\n\n2) 의뢰자는 관리자 등이 임상시험용 의료기기를 취급하고 보관하는\n\n방법에 대해 문서화된 절차를 가지고 있어야 하며, 이 절차에는\n\n적절하고 안전한 수, 취급, 보관, 미사용 임상시험용 의료기기의\n\n피험자로부터의 반납 및 의뢰자에 대한 반납 등에 대한 방법이\n\n3) 임상시험용 의료기기를 적시에 공급하여야 하며, 임상시험기관\n\n으로의 공급, 임상시험기관의 인수, 임상시험기관으로부터의 반납\n\n4) 의뢰자는 임상시험용 의료기기에 고장 등 문제가 발생하거나\n\n임상시험의 종료 또는 사용기간의 만료 등에 의한 임상시험용\n\n- - 119 -\n<!-- PAGE_126 -->\n#### Ⅳ\n\n<!-- PAGE_126 -->\n#### 참고문헌\n\n- 1.  의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2.  한국판 불면증 임상진료지침.  대한신경정신의학회, 2019.\n - 3.  IEC62304 (Medical device software-software life cycle processes)\n- 4.  ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5. ",
        "original_sentence": "대한신경정신의학회, 2019.\n"
      }
    },
    {
      "chunk_id": "chunk_925",
      "text": "- 3. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 924,
        "window_size": 3,
        "char_count": 5,
        "word_count": 2,
        "page_number": 28,
        "window_text": "의료기기 제조 및 품질관리 기준, 식품의약품안전처고시 제2021-28호, 2021.04 일부개정\n- 2.  한국판 불면증 임상진료지침.  대한신경정신의학회, 2019.\n - 3.  IEC62304 (Medical device software-software life cycle processes)\n- 4.  ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5.  Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J. ",
        "original_sentence": "- 3. "
      }
    },
    {
      "chunk_id": "chunk_926",
      "text": "IEC62304 (Medical device software-software life cycle processes)\n- 4. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 925,
        "window_size": 3,
        "char_count": 70,
        "word_count": 9,
        "page_number": 9,
        "window_text": "한국판 불면증 임상진료지침.  대한신경정신의학회, 2019.\n - 3.  IEC62304 (Medical device software-software life cycle processes)\n- 4.  ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5.  Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J.  (2016). ",
        "original_sentence": "IEC62304 (Medical device software-software life cycle processes)\n- 4. "
      }
    },
    {
      "chunk_id": "chunk_927",
      "text": "ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 926,
        "window_size": 3,
        "char_count": 84,
        "word_count": 13,
        "page_number": 27,
        "window_text": "대한신경정신의학회, 2019.\n - 3.  IEC62304 (Medical device software-software life cycle processes)\n- 4.  ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5.  Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J.  (2016).  Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial. ",
        "original_sentence": "ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5. "
      }
    },
    {
      "chunk_id": "chunk_928",
      "text": "Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 927,
        "window_size": 3,
        "char_count": 129,
        "word_count": 22,
        "page_number": 126,
        "window_text": "- 3.  IEC62304 (Medical device software-software life cycle processes)\n- 4.  ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5.  Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J.  (2016).  Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial.  The Lancet Psychiatry,\n\n- 6. ",
        "original_sentence": "Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J. "
      }
    },
    {
      "chunk_id": "chunk_929",
      "text": "(2016). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 928,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "IEC62304 (Medical device software-software life cycle processes)\n- 4.  ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5.  Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J.  (2016).  Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial.  The Lancet Psychiatry,\n\n- 6.  Ström, L., Pettersson, R., & Andersson, G. ",
        "original_sentence": "(2016). "
      }
    },
    {
      "chunk_id": "chunk_930",
      "text": "Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 929,
        "window_size": 3,
        "char_count": 145,
        "word_count": 19,
        "page_number": 64,
        "window_text": "ISO14971 (Medical devices — Application of risk management to medical devices)\n- 5.  Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J.  (2016).  Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial.  The Lancet Psychiatry,\n\n- 6.  Ström, L., Pettersson, R., & Andersson, G.  (2004). ",
        "original_sentence": "Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial. "
      }
    },
    {
      "chunk_id": "chunk_931",
      "text": "The Lancet Psychiatry,\n\n- 6. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 930,
        "window_size": 3,
        "char_count": 29,
        "word_count": 5,
        "page_number": 36,
        "window_text": "Christensen, H., Batterham, P. J., Gosling, J. A., Ritterband, L. M., Griffiths, K. M., Thorndike, F. P.,\n... & Mackinnon, A. J.  (2016).  Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial.  The Lancet Psychiatry,\n\n- 6.  Ström, L., Pettersson, R., & Andersson, G.  (2004).  Internet-based treatment for insomnia: a\n- 7. ",
        "original_sentence": "The Lancet Psychiatry,\n\n- 6. "
      }
    },
    {
      "chunk_id": "chunk_932",
      "text": "Ström, L., Pettersson, R., & Andersson, G. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 931,
        "window_size": 3,
        "char_count": 43,
        "word_count": 7,
        "page_number": 126,
        "window_text": "(2016).  Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial.  The Lancet Psychiatry,\n\n- 6.  Ström, L., Pettersson, R., & Andersson, G.  (2004).  Internet-based treatment for insomnia: a\n- 7.  Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n",
        "original_sentence": "Ström, L., Pettersson, R., & Andersson, G. "
      }
    },
    {
      "chunk_id": "chunk_933",
      "text": "(2004). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 932,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Effectiveness of an online insomnia program (SHUTi) for prevention\n\nof depressive episodes (the GoodNight Study): a randomised controlled trial.  The Lancet Psychiatry,\n\n- 6.  Ström, L., Pettersson, R., & Andersson, G.  (2004).  Internet-based treatment for insomnia: a\n- 7.  Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n - (2017). ",
        "original_sentence": "(2004). "
      }
    },
    {
      "chunk_id": "chunk_934",
      "text": "Internet-based treatment for insomnia: a\n- 7. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 933,
        "window_size": 3,
        "char_count": 46,
        "word_count": 7,
        "page_number": 36,
        "window_text": "The Lancet Psychiatry,\n\n- 6.  Ström, L., Pettersson, R., & Andersson, G.  (2004).  Internet-based treatment for insomnia: a\n- 7.  Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n - (2017).  The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8. ",
        "original_sentence": "Internet-based treatment for insomnia: a\n- 7. "
      }
    },
    {
      "chunk_id": "chunk_935",
      "text": "Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 934,
        "window_size": 3,
        "char_count": 103,
        "word_count": 20,
        "page_number": 126,
        "window_text": "Ström, L., Pettersson, R., & Andersson, G.  (2004).  Internet-based treatment for insomnia: a\n- 7.  Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n - (2017).  The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8.  Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n",
        "original_sentence": "Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n"
      }
    },
    {
      "chunk_id": "chunk_936",
      "text": "- (2017). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 935,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 9,
        "window_text": "(2004).  Internet-based treatment for insomnia: a\n- 7.  Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n - (2017).  The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8.  Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n - (2019). ",
        "original_sentence": "- (2017). "
      }
    },
    {
      "chunk_id": "chunk_937",
      "text": "The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 936,
        "window_size": 3,
        "char_count": 97,
        "word_count": 16,
        "page_number": 64,
        "window_text": "Internet-based treatment for insomnia: a\n- 7.  Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n - (2017).  The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8.  Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n - (2019).  Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial. ",
        "original_sentence": "The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8. "
      }
    },
    {
      "chunk_id": "chunk_938",
      "text": "Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 937,
        "window_size": 3,
        "char_count": 103,
        "word_count": 21,
        "page_number": 126,
        "window_text": "Freeman, D., Sheaves, B., Goodwin, G. M., Yu, L. M., Nickless, A., Harrison, P. J., ... & Espie, C. A.\n - (2017).  The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8.  Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n - (2019).  Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial.  JAMA Psychiatry, 76(1),\n\n- 9. ",
        "original_sentence": "Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n"
      }
    },
    {
      "chunk_id": "chunk_939",
      "text": "- (2019). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 938,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 9,
        "window_text": "- (2017).  The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8.  Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n - (2019).  Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial.  JAMA Psychiatry, 76(1),\n\n- 9.  Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M. ",
        "original_sentence": "- (2019). "
      }
    },
    {
      "chunk_id": "chunk_940",
      "text": "Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 939,
        "window_size": 3,
        "char_count": 161,
        "word_count": 21,
        "page_number": 9,
        "window_text": "The effects of improving sleep on mental health (OASIS): a randomised controlled trial with\n- 8.  Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n - (2019).  Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial.  JAMA Psychiatry, 76(1),\n\n- 9.  Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M.  (2017). ",
        "original_sentence": "Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial. "
      }
    },
    {
      "chunk_id": "chunk_941",
      "text": "JAMA Psychiatry, 76(1),\n\n- 9. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 940,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 27,
        "window_text": "Espie, C. A., Emsley, R., Kyle, S. D., Gordon, C., Drake, C. L., Siriwardena, A. N., ... & Luik, A. I.\n - (2019).  Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial.  JAMA Psychiatry, 76(1),\n\n- 9.  Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M.  (2017).  Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10. ",
        "original_sentence": "JAMA Psychiatry, 76(1),\n\n- 9. "
      }
    },
    {
      "chunk_id": "chunk_942",
      "text": "Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 941,
        "window_size": 3,
        "char_count": 124,
        "word_count": 21,
        "page_number": 73,
        "window_text": "- (2019).  Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial.  JAMA Psychiatry, 76(1),\n\n- 9.  Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M.  (2017).  Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10.  Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n",
        "original_sentence": "Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M. "
      }
    },
    {
      "chunk_id": "chunk_943",
      "text": "(2017). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 942,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Effect of digital cognitive behavioral therapy for insomnia on health, psychological\nwell-being, and sleep-related quality of life: a randomized clinical trial.  JAMA Psychiatry, 76(1),\n\n- 9.  Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M.  (2017).  Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10.  Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n - (2020). ",
        "original_sentence": "(2017). "
      }
    },
    {
      "chunk_id": "chunk_944",
      "text": "Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 943,
        "window_size": 3,
        "char_count": 69,
        "word_count": 11,
        "page_number": 9,
        "window_text": "JAMA Psychiatry, 76(1),\n\n- 9.  Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M.  (2017).  Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10.  Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n - (2020).  Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study. ",
        "original_sentence": "Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10. "
      }
    },
    {
      "chunk_id": "chunk_945",
      "text": "Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 944,
        "window_size": 3,
        "char_count": 103,
        "word_count": 18,
        "page_number": 126,
        "window_text": "Ritterband, L. M., Thorndike, F. P., Ingersoll, K. S., Lord, H. R., Gonder-Frederick, L., Frederick, C.,\n... & Morin, C. M.  (2017).  Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10.  Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n - (2020).  Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study.  The Lancet Digital Health,\n\n- 11. ",
        "original_sentence": "Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n"
      }
    },
    {
      "chunk_id": "chunk_946",
      "text": "- (2020). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 945,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 9,
        "window_text": "(2017).  Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10.  Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n - (2020).  Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study.  The Lancet Digital Health,\n\n- 11.  Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H. ",
        "original_sentence": "- (2020). "
      }
    },
    {
      "chunk_id": "chunk_947",
      "text": "Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 946,
        "window_size": 3,
        "char_count": 157,
        "word_count": 22,
        "page_number": 126,
        "window_text": "Effect of a web-based cognitive behavior therapy for insomnia\n\n- 10.  Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n - (2020).  Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study.  The Lancet Digital Health,\n\n- 11.  Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H.  (2016). ",
        "original_sentence": "Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study. "
      }
    },
    {
      "chunk_id": "chunk_948",
      "text": "The Lancet Digital Health,\n\n- 11. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 947,
        "window_size": 3,
        "char_count": 34,
        "word_count": 6,
        "page_number": 27,
        "window_text": "Raket, L. L., Jaskolowski, J., Kinon, B. J., Brasen, J. C., Jönsson, L., Wehnert, A., & Fusar-Poli, P.\n - (2020).  Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study.  The Lancet Digital Health,\n\n- 11.  Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H.  (2016).  Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12. ",
        "original_sentence": "The Lancet Digital Health,\n\n- 11. "
      }
    },
    {
      "chunk_id": "chunk_949",
      "text": "Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 948,
        "window_size": 3,
        "char_count": 70,
        "word_count": 13,
        "page_number": 73,
        "window_text": "- (2020).  Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study.  The Lancet Digital Health,\n\n- 11.  Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H.  (2016).  Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12.  Lee, E. ",
        "original_sentence": "Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H. "
      }
    },
    {
      "chunk_id": "chunk_950",
      "text": "(2016). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 949,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Dynamic ElecTronic hEalth reCord deTection (DETECT) of individuals at risk of a first\nepisode of psychosis: a case-control development and validation study.  The Lancet Digital Health,\n\n- 11.  Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H.  (2016).  Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12.  Lee, E.  (2020). ",
        "original_sentence": "(2016). "
      }
    },
    {
      "chunk_id": "chunk_951",
      "text": "Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 950,
        "window_size": 3,
        "char_count": 116,
        "word_count": 15,
        "page_number": 9,
        "window_text": "The Lancet Digital Health,\n\n- 11.  Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H.  (2016).  Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12.  Lee, E.  (2020).  Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia. ",
        "original_sentence": "Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12. "
      }
    },
    {
      "chunk_id": "chunk_952",
      "text": "Lee, E. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 951,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 126,
        "window_text": "Lancee, J., van Straten, A., Morina, N., Kaldo, V., & Kamphuis, J. H.  (2016).  Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12.  Lee, E.  (2020).  Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia.  Chronobiol\n- 13. ",
        "original_sentence": "Lee, E. "
      }
    },
    {
      "chunk_id": "chunk_953",
      "text": "(2020). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 952,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "(2016).  Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12.  Lee, E.  (2020).  Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia.  Chronobiol\n- 13.  Kim, M., & Choi, H. J. ",
        "original_sentence": "(2020). "
      }
    },
    {
      "chunk_id": "chunk_954",
      "text": "Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 953,
        "window_size": 3,
        "char_count": 70,
        "word_count": 9,
        "page_number": 9,
        "window_text": "Guided Online or\nFace-to-Face Cognitive Behavioral Treatment for Insomnia: A Randomized Wait-List Controlled\n\n- 12.  Lee, E.  (2020).  Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia.  Chronobiol\n- 13.  Kim, M., & Choi, H. J.  (2021). ",
        "original_sentence": "Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia. "
      }
    },
    {
      "chunk_id": "chunk_955",
      "text": "Chronobiol\n- 13. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 954,
        "window_size": 3,
        "char_count": 17,
        "word_count": 3,
        "page_number": 27,
        "window_text": "Lee, E.  (2020).  Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia.  Chronobiol\n- 13.  Kim, M., & Choi, H. J.  (2021).  Digital Therapeutics for Obesity and Eating-Related Problems.\n",
        "original_sentence": "Chronobiol\n- 13. "
      }
    },
    {
      "chunk_id": "chunk_956",
      "text": "Kim, M., & Choi, H. J. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 955,
        "window_size": 3,
        "char_count": 23,
        "word_count": 6,
        "page_number": 126,
        "window_text": "(2020).  Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia.  Chronobiol\n- 13.  Kim, M., & Choi, H. J.  (2021).  Digital Therapeutics for Obesity and Eating-Related Problems.\n - 14. ",
        "original_sentence": "Kim, M., & Choi, H. J. "
      }
    },
    {
      "chunk_id": "chunk_957",
      "text": "(2021). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 956,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Cognitive Behavioral Treatment as a Digital Therapeutic for Insomnia.  Chronobiol\n- 13.  Kim, M., & Choi, H. J.  (2021).  Digital Therapeutics for Obesity and Eating-Related Problems.\n - 14.  Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A. ",
        "original_sentence": "(2021). "
      }
    },
    {
      "chunk_id": "chunk_958",
      "text": "Digital Therapeutics for Obesity and Eating-Related Problems.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 957,
        "window_size": 3,
        "char_count": 62,
        "word_count": 7,
        "page_number": 49,
        "window_text": "Chronobiol\n- 13.  Kim, M., & Choi, H. J.  (2021).  Digital Therapeutics for Obesity and Eating-Related Problems.\n - 14.  Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A.  (2020). ",
        "original_sentence": "Digital Therapeutics for Obesity and Eating-Related Problems.\n"
      }
    },
    {
      "chunk_id": "chunk_959",
      "text": "- 14. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 958,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 27,
        "window_text": "Kim, M., & Choi, H. J.  (2021).  Digital Therapeutics for Obesity and Eating-Related Problems.\n - 14.  Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A.  (2020).  Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15. ",
        "original_sentence": "- 14. "
      }
    },
    {
      "chunk_id": "chunk_960",
      "text": "Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 959,
        "window_size": 3,
        "char_count": 74,
        "word_count": 15,
        "page_number": 73,
        "window_text": "(2021).  Digital Therapeutics for Obesity and Eating-Related Problems.\n - 14.  Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A.  (2020).  Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15.  Ahn, D. H. ",
        "original_sentence": "Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A. "
      }
    },
    {
      "chunk_id": "chunk_961",
      "text": "(2020). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 960,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Digital Therapeutics for Obesity and Eating-Related Problems.\n - 14.  Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A.  (2020).  Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15.  Ahn, D. H.  (2013). ",
        "original_sentence": "(2020). "
      }
    },
    {
      "chunk_id": "chunk_962",
      "text": "Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 961,
        "window_size": 3,
        "char_count": 119,
        "word_count": 18,
        "page_number": 9,
        "window_text": "- 14.  Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A.  (2020).  Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15.  Ahn, D. H.  (2013).  불면증: 원인과 진단. ",
        "original_sentence": "Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15. "
      }
    },
    {
      "chunk_id": "chunk_963",
      "text": "Ahn, D. H. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 962,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 126,
        "window_text": "Felder, J. N., Epel, E. S., Neuhaus, J., Krystal, A. D., & Prather, A. A.  (2020).  Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15.  Ahn, D. H.  (2013).  불면증: 원인과 진단.  Hanyang Med Rev, 33, 203-209.\n",
        "original_sentence": "Ahn, D. H. "
      }
    },
    {
      "chunk_id": "chunk_964",
      "text": "(2013). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 963,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "(2020).  Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15.  Ahn, D. H.  (2013).  불면증: 원인과 진단.  Hanyang Med Rev, 33, 203-209.\n - 16. ",
        "original_sentence": "(2013). "
      }
    },
    {
      "chunk_id": "chunk_965",
      "text": "불면증: 원인과 진단. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 964,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 126,
        "window_text": "Efficacy of digital\ncognitive behavioral therapy for the treatment of insomnia symptoms among pregnant women: a\n\n- 15.  Ahn, D. H.  (2013).  불면증: 원인과 진단.  Hanyang Med Rev, 33, 203-209.\n - 16.  이은환, 이상훈, 임영현, & 김욱. ",
        "original_sentence": "불면증: 원인과 진단. "
      }
    },
    {
      "chunk_id": "chunk_966",
      "text": "Hanyang Med Rev, 33, 203-209.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 965,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 9,
        "window_text": "Ahn, D. H.  (2013).  불면증: 원인과 진단.  Hanyang Med Rev, 33, 203-209.\n - 16.  이은환, 이상훈, 임영현, & 김욱.  (2018). ",
        "original_sentence": "Hanyang Med Rev, 33, 203-209.\n"
      }
    },
    {
      "chunk_id": "chunk_967",
      "text": "- 16. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 966,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 27,
        "window_text": "(2013).  불면증: 원인과 진단.  Hanyang Med Rev, 33, 203-209.\n - 16.  이은환, 이상훈, 임영현, & 김욱.  (2018).  경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17. ",
        "original_sentence": "- 16. "
      }
    },
    {
      "chunk_id": "chunk_968",
      "text": "이은환, 이상훈, 임영현, & 김욱. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 967,
        "window_size": 3,
        "char_count": 21,
        "word_count": 5,
        "page_number": 45,
        "window_text": "불면증: 원인과 진단.  Hanyang Med Rev, 33, 203-209.\n - 16.  이은환, 이상훈, 임영현, & 김욱.  (2018).  경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17.  우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠. ",
        "original_sentence": "이은환, 이상훈, 임영현, & 김욱. "
      }
    },
    {
      "chunk_id": "chunk_969",
      "text": "(2018). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 968,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Hanyang Med Rev, 33, 203-209.\n - 16.  이은환, 이상훈, 임영현, & 김욱.  (2018).  경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17.  우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠.  (2011). ",
        "original_sentence": "(2018). "
      }
    },
    {
      "chunk_id": "chunk_970",
      "text": "경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 969,
        "window_size": 3,
        "char_count": 46,
        "word_count": 10,
        "page_number": 18,
        "window_text": "- 16.  이은환, 이상훈, 임영현, & 김욱.  (2018).  경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17.  우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠.  (2011).  근로자의 수면문제에 따른 생산\n성 시간 손실. ",
        "original_sentence": "경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17. "
      }
    },
    {
      "chunk_id": "chunk_971",
      "text": "우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 970,
        "window_size": 3,
        "char_count": 40,
        "word_count": 9,
        "page_number": 45,
        "window_text": "이은환, 이상훈, 임영현, & 김욱.  (2018).  경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17.  우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠.  (2011).  근로자의 수면문제에 따른 생산\n성 시간 손실.  신경정신의학, 50(1), 62-68.\n\n",
        "original_sentence": "우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠. "
      }
    },
    {
      "chunk_id": "chunk_972",
      "text": "(2011). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 971,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "(2018).  경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17.  우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠.  (2011).  근로자의 수면문제에 따른 생산\n성 시간 손실.  신경정신의학, 50(1), 62-68.\n\n - - 120 -\n- 18. ",
        "original_sentence": "(2011). "
      }
    },
    {
      "chunk_id": "chunk_973",
      "text": "근로자의 수면문제에 따른 생산\n성 시간 손실. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 972,
        "window_size": 3,
        "char_count": 26,
        "word_count": 7,
        "page_number": 46,
        "window_text": "경기도 수면산업 (Sleep Industry) 육성을 위한 실태조사 및\n- 17.  우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠.  (2011).  근로자의 수면문제에 따른 생산\n성 시간 손실.  신경정신의학, 50(1), 62-68.\n\n - - 120 -\n- 18.  Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D. ",
        "original_sentence": "근로자의 수면문제에 따른 생산\n성 시간 손실. "
      }
    },
    {
      "chunk_id": "chunk_974",
      "text": "신경정신의학, 50(1), 62-68.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 973,
        "window_size": 3,
        "char_count": 23,
        "word_count": 3,
        "page_number": 9,
        "window_text": "우종민, 현소연, 이상학, 강승걸, 이진성, 김린, ... & 박두흠.  (2011).  근로자의 수면문제에 따른 생산\n성 시간 손실.  신경정신의학, 50(1), 62-68.\n\n - - 120 -\n- 18.  Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D.  (2006). ",
        "original_sentence": "신경정신의학, 50(1), 62-68.\n\n"
      }
    },
    {
      "chunk_id": "chunk_975",
      "text": "- - 120 -\n- 18. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 974,
        "window_size": 3,
        "char_count": 16,
        "word_count": 6,
        "page_number": 9,
        "window_text": "(2011).  근로자의 수면문제에 따른 생산\n성 시간 손실.  신경정신의학, 50(1), 62-68.\n\n - - 120 -\n- 18.  Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D.  (2006).  Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol. ",
        "original_sentence": "- - 120 -\n- 18. "
      }
    },
    {
      "chunk_id": "chunk_976",
      "text": "Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 975,
        "window_size": 3,
        "char_count": 57,
        "word_count": 11,
        "page_number": 127,
        "window_text": "근로자의 수면문제에 따른 생산\n성 시간 손실.  신경정신의학, 50(1), 62-68.\n\n - - 120 -\n- 18.  Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D.  (2006).  Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol.  1). ",
        "original_sentence": "Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D. "
      }
    },
    {
      "chunk_id": "chunk_977",
      "text": "(2006). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 976,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "신경정신의학, 50(1), 62-68.\n\n - - 120 -\n- 18.  Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D.  (2006).  Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol.  1).  Springer Science & Business Media.\n\n",
        "original_sentence": "(2006). "
      }
    },
    {
      "chunk_id": "chunk_978",
      "text": "Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 977,
        "window_size": 3,
        "char_count": 77,
        "word_count": 9,
        "page_number": 9,
        "window_text": "- - 120 -\n- 18.  Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D.  (2006).  Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol.  1).  Springer Science & Business Media.\n\n - 19. ",
        "original_sentence": "Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol. "
      }
    },
    {
      "chunk_id": "chunk_979",
      "text": "1). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 978,
        "window_size": 3,
        "char_count": 4,
        "word_count": 1,
        "page_number": 27,
        "window_text": "Perlis, M. L., Jungquist, C., Smith, M. T., & Posner, D.  (2006).  Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol.  1).  Springer Science & Business Media.\n\n - 19.  Jacobs, G. D. ",
        "original_sentence": "1). "
      }
    },
    {
      "chunk_id": "chunk_980",
      "text": "Springer Science & Business Media.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 979,
        "window_size": 3,
        "char_count": 36,
        "word_count": 5,
        "page_number": 127,
        "window_text": "(2006).  Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol.  1).  Springer Science & Business Media.\n\n - 19.  Jacobs, G. D.  (2009). ",
        "original_sentence": "Springer Science & Business Media.\n\n"
      }
    },
    {
      "chunk_id": "chunk_981",
      "text": "- 19. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 980,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 27,
        "window_text": "Cognitive behavioral treatment of\ninsomnia: A session-by-session guide (Vol.  1).  Springer Science & Business Media.\n\n - 19.  Jacobs, G. D.  (2009).  Say good night to insomnia: the six-week, drug-free program developed at\n- 20. ",
        "original_sentence": "- 19. "
      }
    },
    {
      "chunk_id": "chunk_982",
      "text": "Jacobs, G. D. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 981,
        "window_size": 3,
        "char_count": 14,
        "word_count": 3,
        "page_number": 127,
        "window_text": "1).  Springer Science & Business Media.\n\n - 19.  Jacobs, G. D.  (2009).  Say good night to insomnia: the six-week, drug-free program developed at\n- 20.  Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L. ",
        "original_sentence": "Jacobs, G. D. "
      }
    },
    {
      "chunk_id": "chunk_983",
      "text": "(2009). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 982,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Springer Science & Business Media.\n\n - 19.  Jacobs, G. D.  (2009).  Say good night to insomnia: the six-week, drug-free program developed at\n- 20.  Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L.  (2003). ",
        "original_sentence": "(2009). "
      }
    },
    {
      "chunk_id": "chunk_984",
      "text": "Say good night to insomnia: the six-week, drug-free program developed at\n- 20. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 983,
        "window_size": 3,
        "char_count": 79,
        "word_count": 13,
        "page_number": 49,
        "window_text": "- 19.  Jacobs, G. D.  (2009).  Say good night to insomnia: the six-week, drug-free program developed at\n- 20.  Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L.  (2003).  Primary insomnia: Diagnostic\nissues, treatment and future directions. ",
        "original_sentence": "Say good night to insomnia: the six-week, drug-free program developed at\n- 20. "
      }
    },
    {
      "chunk_id": "chunk_985",
      "text": "Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 984,
        "window_size": 3,
        "char_count": 60,
        "word_count": 12,
        "page_number": 73,
        "window_text": "Jacobs, G. D.  (2009).  Say good night to insomnia: the six-week, drug-free program developed at\n- 20.  Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L.  (2003).  Primary insomnia: Diagnostic\nissues, treatment and future directions.  In: Perlis ML, Lichstein KL. ",
        "original_sentence": "Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L. "
      }
    },
    {
      "chunk_id": "chunk_986",
      "text": "(2003). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 985,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "(2009).  Say good night to insomnia: the six-week, drug-free program developed at\n- 20.  Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L.  (2003).  Primary insomnia: Diagnostic\nissues, treatment and future directions.  In: Perlis ML, Lichstein KL.  Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine. ",
        "original_sentence": "(2003). "
      }
    },
    {
      "chunk_id": "chunk_987",
      "text": "Primary insomnia: Diagnostic\nissues, treatment and future directions. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 986,
        "window_size": 3,
        "char_count": 70,
        "word_count": 8,
        "page_number": 1,
        "window_text": "Say good night to insomnia: the six-week, drug-free program developed at\n- 20.  Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L.  (2003).  Primary insomnia: Diagnostic\nissues, treatment and future directions.  In: Perlis ML, Lichstein KL.  Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine.  1st ed. ",
        "original_sentence": "Primary insomnia: Diagnostic\nissues, treatment and future directions. "
      }
    },
    {
      "chunk_id": "chunk_988",
      "text": "In: Perlis ML, Lichstein KL. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 987,
        "window_size": 3,
        "char_count": 29,
        "word_count": 5,
        "page_number": 127,
        "window_text": "Smith, M. T., Smith, L. J., Nowakowski, S., & Perlis, M. L.  (2003).  Primary insomnia: Diagnostic\nissues, treatment and future directions.  In: Perlis ML, Lichstein KL.  Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine.  1st ed.  Hoboken: John Wiley & Sons, Inc,\n\n- 21. ",
        "original_sentence": "In: Perlis ML, Lichstein KL. "
      }
    },
    {
      "chunk_id": "chunk_989",
      "text": "Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 988,
        "window_size": 3,
        "char_count": 81,
        "word_count": 10,
        "page_number": 9,
        "window_text": "(2003).  Primary insomnia: Diagnostic\nissues, treatment and future directions.  In: Perlis ML, Lichstein KL.  Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine.  1st ed.  Hoboken: John Wiley & Sons, Inc,\n\n- 21.  의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22. ",
        "original_sentence": "Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine. "
      }
    },
    {
      "chunk_id": "chunk_990",
      "text": "1st ed. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 989,
        "window_size": 3,
        "char_count": 8,
        "word_count": 2,
        "page_number": 27,
        "window_text": "Primary insomnia: Diagnostic\nissues, treatment and future directions.  In: Perlis ML, Lichstein KL.  Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine.  1st ed.  Hoboken: John Wiley & Sons, Inc,\n\n- 21.  의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22.  의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23. ",
        "original_sentence": "1st ed. "
      }
    },
    {
      "chunk_id": "chunk_991",
      "text": "Hoboken: John Wiley & Sons, Inc,\n\n- 21. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 990,
        "window_size": 3,
        "char_count": 40,
        "word_count": 8,
        "page_number": 9,
        "window_text": "In: Perlis ML, Lichstein KL.  Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine.  1st ed.  Hoboken: John Wiley & Sons, Inc,\n\n- 21.  의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22.  의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23.  의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24. ",
        "original_sentence": "Hoboken: John Wiley & Sons, Inc,\n\n- 21. "
      }
    },
    {
      "chunk_id": "chunk_992",
      "text": "의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 991,
        "window_size": 3,
        "char_count": 61,
        "word_count": 15,
        "page_number": 43,
        "window_text": "Treating sleep disorders:\n\nprinciples and practice of Behavioral Sleep Medicine.  1st ed.  Hoboken: John Wiley & Sons, Inc,\n\n- 21.  의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22.  의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23.  의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24.  의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25. ",
        "original_sentence": "의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22. "
      }
    },
    {
      "chunk_id": "chunk_993",
      "text": "의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 992,
        "window_size": 3,
        "char_count": 48,
        "word_count": 8,
        "page_number": 9,
        "window_text": "1st ed.  Hoboken: John Wiley & Sons, Inc,\n\n- 21.  의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22.  의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23.  의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24.  의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25.  소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26. ",
        "original_sentence": "의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23. "
      }
    },
    {
      "chunk_id": "chunk_994",
      "text": "의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 993,
        "window_size": 3,
        "char_count": 48,
        "word_count": 8,
        "page_number": 9,
        "window_text": "Hoboken: John Wiley & Sons, Inc,\n\n- 21.  의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22.  의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23.  의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24.  의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25.  소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26.  디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27. ",
        "original_sentence": "의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24. "
      }
    },
    {
      "chunk_id": "chunk_995",
      "text": "의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 994,
        "window_size": 3,
        "char_count": 62,
        "word_count": 12,
        "page_number": 9,
        "window_text": "의료 분야 ICT 융합 제품·서비스의 보안 내재화를 위한 스마트의료 사이버 보안 가이드, 한국인터\n- 22.  의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23.  의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24.  의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25.  소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26.  디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27.  의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. ",
        "original_sentence": "의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25. "
      }
    },
    {
      "chunk_id": "chunk_996",
      "text": "소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 995,
        "window_size": 3,
        "char_count": 56,
        "word_count": 10,
        "page_number": 9,
        "window_text": "의료기기 소프트웨어 허가·심사 가이드라인, 식품의약품안전처, 2018.06\n- 23.  의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24.  의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25.  소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26.  디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27.  의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J.  (2018).\n",
        "original_sentence": "소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26. "
      }
    },
    {
      "chunk_id": "chunk_997",
      "text": "디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 996,
        "window_size": 3,
        "char_count": 53,
        "word_count": 10,
        "page_number": 9,
        "window_text": "의료기기 소프트웨어 밸리데이션 가이드라인, 식품의약품안전처, 2007.03\n- 24.  의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25.  소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26.  디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27.  의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J.  (2018).\n Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. ",
        "original_sentence": "디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27. "
      }
    },
    {
      "chunk_id": "chunk_998",
      "text": "의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 997,
        "window_size": 3,
        "char_count": 142,
        "word_count": 26,
        "page_number": 9,
        "window_text": "의료기기 소프트웨어 개발 산출물 작성 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 25.  소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26.  디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27.  의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J.  (2018).\n Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.  Sleep Medicine\n\n- 29. ",
        "original_sentence": "의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J. "
      }
    },
    {
      "chunk_id": "chunk_999",
      "text": "(2018).\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 998,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "소프트웨어 밸리데이션 규격 안내서, 디지털헬스케어 소프트웨어 시험평가센터, 2018.07\n- 26.  디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27.  의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J.  (2018).\n Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.  Sleep Medicine\n\n- 29.  Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B. ",
        "original_sentence": "(2018).\n"
      }
    },
    {
      "chunk_id": "chunk_1000",
      "text": "Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 999,
        "window_size": 3,
        "char_count": 82,
        "word_count": 11,
        "page_number": 9,
        "window_text": "디지털치료기기 허가 심사 가이드라인 민원인 안내서, 식품의약품안전처, 2020.08\n- 27.  의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J.  (2018).\n Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.  Sleep Medicine\n\n- 29.  Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B.  (2014). ",
        "original_sentence": "Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis. "
      }
    },
    {
      "chunk_id": "chunk_1001",
      "text": "Sleep Medicine\n\n- 29. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1000,
        "window_size": 3,
        "char_count": 22,
        "word_count": 4,
        "page_number": 9,
        "window_text": "의료기기 임상시험 관련 통계기법 가이드라인, 식품의약품안전처, 2010.08\n- 28. van Straten, A., van der Zweerde, T., Kleiboer, A., Cuijpers, P., Morin, C. M., & Lancee, J.  (2018).\n Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.  Sleep Medicine\n\n- 29.  Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B.  (2014).  Benzodiazepine use and risk of Alzheimer's disease: case-control study. ",
        "original_sentence": "Sleep Medicine\n\n- 29. "
      }
    },
    {
      "chunk_id": "chunk_1002",
      "text": "Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1001,
        "window_size": 3,
        "char_count": 112,
        "word_count": 19,
        "page_number": 127,
        "window_text": "(2018).\n Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.  Sleep Medicine\n\n- 29.  Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B.  (2014).  Benzodiazepine use and risk of Alzheimer's disease: case-control study.  BMJ\n\n- 30. ",
        "original_sentence": "Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B. "
      }
    },
    {
      "chunk_id": "chunk_1003",
      "text": "(2014). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1002,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Cognitive and behavioral therapies in the treatment of insomnia: A meta-analysis.  Sleep Medicine\n\n- 29.  Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B.  (2014).  Benzodiazepine use and risk of Alzheimer's disease: case-control study.  BMJ\n\n- 30.  Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. ",
        "original_sentence": "(2014). "
      }
    },
    {
      "chunk_id": "chunk_1004",
      "text": "Benzodiazepine use and risk of Alzheimer's disease: case-control study. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1003,
        "window_size": 3,
        "char_count": 72,
        "word_count": 9,
        "page_number": 64,
        "window_text": "Sleep Medicine\n\n- 29.  Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B.  (2014).  Benzodiazepine use and risk of Alzheimer's disease: case-control study.  BMJ\n\n- 30.  Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.  (2004). ",
        "original_sentence": "Benzodiazepine use and risk of Alzheimer's disease: case-control study. "
      }
    },
    {
      "chunk_id": "chunk_1005",
      "text": "BMJ\n\n- 30. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1004,
        "window_size": 3,
        "char_count": 11,
        "word_count": 3,
        "page_number": 28,
        "window_text": "Billioti de Gage, S., Moride, Y., Ducruet, T., Kurth, T., Verdoux, H., Tournier, M., Pariente, A., &\nBégaud, B.  (2014).  Benzodiazepine use and risk of Alzheimer's disease: case-control study.  BMJ\n\n- 30.  Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.  (2004).  Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. ",
        "original_sentence": "BMJ\n\n- 30. "
      }
    },
    {
      "chunk_id": "chunk_1006",
      "text": "Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1005,
        "window_size": 3,
        "char_count": 64,
        "word_count": 12,
        "page_number": 49,
        "window_text": "(2014).  Benzodiazepine use and risk of Alzheimer's disease: case-control study.  BMJ\n\n- 30.  Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.  (2004).  Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Archives of\n\n- 31. ",
        "original_sentence": "Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W. "
      }
    },
    {
      "chunk_id": "chunk_1007",
      "text": "(2004). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1006,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Benzodiazepine use and risk of Alzheimer's disease: case-control study.  BMJ\n\n- 30.  Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.  (2004).  Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Archives of\n\n- 31.  Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n",
        "original_sentence": "(2004). "
      }
    },
    {
      "chunk_id": "chunk_1008",
      "text": "Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1007,
        "window_size": 3,
        "char_count": 114,
        "word_count": 14,
        "page_number": 9,
        "window_text": "BMJ\n\n- 30.  Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.  (2004).  Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Archives of\n\n- 31.  Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n - (2011). ",
        "original_sentence": "Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison. "
      }
    },
    {
      "chunk_id": "chunk_1009",
      "text": "Archives of\n\n- 31. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1008,
        "window_size": 3,
        "char_count": 19,
        "word_count": 4,
        "page_number": 27,
        "window_text": "Jacobs, G. D., Pace-Schott, E. F., Stickgold, R., & Otto, M. W.  (2004).  Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Archives of\n\n- 31.  Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n - (2011).  Chronic insomnia: clinical and research challenges--an agenda. ",
        "original_sentence": "Archives of\n\n- 31. "
      }
    },
    {
      "chunk_id": "chunk_1010",
      "text": "Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1009,
        "window_size": 3,
        "char_count": 102,
        "word_count": 16,
        "page_number": 127,
        "window_text": "(2004).  Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Archives of\n\n- 31.  Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n - (2011).  Chronic insomnia: clinical and research challenges--an agenda.  Pharmacopsychiatry, 44(1), 1–\n- 32. ",
        "original_sentence": "Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n"
      }
    },
    {
      "chunk_id": "chunk_1011",
      "text": "- (2011). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1010,
        "window_size": 3,
        "char_count": 10,
        "word_count": 2,
        "page_number": 9,
        "window_text": "Cognitive behavior therapy\nand pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Archives of\n\n- 31.  Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n - (2011).  Chronic insomnia: clinical and research challenges--an agenda.  Pharmacopsychiatry, 44(1), 1–\n- 32.  Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. ",
        "original_sentence": "- (2011). "
      }
    },
    {
      "chunk_id": "chunk_1012",
      "text": "Chronic insomnia: clinical and research challenges--an agenda. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1011,
        "window_size": 3,
        "char_count": 63,
        "word_count": 7,
        "page_number": 127,
        "window_text": "Archives of\n\n- 31.  Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n - (2011).  Chronic insomnia: clinical and research challenges--an agenda.  Pharmacopsychiatry, 44(1), 1–\n- 32.  Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E.  (2001). ",
        "original_sentence": "Chronic insomnia: clinical and research challenges--an agenda. "
      }
    },
    {
      "chunk_id": "chunk_1013",
      "text": "Pharmacopsychiatry, 44(1), 1–\n- 32. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1012,
        "window_size": 3,
        "char_count": 36,
        "word_count": 5,
        "page_number": 9,
        "window_text": "Riemann, D., Spiegelhalder, K., Espie, C., Pollmächer, T., Léger, D., Bassetti, C., & van Someren, E.\n - (2011).  Chronic insomnia: clinical and research challenges--an agenda.  Pharmacopsychiatry, 44(1), 1–\n- 32.  Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E.  (2001).  Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?. ",
        "original_sentence": "Pharmacopsychiatry, 44(1), 1–\n- 32. "
      }
    },
    {
      "chunk_id": "chunk_1014",
      "text": "Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1013,
        "window_size": 3,
        "char_count": 82,
        "word_count": 16,
        "page_number": 127,
        "window_text": "- (2011).  Chronic insomnia: clinical and research challenges--an agenda.  Pharmacopsychiatry, 44(1), 1–\n- 32.  Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E.  (2001).  Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  Sleep, 24(5), 591–599.\n\n",
        "original_sentence": "Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E. "
      }
    },
    {
      "chunk_id": "chunk_1015",
      "text": "(2001). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1014,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Chronic insomnia: clinical and research challenges--an agenda.  Pharmacopsychiatry, 44(1), 1–\n- 32.  Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E.  (2001).  Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  Sleep, 24(5), 591–599.\n\n - 33. ",
        "original_sentence": "(2001). "
      }
    },
    {
      "chunk_id": "chunk_1016",
      "text": "Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1015,
        "window_size": 3,
        "char_count": 85,
        "word_count": 9,
        "page_number": 9,
        "window_text": "Pharmacopsychiatry, 44(1), 1–\n- 32.  Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E.  (2001).  Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  Sleep, 24(5), 591–599.\n\n - 33.  Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M. ",
        "original_sentence": "Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?. "
      }
    },
    {
      "chunk_id": "chunk_1017",
      "text": "Sleep, 24(5), 591–599.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1016,
        "window_size": 3,
        "char_count": 24,
        "word_count": 3,
        "page_number": 9,
        "window_text": "Edinger, J. D., Wohlgemuth, W. K., Radtke, R. A., Marsh, G. R., & Quillian, R. E.  (2001).  Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  Sleep, 24(5), 591–599.\n\n - 33.  Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M.  (2018). ",
        "original_sentence": "Sleep, 24(5), 591–599.\n\n"
      }
    },
    {
      "chunk_id": "chunk_1018",
      "text": "- 33. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1017,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 28,
        "window_text": "(2001).  Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  Sleep, 24(5), 591–599.\n\n - 33.  Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M.  (2018).  Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34. ",
        "original_sentence": "- 33. "
      }
    },
    {
      "chunk_id": "chunk_1019",
      "text": "Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1018,
        "window_size": 3,
        "char_count": 118,
        "word_count": 21,
        "page_number": 127,
        "window_text": "Does\ncognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  Sleep, 24(5), 591–599.\n\n - 33.  Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M.  (2018).  Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34.  Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K. ",
        "original_sentence": "Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M. "
      }
    },
    {
      "chunk_id": "chunk_1020",
      "text": "(2018). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1019,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Sleep, 24(5), 591–599.\n\n - 33.  Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M.  (2018).  Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34.  Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K.  (2017). ",
        "original_sentence": "(2018). "
      }
    },
    {
      "chunk_id": "chunk_1021",
      "text": "Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1020,
        "window_size": 3,
        "char_count": 80,
        "word_count": 13,
        "page_number": 9,
        "window_text": "- 33.  Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M.  (2018).  Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34.  Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K.  (2017).  Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'. ",
        "original_sentence": "Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34. "
      }
    },
    {
      "chunk_id": "chunk_1022",
      "text": "Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1021,
        "window_size": 3,
        "char_count": 124,
        "word_count": 21,
        "page_number": 127,
        "window_text": "Chow, P. I., Ingersoll, K. S., Thorndike, F. P., Lord, H. R., Gonder-Frederick, L., Morin, C. M., &\nRitterband, L. M.  (2018).  Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34.  Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K.  (2017).  Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.  BMJ Open, 7(7),\n\n- 35. ",
        "original_sentence": "Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K. "
      }
    },
    {
      "chunk_id": "chunk_1023",
      "text": "(2017). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1022,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "(2018).  Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34.  Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K.  (2017).  Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.  BMJ Open, 7(7),\n\n- 35.  Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. ",
        "original_sentence": "(2017). "
      }
    },
    {
      "chunk_id": "chunk_1024",
      "text": "Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1023,
        "window_size": 3,
        "char_count": 240,
        "word_count": 32,
        "page_number": 49,
        "window_text": "Cognitive mechanisms of sleep outcomes in a randomized clinical trial of\n\n- 34.  Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K.  (2017).  Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.  BMJ Open, 7(7),\n\n- 35.  Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S.  (2012).\n",
        "original_sentence": "Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'. "
      }
    },
    {
      "chunk_id": "chunk_1025",
      "text": "BMJ Open, 7(7),\n\n- 35. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1024,
        "window_size": 3,
        "char_count": 23,
        "word_count": 5,
        "page_number": 28,
        "window_text": "Elison, S., Ward, J., Williams, C., Espie, C., Davies, G., Dugdale, S., Ragan, K., Chisnall, L.,\nLidbetter, N., & Smith, K.  (2017).  Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.  BMJ Open, 7(7),\n\n- 35.  Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S.  (2012).\n A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36. ",
        "original_sentence": "BMJ Open, 7(7),\n\n- 35. "
      }
    },
    {
      "chunk_id": "chunk_1026",
      "text": "Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1025,
        "window_size": 3,
        "char_count": 95,
        "word_count": 20,
        "page_number": 84,
        "window_text": "(2017).  Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.  BMJ Open, 7(7),\n\n- 35.  Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S.  (2012).\n A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36.  Morin, C. M. ",
        "original_sentence": "Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S. "
      }
    },
    {
      "chunk_id": "chunk_1027",
      "text": "(2012).\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1026,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Feasibility of a UK community-based, eTherapy mental health\n\nservice in Greater Manchester: repeated-measures and between-groups study of 'Living Life to the\n\nFull Interactive', 'Sleepio' and 'Breaking Free Online' at 'Self Help Services'.  BMJ Open, 7(7),\n\n- 35.  Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S.  (2012).\n A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36.  Morin, C. M.  (1993). ",
        "original_sentence": "(2012).\n"
      }
    },
    {
      "chunk_id": "chunk_1028",
      "text": "A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1027,
        "window_size": 3,
        "char_count": 106,
        "word_count": 14,
        "page_number": 18,
        "window_text": "BMJ Open, 7(7),\n\n- 35.  Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S.  (2012).\n A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36.  Morin, C. M.  (1993).  Insomnia Severity Index.\n",
        "original_sentence": "A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36. "
      }
    },
    {
      "chunk_id": "chunk_1029",
      "text": "Morin, C. M. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1028,
        "window_size": 3,
        "char_count": 13,
        "word_count": 3,
        "page_number": 126,
        "window_text": "Espie, C. A., Kyle, S. D., Williams, C., Ong, J. C., Douglas, N. J., Hames, P., & Brown, J. S.  (2012).\n A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36.  Morin, C. M.  (1993).  Insomnia Severity Index.\n - 37. ",
        "original_sentence": "Morin, C. M. "
      }
    },
    {
      "chunk_id": "chunk_1030",
      "text": "(1993). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1029,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 27,
        "window_text": "(2012).\n A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36.  Morin, C. M.  (1993).  Insomnia Severity Index.\n - 37.  Johns M. W. ",
        "original_sentence": "(1993). "
      }
    },
    {
      "chunk_id": "chunk_1031",
      "text": "Insomnia Severity Index.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1030,
        "window_size": 3,
        "char_count": 25,
        "word_count": 3,
        "page_number": 127,
        "window_text": "A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia\n\n- 36.  Morin, C. M.  (1993).  Insomnia Severity Index.\n - 37.  Johns M. W.  (1991). ",
        "original_sentence": "Insomnia Severity Index.\n"
      }
    },
    {
      "chunk_id": "chunk_1032",
      "text": "- 37. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1031,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 28,
        "window_text": "Morin, C. M.  (1993).  Insomnia Severity Index.\n - 37.  Johns M. W.  (1991).  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n",
        "original_sentence": "- 37. "
      }
    },
    {
      "chunk_id": "chunk_1033",
      "text": "Johns M. W. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1032,
        "window_size": 3,
        "char_count": 12,
        "word_count": 3,
        "page_number": 127,
        "window_text": "(1993).  Insomnia Severity Index.\n - 37.  Johns M. W.  (1991).  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n - - 121 -\nSleep, 14(6), 540–545.\n\n",
        "original_sentence": "Johns M. W. "
      }
    },
    {
      "chunk_id": "chunk_1034",
      "text": "(1991). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1033,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 27,
        "window_text": "Insomnia Severity Index.\n - 37.  Johns M. W.  (1991).  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n - - 121 -\nSleep, 14(6), 540–545.\n\n - 38. ",
        "original_sentence": "(1991). "
      }
    },
    {
      "chunk_id": "chunk_1035",
      "text": "A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1034,
        "window_size": 3,
        "char_count": 77,
        "word_count": 11,
        "page_number": 127,
        "window_text": "- 37.  Johns M. W.  (1991).  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n - - 121 -\nSleep, 14(6), 540–545.\n\n - 38.  Morin, C. M., Vallières, A., & Ivers, H. ",
        "original_sentence": "A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n"
      }
    },
    {
      "chunk_id": "chunk_1036",
      "text": "- - 121 -\nSleep, 14(6), 540–545.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1035,
        "window_size": 3,
        "char_count": 34,
        "word_count": 7,
        "page_number": 9,
        "window_text": "Johns M. W.  (1991).  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n - - 121 -\nSleep, 14(6), 540–545.\n\n - 38.  Morin, C. M., Vallières, A., & Ivers, H.  (2007). ",
        "original_sentence": "- - 121 -\nSleep, 14(6), 540–545.\n\n"
      }
    },
    {
      "chunk_id": "chunk_1037",
      "text": "- 38. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1036,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 28,
        "window_text": "(1991).  A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n - - 121 -\nSleep, 14(6), 540–545.\n\n - 38.  Morin, C. M., Vallières, A., & Ivers, H.  (2007).  Dysfunctional beliefs and attitudes about sleep\n- 39. ",
        "original_sentence": "- 38. "
      }
    },
    {
      "chunk_id": "chunk_1038",
      "text": "Morin, C. M., Vallières, A., & Ivers, H. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1037,
        "window_size": 3,
        "char_count": 41,
        "word_count": 8,
        "page_number": 128,
        "window_text": "A new method for measuring daytime sleepiness: the Epworth sleepiness scale.\n - - 121 -\nSleep, 14(6), 540–545.\n\n - 38.  Morin, C. M., Vallières, A., & Ivers, H.  (2007).  Dysfunctional beliefs and attitudes about sleep\n- 39.  Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA. ",
        "original_sentence": "Morin, C. M., Vallières, A., & Ivers, H. "
      }
    },
    {
      "chunk_id": "chunk_1039",
      "text": "(2007). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1038,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "- - 121 -\nSleep, 14(6), 540–545.\n\n - 38.  Morin, C. M., Vallières, A., & Ivers, H.  (2007).  Dysfunctional beliefs and attitudes about sleep\n- 39.  Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA.  Polysomnography for the\n- 40. ",
        "original_sentence": "(2007). "
      }
    },
    {
      "chunk_id": "chunk_1040",
      "text": "Dysfunctional beliefs and attitudes about sleep\n- 39. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1039,
        "window_size": 3,
        "char_count": 54,
        "word_count": 8,
        "page_number": 49,
        "window_text": "- 38.  Morin, C. M., Vallières, A., & Ivers, H.  (2007).  Dysfunctional beliefs and attitudes about sleep\n- 39.  Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA.  Polysomnography for the\n- 40.  Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B. ",
        "original_sentence": "Dysfunctional beliefs and attitudes about sleep\n- 39. "
      }
    },
    {
      "chunk_id": "chunk_1041",
      "text": "Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1040,
        "window_size": 3,
        "char_count": 70,
        "word_count": 11,
        "page_number": 9,
        "window_text": "Morin, C. M., Vallières, A., & Ivers, H.  (2007).  Dysfunctional beliefs and attitudes about sleep\n- 39.  Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA.  Polysomnography for the\n- 40.  Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B.  (2003). ",
        "original_sentence": "Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA. "
      }
    },
    {
      "chunk_id": "chunk_1042",
      "text": "Polysomnography for the\n- 40. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1041,
        "window_size": 3,
        "char_count": 30,
        "word_count": 5,
        "page_number": 35,
        "window_text": "(2007).  Dysfunctional beliefs and attitudes about sleep\n- 39.  Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA.  Polysomnography for the\n- 40.  Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B.  (2003).  The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n",
        "original_sentence": "Polysomnography for the\n- 40. "
      }
    },
    {
      "chunk_id": "chunk_1043",
      "text": "Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1042,
        "window_size": 3,
        "char_count": 190,
        "word_count": 37,
        "page_number": 128,
        "window_text": "Dysfunctional beliefs and attitudes about sleep\n- 39.  Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA.  Polysomnography for the\n- 40.  Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B.  (2003).  The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n - 41. ",
        "original_sentence": "Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B. "
      }
    },
    {
      "chunk_id": "chunk_1044",
      "text": "(2003). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1043,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 9,
        "window_text": "Robertson, Marshall & Carno (2014) Robertson B, Marshall B, Carno MA.  Polysomnography for the\n- 40.  Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B.  (2003).  The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n - 41.  Beck AT, Epstein N, Brown G, Steer RA. ",
        "original_sentence": "(2003). "
      }
    },
    {
      "chunk_id": "chunk_1045",
      "text": "The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1044,
        "window_size": 3,
        "char_count": 191,
        "word_count": 23,
        "page_number": 27,
        "window_text": "Polysomnography for the\n- 40.  Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B.  (2003).  The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n - 41.  Beck AT, Epstein N, Brown G, Steer RA.  An inventory for measuring clinical anxiety: psychometric\n- 42. ",
        "original_sentence": "The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n"
      }
    },
    {
      "chunk_id": "chunk_1046",
      "text": "- 41. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1045,
        "window_size": 3,
        "char_count": 6,
        "word_count": 2,
        "page_number": 27,
        "window_text": "Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J.\nC., Ninan, P. T., Kornstein, S., Manber, R., Thase, M. E., Kocsis, J. H., & Keller, M. B.  (2003).  The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n - 41.  Beck AT, Epstein N, Brown G, Steer RA.  An inventory for measuring clinical anxiety: psychometric\n- 42.  Jenkinson, C., Coulter, A., & Wright, L. ",
        "original_sentence": "- 41. "
      }
    },
    {
      "chunk_id": "chunk_1047",
      "text": "Beck AT, Epstein N, Brown G, Steer RA. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1046,
        "window_size": 3,
        "char_count": 39,
        "word_count": 8,
        "page_number": 73,
        "window_text": "(2003).  The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n - 41.  Beck AT, Epstein N, Brown G, Steer RA.  An inventory for measuring clinical anxiety: psychometric\n- 42.  Jenkinson, C., Coulter, A., & Wright, L.  (1993). ",
        "original_sentence": "Beck AT, Epstein N, Brown G, Steer RA. "
      }
    },
    {
      "chunk_id": "chunk_1048",
      "text": "An inventory for measuring clinical anxiety: psychometric\n- 42. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1047,
        "window_size": 3,
        "char_count": 64,
        "word_count": 9,
        "page_number": 128,
        "window_text": "The\n\n16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and\n\nself-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression.\n\n - 41.  Beck AT, Epstein N, Brown G, Steer RA.  An inventory for measuring clinical anxiety: psychometric\n- 42.  Jenkinson, C., Coulter, A., & Wright, L.  (1993).  Short form 36 (SF36) health survey questionnaire:\n- 43. ",
        "original_sentence": "An inventory for measuring clinical anxiety: psychometric\n- 42. "
      }
    },
    {
      "chunk_id": "chunk_1049",
      "text": "Jenkinson, C., Coulter, A., & Wright, L. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1048,
        "window_size": 3,
        "char_count": 41,
        "word_count": 7,
        "page_number": 128,
        "window_text": "- 41.  Beck AT, Epstein N, Brown G, Steer RA.  An inventory for measuring clinical anxiety: psychometric\n- 42.  Jenkinson, C., Coulter, A., & Wright, L.  (1993).  Short form 36 (SF36) health survey questionnaire:\n- 43.  Reilly MC, Zbrozek AS, Dukes EM. ",
        "original_sentence": "Jenkinson, C., Coulter, A., & Wright, L. "
      }
    },
    {
      "chunk_id": "chunk_1050",
      "text": "(1993). ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1049,
        "window_size": 3,
        "char_count": 8,
        "word_count": 1,
        "page_number": 27,
        "window_text": "Beck AT, Epstein N, Brown G, Steer RA.  An inventory for measuring clinical anxiety: psychometric\n- 42.  Jenkinson, C., Coulter, A., & Wright, L.  (1993).  Short form 36 (SF36) health survey questionnaire:\n- 43.  Reilly MC, Zbrozek AS, Dukes EM.  The validity and reproducibility of a work productivity and\n- 44. ",
        "original_sentence": "(1993). "
      }
    },
    {
      "chunk_id": "chunk_1051",
      "text": "Short form 36 (SF36) health survey questionnaire:\n- 43. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1050,
        "window_size": 3,
        "char_count": 56,
        "word_count": 9,
        "page_number": 28,
        "window_text": "An inventory for measuring clinical anxiety: psychometric\n- 42.  Jenkinson, C., Coulter, A., & Wright, L.  (1993).  Short form 36 (SF36) health survey questionnaire:\n- 43.  Reilly MC, Zbrozek AS, Dukes EM.  The validity and reproducibility of a work productivity and\n- 44.  한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -",
        "original_sentence": "Short form 36 (SF36) health survey questionnaire:\n- 43. "
      }
    },
    {
      "chunk_id": "chunk_1052",
      "text": "Reilly MC, Zbrozek AS, Dukes EM. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1051,
        "window_size": 3,
        "char_count": 33,
        "word_count": 6,
        "page_number": 128,
        "window_text": "Jenkinson, C., Coulter, A., & Wright, L.  (1993).  Short form 36 (SF36) health survey questionnaire:\n- 43.  Reilly MC, Zbrozek AS, Dukes EM.  The validity and reproducibility of a work productivity and\n- 44.  한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -",
        "original_sentence": "Reilly MC, Zbrozek AS, Dukes EM. "
      }
    },
    {
      "chunk_id": "chunk_1053",
      "text": "The validity and reproducibility of a work productivity and\n- 44. ",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1052,
        "window_size": 3,
        "char_count": 66,
        "word_count": 11,
        "page_number": 64,
        "window_text": "(1993).  Short form 36 (SF36) health survey questionnaire:\n- 43.  Reilly MC, Zbrozek AS, Dukes EM.  The validity and reproducibility of a work productivity and\n- 44.  한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -",
        "original_sentence": "The validity and reproducibility of a work productivity and\n- 44. "
      }
    },
    {
      "chunk_id": "chunk_1054",
      "text": "한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -",
      "metadata": {
        "source": "불면증+개선+디지털치료기기+안전성·성능+평가+및+임상시험계획서+작성+가이드라인(민원인+안내서).pdf",
        "chunk_index": 1053,
        "window_size": 3,
        "char_count": 361,
        "word_count": 91,
        "page_number": 130,
        "window_text": "Short form 36 (SF36) health survey questionnaire:\n- 43.  Reilly MC, Zbrozek AS, Dukes EM.  The validity and reproducibility of a work productivity and\n- 44.  한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -",
        "original_sentence": "한국보건의료연구원(2011), 보건의료분야에서 비용 산출 방법\n- - 122 -\n[증례기록서 예시]\n\n- - 123 -\n<!-- PAGE_130 -->\n##### Case Report Form 작성 지침\n\n- - 124 -\n**[표 시작]**\n\n**치료 기간 종료**\n\n**[표 끝]**\n\n이메일, 문자, SNS\n\n- - 125 -\n◈ 방문 1 (스크리닝 및 검사일)\n\n- - 126 -\n◈ 무작위 번호\n\n◈ 임상시험 검사\n\n◈ 이상 반응\n\n- - 127 -\n◈ 임상시험 완료 평가\n\n- - 128 -\n[이상반응 서식지 예시]\n\n- - 129 -\n<!-- PAGE_136 -->\n##### SPECIAL FORM 이상반응서식지\n\n- - 130 -"
      }
    }
  ],
  "chunking_analysis": {
    "total_chunks": 1054,
    "avg_chunk_length": 95.9933586337761,
    "min_chunk_length": 3,
    "max_chunk_length": 1332,
    "total_characters": 101177,
    "total_words": 23568,
    "window_size": 3
  },
  "statistics": {
    "total_text_blocks": 4083,
    "heading_count": 50,
    "paragraph_count": 1328,
    "list_item_count": 406,
    "table_cell_count": 2299,
    "tables_detected": 23,
    "chunks_generated": 1054
  }
}